PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kjer-Nielsen, L; Patel, O; Corbett, AJ; Le Nours, J; Meehan, B; Liu, LG; Bhati, M; Chen, ZJ; Kostenko, L; Reantragoon, R; Williamson, NA; Purcell, AW; Dudek, NL; McConville, MJ; O'Hair, RAJ; Khairallah, GN; Godfrey, DI; Fairlie, DP; Rossjohn, J; McCluskey, J				Kjer-Nielsen, Lars; Patel, Onisha; Corbett, Alexandra J.; Le Nours, Jerome; Meehan, Bronwyn; Liu, Ligong; Bhati, Mugdha; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.; O'Hair, Richard A. J.; Khairallah, George N.; Godfrey, Dale I.; Fairlie, David P.; Rossjohn, Jamie; McCluskey, James			MR1 presents microbial vitamin B metabolites to MAIT cells	NATURE			English	Article							INVARIANT T-CELLS; CRYSTAL-STRUCTURE; ANTIGEN PRESENTATION; SELECTION	Antigen-presenting molecules, encoded by the major histocompatibility complex (MHC) and CD1 family, bind peptide- and lipid-based antigens, respectively, for recognition by T cells. Mucosal-associated invariant T (MAIT) cells are an abundant population of innate-like T cells in humans that are activated by an antigen(s) bound to the MHC class I-like molecule MR1. Although the identity of MR1-restricted antigen(s) is unknown, it is present in numerous bacteria and yeast. Here we show that the structure and chemistry within the antigen-binding cleft of MR1 is distinct from the MHC and CD1 families. MR1 is ideally suited to bind ligands originating from vitamin metabolites. The structure of MR1 in complex with 6-formyl pterin, a folic acid (vitamin B9) metabolite, shows the pterin ring sequestered within MR1. Furthermore, we characterize related MR1-restricted vitamin derivatives, originating from the bacterial riboflavin (vitamin B2) biosynthetic pathway, which specifically and potently activate MAIT cells. Accordingly, we show that metabolites of vitamin B represent a class of antigen that are presented by MR1 for MAIT-cell immunosurveillance. As many vitamin biosynthetic pathways are unique to bacteria and yeast, our data suggest that MAIT cells use these metabolites to detect microbial infection.	[Kjer-Nielsen, Lars; Corbett, Alexandra J.; Meehan, Bronwyn; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Patel, Onisha; Le Nours, Jerome; Bhati, Mugdha; Purcell, Anthony W.; Dudek, Nadine L.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Metabol Australia, Parkville, Vic 3010, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Metabol Australia, Parkville, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, ARC Ctr Excellence Free Radical Chem & Biotechnol, Melbourne, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; Monash University; University of Queensland; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Cardiff University	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019; Fairlie, David P/F-8865-2014; liu, ligong/B-1690-2010; McCluskey, James/A-1291-2007; Corbett, Alexandra/A-1225-2019	Williamson, Nicholas A/0000-0002-2173-3452; Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Fairlie, David P/0000-0002-7856-8566; liu, ligong/0000-0002-2693-1896; McCluskey, James/0000-0002-8597-815X; Corbett, Alexandra/0000-0003-1618-4337; Le Nours, Jerome/0000-0002-2221-7636; Meehan, Bronwyn/0000-0001-7368-2979; Khairallah, George/0000-0002-3359-8358; Patel, Onisha/0000-0001-6701-7139; Godfrey, Dale/0000-0002-3009-5472; O'Hair, Richard/0000-0002-8044-0502; Kostenko, Lyudmila/0000-0002-8466-7966	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank R. Strugnell, T. Stinear, T. Mulhern, P. O'Donnell, J. Pyke, T. Rupasinghe, D. L. Tull, J. Ralton, L. Foster, S. H. Ramarathinam, M. Bharadwaj, D. Pellicci and K. Wun for discussions and technical advice, T. Hansen for the anti-MR1 monoclonal antibody and the staff of the Australian Synchrotron for assistance with data collection. This research was supported by the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council. O.P. was supported by an ARC Future Fellowship; A.W.P. by an NHMRC Senior Research Fellowship; M.J.M. by a NHMRC Principal Research Fellowship; D.I.G. and D.P.F. were supported by NHMRC Senior Principal Research Fellowships; J. R. was supported by an NHMRC Australia Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bricogne G., 2011, AUTOBUSTER V 1 6 0; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, NAT IMMUNOL, V11, P693, DOI 10.1038/ni0810-693; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goldfinch N, 2010, VET RES, V41, DOI 10.1051/vetres/2010034; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hee CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000557; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Off MK, 2005, J PHOTOCH PHOTOBIO B, V80, P47, DOI 10.1016/j.jphotobiol.2005.03.001; PLAUT GWE, 1974, ANNU REV BIOCHEM, V43, P899, DOI 10.1146/annurev.bi.43.070174.004343; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Shimamura M, 2007, EUR J IMMUNOL, V37, P1836, DOI 10.1002/eji.200636689; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432	42	833	870	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					717	+		10.1038/nature11605	http://dx.doi.org/10.1038/nature11605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23051753				2022-12-28	WOS:000311606000036
J	Mathew, R; Seiler, MP; Scanlon, ST; Mao, AP; Constantinides, MG; Bertozzi-Villa, C; Singer, JD; Bendelac, A				Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Singer, Jeffrey D.; Bendelac, Albert			BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs	NATURE			English	Article							UBIQUITIN LIGASE; PROMYELOCYTIC LEUKEMIA; NUCLEAR LAMINA; CHROMATIN; PROTEINS; GENES; MECHANISMS; REPRESSION; ADAPTERS; COMPLEX	The differentiation of several T- and B-cell effector programs in the immune system is directed by signature transcription factors that induce rapid epigenetic remodelling. Here we report that promyelocytic leukaemia zinc finger (PLZF), the BTB-zinc finger (BTB-ZF) transcription factor directing the innate-like effector program of natural killer T-cell thymocytes(1,2), is prominently associated with cullin 3 (CUL3), an E3 ubiquitin ligase previously shown to use BTB domain-containing proteins as adaptors for substrate binding(3-7). PLZF transports CUL3 to the nucleus, where the two proteins are associated within a chromatin-modifying complex. Furthermore, PLZF expression results in selective ubiquitination changes of several components of this complex. CUL3 was also found associated with the BTB-ZF transcription factor BCL6, which directs the germinal-centre B cell and follicular T-helper cell programs. Conditional CUL3 deletion in mice demonstrated an essential role for CUL3 in the development of PLZF- and BCL6-dependent lineages. We conclude that distinct lineage-specific BTB-ZF transcription factors recruit CUL3 to alter the ubiquitination pattern of their associated chromatin-modifying complex. We propose that this new function is essential to direct the differentiation of several T- and B-cell effector programs, and may also be involved in the oncogenic role of PLZF and BCL6 in leukaemias and lymphomas(8,9).	[Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Singer, Jeffrey D.] Portland State Univ, Dept Biol, Portland, OR 97207 USA	Howard Hughes Medical Institute; University of Chicago; Portland State University	Bendelac, A (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Mathew, Rebecca/H-7154-2013	Constantinides, Michael/0000-0003-4770-7751; Scanlon, Seth Thomas/0000-0002-1792-6382	National Institute of Health (NIH) [5RO1GM082940, RO1AI038339]; Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082940] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dinner, J. Licht, G. Prive, A. Ruthenburg, R. Sciammas, H. Singh and P. Wilson for discussions, J. C. Silva and M. Stokes for UbiScan analysis, C. Labno and V. Bindokas for help with confocal microscopy, and K. Block, L. Roach, D. Zabner, F. Meng and L. Bai for help with experiments. This work was supported by National Institute of Health (NIH) grants 5RO1GM082940 (J.D.S.) and RO1AI038339 (A.B.), and an Irvington Institute postdoctoral fellowship from the Cancer Research Institute (R.M.). A.B. is a Howard Hughes Medical Institute Investigator.	Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hyjek E, 2001, BLOOD, V97, P270, DOI 10.1182/blood.V97.1.270; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	33	77	83	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					619	+		10.1038/nature11548	http://dx.doi.org/10.1038/nature11548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086144	Green Accepted			2022-12-28	WOS:000311339800057
J	Aoudjehane, HC; Avice, G; Barrat, JA; Boudouma, O; Chen, G; Duke, MJM; Franchi, IA; Gattacceca, J; Grady, MM; Greenwood, RC; Herd, CDK; Hewins, R; Jambon, A; Marty, B; Rochette, P; Smith, CL; Sautter, V; Verchovsky, A; Weber, P; Zanda, B				Aoudjehane, H. Chennaoui; Avice, G.; Barrat, J. -A.; Boudouma, O.; Chen, G.; Duke, M. J. M.; Franchi, I. A.; Gattacceca, J.; Grady, M. M.; Greenwood, R. C.; Herd, C. D. K.; Hewins, R.; Jambon, A.; Marty, B.; Rochette, P.; Smith, C. L.; Sautter, V.; Verchovsky, A.; Weber, P.; Zanda, B.			Tissint Martian Meteorite: A Fresh Look at the Interior, Surface, and Atmosphere of Mars	SCIENCE			English	Article							SHERGOTTITES; GEOCHEMISTRY; CHEMISTRY; DAR-AL-GANI-476; NITROGEN; SYSTEM; GASES; HF	Tissint (Morocco) is the fifth martian meteorite collected after it was witnessed falling to Earth. Our integrated mineralogical, petrological, and geochemical study shows that it is a depleted picritic shergottite similar to EETA79001A. Highly magnesian olivine and abundant glass containing martian atmosphere are present in Tissint. Refractory trace element, sulfur, and fluorine data for the matrix and glass veins in the meteorite indicate the presence of a martian surface component. Thus, the influence of in situ martian weathering can be unambiguously distinguished from terrestrial contamination in this meteorite. Martian weathering features in Tissint are compatible with the results of spacecraft observations of Mars. Tissint has a cosmic-ray exposure age of 0.7 +/- 0.3 million years, consistent with those of many other shergottites, notably EETA79001, suggesting that they were ejected from Mars during the same event.	[Aoudjehane, H. Chennaoui] Hassan II Univ Casablanca, GAIA Lab, Fac Sci, Casablanca, Morocco; [Aoudjehane, H. Chennaoui; Boudouma, O.; Jambon, A.] Univ Paris 06, Inst Terre Paris, UMR 7193, F-75005 Paris, France; [Avice, G.; Marty, B.] Univ Lorraine, Ctr Rech Petrograph & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Barrat, J. -A.] Univ Bretagne Occidentale, Inst Univ Europeen Mer, UMR 6538, F-29280 Plouzane, France; [Chen, G.; Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Duke, M. J. M.] Univ Alberta, SLOWPOKE Nucl Reactor Facil, Edmonton, AB T6G 2J9, Canada; [Grady, M. M.; Greenwood, R. C.; Verchovsky, A.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Rochette, P.] Aix Marseille Univ, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence 4, France; [Grady, M. M.; Smith, C. L.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Hewins, R.; Sautter, V.; Zanda, B.] Museum Natl Hist Nat, Lab Etud Mat Extraterrestre, F-75005 Paris, France; [Hewins, R.; Sautter, V.; Zanda, B.] CNRS, UMS2679, F-75005 Paris, France; [Smith, C. L.] ESA European Space Agcy, European Space Res & Technol Ctr, NL-2200 AG Noordwijk, Netherlands; [Smith, C. L.] UK Space Agcy, ESA Harwell Ctr, Didcot OX11 0QX, Oxon, England; [Weber, P.] Univ Bern, Albert Einstein Ctr Fundamental Phys, CH-3012 Bern, Switzerland	Hassan II University of Casablanca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Alberta; University of Alberta; Open University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); European Space Agency; University of Bern	Aoudjehane, HC (corresponding author), Hassan II Univ Casablanca, GAIA Lab, Fac Sci, BP 5366 Maarif, Casablanca, Morocco.	chennaoui_h@yahoo.fr	Smith, Caroline/AAO-3652-2020; Rochette, Pierre/O-4612-2019; Gattacceca, Jerome/AAG-5651-2019; IMPMC, ROCKS @/U-8478-2017; Barrat, Jean-Alix/C-8416-2017; Zanda, Brigitte M/D-6787-2015	Smith, Caroline/0000-0001-7005-6470; Rochette, Pierre/0000-0002-7362-0660; Gattacceca, Jerome/0000-0002-1639-7140; Barrat, Jean-Alix/0000-0003-3158-3109; Zanda, Brigitte M/0000-0002-4210-7151; Grady, Monica/0000-0002-4055-533X; Chennaoui, Hasnaa/0000-0001-8792-246X; Avice, Guillaume/0000-0003-0962-0049; Herd, Christopher/0000-0001-5210-4002; Greenwood, Richard/0000-0002-5544-8027	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France [01/10]; Comite Mixte Inter Universitaire Franco-Marocain Volubilis [MA/11/252]; CRPG Nancy, France; CNES; CNRS; European Research Council under the European Community's Seventh Framework Programme [267255]; Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council; University of Alberta; Natural Sciences and Engineering Research Council of Canada [261740-03]; Science and Technology Facilities Council [ST/I002820/1, ST/I001964/1] Funding Source: researchfish; STFC [ST/I001964/1] Funding Source: UKRI	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France(Centre National de la Recherche Scientifique (CNRS)); Comite Mixte Inter Universitaire Franco-Marocain Volubilis; CRPG Nancy, France; CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council under the European Community's Seventh Framework Programme(European Commission); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); University of Alberta(University of Alberta); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge D. N. Menegas and family for their generous donation enabling the acquisition of Tissint (BM.2012,M1), M. Aoudjehane for fieldwork, A. Aaranson for field information, J. Gibson for assistance with oxygen isotope analysis, L. Labenne for loan of a sample, and A. Irving for 400 mg of powdered sample. This study was funded at Hassan II University Casablanca, Faculte des Sciences Ain Chock, by Centre de Recherches Scientifiques et Techniques Morocco and CNRS France (Projet International de Cooperation Scientifique, Sciences de l'Univers 01/10), and by Comite Mixte Inter Universitaire Franco-Marocain Volubilis (MA/11/252); CRPG Nancy, France, by the CNES, CNRS, and European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 no. 267255); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France, by the Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University, by Science and Technology Facilities Council grant to the Planetary and Space Sciences Discipline; and University of Alberta, by the Natural Sciences and Engineering Research Council of Canada (grant 261740-03).	ARVIDSON RE, 1989, REV GEOPHYS, V27, P39, DOI 10.1029/RG027i001p00039; Barrat JA, 2012, GEOCHIM COSMOCHIM AC, V83, P79, DOI 10.1016/j.gca.2011.12.011; Barrat JA, 2002, GEOCHIM COSMOCHIM AC, V66, P3505, DOI 10.1016/S0016-7037(02)00934-1; Barrat JA, 2001, METEORIT PLANET SCI, V36, P23, DOI 10.1111/j.1945-5100.2001.tb01807.x; Beck P, 2006, GEOCHIM COSMOCHIM AC, V70, P2127, DOI 10.1016/j.gca.2006.01.016; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Crozaz G, 2001, GEOCHIM COSMOCHIM AC, V65, P971, DOI 10.1016/S0016-7037(00)00586-X; Dreibus G, 2000, METEORIT PLANET SCI, V35, pA49; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; MARTI K, 1995, SCIENCE, V267, P1981, DOI 10.1126/science.7701319; Marty B, 2003, SPACE SCI REV, V106, P175, DOI 10.1023/A:1024689721371; Mittlefehldt DW, 2003, GEOCHIM COSMOCHIM AC, V67, P1911, DOI 10.1016/S0016-7037(02)01411-4; Neal C. R., 2001, LUNAR PLANET SCI, V32, P1671; Nier A. O., 1977, Journal of Geophysical Research, V82, P4341, DOI 10.1126/science.194.4271.1298; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Rao MN, 1999, GEOPHYS RES LETT, V26, P3265, DOI 10.1029/1999GL005388; Rochette P, 2005, METEORIT PLANET SCI, V40, P529, DOI 10.1111/j.1945-5100.2005.tb00961.x; Sautter V, 2002, EARTH PLANET SC LETT, V195, P223, DOI 10.1016/S0012-821X(01)00591-X; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Walton EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4829, DOI 10.1016/j.gca.2010.04.065	24	104	104	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					785	788		10.1126/science.1224514	http://dx.doi.org/10.1126/science.1224514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23065902				2022-12-28	WOS:000310839500040
J	Trivedi, TK; DeSalvo, T; Lee, L; Palumbo, A; Moll, M; Curns, A; Hall, AJ; Patel, M; Parashar, UD; Lopman, BA				Trivedi, Tarak K.; DeSalvo, Traci; Lee, Lore; Palumbo, Aimee; Moll, Maria; Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.			Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM-CARE FACILITIES; MINIMUM DATA SET; GASTROENTERITIS OUTBREAKS; RESIDENT ASSESSMENT; NORWALK VIRUS; UNITED-STATES; ENGLAND; SURVEILLANCE; OUTCOMES; DEATHS	Context Norovirus outbreaks are common among vulnerable, elderly populations in US nursing homes. Objectives To assess whether all-cause hospitalization and mortality rates are increased during norovirus outbreak vs nonoutbreak periods in nursing homes, and to identify factors associated with increased risk. Design, Setting, and Participants A retrospective cohort study of Medicare-certified nursing homes in Oregon, Wisconsin, and Pennsylvania that reported at least 1 confirmed or suspected norovirus outbreak to the Centers for Disease Control and Prevention's National Outbreak Reporting System (NORS), January 2009 to December 2010. Deaths and hospitalizations occurring among residents of these nursing homes were identified through the Medicare Minimum Data Set (MDS). Main Outcome Measures Rates of all-cause hospitalization and mortality during outbreak compared with nonoutbreak periods were estimated using a random-effects Poisson regression model controlling for background seasonality in both outcomes. Results The cohort consisted of 308 nursing homes that reported 407 norovirus outbreaks to NORS. Per MDS, 67 730 hospitalizations and 26 055 deaths occurred in these homes during the 2-year study. Hospitalization rates were 124.0 (95% CI, 119.4-129.1) vs 109.5 (95% CI, 108.6-110.3) hospitalizations per nursing home-year during outbreak vs nonoutbreak periods, yielding a seasonally adjusted rate ratio (RR) of 1.09 (95% CI, 1.05-1.14). Similarly, mortality rates were 53.7 (95% CI, 50.6-57.0) vs 41.9 (95% CI, 41.4-42.4) deaths per nursing home-year in outbreak vs nonoutbreak periods (seasonally adjusted RR, 1.11; 95% CI, 1.05-1.18). The increases in hospitalizations and mortality were concentrated in the first 2 weeks (week 0 and 1) and the initial week (week 0) of the outbreak, respectively. Homes with lower daily registered nurse (RN) hours per resident (<0.75) had increased mortality rates during norovirus outbreaks compared with baseline (RR, 1.26; 95% CI, 1.14-1.40), while no increased risk (RR, 1.03; 95% CI, 0.96-1.12) was observed in homes with higher daily RN hours per resident (P=.007 by likelihood ratio test); the increase in hospitalization rates did not show a similar pattern. Conclusion Norovirus outbreaks were associated with significant concurrent increases in all-cause hospitalization and mortality in nursing homes. JAMA. 2012;308(16):1668-1675 Published online October 18, 2012. doi:10.1001/jama.2012.14023 www.jama.com	[Trivedi, Tarak K.] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [DeSalvo, Traci] Wisconsin Dept Hlth Serv, Div Publ Hlth, Madison, WI USA; [Lee, Lore] Oregon Publ Hlth Div, Portland, OR USA; [Palumbo, Aimee; Moll, Maria] Div Infect Dis Epidemiol, Harrisburg, PA USA; [Palumbo, Aimee; Moll, Maria] Penn Dept Hlth, Harrisburg, PA 17108 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Trivedi, TK (corresponding author), Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, 1600 Clifton Rd NE,MS A34, Atlanta, GA 30333 USA.	ttrivedi@uchicago.edu	Trivedi, Tarak/S-9107-2019; Palumbo, Aimee/AAE-1762-2022	Trivedi, Tarak/0000-0003-3357-9525; Palumbo, Aimee/0000-0003-0769-6015	Centers for Disease Control and Prevention (CDC); Pfizer Inc.; CDC	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer Inc.(Pfizer); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Trivedi reports being a fellow of The CDC Experience, a 1-year fellowship for medical students in applied epidemiology at the Centers for Disease Control and Prevention (CDC) and made possible by a public/private partnership supported by a grant to the CDC Foundation from external medical affairs, Pfizer Inc. Ms DeSalvo reports receipt of a grant to the institution and travel support to the institution from the CDC; and travel/accommodations/meeting expenses unrelated to activities listed from the Association of Public Health Laboratories and the Council of State and Territorial Epidemiologists. The other authors report no disclosures.	Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Blaney DD, 2011, AM J INFECT CONTROL, V39, P296, DOI 10.1016/j.ajic.2010.10.010; Centers for Disease Control and Prevention, FLUV WEEKL INFL SURV; Centers for Medicare and Medicaid Services, NURS HOM DAT COMP; Centers for Medicare and Medicaid Services, NURS HOM COMP; Centers for Medicare & Medicaid Services, IMPR NURS HOM COMP C; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2000, GERONTOLOGIST, V40, P5; Harris JP, 2010, J HOSP INFECT, V74, P1, DOI 10.1016/j.jhin.2009.07.025; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Horn SD, 2005, AM J NURS, V105, P58, DOI 10.1097/00000446-200511000-00028; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; MacCannell T, 2011, INFECT CONT HOSP EP, V32, P939, DOI 10.1086/662025; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; Rosenthal NA, 2011, EPIDEMIOL INFECT, V139, P286, DOI 10.1017/S095026881000083X; Turcios RM, 2006, CLIN INFECT DIS, V42, P964, DOI 10.1086/500940; US Social Security Administration, COMP SOC SEC LAWS RE; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Wikswo M, 2012, INT C EM INF DIS ICE; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478	31	68	69	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1668	1675		10.1001/jama.2012.14023	http://dx.doi.org/10.1001/jama.2012.14023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028PI	23079758	Bronze			2022-12-28	WOS:000310434100021
J	Cohen, D				Cohen, Deborah			MEDICAL DEVICE REGULATION Faulty hip implant shows up failings of EU regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126	2	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 23	2012	345								e7163	10.1136/bmj.e7163	http://dx.doi.org/10.1136/bmj.e7163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MT	23092939				2022-12-28	WOS:000310427100008
J	Okada, S; Takarabe, S; Nogawa, S; Abe, T; Morishita, T; Mori, M; Nishida, J				Okada, Satoshi; Takarabe, Sakiko; Nogawa, Shigeru; Abe, Takato; Morishita, Tetsuo; Mori, Masahiro; Nishida, Jiro			Persistent hiccups followed by cardiorespiratory arrest	LANCET			English	Editorial Material							NEUROMYELITIS-OPTICA; INTRACTABLE HICCUP		[Okada, Satoshi; Nogawa, Shigeru; Abe, Takato; Morishita, Tetsuo; Nishida, Jiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Internal Med, Ichikawa 2728513, Japan; [Takarabe, Sakiko; Nishida, Jiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Gastroenterol, Ichikawa 2728513, Japan; [Mori, Masahiro] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan	Tokyo Dental College; Tokyo Dental College; Chiba University	Okada, S (corresponding author), Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Internal Med, 5-11-13 Sugano, Ichikawa 2728513, Japan.	sokada@tdc.ac.jp	Abe, Takato/L-8393-2013	Abe, Takato/0000-0002-4185-5254				Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Misu T, 2005, NEUROLOGY, V65, P1479, DOI 10.1212/01.wnl.0000183151.19351.82; Payne BR, 2005, J NEUROSURG, V102, P935, DOI 10.3171/jns.2005.102.5.0935; SOUADJIAN JV, 1968, POSTGRAD MED, V43, P72, DOI 10.1080/00325481.1968.11693139	5	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1444	1444		10.1016/S0140-6736(12)60900-3	http://dx.doi.org/10.1016/S0140-6736(12)60900-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	23084457				2022-12-28	WOS:000310196500035
J	Petersson, KD; McFaul, LW; Schroer, MD; Jung, M; Taylor, JM; Houck, AA; Petta, JR				Petersson, K. D.; McFaul, L. W.; Schroer, M. D.; Jung, M.; Taylor, J. M.; Houck, A. A.; Petta, J. R.			Circuit quantum electrodynamics with a spin qubit	NATURE			English	Article							DOTS; PHOTON	Electron spins trapped in quantum dots have been proposed as basic building blocks of a future quantum processor(1-3). Although fast, 180-picosecond, two-quantum-bit (two-qubit) operations can be realized using nearest-neighbour exchange coupling(4), a scalable, spin-based quantum computing architecture will almost certainly require long-range qubit interactions. Circuit quantum electrodynamics (cQED) allows spatially separated superconducting qubits to interact via a superconducting microwave cavity that acts as a 'quantum bus', making possible two-qubit entanglement and the implementation of simple quantum algorithms(5-7). Here we combine the cQED architecture with spin qubits by coupling an indium arsenide nanowire double quantum dot to a superconducting cavity(8,9). The architecture allows us to achieve a charge-cavity coupling rate of about 30 megahertz, consistent with coupling rates obtained in gallium arsenide quantum dots(10). Furthermore, the strong spin-orbit interaction of indium arsenide allows us to drive spin rotations electrically with a local gate electrode, and the charge-cavity interaction provides a measurement of the resulting spin dynamics. Our results demonstrate how the cQED architecture can be used as a sensitive probe of single-spin physics and that a spin-cavity coupling rate of about one megahertz is feasible, presenting the possibility of long-range spin coupling via superconducting microwave cavities.	[Petersson, K. D.; McFaul, L. W.; Schroer, M. D.; Jung, M.; Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Taylor, J. M.] Joint Quantum Inst NIST, College Pk, MD 20742 USA; [Houck, A. A.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Petta, J. R.] Princeton Univ, Princeton Inst Sci & Technol Mat PRISM, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu	Taylor, Jacob M/B-7826-2011; Petersson, Karl D/P-7209-2014; Taylor, Jacob/O-1670-2019; Petta, Jason R/J-6663-2013	Taylor, Jacob M/0000-0003-0493-5594; Petersson, Karl D/0000-0002-1012-7895; Taylor, Jacob/0000-0003-0493-5594; Petta, Jason R/0000-0002-6416-0789; Jung, Minkyung/0000-0003-1515-5913; Houck, Andrew/0000-0002-9788-5874	Alfred P. Sloan Foundation; David and Lucile Packard Foundation; US Army Research Office [W911NF-08-1-0189]; DARPA QuEST [HR0011-09-1-0007]; US National Science Foundation through the Princeton Center for Complex Materials [DMR-0819860]; US National Science Foundation through CAREER award [DMR-0846341]; ARO MURI [W911NF-09-1-0406]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US Army Research Office; DARPA QuEST(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Science Foundation through the Princeton Center for Complex Materials; US National Science Foundation through CAREER award; ARO MURI(MURI)	Research at Princeton University was supported by the Alfred P. Sloan Foundation, the David and Lucile Packard Foundation, US Army Research Office grant W911NF-08-1-0189, DARPA QuEST award HR0011-09-1-0007 and the US National Science Foundation through the Princeton Center for Complex Materials (DMR-0819860) and CAREER award DMR-0846341. J.M.T. acknowledges support from ARO MURI award W911NF-09-1-0406.	Amsuss R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060502; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Chen F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573824; Delbecq MR, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256804; Fasth C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266801; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Friesen M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230503; Golovach VN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165319; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Imamoglu A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.083602; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Kubo Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.220501; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; Petersson KD, 2010, NANO LETT, V10, P2789, DOI 10.1021/nl100663w; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Schroer MD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.176811; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster DI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140501; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Trif M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045434; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	30	335	337	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					380	383		10.1038/nature11559	http://dx.doi.org/10.1038/nature11559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075988	Green Submitted			2022-12-28	WOS:000309918500041
J	Rigotti, NA				Rigotti, Nancy A.			Strategies to Help a Smoker Who Is Struggling to Quit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; SMOKING-CESSATION; TOBACCO DEPENDENCE; ADVERSE EVENTS; DOUBLE-BLIND; VARENICLINE; PLACEBO; THERAPY; SAFETY	Tobacco use is the leading preventable cause of death worldwide. Stopping tobacco use benefits virtually every smoker. Most of the 19% of US residents who smoke want to quit and have tried to do so. Most individual quit attempts fail, but two-thirds of smokers use no treatment when trying to quit. Treating tobacco dependence is one of the most cost-effective actions in health care. With a brief intervention, physicians can prompt smokers to attempt to quit and connect them to evidence-based treatment that includes pharmacotherapy and behavioral support (ie, counseling). Physicians can link smokers to effective counseling support offered by a free national network of telephone quit lines. Smokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit double their odds of success. The most effective way to use NRT is to combine the long-acting nicotine patch with a shorter-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks. Observational studies have not confirmed case reports of behavior changes associated with varenicline and bupropion, and these drugs' benefits outweigh potential risks. A chronic disease management model is effective for treating tobacco dependence, which deserves as high a priority in health care systems as treating other chronic diseases like diabetes and hypertension. JAMA. 2012;308(15):1573-1580 www.jama.com	[Rigotti, Nancy A.] Harvard Univ, Massachusetts Gen Hosp, Div Gen Med, Dept Med,Med Sch, Boston, MA 02114 USA; [Rigotti, Nancy A.] Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Div Gen Med, Dept Med,Med Sch, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	nrigotti@partners.org			Nabi Biopharmaceuticals Inc; Pfizer Inc.; National Institutes of Health, National Heart, Lung, and Blood Institute [5K24HL4440-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004440] Funding Source: NIH RePORTER	Nabi Biopharmaceuticals Inc; Pfizer Inc.(Pfizer); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported that she has received royalties from UpToDate Inc and research grants to her institution from Nabi Biopharmaceuticals Inc, and Pfizer Inc. She also reported that she has served as an unpaid consultant for Pfizer Inc and Alere Wellbeing Inc.; This was supported by grant 5K24HL4440-10, a Mid-Career Investigator Award in Patient-Oriented Research from the National Institutes of Health, National Heart, Lung, and Blood Institute.	Abroms LC, 2011, AM J PREV MED, V40, P279, DOI 10.1016/j.amepre.2010.10.032; [Anonymous], COCHR SUMM; Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Aveyard P, 2012, TOB CONTROL, V21, P252, DOI 10.1136/tobaccocontrol-2011-050348; Barry MB, US QUITLINES CROSS R; Benowitz NL, 2011, CLIN PHARMACOL THER, V90, P491, DOI 10.1038/clpt.2011.191; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Cahill K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub5; Centers for Disease Control and Prevention, GUID COMM PREV SERV; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Cochrane Tobacco Addiction Group, COCHRANE LIB; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ebbert JO, 2009, NICOTINE TOB RES, V11, P572, DOI 10.1093/ntr/ntp042; Ebbert JO, 2009, NICOTINE TOB RES, V11, P234, DOI 10.1093/ntr/ntn031; Ferguson SG, 2012, ADDICTION, V107, P1349, DOI 10.1111/j.1360-0443.2012.03801.x; Fiore MC, 2008, TREATING TOBACCO USE; Fiore MC, 2011, NEW ENGL J MED, V365, P1222, DOI 10.1056/NEJMcp1101512; Food and Drug Administration, FDA DRUG SAF COMM CH; Food and Drug Administration, FDA DRUG SAF COMM SA; Food and Drug Administration, PUBL HLTH ADV FDA RE; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gourlay S G, 2004, Cochrane Database Syst Rev, pCD000058, DOI 10.1002/14651858.CD000058.pub2; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Hays JT, 2011, CAN MED ASSOC J, V183, P1346, DOI 10.1503/cmaj.110804; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Joseph AM, 2011, ARCH INTERN MED, V171, P1894, DOI 10.1001/archinternmed.2011.500; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Lindson N, 2011, PSYCHOPHARMACOLOGY, V214, P579, DOI 10.1007/s00213-010-2069-3; Lindson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub2; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Meyer TE, 2011, PHARMACOEPIDEM DR S, V20, pS245; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; North American Quitline Consortium, FREE DISC MED; Pachas GN, 2012, J DUAL DIAGN, V8, P117, DOI 10.1080/15504263.2012.663675; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Primack BA, 2008, ANN BEHAV MED, V36, P81, DOI 10.1007/s12160-008-9047-6; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rigotti NA, 2011, AM J PREV MED, V41, P498, DOI 10.1016/j.amepre.2011.07.022; Rigotti NA, 2011, ARCH INTERN MED, V171, P53, DOI 10.1001/archinternmed.2010.491; Schnoll RA, 2010, ANN INTERN MED, V152, P144, DOI 10.7326/0003-4819-152-3-201002020-00005; Schroeder SA, 2009, JAMA-J AM MED ASSOC, V301, P522, DOI 10.1001/jama.2008.982; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; Shiffman S, 2008, ADDICTION, V103, P1371, DOI 10.1111/j.1360-0443.2008.02268.x; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000165.PUB3; Steinberg MB, 2008, ANN INTERN MED, V148, P554, DOI 10.7326/0003-4819-148-7-200804010-00012; Steinberg MB, 2009, ANN INTERN MED, V150, P447, DOI 10.7326/0003-4819-150-7-200904070-00004; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Tynan M., 2010, Morbidity and Mortality Weekly Report, V59, P487; U.S. Department of Health and Human Services, 2010, END TOB EP TOB CONTR; US Food and Drug Administration, CHANT VAR DRUG LABL; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522	65	69	69	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1573	1580		10.1001/jama.2012.13043	http://dx.doi.org/10.1001/jama.2012.13043			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021AQ	23073954	Green Accepted			2022-12-28	WOS:000309858100024
J	Spiro, T; Lee, EO; Emanuel, EJ				Spiro, Topher; Lee, Emily Oshima; Emanuel, Ezekiel J.			Price and Utilization: Why We Must Target Both to Curb Health Care Costs	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; PROVIDERS; SERVICES; GROWTH; PAID	The United States spends nearly $8000 per person on health care annually. Even for a wealthy country, this amount is substantially more than would be expected and 2.5 times the average spent by other Organization for Economic Cooperation and Development (OECD) countries. The growth rate of health care spending in the United States has also far outpaced that in all other high-income OECD countries since 1970, even accounting for population growth. This increase in health spending threatens to squeeze out critical investments in education and infrastructure. To successfully develop and implement policies that effectively address both the level and growth of U. S. health care costs, it is critical to first understand cost drivers. Many health policy and economics scholars have contributed to an ongoing debate on whether to blame high prices or high utilization of services for escalating health care spending in the United States. This paper argues that price and volume both contribute to high and increasing health care costs, along with high administrative costs, supply issues, and the fee-for-service payment system. Initial strategies to contain costs might include implementation and expansion of bundled payment systems and competitive bidding.	[Lee, Emily Oshima] Ctr Amer Progress, Washington, DC 20005 USA; Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, EO (corresponding author), Ctr Amer Progress, 1333 H St NW, Washington, DC 20005 USA.	eoshima@americanprogress.org			Peter G. Peterson Foundation	Peter G. Peterson Foundation	Grant Support: By the Peter G. Peterson Foundation.	Berenson RA, 2012, HEALTH AFFAIR, V31, P973, DOI 10.1377/hlthaff.2011.0920; Centers for Medicare & Medicaid Services, 2012, COMP BIDD UPD ON YEA; Congressional Budget Office, 2008, CBO PUBL, V2764; Cutler DM, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.2.3; Emanuel E, 2012, N ENGL J MED; Factors Underlying the Growth in Medicare's Spending for Physicians' Services, 2007, CBO PUBL; Farrell D, 2008, ACCOUNTING COST US H; Federal Employees Health Benefits Program, 2005, GAO05856; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; FUCHS VR, 1990, NEW ENGL J MED, V323, P884, DOI 10.1056/NEJM199009273231306; Hayes KJ, 2007, HEALTH AFFAIR, V26, P124, DOI 10.1377/hlthaff.26.1.124; International Federation of Health Plans, 2012, IFHP 2011 COMP PRIC; Laugesen MJ, 2011, HEALTH AFFAIR, V30, P1647, DOI 10.1377/hlthaff.2010.0204; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Organisation for Economic Co operation and Development, 2011, OECD HLTH DAT 2011; Organization for Economic Cooperation and Development, 2011, WHY IS HLTH SPEND US; Pollack HA, 2011, J HEALTH POLIT POLIC, V36, P771, DOI 10.1215/03616878-1334722; Porter M.E., 2006, REDEFINING HLTH CARE; Reinhardt UE, 2002, HEALTH AFFAIR, V21, P169, DOI 10.1377/hlthaff.21.3.169; Reinhardt UE, 2011, HEALTH AFFAIR, V30, P2125, DOI 10.1377/hlthaff.2011.0813; Schreyer P., 2010, OECD HLTH WORKING PA, V53; Skinner J, 2011, J HEALTH POLIT POLIC, V36, P791, DOI 10.1215/03616878-1302939; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Thompson A, 2009, 295 FED TRAD COMM; White C, 2007, HEALTH AFFAIR, V26, P154, DOI 10.1377/hlthaff.26.1.154	26	11	11	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					586	+		10.7326/0003-4819-157-8-201210160-00014	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00014			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SP	23070492				2022-12-28	WOS:000309906000022
J	Steiner, JF				Steiner, John F.			Rethinking Adherence	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION ADHERENCE; HEALTH-CARE; STATIN ADHERENCE; PHARMACY RECORDS; HEART-FAILURE; SELF-REPORT; DRUG-USE; PATIENT; HYPERTENSION; NONADHERENCE	In 2012, the Centers for Medicare & Medicaid Services (CMS) will introduce measures of adherence to oral hypoglycemic, antihypertensive, and cholesterol-lowering drugs into its Medicare Advantage quality program. To meet these quality goals, delivery systems will need to develop and disseminate strategies to improve adherence. The design of adherence interventions has too often been guided by the mistaken assumptions that adherence is a single behavior that can be predicted from readily available patient characteristics and that individual clinicians alone can improve adherence at the population level. Effective interventions require recognition that adherence is a set of interacting behaviors influenced by individual, social, and environmental forces; adherence interventions must be broadly based, rather than targeted to specific population subgroups; and counseling with a trusted clinician needs to be complemented by outreach interventions and removal of structural and organizational barriers. To achieve the adherence goals set by CMS, front-line clinicians, interdisciplinary teams, organizational leaders, and policy-makers will need to coordinate efforts in ways that exemplify the underlying principles of health care reform.	Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80237 USA	Kaiser Permanente	Steiner, JF (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, POB 378066, Denver, CO 80237 USA.	john.f.steiner@kp.org			Agency for Healthcare Research and Quality [R01HS019859]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019859] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By grant R01HS019859 from the Agency for Healthcare Research and Quality.	Batal HA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-175; Bogart LM, 2001, MED DECIS MAKING, V21, P28, DOI 10.1177/0272989X0102100104; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Bryson CL, 2008, ANN INTERN MED, V149, P795, DOI 10.7326/0003-4819-149-11-200812020-00004; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; Centers for Medicare & Medicaid Services, 2012, MED HLTH DRUG PLAN C; Centers for Medicare & Medicaid Services, 2012, MED HLTH DRUG PLAN D; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Chernew M, 2008, J GEN INTERN MED, V23, P1131, DOI 10.1007/s11606-008-0614-0; Chiasson MA, 2010, JAIDS-J ACQ IMM DEF, V55, pS94, DOI 10.1097/QAI.0b013e3181fcb878; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Fenton WS, 2006, CURR OPIN PSYCHIATR, V19, P421, DOI 10.1097/01.yco.0000228765.33356.9f; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Foster DG, 2011, OBSTET GYNECOL, V117, P566, DOI 10.1097/AOG.0b013e3182056309; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Gardner EA, 2008, AIDS, V22, P75, DOI 10.1097/QAD.0b013e3282f366ff; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Green LW, 1991, PATIENT COMPLIANCE M, P373; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Hicks PL, 2007, AIDS CARE, V19, P1134, DOI 10.1080/09540120701351888; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Hudon E, 2004, FAM PRACT, V21, P11, DOI 10.1093/fampra/cmh104; Jerant A, 2008, MED CARE, V46, P1134, DOI 10.1097/MLR.0b013e31817924e4; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Lacy NL, 2004, ANN FAM MED, V2, P541, DOI 10.1370/afm.123; Li PX, 2012, ANN INTERN MED, V156, P776, DOI 10.7326/0003-4819-156-11-201206050-00004; Lutfey KE, 2005, HEALTH SERV RES, V40, P1803, DOI 10.1111/j.1475-6773.2005.00433.x; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Patient-Centered Primary Care Collaborative, 2007, JOINT PRINC PAT CTR; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Polinski JM, 2010, J AM GERIATR SOC, V58, P1764, DOI 10.1111/j.1532-5415.2010.03025.x; Raebel MA, 2012, J GEN INTERN MED, V27, P57, DOI 10.1007/s11606-011-1829-z; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schmittdiel JA, 2011, J GEN INTERN MED, V26, P1396, DOI 10.1007/s11606-011-1805-7; Shrank WH, 2010, ANN INTERN MED, V153, P633, DOI 10.7326/0003-4819-153-10-201011160-00005; Siegel D, 2007, AM J MED, V120, P26, DOI 10.1016/j.amjmed.2006.06.028; Steiner JF, 2000, ANN INTERN MED, V132, P926, DOI 10.7326/0003-4819-132-11-200006060-00026; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Steiner JF, 2009, CIRC-CARDIOVASC QUAL, V2, P451, DOI 10.1161/CIRCOUTCOMES.108.841635; Steiner JF, 2010, MED CARE, V48, P193, DOI 10.1097/MLR.0b013e3181d51ddf; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; Thorpe CT, 2009, MED CARE, V47, P474, DOI 10.1097/MLR.0b013e31818e7d4d; Turner BJ, 2009, PHARMACOEPIDEM DR S, V18, P672, DOI 10.1002/pds.1766; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wong MD, 2004, J GEN INTERN MED, V19, P366, DOI 10.1111/j.1525-1497.2004.30429.x; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	53	75	75	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					580	+		10.7326/0003-4819-157-8-201210160-00013	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00013			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SP	23070491				2022-12-28	WOS:000309906000021
J	Blumenthal, D; Dixon, J				Blumenthal, David; Dixon, Jennifer			Health-care reforms in the USA and England: areas for useful learning	LANCET			English	Article							LESSONS	Two landmark and controversial bills reforming health care in the USA and England were recently passed. Despite the different history and context to health care in both countries, there is much room for mutual learning. This paper identifies three areas relating to financing, organisation, and information technology. For example, new payment mechanisms to encourage higher quality and efficiency are being developed and tested, particularly bundled payments, pay for performance, and value-based purchasing. In the USA, new national bodies to scrutinise payments in health care and to test promising new interventions to improve quality and efficiency will have lessons for the NHS. The faster adoption of electronic health records and their use in England to assess quality is a useful lesson for the USA. The new accountable care organisations and clinical commissioning groups have much to learn from each other as they develop.	[Dixon, Jennifer] Nuffield Trust, London W1G 7LP, England; [Blumenthal, David] Harvard Univ, Sch Med, Boston, MA USA; [Blumenthal, David] Partners Hlth Syst, Boston, MA USA	Harvard University; Harvard Medical School; Partners Healthcare System	Dixon, J (corresponding author), Nuffield Trust, London W1G 7LP, England.	jennifer.dixon@nuffieldtrust.org.uk						Aaron HJ, 2011, NEW ENGL J MED, V364, P2377, DOI 10.1056/NEJMp1105144; Black N, 2012, LANCET, V379, P1167, DOI 10.1016/S0140-6736(11)61782-0; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Center for Medicare and Medicaid Innovation, CMS INN CTR; Chantrill C, UK PUBLIC SPENDING 1; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Cutler D, 2010, HEALTH AFFAIR, V29, P1131, DOI 10.1377/hlthaff.2010.0416; DeNavas-Walt C, 2011, INCOME POVERTY HLTH; Department of Health, 2012, CONF PAYM RES ARR 20; Department of Health, 2012, NHS CONST NHS BEL US; Department of Health, QIPP; Department of Health, POW INF PUTT ALL US; Department of Health, 2010, NHS OUTC FRAM; Department of Health, PAYM RES; Department of Health and Human Services, 2011, ADM IMPL AFF CAR ACT; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Ham C, 2012, LANCET, V379, P189, DOI 10.1016/S0140-6736(11)61088-X; Klaxton K, 2008, BRIT MED J, V336, P251; Langel S, 2011, HEALTH AFFAIR, V30, P1819, DOI 10.1377/hlthaff.2011.1057; Leatherman S, 2008, QUEST QUALITY NHS RE; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; Nuffield Trust, 2012, NHS SOC CAR FUND OUT; Rayman G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5446; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Simon C, 2008, INNOVAIT, V1, P134, DOI DOI 10.1093/INNOVAIT/INN010; The Commonweath Fund on a High Performance Health System, 2012, PERF IMPR IMP UT COO; The Henry J. Kaiser Family Foundation, 2011, SUMM NEW HLTH REF LA; The Information Centre for health and social care, 2012, PAT REP OUTC MEAS PR; The Mid Staffordshire NHS Foundation Trust Inquiry, 2010, IND INQ CAR PROV MID; Thomson S, 2010, PRIMARY CARE PRESCRI; UK Research and Innovation (UKRI), 2022, FRAMEWORK RESPONSIBL; Wilensky GR, 2011, NEW ENGL J MED, V365, P1659, DOI 10.1056/NEJMp1110185; [No title captured]	35	30	30	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1352	1357		10.1016/S0140-6736(12)60956-8	http://dx.doi.org/10.1016/S0140-6736(12)60956-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	23063284				2022-12-28	WOS:000309931400034
J	Pollard, TD				Pollard, Thomas D.			The Obligation for Biologists to Commit to Political Advocacy	CELL			English	Editorial Material									[Pollard, Thomas D.] Yale Univ, Dept Mol Cellular, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu						American Association for the Advancement of Science (AAAS), 2012, 37 AAAS; CQ Roll Call, 2010, GUID NEW C; Ehrlich E, 2011, EC ENGINE NIH RES EM; Gitlin JM, 2011, CALCULATING EC IMPAC; Goldstein LSB, 2010, TRENDS CELL BIOL, V20, P695, DOI 10.1016/j.tcb.2010.09.008; Masci D., 2009, PUBLIC OPINION RELIG	6	8	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					239	243		10.1016/j.cell.2012.09.026	http://dx.doi.org/10.1016/j.cell.2012.09.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063115	Bronze			2022-12-28	WOS:000309981000001
J	Davies, P				Davies, Peter			Could a passage to India be the way to get more surgical experience?	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com							0	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 10	2012	345								e6637	10.1136/bmj.e6637	http://dx.doi.org/10.1136/bmj.e6637			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054046				2022-12-28	WOS:000309907400018
J	Blakemore, SJ				Blakemore, Sarah-Jayne			Teenage kicks: cannabis and the adolescent brain	LANCET			English	Editorial Material									UCL Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Blakemore, SJ (corresponding author), UCL Inst Cognit Neurosci, London WC1N 3AR, England.	s.blakemore@ucl.ac.uk	Blakemore, Sarah-Jayne/A-1792-2010	Blakemore, Sarah-Jayne/0000-0002-1690-2805				Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Steinberg L, 2010, ADOLESCENCE; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	11	13	13	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					888	889		10.1016/S0140-6736(12)61578-5	http://dx.doi.org/10.1016/S0140-6736(12)61578-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23117180				2022-12-28	WOS:000316069700010
J	Darlison, MW; Modell, B				Darlison, Matthew W.; Modell, Bernadette			Sickle-cell disorders: limits of descriptive epidemiology	LANCET			English	Editorial Material									[Darlison, Matthew W.; Modell, Bernadette] UCL Ctr Hlth Informat & Multiprofess Educ CHIME, WHO Collaborating Ctr Community Control Hereditar, London N19 5LW, England	University of London; University College London	Darlison, MW (corresponding author), UCL Ctr Hlth Informat & Multiprofess Educ CHIME, WHO Collaborating Ctr Community Control Hereditar, London N19 5LW, England.	m.darlison@ucl.ac.uk						Firdous N, 2011, J COMMUN GENET, V2, P173, DOI 10.1007/s12687-011-0054-0; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Piel FB, 2012, LANCET; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; UN, UN DEM YB SER; United Nations, WORLD POP PROSP 2010	6	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					98	99		10.1016/S0140-6736(12)61817-0	http://dx.doi.org/10.1016/S0140-6736(12)61817-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069FO	23103088				2022-12-28	WOS:000313420900008
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CONJUGATED EQUINE ESTROGENS; POSTMENOPAUSAL WOMEN; LIFETIME RISK; STROKE; HYSTERECTOMY; DEMENTIA; CANCER; UPDATE	Description: Update of the 2005 U. S. Preventive Services Task Force (USPSTF) recommendation statement on hormone therapy for the prevention of chronic conditions in postmenopausal women. Methods: The USPSTF commissioned a review of the literature to update evidence about the benefits and harms of using menopausal hormone therapy to prevent chronic conditions, as well as whether the benefits and harms of hormone therapy differ by population subgroups defined by age; the presence of comorbid medical conditions; and the type, dose, and method of hormonal delivery. Population: This recommendation applies to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. It does not apply to women who are considering hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryness. It also does not apply to women younger than 50 years who have had surgical menopause. Recommendation: The USPSTF recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women. (Grade D recommendation). The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy. (Grade D recommendation). Ann Intern Med. 2013;158:47-54. www.annals.org For author affiliation, see end of text.	[Moyer, Virginia A.; US Preventive Serv Task Force] US Preventive Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Preventive Serv Task Force, Rockville, MD USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Alzheimer's Association, 2011, 2011 ALZH DIS FACTS; American Academy of Family Physicians, 2005, HORM REPL THER; American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, 2008, Obstet Gynecol, V112, P1189, DOI 10.1097/AOG.0b013e31818e8782; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Berg AO, 2002, ANN INTERN MED, V137, P56, DOI 10.7326/0003-4819-137-1-200207020-00016; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Chlebowski RT, 2012, JNCI-J NATL CANCER I, V104, P517, DOI 10.1093/jnci/djs014; Chlebowski RT, 2010, JNCI-J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Howlader N, 2011, SEER CANC STAT REV 1; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Nelson HD, 2012, AHRQ PUBLICATION, V12-05167-EF-1; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Pfizer Pharmaceuticals, 2011, PREM PACK INS; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Shamliyan T, 2012, COMP EFFECTIVENESS R; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; U.S. Food and Drug Administration, 2008, BIOID SORT MYTHS FAC; Wathen CN, 2004, CAN MED ASSOC J, V170, P1535, DOI 10.1503/cmaj.1030756; Yang XP, 2011, CURR OPIN NEPHROL HY, V20, P133, DOI 10.1097/MNH.0b013e3283431921	28	78	80	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					47	U123		10.7326/0003-4819-158-1-201301010-00553	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00553			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23090711				2022-12-28	WOS:000313119900007
J	Neumann, PJ; Chambers, JD				Neumann, Peter J.; Chambers, James D.			Medicare's Enduring Struggle to Define "Reasonable and Necessary" Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neumann, Peter J.; Chambers, James D.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA.							Fox J, 2010, U CINCI LAW REV, V79, P1; Redberg RF, 2008, NEW ENGL J MED, V359, P2309, DOI 10.1056/NEJMp0805920; Tunis S. R., 2011, IMPROVING QUALITY EF	3	39	39	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1775	1777		10.1056/NEJMp1208386	http://dx.doi.org/10.1056/NEJMp1208386			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23113832				2022-12-28	WOS:000310773200002
J	Dyson, AE				Dyson, Anne E.			It is too difficult for ill people to claim benefits	BRITISH MEDICAL JOURNAL			English	Editorial Material									Brickfields Surg, S Woodham Ferrers CM3 5XB, Essex, England		Dyson, AE (corresponding author), Brickfields Surg, 4 Brickfields Rd, S Woodham Ferrers CM3 5XB, Essex, England.	annedyson58@hotmail.com							0	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 30	2012	345								e7209	10.1136/bmj.e7209	http://dx.doi.org/10.1136/bmj.e7209			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EY	23112119				2022-12-28	WOS:000310778200008
J	de Wijn, AG				de Wijn, Alfred G.			Measuring Solar Magnetism	SCIENCE			English	Editorial Material							DYNAMICS-OBSERVATORY SDO; FIELD; MISSION		Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	de Wijn, AG (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	dwijn@ucar.edu		de Wijn, Alfred/0000-0002-5084-4661				AUER LH, 1977, SOL PHYS, V55, P47, DOI 10.1007/BF00150873; Borrero JM, 2011, SOL PHYS, V273, P267, DOI 10.1007/s11207-010-9515-6; Casini R, 2003, ASTROPHYS J, V598, pL67, DOI 10.1086/380496; DeRosa ML, 2009, ASTROPHYS J, V696, P1780, DOI 10.1088/0004-637X/696/2/1780; Hale GE, 1908, ASTROPHYS J, V28, P315, DOI 10.1086/141602; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kuckein C, 2009, ASTRON ASTROPHYS, V501, P1113, DOI 10.1051/0004-6361/200911800; LITES BW, 1982, ASTROPHYS J SUPPL S, V49, P293, DOI 10.1086/190800; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; SKUMANICH A, 1987, ASTROPHYS J, V322, P473, DOI 10.1086/165743; STENFLO JO, 1973, SOL PHYS, V32, P41, DOI 10.1007/BF00152728; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Zeeman P., 1896, VERSL GEW VERG AFD N, P181	15	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					476	477		10.1126/science.1226336	http://dx.doi.org/10.1126/science.1226336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112318				2022-12-28	WOS:000310195800040
J	Marguerat, S; Schmidt, A; Codlin, S; Chen, W; Aebersold, R; Bahler, J				Marguerat, Samuel; Schmidt, Alexander; Codlin, Sandra; Chen, Wei; Aebersold, Ruedi; Baehler, Juerg			Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in Proliferating and Quiescent Cells	CELL			English	Article							GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; ABSOLUTE QUANTIFICATION; SEXUAL-DIFFERENTIATION; PROTEIN; HETEROCHROMATIN; RESOLUTION; RESPONSES; DIVISION	Data on absolute molecule numbers will empower the modeling, understanding, and comparison of cellular functions and biological systems. We quantified transcriptomes and proteomes in fission yeast during cellular proliferation and quiescence. This rich resource provides the first comprehensive reference for all RNA and most protein concentrations in a eukaryote under two key physiological conditions. The integrated data set supports quantitative biology and affords unique insights into cell regulation. Although mRNAs are typically expressed in a narrow range above 1 copy/cell, most long, noncoding RNAs, except for a distinct subset, are tightly repressed below 1 copy/cell. Cell-cycle-regulated transcription tunes mRNA numbers to phase-specific requirements but can also bring about more switch-like expression. Proteins greatly exceed mRNAs in abundance and dynamic range, and concentrations are regulated to functional demands. Upon transition to quiescence, the proteome changes substantially, but, in stark contrast to mRNAs, proteins do not uniformly decrease but scale with cell volume.	[Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Schmidt, Alexander] Univ Basel, Proteom Core Facil, Biozentrum, CH-4056 Basel, Switzerland; [Chen, Wei] Max Delbruck Ctr Mol Med MDC, Berlin Inst Med Syst Biol, D-13092 Berlin, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; University of London; University College London; University of Basel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch; j.bahler@ucl.ac.uk	Marguerat, Samuel/AAY-3792-2020; Chen, Wei/C-1273-2011; Bahler, Jurg/B-4572-2009	Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532; Chen, Wei/0000-0003-3263-1627	PhenOxiGEn (an EU FP7 research project); BBSRC [BB/I012451/1]; Wellcome Trust; SystemsX.ch; ERC; Biotechnology and Biological Sciences Research Council [BB/I012451/1] Funding Source: researchfish; Wellcome Trust [095598/Z/11/Z] Funding Source: researchfish	PhenOxiGEn (an EU FP7 research project); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SystemsX.ch; ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Bachand, D. Bitton, L. Foukas, A. Lock, D. Lovell, J. Mata, and V. Wood for comments on the manuscript, P. Gardner for advice on lncRNA sequences, and P. Oliveri for help with nCounter. This research was funded by PhenOxiGEn (an EU FP7 research project), a BBSRC Research Grant BB/I012451/1, and a Wellcome Trust Senior Investigator Award to J. B., and by SystemsX.ch and an ERC Advanced Grant to R.A.	Atkinson SR, 2012, SEMIN CELL DEV BIOL, V23, P200, DOI 10.1016/j.semcdb.2011.12.003; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Coller HA, 2011, SCIENCE, V334, P1074, DOI 10.1126/science.1216242; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovell D, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P193; MACLEAN N, 1965, NATURE, V207, P322, DOI 10.1038/207322a0; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	52	360	364	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					671	683		10.1016/j.cell.2012.09.019	http://dx.doi.org/10.1016/j.cell.2012.09.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101633	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000310529300021
J	Cohen, D				Cohen, Deborah			Manufacturers offered helping hand with EU approval	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 25	2012	345								e7225	10.1136/bmj.e7225	http://dx.doi.org/10.1136/bmj.e7225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MZ	23100373				2022-12-28	WOS:000310427800010
J	Nielsen, JC; Johannessen, A; Raatikainen, P; Hindricks, G; Walfridsson, H; Kongstad, O; Pehrson, S; Englund, A; Hartikainen, J; Mortensen, LS; Hansen, PS				Nielsen, Jens Cosedis; Johannessen, Arne; Raatikainen, Pekka; Hindricks, Gerhard; Walfridsson, Hakan; Kongstad, Ole; Pehrson, Steen; Englund, Anders; Hartikainen, Juha; Mortensen, Leif Spange; Hansen, Peter Steen			Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY VEIN ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; CATHETER ABLATION; GUIDELINES; MANAGEMENT; COMPLICATIONS; SUBSTRATE; EFFICACY; SOCIETY; TRIAL	Background There are limited data comparing radiofrequency catheter ablation with antiarrhythmic drug therapy as first-line treatment in patients with paroxysmal atrial fibrillation. Methods We randomly assigned 294 patients with paroxysmal atrial fibrillation and no history of antiarrhythmic drug use to an initial treatment strategy of either radiofrequency catheter ablation (146 patients) or therapy with class IC or class III antiarrhythmic agents (148 patients). Follow-up included 7-day Holter-monitor recording at 3, 6, 12, 18, and 24 months. Primary end points were the cumulative and per-visit burden of atrial fibrillation (i.e., percentage of time in atrial fibrillation on Holter-monitor recordings). Analyses were performed on an intention-to-treat basis. Results There was no significant difference between the ablation and drug-therapy groups in the cumulative burden of atrial fibrillation (90th percentile of arrhythmia burden, 13% and 19%, respectively; P = 0.10) or the burden at 3, 6, 12, or 18 months. At 24 months, the burden of atrial fibrillation was significantly lower in the ablation group than in the drug-therapy group (90th percentile, 9% vs. 18%; P = 0.007), and more patients in the ablation group were free from any atrial fibrillation (85% vs. 71%, P = 0.004) and from symptomatic atrial fibrillation (93% vs. 84%, P = 0.01). One death in the ablation group was due to a procedure-related stroke; there were three cases of cardiac tamponade in the ablation group. In the drug-therapy group, 54 patients (36%) underwent supplementary ablation. Conclusions In comparing radiofrequency ablation with antiarrhythmic drug therapy as first-line treatment in patients with paroxysmal atrial fibrillation, we found no significant difference between the treatment groups in the cumulative burden of atrial fibrillation over a period of 2 years. (Funded by the Danish Heart Foundation and others; MANTRA-PAF ClinicalTrials.gov number, NCT00133211.)	[Nielsen, Jens Cosedis; Hansen, Peter Steen] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Pehrson, Steen] Rigshosp, DK-2100 Copenhagen, Denmark; [Johannessen, Arne] Gentofte Univ Hosp, Copenhagen, Denmark; [Mortensen, Leif Spange] Danish Informat Technol Ctr Educ & Res, UNI C, Aarhus, Denmark; [Raatikainen, Pekka] Tampere Univ Hosp, Ctr Heart, Tampere, Finland; [Hartikainen, Juha] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Hindricks, Gerhard] Leipzig Univ Hosp, Leipzig, Germany; [Walfridsson, Hakan] Linkoping Univ Hosp, Dept Cardiol, Ctr Heart, S-58185 Linkoping, Sweden; [Kongstad, Ole] Univ Lund Hosp, S-22185 Lund, Sweden; [Englund, Anders] Univ Hosp, Orebro, Sweden	Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Tampere University; Tampere University Hospital; Kuopio University Hospital; University of Eastern Finland; Leipzig University; Linkoping University; Lund University; Skane University Hospital; Orebro University	Nielsen, JC (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	jenniels@rm.dk	Walfridsson, Hakan/AAE-7729-2020; Raatikainen, Pekka/AAM-7759-2020	Nielsen, Jens Cosedis/0000-0001-9414-1653	Danish Heart Foundation [05-4-B284-A466-22237]; Biosense Webster; Finnish Foundation for Cardiovascular Research; Biotronik; Medtronic; St. Jude Medical	Danish Heart Foundation; Biosense Webster; Finnish Foundation for Cardiovascular Research; Biotronik; Medtronic(Medtronic); St. Jude Medical(St. Jude Medical)	Supported by unrestricted grants from the Danish Heart Foundation (05-4-B284-A466-22237) and Biosense Webster and by a grant from the Finnish Foundation for Cardiovascular Research (to Dr. Raatikainen).; Dr. Cosedis Nielsen reports serving as an advisory-board member of Sanofi-Aventis and receiving lecture fees from Biotronik, Medtronic, and St. Jude Medical; Dr. Hindricks, serving as a board member of and receiving consulting fees, lecture fees, and grant support from Biosense Webster, serving as a board member of and receiving lecture fees and grant support from Biotronik, and serving as a board member of and receiving consulting fees, lecture fees, and grant support from St. Jude Medical; and Dr. Raatikainen, serving as an advisory-board member of Sanofi-Aventis and Stereotaxis, serving as an advisory-board member of and receiving grant support from St. Jude Medical, and receiving consulting fees from Biosense Webster. No other potential conflict of interest relevant to this article was reported.	Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Augello G, 2009, HEART RHYTHM, V6, P1706, DOI 10.1016/j.hrthm.2009.09.008; Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2011, EUR HEART J, V32, P1172, DOI 10.1093/eurheartj/ehq512; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x; de Groot NMS, 2010, CIRCULATION, V122, P1674, DOI 10.1161/CIRCULATIONAHA.109.910901; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gillis AM, 2011, CAN J CARDIOL, V27, P47, DOI 10.1016/j.cjca.2010.11.001; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Hoyt H, 2011, HEART RHYTHM, V8, P1869, DOI 10.1016/j.hrthm.2011.07.025; Jais P, 2009, CIRCULATION, V120, pE83, DOI 10.1161/CIRCULATIONAHA.109.192636; Jons C, 2009, EUROPACE, V11, P917, DOI 10.1093/europace/eup122; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kirchhof P, 2009, EUR HEART J, V30, P2969, DOI 10.1093/eurheartj/ehp235; Leong-Sit P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P452, DOI 10.1161/CIRCEP.110.938860; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Piorkowski C, 2005, J CARDIOVASC ELECTR, V16, P1286, DOI 10.1111/j.1540-8167.2005.00245.x; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Tamborero D, 2010, HEART RHYTHM, V7, P612, DOI 10.1016/j.hrthm.2010.01.021; Tanner H, 2011, EUROPACE, V13, P646, DOI 10.1093/europace/eur065; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	26	428	437	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1587	1595		10.1056/NEJMoa1113566	http://dx.doi.org/10.1056/NEJMoa1113566			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094720	Green Published, Bronze			2022-12-28	WOS:000310131700005
J	Sasson, C; Magid, DJ; Chan, P; Root, ED; McNally, BF; Kellermann, AL; Haukoos, JS				Sasson, Comilla; Magid, David J.; Chan, Paul; Root, Elisabeth D.; McNally, Bryan F.; Kellermann, Arthur L.; Haukoos, Jason S.		CARES Surveillance Grp	Association of Neighborhood Characteristics with Bystander-Initiated CPR	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; CARDIOPULMONARY-RESUSCITATION; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; RACIAL-DIFFERENCES; STROKE-FOUNDATION; TASK-FORCE; SURVIVAL	BACKGROUND For persons who have an out-of-hospital cardiac arrest, the probability of receiving bystander-initiated cardiopulmonary resuscitation (CPR) may be influenced by neighborhood characteristics. METHODS We analyzed surveillance data prospectively submitted from 29 U. S. sites to the Cardiac Arrest Registry to Enhance Survival between October 1, 2005, and December 31, 2009. The neighborhood in which each cardiac arrest occurred was determined from census-tract data. We classified neighborhoods as high-income or low-income on the basis of a median household income threshold of $40,000 and as white or black if more than 80% of the census tract was predominantly of one race. Neighborhoods without a predominant racial composition were classified as integrated. We analyzed the relationship between the median income and racial composition of a neighborhood and the performance of bystander-initiated CPR. RESULTS Among 14,225 patients with cardiac arrest, bystander-initiated CPR was provided to 4068 (28.6%). As compared with patients who had a cardiac arrest in high-income white neighborhoods, those in low-income black neighborhoods were less likely to receive bystander-initiated CPR (odds ratio, 0.49; 95% confidence interval [CI], 0.41 to 0.58). The same was true of patients with cardiac arrest in neighborhoods characterized as low-income white (odds ratio, 0.65; 95% CI, 0.51 to 0.82), low-income integrated (odds ratio, 0.62; 95% CI, 0.56 to 0.70), and high-income black (odds ratio, 0.77; 95% CI, 0.68 to 0.86). The odds ratio for bystander-initiated CPR in high-income integrated neighborhoods (1.03; 95% CI, 0.64 to 1.65) was similar to that for high-income white neighborhoods. CONCLUSIONS In a large cohort study, we found that patients who had an out-of-hospital cardiac arrest in low-income black neighborhoods were less likely to receive bystander-initiated CPR than those in high-income white neighborhoods. (Funded by the Centers for Disease Control and Prevention and others.)	[Sasson, Comilla; Haukoos, Jason S.] Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA; [Magid, David J.] Kaiser Permanente, Inst Healthcare Res, Denver, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO USA; [Chan, Paul] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Root, Elisabeth D.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [McNally, Bryan F.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Kellermann, Arthur L.] RAND Corp, Washington, DC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Colorado School of Public Health; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Colorado System; University of Colorado Boulder; Emory University; RAND Corporation	Sasson, C (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA.	comilla.sasson@ucdenver.edu	McNally, Bryan/AAE-9332-2020; Root, Elisabeth/A-7429-2016	Root, Elisabeth/0000-0002-9566-4031; McMullan, Jason/0000-0002-7656-7447	Cardiac Arrest Registry to Enhance Survival [U18 PS000314]; Centers for Disease Control and Prevention [U18 PS000314]; Emergency Medicine Foundation; American Heart Association; Agency for Healthcare Research and Quality [K02 HS017526]; National Heart, Lung, and Blood Institute [K23HL102224]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	Cardiac Arrest Registry to Enhance Survival; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Emergency Medicine Foundation; American Heart Association(American Heart Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a cooperative agreement between the Cardiac Arrest Registry to Enhance Survival and the Centers for Disease Control and Prevention (U18 PS000314); grants from the Emergency Medicine Foundation and the American Heart Association (to Dr. Sasson); an Independent Scientist Award from the Agency for Healthcare Research and Quality (K02 HS017526, to Dr. Haukoos); and a grant from the National Heart, Lung, and Blood Institute (K23HL102224, to Dr. Chan).	Abella BS, 2008, CIRCULATION, V117, P704, DOI 10.1161/CIRCULATIONAHA.107.188486; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BROOKOFF D, 1994, ANN EMERG MED, V24, P1147, DOI 10.1016/S0196-0644(94)70246-2; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1993, ANNU REV PUBL HEALTH, V14, P313; Diez-Roux AV, 2000, SOC SCI MED, V50, P673, DOI 10.1016/S0277-9536(99)00320-2; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan P, 2012, RESUSCITATION, V83, P76, DOI 10.1016/j.resuscitation.2011.06.026; Grenvik ASP., 1981, BRAIN FAILURE RESUSC, P155; Iwashyna TJ, 1999, ANN EMERG MED, V34, P459, DOI 10.1016/S0196-0644(99)80047-X; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lisabeth LD, 2007, AM J EPIDEMIOL, V165, P279, DOI 10.1093/aje/kwk005; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Petersen LA, 2002, MED CARE, V40, P86; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, ANN INTERN MED, V153, P19, DOI 10.7326/0003-4819-153-1-201007060-00255; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; U.S. Census Bureau, TOP INT GEOGR ENC RE; Vadeboncoeur TF, 2008, AM J EMERG MED, V26, P655, DOI 10.1016/j.ajem.2007.10.002; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012	32	183	189	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1607	1615		10.1056/NEJMoa1110700	http://dx.doi.org/10.1056/NEJMoa1110700			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094722	Green Accepted			2022-12-28	WOS:000310131700007
J	Cohen, D				Cohen, Deborah			The truth behind "made in Europe" labels on medical devices	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7193	10.1136/bmj.e7193	http://dx.doi.org/10.1136/bmj.e7193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097557				2022-12-28	WOS:000310427600025
J	Chopra, V; Flanders, SA; Saint, S				Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay			The Problem With Peripherally Inserted Central Catheters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETER; CENTERS		[Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, Hosp Outcomes Program Excellence, Patient Safety Enhancement Program, Ann Arbor, MI USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Chopra, V (corresponding author), 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	vineetc@med.umich.edu	Kokot, Antonio/O-3111-2019; Saint, Sanjay/AAF-5126-2019; Kokot, Antonio/B-3276-2017	Kokot, Antonio/0000-0002-4836-7536; Chopra, Vineet/0000-0001-8670-9376				Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Climo M, 2003, INFECT CONT HOSP EP, V24, P942, DOI 10.1086/502163; Ajenjo MC, 2011, INFECT CONT HOSP EP, V32, P125, DOI 10.1086/657942; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; El Ters M, 2012, AM J KIDNEY DIS, V60, P601, DOI 10.1053/j.ajkd.2012.05.007; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Tsan L, 2010, AM J INFECT CONTROL, V38, P461, DOI 10.1016/j.ajic.2009.12.009; Woller SC, 2011, AM J MED, V124, P947, DOI 10.1016/j.amjmed.2011.06.004	9	75	77	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1527	1528		10.1001/jama.2012.12704	http://dx.doi.org/10.1001/jama.2012.12704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073947				2022-12-28	WOS:000309858100016
J	Roche, SE				Roche, Sean E.			Doctors must challenge political decisions that will cause medical harm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Roche, Sean E.] Dennis Scott Unit, Edgware HA8 0AD, Middx, England; [Roche, Sean E.] Kings Coll London, Dept Philosophy, London WC2R 2LS, England	University of London; King's College London	Roche, SE (corresponding author), Dennis Scott Unit, Edgware HA8 0AD, Middx, England.	sean.roche@kcl.ac.uk						[Anonymous], 2011, STAT B; [Anonymous], 2012, GUARDIAN; [Anonymous], 2012, TELEGRAPH; [Anonymous], 2012, EURONEWS; [Anonymous], 2011, GREEK DOCT STRIK REV; Fukuyama Francis, 1989, NATL INTEREST, P3; Gunnell D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6030; Smith R., 2012, TELEGRAPH; Sullivan D, 2009, Q J ECON, V124, P1265, DOI 10.1162/qjec.2009.124.3.1265; Treanor Jill, 2012, GUARDIAN; Wilkinson Richard, 2009, SPIRIT LEVEL WHY EQU	11	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2012	345								e6894	10.1136/bmj.e6894	http://dx.doi.org/10.1136/bmj.e6894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WG	23077326				2022-12-28	WOS:000310140600017
J	Henson, AB; Gersten, S; Shagam, Y; Narevicius, J; Narevicius, E				Henson, A. B.; Gersten, S.; Shagam, Y.; Narevicius, J.; Narevicius, E.			Observation of Resonances in Penning Ionization Reactions at Sub-Kelvin Temperatures in Merged Beams	SCIENCE			English	Article							ORBITING RESONANCES; MOLECULAR-BEAM; CROSS-SECTIONS; SCATTERING; ATOMS; POTENTIALS	Experiments have lagged theory in exploring chemical interactions at temperatures so low that translational degrees of freedom can no longer be treated classically. The difficulty has been to realize in the laboratory low-enough collisional velocities between neutral reactants to access this regime. We report here the realization of merged neutral supersonic beams and the manifestation of clear nonclassical effects in the resulting reactions. We observed orbiting resonances in the Penning ionization reaction of argon and molecular hydrogen with metastable helium, leading to a sharp absolute ionization rate increase in the energy range corresponding to a few degrees kelvin down to 10 millikelvin. Our method should be widely applicable to many canonical chemical reactions.	[Henson, A. B.; Gersten, S.; Shagam, Y.; Narevicius, J.; Narevicius, E.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Narevicius, E (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	edn@weizmann.ac.il	Shagam, Yuval/K-8956-2019; Henson, Alon Brent/D-9551-2018	Shagam, Yuval/0000-0002-6994-4814; Henson, Alon Brent/0000-0001-6028-439X	Israel Science Foundation; Minerva Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation	We acknowledge U. Even for many helpful discussions and sound advice. We thank R. Ozeri for most fruitful discussions; M. Raizen, R. Naaman, Y. Prior, and B. Dayan for a careful reading of the manuscript; and S. Assayag and M. Vinetsky from the Weizmann machine shop for assistance in designing and manufacturing of our vacuum chamber. This research was made possible, in part, by the historic generosity of the Harold Perlman Family. E.N. acknowledges support from the Israel Science Foundation and Minerva Foundation.	Balakrishnan N, 2001, CHEM PHYS LETT, V341, P652, DOI 10.1016/S0009-2614(01)00515-2; Ball CD, 1998, PHYS REV LETT, V81, P305, DOI 10.1103/PhysRevLett.81.305; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; Bodo E, 2002, J CHEM PHYS, V116, P9222, DOI 10.1063/1.1472515; Boltzmann L., 1989, VORLESUNG GASTHEORIE; BRUTSCHY B, 1976, J PHYS B-AT MOL OPT, V9, P2693, DOI 10.1088/0022-3700/9/15/019; Buggle C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173202; BUNKER DL, 1958, J AM CHEM SOC, V80, P5085, DOI 10.1021/ja01552a023; BURDENSKI S, 1981, CHEM PHYS LETT, V78, P296, DOI 10.1016/0009-2614(81)80020-6; Chandler DW, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357286; Chefdeville S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.023201; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; COLBERT DT, 1992, J CHEM PHYS, V96, P1982, DOI 10.1063/1.462100; DOYLE JM, 1995, PHYS REV A, V52, pR2515, DOI 10.1103/PhysRevA.52.R2515; Druyvesteyn MJ, 1940, REV MOD PHYS, V12, P0087, DOI 10.1103/RevModPhys.12.87; Even U, 2000, J CHEM PHYS, V112, P8068, DOI 10.1063/1.481405; FRIDMAN A, 2008, PLASMA CHEM; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Harada Y, 1997, CHEM REV, V97, P1897, DOI 10.1021/cr940315v; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; LEE YT, 1969, REV SCI INSTRUM, V40, P1402, DOI 10.1063/1.1683809; Lique F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603453; Luria K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3244085; MARTIN DW, 1989, J CHEM PHYS, V90, P1564, DOI 10.1063/1.456049; MAZELY TL, 1988, CHEM PHYS LETT, V144, P563, DOI 10.1016/0009-2614(88)87316-0; MILLER WH, 1970, J CHEM PHYS, V52, P3563, DOI 10.1063/1.1673523; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Neynaber R. H., 1969, ADV ATOM MOL PHYS, V5, P57; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Parazzoli LP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.193201; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Quemener G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3035904; ROWE BR, 1984, J CHEM PHYS, V80, P4915, DOI 10.1063/1.446513; Sawyer BC, 2011, PHYS CHEM CHEM PHYS, V13, P19059, DOI 10.1039/c1cp21203f; Sawyer BC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203203; Schreiner PR, 2011, SCIENCE, V332, P1300, DOI 10.1126/science.1203761; SCHUTTE A, 1972, PHYS REV LETT, V29, P979, DOI 10.1103/PhysRevLett.29.979; Singh V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.203201; SISKA PE, 1993, REV MOD PHYS, V65, P337, DOI 10.1103/RevModPhys.65.337; Smith IWM, 2006, ANGEW CHEM INT EDIT, V45, P2842, DOI 10.1002/anie.200502747; TANG KT, 1984, J CHEM PHYS, V80, P3726, DOI 10.1063/1.447150; Thomas NR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173201; TOENNIES JP, 1979, J CHEM PHYS, V71, P614, DOI 10.1063/1.438414; TOENNIES JP, 1974, J CHEM PHYS, V61, P2461, DOI 10.1063/1.1682349; Weck PF, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1884115; Wei Q, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739315; WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002; Willitsch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043203	48	227	227	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					234	238		10.1126/science.1229141	http://dx.doi.org/10.1126/science.1229141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066076	Green Submitted			2022-12-28	WOS:000309712300040
J	Henton, J; Jain, A; Medhurst, C; Hettiaratchy, S				Henton, John; Jain, Abhilash; Medhurst, Claire; Hettiaratchy, Shehan			Adult trigger finger	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INJECTION; SPLINT		[Henton, John; Jain, Abhilash; Hettiaratchy, Shehan] Imperial Coll Healthcare NHS Trust, Hand & Extrem Reconstruct Serv, Dept Plast & Reconstruct Surg, London W6 8RF, England; [Jain, Abhilash] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Medhurst, Claire] Baddow Village Surg, Chelmsford CM2 7EZ, Essex, England	Imperial College London; University of Oxford	Henton, J (corresponding author), Imperial Coll Healthcare NHS Trust, Hand & Extrem Reconstruct Serv, Dept Plast & Reconstruct Surg, London W6 8RF, England.	johnhenton@ymail.com						Benson LS, 1997, J HAND SURG-AM, V22A, P138, DOI 10.1016/S0363-5023(05)80194-7; Colbourn J, 2008, J HAND THER, V21, P336, DOI 10.1197/j.jht.2008.05.001; Makkouk AH, 2008, CURR REV MUSCULOSKE, V1, P92, DOI 10.1007/s12178-007-9012-1; PATEL MR, 1992, J HAND SURG-AM, V17A, P110, DOI 10.1016/0363-5023(92)90124-8; Peters-Veluthamaningal C, 2008, ANN RHEUM DIS, V67, P1262, DOI 10.1136/ard.2007.073106; Rodgers JA, 1998, ORTHOPEDICS, V21, P305; Ryzewicz M, 2006, J HAND SURG-AM, V31A, P135, DOI 10.1016/j.jhsa.2005.10.013; Sato ES, 2012, RHEUMATOLOGY, V51, P93, DOI 10.1093/rheumatology/ker315; Tarbhai K, 2012, J HAND SURG-AM, V37A, P243, DOI 10.1016/j.jhsa.2011.10.038	9	6	6	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2012	345								e5743	10.1136/bmj.e5743	http://dx.doi.org/10.1136/bmj.e5743			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TO	23065242				2022-12-28	WOS:000309908500007
J	Spence, D				Spence, Des			Bad medicine: clinical breast examination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						American Cancer Society, BREAST CANC EARL DET; [Anonymous], 2012, BBC NEWS; Fenton Joshua J, 2005, J Natl Cancer Inst Monogr, P67, DOI 10.1093/jncimonographs/lgi040; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC C; U.S. Preventive Services Task Force, 2009, SCREEN BREAST CANC	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2012	345								e6789	10.1136/bmj.e6789	http://dx.doi.org/10.1136/bmj.e6789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TI	23060657				2022-12-28	WOS:000309907900006
J	McCarthy, M				McCarthy, Michael			How US politicians are playing the health card	BRITISH MEDICAL JOURNAL			English	Editorial Material									LocalHealthGuide Com, Seattle, WA USA		McCarthy, M (corresponding author), LocalHealthGuide Com, Seattle, WA USA.	Michaelmccarthy007@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6413	10.1136/bmj.e6413	http://dx.doi.org/10.1136/bmj.e6413			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044988	Green Submitted			2022-12-28	WOS:000309386700011
J	Robinovitch, SN; Feldman, F; Yang, YJ; Schonnop, R; Leung, PM; Sarraf, T; Sims-Gould, J; Loughin, M				Robinovitch, Stephen N.; Feldman, Fabio; Yang, Yijian; Schonnop, Rebecca; Leung, Pet Ming; Sarraf, Thiago; Sims-Gould, Joanie; Loughin, Marie			Video capture of the circumstances of falls in elderly people residing in long-term care: an observational study	LANCET			English	Article							RISK; HIP; FRACTURES; DEMENTIA; BALANCE; ADULTS; GAIT; AGE	Background Falls in elderly people are a major health burden, especially in the long-term care environment. Yet little objective evidence is available for how and why falls occur in this population. We aimed to provide such evidence by analysing real-life falls in long-term care captured on video. Methods We did this observational study between April 20, 2007, and June 23, 2010, in two long-term care facilities in British Columbia, Canada. Digital video cameras were installed in common areas (dining rooms, lounges, hallways). When a fall occurred, facility staff completed an incident report and contacted our teams so that we could collect video footage. A team reviewed each fall video with a validated questionnaire that probed the cause of imbalance and activity at the time of falling. We then tested whether differences existed in the proportion of participants falling due to the various causes, and while engaging in various activities, with generalised linear models, repeated measures logistic regression, and log-linear Poisson regression. Findings We captured 227 falls from 130 individuals (mean age 78 years, SD 10). The most frequent cause of falling was incorrect weight shifting, which accounted for 41% (93 of 227) of falls, followed by trip or stumble (48, 21%), hit or bump (25, 11%), loss of support (25, 11%), and collapse (24, 11%). Slipping accounted for only 3% (six) of falls. The three activities associated with the highest proportion of falls were forward walking (54 of 227 falls, 24%), standing quietly (29 falls, 13%), and sitting down (28 falls, 12%). Compared with previous reports from the long-term care setting, we identified a higher occurrence of falls during standing and transferring, a lower occurrence during walking, and a larger proportion due to centre-of-mass perturbations than base-of-support perturbations. Interpretation By providing insight into the sequences of events that most commonly lead to falls, our results should lead to more valid and effective approaches for balance assessment and fall prevention in long-term care.	[Robinovitch, Stephen N.; Feldman, Fabio; Yang, Yijian; Schonnop, Rebecca; Leung, Pet Ming; Sarraf, Thiago] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Injury Prevent & Mobil Lab, Technol Injury Prevent Seniors Program, Burnaby, BC V5A 1S6, Canada; [Feldman, Fabio; Leung, Pet Ming] Fraser Hlth Author, Surrey, BC, Canada; [Sims-Gould, Joanie] Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Loughin, Marie] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Robinovitch, SN (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Injury Prevent & Mobil Lab, Technol Injury Prevent Seniors Program, Burnaby, BC V5A 1S6, Canada.	stever@sfu.ca	Yang, Yijian/G-1580-2016	Yang, Yijian/0000-0002-5831-186X; Robinovitch, Stephen/0000-0003-3881-6227; Schonnop, Rebecca/0000-0003-0236-6711; Sims Gould, Joanie/0000-0003-1260-5405	Canadian Institutes for Health Research [TIR-103945, AMG-100487]; Canada Research Chair award (in Injury Prevention and Mobility Biomechanics)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award (in Injury Prevention and Mobility Biomechanics)	Funding Canadian Institutes for Health Research.; This study was supported by grants from the Canadian Institutes for Health Research (TIR-103945 and AMG-100487). SNR was supported by a Canada Research Chair award (in Injury Prevention and Mobility Biomechanics). We thank the staff and residents of Delta View Life Enrichment Centre and Habilitation Centre, and New Vista Society Care Home for their partnership in this study.	BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Brocklehurst J C, 1978, Age Ageing, V7, P2; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Feldman F, 2006, OSTEOPOROSIS INT, V18, pS4; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Gillespie L, 2008, COCHRANE DB SYST REV, V4; GRISSO JA, 1990, J AM GERIATR SOC, V38, P1326, DOI 10.1111/j.1532-5415.1990.tb03456.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Herman M., 2006, EVOLUTION SENIORS FA; Holliday P, 1990, SLIPS, P7; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Noury N, 2007, P ANN INT IEEE EMBS, P1663, DOI 10.1109/IEMBS.2007.4352627; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; OVERSTALL PW, 1977, BRIT MED J, V1, P261, DOI 10.1136/bmj.1.6056.261; Palvanen M, 2000, OSTEOPOROSIS INT, V11, P822, DOI 10.1007/s001980070040; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Prudham D, 1981, Age Ageing, V10, P141; Rapp K, 2011, J AM MED DIR ASSOC, V13, P187; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Sparrow WA, 2005, GAIT POSTURE, V22, P362, DOI 10.1016/j.gaitpost.2004.11.005; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TOPPER AK, 1993, J AM GERIATR SOC, V41, P479, DOI 10.1111/j.1532-5415.1993.tb01881.x; Wang TY, 2011, NEUROSCIENCE, V180, P85, DOI 10.1016/j.neuroscience.2011.02.039; Zecevic AA, 2006, GERONTOLOGIST, V46, P367, DOI 10.1093/geront/46.3.367; Zieschang T, 2012, INT PSYCHOGERIATR, V24, P587, DOI 10.1017/S1041610211002122	31	495	505	3	137	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					47	54		10.1016/S0140-6736(12)61263-X	http://dx.doi.org/10.1016/S0140-6736(12)61263-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23083889	Green Accepted			2022-12-28	WOS:000313044300026
J	Baker, DW; Qaseem, A; Reynolds, PP; Gardner, LA; Schneider, EC				Baker, David W.; Qaseem, Amir; Reynolds, P. Preston; Gardner, Lea Anne; Schneider, Eric C.		Amer Coll Phys Performance	Design and Use of Performance Measures to Decrease Low-Value Services and Achieve Cost-Conscious Care	ANNALS OF INTERNAL MEDICINE			English	Review							HEALTH-CARE; CORONARY-ANGIOGRAPHY; DECISION-SUPPORT; QUALITY; OUTCOMES; SURGERY; YIELD	Improving quality of care while decreasing the cost of health care is a national priority. The American College of Physicians recently launched its High-Value Care Initiative to help physicians and patients understand the benefits, harms, and costs of interventions and to determine whether services provide good value. Public and private payers continue to measure underuse of high-value services (for example, preventive services, medications for chronic disease), but they are now widely using performance measures to assess use of low-value interventions (such as imaging for patients with uncomplicated low back pain) and using the results for public reporting and pay-for-performance. This paper gives an overview of performance measures that target low-value services to help physicians understand the strengths and limitations of these measures, provides specific examples of measures that assess use of low-value services, and discusses how these measures can be used in clinical practice and policy. Ann Intern Med. 2013;158:55-59.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Feinberg Sch Med Chicago, Chicago, IL USA; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; ECRI Inst, Plymouth Meeting, PA USA; RAND, Boston, MA USA	American College of Physicians; Northwestern University; Feinberg School of Medicine; University of Virginia; RAND Corporation	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Schneider, Eric/0000-0002-1132-5084	American College of Physicians operating budget	American College of Physicians operating budget	Financial support for the development of this paper comes exclusively from the American College of Physicians operating budget.	Agency for Healthcare Research and Quality, 2006, CLOS QUAL GAP CRIT A, V4; American College of Physicians, 2010, HIGH VAL CAR; American College of Physicians, 2011, CAN OUR NAT CONS DIS; Bernstein S J, 1993, Int J Technol Assess Health Care, V9, P3; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Medicare & Medicaid Services, HOSP COMP WEB SIT; Centers for Medicare & Medicaid Services, PHYS COMP; Centers for Medicare & Medicaid Services, 2005, CAG00093R CTR MED ME; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; French SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006094.pub2; GRAY D, 1990, LANCET, V335, P1317, DOI 10.1016/0140-6736(90)91196-H; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kawamoto Kensaku, 2010, AMIA Annu Symp Proc, V2010, P377; National Committee for Quality Assurance, 2006, HEDIS TECHN SPEC; National Priorities Partnership, 2008, NAT PRIOR GOALS ALIG; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Persell SD, 2011, MED CARE, V49, P117, DOI 10.1097/MLR.0b013e318202913d; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Schneider EC, 2001, QUAL HEALTH CARE, V10, P96, DOI 10.1136/qhc.10.2.96; Sequist TD, 2011, ARCH INTERN MED, V171, P636, DOI 10.1001/archinternmed.2010.467; Shah BR, 2010, J AM COLL CARDIOL, V56, P1328, DOI 10.1016/j.jacc.2010.03.093; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Steinman MA, 2006, MED CARE, V44, P617, DOI 10.1097/01.mlr.0000215846.25591.22; Vartanians VM, 2010, RADIOLOGY, V255, P842, DOI 10.1148/radiol.10091228; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706	32	64	64	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					55	U129		10.7326/0003-4819-158-1-201301010-00560	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00560			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23108285				2022-12-28	WOS:000313119900008
J	Bernards, R				Bernards, Rene			A Missing Link in Genotype-Directed Cancer Therapy	CELL			English	Editorial Material							INHIBITION; VEMURAFENIB; EGFR	Genotype-directed therapy holds great promise for the treatment of cancer, but crosstalk between signaling pathways often confounds simple genotype-drug response relationships. To deliver on the promise of precision medicine, a coordinated effort is needed to make a comprehensive inventory of the many signaling feedback circuits that exist in cancer cells.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	9	76	79	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					465	468		10.1016/j.cell.2012.10.014	http://dx.doi.org/10.1016/j.cell.2012.10.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101617	Bronze			2022-12-28	WOS:000310529300002
J	Minko, Y; Pasco, M; Lercher, L; Botoshansky, M; Marek, I				Minko, Yury; Pasco, Morgane; Lercher, Lukas; Botoshansky, Mark; Marek, Ilan			Forming all-carbon quaternary stereogenic centres in acyclic systems from alkynes	NATURE			English	Article							IRELAND-CLAISEN REARRANGEMENT; DIASTEREOSELECTIVE PREPARATION; STEREOSELECTIVE CONSTRUCTION; STEREOCENTERS; GENERATION; PRODUCTS; REAGENTS; CREATION; ESTERS	The formation of all-carbon quaternary stereocentres in acyclic systems is one of the most difficult contemporary challenges in modern synthetic organic chemistry(1,2). Particularly challenging is the preparation of all-carbon quaternary stereocentres in aldol adducts(3); this difficulty is problematic because the aldol reaction represents one of the most valuable chemical transformations in organic synthesis(4). The main problem that limits the formation of these stereocentres is the absence of an efficient method of preparing stereodefined trisubstituted enolates in acyclic systems(5-8). Here we describe a different approach that involves the formation of two new stereogenic centres-including the all-carbon quaternary one-via a combined carbometalation-oxidation reaction of an organocuprate to give a stereodefined trisubstituted enolate. We use this method to generate a series of aldol and Mannich products from ynamides with excellent diastereomeric and enantiomeric ratios and moderate yields.	[Minko, Yury; Pasco, Morgane; Lercher, Lukas; Marek, Ilan] Technion Israel Inst Technol, Schulich Fac Chem, Mallat Family Lab Organ Chem, IL-32000 Haifa, Israel; [Minko, Yury; Pasco, Morgane; Lercher, Lukas; Marek, Ilan] Technion Israel Inst Technol, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-32000 Haifa, Israel; [Botoshansky, Mark] Technion Israel Inst Technol, Xray Anal Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Marek, I (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, Mallat Family Lab Organ Chem, IL-32000 Haifa, Israel.	chilanm@tx.technion.ac.il	Minko, Yury/AAE-9679-2019	Pasco, Morgane/0000-0002-1556-2802; Minko, Yury/0000-0001-8241-6795; Lercher, Lukas August/0000-0003-1810-4310	Israel Science Foundation [140/12]; Fund for Promotion of Research at the Technion; Bayer-Stiftung	Israel Science Foundation(Israel Science Foundation); Fund for Promotion of Research at the Technion; Bayer-Stiftung	This research was supported by the Israel Science Foundation administrated by the Israel Academy of Sciences and Humanities (140/12), and by the Fund for Promotion of Research at the Technion. L.L. thanks the Bayer-Stiftung for financial support. I.M. is holder of the Sir Michael and Lady Sobell Academic Chair.	Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Carreira E. M., 2001, MODERN CARBONYL CHEM, P227; Chechik-Lankin H, 2005, SYNLETT, P2098, DOI 10.1055/s-2005-871962; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Das JP, 2009, NAT CHEM, V1, P128, DOI [10.1038/NCHEM.131, 10.1038/nchem.131]; DeBergh JR, 2008, J AM CHEM SOC, V130, P7828, DOI 10.1021/ja803480b; Denmark SE, 2007, J AM CHEM SOC, V129, P14864, DOI 10.1021/ja077134y; Dutta B, 2010, J AM CHEM SOC, V132, P5588, DOI 10.1021/ja101371x; Evano G, 2010, ANGEW CHEM INT EDIT, V49, P2840, DOI 10.1002/anie.200905817; EVANS DA, 1981, J AM CHEM SOC, V103, P2127, DOI 10.1021/ja00398a058; Gilboa N, 2011, CHEM-EUR J, V17, P8000, DOI 10.1002/chem.201101049; Gu ZH, 2010, SYNLETT, P1717, DOI 10.1055/s-0029-1219965; HANER R, 1985, J AM CHEM SOC, V107, P5396; Hawner C, 2010, CHEM COMMUN, V46, P7295, DOI 10.1039/c0cc02309d; Kummer DA, 2008, J AM CHEM SOC, V130, P13231, DOI 10.1021/ja806021y; Manthorpe JM, 2001, J AM CHEM SOC, V123, P2091, DOI 10.1021/ja0058280; Marek I, 2008, CHEM-EUR J, V14, P7460, DOI 10.1002/chem.200800580; Mase N, 2004, ANGEW CHEM INT EDIT, V43, P2420, DOI 10.1002/anie.200353546; Newhouse T, 2009, CHEM SOC REV, V38, P3010, DOI 10.1039/b821200g; PANEK EJ, 1977, J AM CHEM SOC, V99, P3708, DOI 10.1021/ja00453a032; Qin YC, 2007, ANGEW CHEM INT EDIT, V46, P7466, DOI 10.1002/anie.200702142; Scott HK, 2011, CHEM-EUR J, V17, P13124, DOI 10.1002/chem.201102581; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Sklute G, 2006, J AM CHEM SOC, V128, P4642, DOI 10.1021/ja060498q; Stivala CE, 2008, J AM CHEM SOC, V130, P3774, DOI 10.1021/ja800435j; Tiong EA, 2009, ORG LETT, V11, P1725, DOI 10.1021/ol802643k; Wender PA, 2009, NATURE, V460, P197, DOI 10.1038/460197a; Wendlandt AE, 2011, ANGEW CHEM INT EDIT, V50, P11062, DOI 10.1002/anie.201103945; YAMAGO S, 1991, J ORG CHEM, V56, P2098, DOI 10.1021/jo00006a026; Zhang DH, 2005, ORG LETT, V7, P5681, DOI 10.1021/ol052413g	30	149	150	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					522	526		10.1038/nature11569	http://dx.doi.org/10.1038/nature11569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099407				2022-12-28	WOS:000310196200038
J	Spence, D				Spence, Des			FROM THE FRONTLINE A licence to bill	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 23	2012	345								e7078	10.1136/bmj.e7078	http://dx.doi.org/10.1136/bmj.e7078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MT	23092902				2022-12-28	WOS:000310427100002
J	Frieda, KL; Block, SM				Frieda, Kirsten L.; Block, Steven M.			Direct Observation of Cotranscriptional Folding in an Adenine Riboswitch	SCIENCE			English	Article							RNA-POLYMERASE; NASCENT RNA; TRANSCRIPTION; ELONGATION; KINETICS; BINDING; RIBOZYME	Growing RNA chains fold cotranscriptionally as they are synthesized by RNA polymerase. Riboswitches, which regulate gene expression by adopting alternative RNA folds, are sensitive to cotranscriptional events. We developed an optical-trapping assay to follow the cotranscriptional folding of a nascent RNA and used it to monitor individual transcripts of the pbuE adenine riboswitch, visualizing distinct folding transitions. We report a particular folding signature for the riboswitch aptamer whose presence directs the gene-regulatory transcription outcome, and we measured the termination frequency as a function of adenine level and tension applied to the RNA. Our results demonstrate that the outcome is kinetically controlled. These experiments furnish a means to observe conformational switching in real time and enable the precise mapping of events during cotranscriptional folding.	[Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu			National Institute of General Medical Services, NIH; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057035] Funding Source: NIH RePORTER	National Institute of General Medical Services, NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Landick for providing purified RNAP and C. Garcia-Garcia, V. Schweikhard, W. Greenleaf, P. Anthony, and other members of the Block lab for useful discussions. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by a grant from the National Institute of General Medical Services, NIH (S. M. B.), and an NSF Graduate Research Fellowship and Stanford Graduate Fellowship (K.L.F.).	Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pan T, 1999, J MOL BIOL, V286, P721, DOI 10.1006/jmbi.1998.2516; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Xayaphoummine A, 2007, NUCLEIC ACIDS RES, V35, P614, DOI 10.1093/nar/gkl1036	26	127	130	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					397	400		10.1126/science.1225722	http://dx.doi.org/10.1126/science.1225722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087247	Green Accepted			2022-12-28	WOS:000309955800045
J	Keller, R				Keller, Ray			Physical Biology Returns to Morphogenesis	SCIENCE			English	Editorial Material							GASTRULATION; MECHANICS; SHAPE; ADHESION; CELLS		Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Keller, R (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	rek3k@virginia.edu						Bellairs R., 1982, CELL BEHAV; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; GUSTAFSON T, 1963, INT REV CYTOL, V15, P139, DOI 10.1016/S0074-7696(08)61117-1; HARDIN JD, 1986, DEV BIOL, V115, P490, DOI 10.1016/0012-1606(86)90269-1; Holtfreter J, 1944, J EXP ZOOL, V95, P171, DOI 10.1002/jez.1400950203; Holtfreter J, 1943, J EXP ZOOL, V94, P261, DOI 10.1002/jez.1400940302; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; Holtreter J, 1939, ARCH EXP ZELLFORSCH, V23, P169; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; Koehl M.A.R., 1990, Seminars in Developmental Biology, V1, P367; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; STEINBERG M S, 1978, P25; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Trinkaus J. P., 1984, CELLS ORGANS FORCES; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667	18	59	60	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					201	203		10.1126/science.1230718	http://dx.doi.org/10.1126/science.1230718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066066				2022-12-28	WOS:000309712300026
J	Chalmers, M				Chalmers, Matthew			COSMOLOGY Out of the darkness	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S2	S4		10.1038/490S2a	http://dx.doi.org/10.1038/490S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051769	Bronze			2022-12-28	WOS:000309733300002
J	Black, ME				Black, Mary E.			Prepared to fail?	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 8	2012	345								e6764	10.1136/bmj.e6764	http://dx.doi.org/10.1136/bmj.e6764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SV	23044696				2022-12-28	WOS:000309906600004
J	McCabe, MT; Ott, HM; Ganji, G; Korenchuk, S; Thompson, C; Van Aller, GS; Liu, Y; Graves, AP; Della Pietra, A; Diaz, E; LaFrance, LV; Mellinger, M; Duquenne, C; Tian, XR; Kruger, RG; McHugh, CF; Brandt, M; Miller, WH; Dhanak, D; Verma, SK; Tummino, PJ; Creasy, CL				McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Graves, Alan P.; Della Pietra, Anthony, III; Diaz, Elsie; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Brandt, Martin; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.			EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations	NATURE			English	Article							HISTONE METHYLTRANSFERASE EZH2; LYSINE 27; SOMATIC MUTATIONS; GENES; H3; HYPERTRIMETHYLATION; METHYLATION; SUBSTRATE; CANCER; H3K27	In eukaryotes, post-translational modification of histones is critical for regulation of chromatin structure and gene expression. EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and is involved in repressing gene expression through methylation of histone H3 on lysine 27 (H3K27). EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumour types(1-5). Additionally, somatic heterozygous mutations of Y641 and A677 residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma(6-10). The Y641 residue is the most frequently mutated residue, with up to 22% of germinal centre B-cell DLBCL and follicular lymphoma harbouring mutations at this site. These lymphomas have increased H3K27 tri-methylation (H3K27me3) owing to altered substrate preferences of the mutant enzymes(9,11-13). However, it is unknown whether specific, direct inhibition of EZH2 methyltransferase activity will be effective in treating EZH2 mutant lymphomas. Here we demonstrate that GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes. GSK126 effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice. Together, these data demonstrate that pharmacological inhibition of EZH2 activity may provide a promising treatment for EZH2 mutant lymphoma.	[McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Della Pietra, Anthony, III; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, Collegeville, PA 19426 USA; [Graves, Alan P.; Diaz, Elsie; Brandt, Martin] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Creasy, CL (corresponding author), GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	caretha.l.creasy@gsk.com	Thompson, Christine/GWV-6539-2022	Graves, Alan/0000-0002-8949-4961				Al-Katib AM, 1998, CLIN CANCER RES, V4, P1305; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chou RH, 2011, AM J TRANSL RES, V3, P243; Diaz E., 2012, J BIOMOL SCREEN; DYER MJS, 1990, BLOOD, V75, P709; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; TORNHEIM K, 1994, ANAL BIOCHEM, V221, P53, DOI 10.1006/abio.1994.1377; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	30	1275	1347	7	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					108	+		10.1038/nature11606	http://dx.doi.org/10.1038/nature11606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23051747				2022-12-28	WOS:000311893400055
J	Warnecke, G; Moradiellos, J; Tudorache, I; Kuhn, C; Avsar, M; Wiegmann, B; Sommer, W; Ius, F; Kunze, C; Gottlieb, J; Varela, A; Haverich, A				Warnecke, Gregor; Moradiellos, Javier; Tudorache, Igor; Kuehn, Christian; Avsar, Murat; Wiegmann, Bettina; Sommer, Wiebke; Ius, Fabio; Kunze, Claudia; Gottlieb, Jens; Varela, Andres; Haverich, Axel			Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients	LANCET			English	Article							PRIMARY GRAFT DYSFUNCTION; HEART-BEATING DONORS; ISHLT WORKING GROUP; EX-VIVO; INTERNATIONAL-SOCIETY; COLD ISCHEMIA; RISK-FACTORS; FAILURE; OXYGENATION; SURVIVAL	Background Cold flush and static cold storage is the standard preservation technique for donor lungs before transplantations. Several research groups have assessed normothermic perfusion of donor lungs but all devices investigated were non-portable. We report first-in-man experience of the portable Organ Care System (OCS) Lung device for concomitant preservation, assessment, and transport of donor lungs. Methods Between Feb 18, and July 1, 2011, 12 patients were transplanted at two academic lung transplantation centres in Hanover, Germany and Madrid, Spain. Lungs were perfused with low-potassium dextran solution, explanted, immediately connected to the OCS Lung, perfused with Steen's solution supplemented with two red-cell concentrates. We assessed donor and recipient characteristics and monitored extended criteria donor lung scores; primary graft dysfunction scores at 0, 24, 48, and 72 h; time on mechanical ventilation after surgery; length of stays in hospital and the intensive-care unit after surgery; blood gases; and survival of grafts and patients. Findings Eight donors were female and four were male (mean age 44.5 years, range 14-72). Seven recipients were female and five were male (mean age 50.0 years, range 31-59). The preharvest donor ratio of partial pressure of oxyen (PaO2) to fractional concentration of oxygen in inspired air (F1O2) was 463.9 (SD 91.4). The final ratio of PaO2 to F1O2 measured with the OCS Lung was 471.58 (127.9). The difference between these ratios was not significant (p=0.72). All grafts and patients survived to 30 days; all recipients recovered and were discharged from hospital. Interpretation Lungs can be safely preserved with the OCS Lung, resulting in complete organ use and successful transplantation in our series of high-risk recipients. In November, 2011, we began recruitment for a prospective, randomised, multicentre trial (INSPIRE) to compare preservation with OCS Lung with standard cold storage.	[Warnecke, Gregor; Tudorache, Igor; Kuehn, Christian; Avsar, Murat; Wiegmann, Bettina; Sommer, Wiebke; Ius, Fabio; Kunze, Claudia; Haverich, Axel] Hannover Med Sch, Div Cardiac Thorac Transplantat & Vasc Surg, D-30623 Hannover, Germany; [Warnecke, Gregor; Gottlieb, Jens; Haverich, Axel] German Ctr Lung Res, Hannover, Germany; [Kuehn, Christian; Wiegmann, Bettina; Haverich, Axel] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, D-30623 Hannover, Germany; [Moradiellos, Javier; Varela, Andres] Hosp Univ Puerta de Hierro, Div Thorac Surg, Madrid, Spain; [Gottlieb, Jens] Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hospital Puerta de Hierro-Majadahonda; Hannover Medical School	Warnecke, G (corresponding author), Hannover Med Sch, Div Cardiac Thorac Transplantat & Vasc Surg, Carl Neuberg Str 1, D-30623 Hannover, Germany.	warnecke.gregor@mh-hannover.de	Varela de Ugarte, Andres/B-4837-2017; Haverich, Axel/AAC-7552-2022	Varela de Ugarte, Andres/0000-0001-8827-2454; Gottlieb, Prof. Jens/0000-0002-9540-9022	TransMedics; German Federal Ministry of Education and Research [01E00802]	TransMedics; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	TransMedics and German Federal Ministry of Education and Research.; This study was supported by a grant from the German Federal Ministry of Education and Research (reference number 01E00802), which partly pays the salary of BW.	Aigner C, 2012, AM J TRANSPLANT, V12, P1839, DOI 10.1111/j.1600-6143.2012.04027.x; Arcasoy SM, 2005, J HEART LUNG TRANSPL, V24, P1483, DOI 10.1016/j.healun.2004.11.314; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1231, DOI 10.1016/j.healun.2010.05.013; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; Christie JD, 1998, CHEST, V114, P51, DOI 10.1378/chest.114.1.51; Christie JD, REGISTRY INT SOC HEA; Cypel M, 2011, CLIN CHEST MED, V32, P233, DOI 10.1016/j.ccm.2011.02.003; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Fisher AJ, 2001, AM J RESP CRIT CARE, V163, P259, DOI 10.1164/ajrccm.163.1.2005093; Fuehner T, 2012, AM J RESP CRIT CARE, V185, P763, DOI 10.1164/rccm.201109-1599OC; Gohrbandt B, 2006, J THORAC CARDIOV SUR, V131, P724, DOI 10.1016/j.jtcvs.2005.09.049; Gomez-de-Antonio D, 2012, J HEART LUNG TRANSPL, V31, P349, DOI 10.1016/j.healun.2011.12.007; Ingemansson R, 2009, ANN THORAC SURG, V87, P255, DOI 10.1016/j.athoracsur.2008.09.049; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Kuntz CL, 2009, CLIN TRANSPLANT, V23, P819, DOI 10.1111/j.1399-0012.2008.00951.x; Ladowski J S, 1985, J Heart Transplant, V4, P330; Marasco SF, 2011, J HEART LUNG TRANSPL, V30, P414, DOI 10.1016/j.healun.2010.10.002; Pilcher DV, 2005, J HEART LUNG TRANSPL, V24, P1814, DOI 10.1016/j.healun.2005.04.003; Prekker ME, 2006, J HEART LUNG TRANSPL, V25, P371, DOI 10.1016/j.healun.2005.11.436; Robicsek F, 1985, J Heart Transplant, V4, P334; Smits JM, 2011, TRANSPL INT, V24, P393, DOI 10.1111/j.1432-2277.2010.01207.x; Sommer SP, 2004, EUR J CARDIO-THORAC, V26, P151, DOI 10.1016/j.ejcts.2004.02.019; Thabut G, 2005, AM J RESP CRIT CARE, V171, P786, DOI 10.1164/rccm.200409-1248OC; Warnecke G, 2001, TRANSPLANTATION, V71, P1238, DOI 10.1097/00007890-200105150-00010; Whitson BA, 2006, J THORAC CARDIOV SUR, V131, P73, DOI 10.1016/j.jtcvs.2005.08.039; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; Zych B, 2012, J HEART LUNG TRANSPL, V31, P274, DOI 10.1016/j.healun.2011.10.008	30	164	181	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1851	1858		10.1016/S0140-6736(12)61344-0	http://dx.doi.org/10.1016/S0140-6736(12)61344-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23063317				2022-12-28	WOS:000311435000030
J	Roth, EM; McKenney, JM; Hanotin, C; Asset, G; Stein, EA				Roth, Eli M.; McKenney, James M.; Hanotin, Corinne; Asset, Gaelle; Stein, Evan A.			Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; MONOCLONAL-ANTIBODY; THERAPY	BACKGROUND Serum proprotein convertase subtilisin/kexin 9 (PCSK9) binds to low-density lipoprotein (LDL) receptors, increasing the degradation of LDL receptors and reducing the rate at which LDL cholesterol is removed from the circulation. REGN727/SAR236553 (designated here as SAR236553), a fully human PCSK9 monoclonal antibody, increases the recycling of LDL receptors and reduces LDL cholesterol levels. METHODS We performed a phase 2, multicenter, double-blind, placebo-controlled trial involving 92 patients who had LDL cholesterol levels of 100 mg per deciliter (2.6 mmol per liter) or higher after treatment with 10 mg of atorvastatin for at least 7 weeks. Patients were randomly assigned to receive 8 weeks of treatment with 80 mg of atorvastatin daily plus SAR236553 once every 2 weeks, 10 mg of atorvastatin daily plus SAR236553 once every 2 weeks, or 80 mg of atorvastatin daily plus placebo once every 2 weeks and were followed for an additional 8 weeks after treatment. RESULTS The least-squares mean (+/- SE) percent reduction from baseline in LDL cholesterol was 73.2 +/- 3.5 with 80 mg of atorvastatin plus SAR236553, as compared with 17.3 +/- 3.5 with 80 mg of atorvastatin plus placebo (P<0.001) and 66.2 +/- 3.5 with 10 mg of atorvastatin plus SAR236553. All the patients who received SAR236553, as compared with 52% of those who received 80 mg of atorvastatin plus placebo, attained an LDL cholesterol level of less than 100 mg per deciliter, and at least 90% of the patients who received SAR236553, as compared with 17% who received 80 mg of atorvastatin plus placebo, attained LDL cholesterol levels of less than 70 mg per deciliter (1.8 mmol per liter). CONCLUSIONS In a randomized trial involving patients with primary hypercholesterolemia, adding SAR236553 to either 10 mg of atorvastatin or 80 mg of atorvastatin resulted in a significantly greater reduction in LDL cholesterol than that attained with 80 mg of atorvastatin alone. (Funded by Sanofi and Regeneron Pharmaceuticals; ClinicalTrials. gov number, NCT01288469.)	[Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45227 USA; [Roth, Eli M.] Sterling Res Grp, Cincinnati, OH USA; [Stein, Evan A.] Medpace Reference Labs, Cincinnati, OH USA; [McKenney, James M.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Hanotin, Corinne] Sanofi, Paris, France; [Asset, Gaelle] Sanofi, Chilly Mazarin, France	Virginia Commonwealth University; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, 5355 Medpace Way, Cincinnati, OH 45227 USA.	esteinmrl@aol.com			Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	Funded by Sanofi and Regeneron Pharmaceuticals;	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stone N, 2002, EUR HEART J SUPPL, V4, pJ19, DOI 10.1016/S1520-765X(02)90078-7; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	15	377	429	3	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1891	1900		10.1056/NEJMoa1201832	http://dx.doi.org/10.1056/NEJMoa1201832			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23113833	Green Published			2022-12-28	WOS:000311029300005
J	Tidow, H; Poulsen, LR; Andreeva, A; Knudsen, M; Hein, KL; Wiuf, C; Palmgren, MG; Nissen, P				Tidow, Henning; Poulsen, Lisbeth R.; Andreeva, Antonina; Knudsen, Michael; Hein, Kim L.; Wiuf, Carsten; Palmgren, Michael G.; Nissen, Poul			A bimodular mechanism of calcium control in eukaryotes	NATURE			English	Article							MEMBRANE CA2+ PUMP; STRUCTURE VALIDATION; REGULATORY DOMAIN; BINDING DOMAIN; CALMODULIN; PLANT; CA2+-ATPASE; ACTIVATION; DIVERSITY; PROTEINS	Calcium ions (Ca2+) have an important role as secondary messengers in numerous signal transduction processes(1-4), and cells invest much energy in controlling and maintaining a steep gradient between intracellular (similar to 0.1-micromolar) and extracellular (similar to 2-millimolar) Ca2+ concentrations(1). Calmodulin-stimulated calcium pumps, which include the plasma-membrane Ca2+-ATPases (PMCAs), are key regulators of intracellular Ca2+ in eukaryotes(5-8). They contain a unique amino- or carboxy-terminal regulatory domain responsible for autoinhibition, and binding of calcium-loaded calmodulin to this domain releases autoinhibition and activates the pump. However, the structural basis for the activation mechanism is unknown and a key remaining question is how calmodulin-mediated PMCA regulation can cover both basal Ca2+ levels in the nanomolar range as well as micromolar-range Ca2+ transients generated by cell stimulation(7). Here we present an integrated study combining the determination of the high-resolution crystal structure of a PMCA regulatory-domain/calmodulin complex with in vivo characterization and biochemical, biophysical and bioinformatics data that provide mechanistic insights into a two-step PMCA activation mechanism mediated by calcium-loaded calmodulin. The structure shows the entire PMCA regulatory domain and reveals an unexpected 2: 1 stoichiometry with two calcium-loaded calmodulin molecules binding to different sites on a long helix. A multifaceted characterization of the role of both sites leads to a general structural-model for calmodulin-mediated regulation of PMCAs that allows stringent, highly responsive control of intracellular calcium in eukaryotes, making it possible to maintain a stable, basal level at a threshold Ca2+ concentration, where steep activation occurs.	[Tidow, Henning; Poulsen, Lisbeth R.; Knudsen, Michael; Hein, Kim L.; Palmgren, Michael G.; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Tidow, Henning; Hein, Kim L.; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Andreeva, Antonina] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Knudsen, Michael] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Wiuf, Carsten] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; MRC Laboratory Molecular Biology; Aarhus University; University of Copenhagen	Palmgren, MG (corresponding author), Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	palmgren@life.ku.dk; pn@mb.au.dk	Poulsen, Lisbeth R/I-1843-2014; Palmgren, Michael/A-9808-2013; Wiuf, Carsten/H-6320-2011; Poulsen, Lisbeth Rosager/AAP-1301-2020; Nissen, Poul/D-5774-2014; Tidow, Henning/K-3420-2015	Poulsen, Lisbeth R/0000-0002-9133-3358; Palmgren, Michael/0000-0002-9982-6114; Wiuf, Carsten/0000-0002-1302-4445; Nissen, Poul/0000-0003-0948-6628; Knudsen, Michael/0000-0002-6294-2517; Tidow, Henning/0000-0002-4702-9332; Andreeva, Antonina/0000-0002-0450-0091	EMBO Long-Term Fellowship; Marie-Curie Intra-European Fellowship; HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); MRC [MC_U105192716] Funding Source: UKRI; Medical Research Council [MC_U105192716] Funding Source: researchfish	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission); HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Nissen and Palmgren labs for discussions, and P. Gourdon for help with data collection. We thank the staff at beamlines ID23-2 at the European Radiation Synchrotron Facility, France; PX3 at the Swiss Light Source, Paul Scherrer Institute, Switzerland; and X33 at EMBL/DESY, Germany. We are grateful to K. Nagai for a plasmid expressing mammalian CaM. Support from the European Community-Research Infrastructure Action under the FP7 is acknowledged for access to EMBL/DESY. H. T. is a Junior Research Fellow at Trinity College, Cambridge, and was supported by an EMBO Long-Term Fellowship, a Marie-Curie Intra-European Fellowship and an HFSP Long-Term Fellowship. P.N. was supported by an ERC advanced grant (BIOMEMOS).	Afonine PV, 2005, CCP4 NEWSL, V42; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; Brini M, 2011, COLD SPRING HARB PER, V3, DOI [DOI 10.1101/CSHPERSPECT.A004168, 10.1101/cshperspect.a004168]; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Malmstrom S, 1997, FEBS LETT, V400, P324, DOI 10.1016/S0014-5793(96)01448-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tidow H, 2010, ACTA CRYSTALLOGR F, V66, P361, DOI 10.1107/S1744309110003805	48	83	84	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					468	+		10.1038/nature11539	http://dx.doi.org/10.1038/nature11539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086147				2022-12-28	WOS:000311031600051
J	Joiner, MLA; Koval, OM; Li, JD; He, BJ; Allamargot, C; Gao, Z; Luczak, ED; Hall, DD; Fink, BD; Chen, BY; Yang, JY; Moore, SA; Scholz, TD; Strack, S; Mohler, PJ; Sivitz, WI; Song, LS; Anderson, ME				Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Allamargot, Chantal; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Fink, Brian D.; Chen, Biyi; Yang, Jinying; Moore, Steven A.; Scholz, Thomas D.; Strack, Stefan; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.			CaMKII determines mitochondrial stress responses in heart	NATURE			English	Article							II INHIBITION PROTECTS; KINASE-II; CALMODULIN KINASE; CALCIUM UNIPORTER; IN-VIVO; INNER MEMBRANE; FAILURE; HYPERTROPHY; APOPTOSIS; OXIDATION	Myocardial cell death is initiated by excessive mitochondrial Ca2+ entry causing Ca2+ overload, mitochondrial permeability transition pore (mPTP) opening and dissipation of the mitochondrial inner membrane potential (Delta Psi m)(1,2). However, the signalling pathways that control mitochondrial Ca2+ entry through the inner membrane mitochondrial Ca2+ uniporter (MCU)(3-5) are not known. The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated in ischaemia reperfusion, myocardial infarction and neurohumoral injury, common causes of myocardial death and heart failure; these findings suggest that CaMKII could couple disease stress to mitochondrial injury. Here we show that CaMKII promotes mPTP opening and myocardial death by increasing MCU current (I-MCU). Mitochondrial-targeted CaMKII inhibitory protein or cyclosporin A, an mPTP antagonist with clinical efficacy in ischaemia reperfusion injury(6), equivalently prevent mPTP opening, Delta Psi m deterioration and diminish mitochondrial disruption and programmed cell death in response to ischaemia reperfusion injury. Mice with myocardial and mitochondrial-targeted CaMKII inhibition have reduced I-MCU and are resistant to ischaemia reperfusion injury, myocardial infarction and neurohumoral injury, suggesting that pathological actions of CaMKII are substantially mediated by increasing I-MCU. Our findings identify CaMKII activity as a central mechanism for mitochondrial Ca2+ entry in myocardial cell death, and indicate that mitochondrial-targeted CaMKII inhibition could prevent or reduce myocardial death and heart failure in response to common experimental forms of pathophysiological stress.	[Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Ctr Cardiovasc, Carver Coll Med, Iowa City, IA 52242 USA; [He, B. Julie; Moore, Steven A.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Carver Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Fink, Brian D.; Sivitz, William I.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Scholz, Thomas D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Joiner, MLA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	mei-ling-joiner@uiowa.edu; mark-e-anderson@uiowa.edu	Hall, Duane/ACD-6815-2022; Chen, Biyi/AAF-3077-2021	Hall, Duane/0000-0003-2228-0966; Joiner, Mei-ling/0000-0002-7775-7349; Moore, Steven/0000-0002-6353-7900; Fink, Brian/0000-0002-1149-7935; Song, Long-Sheng/0000-0002-6035-8106; Koval, Olha/0000-0003-1644-0046; Scholz, Thomas/0000-0003-0759-2486; Sivitz, William/0000-0002-7829-0189; Strack, Stefan/0000-0002-6175-7280	AHA [0635357N]; NIH [R01 HL090905, R01 HL079031, R01 HL62494, R01 HL70250, R01 HL113001, R01 HL084583, R01 HL083422]; Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062494, R01HL090905, R01HL070250, R01HL083422, R01HL113001, R01HL084583, R01HL079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge discussions with A. Lee, B. Davidson, K. Campbell and C. Sigmund. This work was funded by: AHA 0635357N (M.A.J.); (NIH R01 HL090905 (L.-S.S.); NIH R01 HL079031, R01 HL62494, R01 HL70250 and R01 HL113001 and supported by a grant from the Fondation Leducq for the Alliance for CaMKII Signaling (M. E. A.); NIH R01 HL084583, R01 HL083422 and Pew Scholars Trust (P.J.M.).	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Feldman DS, 2005, NAT CLIN PRACT CARD, V2, P475, DOI 10.1038/ncpcardio0309; FONG YL, 1989, J BIOL CHEM, V264, P16759; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Saotome M, 2005, AM J PHYSIOL-HEART C, V288, pH1820, DOI 10.1152/ajpheart.00589.2004; Sharma V, 2010, MOL CELL BIOCHEM, V337, P223, DOI 10.1007/s11010-009-0303-2; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	31	292	308	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					269	+		10.1038/nature11444	http://dx.doi.org/10.1038/nature11444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23051746	Green Accepted			2022-12-28	WOS:000310774300047
J	Camm, AJ				Camm, A. John			Cardiac arrhythmias-trials and tribulations	LANCET			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ATRIAL-FIBRILLATION; ANTIARRHYTHMIC-DRUGS; PROPHYLACTIC IMPLANTATION; VENTRICULAR-ARRHYTHMIAS; CATHETER ABLATION; RHYTHM CONTROL; HIGH-RISK; PREVENTION; THERAPY		St Georges Univ London, Dept Clin Sci, London SW17 0RE, England	St Georges University London	Camm, AJ (corresponding author), St Georges Univ London, Dept Clin Sci, London SW17 0RE, England.	jcamm@sgul.ac.uk						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Brignole M, 2012, CIRCULATION, V125, P2566, DOI 10.1161/CIRCULATIONAHA.111.082313; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2007, EUROPACE, V9, P1110, DOI 10.1093/europace/eum253; Camm A J, 2012, J R Coll Physicians Edinb, V42 Suppl 18, P23, DOI 10.4997/JRCPE.2012.S03; Camm AJ, 2010, EUROPACE, V12, P1356, DOI 10.1093/europace/euq183; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Einthoven W., 1906, ARCH INT PHYSIOL, V4, P132; Gold MR, 2009, HEART RHYTHM, V6, P295, DOI 10.1016/j.hrthm.2008.11.033; Grace AA, 2012, LANCET, V380, P1498, DOI 10.1016/S0140-6736(12)61462-7; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Healey JS, 2006, CIRCULATION, V114, P11, DOI 10.1161/CIRCULATIONAHA.105.610303; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Morillo C, 2012, LAT BREAK TRIALS HEA, P9; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; Romme JJ, 2011, COCHRANE DB SYST REV, V10; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Savelieva I, 2008, EUROPACE, V10, P647, DOI 10.1093/europace/eun130; Savelieva I, 2011, EUROPACE, V13, P1063, DOI 10.1093/europace/eur181; Theuns DAMJ, 2010, EUROPACE, V12, P1564, DOI 10.1093/europace/euq329; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; Wells G, 2011, CAN MED ASSOC J, V183, P421, DOI 10.1503/cmaj.101685; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	32	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1448	1451		10.1016/S0140-6736(12)61773-5	http://dx.doi.org/10.1016/S0140-6736(12)61773-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101702				2022-12-28	WOS:000310272000005
J	Grace, AA; Roden, DM				Grace, Andrew A.; Roden, Dan M.			Systems biology and cardiac arrhythmias	LANCET			English	Article							GENOME-WIDE ASSOCIATION; LONG-QT SYNDROME; ATRIAL-FIBRILLATION; COMMON VARIANTS; ION-CHANNEL; VENTRICULAR-ARRHYTHMIAS; SUDDEN-DEATH; RISK-FACTORS; PR INTERVAL; CELL MODEL	During the past few years, the development of effective, empirical technologies for treatment of cardiac arrhythmias has exceeded the pace at which detailed knowledge of the underlying biology has accumulated. As a result, although some clinical arrhythmias can be cured with techniques such as catheter ablation, drug treatment and prediction of the risk of sudden death remain fairly primitive. The identification of key candidate genes for monogenic arrhythmia syndromes shows that to bring basic biology to the clinic is a powerful approach. Increasingly sophisticated experimental models and methods of measurement, including stem cell-based models of human cardiac arrhythmias, are being deployed to study how perturbations in several biologic pathways can result in an arrhythmia-prone heart. The biology of arrhythmia is largely quantifiable, which allows for systematic analysis that could transform treatment strategies that are often still empirical into management based on molecular evidence.	[Grace, Andrew A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Grace, Andrew A.] Papworth Hosp, Cambridge CB3 8RE, England; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	University of Cambridge; Papworth Hospital; Vanderbilt University	Grace, AA (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	aag1000@cam.ac.uk	Roden, Dan/ABD-5412-2021		Clinical Data (Forest Laboratories); British Heart Foundation; UK Medical Research Council; Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; US Public Health Service [HL49989, HL65962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049989, U19HL065962, U01HL065962] Funding Source: NIH RePORTER	Clinical Data (Forest Laboratories); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AAG is a consultant for Xention. DMR has received patent royalties from Clinical Data (Forest Laboratories).; AAG is supported by the British Heart Foundation, the UK Medical Research Council, the Wellcome Trust, and the UK Biotechnology and Biological Sciences Research Council. DMR is supported by grants from the US Public Health Service, including grant numbers HL49989 and HL65962.	Ackerman MJ, 2010, CIRC RES, V107, P457, DOI 10.1161/CIRCRESAHA.110.224592; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Barsheshet A, 2012, CIRCULATION, V125, P1988, DOI 10.1161/CIRCULATIONAHA.111.048041; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Cerrone M, 2009, HEART RHYTHM, V6, P1652, DOI 10.1016/j.hrthm.2009.06.033; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2010, NAT REV CARDIOL, V7, P318, DOI 10.1038/nrcardio.2010.52; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Dewey FE, 2012, CIRCULATION, V125, P931, DOI 10.1161/CIRCULATIONAHA.110.972828; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Jons C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001551; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; Lalani GG, 2012, J AM COLL CARDIOL, V59, P595, DOI 10.1016/j.jacc.2011.10.879; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Magnani JW, 2011, CIRCULATION, V124, P1982, DOI 10.1161/CIRCULATIONAHA.111.039677; Mann SA, 2012, J AM COLL CARDIOL, V59, P1017, DOI 10.1016/j.jacc.2011.11.039; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Murray SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025387; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Rienstra M, 2012, CIRCULATION, V125, P2933, DOI 10.1161/CIRCULATIONAHA.111.069450; Ritchie MD, 2012, J AM COLL CARDIOL, V60, P1173, DOI 10.1016/j.jacc.2012.04.030; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Thomsen PEB, 2010, CIRCULATION, V122, P1258, DOI 10.1161/CIRCULATIONAHA.109.902148; Thul R, 2012, P NATL ACAD SCI USA, V109, P2150, DOI 10.1073/pnas.1115855109; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2011, CIRCULATION, V124, P1001, DOI 10.1161/CIRCULATIONAHA.110.987248; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	100	23	25	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1498	1508		10.1016/S0140-6736(12)61462-7	http://dx.doi.org/10.1016/S0140-6736(12)61462-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101717	Green Accepted			2022-12-28	WOS:000310272000030
J	Kong, D; Tong, QC; Ye, CP; Koda, S; Fuller, PM; Krashes, MJ; Vong, L; Ray, RS; Olson, DP; Lowell, BB				Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Fuller, Patrick M.; Krashes, Michael J.; Vong, Linh; Ray, Russell S.; Olson, David P.; Lowell, Bradford B.			GABAergic RIP-Cre Neurons in the Arcuate Nucleus Selectively Regulate Energy Expenditure	CELL			English	Article							BROWN ADIPOSE-TISSUE; INSULIN-RECEPTOR SUBSTRATE-2; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PANCREATIC BETA-CELL; GLUCOSE-HOMEOSTASIS; AGRP NEURONS; VENTROLATERAL MEDULLA; SYMPATHETIC OUTFLOW; TRACTUS-SOLITARIUS; LEPTIN RESISTANCE	Neural regulation of energy expenditure is incompletely understood. By genetically disrupting GABAergic transmission in a cell-specific fashion, and by combining this with selective pharmacogenetic activation and optogenetic mapping techniques, we have uncovered an arcuate-based circuit that selectively drives energy expenditure. Specifically, mice lacking synaptic GABA release from RIP-Cre neurons have reduced energy expenditure, become obese and are extremely sensitive to high-fat diet-induced obesity, the latter due to defective diet-induced thermogenesis. Leptin's ability to stimulate thermogenesis, but not to reduce feeding, is markedly attenuated. Acute, selective activation of arcuate GABAergic RIP-Cre neurons, which monosynaptically innervate PVH neurons projecting to the NTS, rapidly stimulates brown fat and increases energy expenditure but does not affect feeding. Importantly, this response is dependent upon GABA release from RIP-Cre neurons. Thus, GABAergic RIP-Cre neurons in the arcuate selectively drive energy expenditure, contribute to leptin's stimulatory effect on thermogenesis, and protect against diet-induced obesity.	[Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Krashes, Michael J.; Vong, Linh; Olson, David P.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Fuller, Patrick M.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Ray, Russell S.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Tong, Qingchun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA; [Koda, Shuichi] Asubio Pharma, Kobe, Hyogo 6500047, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; Asubio Pharma Co., Ltd.	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu	Krashes, Michael/P-7677-2019	Tong, Qingchun/0000-0002-4561-2540; Olson, David/0000-0001-9249-7760	BNORC & BADERC Transgenic Core Grant [P30DK046200, P30DK057521]; P&F from BADERC BNORC Grant [P30DK057521, P30DK0460200, R01 DK092605, AHA SDG3280017, NS0736313];  [R01 DK089044];  [R01 DK071051];  [R01 DK075632];  [R37 DK053477]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071051, R01DK075632, R01DK096010, R01DK089044, P30DK020572, R37DK053477, P30DK046200, P30DK057521, R01DK092605, K08DK071561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073613] Funding Source: NIH RePORTER	BNORC & BADERC Transgenic Core Grant; P&F from BADERC BNORC Grant; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge J. Lu, J. B. Ding, and members of the B. B. L. lab for helpful discussion; Z. Yang, J. Yu, B. Choi, X. Hu, S. Ma, and D. Cusher for technical support; C. B. Saper for insightful suggestions and reading the manuscript; K. Deisseroth for AAV-Flex-ChR2(H134R)-mCherry; and B. L. Roth for AAV-FLEX-hM3Dq-mCherry. This work was supported by Grants R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, and BNORC & BADERC Transgenic Core Grants P30DK046200 and P30DK057521 (to B. B. L.), P&F from BADERC & BNORC Grants P30DK057521 and P30DK0460200 (to D. K.), R01 DK092605 and AHA SDG3280017 (to Q. T.), and NS0736313 (to P. M. F.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Cao WH, 2010, AM J PHYSIOL-REG I, V299, pR277, DOI 10.1152/ajpregu.00039.2010; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fuller PM, 2002, P NATL ACAD SCI USA, V99, P15723, DOI 10.1073/pnas.242251499; Geerling JC, 2006, J COMP NEUROL, V497, P646, DOI 10.1002/cne.21019; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; GOLD RM, 1977, PHYSIOL BEHAV, V18, P1111, DOI 10.1016/0031-9384(77)90019-1; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; LEIBOWITZ SF, 1978, PHARMACOL BIOCHEM BE, V8, P163, DOI 10.1016/0091-3057(78)90333-7; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Madden CJ, 2012, AM J PHYSIOL-REG I, V302, pR224, DOI 10.1152/ajpregu.00449.2011; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	59	154	156	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					645	657		10.1016/j.cell.2012.09.020	http://dx.doi.org/10.1016/j.cell.2012.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101631	Bronze, Green Accepted			2022-12-28	WOS:000310529300019
J	Annas, GJ				Annas, George J.			Strip Searches in the Supreme Court - Prisons and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Annas, George J.] Boston Univ, Sch Med, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02118 USA; [Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Med, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02118 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2006, NEW ENGL J MED, V354, P2715, DOI 10.1056/NEJMlim060344; [Anonymous], 2002, NY TIMES, pA12; [Anonymous], 2011, CLIN PRACT GUID LIC; Bick JA, 2007, CLIN INFECT DIS, V45, P1047, DOI 10.1086/521910; Carlson PM, 2007, PRISON JAIL ADM PRAC; Deger Grant E, 2009, J Correct Health Care, V15, P174, DOI 10.1177/1078345808326623; Federal Bureau of Prisons, 2011, CLIN PRACT GUID MAN; JOHNSTON D, 1995, NY TIMES        0417, pA1; McQuiston John T., 1994, NY TIMES, pB6; Morava K, 2009, TROOPER WHO ARRESTED; Publishing risky research, 2012, NATURE, V485, P5	11	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1653	1657		10.1056/NEJMhle1205592	http://dx.doi.org/10.1056/NEJMhle1205592			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094730				2022-12-28	WOS:000310131700017
J	Nasvall, J; Sun, L; Roth, JR; Andersson, DI				Nasvall, Joakim; Sun, Lei; Roth, John R.; Andersson, Dan I.			Real-Time Evolution of New Genes by Innovation, Amplification, and Divergence	SCIENCE			English	Article							DUPLICATION	Gene duplications allow evolution of genes with new functions. Here, we describe the innovation-amplification-divergence (IAD) model in which the new function appears before duplication and functionally distinct new genes evolve under continuous selection. One example fitting this model is a preexisting parental gene in Salmonella enterica that has low levels of two distinct activities. This gene is amplified to a high copy number, and the amplified gene copies accumulate mutations that provide enzymatic specialization of different copies and faster growth. Selection maintains the initial amplification and beneficial mutant alleles but is relaxed for other less improved gene copies, allowing their loss. This rapid process, completed in fewer than 3000 generations, shows the efficacy of the IAD model and allows the study of gene evolution in real time.	[Nasvall, Joakim; Sun, Lei; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Roth, John R.] Univ Calif Davis, Dept Biol, Davis, CA 95616 USA	Uppsala University; University of California System; University of California Davis	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se	zhou, hua/A-6862-2017; Näsvall, Joakim/F-8750-2018; Sun, Lei/C-3687-2014	Näsvall, Joakim/0000-0002-6831-3105; Sun, Lei/0000-0002-7222-3137; Andersson, Dan/0000-0001-6640-2174	Swedish Research Council; NIH [GM27068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027068] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Swedish Research Council to D. I. A. and from the NIH (grant GM27068) to J.R.R. The raw Illumina sequencing data sets have been deposited in the National Center for Biotechnology Information Sequence Read Archive (www.ncbi.nlm.nih.gov/Traces/sra/) with accession numbers SRX180378, SRX180382, SRX180383, SRX180384, SRX180385, SRX180387, SRX180388, SRX180390, SRX180391, and SRX180392.	ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hooper SD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r48; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; Pettersson ME, 2009, GENETICA, V135, P309, DOI 10.1007/s10709-008-9289-z; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100	20	148	150	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					384	387		10.1126/science.1226521	http://dx.doi.org/10.1126/science.1226521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087246	Green Accepted			2022-12-28	WOS:000309955800041
J	Low, EV; Avery, AJ; Gupta, V; Schedlbauer, A; Grocott, MPW				Low, Emma V.; Avery, Anthony J.; Gupta, Vaibhav; Schedlbauer, Angela; Grocott, Michael P. W.			Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-ALTITUDE; GINKGO-BILOBA; DOUBLE-BLIND; PREVENTION; PLACEBO; EFFICACY; DEXAMETHASONE; TRIAL	Objectives To assess the efficacy of three different daily doses of acetazolamide in the prevention of acute mountain sickness and to determine the lowest effective dose. Design Systematic review and meta-analysis. Data sources Medline and Embase along with a hand search of selected bibliographies. No language restrictions were applied. Study selection Randomised controlled trials assessing the use of acetazolamide at 250 mg, 500 mg, or 750 mg daily versus placebo in adults as a drug intervention for the prophylaxis of acute mountain sickness. Included studies were required to state the administered dose of acetazolamide and to randomise participants before ascent to either acetazolamide or placebo. Two reviewers independently carried out the selection process. Data extraction Two reviewers extracted data concerning study methods, pharmacological intervention with acetazolamide, method of assessment of acute mountain sickness, and event rates in both control and intervention groups, which were verified and analysed by the review team collaboratively. Data synthesis 11 studies (with 12 interventions arms) were included in the review. Acetazolamide at doses of 250 mg, 500 mg, and 750 mg were all effective in preventing acute mountain sickness above 3000 m, with a combined odds ratio of 0.36 (95% confidence interval 0.28 to 0.46). At a dose of 250 mg daily the number needed to treat for acetazolamide to prevent acute mountain sickness was 6 (95% confidence interval 5 to 11). Heterogeneity ranged from I-2=0% (500 mg subgroup) to I-2=44% (750 mg subgroup). Conclusions Acetazolamide in doses of 250 mg, 500 mg, and 750 mg daily are all more effective than placebo for preventing acute mountain sickness. Acetazolamide 250 mg daily is the lowest effective dose to prevent acute mountain sickness for which evidence is available.	[Avery, Anthony J.; Gupta, Vaibhav] Univ Nottingham, Sch Med, Queens Med Ctr, Div Primary Care,Sch Community Hlth Sci, Nottingham NG7 2UH, England; [Low, Emma V.] Univ Southampton, Southampton Gen Hosp, Sch Med, Southampton, Hants, England; [Schedlbauer, Angela] Univ Nottingham, Sch Community Hlth Sci, Div Primary Care, Nottingham NG7 2UH, England; [Grocott, Michael P. W.] Univ Hosp Southampton NHS Fdn Trust, Anaesthesia & Crit Care Res Unit, Southampton, Hants, England	University of Nottingham; University of Southampton; University of Nottingham; University of Southampton; University Hospital Southampton NHS Foundation Trust	Avery, AJ (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Primary Care,Sch Community Hlth Sci, Nottingham NG7 2UH, England.	anthony.avery@nottingham.ac.uk	Grocott, Michael/C-4394-2008	Grocott, Michael/0000-0002-9484-7581; Low, Emma/0000-0003-4601-3248; imray, chris/0000-0001-8451-4102; Avery, Anthony/0000-0001-7591-4438	University of Nottingham	University of Nottingham	EVL and VG have received funding from the University of Nottingham to complete the study. No other funding was received for this study.	[Anonymous], 1981, LANCET, V1, P180; Bailey DM, 2001, HIGH ALT MED BIOL, V2, P21, DOI 10.1089/152702901750067882; BANDERET LE, 1977, AVIAT SPACE ENVIR MD, V48, P19; Basnyat B, 2006, HIGH ALT MED BIOL, V7, P17, DOI 10.1089/ham.2006.7.17; Basnyat B, 2003, HIGH ALT MED BIOL, V4, P45, DOI 10.1089/152702903321488979; Basnyat B, 2008, HIGH ALT MED BIOL, V9, P209, DOI 10.1089/ham.2007.1073; Basnyat B, 2011, WILD ENVIRON MED, V22, P15, DOI 10.1016/j.wem.2010.10.009; BURKI NK, 1992, CHEST, V101, P736, DOI 10.1378/chest.101.3.736; Carlsten C, 2004, HIGH ALT MED BIOL, V5, P33, DOI 10.1089/152702904322963672; Chow T, 2005, ARCH INTERN MED, V165, P296, DOI 10.1001/archinte.165.3.296; Dumont L, 2000, BRIT MED J, V321, P267, DOI 10.1136/bmj.321.7256.267; ELLSWORTH AJ, 1987, AM J MED, V83, P1024, DOI 10.1016/0002-9343(87)90937-5; ELLSWORTH AJ, 1991, WESTERN J MED, V154, P289; Fischer R, 2004, EUR RESPIR J, V23, P47, DOI 10.1183/09031936.03.00113102; Gertsch JH, 2010, WILD ENVIRON MED, V21, P236, DOI 10.1016/j.wem.2010.06.009; Gertsch JH, 2004, BRIT MED J, V328, P797, DOI 10.1136/bmj.38043.501690.7C; Gertsch JH, 2002, HIGH ALT MED BIOL, V3, P29, DOI 10.1089/152702902753639522; GREENE MK, 1981, BRIT MED J, V283, P811, DOI 10.1136/bmj.283.6295.811; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hillenbrand P, 2006, WILD ENVIRON MED, V17, P87, DOI 10.1580/1080-6032-17.2.87; Hunt L, 2010, TELEGRAPH TRAVEL; Hussain M M, 2001, J Pak Med Assoc, V51, P173; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; Joint Formulary Committee, 2011, BRIT NATL FORMULARY; Kayser B, 2008, HIGH ALT MED BIOL, V9, P15, DOI 10.1089/ham.2007.1037; Kayser B, 2012, HIGH ALT MED BIOL, V13, P82, DOI 10.1089/ham.2011.1084; KRONENBERG RS, 1968, AEROSPACE MED, V39, P296; LARSON EB, 1982, JAMA-J AM MED ASSOC, V248, P328, DOI 10.1001/jama.248.3.328; Moraga FA, 2007, WILD ENVIRON MED, V18, P251, DOI 10.1580/06-WEME-OR-062R2.1; NICHOLSON AN, 1988, SLEEP, V11, P354, DOI 10.1093/sleep/11.4.354; Olzowy M, 1975, Fortschr Med, V93, P1415; REINHART WH, 1994, J WILDERNESS MED, V5, P312, DOI 10.1580/0953-9859-5.3.312; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roncin JP, 1996, AVIAT SPACE ENVIR MD, V67, P445; Salisbury R., 2011, HIMALAYA NUMBERS STA; Seupaul RA, 2012, ANN EMERG MED, V59, P307, DOI 10.1016/j.annemergmed.2011.10.015; UTZ G, 1970, Muenchener Medizinische Wochenschrift, V112, P1122; van Patot MCT, 2008, HIGH ALT MED BIOL, V9, P289, DOI 10.1089/ham.2008.1029; ZELL SC, 1988, WESTERN J MED, V148, P541	43	65	65	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2012	345								e6779	10.1136/bmj.e6779	http://dx.doi.org/10.1136/bmj.e6779			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WU	23081689	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310142300002
J	Schons, KRR; Beber, AAC				Rosso Schons, Karen Regina; Costa Beber, Andre Avelino			Cutis Verticis Gyrata	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosso Schons, Karen Regina; Costa Beber, Andre Avelino] Univ Hosp, Santa Maria, RS, Brazil		Schons, KRR (corresponding author), Univ Hosp, Santa Maria, RS, Brazil.	ka.bras@bol.com.br							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					E23	E23		10.1056/NEJMicm1201183	http://dx.doi.org/10.1056/NEJMicm1201183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075200				2022-12-28	WOS:000309904500001
J	Weinberger, SE; Lawrence, HC; Henley, DE; Alden, ER; Hoyt, DB				Weinberger, Steven E.; Lawrence, Hal C., III; Henley, Douglas E.; Alden, Errol R.; Hoyt, David B.			Legislative Interference with the Patient-Physician Relationship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA USA; [Lawrence, Hal C., III] Amer Coll Obstetricians & Gynecologists, Washington, DC 20024 USA; [Henley, Douglas E.] Amer Acad Family Physicians, Leawood, KS USA; [Alden, Errol R.] Amer Acad Pediat, Elk Grove Village, IL USA; [Hoyt, David B.] Amer Coll Surg, Chicago, IL USA	American College of Physicians; American Academy of Pediatrics; American College of Surgeons	Weinberger, SE (corresponding author), Amer Coll Physicians, Philadelphia, PA USA.							[Anonymous], 2012, FRACK DISCL COL COMP; Astrow AB, 2011, NEW ENGL J MED, V364, P1885, DOI 10.1056/NEJMp1102392; Bassett Laura, 2012, HUFFINGTON POST; Brody J. E., 2011, NY TIMES; McDonnell Robert F., 2012, COMMUNICATION; Sheppard K, 2012, PENNSYLVANIAS DOCTOR; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001	7	50	51	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1557	1559		10.1056/NEJMsb1209858	http://dx.doi.org/10.1056/NEJMsb1209858			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075183				2022-12-28	WOS:000309904500014
J	Isanaka, S; Mugusi, F; Hawkins, C; Spiegelman, D; Okuma, J; Aboud, S; Guerino, C; Fawzi, WW				Isanaka, Sheila; Mugusi, Ferdinand; Hawkins, Claudia; Spiegelman, Donna; Okuma, James; Aboud, Said; Guerino, Chalamilla; Fawzi, Wafaie W.			Effect of High-Dose vs Standard-Dose Multivitamin Supplementation at the Initiation of HAART on HIV Disease Progression and Mortality in Tanzania A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; MICRONUTRIENT SUPPLEMENTATION; HIV-1-INFECTED PATIENTS; IMMUNE RECONSTITUTION; INFECTED INDIVIDUALS; TREATMENT PROGRAM; ALPHA-TOCOPHEROL; DIETARY-INTAKE; VITAMIN-E	Context Large randomized trials have previously shown that high-dose micronutrient supplementation can increase CD4 counts and reduce human immunodeficiency virus (HIV) disease progression and mortality among individuals not receiving highly active antiretroviral therapy (HAART); however, the safety and efficacy of such supplementation has not been established in the context of HAART. Objective To test the hypothesis that high-dose multivitamin supplementation vs standard-dose multivitamin supplementation decreases the risk of HIV disease progression or death and improves immunological, virological, and nutritional parameters in patients with HIV initiating HAART. Design, Setting, and Participants A randomized, double-blind, controlled trial of high-dose vs standard-dose multivitamin supplementation for 24 months in 3418 patients with HIV initiating HAART between November 2006 and November 2008 in 7 clinics in Dar es Salaam, Tanzania. Intervention The provision of daily oral supplements of vitamin B complex, vitamin C, and vitamin E at high levels or standard levels of the recommended dietary allowance. Main Outcome Measure The composite of HIV disease progression or death from any cause. Results The study was stopped early in March 2009 because of evidence of increased levels of alanine transaminase (ALT) in patients receiving the high-dose multivitamin supplement. At the time of stopping, 3418 patients were enrolled (median follow-up, 15 months), and there were 2374 HIV disease progression events and 453 observed deaths (2460 total combined events). Compared with standard-dose multivitamin supplementation, high-dose supplementation did not reduce the risk of HIV disease progression or death. The absolute risk of HIV progression or death was 72% in the high-dose group vs 72% in the standard-dose group (risk ratio [RR], 1.00; 95% CI, 0.96-1.04). High-dose supplementation had no effect on CD4 count, plasma viral load, body mass index, or hemoglobin level concentration, but increased the risk of ALT elevations (1239 events per 1215 person-years vs 879 events per 1236 person-years; RR, 1.44; 95% CI, 1.11-1.87) vs standard-dose supplementation. Conclusion In adults receiving HAART, use of high-dose multivitamin supplements compared with standard-dose multivitamin supplements did not result in a decrease in HIV disease progression or death but may have resulted in an increase in ALT levels.	[Isanaka, Sheila; Okuma, James; Guerino, Chalamilla; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Spiegelman, Donna; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Hawkins, Claudia] Northwestern Univ, Ctr Global Hlth, Feinberg Sch Med, Chicago, IL 60611 USA; [Guerino, Chalamilla] Management & Dev Hlth, Dar Es Salaam, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Northwestern University; Feinberg School of Medicine	Isanaka, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	sisanaka@hsph.harvard.edu	Isanaka, Sheila/AAQ-9056-2020		National Institute of Child Health and Human Development [R01 HD32257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032257] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01 HD32257 from the National Institute of Child Health and Human Development.	ABRAMS B, 1993, J ACQ IMMUN DEF SYND, V6, P949; Allard JP, 1998, AIDS, V12, P1653, DOI 10.1097/00002030-199813000-00013; [Anonymous], POL GUID US EM PLAN; [Anonymous], 1998, REP STAND COMM SCI E; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Balding DJ, 2004, APPL LONGITUDINAL AN; BAUM M, 1994, NUTRITION, V10, P16; BAUM MK, 1992, ANN NY ACAD SCI, V669, P165; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chandra RK, 1988, NUTR IMMUNOLOGY; Coyne-Meyers Kristen, 2004, Nutr Clin Pract, V19, P340, DOI 10.1177/0115426504019004340; de Requena DG, 2002, AIDS, V16, P290, DOI 10.1097/00002030-200201250-00020; de Souza O, 2005, CLIN CHEM LAB MED, V43, P376, DOI 10.1515/CCLM.2005.068; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fawzi WW, 1998, LANCET, V351, P1477, DOI 10.1016/S0140-6736(98)04197-X; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, 2000, DIET REF INT VIT C V; Jaruga P, 2002, FREE RADICAL BIO MED, V32, P414, DOI 10.1016/S0891-5849(01)00821-8; Jiamton S, 2003, AIDS, V17, P2461, DOI 10.1097/00002030-200311210-00008; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Kaiser JD, 2006, JAIDS-J ACQ IMM DEF, V42, P523, DOI 10.1097/01.qai.0000230529.25083.42; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Koethe JR, 2009, CLIN INFECT DIS, V49, P787, DOI 10.1086/605285; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lederman HM, 2003, J INFECT DIS, V188, P1794, DOI 10.1086/379900; Mahlungulu S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub2; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Ministry of Health of the United Republic of Tanzania, 2005, NAT GUID CLIN MAN HI; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PrayGod G, 2011, J NUTR, V141, P685, DOI 10.3945/jn.110.131672; Slain D, 2005, PHARMACOTHERAPY, V25, P165, DOI 10.1592/phco.25.2.165.56945; Spada C, 2002, CLIN CHEM LAB MED, V40, P456, DOI 10.1515/CCLM.2002.078; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tang AM, 1997, AIDS, V11, P613, DOI 10.1097/00002030-199705000-00009; Tang AM, 1996, AM J EPIDEMIOL, V143, P1244, DOI 10.1093/oxfordjournals.aje.a008712; TRABER MG, 1987, NEW ENGL J MED, V317, P262, DOI 10.1056/NEJM198707303170502; van Oosterhout JJ, 2010, AIDS CARE, V22, P737, DOI 10.1080/09540120903373581; Webb AL, 2007, NUTR REV, V65, P181, DOI 10.1111/j.1753-4887.2007.tb00298.x; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2007, VERB AUT STAND ASC A; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2006, ANT THER HIV INF AD; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	54	35	35	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1535	1544		10.1001/jama.2012.13083	http://dx.doi.org/10.1001/jama.2012.13083			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073950	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000309858100020
J	Handley, SA; Thackray, LB; Zhao, G; Presti, R; Miller, AD; Droit, L; Abbink, P; Maxfield, LF; Kambal, A; Duan, E; Stanley, K; Kramer, J; Macri, SC; Permar, SR; Schmitz, JE; Mansfield, K; Brenchley, JM; Veazey, RS; Stappenbeck, TS; Wang, D; Barouch, DH; Virgin, HW				Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Presti, Rachel; Miller, Andrew D.; Droit, Lindsay; Abbink, Peter; Maxfield, Lori F.; Kambal, Amal; Duan, Erning; Stanley, Kelly; Kramer, Joshua; Macri, Sheila C.; Permar, Sallie R.; Schmitz, Joern E.; Mansfield, Keith; Brenchley, Jason M.; Veazey, Ronald S.; Stappenbeck, Thaddeus S.; Wang, David; Barouch, Dan H.; Virgin, Herbert W.			Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome	CELL			English	Article							GUT MICROBIOME; IMMUNE ACTIVATION; HIV-INFECTION; GENE ATG16L1; METAGENOMICS; DISEASE; MOUSE; TRANSLOCATION; SEQUENCES; COLITIS	Pathogenic simian immunodeficiency virus (SIV) infection is associated with enteropathy, which likely contributes to AIDS progression. To identify candidate etiologies for AIDS enteropathy, we used next-generation sequencing to define the enteric virome during SIV infection in nonhuman primates. Pathogenic, but not nonpathogenic, SIV infection was associated with significant expansion of the enteric virome. We identified at least 32 previously undescribed enteric viruses during pathogenic SIV infection and confirmed their presence by using viral culture and PCR testing. We detected unsuspected mucosal adenovirus infection associated with enteritis as well as parvovirus viremia in animals with advanced AIDS, indicating the pathogenic potential of SIV-associated expansion of the enteric virome. No association between pathogenic SIV infection and the family-level taxonomy of enteric bacteria was detected. Thus, enteric viral infections may contribute to AIDS enteropathy and disease progression. These findings underline the importance of metagenomic analysis of the virome for understanding AIDS pathogenesis.	[Abbink, Peter; Maxfield, Lori F.; Stanley, Kelly; Schmitz, Joern E.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Droit, Lindsay; Kambal, Amal; Duan, Erning; Stappenbeck, Thaddeus S.; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhao, Guoyan; Droit, Lindsay; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Presti, Rachel] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Comparat Pathol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Vet Resources, New England Primate Res Ctr, Southborough, MA 01772 USA; [Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [Brenchley, Jason M.] NIAID, Program Barrier Immun, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Repair & Immunopathogenesis Unit, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Veazey, Ronald S.] Tulane Univ, Tulane Natl Primate Res Ctr, Sch Med, Covington, LA 70433 USA; [Barouch, Dan H.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Barouch, Dan H.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; virgin@wustl.edu	Duan, Erning/H-4608-2014; Brenchley, Jason/AAC-5085-2019; Schmitz, Joern/A-4929-2018; Barouch, Dan/Y-3918-2019	Schmitz, Joern/0000-0001-8803-0922; Presti, Rachel/0000-0002-5469-0727; Brenchley, Jason/0000-0001-8357-2984; Virgin, Herbert/0000-0001-8580-7628	Project 10 [U54 AI057160-08]; National Center for Research Resources [1R01 RR032309]; Office of Research Infrastructure Programs [OD11170-02]; Crohn's and Colitis Foundation [3132];  [AI066305];  [AI066924];  [AI078526];  [AI095985];  [AI65335];  [8P51OD011103-5]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR032309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066924, R01AI065335, U19AI078526, U19AI066305, P30AI060354, K08AI087992, ZIAAI001029, U54AI057160, U19AI095985] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170, P51OD011103] Funding Source: NIH RePORTER	Project 10; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; Crohn's and Colitis Foundation; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Project 10 of U54 AI057160-08 to D. W. for development of VirusHunter software, was initially funded by the National Center for Research Resources 1R01 RR032309, and is currently supported by the Office of Research Infrastructure Programs OD11170-02 to H. W. V. and D. H. B.; Crohn's and Colitis Foundation Grant 3132 to H. W. V. and T. S. S.; grants AI066305, AI066924, AI078526, and AI095985 to D. H. B.; AI65335 to J.E.S.; and grant 8P51OD011103-5 to A. D. M. and J.K. We would like to thank Angela Carville, Elizabeth Curran, and Vanessa Hirsch for assistance with these experiments.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey C, 2010, VET PATHOL, V47, P462, DOI 10.1177/0300985810363719; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Legendre P., 2012, NUMERICAL ECOLOGY; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Oberste MS, 2007, J GEN VIROL, V88, P3360, DOI 10.1099/vir.0.83124-0; Oberste MS, 2002, J VIROL, V76, P1244, DOI 10.1128/JVI.76.3.1244-1251.2002; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sasseville VG, 2010, J IMMUNOTOXICOL, V7, P79, DOI 10.3109/15476910903213521; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao GY, 2011, J VIROL, V85, P10230, DOI 10.1128/JVI.00637-11	38	210	218	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					253	266		10.1016/j.cell.2012.09.024	http://dx.doi.org/10.1016/j.cell.2012.09.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063120	Green Accepted, Bronze			2022-12-28	WOS:000309981000006
J	Hardie, RC; Franze, K				Hardie, Roger C.; Franze, Kristian			Photomechanical Responses in Drosophila Photoreceptors	SCIENCE			English	Article							LIGHT-SENSITIVE CHANNELS; MEMBRANE-PROTEIN FUNCTION; PHOSPHOLIPASE-C; ION CHANNELS; TRP; ACTIVATION	Phototransduction in Drosophila microvillar photoreceptor cells is mediated by a G protein-activated phospholipase C (PLC). PLC hydrolyzes the minor membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), leading by an unknown mechanism to activation of the prototypical transient receptor potential (TRP) and TRP-like (TRPL) channels. We found that light exposure evoked rapid PLC-mediated contractions of the photoreceptor cells and modulated the activity of mechanosensitive channels introduced into photoreceptor cells. Furthermore, photoreceptor light responses were facilitated by membrane stretch and were inhibited by amphipaths, which alter lipid bilayer properties. These results indicate that, by cleaving PIP2, PLC generates rapid physical changes in the lipid bilayer that lead to contractions of the microvilli, and suggest that the resultant mechanical forces contribute to gating the light-sensitive channels.	[Hardie, Roger C.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	rch14@cam.ac.uk		Franze, Kristian/0000-0002-8425-7297; Hardie, Roger/0000-0001-5531-3264	UK Biotechnology and Biological Sciences Research Council [BB/G0068651]; UK Medical Research Council Career Development Award; BBSRC [BB/J009253/1] Funding Source: UKRI; MRC [G1100312] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009253/1] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. G. Stavenga, S. B. Laughlin, and M. Postma for comments on the manuscript; O. Andersen for advice on the use of gramicidin; and J. Grosche (Effigos AG) for artwork for Fig. 1A. Supported by UK Biotechnology and Biological Sciences Research Council grant BB/G0068651 (R. C. H.) and a UK Medical Research Council Career Development Award (K. F.). Author contributions: project initiation, R. C. H.; whole-cell electrophysiology experiments, R. C. H.; AFM measurements, K. F., R. C. H.; paper written by R. C. H. with contribution from K.F.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Franze K, 2011, CURR OPIN GENET DEV, V21, P530, DOI 10.1016/j.gde.2011.07.001; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2012, WILEY INTERDISCIPLIN, V1, P162, DOI [10.1002/wmts.20, DOI 10.1002/WMTS.20]; Holopainen JM, 2002, BIOPHYS J, V83, P932, DOI 10.1016/S0006-3495(02)75219-3; HUANG JH, 2010, FASD, V20, P189, DOI DOI 10.1016/J.CUB.2009.12.019; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Patel A., 2010, FADS, V460, P571; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3	21	136	137	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					260	263		10.1126/science.1222376	http://dx.doi.org/10.1126/science.1222376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066080				2022-12-28	WOS:000309712300047
J	Broderick, CR; Herbert, RD; Latimer, J; Barnes, C; Curtin, JA; Mathieu, E; Monagle, P; Brown, SA				Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane; Barnes, Chris; Curtin, Julie A.; Mathieu, Erin; Monagle, Paul; Brown, Simon A.			Association Between Physical Activity and Risk of Bleeding in Children With Hemophilia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT FACTOR-VIII; FACTOR-IX; PROPHYLACTIC TREATMENT; PHARMACOKINETICS; PARTICIPATION; OUTCOMES; PATIENT; DISEASE; SAFETY	Context Vigorous physical activity is thought to increase risk of bleeds in children with hemophilia, but the magnitude of the risk is unknown. Objective To quantify the transient increase in risk of bleeds associated with physical activity in children with hemophilia. Design, Setting, and Participants A case-crossover study nested within a prospective cohort study was conducted at 3 pediatric hemophilia centers in Australia between July 2008 and October 2010. A total of 104 children and adolescent boys aged 4 through 18 years with moderate or severe hemophilia A or B were monitored for bleeds for up to 1 year. Following each bleed, the child or parent was interviewed to ascertain exposures to physical activity preceding the bleed. Physical activity was categorized according to expected frequency and severity of collisions. The risk of bleeds associated with physical activity was estimated by contrasting exposure to physical activity in the 8 hours before the bleed with exposures in two 8-hour control windows, controlling for levels of clotting factor in the blood. Main Outcome Measures Association of physical activity and factor level with risk of bleeding. Results The participants were observed for 4839 person-weeks during which time 436 bleeds occurred. Of these, 336 bleeds occurred more than 2 weeks after the preceding bleed and were used in the primary analysis of risk. Compared with inactivity and category 1 activities (eg, swimming), category 2 activities (eg, basketball) were associated with a transient increase in the risk of bleeding (30.6% of bleed windows vs 24.8% of first control windows; odds ratio, 2.7; 95% CI, 1.7-4.8, P < .001). Category 3 activities (eg, wrestling) were associated with a greater transient increase in risk (7.0% of bleed windows vs 3.4% of first control windows; odds ratio, 3.7; 95% CI, 2.3-7.3, P < .001). To illustrate absolute risk increase, for a child who bleeds 5 times annually and is exposed on average to category 2 activities twice weekly and to category 3 activities once weekly, exposure to these activities was associated with only 1 of the 5 annual bleeds. For every 1% increase in clotting factor level, bleeding incidence was lower by 2% (95% CI, 1%-3%; P=.004). Conclusions In children and adolescents with hemophilia, vigorous physical activity was transiently associated with a moderate relative increase in risk of bleeding. Because the increased relative risk is transient, the absolute increase in risk of bleeds associated with physical activity is likely to be small. JAMA. 2012;308(14):1452-1459 www.jama.com	[Broderick, Carolyn R.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia; [Broderick, Carolyn R.; Latimer, Jane; Mathieu, Erin] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Broderick, Carolyn R.] Childrens Hosp Westmead, Childrens Hosp Inst Sports Med, Westmead, NSW, Australia; [Curtin, Julie A.] Childrens Hosp Westmead, Dept Haematol, Westmead, NSW, Australia; [Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane] George Inst Global Hlth, Musculoskeletal Div, Sydney, NSW, Australia; [Herbert, Robert D.] Neurosci Res Australia, Randwick, NSW, Australia; [Barnes, Chris; Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Monagle, Paul] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Brown, Simon A.] Royal Childrens Hosp, Dept Haematol & Oncol, Herston, Qld, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; Neuroscience Research Australia; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Brisbane	Broderick, CR (corresponding author), Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia.	c.broderick@unsw.edu.au	Herbert, Rob/E-9442-2012	Herbert, Rob/0000-0003-4188-9195; Mathieu, Erin/0000-0002-5209-7989; Monagle, Paul/0000-0002-3970-8984; Broderick, Carolyn/0000-0003-0096-796X	Bayer Hemophilia Awards Program; NovoNordisk; Bayer; Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer; National Health and Medical Research Council (NHMRC); Australian NHMRC; Australian Research Council	Bayer Hemophilia Awards Program; NovoNordisk(Novo Nordisk); Bayer(Bayer AG); Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer(Pfizer); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Broderick, Herbert, Latimer, and Curtin reported that they have previously received a competitive research grant from the Bayer Hemophilia Awards Program. Dr Barnes reported receiving speaker fees from NovoNordisk, Bayer, Baxter Health Care, and CSL-Behring. He has also received consultant fees from NovoNordisk and BaxterHealthCare. Dr Curtin reported that she is a paid consultant of the Novo Nordisk Hemophilia Advisory Board and has received research support from CSL. She has also received conference travel support from Baxter and Pfizer. Dr Brown has previously received an honorarium from Novo Nordisk.; This study was supported by a project grant from the National Health and Medical Research Council (NHMRC). Dr Herbert is supported by a research fellowship from the Australian NHMRC, and Dr Latimer is supported by a Future Fellowship from the Australian Research Council.	ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Anderson A, 2005, PLAYING IT SAFE BLEE; Barnes C, 2006, HAEMOPHILIA, V12, P40, DOI 10.1111/j.1365-2516.2006.01333.x; Bjorkman S, 1997, HAEMOPHILIA, V3, P1, DOI 10.1046/j.1365-2516.1997.00074.x; Bjorkman S, 2001, HAEMOPHILIA, V7, P133, DOI 10.1046/j.1365-2516.2001.00465.x; Blanchette VS, 2008, J THROMB HAEMOST, V6, P1319, DOI 10.1111/j.1538-7836.2008.03032.x; Broderick CR, 2013, HAEMOPHILIA, V19, P59, DOI 10.1111/j.1365-2516.2012.02904.x; Broderick Carolyn R, 2008, BMC Blood Disord, V8, P2, DOI 10.1186/1471-2326-8-2; CARLSSON N, 1993, EUR J HAEMATOL, V51, P247; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fischer K, 2002, HAEMOPHILIA, V8, P753, DOI 10.1046/j.1365-2516.2002.00694.x; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Karafoulidou A, 2009, EUR J CLIN PHARMACOL, V65, P1121, DOI 10.1007/s00228-009-0699-3; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Poon MC, 2002, THROMB HAEMOSTASIS, V87, P431; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Ross C, 2009, PEDIATRICS, V124, P1267, DOI 10.1542/peds.2009-0072; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Srivastava A, 2003, HAEMOPHILIA, V9, P391, DOI 10.1046/j.1365-2516.2003.00766.x; Tiktinsky R, 2009, HAEMOPHILIA, V15, P695, DOI 10.1111/j.1365-2516.2009.01990.x; Twisk JWR, 2003, APPL LONGITUDINAL DA; Van den Berg HM, 2007, J THROMB HAEMOST, V5, P151, DOI 10.1111/j.1538-7836.2007.02503.x; Weigel N, 1975, Am Correct Ther J, V29, P197	25	92	94	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1452	1459		10.1001/jama.2012.12727	http://dx.doi.org/10.1001/jama.2012.12727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047359	Bronze			2022-12-28	WOS:000309579300024
J	Laharie, D; Bourreille, A; Branche, J; Allez, M; Bouhnik, Y; Filippi, J; Zerbib, F; Savoye, G; Nachury, M; Moreau, J; Delchier, JC; Cosnes, J; Ricart, E; Dewit, O; Lopez-Sanroman, A; Dupas, JL; Carbonnel, F; Bommelaer, G; Coffin, B; Roblin, X; Van Assche, G; Esteve, M; Farkkila, M; Gisbert, JP; Marteau, P; Nahon, S; de Vos, M; Franchimont, D; Mary, JY; Colombel, JF; Lemann, M				Laharie, David; Bourreille, Arnaud; Branche, Julien; Allez, Matthieu; Bouhnik, Yoram; Filippi, Jerome; Zerbib, Frank; Savoye, Guillaume; Nachury, Maria; Moreau, Jacques; Delchier, Jean-Charles; Cosnes, Jacques; Ricart, Elena; Dewit, Olivier; Lopez-Sanroman, Antonio; Dupas, Jean-Louis; Carbonnel, Franck; Bommelaer, Gilles; Coffin, Benoit; Roblin, Xavier; Van Assche, Gert; Esteve, Maria; Farkkila, Martti; Gisbert, Javier P.; Marteau, Philippe; Nahon, Stephane; de Vos, Martine; Franchimont, Denis; Mary, Jean-Yves; Colombel, Jean-Frederic; Lemann, Marc		Grp Etud Therapeutiques des Affect	Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial	LANCET			English	Article							5-AMINOSALICYLIC ACID; THERAPY; EFFICACY; AZATHIOPRINE; MULTICENTER; EXPERIENCE; COLECTOMY; CONSENSUS; OUTCOMES	Background Ciclosporin and infliximab are potential rescue treatments to avoid colectomy in patients with acute severe ulcerative colitis refractory to intravenous corticosteroids. We compared the efficacy and safety of these drugs for this indication. Methods In this parallel, open-label, randomised controlled trial, patients were aged at least 18 years, had an acute severe flare of ulcerative colitis defined by a Lichtiger score greater than 10 points, and had been given an unsuccessful course of high-dose intravenous steroids. None of the patients had previously received ciclosporin or infliximab. Between June 1, 2007, and Aug 31, 2010, patients at 27 European centres were randomly assigned (via computer-derived permutation tables; 1:1) to receive either intravenous ciclosporin (2 mg/kg per day for 1 week, followed by oral drug until day 98) or infliximab (5 mg/kg on days 0, 14, and 42). In both groups, azathioprine was started at day 7 in patients with a clinical response. Neither patients nor investigators were masked to study treatment. The primary efficacy outcome was treatment failure defined by absence of a clinical response at day 7, a relapse between day 7 and day 98, absence of steroid-free remission at day 98, a severe adverse event leading to treatment interruption, colectomy, or death. Analysis was by intention to treat. This trial is registered with EudraCT (2006-005299-42) and ClinicalTrials.gov (NCT00542152). Findings 115 patients were randomly assigned; 58 patients were allocated to receive ciclosporin and 57 to receive infliximab. Treatment failure occurred in 35 (60%) patients given ciclosporin and 31 (54%) given infliximab (absolute risk difference 6%; 95% CI -7 to 19; p=0.52). Nine (16%) patients in the ciclosporin group and 14 (25%) in the infliximab group had severe adverse events. Interpretation Ciclosporin was not more effective than infliximab in patients with acute severe ulcerative colitis refractory to intravenous steroids. In clinical practice, treatment choice should be guided by physician and centre experience.	[Laharie, David] CHU Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, Bordeaux, France; [Laharie, David] Univ Bordeaux, Lab Bacteriol, Bordeaux, France; [Bourreille, Arnaud] CHU Nantes, Hotel Dieu, Inst Malad Appareil Digestif, F-44035 Nantes 01, France; [Branche, Julien; Colombel, Jean-Frederic] CHRU Lille, Hop Claude Huriez, Serv Malad Appareil Digestif Endoscopie Digest, Lille, France; [Lemann, Marc] Univ Paris 07, Hop St Louis, APHP, Serv Hepatogastroenterol, Paris, France; [Bouhnik, Yoram] Univ Paris 07, Hop Beaujon Gastroenterol,Malad Inflammatoires Ch, APHP, Clichy, France; [Filippi, Jerome] CHU Nice, Hop Archet 2, Serv Gastroenterol & Nutr Clin, Nice, France; [Zerbib, Frank] Univ Bordeaux Segalen, Hop St Andre, Serv Hepatogastroenterol, Bordeaux, France; [Savoye, Guillaume] Univ Rouen, CHU Rouen, Hop Charles Nicolle,Equipe Avenir 4311, Serv Gastroenterol Appareil Digestif Environm & N, Rouen, France; [Nachury, Maria] CHU Besancon, Hop Jean Minjoz, Serv Gastroenterol, F-25030 Besancon, France; [Moreau, Jacques] CHU Toulouse, Hop Rangueil, Serv Gastroenterol & Nutr, Toulouse, France; [Delchier, Jean-Charles] Univ Paris 11, Hop Henri Mondor, APHP, Serv Hepatogastroenterol, Creteil, France; [Cosnes, Jacques] Hop St Antoine, Serv Gastroenterol, F-75571 Paris, France; [Ricart, Elena] Hosp Clin Barcelona, Dept Gastroenterol, Barcelona, Spain; [Ricart, Elena] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Dewit, Olivier] Univ Catholique Louvain St Luc, Serv Gastroenterol, Brussels, Belgium; [Lopez-Sanroman, Antonio] Hosp Ramon & Cajal, Unidad EII, Servicio Gastroenterol, E-28034 Madrid, Spain; [Dupas, Jean-Louis] CHU Amiens, Hop Nord, Serv Hepatogastroenterol, Amiens, France; [Carbonnel, Franck] Univ Paris 11, Hop Bicetre, APHP, Serv Hepatogastroenterol, Le Kremlin Bicetre, France; [Bommelaer, Gilles] CHU Clermont Ferrand, Serv Hepatol Gastroenterol, Clermont Ferrand, France; [Coffin, Benoit] Univ Paris 07, Hop Louis Mourier, Serv Hepatogastroenterol, Colombes, France; [Roblin, Xavier] CHU St Etienne, Hop Nord, Serv Gastroenterol & Hepatol, St Etienne, France; [Van Assche, Gert] Katholieke Univ Leuven Hosp, Div Gastroenterol, Louvain, Belgium; [Esteve, Maria] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, Terrassa, Spain; [Farkkila, Martti] Univ Helsinki, Dept Med, Helsinki, Finland; Univ Helsinki, Cent Hosp, Gastroenterol Clin, Helsinki, Finland	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU de Rouen; Universite de Rouen Normandie; Universite de Franche-Comte; CHU Besancon; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Hospital Universitario Ramon y Cajal; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Hospital Universitario Mutua Terrassa; University of Barcelona; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Laharie, D (corresponding author), CHU Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, Bordeaux, France.		Gisbert, Javier P/GRY-2719-2022; Färkkilä, Martti/AAG-6970-2021; Bourreille, Arnaud/K-2398-2015; Gisbert, Javier P/ABB-7531-2021; Nachury, Maria/M-4399-2018	Färkkilä, Martti/0000-0002-0250-8559; Gisbert, Javier P/0000-0003-2090-3445; Nahon, Stephane/0000-0003-0392-3989; Nachury, Maria/0000-0001-9583-8946; ESTEVE, MARIA/0000-0001-7716-0027; Roblin, Xavier/0000-0002-7929-4878; Savoye, Guillaume/0000-0002-9200-2067; Allez, Matthieu/0000-0002-2012-7522	Association Francois Aupetit; Societe Nationale Francaise de Gastroenterologie; International Organization for the study of Inflammatory Bowel Disease; Merck Sharp Dohme; Abbott; Ferring; ActoGeniX NV; Affi logic; AlbireoPharma; AstraZeneca; Bayer Schering Pharma; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Cellerix SL; Chemocentryx; Centocor; Cosmo Technologies; Danone France; Elan Pharmaceuticals; Genentech; Giuliani SPA; Given Imaging; GlaxoSmithKline; Merck; Millennium Pharmaceuticals; Neovacs SA; Ocerra Therapeutics; Otsuka American Pharmaceuticals; PDL Biopharma; Pfizer; RiboVacs Biotech; Schering Plough Corporation; Shire Pharmaceuticals; Synta Pharmaceutical Corporation; Takeda; Teva Pharmaceuticals; Therakos; UCB Pharma; Wyeth Pharmaceuticals; Lesaffre; Danisco; Danone; Roquette; Mapi Naxis; Dysphar	Association Francois Aupetit; Societe Nationale Francaise de Gastroenterologie; International Organization for the study of Inflammatory Bowel Disease; Merck Sharp Dohme(Merck & Company); Abbott(Abbott Laboratories); Ferring(Ferring Pharmaceuticals); ActoGeniX NV; Affi logic; AlbireoPharma; AstraZeneca(AstraZeneca); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Cellerix SL; Chemocentryx; Centocor; Cosmo Technologies; Danone France(Danone Nutricia); Elan Pharmaceuticals; Genentech(Roche HoldingGenentech); Giuliani SPA; Given Imaging; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Neovacs SA; Ocerra Therapeutics; Otsuka American Pharmaceuticals(Otsuka Pharmaceutical); PDL Biopharma; Pfizer(Pfizer); RiboVacs Biotech; Schering Plough Corporation(Merck & CompanySchering Plough Corporation); Shire Pharmaceuticals; Synta Pharmaceutical Corporation; Takeda(Takeda Pharmaceutical Company Ltd); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Therakos; UCB Pharma(UCB Pharma SA); Wyeth Pharmaceuticals(Wyeth); Lesaffre; Danisco; Danone(Danone Nutricia); Roquette; Mapi Naxis; Dysphar	Association Francois Aupetit, Societe Nationale Francaise de Gastroenterologie, and the International Organization for the study of Inflammatory Bowel Disease.; DL, AB, MA, GS, ER, OD, and ML have lectured for Merck Sharp & Dohme. YB has lectured for Merck Sharp & Dohme, Abbott, Ferring, Norgine, and Vifor Pharma. FZ has received travel grants from Merck Sharp & Dohme. JC has lectured for Abbott, Merck Sharp & Dohme, and Tilliot Pharma, and has received research funding from Abbott. AL-S and MF have lectured for Abbott and Merck Sharp & Dohme. GVA has received honoraria and research support from Merck Sharp & Dohme and honoraria from Novartis. ME has been on the advisory board and lectured for Merck Sharp & Dohme, Abbott, and Shire Pharmaceuticals. MDV has received consultancy fees from Abbott, Merck Sharp & Dohme, and Ferring, research and educational grants from Merck Sharp & Dohme and Abbott, and has lectured for Abbott, Ferring, and Merck Sharp & Dohme. J-FC has received consulting fees from or been on paid advisory boards for Abbott, ActoGeniX NV, Affi logic, AlbireoPharma, AstraZeneca, Bayer Schering Pharma, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Cellerix SL, Chemocentryx, Centocor, Cosmo Technologies, Danone France, Elan Pharmaceuticals, Genentech, Giuliani SPA, Given Imaging, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Neovacs SA, Ocerra Therapeutics, Otsuka American Pharmaceuticals, PDL Biopharma, Pfizer, RiboVacs Biotech, Schering Plough Corporation, Shire Pharmaceuticals, Synta Pharmaceutical Corporation, Takeda, Teva Pharmaceuticals, Therakos, UCB Pharma, and Wyeth Pharmaceuticals and received grant support from AstraZeneca, Ferring, Schering Plough Corporation, UCB Pharma, Lesaffre, Giuliani SPA, Danisco, Ocerra Therapeutics, Danone, Roquette, Mapi Naxis, and Dysphar. JB, JF, MN, JM, J-CD, J-LD, FC, GB, BC, XR, JPG, PM, SN, J-YM and DF declare that they have no conflicts of interest.	Actis GC, 2001, ALIMENT PHARM THER, V15, P1307, DOI 10.1046/j.1365-2036.2001.01019.x; Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Arts J, 2004, INFLAMM BOWEL DIS, V10, P73, DOI 10.1097/00054725-200403000-00002; Cacheux W, 2008, AM J GASTROENTEROL, V103, P637, DOI 10.1111/j.1572-0241.2007.01653.x; Cohen RD, 1999, AM J GASTROENTEROL, V94, P1587; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1989, ANAL BINARY DATA; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dinesen LC, 2010, J CROHNS COLITIS, V4, P431, DOI 10.1016/j.crohns.2010.02.001; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; EDWARDS FC, 1963, GUT, V4, P299, DOI 10.1136/gut.4.4.299; Eidelwein AP, 2005, INFLAMM BOWEL DIS, V11, P213, DOI 10.1097/01.MIB.0000160803.44449.a5; Gornet JM, 2003, ALIMENT PHARM THER, V18, P175, DOI 10.1046/j.1365-2036.2003.01686.x; Hoie O, 2007, GASTROENTEROLOGY, V132, P507, DOI 10.1053/j.gastro.2006.11.015; Jakobovits SL, 2007, ALIMENT PHARM THERAP, V25, P1055, DOI 10.1111/j.1365-2036.2007.03300.x; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kohn A, 2007, ALIMENT PHARM THERAP, V26, P747, DOI 10.1111/j.1365-2036.2007.03415.x; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Oussalah A, 2010, AM J GASTROENTEROL, V105, P2617, DOI 10.1038/ajg.2010.345; Panaccione R, 2011, J CROHNS COLITIS, V5, pS8, DOI DOI 10.4292/WJGPT.V8.I2.103; Probert CSJ, 2003, GUT, V52, P998, DOI 10.1136/gut.52.7.998; Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; SIEGEL S., 1956, NONPARAMETRIC STAT B; Su CY, 2002, AM J GASTROENTEROL, V97, P2577; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Van Assche G, 2003, GASTROENTEROLOGY, V125, P1025, DOI 10.1016/S0016-5085(03)01214-9	34	366	378	2	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1909	1915		10.1016/S0140-6736(12)61084-8	http://dx.doi.org/10.1016/S0140-6736(12)61084-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23063316				2022-12-28	WOS:000311758500027
J	Friedmann-Morvinski, D; Bushong, EA; Ke, E; Soda, Y; Marumoto, T; Singer, O; Ellisman, MH; Verma, IM				Friedmann-Morvinski, Dinorah; Bushong, Eric A.; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Ellisman, Mark H.; Verma, Inder M.			Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice	SCIENCE			English	Article							NEURAL STEM-CELLS; MOUSE MODELS; BRAIN; GLIOBLASTOMA; ORIGIN; NF1; NEUROGENESIS; PROGRESSION; EXPRESSION; DISEASE	Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here we show that gliomas can originate from differentiated cells in the central nervous system (CNS), including cortical neurons. Transduction by oncogenic lentiviral vectors of neural stem cells (NSCs), astrocytes, or even mature neurons in the brains of mice can give rise to malignant gliomas. All the tumors, irrespective of the site of lentiviral vector injection (the initiating population), shared common features of high expression of stem or progenitor markers and low expression of differentiation markers. Microarray analysis revealed that tumors of astrocytic and neuronal origin match the mesenchymal GBM subtype. We propose that most differentiated cells in the CNS upon defined genetic alterations undergo dedifferentiation to generate a NSC or progenitor state to initiate and maintain the tumor progression, as well as to give rise to the heterogeneous populations observed in malignant gliomas.	[Friedmann-Morvinski, Dinorah; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ke, Eugene] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Marumoto, Tomotoshi] Kyushu Univ, Dept Mol Genet, Div Mol & Clin Genet, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyushu University	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH) [HL053670]; Cancer Center Core Grant [P30 CA014195-38]; Ipsen/Biomeasure; Sanofi Aventis; H. N. and Frances C. Berger Foundation; National Center for Research Resources [5P41RR004050]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; Ipsen/Biomeasure; Sanofi Aventis(Sanofi-Aventis); H. N. and Frances C. Berger Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Estepa for her technical help, F. H. Gage and S. Subramaniam for useful discussions, and N. Varki and S. Kesari for pathological analysis. I. M. V. is an American Cancer Society Professor of Molecular Biology and holds the Irwin and Joan Jacobs Chair in Exemplary Life Sciences. D. F.-M. was supported by a fellowship from the European Molecular Biology Organization. This work was supported in part by grants from the National Institutes of Health (NIH) (HL053670), a Cancer Center Core Grant (P30 CA014195-38), Ipsen/Biomeasure, Sanofi Aventis, the H. N. and Frances C. Berger Foundation, and National Center for Research Resources grant 5P41RR004050 to M. H. E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or NIH. Microarray data have been deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE35917). The authors (T. M., I. M. V., and Y.S.) and the Salk Institute have filed a patent application relating to mouse tumor models created with lentiviral vectors.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hide T, 2011, STEM CELLS, V29, P590, DOI 10.1002/stem.618; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Price DL, 2006, NEUROINFORMATICS, V4, P65, DOI 10.1385/NI:4:1:65; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	23	369	382	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1080	1084		10.1126/science.1226929	http://dx.doi.org/10.1126/science.1226929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23087000	Green Accepted			2022-12-28	WOS:000311390600044
J	Legood, R; Smith, M; Lew, JB; Walker, R; Moss, S; Kitchener, H; Patnick, J; Canfell, K				Legood, Rosa; Smith, Megan; Lew, Jie-Bin; Walker, Robert; Moss, Sue; Kitchener, Henry; Patnick, Julietta; Canfell, Karen			Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM RISK; FOLLOW-UP; CANCER; CYTOLOGY; AUSTRALIA; EXCISION; OUTCOMES; WOMEN; UK	Objectives To evaluate the cost effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia (CIN). Design Economic analysis using a Markov modelling approach to combine cost and epidemiological data from the NHS Sentinel Sites Study with data from previous studies of post-treatment recurrence rates. Setting English NHS Cervical Cancer Screening Programme. Interventions Management guidelines after treatment of CIN involving annual cytology follow-up for 10 years, compared with alternative protocols using the human papillomavirus test to reduce the amount of post-treatment surveillance. Main outcome measures Cases of underlying CIN3+ averted at 10 years and costs per 1000 women treated. Results Model predictions indicated that, at observed levels of compliance with post-treatment recommendations, management with only cytological follow-up would result in 29 residual cases of recurrent CIN3+ by 10 years and would cost 358 pound 222 ((sic)440 426; $574 910) (discounted) per 1000 women treated. Implementation of human papillomavirus test of cure in cytologically negative women according to the sentinel sites protocol would avert an additional 8.4 cases of CIN 3+ and reduce costs by 9388 pound per 1000 women treated. Conclusions Human papillomavirus test of cure would be more effective and would be cost saving compared with cytology only follow-up. The results of this evaluation support the full scale implementation of human papillomavirus test of cure after treatment of CIN within the NHS Cervical Screening Programme.	[Legood, Rosa] London Sch Hyg & Trop Med, Hlth Serv Res & Policy Unit, London WC1 9HS, England; [Smith, Megan; Lew, Jie-Bin; Walker, Robert; Canfell, Karen] NSW Canc Council, Canc Res Div, Woolloomooloo, NSW 2011, Australia; [Moss, Sue] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England; [Kitchener, Henry] Univ Manchester, St Marys Hosp, Sch Canc & Enabling Sci, Manchester M13 9WL, Lancs, England; [Patnick, Julietta] NHS Canc Screening Programme, Sheffield S10 3TH, S Yorkshire, England; [Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of London; London School of Hygiene & Tropical Medicine; Cancer Council New South Wales; University of London; Queen Mary University London; University of Manchester; University of Sydney	Legood, R (corresponding author), London Sch Hyg & Trop Med, Hlth Serv Res & Policy Unit, London WC1 9HS, England.	rosa.legood@lshtm.ac.uk	Legood, Rosa/GQZ-9121-2022	Legood, Rosa/0000-0003-2761-5227; Canfell, Karen/0000-0002-6443-6618; Lew, Jie-Bin/0000-0003-2837-3565; Smith, Megan/0000-0002-0401-2653	NHS Cancer Screening Programme	NHS Cancer Screening Programme	The study was funded by the NHS Cancer Screening Programme. The analyses and decision to publish were independent of the funders.	[Anonymous], 2009, HUM PAP TRIAG TEST W; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Canfell K, 2004, BRIT J CANCER, V91, P530, DOI 10.1038/sj.bjc.6602002; Canfell K, 2006, MED J AUSTRALIA, V185, P482, DOI 10.5694/j.1326-5377.2006.tb00661.x; Cecchini S, 2002, TUMORI, V88, P478, DOI 10.1177/030089160208800609; Chan BKS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.031; Coupe VMH, 2007, BJOG-INT J OBSTET GY, V114, P416, DOI 10.1111/j.1471-0528.2007.01265.x; Creighton P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-734; Cruikshank M, 2011, HPV TEST CURE EFFECT; Curtis L., 2010, UNIT COSTS HLTH SOCI; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Flannelly G, 1997, BRIT J OBSTET GYNAEC, V104, P718, DOI 10.1111/j.1471-0528.1997.tb11983.x; Health and Social Care Information Centre, 2008, CERV SCREEN PROGR EN; Kelly RS, 2011, BRIT J CANCER, V105, P983, DOI 10.1038/bjc.2011.326; Kitchener HC, 2008, BJOG-INT J OBSTET GY, V115, P1001, DOI 10.1111/j.1471-0528.2008.01748.x; Luesley D, 2004, COLPOSCOPY PROGRAMME; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Medical Services Advisory Committee, 2009, AUT ASS LIQ BAS CYT; Melnikow J, 2010, OBSTET GYNECOL, V116, P1158, DOI 10.1097/AOG.0b013e3181f88e72; Melnikow J, 2009, JNCI-J NATL CANCER I, V101, P721, DOI 10.1093/jnci/djp089; MOSS SM, 2004, EVALUATION HPV LBC C; National Cervical Screening Program, 2005, SCREEN PREV CERV CAN; National Institute for Health and Clinical Excellence, 2008, GUID METH HLTH TECHN; National Screening Unit, 2008, GUID CERV SCREEN NZ; Paraskevaidis E, 2004, CANCER TREAT REV, V30, P205, DOI 10.1016/j.ctrv.2003.07.008; Rema P, 2007, EFFECTIVENESS ACCEPT; Sherlaw-Johnson C, 2004, BRIT J CANCER, V91, P84, DOI 10.1038/sj.bjc.6601884; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Strander B, 2007, BMJ-BRIT MED J, V335, P1077, DOI 10.1136/bmj.39363.471806.BE	30	24	24	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2012	345								e7086	10.1136/bmj.e7086	http://dx.doi.org/10.1136/bmj.e7086			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033FG	23117060	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000310779000004
J	Felton, SJ; Ferguson, JE				Felton, Sarah J.; Ferguson, Janice E.			Multiple Cutaneous Swellings Associated With Sudden Collapse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RUBBER BLEB NEVUS		[Felton, Sarah J.; Ferguson, Janice E.] Salford Royal NHS Fdn Trust, Dermatol Ctr, Salford M6 8HD, Lancs, England; [Ferguson, Janice E.] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England	Salford Royal NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Felton, SJ (corresponding author), Salford Royal NHS Fdn Trust, Dermatol Ctr, Stott Lane, Salford M6 8HD, Lancs, England.	sarah.felton@srft.nhs.uk	Felton, Sarah/AAI-5603-2020	Felton, Sarah/0000-0003-3304-0490				Bean WB, VASC SPIDERS REL LES, P178; da Fonseca LM, 2009, J AM COLL SURGEONS, V208, P1143, DOI 10.1016/j.jamcollsurg.2008.11.020; Deng ZH, 2008, WORLD J PEDIATR, V4, P70, DOI 10.1007/s12519-008-0015-9; Giordano C, 2004, CARDIOVASC PATHOL, V13, P317, DOI 10.1016/j.carpath.2004.07.004; Liu Q, 2007, CHINESE MED J-PEKING, V120, P731, DOI 10.1097/00029330-200704020-00025; Mogler C, 2010, RARE TUMORS, V2, P99, DOI 10.4081/rt.2010.e36; Nahm WK, 2004, J AM ACAD DERMATOL, V50, pS101; Ng EK, 2009, DIGEST ENDOSC, V21, P40, DOI 10.1111/j.1443-1661.2008.00817.x; OLSEN TG, 1979, ARCH DERMATOL, V115, P81, DOI 10.1001/archderm.115.1.81; Stavropoulou E, 2009, DERMATOL SURG, V35, P1442, DOI 10.1111/j.1524-4725.2009.01257.x	10	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1685	1686		10.1001/jama.2012.13656	http://dx.doi.org/10.1001/jama.2012.13656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093166				2022-12-28	WOS:000310434100023
J	Wang, T; Zhuang, JQ; Lynch, J; Chen, O; Wang, ZL; Wang, XR; LaMontagne, D; Wu, HM; Wang, ZW; Cao, YC				Wang, Tie; Zhuang, Jiaqi; Lynch, Jared; Chen, Ou; Wang, Zhongliang; Wang, Xirui; LaMontagne, Derek; Wu, Huimeng; Wang, Zhongwu; Cao, Y. Charles			Self-Assembled Colloidal Superparticles from Nanorods	SCIENCE			English	Article							SEEDED GROWTH; HETEROSTRUCTURES; NANOCRYSTALS; COMPLEX; ROD	Colloidal superparticles are nanoparticle assemblies in the form of colloidal particles. The assembly of nanoscopic objects into mesoscopic or macroscopic complex architectures allows bottom-up fabrication of functional materials. We report that the self-assembly of cadmium selenide-cadmium sulfide (CdSe-CdS) core-shell semiconductor nanorods, mediated by shape and structural anisotropy, produces mesoscopic colloidal superparticles having multiple well-defined supercrystalline domains. Moreover, functionality-based anisotropic interactions between these CdSe-CdS nanorods can be kinetically introduced during the self-assembly and, in turn, yield single-domain, needle-like superparticles with parallel alignment of constituent nanorods. Unidirectional patterning of these mesoscopic needle-like superparticles gives rise to the lateral alignment of CdSe-CdS nanorods into macroscopic, uniform, freestanding polymer films that exhibit strong photoluminescence with a striking anisotropy, enabling their use as downconversion phosphors to create polarized light-emitting diodes.	[Wang, Tie; Zhuang, Jiaqi; Lynch, Jared; Chen, Ou; Wang, Zhongliang; Wang, Xirui; LaMontagne, Derek; Wu, Huimeng; Cao, Y. Charles] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Wang, Zhongwu] Cornell Univ, Wilson Lab, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA	State University System of Florida; University of Florida; Cornell University	Cao, YC (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	cao@chem.ufl.edu	Wang, Zhongliang/J-8674-2012; Wang, Xirui/ABC-8146-2021; Wang, Tie/L-5060-2015	Wang, Zhongliang/0000-0001-9388-149X; Wang, Xirui/0000-0002-4449-7798; Wang, Tie/0000-0001-5965-6520	Office of Naval Research [N00014-09-1-0441]; NSF [DMR-0645520]; Cornell High Energy Synchrotron Source through NSF award [DMR-0936384]	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Cornell High Energy Synchrotron Source through NSF award	Supported by Office of Naval Research grant N00014-09-1-0441 (Y.C.C.), NSF Career Award DMR-0645520, and the Cornell High Energy Synchrotron Source through NSF award DMR-0936384. We thank S. Zou for helpful discussions and X. Liu for providing line-patterned Si<INF>3</INF>N<INF>4</INF> substrates. Transmission electron microscope work was conducted at the Major Analytical Instrumentation Center at the University of Florida. A PCT International Patent Application has been filed (docket no. 995XC1PCT, "Laterally Aligned Colloidal Nanorods Assemblies," serial no. PCT/US2012/042958).	Ball P., 2000, SELF MADE TAPESTRY P; Black CT, 2000, SCIENCE, V290, P1131, DOI 10.1126/science.290.5494.1131; Carbone L, 2007, NANO LETT, V7, P2942, DOI 10.1021/nl0717661; Courty A, 2005, NAT MATER, V4, P395, DOI 10.1038/nmat1366; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; MARKS LD, 1983, NATURE, V303, P316, DOI 10.1038/303316a0; MARKS LD, 1983, J CRYST GROWTH, V61, P556, DOI 10.1016/0022-0248(83)90184-7; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Nagaoka Y, 2012, SMALL, V8, P843, DOI 10.1002/smll.201101902; Rycenga M, 2008, ADV MATER, V20, P2416, DOI 10.1002/adma.200800360; Salant A, 2006, J AM CHEM SOC, V128, P10006, DOI 10.1021/ja063192s; Sitt A, 2011, NANO LETT, V11, P2054, DOI 10.1021/nl200519b; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Talapin DV, 2003, NANO LETT, V3, P1677, DOI 10.1021/nl034815s; Tang ML, 2011, J AM CHEM SOC, V133, P13220, DOI 10.1021/ja203215b; Urban JJ, 2007, NAT MATER, V6, P115, DOI 10.1038/nmat1826; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Wang SY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1357; Wei QS, 2009, J AM CHEM SOC, V131, P9728, DOI 10.1021/ja901562j; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Williams DB, 2009, SPRINGER, P407, DOI DOI 10.1295/KOBUNSHI.43.94; Xia YN, 2003, ADV FUNCT MATER, V13, P907, DOI 10.1002/adfm.200300002; Yamada Y, 2011, NAT CHEM, V3, P372, DOI [10.1038/NCHEM.1018, 10.1038/nchem.1018]; Zhuang JQ, 2008, ANGEW CHEM INT EDIT, V47, P2208, DOI 10.1002/anie.200705049; Zhuang JQ, 2009, J AM CHEM SOC, V131, P6084, DOI 10.1021/ja9015183	27	284	292	15	799	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					358	363		10.1126/science.1224221	http://dx.doi.org/10.1126/science.1224221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087242				2022-12-28	WOS:000309955800035
J	Messerli, FH				Messerli, Franz H.			Chocolate Consumption, Cognitive Function, and Nobel Laureates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COCOA		[Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Messerli, Franz H.] Columbia Univ, New York, NY USA	Mount Sinai St. Luke's; Mount Sinai West; Columbia University	Messerli, FH (corresponding author), St Lukes Roosevelt Hosp, New York, NY 10025 USA.		Messerli, Franz/AAR-4783-2021					Bisson JF, 2008, BRIT J NUTR, V100, P94, DOI 10.1017/S0007114507886375; Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022; Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060; Nurk E, 2009, J NUTR, V139, P120, DOI 10.3945/jn.108.095182; Sorond Farzaneh A, 2008, Neuropsychiatr Dis Treat, V4, P433	5	95	96	34	273	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1562	1564		10.1056/NEJMon1211064	http://dx.doi.org/10.1056/NEJMon1211064			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23050509				2022-12-28	WOS:000309904500016
J	Jain, M; Rosenberg, M				Jain, Meera; Rosenberg, Mark			Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jain, Meera; Rosenberg, Mark] Providence Portland Med Ctr, Portland, OR USA	Providence Portland Medical Center	Jain, M (corresponding author), Providence Portland Med Ctr, Portland, OR USA.							Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; National Cholesterol Education Program, RISK ASS EST 10 YEAR; Rojas-Fernandez CH, 2012, ANN PHARMACOTHER, V46, P549, DOI 10.1345/aph.1Q620; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6	4	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-2	10.7326/0003-4819-157-8-201210160-02002	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070504				2022-12-28	WOS:000309906000001
J	Sokol, DK				Sokol, Daniel K.			Law, ethics, and the duty of care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						General Medical Council, GOOD MED PRACT TREAT; Hadfield S, 1958, LAW ETHICS DOCTORS, P41	2	4	4	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6804	10.1136/bmj.e6804	http://dx.doi.org/10.1136/bmj.e6804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054053				2022-12-28	WOS:000309907400006
J	Spence, D				Spence, Des			A beacon of generalism	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 10	2012	345								e6803	10.1136/bmj.e6803	http://dx.doi.org/10.1136/bmj.e6803			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054052				2022-12-28	WOS:000309907400010
J	Park, SH; Das, BB; Casagrande, F; Tian, Y; Nothnagel, HJ; Chu, MN; Kiefer, H; Maier, K; De Angelis, AA; Marassi, FM; Opella, SJ				Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Kiefer, Hans; Maier, Klaus; De Angelis, Anna A.; Marassi, Francesca M.; Opella, Stanley J.			Structure of the chemokine receptor CXCR1 in phospholipid bilayers	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN INTERLEUKIN-8 RECEPTOR; NMR CHEMICAL-SHIFTS; SOLID-STATE NMR; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SPECTROSCOPY; GPCR; PROTEOLIPOSOMES; REFINEMENT	CXCR1 is one of two high-affinity receptors for the CXC chemokine interleukin-8 (IL-8), a major mediator of immune and inflammatory responses implicated in many disorders, including tumour growth(1-3). IL-8, released in response to inflammatory stimuli, binds to the extracellular side of CXCR1. The ligand-activated intracellular signalling pathways result in neutrophil migration to the site of inflammation(2). CXCR1 is a class A, rhodopsin-like G-protein-coupled receptor (GPCR), the largest class of integral membrane proteins responsible for cellular signal transduction and targeted as drug receptors(4-7). Despite its importance, the molecular mechanism of CXCR1 signal transduction is poorly understood owing to the limited structural information available. Recent structural determination of GPCRs has advanced by modifying the receptors with stabilizing mutations, insertion of the protein T4 lysozyme and truncations of their amino acid sequences(8), as well as addition of stabilizing antibodies and small molecules(9) that facilitate crystallization in cubic phase monoolein mixtures(10). The intracellular loops of GPCRs are crucial for G-protein interactions(11), and activation of CXCR1 involves both amino-terminal residues and extracellular loops(2,12,13). Our previous nuclear magnetic resonance studies indicate that IL-8 binding to the N-terminal residues is mediated by the membrane, underscoring the importance of the phospholipid bilayer for physiological activity(14). Here we report the three-dimensional structure of human CXCR1 determined by NMR spectroscopy. The receptor is in liquid crystalline phospholipid bilayers, without modification of its amino acid sequence and under physiological conditions. Features important for intracellular G-protein activation and signal transduction are revealed. The structure of human CXCR1 in a lipid bilayer should help to facilitate the discovery of new compounds that interact with GPCRs and combat diseases such as breast cancer.	[Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Tian, Ye; Marassi, Francesca M.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Kiefer, Hans] HBC Hsch Biberach, D-88400 Biberach, Germany; [Maier, Klaus; De Angelis, Anna A.] Membrane Receptor Technol, San Diego, CA 92121 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Opella, SJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sopella@ucsd.edu	Das, Bibhuti B./ABC-9067-2021; Park, Sang Ho/AAK-3432-2020	Das, Bibhuti B./0000-0001-9530-8785; Kiefer, Hans/0000-0002-8574-9867	National Institutes of Health (NIH) [R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805, P41EB002031]; Swiss National Science Foundation [PBBSP3-123151]; Novartis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005161, P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM094727, R01GM099986, R21GM075917, R01GM075877] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805 and P41EB002031 from the National Institutes of Health (NIH). Further support came from Cambridge Isotope Laboratories. F.C. was supported by fellowships from the Swiss National Science Foundation (PBBSP3-123151) and the Novartis Foundation.	Casagrande F, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P297; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das BB, 2012, J AM CHEM SOC, V134, P2047, DOI 10.1021/ja209464f; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano WL, 2005, PYMOL; Denny JK, 2001, J MAGN RESON, V152, P217, DOI 10.1006/jmre.2001.2405; EDIDIN M, 1974, ANNU REV BIOPHYS BIO, V3, P179, DOI 10.1146/annurev.bb.03.060174.001143; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goncalves JA, 2010, PROG NUCL MAG RES SP, V57, P159, DOI 10.1016/j.pnmrs.2010.04.004; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; Mesleh MF, 2003, J AM CHEM SOC, V125, P8928, DOI 10.1021/ja034211q; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park SH, 2006, J AM CHEM SOC, V128, P7402, DOI 10.1021/ja0606632; Park SH, 2012, BBA-BIOMEMBRANES, V1818, P584, DOI 10.1016/j.bbamem.2011.10.008; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Park SH, 2011, BIOCHEMISTRY-US, V50, P2371, DOI 10.1021/bi101568j; Park SH, 2010, J PHYS CHEM B, V114, P13995, DOI 10.1021/jp106043w; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817	46	357	361	7	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					779	+		10.1038/nature11580	http://dx.doi.org/10.1038/nature11580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23086146	Green Accepted, Green Submitted			2022-12-28	WOS:000311606000050
J	Young, GR; Eksmond, U; Salcedo, R; Alexopoulou, L; Stoye, JP; Kassiotis, G				Young, George R.; Eksmond, Urszula; Salcedo, Rosalba; Alexopoulou, Lena; Stoye, Jonathan P.; Kassiotis, George			Resurrection of endogenous retroviruses in antibody-deficient mice	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; B-CELL RESPONSES; TARGETED DISRUPTION; RECEPTOR; LYMPHOCYTES; MOUSE; RETROELEMENTS; EXPRESSION; INDUCTION; LIPOPOLYSACCHARIDE	The mammalian host has developed a long-standing symbiotic relationship with a considerable number of microbial species. These include the microbiota on environmental surfaces, such as the respiratory and gastrointestinal tracts(1), and also endogenous retroviruses (ERVs), comprising a substantial fraction of the mammalian genome(2,3). The long-term consequences for the host of interactions with these microbial species can range from mutualism to parasitism and are not always completely understood. The potential effect of one microbial symbiont on another is even less clear. Here we study the control of ERVs in the commonly used C57BL/6 (B6) mouse strain, which lacks endogenous murine leukaemia viruses (MLVs) able to replicate in murine cells. We demonstrate the spontaneous emergence of fully infectious ecotropic(4) MLV in B6 mice with a range of distinct immune deficiencies affecting antibody production. These recombinant retroviruses establish infection of immunodeficient mouse colonies, and ultimately result in retrovirus-induced lymphomas. Notably, ERV activation in immunodeficient mice is prevented in husbandry conditions associated with reduced or absent intestinal microbiota. Our results shed light onto a previously unappreciated role for immunity in the control of ERVs and provide a potential mechanistic link between immune activation by microbial triggers and a range of pathologies associated with ERVs, including cancer.	[Young, George R.; Eksmond, Urszula; Kassiotis, George] MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; [Salcedo, Rosalba] SAIC Frederick Inc, Basic Sci Program, NIH, Frederick, MD 21701 USA; [Salcedo, Rosalba] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Alexopoulou, Lena] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy CIML,INSERM, U1104,CNRS UMR7280, Marseille, France; [Stoye, Jonathan P.] MRC Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; MRC National Institute for Medical Research	Kassiotis, G (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England.	gkassio@nimr.mrc.ac.uk	Young, George/C-6733-2009; Alexopoulou, Lena/A-5041-2017	Young, George/0000-0002-1203-588X; Alexopoulou, Lena/0000-0003-4619-697X; Stoye, Jonathan/0000-0003-3377-323X; Kassiotis, George/0000-0002-8457-2633	UK Medical Research Council [U117581330, U117512710]; Medical Research Council [MC_U117581330, MC_U117512710] Funding Source: researchfish; MRC [MC_U117512710, MC_U117581330] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank W.-D. Hardt for mouse samples and discussion, L. Selles Vidal for technical assistance, and colleagues for critical reading of the manuscript. We also wish to thank the staff of the Unit for Laboratory Animal Medicine, University of Michigan, for the provision of germ-free mice. We are grateful for assistance from the Division of Biological Services, the Flow Cytometry, Electron Microscopy and Microarray facilities at NIMR. This work was supported by the UK Medical Research Council (U117581330 and U117512710).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bromham L, 2001, J VIROL, V75, P3053, DOI 10.1128/JVI.75.6.3053-3057.2001; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING SR, 1988, VIROLOGY, V162, P1, DOI 10.1016/0042-6822(88)90388-1; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOZAK CA, 1980, J EXP MED, V152, P219, DOI 10.1084/jem.152.1.219; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Li MF, 1999, J VIROL, V73, P9178, DOI 10.1128/JVI.73.11.9178-9186.1999; Lim A, 2011, AIDS, V25, P1379, DOI 10.1097/QAD.0b013e328348a789; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MCCUBREY J, 1982, CELL, V28, P881, DOI 10.1016/0092-8674(82)90067-8; MELAMEDOFF M, 1983, J EXP MED, V158, P506, DOI 10.1084/jem.158.2.506; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORONI C, 1975, NATURE, V254, P60, DOI 10.1038/254060a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Reid RR, 1997, J IMMUNOL, V159, P970; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; STOYE JP, 1983, J EXP MED, V157, P1660, DOI 10.1084/jem.157.5.1660; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wu Licheng, 2006, Current Issues in Intestinal Microbiology, V7, P19; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshinobu K, 2009, J IMMUNOL, V182, P8094, DOI 10.4049/jimmunol.0900263; Young GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002709	59	152	158	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					774	+		10.1038/nature11599	http://dx.doi.org/10.1038/nature11599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103862	Green Accepted			2022-12-28	WOS:000311606000049
J	Harnett, MT; Makara, JK; Spruston, N; Kath, WL; Magee, JC				Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Kath, William L.; Magee, Jeffrey C.			Synaptic amplification by dendritic spines enhances input cooperativity	NATURE			English	Article							PYRAMIDAL NEURON DENDRITES; ELECTRICAL COMPARTMENTALIZATION; LEARNING RULES; PLASTICITY; COMPUTATION; INTEGRATION; MEMBRANE; SIGNALS; MODEL; NECK	Dendritic spines are the nearly ubiquitous site of excitatory synaptic input onto neurons(1,2) and as such are critically positioned to influence diverse aspects of neuronal signalling. Decades of theoretical studies have proposed that spines may function as highly effective and modifiable chemical and electrical compartments that regulate synaptic efficacy, integration and plasticity(3-8). Experimental studies have confirmed activity-dependent structural dynamics and biochemical compartmentalization by spines(9-12). However, there is a longstanding debate over the influence of spines on the electrical aspects of synaptic transmission and dendritic operation(3-8,13-18). Here we measure the amplitude ratio of spine head to parent dendrite voltage across a range of dendritic compartments and calculate the associated spine neck resistance (R-neck) for spines at apical trunk dendrites in rat hippocampal CA1 pyramidal neurons. We find that R-neck is large enough (similar to 500M Omega) to amplify substantially the spine head depolarization associated with a unitary synaptic input by similar to 1.5- to similar to 45-fold, depending on parent dendritic impedance. A morphologically realistic compartmental model capable of reproducing the observed spatial profile of the amplitude ratio indicates that spines provide a consistently high-impedance input structure throughout the dendritic arborization. Finally, we demonstrate that the amplification produced by spines encourages electrical interaction among coactive inputs through an R-neck-dependent increase in spine head voltage-gated conductance activation. We conclude that the electrical properties of spines promote nonlinear dendritic processing and associated forms of plasticity and storage, thus fundamentally enhancing the computational capabilities of neurons(19-21).	[Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Magee, Jeffrey C.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Makara, Judit K.] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Kath, William L.] Northwestern Univ, Dept Appl Math, Evanston, IL 60208 USA; [Kath, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Northwestern University; Northwestern University	Magee, JC (corresponding author), HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Kath, William/B-6771-2009	Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783	Howard Hughes Medical Institute; National Institutes of Health [NS-046064, NS-077601]; Wellcome Trust [090915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046064, R01NS077601] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Milstein, S. Gale and R. Chitwood for help in creating analysis tools and G. Murphy, S. Williams and D. Johnston for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health (NS-046064, NS-077601) and the Wellcome Trust (International Senior Research Fellowship to J.K.M., grant number 090915).	Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Chen Y, 2012, CURR OPIN NEUROBIOL, V22, P389, DOI 10.1016/j.conb.2012.03.003; Dowell M., 1971, BIT (Nordisk Tidskrift for Informationsbehandling), V11, P168, DOI 10.1007/BF01934364; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036007; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hao J, 2012, CURR OPIN NEUROBIOL, V22, P509, DOI 10.1016/j.conb.2011.10.004; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Johnston D., 1995, FDN CELLULAR NEUROPH, P400; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; KOCH C, 1993, J NEUROSCI, V13, P413; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; MILLER JP, 1985, BRAIN RES, V325, P325, DOI 10.1016/0006-8993(85)90333-6; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rall W., 1974, CELLULAR MECH SUBSER; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; Yasuda R, 2011, CURR OPIN NEUROBIOL, V21, P313, DOI 10.1016/j.conb.2011.02.008; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	39	173	175	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					599	+		10.1038/nature11554	http://dx.doi.org/10.1038/nature11554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103868	Green Accepted			2022-12-28	WOS:000311339800053
J	Mancusso, R; Gregorio, GG; Liu, Q; Wang, DN				Mancusso, Romina; Gregorio, G. Glenn; Liu, Qun; Wang, Da-Neng			Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter	NATURE			English	Article							COUPLED CITRATE TRANSPORTER; CRYSTAL-STRUCTURE; NA+/DICARBOXYLATE COTRANSPORTER; ANOMALOUS DIFFRACTION; CARRIER PROTEIN; MEMBRANE; EXPRESSION; SYSTEM; RESIDUES; INSIGHTS	In human cells, cytosolic citrate is a chief precursor for the synthesis of fatty acids, triacylglycerols, cholesterol and low-density lipoprotein. Cytosolic citrate further regulates the energy balance of the cell by activating the fatty-acid-synthesis pathway while downregulating both the glycolysis and fatty-acid beta-oxidation pathways(1-4). The rate of fatty-acid synthesis in liver and adipose cells, the two main tissue types for such synthesis, correlates directly with the concentration of citrate in the cytosol(2-5), with the cytosolic citrate concentration partially depending on direct import across the plasma membrane through the Na+-dependent citrate transporter (NaCT)(6,7). Mutations of the homologous fly gene (Indy; I'm not dead yet) result in reduced fat storage through calorie restriction(8). More recently, Nact (also known as Slc13a5)-knockout mice have been found to have increased hepatic mitochondrial biogenesis, higher lipid oxidation and energy expenditure, and reduced lipogenesis, which taken together protect the mice from obesity and insulin resistance(9). To understand the transport mechanism of NaCT and INDY proteins, here we report the 3.2 angstrom crystal structure of a bacterial INDY homologue. One citrate molecule and one sodium ion are bound per protein, and their binding sites are defined by conserved amino acid motifs, forming the structural basis for understanding the specificity of the transporter. Comparison of the structures of the two symmetrical halves of the transporter suggests conformational changes that propel substrate translocation.	[Mancusso, Romina; Gregorio, G. Glenn; Wang, Da-Neng] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Mancusso, Romina] NYU, Sch Med, Mol Biophys Grad Program, New York, NY 10016 USA; [Liu, Qun] Brookhaven Natl Lab, NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; United States Department of Energy (DOE); Brookhaven National Laboratory; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10016 USA.	wang@saturn.med.nyu.edu	Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Gregorio, Gabriel Glenn/0000-0001-8677-133X; Wang, Da-Neng/0000-0002-6496-4699	National Institutes of Health [U54-GM075026, R01-DK073973, R01-GM093825, R01-MH083840]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073973, R01DK053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R01GM093825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Punta and B. Rost for bioinformatics analysis of membrane transporters, to J. Love and B. Kloss for assistance in cloning, and to the staff at beamlines X4, X25 and X29 of the National Synchrotron Light Source in the Brookhaven National Laboratory and at the 23ID at the Advanced Photon Source at the Argonne National Laboratory for assistance in X-ray diffraction experiments, and to J. Llodra for help with artwork. We thank B. K. Czyzewski, W. A. Hendrickson, N. K. Karpowich, F. Mancia and J. J. Marden for discussions and for participating in synchrotron trips. This work was financially supported by National Institutes of Health grants U54-GM075026, R01-DK073973, R01-GM093825 and R01-MH083840.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; BLOCH K, 1977, ANNU REV BIOCHEM, V46, P263, DOI 10.1146/annurev.bi.46.070177.001403; Boulter JM, 2001, PROTEIN EXPRES PURIF, V22, P337, DOI 10.1006/prep.2001.1440; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Hall JA, 2005, J BACTERIOL, V187, P5189, DOI 10.1128/JB.187.15.5189-5194.2005; Hall JA, 2007, J BACTERIOL, V189, P880, DOI 10.1128/JB.01452-06; HIRATO T, 1984, J BACTERIOL, V160, P421, DOI 10.1128/JB.160.1.421-426.1984; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Joshi A. D., 1945, BIOCHEMISTRY-US, V45, P4231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Li XD, 2001, FEBS LETT, V494, P165, DOI 10.1016/S0014-5793(01)02334-1; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; NISHIKOR.K, 1973, FEBS LETT, V32, P19, DOI 10.1016/0014-5793(73)80725-2; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; Pajor AM, 2010, AM J PHYSIOL-RENAL, V299, pF704, DOI 10.1152/ajprenal.00213.2010; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPENCER AF, 1962, J BIOL CHEM, V237, P3640; Strickler MA, 2009, BBA-BIOMEMBRANES, V1788, P2489, DOI 10.1016/j.bbamem.2009.10.008; Sul HS, 2008, N COMP BIOC, P155, DOI 10.1016/B978-044453219-0.50008-8; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; WRIGHT SH, 1980, J MEMBRANE BIOL, V57, P73, DOI 10.1007/BF01868987; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Zhang FF, 2001, BBA-BIOMEMBRANES, V1511, P80, DOI 10.1016/S0005-2736(00)00385-0	49	126	127	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					622	+		10.1038/nature11542	http://dx.doi.org/10.1038/nature11542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086149	Green Accepted			2022-12-28	WOS:000311339800058
J	Lorang, J; Kidarsa, T; Bradford, CS; Gilbert, B; Curtis, M; Tzeng, SC; Maier, CS; Wolpert, TJ				Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Tzeng, S. -C.; Maier, C. S.; Wolpert, T. J.			Tricking the Guard: Exploiting Plant Defense for Disease Susceptibility	SCIENCE			English	Article							HOST-SELECTIVE TOXINS; VICTORIN SENSITIVITY; RESISTANCE GENE; THIOREDOXIN H5; LRR GENE; ARABIDOPSIS; PROTEINS; FEATURES	Typically, pathogens deploy virulence effectors to disable defense. Plants defeat effectors with resistance proteins that guard effector targets. We found that a pathogen exploits a resistance protein by activating it to confer susceptibility in Arabidopsis. The guard mechanism of plant defense is recapitulated by interactions among victorin (an effector produced by the necrotrophic fungus Cochliobolus victoriae), TRX-h5 (a defense-associated thioredoxin), and LOV1 (an Arabidopsis susceptibility protein). In LOV1's absence, victorin inhibits TRX-h5, resulting in compromised defense but not disease by C. victoriae. In LOV1's presence, victorin binding to TRX-h5 activates LOV1 and elicits a resistance-like response that confers disease susceptibility. We propose that victorin is, or mimics, a conventional pathogen virulence effector that was defeated by LOV1 and confers virulence to C. victoriae solely because it incites defense.	[Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Tzeng, S. -C.; Maier, C. S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Wolpert, TJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	wolpertt@science.oregonstate.edu		Maier, Claudia S./0000-0003-0743-8956	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society; BBSRC [BB/H008039/1, BB/D016541/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Lorang J, 2010, MOL BREEDING, V26, P545, DOI 10.1007/s11032-010-9458-5; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mundt CC, 2009, PHYTOPATHOLOGY, V99, P1116, DOI 10.1094/PHYTO-99-10-1116; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Sweat TA, 2008, MOL PLANT MICROBE IN, V21, P7, DOI 10.1094/MPMI-21-1-0007; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; WOLPERT TJ, 1988, PLANT PHYSIOL, V88, P37, DOI 10.1104/pp.88.1.37; Wroblewski T, 2009, PLANT PHYSIOL, V150, P1733, DOI 10.1104/pp.109.140251	16	129	130	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					659	662		10.1126/science.1226743	http://dx.doi.org/10.1126/science.1226743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23087001	Green Accepted			2022-12-28	WOS:000310516000051
J	Spence, D				Spence, Des			How the Liverpool care pathway has transformed end of life care	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Bowater D., 2012, TELEGRAPH; Doughty, 2012, DAILY MAIL	2	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7308	10.1136/bmj.e7308	http://dx.doi.org/10.1136/bmj.e7308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114070				2022-12-28	WOS:000310778900012
J	Payne, D				Payne, David			Tamiflu: the battle for secret drug data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA					dpayne@bmj.com						Centers for Disease Control and Prevention, REC INFL ANT MED REM; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7168; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374	7	12	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2012	345								e7303	10.1136/bmj.e7303	http://dx.doi.org/10.1136/bmj.e7303			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109482	Bronze			2022-12-28	WOS:000310778000010
J	McKee, M; Belcher, P; Kosinska, M				McKee, Martin; Belcher, Paul; Kosinska, Monika			The EU Tobacco Products Directive must not be derailed	LANCET			English	Editorial Material							SMOKELESS TOBACCO		[McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Belcher, Paul] Royal Coll Physicians, EU Govt Affairs, London NW1 4LE, England; [Kosinska, Monika] European Publ Hlth Alliance, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; Royal College of Physicians	McKee, M (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				Anderson SJ, 2005, TOB CONTROL, V14, P127, DOI 10.1136/tc.2004.009076; Boseley Sara, 2012, GUARDIAN; Keating D, 2012, EUROPEAN VOICE  1018; McKee M, 2007, INT J EPIDEMIOL, V36, P805, DOI 10.1093/ije/dym101; Melikian AA, 2009, BIOMARKERS, V14, P85, DOI 10.1080/13547500902965401; Petitjean S, 2012, EUROPOLITICS    0914; Rabinoff M, 2007, AM J PUBLIC HEALTH, V97, P1981, DOI 10.2105/AJPH.2005.078014; Sansone K, 2012, TIMES MALTA     1021; Smokefree ACTION, 2012, PLAIN PACK PROT CHIL; TimesofMalta.com, 2012, DALL SAYS ZAMM NEV M; Wertz MS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001145	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1447	1448		10.1016/S0140-6736(12)61774-7	http://dx.doi.org/10.1016/S0140-6736(12)61774-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026JJ	23101701				2022-12-28	WOS:000310272000004
J	Chojnacki, J; Staudt, T; Glass, B; Bingen, P; Engelhardt, J; Anders, M; Schneider, J; Muller, B; Hell, SW; Krausslich, HG				Chojnacki, Jakub; Staudt, Thorsten; Glass, Baerbel; Bingen, Pit; Engelhardt, Johann; Anders, Maria; Schneider, Jale; Mueller, Barbara; Hell, Stefan W.; Kraeusslich, Hans-Georg			Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN INCORPORATION; GP41 CYTOPLASMIC TAIL; INFLUENZA-VIRUS; TYPE-1; VIRIONS; FUSION; ENV; ORGANIZATION; TOMOGRAPHY	Human immunodeficiency virus type 1 (HIV-1) buds from the cell as an immature particle requiring subsequent proteolysis of the main structural polyprotein Gag for morphological maturation and infectivity. Visualization of the viral envelope (Env) glycoprotein distribution on the surface of individual HIV-1 particles with stimulated emission depletion (STED) superresolution fluorescence microscopy revealed maturation-induced clustering of Env proteins that depended on the Gag-interacting Env tail. Correlation of Env surface clustering with the viral entry efficiency revealed coupling between the viral interior and exterior: Rearrangements of the inner protein lattice facilitated the alteration of the virus surface in preparation for productive entry. We propose that Gag proteolysis-dependent clustering of the sparse Env trimers on the viral surface may be an essential aspect of HIV-1 maturation.	[Chojnacki, Jakub; Glass, Baerbel; Anders, Maria; Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] BIOQUANT, D-69120 Heidelberg, Germany; [Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Krausslich, HG (corresponding author), Univ Heidelberg, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Chojnacki, Jakub/AAL-8170-2021; Muller, Barbara/AAC-4483-2020	Muller, Barbara/0000-0001-5726-5585; Krausslich, Hans-Georg/0000-0002-8756-329X; Chojnacki, Jakub/0000-0002-4457-8096	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	We are grateful to J. Mak (Burnet Institute, Melbourne) for purified recombinant HIV-1 Gag and to P. Guardado-Calves (Institut Pasteur, Paris) for monomeric and trimeric Env gp140. We thank L. Castillo for purified recombinant HIV-1 CA, V. Bosch (DKFZ Heidelberg) for HIV-1 gp120 and CD4 antisera as well as HIV-1 Env expression plasmids, R. Doms (University of Pennsylvania) for SupT1R5 cells, C. Aiken (Vanderbilt University Medical Center) for infectious HIV-1 variant plasmids, and T. Hope (Northwestern University Chicago) for the eGFP. Vpr construct. H.-G.K. is an investigator of the Excellence Cluster CellNetworks funded by the German Research Foundation (DFG). S.W.H. holds a patent on STED microscopy in several European countries and the United States, which has been licensed to Leica, a microscope manufacturer.	Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHENG RH, 1995, CELL, V80, P621; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Holtkotte D, 2006, AIDS RES HUM RETROV, V22, P57, DOI 10.1089/aid.2006.22.57; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	26	189	193	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					524	528		10.1126/science.1226359	http://dx.doi.org/10.1126/science.1226359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112332	Green Submitted			2022-12-28	WOS:000310195800057
J	Lee, J; Sayed, N; Hunter, A; Au, KF; Wong, WH; Mocarski, ES; Pera, RR; Yakubov, E; Cooke, JP				Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Au, Kin Fai; Wong, Wing H.; Mocarski, Edward S.; Pera, Renee Reijo; Yakubov, Eduard; Cooke, John P.			Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; NF-KAPPA-B; MURINE LEUKEMIA-VIRUS; TOLL-LIKE RECEPTOR-3; HISTONE H3; GENE-EXPRESSION; SOMATIC-CELLS; BINDING-SITE; LYSINE 9; FIBROBLASTS	Retroviral overexpression of reprogramming factors (Oct4, Sox2, Klf4, c-Myc) generates induced pluripotent stem cells (iPSCs). However, the integration of foreign DNA could induce genomic dysregulation. Cell-permeant proteins (CPPs) could overcome this limitation. To date, this approach has proved exceedingly inefficient. We discovered a striking difference in the pattern of gene expression induced by viral versus CPP-based delivery of the reprogramming factors, suggesting that a signaling pathway required for efficient nuclear reprogramming was activated by the retroviral, but not CPP approach. In gain-and loss-of-function studies, we find that the toll-like receptor 3 (TLR3) pathway enables efficient induction of pluripotency by viral or mmRNA approaches. Stimulation of TLR3 causes rapid and global changes in the expression of epigenetic modifiers to enhance chromatin remodeling and nuclear reprogramming. Activation of inflammatory pathways are required for efficient nuclear reprogramming in the induction of pluripotency.	[Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Yakubov, Eduard; Cooke, John P.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Au, Kin Fai; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mocarski, Edward S.] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA	Stanford University; Stanford University; Stanford University; Emory University	Cooke, JP (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	john.cooke@stanford.edu	Mocarski, Edward/ABC-2893-2020	Cooke, John/0000-0003-0033-9138; Reijo Pera, Renee/0000-0002-6487-1329; Sayed, Nazish/0000-0002-8229-721X	National Institutes of Health [U01HL100397, RC2HL103400]; University of California; NRSA grant [HL098049-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049, U01HL100397, RC2HL103400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NRSA grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs. Joanna Wysocka, Karla Kirkegaard, and Vittorio Sebastiano for their guidance; Mr. Liqun Zhu for technical assistance; and Dr. Yaso Natkunam for histological studies. This work was supported by grants to J. P. C from National Institutes of Health (U01HL100397 and RC2HL103400). J. L. was supported by grant from the Tobacco Related Disease Research Program of the University of California. N. S was supported by NRSA grant (HL098049-01A1). J. P. C., N. S., and J. L. are inventors of the intellectual property, assigned to Stanford University, which was generated by this research.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; HAGINOYAMAGISHI K, 1987, J VIROL, V61, P1964, DOI 10.1128/JVI.61.6.1964-1971.1987; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang WC, 2009, BIOTECHNOL BIOENG, V104, P1047, DOI 10.1002/bit.22517; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	42	241	262	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					547	558		10.1016/j.cell.2012.09.034	http://dx.doi.org/10.1016/j.cell.2012.09.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101625	Green Accepted, Bronze			2022-12-28	WOS:000310529300012
J	White, JF; Noinaj, N; Shibata, Y; Love, J; Kloss, B; Xu, F; Gvozdenovic-Jeremic, J; Shah, P; Shiloach, J; Tate, CG; Grisshammer, R				White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard			Structure of the agonist-bound neurotensin receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; OPIOID RECEPTOR; BINDING-SITE; ACTIVE STATE; PEPTIDE; GPCR; ACTIVATION; INSIGHTS	Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR). In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes. Here we present the structure at 2.8 angstrom resolution of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor. The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core. Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurological disorders, cancer and obesity.	[White, Jim F.; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Grisshammer, Reinhard] Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA; [Noinaj, Nicholas] NIDDKD, Mol Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Shibata, Yoko; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Love, James; Kloss, Brian] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, Prot Prod Facil, New York, NY 10027 USA; [Shiloach, Joseph] NIDDKD, Biotechnol Core Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Grisshammer, R (corresponding author), Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA.	rkgriss@helix.nih.gov	Grisshammer, Reinhard/C-3089-2015	Tate, Christopher/0000-0002-2008-9183; Kloss, Brian/0000-0003-0130-8739	National Institutes of Health (National Institute of Neurological Disorders and Stroke); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases); Pfizer Global Research and Development; MRCT Development Gap Fund; UK Medical Research Council [MRC U105197215]; National Institutes of Health [U54GM075026]; NIH Roadmap grant [P50 GM073197]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; MRC [MC_U105197215] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, P50GM073197] Funding Source: NIH RePORTER; Medical Research Council [MC_U105197215] Funding Source: researchfish	National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pfizer Global Research and Development(Pfizer); MRCT Development Gap Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health (J.F.W., J.G.-J., P.S. and R.G.: National Institute of Neurological Disorders and Stroke; N.N. and J.S.: National Institute of Diabetes and Digestive and Kidney Diseases) and a joint grant from Pfizer Global Research and Development and the MRCT Development Gap Fund in addition to core funding from the UK Medical Research Council MRC U105197215 (Y.S., C.G.T.). The Protein Production Facility of the New York Consortium on Membrane Protein Structure was supported by the National Institutes of Health grant U54GM075026 (J.L., B.K.). We acknowledge the NIH Roadmap grant P50 GM073197 for technology development (to R. C. Stevens) for visitor support at The Scripps Research Institute. We thank the staff at the General Medicine and Cancer Institute's Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source, Argonne National Laboratory for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barroso S, 2002, BRIT J PHARMACOL, V135, P997, DOI 10.1038/sj.bjp.0704546; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Harterich S, 2008, BIOORGAN MED CHEM, V16, P9359, DOI 10.1016/j.bmc.2008.08.051; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; HENRY JA, 1993, BIOORG MED CHEM LETT, V3, P949, DOI 10.1016/S0960-894X(00)80698-8; Hilgart MC, 2011, J SYNCHROTRON RADIAT, V18, P717, DOI 10.1107/S0909049511029918; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lebon G., 2012, CURR OPIN STRUC BIOL, V22, P1; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Luca S, 2003, P NATL ACAD SCI USA, V100, P10706, DOI 10.1073/pnas.1834523100; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	59	373	383	7	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					508	+		10.1038/nature11558	http://dx.doi.org/10.1038/nature11558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23051748	Green Accepted			2022-12-28	WOS:000310196200035
J	Anasetti, C; Logan, BR; Lee, SJ; Waller, EK; Weisdorf, DJ; Wingard, JR; Cutler, CS; Westervelt, P; Woolfrey, A; Couban, S; Ehninger, G; Johnston, L; Maziarz, RT; Pulsipher, MA; Porter, DL; Mineishi, S; McCarty, JM; Khan, SP; Anderlini, P; Bensinger, WI; Leitman, SF; Rowley, SD; Bredeson, C; Carter, SL; Horowitz, MM; Confer, DL				Anasetti, Claudio; Logan, Brent R.; Lee, Stephanie J.; Waller, Edmund K.; Weisdorf, Daniel J.; Wingard, John R.; Cutler, Corey S.; Westervelt, Peter; Woolfrey, Ann; Couban, Stephen; Ehninger, Gerhard; Johnston, Laura; Maziarz, Richard T.; Pulsipher, Michael A.; Porter, David L.; Mineishi, Shin; McCarty, John M.; Khan, Shakila P.; Anderlini, Paolo; Bensinger, William I.; Leitman, Susan F.; Rowley, Scott D.; Bredeson, Christopher; Carter, Shelly L.; Horowitz, Mary M.; Confer, Dennis L.		Blood And Marrow Transplant Clinic	Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; COLONY-STIMULATING FACTOR; TERM-FOLLOW-UP; RANDOMIZED-TRIAL; CHRONIC GRAFT; PROGENITOR CELLS; ALLOGENEIC TRANSPLANTATION; LEUKEMIA; RECIPIENTS; MALIGNANCIES	BACKGROUND Randomized trials have shown that the transplantation of filgrastim-mobilized peripheral-blood stem cells from HLA-identical siblings accelerates engraftment but increases the risks of acute and chronic graft-versus-host disease (GVHD), as compared with the transplantation of bone marrow. Some studies have also shown that peripheral-blood stem cells are associated with a decreased rate of relapse and improved survival among recipients with high-risk leukemia. METHODS We conducted a phase 3, multicenter, randomized trial of transplantation of peripheral-blood stem cells versus bone marrow from unrelated donors to compare 2-year survival probabilities with the use of an intention-to-treat analysis. Between March 2004 and September 2009, we enrolled 551 patients at 48 centers. Patients were randomly assigned in a 1: 1 ratio to peripheral-blood stem-cell or bone marrow transplantation, stratified according to transplantation center and disease risk. The median follow-up of surviving patients was 36 months (interquartile range, 30 to 37). RESULTS The overall survival rate at 2 years in the peripheral-blood group was 51% (95% confidence interval [CI], 45 to 57), as compared with 46% (95% CI, 40 to 52) in the bone marrow group (P = 0.29), with an absolute difference of 5 percentage points (95% CI, -3 to 14). The overall incidence of graft failure in the peripheral-blood group was 3% (95% CI, 1 to 5), versus 9% (95% CI, 6 to 13) in the bone marrow group (P = 0.002). The incidence of chronic GVHD at 2 years in the peripheral-blood group was 53% (95% CI, 45 to 61), as compared with 41% (95% CI, 34 to 48) in the bone marrow group (P = 0.01). There were no significant between-group differences in the incidence of acute GVHD or relapse. CONCLUSIONS We did not detect significant survival differences between peripheral-blood stem-cell and bone marrow transplantation from unrelated donors. Exploratory analyses of secondary end points indicated that peripheral-blood stem cells may reduce the risk of graft failure, whereas bone marrow may reduce the risk of chronic GVHD. (Funded by the National Heart, Lung, and Blood Institute-National Cancer Institute and others; ClinicalTrials.gov number, NCT00075816.)	[Anasetti, Claudio] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Logan, Brent R.; Horowitz, Mary M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Lee, Stephanie J.; Woolfrey, Ann; Bensinger, William I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Waller, Edmund K.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Weisdorf, Daniel J.] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Khan, Shakila P.] Mayo Clin, Rochester, MN USA; [Confer, Dennis L.] Natl Marrow Donor Program, Minneapolis, MN USA; [Cutler, Corey S.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Westervelt, Peter] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Couban, Stephen] Dalhousie Univ, Halifax, NS, Canada; [Bredeson, Christopher] Ottawa Hosp, Ottawa, ON, Canada; [Ehninger, Gerhard] Univ Hosp Dresden, Dresden, Germany; [Johnston, Laura] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Maziarz, Richard T.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Pulsipher, Michael A.] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA; [Porter, David L.] Univ Penn, Philadelphia, PA 19104 USA; [Mineishi, Shin] Univ Michigan, Ann Arbor, MI 48109 USA; [McCarty, John M.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA; [Anderlini, Paolo] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Leitman, Susan F.] NIH, Bethesda, MD 20892 USA; [Carter, Shelly L.] EMMES Corp, Rockville, MD USA; [Rowley, Scott D.] Hackensack Univ, John Theurer Canc Ctr, Hackensack, NJ USA; [Wingard, John R.] Univ Florida, Shands Canc Ctr, Gainesville, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Medical College of Wisconsin; Fred Hutchinson Cancer Center; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; National Marrow Donor Program; Harvard University; Dana-Farber Cancer Institute; Siteman Cancer Center; Washington University (WUSTL); Dalhousie University; University of Ottawa; Ottawa Hospital Research Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Stanford University; Oregon Health & Science University; Utah System of Higher Education; University of Utah; University of Pennsylvania; University of Michigan System; University of Michigan; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; Emmes Corporation; Hackensack University Medical Center; State University System of Florida; University of Florida	Anasetti, C (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	claudio.anasetti@moffitt.org	horowitz, Mary/ABH-2173-2021; Waller, Edmund K/AAP-3055-2020	Agha, Mounzer/0000-0002-2275-7544; Leber, Brian/0000-0001-5502-1480; Wingard, John/0000-0001-7478-5398; Roy, Jean/0000-0002-7716-6864	National Heart, Lung, and Blood Institute-National Cancer Institute; National Heart, Lung, and Blood Institute; National Cancer Institute [U10HL069294]; Office of Naval Research; National Marrow Donor Program; NATIONAL CANCER INSTITUTE [U24CA076518, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL069334, U10HL069254, U10HL069249, U10HL069348, U10HL069286, U10HL069330, U10HL069294, U10HL069301, U10HL069290] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002091] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Naval Research(Office of Naval Research); National Marrow Donor Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	Funded by the National Heart, Lung, and Blood Institute-National Cancer Institute and others; ClinicalTrials.gov number, NCT00075816.; Supported by a grant from the National Heart, Lung, and Blood Institute and the National Cancer Institute (U10HL069294), by the Office of Naval Research, and by the National Marrow Donor Program.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Bacigalupo A, 2006, BIOL BLOOD MARROW TR, V12, P560, DOI 10.1016/j.bbmt.2005.12.034; Bensinger WI, 2001, NEW ENGL J MED, V344, P175, DOI 10.1056/NEJM200101183440303; BENSINGER WI, 1995, BLOOD, V85, P1655, DOI 10.1182/blood.V85.6.1655.bloodjournal8561655; Blaise D, 2000, J CLIN ONCOL, V18, P537, DOI 10.1200/JCO.2000.18.3.537; Couban S, 2002, BLOOD, V100, P1525, DOI 10.1182/blood-2002-01-0048; DREGER P, 1993, BLOOD, V81, P1404; Eapen M, 2007, BIOL BLOOD MARROW TR, V13, P1461, DOI 10.1016/j.bbmt.2007.08.006; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Flowers MED, 2002, BLOOD, V100, P415, DOI 10.1182/blood-2002-01-0011; Friedrichs B, 2010, LANCET ONCOL, V11, P331, DOI 10.1016/S1470-2045(09)70352-3; Guardiola P, 2002, BLOOD, V99, P4370, DOI 10.1182/blood.V99.12.4370; KORBLING M, 1995, BLOOD, V85, P1659, DOI 10.1182/blood.V85.6.1659.bloodjournal8561659; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Morton J, 2001, BLOOD, V98, P3186, DOI 10.1182/blood.V98.12.3186; Oehler VG, 2005, BIOL BLOOD MARROW TR, V11, P85, DOI 10.1016/j.bbmt.2004.09.010; Pasquini Marcelo C, 2010, Clin Transpl, P87; Petersdorf EW, 2001, NEW ENGL J MED, V345, P1794, DOI 10.1056/NEJMoa011826; Pidala J, 2009, BIOL BLOOD MARROW TR, V15, P1415, DOI 10.1016/j.bbmt.2009.07.009; Powles R, 2000, LANCET, V355, P1231, DOI 10.1016/S0140-6736(00)02090-0; RUSSELL NH, 1993, LANCET, V341, P1482, DOI 10.1016/0140-6736(93)90929-B; SCHMITZ N, 1995, BLOOD, V85, P1666, DOI 10.1182/blood.V85.6.1666.bloodjournal8561666; Schmitz N, 2002, BLOOD, V100, P761, DOI 10.1182/blood-2001-12-0304; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Sierra J, 1997, BLOOD, V89, P4226, DOI 10.1182/blood.V89.11.4226; Spellman S, 2010, BLOOD, V115, P2704, DOI 10.1182/blood-2009-09-244525; Switzer GE, 2000, 52 ASH ANN M EXP ORL	29	554	561	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1487	1496		10.1056/NEJMoa1203517	http://dx.doi.org/10.1056/NEJMoa1203517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23075175	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000309904500006
J	Roselli, F; Caroni, P				Roselli, Francesco; Caroni, Pico			A Circuit Mechanism for Neurodegeneration	CELL			English	Editorial Material							SPINAL MUSCULAR-ATROPHY; MOUSE MODEL; MICE; SURVIVAL; PROTEIN; RESCUE		[Roselli, Francesco; Caroni, Pico] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	roselli, francesco/O-8847-2019; roselli, francesco/G-6701-2013	roselli, francesco/0000-0001-9935-6899; 				Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046	9	7	7	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					250	252		10.1016/j.cell.2012.09.030	http://dx.doi.org/10.1016/j.cell.2012.09.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063119	Bronze			2022-12-28	WOS:000309981000005
J	Teperino, R; Amann, S; Bayer, M; Mcgee, SL; Loipetzberger, A; Connor, T; Jaeger, C; Kammerer, B; Winter, L; Wiche, G; Dalgaard, K; Selvaraj, M; Gaster, M; Lee-Young, RS; Febbraio, MA; Knauf, C; Cani, PD; Aberger, F; Penninger, JM; Pospisilik, JA; Esterbauer, H				Teperino, Raffaele; Amann, Sabine; Bayer, Martina; Mcgee, Sean L.; Loipetzberger, Andrea; Connor, Timothy; Jaeger, Carsten; Kammerer, Bernd; Winter, Lilli; Wiche, Gerhard; Dalgaard, Kevin; Selvaraj, Madhan; Gaster, Michael; Lee-Young, Robert S.; Febbraio, Mark A.; Knauf, Claude; Cani, Patrice D.; Aberger, Fritz; Penninger, Josef M.; Pospisilik, J. Andrew; Esterbauer, Harald			Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat	CELL			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PRIMARY CILIA; PATHWAY; PROMOTE; OBESITY; REQUIREMENT; INHIBITION; OXYSTEROLS; MECHANISMS	Diabetes, obesity, and cancer affect upward of 15% of the world's population. Interestingly, all three diseases juxtapose dysregulated intracellular signaling with altered metabolic state. Exactly which genetic factors define stable metabolic set points in vivo remains poorly understood. Here, we show that hedgehog signaling rewires cellular metabolism. We identify a cilium-dependent Smo-Ca2+-Ampk axis that triggers rapid Warburg-like metabolic reprogramming within minutes of activation and is required for proper metabolic selectivity and flexibility. We show that Smo modulators can uncouple the Smo-Ampk axis from canonical signaling and identify cyclopamine as one of a new class of "selective partial agonists," capable of concomitant inhibition of canonical and activation of noncanonical hedgehog signaling. Intriguingly, activation of the Smo-Ampk axis in vivo drives robust insulin-independent glucose uptake in muscle and brown adipose tissue. These data identify multiple noncanonical endpoints that are pivotal for rational design of hedgehog modulators and provide a new therapeutic avenue for obesity and diabetes.	[Teperino, Raffaele; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Amann, Sabine; Bayer, Martina; Dalgaard, Kevin; Selvaraj, Madhan; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Mcgee, Sean L.; Connor, Timothy] Deakin Univ, Metabol Remodeling Lab, Metab Res Unit, Sch Med, Geelong, Vic 3220, Australia; [Loipetzberger, Andrea; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Jaeger, Carsten; Kammerer, Bernd] Ctr Biol Syst Anal ZBSA, Metabol Core, D-79104 Freiburg, Germany; [Winter, Lilli; Wiche, Gerhard] Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria; [Gaster, Michael] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Lee-Young, Robert S.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; [Knauf, Claude] Univ Toulouse 3, Inst Med Mol Rangueil, Team 3, CHU Rangueil,INSERM,U1048, F-31432 Toulouse 4, France; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Max Planck Society; Medical University of Vienna; Deakin University; Salzburg University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Baker Heart and Diabetes Institute; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	D., Cani Patrice/M-8055-2016; Winter, Lilli/ABB-3043-2021; Winter, Lilli/R-5949-2017; Penninger, Josef M/I-6860-2013; Aberger, Fritz/B-6357-2012; WICHE, Gerhard/AAA-3227-2021; Febbraio, Mark/AAE-9632-2019	D., Cani Patrice/0000-0003-2040-2448; Winter, Lilli/0000-0002-6368-1160; Winter, Lilli/0000-0002-6368-1160; Penninger, Josef M/0000-0002-8194-3777; Aberger, Fritz/0000-0003-2009-6305; Lee, Robert/0000-0002-8166-142X; Knauf, Claude/0000-0001-5213-5378; Wiche, Gerhard/0000-0001-9550-5463; Esterbauer, Harald/0000-0001-7343-7455; Teperino, Raffaele/0000-0001-8815-1409; Jaeger, Carsten/0000-0003-2192-1792; McGee, Sean/0000-0001-6953-106X; Febbraio, Mark/0000-0002-9296-4418	DART; AIRC; Marie-Curie; JDRF; WWTF; MPG; FWF; FFG; OeAW; Austrian Science Fund (FWF) [I 1207, I 413, P 23729] Funding Source: researchfish	DART; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie-Curie(European Commission); JDRF(Juvenile Diabetes Research Foundation); WWTF; MPG(Max Planck Society); FWF(Austrian Science Fund (FWF)); FFG; OeAW; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are indebted to the DART, AIRC, Marie-Curie, and JDRF for fellowships and WWTF, MPG, FWF, FFG (GenAU-program), and OeAW for funding. S. L. M. is a Career Development Fellow and M. A. F. a Senior Research Fellow of the National Health and Medical Research Council of Australia. The authors are grateful to E. Hobeika, M. Bilban, E. Einwallner, A. Jais, I. Lynfort, and B. Vind for critical technical and theoretical help. The authors are also grateful to M. Scott for providing Smoothened expression constructs, to J. Reiter for Smo-CLD and providing Kif3a<SUP>-/-</SUP> and Ift88<SUP>-/-</SUP> cells, to J. Taipale for providing Smo<SUP>-/-</SUP> cells, and to L. Cantley for the AMPKAR vector.	Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Li YW, 2012, EXPERT OPIN THER TAR, V16, P49, DOI 10.1517/14728222.2011.617367; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Roudaut H, 2011, MOL PHARMACOL, V79, P453, DOI 10.1124/mol.110.069708; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	56	191	193	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					414	426		10.1016/j.cell.2012.09.021	http://dx.doi.org/10.1016/j.cell.2012.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063129	Bronze, Green Published			2022-12-28	WOS:000309981000018
J	Banerjee, S; Narayanan, M; Gould, K				Banerjee, Suryabrata; Narayanan, Manjusha; Gould, Kate			Monitoring aminoglycoside level	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; ADULTS		[Banerjee, Suryabrata] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [Narayanan, Manjusha] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gould, Kate] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	Banerjee, S (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	drsuryabrata@yahoo.co.uk	Banerjee, Suryabrata/AAY-7602-2021	Banerjee, Suryabrata/0000-0001-8200-4432				American Speech-Language-Hearing Association, 1994, AUD MAN IND REC COCH; Anaizi N, 1997, INT J CLIN PHARM TH, V35, P223; Begg EJ, 1999, BRIT J CLIN PHARMACO, V47, P23, DOI 10.1046/j.1365-2125.1999.00850.x; Chabner B., 2010, GOODMAN GILLMAN PHAR, V12th; Edson RS, 1999, MAYO CLIN PROC, V74, P519, DOI 10.4065/74.5.519; Gilbert DN, 2010, MANDELL DOUGLAS BENN; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Naughton CA, 2008, AM FAM PHYSICIAN, V78, P743; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Ramakrishnan K, 2005, AM FAM PHYSICIAN, V71, P933; Scottish Medicines Consortium Scottish Antimicrobial Prescribing Group, 2009, GUID US GENT VANC AD; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; Urban A W, 1997, Curr Clin Top Infect Dis, V17, P236	13	7	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6354	10.1136/bmj.e6354	http://dx.doi.org/10.1136/bmj.e6354			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044986				2022-12-28	WOS:000309386700009
J	Kirby, T				Kirby, Tony			Andrew Grace: tackling the rising tide of arrhythmia	LANCET			English	Biographical-Item																		GRACE A, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1464	1464		10.1016/S0140-6736(12)61829-7	http://dx.doi.org/10.1016/S0140-6736(12)61829-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101704				2022-12-28	WOS:000310272000013
J	Buesseler, KO				Buesseler, Ken O.			Fishing for Answers off Fukushima	SCIENCE			English	Editorial Material							RADIONUCLIDES; RADIOCESIUM; JAPAN		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu						Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029295; International Atomic Energy Agency, 2004, TECHN REP SER, V422; Japan Ministry of Agriculture, 2012, RES INSP RAD MAT FIS; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Ministry of Education, 2012, READ MAR SOIL MON SE; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; Tokyo Electric Power Company, 2012, NUCL AN RES FISH SHE; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493	11	88	96	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					480	482		10.1126/science.1228250	http://dx.doi.org/10.1126/science.1228250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112321	Green Submitted			2022-12-28	WOS:000310195800043
J	Garrison, JL; Macosko, EZ; Bernstein, S; Pokala, N; Albrecht, DR; Bargmann, CI				Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.			Oxytocin/Vasopressin-Related Peptides Have an Ancient Role in Reproductive Behavior	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS; C-ELEGANS; OXYTOCIN	Many biological functions are conserved, but the extent to which conservation applies to integrative behaviors is unknown. Vasopressin and oxytocin neuropeptides are strongly implicated in mammalian reproductive and social behaviors, yet rodent loss-of-function mutants have relatively subtle behavioral defects. Here we identify an oxytocin/vasopressin-like signaling system in Caenorhabditis elegans, consisting of a peptide and two receptors that are expressed in sexually dimorphic patterns. Males lacking the peptide or its receptors perform poorly in reproductive behaviors, including mate search, mate recognition, and mating, but other sensorimotor behaviors are intact. Quantitative analysis indicates that mating motor patterns are fragmented and inefficient in mutants, suggesting that oxytocin/vasopressin peptides increase the coherence of mating behaviors. These results indicate that conserved molecules coordinate diverse behavioral motifs in reproductive behavior.	[Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Garrison, JL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.		Pokala, Navin/AAH-5719-2019; Macosko, Evan/X-4664-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH [K99GM092859, GM07739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092859, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Strains bearing ntc-1, ntr-1, and ntr-2 mutations are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement. Sequence accession numbers are as follows: NM_001038459.1 (ntc-1), NM_060792 (ntr-1), NM_078076 (ntr-2). We thank S. Emmons for sharing the male wiring diagram before publication; D. Anderson, S. Emmons, S. Flavell, A. Gordus, W. Kristan, T. Maniar, P. McGrath, L. Vosshall, and Y. Xu for discussions; S. Chalasani for plasmids; S. Mitani and the National Bioresource Project for ntc-1, ntr-1, and ntr-2 mutants; and the Rockefeller Proteomics Facility, the Rockefeller Bioimaging Facility, and the Rockefeller High Throughput Screening Facility for technical support. This work was supported by a grant from the G. Harold and Leila Y. Mathers Foundation, by Harvey Karp and Helen Hay Whitney Fellowships to J.L.G., by NIH grant K99GM092859 to J.L.G., and by NIH grant GM07739 to E.Z.M. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; HODGKIN J, 1987, ANNU REV GENET, V21, P133, DOI 10.1146/annurev.ge.21.120187.001025; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Wagenaar DA, 2010, CURR BIOL, V20, P487, DOI 10.1016/j.cub.2010.02.027; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909	16	163	166	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					540	543		10.1126/science.1226201	http://dx.doi.org/10.1126/science.1226201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112335	Green Accepted			2022-12-28	WOS:000310195800061
J	LaRue, CC; Padilla, PA				LaRue, Candace C.; Padilla, Pamela A.			A Mutant Search-Caenorhabditis elegans and Gene Discovery	SCIENCE			English	Editorial Material									[LaRue, Candace C.; Padilla, Pamela A.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Padilla, PA (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	pamela.padilla@unt.edu			Division Of Integrative Organismal Systems [0747391] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BRENNER S, 1974, GENETICS, V77, P71; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	4	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					487	488		10.1126/science.1215229	http://dx.doi.org/10.1126/science.1215229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112325				2022-12-28	WOS:000310195800047
J	Cooray, A; Smidt, J; De Bernardis, F; Gong, Y; Stern, D; Ashby, MLN; Eisenhardt, PR; Frazer, CC; Gonzalez, AH; Kochanek, CS; Kozlowski, S; Wright, EL				Cooray, Asantha; Smidt, Joseph; De Bernardis, Francesco; Gong, Yan; Stern, Daniel; Ashby, Matthew L. N.; Eisenhardt, Peter R.; Frazer, Christopher C.; Gonzalez, Anthony H.; Kochanek, Christopher S.; Kozlowski, Szymon; Wright, Edward L.			Near-infrared background anisotropies from diffuse intrahalo light of galaxies	NATURE			English	Article							BRIGHTEST CLUSTER GALAXIES; WIDE-FIELD SURVEY; INTRACLUSTER LIGHT; POPULATION-III; STELLAR HALOS; FLUCTUATIONS; STARS; DEEP; REIONIZATION; CALIBRATION	Unresolved anisotropies of the cosmic near-infrared background radiation are expected to have contributions from the earliest galaxies during the epoch of reionization(1-5) and from faint, dwarf galaxies at intermediate redshifts(6,7). Previous measurements(8-12) were unable to pinpoint conclusively the dominant origin because they did not sample spatial scales that were sufficiently large to distinguish between these two possibilities. Here we report a measurement of the anisotropy power spectrum from subarcminute to one-degree angular scales, and find the clustering amplitude to be larger than predicted by the models based on the two existing explanations. As the shot-noise level of the power spectrum is consistent with that expected from faint galaxies, a new source population on the sky is not necessary to explain the observations. However, a physical mechanism that increases the clustering amplitude is needed. Motivated by recent results related to the extended stellar light profile in dark-matter haloes(13-15), we consider the possibility that the fluctuations originate from intrahalo stars of all galaxies. We find that the measured power spectrum can be explained by an intrahalo light fraction of 0.07 to 0.2 per cent relative to the total luminosity in dark-matter haloes of 10(9) to 10(12) solar masses at redshifts of about 1 to 4.	[Cooray, Asantha; Smidt, Joseph; De Bernardis, Francesco; Gong, Yan; Frazer, Christopher C.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Stern, Daniel; Eisenhardt, Peter R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Ashby, Matthew L. N.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Gonzalez, Anthony H.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Kochanek, Christopher S.; Kozlowski, Szymon] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Kozlowski, Szymon] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Wright, Edward L.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University of Warsaw; Warsaw University Observatory; University of California System; University of California Los Angeles	Cooray, A (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	acooray@uci.edu	Kozlowski, Szymon/G-4799-2013	Kozlowski, Szymon/0000-0003-4084-880X; Stern, Daniel/0000-0003-2686-9241	NSF CAREER; NASA ADAP; JPL/Caltech	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA ADAP; JPL/Caltech	We acknowledge support from NSF CAREER (to A.C.), NASA ADAP and an award from JPL/Caltech. We thank R. Arendt for sharing his IRAC self-calibration code. We thank J. Bock and M. Zemcov for their contributions to the SDWFS project. This work is based on observations made with the Spitzer Space Telescope. This work also made use of data products provided by the NOAO Deep Wide-Field Survey. A.C. thanks the Aspen Center for Physics for hospitality.	Amblard A, 2011, NATURE, V470, P510, DOI 10.1038/nature09771; Arendt RG, 2000, ASTROPHYS J, V536, P500, DOI 10.1086/308923; Ashby MLN, 2009, ASTROPHYS J, V701, P428, DOI 10.1088/0004-637X/701/1/428; Carollo D, 2010, ASTROPHYS J, V712, P692, DOI 10.1088/0004-637X/712/1/692; Chary RR, 2008, ASTROPHYS J, V681, P53, DOI 10.1086/588576; Conroy C, 2007, ASTROPHYS J, V668, P826, DOI 10.1086/521425; Cooray A, 2004, ASTROPHYS J, V606, P611, DOI 10.1086/383137; Cooray A, 2002, PHYS REP, V372, P1, DOI 10.1016/S0370-1573(02)00276-4; Cooray A, 2007, ASTROPHYS J, V659, pL91, DOI 10.1086/517969; Cooray A, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/92; Courteau S, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/20; Fernandez ER, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/20; Fernandez ER, 2010, ASTROPHYS J, V710, P1089, DOI 10.1088/0004-637X/710/2/1089; Gonzalez AH, 2005, ASTROPHYS J, V618, P195, DOI 10.1086/425896; Helgason K, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/113; Jannuzi BT, 1999, ASTR SOC P, V191, P111; Kashlinsky A, 2004, ASTROPHYS J, V608, P1, DOI 10.1086/386365; Kashlinsky A, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/63; Kashlinsky A, 2005, NATURE, V438, P45, DOI 10.1038/nature04143; Levenson LR, 2007, ASTROPHYS J, V666, P34, DOI 10.1086/520112; Lin YT, 2004, ASTROPHYS J, V617, P879, DOI 10.1086/425412; Madau P, 2005, MON NOT R ASTRON SOC, V359, pL37, DOI 10.1111/j.1745-3933.2005.00031.x; Matsumoto T, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/124; Purcell CW, 2007, ASTROPHYS J, V666, P20, DOI 10.1086/519787; Purcell CW, 2008, MON NOT R ASTRON SOC, V391, P550, DOI 10.1111/j.1365-2966.2008.13938.x; Rudick CS, 2009, ASTROPHYS J, V699, P1518, DOI 10.1088/0004-637X/699/2/1518; Salvaterra R, 2003, MON NOT R ASTRON SOC, V339, P973, DOI 10.1046/j.1365-8711.2003.06244.x; Santos MR, 2002, MON NOT R ASTRON SOC, V336, P1082, DOI 10.1046/j.1365-8711.2002.05895.x; Tal T, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/2/89; Thompson RI, 2007, ASTROPHYS J, V666, P658, DOI 10.1086/520634	30	75	75	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					514	516		10.1038/nature11474	http://dx.doi.org/10.1038/nature11474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099405				2022-12-28	WOS:000310196200036
J	McFarland, E				McFarland, Eric			Unconventional Chemistry for Unconventional Natural Gas	SCIENCE			English	Editorial Material							CATALYSTS; METHANE; CHLOROMETHANE; OXIDATION		Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA	University of California System; University of California Santa Barbara	McFarland, E (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA.	ewmcfar@engineering.ucsb.edu	McFarland, Eric/G-1763-2014					Chesnokov VV, 2003, J CATAL, V218, P438, DOI 10.1016/S0021-9517(03)00085-X; Ding KL, 2012, ACS CATAL, V2, P479, DOI 10.1021/cs2006058; I.A.U. Energy, 2012, ANN ENERGY OUTLOOK 2; Lange JP, 1996, CHEM ENG SCI, V51, P2379, DOI 10.1016/0009-2509(96)00094-2; LERSCH P, 1991, APPL CATAL, V75, P133, DOI 10.1016/S0166-9834(00)83129-2; Lorkovic IM, 2004, CATAL TODAY, V98, P317, DOI 10.1016/j.cattod.2004.07.058; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Podkolzin SG, 2007, J AM CHEM SOC, V129, P2569, DOI 10.1021/ja066913w; Sousa-Aguiar EF, 2011, CATAL SCI TECHNOL, V1, P698, DOI 10.1039/c1cy00116g; Statistical B. P., 2012, REV WORLD EN 2012; Tullo AH, 2008, CHEM ENG NEWS, V86, P15, DOI 10.1021/cen-v086n011.p015; Ueda W, 2000, APPL CATAL A-GEN, V200, P135, DOI 10.1016/S0926-860X(00)00627-X; WHITE CM, 1992, ENERG FUEL, V6, P76, DOI 10.1021/ef00031a012; Zhang AH, 2011, PHYS CHEM CHEM PHYS, V13, P2550, DOI 10.1039/c0cp01985b	14	313	317	12	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					340	342		10.1126/science.1226840	http://dx.doi.org/10.1126/science.1226840			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087239				2022-12-28	WOS:000309955800030
J	Deegan, LA; Johnson, DS; Warren, RS; Peterson, BJ; Fleeger, JW; Fagherazzi, S; Wollheim, WM				Deegan, Linda A.; Johnson, David Samuel; Warren, R. Scott; Peterson, Bruce J.; Fleeger, John W.; Fagherazzi, Sergio; Wollheim, Wilfred M.			Coastal eutrophication as a driver of salt marsh loss	NATURE			English	Article							NUTRIENT ENRICHMENT; NITROGEN; DENITRIFICATION; WATER; PSEUDOREPLICATION; VEGETATION; REDUCTION; STABILITY; SEAGRASS; ECOLOGY	Salt marshes are highly productive coastal wetlands that provide important ecosystem services such as storm protection for coastal cities, nutrient removal and carbon sequestration. Despite protective measures, however, worldwide losses of these ecosystems have accelerated in recent decades(1). Here we present data from a nine-year whole-ecosystem nutrient-enrichment experiment. Our study demonstrates that nutrient enrichment, a global problem for coastal ecosystems(2-4), can be a driver of salt marsh loss. We show that nutrient levels commonly associated with coastal eutrophication increased above-ground leaf biomass, decreased the dense, below-ground biomass of bank-stabilizing roots, and increased microbial decomposition of organic matter. Alterations in these key ecosystem properties reduced geomorphic stability, resulting in creek-bank collapse with significant areas of creek-bank marsh converted to unvegetated mud. This pattern of marsh loss parallels observations for anthropogenically nutrient-enriched marshes worldwide, with creek-edge and bay-edge marsh evolving into mudflats and wider creeks(5-7). Our work suggests that current nutrient loading rates to many coastal ecosystems have overwhelmed the capacity of marshes to remove nitrogen without deleterious effects. Projected increases in nitrogen flux to the coast, related to increased fertilizer use required to feed an expanding human population, may rapidly result in a coastal landscape with less marsh, which would reduce the capacity of coastal regions to provide important ecological and economic services.	[Deegan, Linda A.; Johnson, David Samuel; Peterson, Bruce J.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Johnson, David Samuel] Sewanee Univ S, Dept Biol, Sewanee, TN 37383 USA; [Warren, R. Scott] Connecticut Coll, Dept Bot, New London, CT 06320 USA; [Fleeger, John W.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fagherazzi, Sergio] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Wollheim, Wilfred M.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	Marine Biological Laboratory - Woods Hole; Sewanee: University of the South; Connecticut College; Louisiana State University System; Louisiana State University; Boston University; University System Of New Hampshire; University of New Hampshire	Deegan, LA (corresponding author), Marine Biol Lab, Ctr Ecosyst, 7 MBL St, Woods Hole, MA 02543 USA.	ldeegan@mbl.edu	Wollheim, Wilfred/AAA-3516-2022; Fagherazzi, Sergio/K-4245-2016; Fleeger, John W/A-6215-2013	Fagherazzi, Sergio/0000-0002-4048-5968; Wollheim, Wilfred/0000-0002-5009-3212; Johnson, David/0000-0002-7898-4893	NSF [DEB0816963, DEB0213767, OCE0923689, OCE 0423565, OCE0924287]; NOAA; Mellon Foundation; EPSCoR [1101245] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Mellon Foundation; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank our TIDE (Trophic cascades and Interacting control processes in a Detritus-based Ecosystem), LENS (Landscape Evolution in a Nutrient enriched Saltmarsh) and PIE-LTER (Plum Island Ecosystems Long-term Ecological Research) colleagues for field assistance and comments. We thank the many research assistants, graduate and undergraduate students who maintained the nutrient enrichment and analysed samples. This work is supported by grants from the NSF (DEB0816963, DEB0213767, OCE0923689, OCE 0423565, OCE0924287), the NOAA and The Mellon Foundation.	[Anonymous], 2007, NOAA COASTAL OCEAN P; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Bernot MJ, 2003, APPL ENVIRON MICROB, V69, P5950, DOI 10.1128/AEM.69.10.5950-5956.2003; Bertness MD, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P39; Bowen JL, 2009, LIMNOL OCEANOGR, V54, P713, DOI 10.4319/lo.2009.54.3.0713; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; CARPENTER SR, 1995, SCIENCE, V269, P324, DOI 10.1126/science.269.5222.324; Childers DL, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P391; Craft C, 1999, ECOL APPL, V9, P1405, DOI 10.1890/1051-0761(1999)009[1405:TFYOED]2.0.CO;2; Darby FA, 2008, MAR ECOL PROG SER, V363, P63, DOI 10.3354/meps07423; Davey E, 2011, ECOL APPL, V21, P2156, DOI 10.1890/10-2037.1; Deegan LA, 2002, ESTUARIES, V25, P727, DOI 10.1007/BF02804902; Deegan Linda A., 2007, Ecological Applications, V17, pS42, DOI 10.1890/06-0452.1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Drake DC, 2009, ECOLOGY, V90, P2535, DOI 10.1890/08-1051.1; EFFLAND MJ, 1977, TAPPI, V60, P143; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Hartig EK, 2002, WETLANDS, V22, P71, DOI 10.1672/0277-5212(2002)022[0071:AACCIO]2.0.CO;2; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Johnson DS, 2011, MAR ECOL PROG SER, V438, P143, DOI 10.3354/meps09306; Johnson DS, 2009, J EXP MAR BIOL ECOL, V373, P35, DOI 10.1016/j.jembe.2009.03.003; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Koop-Jakobsen K, 2010, LIMNOL OCEANOGR, V55, P789, DOI 10.4319/lo.2009.55.2.0789; MacGarvin M., 2001, OUT SIGHT OUT MIND M; Mariotti G, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005892; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Millennium, 2005, EC HUM WELL BEING SY; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Morris JT, 1999, LIMNOL OCEANOGR, V44, P699, DOI 10.4319/lo.1999.44.3.0699; Mozdzer TJ, 2011, MAR ECOL PROG SER, V433, P43, DOI 10.3354/meps09117; Murray B. C., 2011, Green payments for blue carbon: economic incentives for protecting threatened coastal habitats; NIERING WA, 1980, BIOSCIENCE, V30, P301, DOI 10.2307/1307853; O'Shea ML, 2000, ESTUARIES, V23, P877, DOI 10.2307/1353004; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Osman N, 2006, ECOL ENG, V28, P90, DOI 10.1016/j.ecoleng.2006.04.004; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Pinthis M. J., 1973, Advances in Agronomy, V25, P209; REDFIELD AC, 1965, SCIENCE, V147, P50, DOI 10.1126/science.147.3653.50; Rinaldi M, 2004, EARTH SURF PROC LAND, V29, P237, DOI 10.1002/esp.1042; Schindler DW, 1998, ECOSYSTEMS, V1, P323, DOI 10.1007/s100219900026; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Selman M., 2008, EUTR HYP COAST AR GL; Sousa AI, 2008, ENVIRON POLLUT, V156, P628, DOI 10.1016/j.envpol.2008.06.022; Terzaghi K., 1996, SOIL MECH ENG PRACTI; Tiner R.W., 2006, SALT MARSH TRENDS SE; Turner RE, 2011, ESTUAR COAST, V34, P1084, DOI 10.1007/s12237-010-9341-y; Turner RE, 2009, LIMNOL OCEANOGR, V54, P1634, DOI 10.4319/lo.2009.54.5.1634; USEPA, 2005, SUP PROGR PROP PLAN; VALIELA I, 1976, LIMNOL OCEANOGR, V21, P245, DOI 10.4319/lo.1976.21.2.0245; Valiela I, 2002, ECOSYSTEMS, V5, P92, DOI 10.1007/s10021-001-0058-4; VANEERDT MM, 1985, VEGETATIO, V62, P367; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Wigand C, 2009, WETLANDS, V29, P952, DOI 10.1672/08-147.1; Wollheim WM, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002963; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	57	628	657	66	915	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					388	+		10.1038/nature11533	http://dx.doi.org/10.1038/nature11533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075989				2022-12-28	WOS:000309918500043
J	Glassock, RJ; Khorashadi, L; Kushner, YB				Glassock, Richard J.; Khorashadi, Leila; Kushner, Yael B.			Case 32-2012: A 35-Year-Old Man with Respiratory and Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DIFFUSE ALVEOLAR HEMORRHAGE; PULMONARY CAPILLARITIS; LUNG HEMORRHAGE; VASCULITIS; NEPHRITIS; GLOMERULONEPHRITIS; ANTIBODIES		[Glassock, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Khorashadi, Leila] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kushner, Yael B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Khorashadi, Leila] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kushner, Yael B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Glassock, RJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.				Harvard Medical School Department of Continuing Education; QuestCor; BioMarin; Novartis; Eli Lilly; Bristol-Myers Squibb; Genentech; Vifor; Genzyme-Sanofi; American Renal Associates; Renal Ventures	Harvard Medical School Department of Continuing Education; QuestCor; BioMarin; Novartis(Novartis); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); Vifor; Genzyme-Sanofi(Sanofi-AventisGenzyme Corporation); American Renal Associates; Renal Ventures	This case was presented at the Harvard Medical School postgraduate course MGH Nephrology Update (Directors, Drs. Mario F. Rubin, Hasan Bazari, and M. Amin Arnaout), sponsored by the Harvard Medical School Department of Continuing Education.; Dr. Glassock reports receiving consulting fees from QuestCor, BioMarin, Novartis, Eli Lilly, Bristol-Myers Squibb, Genentech, Vifor, Genzyme-Sanofi, and American Renal Associates; receiving fees for expert opinions for patients and caregivers in legal cases involving renal disease and for expert testimony for the defense in a lawsuit involving alleged renal injury from volatile hydrocarbons; receiving lecture fees from Renal Ventures and Genentech; receiving payment from Lighthouse Learning for the development of educational presentations; receiving editorial stipends from UpToDate; receiving royalties from Oxford Medical Publishers and UpToDate; owning stock or stock options in Reata and La Jolla Pharmaceuticals; and serving as an unpaid board member for LABioMed and UKRO. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1978, N ENGL J MED, V298, P1014; APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499; Bautz DJ, 2008, J AM SOC NEPHROL, V19, P2421, DOI 10.1681/ASN.2008030270; Bolton WK, 2010, CONTRIB NEPHROL, V165, P166, DOI 10.1159/000313756; Chang MY, 2002, RENAL FAILURE, V24, P791, DOI 10.1081/JDI-120015681; Collins RD, 2002, E WILLIAM GOODPASTUR; Collins RD, 2010, ANN DIAGN PATHOL, V14, P194, DOI 10.1016/j.anndiagpath.2010.02.003; Deane KD, 2005, SEMIN ARTHRITIS RHEU, V35, P154, DOI 10.1016/j.semarthrit.2005.05.006; EAGEN JW, 1978, MEDICINE, V57, P545, DOI 10.1097/00005792-197811000-00005; Falk RJ, 2000, SEMIN NEPHROL, V20, P233; Gallagher H, 2002, AM J KIDNEY DIS, V39, P42, DOI 10.1053/ajkd.2002.29876; Goodpasture EW, 2009, AM J MED SCI, V338, P148, DOI 10.1097/MAJ.0b013e31818fff94; Green RJ, 1996, CHEST, V110, P1305, DOI 10.1378/chest.110.5.1305; Green RJ, 1997, CHEST, V112, P300; HENKIN RI, 1962, ANN INTERN MED, V57, P1001, DOI 10.7326/0003-4819-57-6-1001; Isono M, 2011, CLIN EXP NEPHROL, V15, P294, DOI 10.1007/s10157-010-0394-9; Jennette JC, 2011, CURR OPIN NEPHROL HY, V20, P263, DOI 10.1097/MNH.0b013e3283456731; Karami-Djurabi R, 2009, AM J MED, V122, P1050, DOI 10.1016/j.amjmed.2009.03.032; Kwok SK, 2011, LUPUS, V20, P102, DOI 10.1177/0961203310381511; LEATHERMAN JW, 1984, MEDICINE, V63, P343, DOI 10.1097/00005792-198411000-00002; Niles JL, 1996, ARCH INTERN MED, V156, P440, DOI 10.1001/archinte.156.4.440; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps R, 2010, COMPREHENSIVE CLIN N, P282; SCHMIDT HW, 1963, CAN MED ASSOC J, V88, P658; Schwartz MM, 2009, LUPUS, V18, P149, DOI 10.1177/0961203308095947; Shen M, 2010, LUPUS, V19, P1326, DOI 10.1177/0961203310373106; STANTON M. C., 1958, AUSTRALASEAN ANN MED, V7, P132; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Yadla M, 2011, SAUDI J KIDNEY DIS T, V22, P349; Zamora MR, 1997, MEDICINE, V76, P192, DOI 10.1097/00005792-199705000-00005	30	3	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1540	1553		10.1056/NEJMcpc1201412	http://dx.doi.org/10.1056/NEJMcpc1201412			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23075181				2022-12-28	WOS:000309904500012
J	Lee, M; Lee, J; Carroll, MW; Choi, H; Min, S; Song, T; Via, LE; Goldfeder, LC; Kang, E; Jin, B; Park, H; Kwak, H; Kim, H; Jeon, HS; Jeong, I; Joh, JS; Chen, RY; Olivier, KN; Shaw, PA; Follmann, D; Song, SD; Lee, JK; Lee, D; Kim, CT; Dartois, V; Park, SK; Cho, SN; Barry, CE				Lee, Myungsun; Lee, Jongseok; Carroll, Matthew W.; Choi, Hongjo; Min, Seonyeong; Song, Taeksun; Via, Laura E.; Goldfeder, Lisa C.; Kang, Eunhwa; Jin, Boyoung; Park, Hyeeun; Kwak, Hyunkyung; Kim, Hyunchul; Jeon, Han-Seung; Jeong, Ina; Joh, Joon Sung; Chen, Ray Y.; Olivier, Kenneth N.; Shaw, Pamela A.; Follmann, Dean; Song, Sun Dae; Lee, Jong-Koo; Lee, Dukhyoung; Kim, Cheon Tae; Dartois, Veronique; Park, Seung-Kyu; Cho, Sang-Nae; Barry, Clifton E., III			Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACTABLE MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; OXAZOLIDINONE ANTIBACTERIAL; MURINE MODEL; PHARMACOKINETICS; TOLERABILITY; MOXIFLOXACIN; OFLOXACIN; EFFICACY	BACKGROUND Linezolid has antimycobacterial activity in vitro and is increasingly used for patients with highly drug-resistant tuberculosis. METHODS We enrolled 41 patients who had sputum-culture-positive extensively drug-resistant (XDR) tuberculosis and who had not had a response to any available chemotherapeutic option during the previous 6 months. Patients were randomly assigned to linezolid therapy that started immediately or after 2 months, at a dose of 600 mg per day, without a change in their background regimen. The primary end point was the time to sputum-culture conversion on solid medium, with data censored 4 months after study entry. After confirmed sputum-smear conversion or 4 months (whichever came first), patients underwent a second randomization to continued linezolid therapy at a dose of 600 mg per day or 300 mg per day for at least an additional 18 months, with careful toxicity monitoring. RESULTS By 4 months, 15 of the 19 patients (79%) in the immediate-start group and 7 of the 20 (35%) in the delayed-start group had culture conversion (P = 0.001). Most patients (34 of 39 [87%]) had a negative sputum culture within 6 months after linezolid had been added to their drug regimen. Of the 38 patients with exposure to linezolid, 31 (82%) had clinically significant adverse events that were possibly or probably related to linezolid, including 3 patients who discontinued therapy. Patients who received 300 mg per day after the second randomization had fewer adverse events than those who continued taking 600 mg per day. Thirteen patients completed therapy and have not had a relapse. Four cases of acquired resistance to linezolid have been observed. CONCLUSIONS Linezolid is effective at achieving culture conversion among patients with treatment-refractory XDR pulmonary tuberculosis, but patients must be monitored carefully for adverse events. (Funded by the National Institute of Allergy and Infectious Diseases and the Ministry of Health and Welfare, South Korea; ClinicalTrials.gov number, NCT00727844.)	[Carroll, Matthew W.; Via, Laura E.; Goldfeder, Lisa C.; Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Lee, Myungsun; Lee, Jongseok; Choi, Hongjo; Min, Seonyeong; Song, Taeksun; Kang, Eunhwa; Jin, Boyoung; Park, Hyeeun; Kwak, Hyunkyung; Kim, Hyunchul; Jeon, Han-Seung; Song, Sun Dae] Int TB Res Ctr, Chang Won, South Korea; [Jeong, Ina; Joh, Joon Sung] Natl Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Jong-Koo] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Lee, Dukhyoung] Korea Ctr Dis Control & Prevent, Osong, South Korea; [Kim, Cheon Tae; Park, Seung-Kyu] Natl Masan Hosp, Masan, South Korea; [Cho, Sang-Nae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Cho, Sang-Nae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Olivier, Kenneth N.] NIAID, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; [Chen, Ray Y.] NIAID, Lab Clin Infect Dis, Off Global Res, NIH, Bethesda, MD 20892 USA; [Shaw, Pamela A.; Follmann, Dean] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Dartois, Veronique] Novartis Inst Trop Dis, Singapore, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Medical Center - Korea; Seoul National University (SNU); Seoul National University Hospital; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis	Barry, CE (corresponding author), NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@niaid.nih.gov	Joh, Joon-Sung/AAW-5784-2020; Barry, III, Clifton/H-3839-2012; Chen, Ray/T-5102-2019; Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021; Chen, Ray/GRJ-6736-2022	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; Chen, Ray/0000-0001-6344-1442	National Institute of Allergy and Infectious Diseases, National Institutes of Health; Ministry of Health and Welfare, South Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Health and Welfare, South Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by the Ministry of Health and Welfare, South Korea.	Anger HA, 2010, J ANTIMICROB CHEMOTH, V65, P775, DOI 10.1093/jac/dkq017; [Anonymous], 1948, BMJ, V2, P769; [Anonymous], 1960, TUBERCLE, V41, P83; ASHTEKAR DR, 1991, DIAGN MICR INFEC DIS, V14, P465, DOI 10.1016/0732-8893(91)90002-W; Barbachyn MR, 1996, J MED CHEM, V39, P680, DOI 10.1021/jm950956y; Beckert P, 2012, ANTIMICROB AGENTS CH, V56, P2743, DOI 10.1128/AAC.06227-11; Beekmann SE, 2008, DIAGN MICR INFEC DIS, V62, P407, DOI 10.1016/j.diagmicrobio.2008.08.009; Boselli E, 2005, CRIT CARE MED, V33, P1529, DOI 10.1097/01.CCM.0000168206.59873.80; Carroll MW, 2012, CLIN INFECT DIS, V54, P1624, DOI 10.1093/cid/cis293; Condos Rany, 2008, Chest, V134, P187, DOI 10.1378/chest.07-1988; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Cynamon MH, 1999, ANTIMICROB AGENTS CH, V43, P1189, DOI 10.1128/AAC.43.5.1189; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; Di Paolo A, 2010, CLIN PHARMACOKINET, V49, P439, DOI 10.2165/11319960-000000000-00000; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dietze R, 2008, AM J RESP CRIT CARE, V178, P1180, DOI 10.1164/rccm.200806-892OC; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Fortun J, 2005, J ANTIMICROB CHEMOTH, V56, P180, DOI 10.1093/jac/dki148; Guidelines for tuberculosis control, 2010, GUID TUB CONTR 2010; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hillemann D, 2008, ANTIMICROB AGENTS CH, V52, P800, DOI 10.1128/AAC.01189-07; Ippolito JA, 2008, J MED CHEM, V51, P3353, DOI 10.1021/jm800379d; Koh WJ, 2009, J ANTIMICROB CHEMOTH, V64, P388, DOI 10.1093/jac/dkp171; Leach KL, 2011, ANN NY ACAD SCI, V1222, P49, DOI 10.1111/j.1749-6632.2011.05962.x; Lee E, 2003, CLIN INFECT DIS, V37, P1389, DOI 10.1086/379012; McArthur J H, 1998, J Assoc Nurses AIDS Care, V9, P84, DOI 10.1016/S1055-3290(98)80048-4; McGee B, 2009, ANTIMICROB AGENTS CH, V53, P3981, DOI 10.1128/AAC.01378-08; Nagiec EE, 2005, ANTIMICROB AGENTS CH, V49, P3896, DOI 10.1128/AAC.49.9.3896-3902.2005; Park IN, 2006, J ANTIMICROB CHEMOTH, V58, P701, DOI 10.1093/jac/dkl298; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Richter E, 2007, ANTIMICROB AGENTS CH, V51, P1534, DOI 10.1128/AAC.01113-06; Rodriguez JC, 2004, J ANTIMICROB CHEMOTH, V53, P441, DOI 10.1093/jac/dkh119; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Sander P, 2002, MOL MICROBIOL, V46, P1295, DOI 10.1046/j.1365-2958.2002.03242.x; Saralaya D, 2004, J ANTIMICROB CHEMOTH, V53, P325, DOI 10.1093/jac/dkh072; Schecter GF, 2010, CLIN INFECT DIS, V50, P49, DOI 10.1086/648675; Singla R, 2012, EUR RESPIR J, V39, P956, DOI 10.1183/09031936.00076811; Stalker DJ, 2003, CLIN PHARMACOKINET, V42, P1129, DOI 10.2165/00003088-200342130-00004; Tato M, 2006, INT J ANTIMICROB AG, V28, P75, DOI 10.1016/j.ijantimicag.2006.02.011; Traunmuller F, 2010, INT J ANTIMICROB AG, V36, P84, DOI 10.1016/j.ijantimicag.2010.03.007; Vinh DC, 2009, J INFECTION, V59, pS59, DOI 10.1016/S0163-4453(09)60009-8; von der Lippe B, 2006, J INFECTION, V52, P92, DOI 10.1016/j.jinf.2005.04.007; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476; Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839, DOI 10.1128/AAC.40.4.839	45	398	422	4	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1508	1518		10.1056/NEJMoa1201964	http://dx.doi.org/10.1056/NEJMoa1201964			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23075177	Green Accepted			2022-12-28	WOS:000309904500008
J	Talbert, J; Blumenschein, K; Burke, A; Stromberg, A; Freeman, P				Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia			Pseudoephedrine Sales and Seizures of Clandestine Methamphetamine Laboratories in Kentucky	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia] Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA	University of Kentucky	Talbert, J (corresponding author), Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA.	jtalb1@uky.edu	Talbert, Jeffery C/F-3929-2011; Freeman, Patricia/W-2473-2019; Freeman, Patricia R./L-3752-2019	Talbert, Jeffery C/0000-0002-4304-5167; Freeman, Patricia/0000-0002-4749-6563	NCATS NIH HHS [UL1 TR000117, UL1TR000117, UL1 TR001998] Funding Source: Medline; NCRR NIH HHS [UL1RR033173, UL1 RR033173] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Kentucky State Police, 2010, METH MAN KENT; McKetin R, 2011, ADDICTION, V106, P1911, DOI 10.1111/j.1360-0443.2011.03582.x; Nonnemaker J, 2011, HEALTH ECON, V20, P519, DOI 10.1002/hec.1610; Prah PM, 2005, CQ RES, P589; US Department of Justice National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS	5	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1524	1526		10.1001/jama.2012.12992	http://dx.doi.org/10.1001/jama.2012.12992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073945	Bronze, Green Accepted			2022-12-28	WOS:000309858100014
J	Dandekar, AA; Chugani, S; Greenberg, EP				Dandekar, Ajai A.; Chugani, Sudha; Greenberg, E. Peter			Bacterial Quorum Sensing and Metabolic Incentives to Cooperate	SCIENCE			English	Article							LUXR-LUXI FAMILY; PSEUDOMONAS-AERUGINOSA; POPULATIONS; CONFLICT; REGULATORS; MECHANISM	The opportunistic pathogen Pseudomonas aeruginosa uses a cell-cell communication system termed "quorum sensing" to control production of public goods, extracellular products that can be used by any community member. Not all individuals respond to quorum-sensing signals and synthesize public goods. Such social cheaters enjoy the benefits of the products secreted by cooperators. There are some P. aeruginosa cellular enzymes controlled by quorum sensing, and we show that quorum sensing-controlled expression of such private goods can put a metabolic constraint on social cheating and prevent a tragedy of the commons. Metabolic constraint of social cheating provides an explanation for private-goods regulation by a cooperative system and has general implications for population biology, infection control, and stabilization of quorum-sensing circuits in synthetic biology.	[Chugani, Sudha; Greenberg, E. Peter] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Dandekar, Ajai A.] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Greenberg, EP (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	epgreen@u.washington.edu		Dandekar, Ajai/0000-0002-2992-6523; Greenberg, Everett/0000-0001-9474-8041	U.S. Public Health Service [GM-59026, P30 DK 89507]; Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059026] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service grants GM-59026 and P30 DK 89507 to E. P. G. A. A. D. is supported by a Cystic Fibrosis Foundation Leroy Matthews Fellowship. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/DRYAD.122SV.	BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Kurachi M., 1958, B I CHEM RES, V36, P163; Kuzdzal-Fick JJ, 2011, SCIENCE, V334, P1548, DOI 10.1126/science.1213272; Mellbye B, 2011, MBIO, V2, DOI 10.1128/mBio.00131-11; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x	19	208	220	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					264	266		10.1126/science.1227289	http://dx.doi.org/10.1126/science.1227289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066081	Green Accepted			2022-12-28	WOS:000309712300048
J	Fedorenko, A; Lishko, PV; Kirichok, Y				Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy			Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria	CELL			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; PHYSIOLOGICAL REGULATION; TRANSPORT ACTIVITY; INNER MEMBRANE; PROTEIN; SEQUENCE; BINDING; PHOSPHOLIPIDS; NUCLEOTIDE; VALUES	Mitochondrial uncoupling protein 1 (UCP1) is responsible for nonshivering thermogenesis in brown adipose tissue (BAT). Upon activation by long-chain fatty acids (LCFAs), UCP1 increases the conductance of the inner mitochondrial membrane (IMM) to make BAT mitochondria generate heat rather than ATP. Despite being a member of the family of mitochondrial anion carriers (SLC25), UCP1 is believed to transport H+ by an unusual mechanism that has long remained unresolved. Here, we achieved direct patch-clamp measurements of UCP1 currents from the IMM of BAT mitochondria. We show that UCP1 is an LCFA anion/H+ symporter. However, the LCFA anions cannot dissociate from UCP1 due to hydrophobic interactions established by their hydrophobic tails, and UCP1 effectively operates as an H+ carrier activated by LCFA. A similar LCFA-dependent mechanism of transmembrane H+ transport may be employed by other SLC25 members and be responsible for mitochondrial uncoupling and regulation of metabolic efficiency in various tissues.	[Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall,Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/L-1191-2017; Lishko, Polina/GQH-9569-2022		NIH [DP2OD004656]; UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Drs. David Nicholls, Eduardo Rial, Robert Farese, Frederick Sachs, and Francesca Fieni for advice and to Dr. Leslie Kozak for the UCP1<SUP>-/-</SUP> mice. This work was funded by the NIH Director's New Innovator Award DP2OD004656, the UCSF Program for Breakthrough Biomedical Research, and a Larry L. Hillblom Foundation Start-up Award. A. F. and Y.K. conceived the project and designed the experiments. A. F. performed most of the experiments. Y. K. and P. V. L. helped with pilot experiments for the project. All authors discussed the results and commented on the manuscript.	ANEL A, 1993, BIOCHEMISTRY-US, V32, P530, DOI 10.1021/bi00053a018; Annunziata O, 1999, J COLLOID INTERF SCI, V216, P16, DOI 10.1006/jcis.1999.6269; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BHAMIDIPATI SP, 1995, BIOCHEMISTRY-US, V34, P5666, DOI 10.1021/bi00016a043; Borecky J, 1997, J BIOL CHEM, V272, P19282; BOUILLAUD F, 1986, J BIOL CHEM, V261, P1487; Bruce P.Y, 2001, ORGANIC CHEM; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1977, FEBS LETT, V74, P43, DOI 10.1016/0014-5793(77)80748-5; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Goss KU, 2008, ENVIRON SCI TECHNOL, V42, P456, DOI 10.1021/es702192c; GUTHRIE JP, 1978, CAN J CHEM, V56, P2342, DOI 10.1139/v78-385; Hamilton JA, 1998, J LIPID RES, V39, P467; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Huang SG, 2003, ARCH BIOCHEM BIOPHYS, V412, P142, DOI 10.1016/S0003-9861(03)00031-6; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; JEZEK P, 1990, J BIOL CHEM, V265, P19303; JEZEK P, 1989, AM J PHYSIOL, V257, pC1142, DOI 10.1152/ajpcell.1989.257.6.C1142; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Lide D., 1998, HDB CHEM PHYS; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; Rial E, 2004, BBA-BIOENERGETICS, V1608, P122, DOI 10.1016/j.bbabio.2003.11.001; Rial E, 2001, BBA-BIOENERGETICS, V1504, P70, DOI 10.1016/S0005-2728(00)00240-1; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; RIDLEY RG, 1986, NUCLEIC ACIDS RES, V14, P4025, DOI 10.1093/nar/14.10.4025; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; ZURINI M, 1981, EUR J BIOCHEM, V119, P517, DOI 10.1111/j.1432-1033.1981.tb05638.x	48	544	564	10	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					400	413		10.1016/j.cell.2012.09.010	http://dx.doi.org/10.1016/j.cell.2012.09.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063128	Green Accepted, Bronze			2022-12-28	WOS:000309981000017
J	Melander, O; Maisel, AS; Almgren, P; Manjer, J; Belting, M; Hedblad, B; Engstrom, G; Kilger, U; Nilsson, P; Bergmann, A; Orho-Melander, M				Melander, Olle; Maisel, Alan S.; Almgren, Peter; Manjer, Jonas; Belting, Mattias; Hedblad, Bo; Engstrom, Gunnar; Kilger, Ute; Nilsson, Peter; Bergmann, Andreas; Orho-Melander, Marju			Plasma Proneurotensin and Incidence of Diabetes, Cardiovascular Disease, Breast Cancer, and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; BARIATRIC SURGERY; REGULATORY PEPTIDES; GASTRIC BYPASS; NEUROMEDIN-N; NEUROTENSIN; PROGRESSION; EVENTS; INTERVENTION; EXPRESSION	Context Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans. Objective To test if fasting plasma concentration of a stable 117-amino acid fragment from the neurotensin precursor hormone proneurotensin is associated with development of diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Design, Setting, and Participants Proneurotensin was measured in plasma from 4632 fasting participants of the population-based Malmo Diet and Cancer Study baseline examination 1991-1994. Multivariate Cox proportional hazards models were used to relate baseline proneurotensin to first events and death during long-term follow-up until January 2009, with median follow-up ranging from 13.2 to 15.7 years depending on the disease. Main Outcome Measures Incident diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Results Overall, proneurotensin (hazard ratio [HR] per SD increment of log-transformed proneurotensin) was related to risk of incident diabetes (142 events; HR, 1.28; 95% CI, 1.09-1.50; P=.003), cardiovascular disease (519 events; HR, 1.17; 95% CI, 1.07-1.27; P<.001), and cardiovascular mortality (174 events; HR, 1.29; 95% CI, 1.12-1.49; P=.001) with a significant interaction between proneurotensin and sex (P<.001) on risk of cardiovascular disease. Exclusively in women, proneurotensin was related to incident diabetes (74 events; HR, 1.41; 95% CI, 1.12-1.77; P=.003), cardiovascular disease (224 events; HR, 1.33; 95% CI, 1.17-1.51; P<.001), breast cancer (123 events; HR, 1.44; 95% CI, 1.21-1.71; P<.001), total mortality (285 events; HR, 1.13; 95% CI, 1.01-1.27; P=.03), and cardiovascular mortality (75 events; HR, 1.50; 95% CI, 1.20-1.87; P<.001). Conclusion Fasting proneurotensin was significantly associated with the development of diabetes, cardiovascular disease, breast cancer, and with total and cardiovascular mortality. JAMA. 2012;308(14):1469-1475 www.jama.com	[Belting, Mattias] Sect Oncol, Lund, Sweden; [Melander, Olle; Hedblad, Bo; Nilsson, Peter] Skane Univ Hosp, Ctr Emergency Med, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, SE-20502 Malmo, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, SE-20502 Malmo, Sweden; [Maisel, Alan S.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Kilger, Ute; Bergmann, Andreas] SphingoTec GmbH, Hohen Neuendorf, Germany; [Bergmann, Andreas] Waltraut Bergmann Fdn, Hohen Neuendorf, Germany; [Melander, Olle] Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, SE-20502 Malmo, Sweden; [Melander, Olle; Almgren, Peter; Manjer, Jonas; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Lund University; Skane University Hospital; Lund University	Melander, O (corresponding author), Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, Ent 72,Bldg 91,Level 12, SE-20502 Malmo, Sweden.	olle.melander@med.lu.se		Belting, Mattias/0000-0003-1585-5434; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Melander, Olle/0000-0002-2581-484X; Engstrom, Gunnar/0000-0002-8618-9152	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	Funding was obtained from the European Research Council (StG-282255) (Dr Melander); the Swedish Heart and Lung Foundation, and the Swedish Research Council (Drs Melander and Orho-Melander); the Skane University Hospital donation funds; the Medical Faculty, Lund University (Dr Melander); the governmental funding of clinical research within the national health services (Drs Melander and Orho-Melander); and the Albert Pahlsson Research Foundation, Region Skane, the King Gustaf V and Queen Victoria Foundation, and the Marianne and Marcus Wallenberg Foundation (Dr Melander).	ALEXANDER MJ, 1993, ENDOCRINOLOGY, V133, P1809, DOI 10.1210/en.133.4.1809; [Anonymous], 1993, J INTERN MED, V233, P39; Belting M, 2012, CANCER EPIDEM BIOMAR, V21, P513, DOI 10.1158/1055-9965.EPI-11-0840; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Christ-Crain M, 2006, J CLIN ENDOCR METAB, V91, P3544, DOI 10.1210/jc.2006-0256; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Friry C, 2002, BIOCHEM BIOPH RES CO, V290, P1161, DOI 10.1006/bbrc.2001.6308; Holdstock C, 2008, INT J OBESITY, V32, P1640, DOI 10.1038/ijo.2008.157; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim ER, 2010, NEUROSCI LETT, V468, P64, DOI 10.1016/j.neulet.2009.10.064; KITABGI P, 1976, J BIOL CHEM, V251, P7053; Kitabgi P, 2006, J MOL MED, V84, P628, DOI 10.1007/s00109-006-0044-6; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Watters JJ, 1998, J NEUROSCI, V18, P6672; WISEN O, 1992, REGUL PEPTIDES, V39, P43, DOI 10.1016/0167-0115(92)90007-H	33	99	108	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1469	1475		10.1001/jama.2012.12998	http://dx.doi.org/10.1001/jama.2012.12998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047361	Bronze			2022-12-28	WOS:000309579300026
J	Kearney, S; Carr, AS; McConville, J; McCarron, MO				Kearney, S.; Carr, A. S.; McConville, J.; McCarron, M. O.		No Ireland Neurology Network	Rhabdomyolysis after co-prescription of statin and fusidic acid	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATORVASTATIN		[Kearney, S.; Carr, A. S.] Belfast Hlth & Social Care Trust, Royal Victoria Hosp, Dept Neurol, Belfast, Antrim, North Ireland; [McConville, J.] S Eastern Hlth & Social Care Trust, Ulster Hosp, Dept Neurol, Dundonald, North Ireland; [McCarron, M. O.] Western Hlth & Social Care Trust, Altnagelvin Hosp, Dept Neurol, Derry BT47 6SB, North Ireland		Kearney, S (corresponding author), Belfast Hlth & Social Care Trust, Royal Victoria Hosp, Dept Neurol, Belfast, Antrim, North Ireland.	seamuskearney1@googlemail.com	De Vries, Courtney E/A-4692-2014	De Vries, Courtney E/0000-0001-5887-2125				Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2011, BRIT NATL FORMULARY; Burtenshaw AJ, 2008, ANAESTHESIA, V63, P656, DOI 10.1111/j.1365-2044.2007.05434.x; Business Services Organisation, 2011, AN INF EXTR NO IR PH; Collidge TA, 2010, DIABETIC MED, V27, P696, DOI 10.1111/j.1464-5491.2010.02984.x; DROMER C, 1992, REV RHUM, V59, P281; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Herring Roselle, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.03.2009.1722; Kahri J, 2005, EUR J CLIN PHARMACOL, V60, P905, DOI 10.1007/s00228-004-0858-5; Kotanko P, 2002, NEPHRON, V90, P234, DOI 10.1159/000049053; Magee CN, 2010, AM J KIDNEY DIS, V56, pE11, DOI 10.1053/j.ajkd.2010.07.011; O'Mahony C, 2008, POSTGRAD MED J, V84, P325, DOI 10.1136/pgmj.2007.064097; Omar MA, 2001, ANN PHARMACOTHER, V35, P1096, DOI 10.1345/aph.10228; Pineda A, 2011, CURR ATHEROSCLER REP, V13, P23, DOI 10.1007/s11883-010-0148-x; Saeed Nabeel Tahir Muhammad, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.06.2009.2040; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Teckchandani S, 2010, J ROY COLL PHYS EDIN, V40, P33, DOI 10.4997/JRCPE.2010.108; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; TRISCARI J, 1995, J CLIN PHARMACOL, V35, P142, DOI 10.1002/j.1552-4604.1995.tb05002.x; Turnidge J, 1999, INT J ANTIMICROB AG, V12, pS23, DOI 10.1016/S0924-8579(98)00071-5; Wenisch C, 2000, AM J MED, V109, P78, DOI 10.1016/S0002-9343(00)00367-3; Yuen SLS, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05482.x	22	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6562	10.1136/bmj.e6562	http://dx.doi.org/10.1136/bmj.e6562			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23047962				2022-12-28	WOS:000309907100010
J	Nandakumar, J; Bell, CF; Weidenfeld, I; Zaug, AJ; Leinwand, LA; Cech, TR				Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.			The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity	NATURE			English	Article							SINGLE-STRANDED-DNA; FISSION YEAST; LENGTH REGULATOR; POT1; PROTECTION; GENE; LOCALIZATION; TEL1(ATM); INTERACTS; REQUIRES	Human chromosome ends are capped by shelterin, a protein complex that protects the natural ends from being recognized as sites of DNA damage and also regulates the telomere-replicating enzyme, telomerase(1-3). Shelterin includes the heterodimeric POT1-TPP1 protein, which binds the telomeric single-stranded DNA tail(4-9). TPP1 has been implicated both in recruiting telomerase to telomeres and in stimulating telomerase processivity (the addition of multiple DNA repeats after a single primer-binding event)(9-14). Determining the mechanisms of these activities has been difficult, especially because genetic perturbations also tend to affect the essential chromosome end-protection function of TPP1 (refs 15-17). Here we identify separation-of-function mutants of human TPP1 that retain full telomere-capping function in vitro and in vivo, yet are defective in binding human telomerase. The seven separation-of-function mutations map to a patch of amino acids on the surface of TPP1, the TEL patch, that both recruits telomerase to telomeres and promotes high-processivity DNA synthesis, indicating that these two activities are manifestations of the same molecular interaction. Given that the interaction between telomerase and TPP1 is required for telomerase function in vivo, the TEL patch of TPP1 provides a new target for anticancer drug development.	[Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Weidenfeld, Ina; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Bell, Caitlin/0000-0001-7352-142X; LEINWAND, LESLIE/0000-0003-1470-4810; Nandakumar, Jayakrishnan/0000-0001-9146-2785	National Cancer Institute of the National Institutes of Health [K99CA167644]; US National Institutes of Health [R01GM29090, R01GM099705]; NATIONAL CANCER INSTITUTE [K99CA167644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705, R01GM029090] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. de Lange, M. Terns and S. Langer for suggestions and sharing protocols; T. Nahreini for maintenance of the departmental tissue culture facility; J. Friedman and G. Voeltz for help with confocal microscopy; and A. Berman, S. Borah and M. Nakashima for critical reading of the manuscript. T.R.C. is an investigator of the Howard Hughes Medical Institute (HHMI). J.N. was an HHMI fellow of the Helen Hay Whitney Foundation during a major part of this study and is supported by the National Cancer Institute of the National Institutes of Health under award number K99CA167644. This work was supported in part by US National Institutes of Health grant R01GM29090 to L.A.L. and R01GM099705 to T.R.C.	Abell AN, 2004, J CELL SCI, V117, P243, DOI 10.1242/jcs.00853; Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Majerska J, 2011, MOL BIOSYST, V7, P1013, DOI 10.1039/c0mb00268b; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moser BA, 2011, NAT STRUCT MOL BIOL, V18, P1408, DOI 10.1038/nsmb.2187; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nandakumar J, 2010, P NATL ACAD SCI USA, V107, P651, DOI 10.1073/pnas.0911099107; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Sexton A. N, 2012, J BIOL CHEM; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Weidenfeld I, 2012, METHODS MOL BIOL, V815, P289, DOI 10.1007/978-1-61779-424-7_22; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	33	231	237	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					285	+		10.1038/nature11648	http://dx.doi.org/10.1038/nature11648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23103865	Green Accepted			2022-12-28	WOS:000312259300049
J	Rucklin, M; Donoghue, PCJ; Johanson, Z; Trinajstic, K; Marone, F; Stampanoni, M				Ruecklin, Martin; Donoghue, Philip C. J.; Johanson, Zerina; Trinajstic, Kate; Marone, Federica; Stampanoni, Marco			Development of teeth and jaws in the earliest jawed vertebrates	NATURE			English	Article							EVOLUTIONARY ORIGINS; PHARYNGEAL DENTICLES; PLACODERMS; DENTITION; SKELETON; GROWTH; FISH	Teeth and jaws constitute a model of the evolutionary developmental biology concept of modularity(1) and they have been considered the key innovations underpinning a classic example of adaptive radiation(2). However, their evolutionary origins are much debated. Placoderms comprise an extinct sister clade(3) or grade(4,5) to the clade containing chondrichthyans and osteichthyans, and although they clearly possess jaws, previous studies have suggested that they lack teeth(6-8), that they possess convergently evolved tooth-like structures(9-11) or that they possess true teeth(12). Here we use synchrotron radiation X-ray tomographic microscopy (SRXTM)(13) of a developmental series of Compagopiscis croucheri (Arthrodira) to show that placoderm jaws are composed of distinct cartilages and gnathal ossifications in both jaws, and a dermal element in the lower jaw. The gnathal ossification is a composite of distinct teeth that developed in succession, polarized along three distinct vectors, comparable to tooth families. The teeth are composed of dentine and bone, and show a distinct pulp cavity that is infilled centripetally as development proceeds. This pattern is repeated in other placoderms, but differs from the structure and development of tooth-like structures in the postbranchial lamina and dermal skeleton of Compagopiscis and other placoderms. We interpret this evidence to indicate that Compagopiscis and other arthrodires possessed teeth, but that tooth and jaw development was not developmentally or structurally integrated in placoderms. Teeth did not evolve convergently among the extant and extinct classes of early jawed vertebrates but, rather, successional teeth evolved within the gnathostome stem-lineage soon after the origin of jaws. The chimaeric developmental origin of this model of modularity reflects the distinct evolutionary origins of teeth and of component elements of the jaws.	[Ruecklin, Martin; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England; [Trinajstic, Kate] Curtin Univ Technol, Dept Chem, Bentley, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool 6106, Australia; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	University of Bristol; Natural History Museum London; Curtin University; Western Australian Museum; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rucklin, M (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	m.ruecklin@bristol.ac.uk; phil.donoghue@bristol.ac.uk	Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Rücklin, Martin/D-7948-2018; Stampanoni, Marco/J-4099-2013	Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Rücklin, Martin/0000-0002-7254-837X; Stampanoni, Marco/0000-0001-7486-6681; Trinajstic, Kate/0000-0002-6519-6396; Johanson, Zerina/0000-0002-8444-6776	EU; Australian Research Council [DP 110101127]; Natural Environment Research Council [NE/G016623/1]; Paul Scherrer Institut; NERC [NE/G020264/1, NE/G016623/1] Funding Source: UKRI; Natural Environment Research Council [NE/G020264/1] Funding Source: researchfish	EU(European Commission); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Paul Scherrer Institut; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Bengtson, J. Cunningham, D. Murdock, S. Giles and A. Hetherington for help at the TOMCAT beamline; K. Robson-Brown for help at the Micro-CT, and H. Lelievre and G. Clement for loan of specimens. The study was funded by EU grant FP7 MC-IEF (to M.R. and P.C.J.D.), Australian Research Council Grant DP 110101127 (to Z.J. and K.T.), Natural Environment Research Council grant NE/G016623/1 (to P.C.J.D.) and the Paul Scherrer Institut (P.C.J.D.).	ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2003, SCIENCE, V300; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Downs JP, 2009, J MORPHOL, V270, P1364, DOI 10.1002/jmor.10765; Finarelli JA, 2012, P ROY SOC B-BIOL SCI, V279, P775, DOI 10.1098/rspb.2011.1107; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Huysseune A, 2008, DEV GENES EVOL, V218, P427, DOI 10.1007/s00427-008-0237-9; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Johanson Z, 2003, J MORPHOL, V257, P289, DOI 10.1002/jmor.10124; Lelievre Herve, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P163; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; Orvig T., 1973, Palaeontographica Abt A, V143, P119; REIF WE, 1982, EVOL BIOL, V15, P287; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; SMITH MM, 1985, J ANAT, V140, P627; Soukup V, 2008, NATURE, V455, P795, DOI 10.1038/nature07304; Stampanoni M, 2007, AIP CONF PROC, V879, P848; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; Young GC, 2003, J VERTEBR PALEONTOL, V23, P987, DOI 10.1671/31; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	29	77	82	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					748	+		10.1038/nature11555	http://dx.doi.org/10.1038/nature11555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23075852				2022-12-28	WOS:000311606000043
J	Elsasser, SJ; Huang, HD; Lewis, PW; Chin, JW; Allis, CD; Patel, DJ				Elsaesser, Simon J.; Huang, Hongda; Lewis, Peter W.; Chin, Jason W.; Allis, C. David; Patel, Dinshaw J.			DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition	NATURE			English	Article							STRUCTURAL BASIS; CHAPERONE; ATRX; H3; GENES	Histone chaperones represent a structurally and functionally diverse family of histone-binding proteins that prevent promiscuous interactions of histones before their assembly into chromatin. DAXX is a metazoan histone chaperone specific to the evolutionarily conserved histone variant H3.3. Here we report the crystal structures of the DAXX histone-binding domain with a histone H3.3-H4 dimer, including mutants within DAXX and H3.3, together with in vitro and in vivo functional studies that elucidate the principles underlying H3.3 recognition specificity. Occupying 40% of the histone surface-accessible area, DAXX wraps around the H3.3-H4 dimer, with complex formation accompanied by structural transitions in the H3.3-H4 histone fold. DAXX uses an extended a-helical conformation to compete with major inter-histone, DNA and ASF1 interaction sites. Our structural studies identify recognition elements that read out H3.3-specific residues, and functional studies address the contributions of Gly 90 in H3.3 and Glu 225 in DAXX to chaperone-mediated H3.3 variant recognition specificity.	[Elsaesser, Simon J.; Lewis, Peter W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Elsaesser, Simon J.; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Huang, Hongda; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Rockefeller University; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu; pated@mskcc.org	Elsässer, Simon/AAM-3986-2020; Elsässer, Simon/B-8911-2014; Huang, Hongda/G-8962-2015	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Lewis, Peter/0000-0002-9816-7823	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P30-EB-009998]; National Center for Research Resources of the NIH [1S10RR022321-01, 1S10RR027037-01]; Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC) [U105181009, UD99999908]; Boehringer Ingelheim Funds fellowship; David Rockefeller Graduate Program; MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027037, S10RR022321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Funds fellowship(Boehringer Ingelheim); David Rockefeller Graduate Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the personnel of synchrotron beam lines 24-I/D-C/E at the Advanced Photon Source (Argonne National Laboratory) and beam line X29 at the Brookhaven National Laboratory for their assistance, and the Center for Synchrotron Biosciences grant, P30-EB-009998, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) for funding. The use of the Rigaku/MSC microMax 007HF and Formulator in the Rockefeller University Structural Biology Resource Center was made possible by grant numbers 1S10RR022321-01 and 1S10RR027037-01 from the National Center for Research Resources of the NIH. We thank B. Black for sharing data before publication, A. Ruthenburg, J. Song and Z. Cheng for advice and discussions, and E. Datan for help in expressing DAXX protein. D. J. P. was supported by funds from the Abby Rockefeller Mauze Trust, and the Maloris and STARR Foundations. C. D. A. also acknowledges support from the STARR Foundation and The Rockefeller University. J. W. C. acknowledges support from UK Medical Research Council (MRC) (grants U105181009 and UD99999908). S. J. E. was supported by a Boehringer Ingelheim Funds fellowship and the David Rockefeller Graduate Program and holds an EMBO ALTF 1232-2011.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hamiche A, 2012, BBA-GENE REGUL MECH, V1819, P230, DOI 10.1016/j.bbagrm.2011.08.009; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	29	166	169	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					560	+		10.1038/nature11608	http://dx.doi.org/10.1038/nature11608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075851	Green Accepted			2022-12-28	WOS:000311339800044
J	Paltiel, AD; Walensky, RP				Paltiel, A. David; Walensky, Rochelle P.			Home HIV Testing: Good News but Not a Game Changer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Management, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Paltiel, AD (corresponding author), Yale Univ, Sch Publ Hlth, 60 Coll St,Room 305, New Haven, CT 06520 USA.	david.paltiel@yale.edu		Walensky, Rochelle P./0000-0002-8795-379X	NIAID NIH HHS [P30 AI060354, R37 AI042006, R37 AI42006] Funding Source: Medline; NIDA NIH HHS [R01 DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH065869, R01 MH65869] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; McNeil DG, 2012, NY TIMES, pA1; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Paltiel AD, 2010, MED DECIS MAKING, V30, P217, DOI 10.1177/0272989X09334420; Sax PE, J WATCH BLOGS HIV ID; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Food and Drug Administration, VACC BLOOD BIOL INF; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010	10	19	21	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					744	+		10.7326/0003-4819-157-10-201211200-00545	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23044643	Green Accepted			2022-12-28	WOS:000311580000020
J	Dickie, IA; Hurst, JM; Bellingham, PJ				Dickie, Ian A.; Hurst, Jennifer M.; Bellingham, Peter J.			Comment on "Conspecific Negative Density Dependence and Forest Diversity"	SCIENCE			English	Editorial Material								Johnson and colleagues (Reports, 18 May 2012, p. 904) claim that conspecific negative density dependence is a pervasive mechanism driving forest diversity, especially for rare tree species. We show that their results are due to a statistical bias in their analysis caused by the exclusion of joint absences.	[Dickie, Ian A.; Hurst, Jennifer M.; Bellingham, Peter J.] Landcare Res, Lincoln 7640, New Zealand; [Hurst, Jennifer M.] Univ Canterbury, New Zealand Sch Forestry, Christchurch 8140, New Zealand	Landcare Research - New Zealand; University of Canterbury	Dickie, IA (corresponding author), Landcare Res, Lincoln 7640, New Zealand.	dickiei@landcareresearch.co.nz	Dickie, Ian/AAH-2973-2019; Dickie, Ian A/C-5419-2013; Bellingham, Peter/AAP-4302-2020	Dickie, Ian/0000-0002-2740-2128; Dickie, Ian A/0000-0002-2740-2128; 				Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x	2	10	10	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106								10.1126/science.1225520	http://dx.doi.org/10.1126/science.1225520			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112313				2022-12-28	WOS:000310195800033
J	Okaz, E; Arguello-Miranda, O; Bogdanova, A; Vinod, PK; Lipp, JJ; Markova, Z; Zagoriy, I; Novak, B; Zachariae, W				Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Vinod, P. K.; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Novak, Bela; Zachariae, Wolfgang			Meiotic Prophase Requires Proteolysis of M Phase Regulators Mediated by the Meiosis-Specific APC/C-Ama1	CELL			English	Article							ANAPHASE PROMOTING COMPLEX/CYCLOSOME; SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BIOLOGY; YEAST MEIOSIS; BUDDING YEAST; FHA DOMAIN; PROTEIN; KINASE	Whereas proliferating cells enter M phase shortly after DNA replication, the first M phase of meiosis is preceded by an extended prophase in which homologous chromosomes undergo recombination. Exit from prophase I is controlled by the recombination checkpoint (RC), which, in yeast, represses the meiosis-specific transcription factor Ndt80 required for the expression of B-type cyclins and other M phase regulators. We show that an extended prophase I additionally requires the suppression of latent, mitotic cell-cycle controls by the anaphase-promoting complex (APC/C) and its meiosis-specific activator Ama1, which trigger the degradation of M phase regulators and Ndd1, a subunit of a mitotic transcription factor. ama1 Delta mutants exit from prophase I prematurely and independently of the RC, which results in recombination defects and chromosome missegregation. Thus, control of prophase I by meiotic mechanisms depends on the suppression of the alternative, mitotic mechanisms by a meiosis-specific form of the APC/C.	[Argueello-Miranda, Orlando; Bogdanova, Aliona; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Biochem, Lab Chromosome Biol, D-82152 Martinsried, Germany; [Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Okaz, Elwy; Vinod, P. K.; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	Max Planck Society; Max Planck Society; University of Oxford	Zachariae, W (corresponding author), Max Planck Inst Biochem, Lab Chromosome Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	zachar@biochem.mpg.de	Novak, Bela/D-5365-2009; Argüello-Miranda, Orlando/AAU-6814-2020; Arguello, Orlando/AAC-3445-2021; Arguello-Miranda, Orlando/R-8552-2019	Novak, Bela/0000-0002-6961-1366; Argüello-Miranda, Orlando/0000-0002-0579-4650; Zagoriy, Ievgeniia/0000-0003-2523-5132; Vinod, P K/0000-0003-2968-498X	Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1384, ZA519/1-1]; Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	We thank Angelika Amon, Kirsten Benjamin, Rita Cha, Franz Klein, Michael Knop, Shirleen Roeder, Karin Schmekel, and Wolfgang Seufert for strains and reagents. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SPP1384 grant ZA519/1-1 to W. Z.), a Boehringer Ingelheim Fonds scholarship to J. J. L., and European Commission FP7 (UniCellSys, MitoSys) and OCISB grants to B.N.	Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Dayani Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002083; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Johnson R, 2007, PLOS GENET, V3, P2338, DOI 10.1371/journal.pgen.0030223; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6	46	62	62	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					603	618		10.1016/j.cell.2012.08.044	http://dx.doi.org/10.1016/j.cell.2012.08.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101628	Bronze			2022-12-28	WOS:000310529300016
J	Papanikolaou, S; Dimiduk, DM; Choi, W; Sethna, JP; Uchic, MD; Woodward, CF; Zapperi, S				Papanikolaou, Stefanos; Dimiduk, Dennis M.; Choi, Woosong; Sethna, James P.; Uchic, Michael D.; Woodward, Christopher F.; Zapperi, Stefano			Quasi-periodic events in crystal plasticity and the self-organized avalanche oscillator	NATURE			English	Article							FLOW; DYNAMICS; STATISTICS; MODEL; SLIP	When external stresses in a system-physical, social or virtual-are relieved through impulsive events, it is natural to focus on the attributes of these avalanches(1,2). However, during the quiescent periods between them(3), stresses may be relieved through competing processes, such as slowly flowing water between earthquakes(4) or thermally activated dislocation flow(5) between plastic bursts in crystals(6-8). Such smooth responses can in turn have marked effects on the avalanche properties(9). Here we report an experimental investigation of slowly compressed nickel microcrystals, covering three orders of magnitude in nominal strain rate, in which we observe unconventional quasi-periodic avalanche bursts and higher critical exponents as the strain rate is decreased. Our experiments are faithfully reproduced by analytic and computational dislocation avalanche modelling(10,11) that we have extended to incorporate dislocation relaxation, revealing the emergence of the self-organized avalanche oscillator: a novel critical state exhibiting oscillatory approaches towards a depinning critical point(12). This theory suggests that whenever avalanches compete with slow relaxation-in settings ranging from crystal microplasticity to earthquakes-dynamical quasi-periodic scale invariance ought to emerge.	[Papanikolaou, Stefanos] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA; [Papanikolaou, Stefanos] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Dimiduk, Dennis M.; Uchic, Michael D.; Woodward, Christopher F.] USAF, Res Lab, Mat & Mfg Directorate, AFRL RXCM, Wright Patterson AFB, OH 45433 USA; [Choi, Woosong; Sethna, James P.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Zapperi, Stefano] CNR, IENI, I-20125 Milan, Italy; [Zapperi, Stefano] ISI Fdn, I-10126 Turin, Italy	Yale University; Yale University; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Cornell University; Consiglio Nazionale delle Ricerche (CNR)	Papanikolaou, S (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA.	stefanos.papanikolaou@yale.edu	Papanikolaou, Stefanos/C-9263-2011; Zapperi, Stefano/C-9473-2009; Papanikolaou, Stefanos/AAF-7314-2020	Papanikolaou, Stefanos/0000-0001-5239-1275; Zapperi, Stefano/0000-0001-5692-5465; Papanikolaou, Stefanos/0000-0001-5239-1275	DTRA [1-10-1-0021]; DOE-BES [DE-FG02-07ER-46393]; Air Force Office of Scientific Research; Materials and Manufacturing Directorate; ComplexityNet pilot project LOCAT	DTRA(United States Department of DefenseDefense Threat Reduction Agency); DOE-BES(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Materials and Manufacturing Directorate; ComplexityNet pilot project LOCAT	We thank J. Guckenheimer, C. L. Henley, E. A. Jagla, E. Nadgorny, C. O'Hern, R. Thorne, D. Trinkle, E. van der Giessen and V. Vitelli for discussions. We acknowledge support from DTRA 1-10-1-0021 (S.P.), DOE-BES DE-FG02-07ER-46393 (S.P., W.C. and J.P.S.), the Air Force Office of Scientific Research (D. Stargel) and the Materials and Manufacturing Directorate (D.M.D., C.F.W. and M.D.U.) and the ComplexityNet pilot project LOCAT (S.Z.).	Becker R, 1932, Z PHYS, V79, P566, DOI 10.1007/BF01330508; Ben-Zion Y, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002121; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Bharathi MS, 2002, ACTA MATER, V50, P2813, DOI 10.1016/S1359-6454(02)00099-X; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; CARLSON JM, 1994, REV MOD PHYS, V66, P657, DOI 10.1103/RevModPhys.66.657; Corral A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01022; Cottrell A. H., 1953, DISLOCATIONS PLASTIC; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Dahmen KA, 2011, NAT PHYS, V7, P554, DOI [10.1038/nphys1957, 10.1038/NPHYS1957]; Dimiduk DM, 2007, MODEL SIMUL MATER SC, V15, P135, DOI 10.1088/0965-0393/15/2/009; Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; Fisher DS, 1998, PHYS REP, V301, P113, DOI 10.1016/S0370-1573(98)00008-8; Fisher DS, 1997, PHYS REV LETT, V78, P4885, DOI 10.1103/PhysRevLett.78.4885; Jagla EA, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046117; Kardar M, 1998, PHYS REP, V301, P85, DOI 10.1016/S0370-1573(98)00007-6; Kassner M.E., 2004, FUNDAMENTALS CREEP M; Koslowski M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.125502; Kubin LP, 2002, DISLOCATIONS IN SOLIDS, VOL 11, P101, DOI 10.1016/S1572-4859(02)80008-0; Le Doussal P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051105; Lebyodkin M, 2000, ACTA MATER, V48, P2529, DOI 10.1016/S1359-6454(00)00067-7; Lebyodkin MA, 2012, ACTA MATER, V60, P3729, DOI 10.1016/j.actamat.2012.03.026; MIDDLETON AA, 1992, PHYS REV LETT, V68, P670, DOI 10.1103/PhysRevLett.68.670; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; Muratov CB, 2008, CHAOS, V18, DOI 10.1063/1.2779852; Papanikolaou S, 2011, NAT PHYS, V7, P316, DOI [10.1038/nphys1884, 10.1038/NPHYS1884]; Perkovic O, 1999, PHYS REV B, V59, P6106, DOI 10.1103/PhysRevB.59.6106; PRESS WH, 1986, NUMERICAL RECIPES AR; Rao SI, 2010, ACTA MATER, V58, P5547, DOI 10.1016/j.actamat.2010.06.005; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Salerno K. M., 2012, PREPRINT; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Uchic MD, 2009, ANNU REV MATER RES, V39, P361, DOI 10.1146/annurev-matsci-082908-145422; Weiss J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224110; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zaiser M, 2006, ADV PHYS, V55, P185, DOI 10.1080/00018730600583514; Zaiser M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/P04013	37	115	117	4	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					517	+		10.1038/nature11568	http://dx.doi.org/10.1038/nature11568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099406	Green Submitted			2022-12-28	WOS:000310196200037
J	Slawinska, U; Rossignol, S; Bennett, DJ; Schmidt, BJ; Frigon, A; Fouad, K; Jordan, LM				Slawinska, Urszula; Rossignol, Serge; Bennett, David J.; Schmidt, Brian J.; Frigon, Alain; Fouad, Karim; Jordan, Larry M.			Comment on "Restoring Voluntary Control of Locomotion After Paralyzing Spinal Cord Injury"	SCIENCE			English	Editorial Material							PROPRIOSPINAL NEURONS; COMMAND SIGNAL; BULBOSPINAL TRANSMISSION; CONSTITUTIVE ACTIVITY; RECEPTORS; RECOVERY; DEPENDS; PATTERN	Van den Brand et al. (Reports, 1 June 2012, p. 1182) claim to have restored voluntary control of locomotion after paralyzing spinal cord injury. They have not considered recent findings that their upright posture paradigm contributes to locomotor capability after such injuries. We propose that postural adjustments that activate the locomotor central pattern generator in the upright posture, rather than direct voluntary control of locomotion, account for their results.	[Schmidt, Brian J.; Jordan, Larry M.] Univ Manitoba, Dept Physiol, Spinal Cord Res Ctr, Winnipeg, MB, Canada; [Slawinska, Urszula] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland; [Rossignol, Serge] Univ Montreal, Fac Med, Grp Rech Syst Nerveux Cent Pavillon Desmarais, Montreal, PQ H3C 3J7, Canada; [Bennett, David J.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Frigon, Alain] Univ Sherbrooke, Dept Physiol & Biophys, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada	University of Manitoba; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Universite de Montreal; University of Alberta; University of Sherbrooke; University of Alberta	Jordan, LM (corresponding author), Univ Manitoba, Dept Physiol, Spinal Cord Res Ctr, Winnipeg, MB, Canada.	larry@scrc.umanitoba.ca	Slawinska, Urszula/AAV-9919-2021; Slawinska, Urszula/R-4085-2016	Slawinska, Urszula/0000-0003-2856-2729; Slawinska, Urszula/0000-0003-2856-2729; Fouad, Karim/0000-0003-3654-7852; Frigon, Alain/0000-0002-9259-2706				Alluin O., 2009, 39 ANN M SOC NEUR CH; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barriere G, 2010, J NEUROPHYSIOL, V104, P1119, DOI 10.1152/jn.00255.2010; Cowley K. C., 2011, 41 ANN M SOC NEUR WA; Cowley KC, 2008, J PHYSIOL-LONDON, V586, P1623, DOI 10.1113/jphysiol.2007.148361; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Slawinska U, 2012, J PHYSIOL-LONDON, V590, P1721, DOI 10.1113/jphysiol.2011.224931; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Zaporozhets E, 2006, J PHYSIOL-LONDON, V572, P443, DOI 10.1113/jphysiol.2005.102376; Zaporozhets E, 2011, J NEUROPHYSIOL, V105, P2818, DOI 10.1152/jn.00917.2010; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6	14	17	17	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105								10.1126/science.1226082	http://dx.doi.org/10.1126/science.1226082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087231				2022-12-28	WOS:000309955800020
J	Wilensky, GR				Wilensky, Gail R.			The Shortfalls of "Obamacare"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD USA.							Centers for Medicare and Medicaid Services, 2012, 2012 ANN REP BOARDS; Emanuel EJ, 2012, WALL STREET J, pA19; House of Representatives Committee on the Budget, 2011, WYD RYAN ADV BIP PLA; USAID, 2011, WOM WAT WAT ALL CAMP; Wilensky GR, 2009, NEW ENGL J MED, V360, P653, DOI 10.1056/NEJMp0808003	5	16	16	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1479	1481		10.1056/NEJMp1210763	http://dx.doi.org/10.1056/NEJMp1210763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23050511				2022-12-28	WOS:000309904500003
J	Jones, D; Wilson, J; Warnock, NG; Alexander, DJ				Jones, D.; Wilson, J.; Warnock, N. G.; Alexander, D. J.			Abdominal pain in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTESTINAL-OBSTRUCTION; BOWEL OBSTRUCTION; CECAL VOLVULUS; MANAGEMENT; SAFETY		[Jones, D.; Wilson, J.; Warnock, N. G.; Alexander, D. J.] York Hosp, York YO31 8HE, N Yorkshire, England		Jones, D (corresponding author), York Hosp, York YO31 8HE, N Yorkshire, England.	ugm4djj@gmail.com						[Anonymous], 2011, GUID DIAGN TREATM US; BECK WW, 1974, OBSTET GYNECOL, V43, P374; Catena F, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-5; Chase DM, 2009, OBSTET GYNECOL, V114, P475, DOI 10.1097/AOG.0b013e3181989578; de Bakker JK, 2011, SURG ENDOSC, V25, P1574, DOI 10.1007/s00464-010-1441-z; Health Protection Agency The Royal College of Radiologists and the Royal College of Radiographers, 2009, PROT PREGN PAT DIAGN; Hogan BA, 2008, EMERG RADIOL, V15, P127, DOI 10.1007/s10140-007-0642-9; Kalu Emmanuel, 2006, Archives of Gynecology and Obstetrics, V274, P60, DOI 10.1007/s00404-005-0097-8; Khan MR, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-10; Martin RH, 1994, CURRENT OBSTET GYNEC, P493; Masselli G, 2011, ABDOM IMAGING, V36, P596, DOI 10.1007/s00261-010-9654-0; Melnick DM, 2004, AM J SURG, V187, P170, DOI 10.1016/j.amjsurg.2003.11.023; Mirza MS, 2009, ARCH GYNECOL OBSTET, V279, P177, DOI 10.1007/s00404-008-0656-x; PERDUE PW, 1992, AM J SURG, V164, P384, DOI 10.1016/S0002-9610(05)80910-9; RABINOVICI R, 1990, DIS COLON RECTUM, V33, P765, DOI 10.1007/BF02052323; Wallace GW, 2012, ABDOM IMAGING, V37, P849, DOI 10.1007/s00261-011-9827-5; Woodfield CA, 2010, AM J ROENTGENOL, V194, pWS14, DOI 10.2214/AJR.07.7139	17	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2012	345								e6818	10.1136/bmj.e6818	http://dx.doi.org/10.1136/bmj.e6818			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077350				2022-12-28	WOS:000310141900007
J	Dahm, P; Gilbert, S				Dahm, Philipp; Gilbert, Scott			Radical prostatectomy and observation did not differ for mortality in localized prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dahm, Philipp; Gilbert, Scott] Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Dahm, P (corresponding author), Univ Florida, Gainesville, FL 32610 USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				NCIC Clinical Trials Group, 2012, PHAS 3 STUD ACT SURV; US Preventive Services Task Force, 2012, SCREEN PROST CANC US	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-5	10.7326/0003-4819-157-8-201210160-02005	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070507				2022-12-28	WOS:000309906000004
J	Blackburn, EH; Epel, ES				Blackburn, Elizabeth H.; Epel, Elissa S.			Too toxic to ignore	NATURE			English	Editorial Material							TELOMERE LENGTH; LIFE STRESS; CANCER		[Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu						Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Commission on Social Determinants of Health, 2008, CLOS GAP GEN; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Honig LS, 2012, ARCH NEUROL; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Shalev I, 2012, MOL PSYCHIAT; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901	10	101	102	1	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					169	171		10.1038/490169a	http://dx.doi.org/10.1038/490169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060172	Bronze			2022-12-28	WOS:000309733300023
J	Yager, PH; Singhal, AB; Nogueira, RG				Yager, Phoebe H.; Singhal, Aneesh B.; Nogueira, Raul G.			Case 31-2012: An 18-Year-Old Man with Blurred Vision, Dysarthria, and Ataxia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; YOUNG-ADULTS; INTRAVENOUS THROMBOLYSIS; POOLED ANALYSIS; RISK-FACTORS; EXPERIENCE; CLASSIFICATION; HEMORRHAGE; MULTICENTER		[Yager, Phoebe H.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Singhal, Aneesh B.; Nogueira, Raul G.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Yager, Phoebe H.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Singhal, Aneesh B.; Nogueira, Raul G.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yager, PH (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.				Pfizer; Photothera; Stryker/Concentric Medical; Covidien/ev3 Neurovascular; CoAxia; Penumbra; Rapid Medical; Reverse Medical; Neurointervention; Concentric Medical; Covidien	Pfizer(Pfizer); Photothera; Stryker/Concentric Medical; Covidien/ev3 Neurovascular; CoAxia; Penumbra; Rapid Medical; Reverse Medical; Neurointervention; Concentric Medical; Covidien	Dr. Singhal reports grant support to his institution from Pfizer and Photothera and receiving fees for serving as an expert witness in medicolegal cases involving stroke in young adults. Dr. Nogueira reports receiving consulting fees from Stryker/Concentric Medical, Covidien/ev3 Neurovascular, CoAxia, Penumbra, Rapid Medical, Reverse Medical, and Neurointervention; fees from Concentric Medical, Covidien, and Penumbra for participation on committees for clinical trials; and fees for serving on a data safety and monitoring board for Rapid Medical. No other potential conflict of interest relevant to this article was reported.	ADAMS HP, 1995, ARCH NEUROL-CHICAGO, V52, P491, DOI 10.1001/archneur.1995.00540290081021; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, CEREBROVASC DIS, V27, P502, DOI 10.1159/000210433; Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Chatzikonstantinou A, 2012, J NEUROL, V259, P653, DOI 10.1007/s00415-011-6234-3; Christo PP, 2010, ARQ NEURO-PSIQUIAT, V68, P656, DOI 10.1590/S0004-282X2010000400035; Daxboeck F, 2004, J CHILD NEUROL, V19, P865, DOI 10.1177/08830738040190110401; de Ribanpierre S, 2008, SWISS MED WKLY, V138, P59, DOI 2008/05/smw-11958; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Goldmakher GV, 2009, STROKE, V40, P134, DOI 10.1161/STROKEAHA.108.516690; Hacke W, 2004, LANCET, V363, P768; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Jacobs BS, 2002, STROKE, V33, P2789, DOI 10.1161/01.STR.0000038988.64376.3A; Ji R, ARCH NEUROL IN PRESS; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; KITTNER SJ, 1993, STROKE, V24, pI13; Kristensen B, 1997, STROKE, V28, P1702, DOI 10.1161/01.STR.28.9.1702; Kuruvilla A, 2011, J STROKE CEREBROVASC, V20, P523, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.005; Lansberg MG, 2007, CEREBROVASC DIS, V24, P1, DOI 10.1159/000103110; Larrue V, 2011, NEUROLOGY, V76, P1983, DOI 10.1212/WNL.0b013e31821e5517; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liang JT, 2011, CHILD NERV SYST, V27, P1101, DOI 10.1007/s00381-010-1334-4; Mackay MT, 2011, ANN NEUROL, V69, P130, DOI 10.1002/ana.22224; Macleod MR, 2005, CEREBROVASC DIS, V20, P12, DOI 10.1159/000086121; Mehndiratta MM, 2004, MED SCI MONITOR, V10, pCR535; Morris JG, 2010, STROKE, V41, P2985, DOI 10.1161/STROKEAHA.110.595199; Nogueira RG, 2009, AM J NEURORADIOL, V30, P859, DOI 10.3174/ajnr.A1604; Poppe AY, 2009, CAN J NEUROL SCI, V36, P161, DOI 10.1017/S031716710012027X; Putaala J, 2012, STROKE, V43, P356, DOI 10.1161/STROKEAHA.111.635276; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Putaala J, 2009, STROKE, V40, P2085, DOI 10.1161/STROKEAHA.108.541185; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Quintero-Del-Rio AI, 2000, J CHILD NEUROL, V15, P803, DOI 10.1177/088307380001501207; Rafay MF, 2009, STROKE, V40, P58, DOI 10.1161/STROKEAHA.108.519066; Ribo M, 2005, STROKE, V36, P602, DOI 10.1161/01.STR.0000155737.43566.ad; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Shellhaas RA, 2006, PEDIATRICS, V118, P704, DOI 10.1542/peds.2005-2676; Singhal AB, 2011, CEPHALALGIA, V31, P1067, DOI 10.1177/0333102411410084; Smith WS, 2007, STROKE, V38, P701, DOI 10.1161/01.STR.0000247897.33267.42; Su TM, 2003, NEUROSURGERY, V52, P1075, DOI 10.1227/01.NEU.0000057696.79800.1D; Thomalla G, 2007, STROKE, V38, P313, DOI 10.1161/01.STR.0000254565.51807.22; Toni D, 2012, NEUROLOGY, V78, P880, DOI 10.1212/WNL.0b013e31824d966b; Wolff V, 2011, STROKE, V42, P1778, DOI 10.1161/STROKEAHA.110.610915	45	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1450	1460		10.1056/NEJMcpc1208150	http://dx.doi.org/10.1056/NEJMcpc1208150			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050529				2022-12-28	WOS:000309652700013
J	McCartney, M				McCartney, Margaret			What a new consumer health magazine doesn't tell you	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Centers for Disease Control and Prevention, HUM PAP HPV VACC CLO; Oliver M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b873; SHEMESH Z, 1993, AM J OTOLARYNG, V14, P94, DOI 10.1016/0196-0709(93)90046-A; Society for General Microbiology, 2012, THYM MAY BE BETT ACN; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6817	10.1136/bmj.e6817	http://dx.doi.org/10.1136/bmj.e6817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054055				2022-12-28	WOS:000309907400007
J	Mets, OM; de Jong, PA; Prokop, M				Mets, Onno M.; de Jong, Pim A.; Prokop, Mathias			Computed Tomographic Screening for Lung Cancer An Opportunity to Evaluate Other Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-ARTERY CALCIUM; POPULATION; MORTALITY; TRIAL		[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100,Postbus 85500, NL-3508 GA Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Prokop, W.M./H-8081-2014	de Jong, Pim A/0000-0003-4840-6854; Prokop, Mathias/0000-0001-8157-8055				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Budoff MJ, 2010, RADIOLOGY, V257, P434, DOI 10.1148/radiol.10100132; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Sverzellati N, 2012, RADIOLOGY, V262, P460, DOI 10.1148/radiol.11110364; van Ginneken B, 2011, RADIOLOGY, V261, P719, DOI 10.1148/radiol.11091710; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	8	60	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1433	1434		10.1001/jama.2012.12656	http://dx.doi.org/10.1001/jama.2012.12656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047354				2022-12-28	WOS:000309579300018
J	Carrieri, C; Cimatti, L; Biagioli, M; Beugnet, A; Zucchelli, S; Fedele, S; Pesce, E; Ferrer, I; Collavin, L; Santoro, C; Forrest, ARR; Carninci, P; Biffo, S; Stupka, E; Gustincich, S				Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Beugnet, Anne; Zucchelli, Silvia; Fedele, Stefania; Pesce, Elisa; Ferrer, Isidre; Collavin, Licio; Santoro, Claudio; Forrest, Alistair R. R.; Carninci, Piero; Biffo, Stefano; Stupka, Elia; Gustincich, Stefano			Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat	NATURE			English	Article							PARKINSONS-DISEASE; MAMMALIAN GENOME; GENE-EXPRESSION; LEWY BODIES; TRANSCRIPTION; SEQUENCES; DEMENTIA; UCH-L1	Most of the mammalian genome is transcribed(1-3). This generates a vast repertoire of transcripts that includes protein-coding messenger RNAs, long non-coding RNAs (lncRNAs) and repetitive sequences, such as SINEs (short interspersed nuclear elements). A large percentage of ncRNAs are nuclear-enriched with unknown function(4). Antisense lncRNAs may form sense-antisense pairs by pairing with a protein-coding gene on the opposite strand to regulate epigenetic silencing, transcription and mRNA stability(5-10). Here we identify a nuclear-enriched lncRNA antisense to mouse ubiquitin carboxyterminal hydrolase L1 (Uchl1), a gene involved in brain function and neurodegenerative diseases(11). Antisense Uchl1 increases UCHL1 protein synthesis at a post-transcriptional level, hereby identifying a new functional class of lncRNAs. Antisense Uchl1 activity depends on the presence of a 59 overlapping sequence and an embedded inverted SINEB2 element. These features are shared by other natural antisense transcripts and can confer regulatory activity to an artificial antisense to green fluorescent protein. Antisense Uchl1 function is under the control of stress signalling pathways, as mTORC1 inhibition by rapamycin causes an increase in UCHL1 protein that is associated to the shuttling of antisense Uchl1 RNA from the nucleus to the cytoplasm. Antisense Uchl1 RNA is then required for the association of the overlapping sense protein-coding mRNA to active polysomes for translation. These data reveal another layer of gene expression control at the post-transcriptional level.	[Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Zucchelli, Silvia; Fedele, Stefania; Gustincich, Stefano] Int Sch Adv Studies SISSA, Area Neurosci, I-34136 Trieste, Italy; [Biagioli, Marta; Zucchelli, Silvia; Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy; [Beugnet, Anne; Pesce, Elisa; Biffo, Stefano] Ist Sci San Raffaele, DIBIT, Lab Mol Histol & Cell Growth, I-20132 Milan, Italy; [Ferrer, Isidre] Univ Hosp Bellvitge, IDIBELL, Inst Neuropathol, Lhospitalet De Llobregat 08907, Spain; [Collavin, Licio] LNCIB, I-34149 Trieste, Italy; [Collavin, Licio] Univ Trieste, Dept Life Sci DSV, I-34129 Trieste, Italy; [Santoro, Claudio] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy; [Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Biffo, Stefano] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15121 Alessandria, Italy; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; RIKEN; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Gustincich, S (corresponding author), Int Sch Adv Studies SISSA, Area Neurosci, Via Bonomea 265, I-34136 Trieste, Italy.	gustinci@sissa.it	Carninci, Piero/K-1568-2014; Pesce, Elisa/GXH-1752-2022; Collavin, Licio/A-5312-2010	Carninci, Piero/0000-0001-7202-7243; Collavin, Licio/0000-0001-6815-5381; Pesce, Elisa/0000-0003-4214-1904; biffo, stefano/0000-0002-3780-1050; Biagioli, Marta/0000-0001-8295-8025; Carrieri, Claudia/0000-0002-9454-1021; Zucchelli, Silvia/0000-0003-4556-2990; Gustincich, Stefano/0000-0002-2749-2514; Stupka, Elia/0000-0003-3154-4011; Forrest, Alistair/0000-0003-4543-1675	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo(Compagnia di San Paolo)	We thank S. G. laboratory members for thought-provoking discussions and C. Leonesi for technical help. We thank F. Persichetti, A. Mallamaci, E. Calautti, S. Saoncella, A. Lunardi, D. De Pietri Tonelli, R. Sanges, M. E. MacDonald and T. Perlmann for support and discussions; and M. J. Zigmond and B. Joseph for sharing the MN9D cell line. This work was supported by the FP7 Dopaminet to S.G., E.S. and P.C., by The Giovanni Armenise-Harvard Foundation to S.G. and by the Compagnia di San Paolo to S.B.	Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Barrachina M, 2006, NEUROBIOL DIS, V22, P265, DOI 10.1016/j.nbd.2005.11.005; Barrachina M, 2005, NEUROCHEM INT, V46, P253, DOI 10.1016/j.neuint.2004.08.006; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Spigoni G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008658; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	32	673	705	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					454	+		10.1038/nature11508	http://dx.doi.org/10.1038/nature11508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064229	Green Published			2022-12-28	WOS:000311031600048
J	Colman, E; Golden, J; Roberts, M; Egan, A; Weaver, J; Rosebraugh, C				Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis			The FDA's Assessment of Two Drugs for Chronic Weight Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Colman, E (corresponding author), US FDA, Silver Spring, MD USA.							[Anonymous], 2012, M END MET DRUGS ADV; Center for Drug Evaluation and Research Food and Drug Administration US Department of Health and Human Services, 2007, GUID IND DEV PROD WE; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524	4	121	128	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1577	1579		10.1056/NEJMp1211277	http://dx.doi.org/10.1056/NEJMp1211277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23050510				2022-12-28	WOS:000310131700001
J	Broussard, JL; Ehrmann, DA; Van Cauter, E; Tasali, E; Brady, MJ				Broussard, Josiane L.; Ehrmann, David A.; Van Cauter, Eve; Tasali, Esra; Brady, Matthew J.			Impaired Insulin Signaling in Human Adipocytes After Experimental Sleep Restriction A Randomized, Crossover Study	ANNALS OF INTERNAL MEDICINE			English	Article							GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; RISK-FACTOR; DIABETES-MELLITUS; ENERGY-BALANCE; LEPTIN LEVELS; IN-VIVO; DURATION; RESISTANCE; METABOLISM	Background: Insufficient sleep increases the risk for insulin resistance, type 2 diabetes, and obesity, suggesting that sleep restriction may impair peripheral metabolic pathways. Yet, a direct link between sleep restriction and alterations in molecular metabolic pathways in any peripheral human tissue has not been shown. Objective: To determine whether sleep restriction results in reduced insulin sensitivity in subcutaneous fat, a peripheral tissue that plays a pivotal role in energy metabolism and balance. Design: Randomized, 2-period, 2-condition, crossover clinical study. Setting: University of Chicago Clinical Resource Center. Participants: Seven healthy adults (1 woman, 6 men) with a mean age of 23.7 years (SD, 3.8) and mean body mass index of 22.8 kg/m(2) (SD, 1.6). Intervention: Four days of 4.5 hours in bed or 8.5 hours in bed under controlled conditions of caloric intake and physical activity. Measurements: Adipocytes collected from subcutaneous fat biopsy samples after normal and restricted sleep conditions were exposed to incremental insulin concentrations. The ability of insulin to increase levels of phosphorylated Akt (pAkt), a crucial step in the insulin-signaling pathway, was assessed. Total Akt (tAkt) served as a loading control. The insulin concentration for the half-maximal stimulation of the pAkt-tAkt ratio was used as a measure of cellular insulin sensitivity. Total body insulin sensitivity was assessed using a frequently sampled intravenous glucose tolerance test. Results: The insulin concentration for the half-maximal pAkt-tAkt response was nearly 3-fold higher (mean, 0.71 nM [SD, 0.27] vs. 0.24 nM [SD, 0.24]; P = 0.01; mean difference, 0.47 nM [SD, 0.33]; P = 0.01), and the total area under the receiver-operating characteristic curve of the pAkt-tAkt response was 30% lower (P = 0.01) during sleep restriction than during normal sleep. A reduction in total body insulin sensitivity (P = 0.02) paralleled this impaired cellular insulin sensitivity. Limitation: This was a single-center study with a small sample size. Conclusion: Sleep restriction results in an insulin-resistant state in human adipocytes. Sleep may be an important regulator of energy metabolism in peripheral tissues.	[Brady, Matthew J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Brady, MJ (corresponding author), Univ Chicago, Dept Med, 900 E 57th St,KCBD 8124, Chicago, IL 60637 USA.	etasali@medicine.bsd.uchicago.edu; mbrady@medicine.bsd.uchicago.edu	Bergouignan, Audrey/A-2750-2016; Broussard, Josiane/I-4413-2013	Bergouignan, Audrey/0000-0002-1266-5144; 	National Institutes of Health; National Institutes of Health [R01-HL086459, 5T32-HL07909, CTSA UL1-RR024999, P60-DK020595, P50 HD-057796, P01-AG11412]; Society in Science-The Branco Weiss Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD057796] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909, R01HL086459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society in Science-The Branco Weiss Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.; This research was supported by National Institutes of Health grants R01-HL086459, 5T32-HL07909, CTSA UL1-RR024999, P60-DK020595, and P50 HD-057796 and P01-AG11412 and Society in Science-The Branco Weiss Fellowship awarded to Dr. Broussard.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Bjornholm M, 2002, DIABETOLOGIA, V45, P1128, DOI 10.1007/s00125-002-0875-9; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P266, DOI 10.1159/000158874; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Darmon P, 2006, AM J PHYSIOL-ENDOC M, V291, pE995, DOI 10.1152/ajpendo.00654.2005; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; ELASHOFF JD, 1981, GASTROENTEROLOGY, V80, P615; FANTUS IG, 1981, J CLIN ENDOCR METAB, V52, P953, DOI 10.1210/jcem-52-5-953; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hucking K, 2003, J CLIN INVEST, V111, P257, DOI 10.1172/JCI200314466; Iber C., 2007, AASM MANUAL SCORING; KASHIWAGI A, 1983, J CLIN INVEST, V72, P1246, DOI 10.1172/JCI111080; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Leproult R, 1997, SLEEP, V20, P865; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; MARANGOU AG, 1988, METABOLISM, V37, P885, DOI 10.1016/0026-0495(88)90124-2; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Rafalson L, 2010, ANN EPIDEMIOL, V20, P883, DOI 10.1016/j.annepidem.2010.05.002; Schmid SM, 2011, SLEEP, V34, P371, DOI 10.1093/sleep/34.3.371; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Slieker LJ, 1996, J BIOL CHEM, V271, P5301, DOI 10.1074/jbc.271.10.5301; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vassalli A, 2009, EUR J NEUROSCI, V29, P1830, DOI 10.1111/j.1460-9568.2009.06767.x; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004	43	230	236	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					549	557		10.7326/0003-4819-157-8-201210160-00005	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070488	Green Accepted			2022-12-28	WOS:000309906000015
J	Webber, BL; Le Maitre, DC; Kriticos, DJ				Webber, Bruce L.; Le Maitre, David C.; Kriticos, Darren J.			Comment on "Climatic Niche Shifts Are Rare Among Terrestrial Plant Invaders"	SCIENCE			English	Editorial Material							DISTRIBUTIONS; MODELS		[Webber, Bruce L.] CSIRO, Wembley, WA 6913, Australia; [Webber, Bruce L.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; [Le Maitre, David C.] CSIR, ZA-7599 Stellenbosch, South Africa; [Kriticos, Darren J.] CSIRO Ecosyst Sci & Sustainable Agr Flagship, Canberra, ACT 2601, Australia; [Kriticos, Darren J.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Kriticos, Darren J.] Cooperat Res Ctr Plant Biosecur, Bruce, ACT 2617, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Council for Scientific & Industrial Research (CSIR) - South Africa; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Sturt University	Webber, BL (corresponding author), CSIRO, Wembley, WA 6913, Australia.	bruce.webber@csiro.au	Webber, Bruce/C-1057-2009; Kriticos, Darren J/A-4170-2008; Le Maitre, David/M-8791-2015	Webber, Bruce/0000-0001-5934-6557; Kriticos, Darren J/0000-0003-2599-8105; Le Maitre, David/0000-0003-1037-6637				ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; SHELFORD VE, 1963, ECOLOGY N AM; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R. W., 2000, INVASIVE SPECIES CHA, P210; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x	13	38	43	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104								10.1126/science.1225980	http://dx.doi.org/10.1126/science.1225980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066061				2022-12-28	WOS:000309712300019
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE CHARTING THE BRAIN'S NETWORKS	NATURE			English	Editorial Material							NERVOUS-SYSTEM											Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	8	13	13	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					293	298		10.1038/490293a	http://dx.doi.org/10.1038/490293a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060196	Bronze			2022-12-28	WOS:000309733300059
J	Fergusson, DA; Hebert, P; Hogan, DL; LeBel, L; Rouvinez-Bouali, N; Smyth, JA; Sankaran, K; Tinmouth, A; Blajchman, MA; Kovacs, L; Lachance, C; Lee, S; Walker, CR; Hutton, B; Ducharme, R; Balchin, K; Ramsay, T; Ford, JC; Kakadekar, A; Ramesh, K; Shapiro, S				Fergusson, Dean A.; Hebert, Paul; Hogan, Debora L.; LeBel, Louise; Rouvinez-Bouali, Nicole; Smyth, John A.; Sankaran, Koravangattu; Tinmouth, Alan; Blajchman, Morris A.; Kovacs, Lajos; Lachance, Christian; Lee, Shoo; Walker, C. Robin; Hutton, Brian; Ducharme, Robin; Balchin, Katelyn; Ramsay, Tim; Ford, Jason C.; Kakadekar, Ashok; Ramesh, Kuppuchipalayam; Shapiro, Stan			Effect of Fresh Red Blood Cell Transfusions on Clinical Outcomes in Premature, Very Low-Birth-Weight Infants The ARIPI Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL; DONOR EXPOSURE; CARDIAC-SURGERY; STORAGE LESION; NECROTIZING ENTEROCOLITIS; NEONATAL TRANSFUSIONS; LENGTH; AGE; ASSOCIATION; MORTALITY	Context Even though red blood cells (RBCs) are lifesaving in neonatal intensive care, transfusing older RBCs may result in higher rates of organ dysfunction, nosocomial infection, and length of hospital stay. Objective To determine if RBCs stored for 7 days or less compared with usual standards decreased rates of major nosocomial infection and organ dysfunction in neonatal intensive care unit patients requiring at least 1 RBC transfusion. Design, Setting, and Participants Double-blind, randomized controlled trial in 377 premature infants with birth weights less than 1250 g admitted to 6 Canadian tertiary neonatal intensive care units between May 2006 and June 2011. Intervention Patients were randomly assigned to receive transfusion of RBCs stored 7 days or less (n=188) vs standard-issue RBCs in accordance with standard blood bank practice (n=189). Main Outcome Measures The primary outcome was a composite measure of major neonatal morbidities, including necrotizing enterocolitis, retinopathy of prematurity, bronchopulmonary dysplasia, and intraventricular hemorrhage, as well as death. The primary outcome was measured within the entire period of neonatal intensive care unit stay up to 90 days after randomization. The rate of nosocomial infection was a secondary outcome. Results The mean age of transfused blood was 5.1 (SD, 2.0) days in the fresh RBC group and 14.6 (SD, 8.3) days in the standard group. Among neonates in the fresh RBC group, 99 (52.7%) had the primary outcome compared with 100 (52.9%) in the standard RBC group (relative risk, 1.00; 95% CI, 0.82-1.21). The rate of clinically suspected infection in the fresh RBC group was 77.7% (n=146) compared with 77.2% (n=146) in the standard RBC group (relative risk, 1.01; 95% CI, 0.90-1.12), and the rate of positive cultures was 67.5% (n=127) in the fresh RBC group compared with 64.0% (n=121) in the standard RBC group (relative risk, 1.06; 95% CI, 0.91-1.22). Conclusion In this trial, the use of fresh RBCs compared with standard blood bank practice did not improve outcomes in premature, very low-birth-weight infants requiring a transfusion.	[Fergusson, Dean A.; Hebert, Paul; Hogan, Debora L.; LeBel, Louise; Tinmouth, Alan; Hutton, Brian; Ducharme, Robin; Balchin, Katelyn; Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada; [Fergusson, Dean A.; Hebert, Paul; Rouvinez-Bouali, Nicole; Tinmouth, Alan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Hogan, Debora L.; Rouvinez-Bouali, Nicole] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Hutton, Brian; Ducharme, Robin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Smyth, John A.; Ramesh, Kuppuchipalayam] Univ British Columbia, Dept Pediat, Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC V6T 1W5, Canada; [Ford, Jason C.] Univ British Columbia, Div Hematopathol, Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ford, Jason C.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Sankaran, Koravangattu; Kakadekar, Ashok] Royal Univ Hosp, Dept Neonatol, Saskatoon, SK S7N 0W8, Canada; [Sankaran, Koravangattu; Kakadekar, Ashok] Univ Saskatchewan, Saskatoon, SK, Canada; [Blajchman, Morris A.] McMaster Univ, Dept Pathol & Med, Hamilton, ON, Canada; [Kovacs, Lajos] McGill Univ, Jewish Gen Hosp, Dept Neonatol, Montreal, PQ H3T 1E2, Canada; [Kovacs, Lajos] McGill Univ, Dept Med, Montreal, PQ, Canada; [Shapiro, Stan] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lachance, Christian] CHU St Justine, Dept Neonatal, Montreal, PQ, Canada; [Lachance, Christian] Univ Montreal, Montreal, PQ, Canada; [Lee, Shoo] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, MiCare Res Ctr,Inst Human Dev,Canadian Inst Hlth, Toronto, ON M5G 1X5, Canada; [Lee, Shoo] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Walker, C. Robin] Univ Western Ontario, St Josephs Healthcare, London, ON, Canada; [Walker, C. Robin] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada; [Walker, C. Robin] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; BC Women's Hospital & Health Centre; University of British Columbia; BC Women's Hospital & Health Centre; University of British Columbia; University of British Columbia; University of Saskatchewan; University of Saskatchewan; McMaster University; McGill University; McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Fergusson, DA (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Off L 1298A,501 Smyth Rd,Box 201-B, Ottawa, ON K1H 8L6, Canada.	dafer-gusson@ohri.ca	Rouvinez Bouali, Nicole/AGE-6603-2022	Hutton, Brian/0000-0001-5662-8647; Fergusson, Dean/0000-0002-3389-2485; Ducharme, Robin/0000-0002-5665-7429; Ramsay, Tim/0000-0001-8478-8170	Canadian Institutes for Health Research [MCT 75527]; center for ARIPI; Amgen; Novartis; GlaxoSmithKline; Canadian Blood Services	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); center for ARIPI; Amgen(Amgen); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Canadian Blood Services	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rouvinez-Bouali reports receiving a consulting fee from the central coordinating center for ARIPI for adjudication work. Dr Smyth reports receiving payment from Fillmore Riley LLP for expert opinion. Dr Tinmouth reports receiving consulting fees (paid to his institution) from Amgen, Novartis, and GlaxoSmithKline, consulting fees (paid to him) from Canadian Blood Services, and an unrestricted educational grant from Novartis to his institution. Dr Hutton reports receiving consulting fees from Amgen. No other disclosures were reported.; Funding for ARIPI was provided by the Canadian Institutes for Health Research (MCT 75527).	[Anonymous], 2002, PAEDIAT CHILD HLTH, V7, P553; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Card R T, 1988, Transfus Med Rev, V2, P40, DOI 10.1016/S0887-7963(88)70030-9; ChinYee I, 1997, TRANSFUS SCI, V18, P447, DOI 10.1016/S0955-3886(97)00043-X; Claydon JE, 2007, J PERINATOL, V27, P448, DOI 10.1038/sj.jp.7211766; COOK S, 1993, TRANSFUSION, V33, P379, DOI 10.1046/j.1537-2995.1993.33593255596.x; Dani C, 2001, EARLY HUM DEV, V62, P57, DOI 10.1016/S0378-3782(01)00115-3; DENNIS RC, 1978, ANN THORAC SURG, V26, P17, DOI 10.1016/S0003-4975(10)63624-7; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Eikelboom JW, 2010, AM HEART J, V159, P737, DOI 10.1016/j.ahj.2009.12.045; Fergusson D, 2003, JAMA-J AM MED ASSOC, V289, P1950, DOI 10.1001/jama.289.15.1950; Fergusson D, 2009, TRANSFUS MED REV, V23, P55, DOI 10.1016/j.tmrv.2008.09.005; Gauvin F, 2010, TRANSFUSION, V50, P1902, DOI 10.1111/j.1537-2995.2010.02661.x; Gruenwald CE, 2008, J THORAC CARDIOV SUR, V136, P1442, DOI 10.1016/j.jtcvs.2008.08.044; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; Ho J, 2003, CRIT CARE MED, V31, pS687, DOI 10.1097/01.CCM.0000099349.17094.A3; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Karam O, 2010, CRIT CARE, V14, DOI 10.1186/cc8953; Keller ME, 2002, J TRAUMA, V53, P1023, DOI 10.1097/00005373-200211000-00037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; LIU EA, 1994, J PEDIATR-US, V125, P92, DOI 10.1016/S0022-3476(94)70132-6; MARTIN CM, 1994, CLIN INVEST MED, V17, P124; MCGRADY GA, 1987, AM J EPIDEMIOL, V126, P1165, DOI 10.1093/oxfordjournals.aje.a114754; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pettila V, 2011, CRIT CARE, V15, DOI 10.1186/cc10142; Phelan HA, 2012, AM J SURG, V203, P198, DOI 10.1016/j.amjsurg.2011.05.012; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silvers KM, 1998, ARCH DIS CHILD-FETAL, V78, pF214, DOI 10.1136/fn.78.3.F214; Strauss RG, 1996, TRANSFUSION, V36, P873, DOI 10.1046/j.1537-2995.1996.361097017172.x; Strauss RG, 2000, J PEDIATR-US, V136, P215, DOI 10.1016/S0022-3476(00)70104-1; Strauss RG, 2002, PEDIAT TRANSFUSION P, P129; Strauss RG, 2009, ROSSIS PRINCIPLES TR; Tinmouth A, 2001, TRANSFUS MED REV, V15, P91, DOI 10.1053/tmrv.2001.22613; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Vamvakas EC, 1999, TRANSFUSION, V39, P701, DOI 10.1046/j.1537-2995.1999.39070701.x; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; WangRodriguez J, 1996, TRANSFUSION, V36, P64, DOI 10.1046/j.1537-2995.1996.36196190518.x; Weiskopf RB, 2012, ANESTH ANALG, V114, P511, DOI 10.1213/ANE.0b013e318241fcd5; WOLFE LC, 1985, TRANSFUSION, V25, P185, DOI 10.1046/j.1537-2995.1985.25385219897.x; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	42	285	295	1	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1443	1451		10.1001/2012.jama.11953	http://dx.doi.org/10.1001/2012.jama.11953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23045213				2022-12-28	WOS:000309579300023
J	Haas, DM; Caldwell, DM; Kirkpatrick, P; McIntosh, JJ; Welton, NJ				Haas, David M.; Caldwell, Deborah M.; Kirkpatrick, Page; McIntosh, Jennifer J.; Welton, Nicky J.			Tocolytic therapy for preterm delivery: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OXYTOCIN ANTAGONIST ATOSIBAN; PLACEBO-CONTROLLED TRIAL; MIXED TREATMENT COMPARISONS; PATENT DUCTUS-ARTERIOSUS; MAGNESIUM-SULFATE; PREMATURE LABOR; DOUBLE-BLIND; RANDOMIZED-TRIAL; RITODRINE HYDROCHLORIDE; TRANSDERMAL NITROGLYCERIN	Objective To determine the most effective tocolytic agent at delaying delivery. Design Systematic review and network meta-analysis. Data sources Cochrane Central Register of Controlled Trials, Medline, Medline In-Process, Embase, and CINAHL up to 17 February 2012. Study selection Randomised controlled trials of tocolytic therapy in women at risk of preterm delivery. Data extraction At least two reviewers extracted data on study design, characteristics, number of participants, and outcomes reported (neonatal and maternal). A network meta-analysis was done using a random effects model with drug class effect. Two sensitivity analyses were carried out for the primary outcome; restricted to studies at low risk of bias and restricted to studies excluding women at high risk of preterm delivery (those with multiple gestation and ruptured membranes). Results Of the 3263 titles initially identified, 95 randomized controlled trials of tocolytic therapy were reviewed. Compared with placebo, the probability of delivery being delayed by 48 hours was highest with prostaglandin inhibitors (odds ratio 5.39, 95% credible interval 2.14 to 12.34) followed by magnesium sulfate (2.76, 1.58 to 4.94), calcium channel blockers (2.71, 1.17 to 5.91), beta mimetics (2.41, 1.27 to 4.55), and the oxytocin receptor blocker atosiban (2.02, 1.10 to 3.80). No class of tocolytic was significantly superior to placebo in reducing neonatal respiratory distress syndrome. Compared with placebo, side effects requiring a change of medication were significantly higher for beta mimetics (22.68, 7.51 to 73.67), magnesium sulfate (8.15, 2.47 to 27.70), and calcium channel blockers (3.80, 1.02 to 16.92). Prostaglandin inhibitors and calcium channel blockers were the tocolytics with the best probability of being ranked in the top three medication classes for the outcomes of 48 hour delay in delivery, respiratory distress syndrome, neonatal mortality, and maternal side effects (all cause). Conclusions Prostaglandin inhibitors and calcium channel blockers had the highest probability of delaying delivery and improving neonatal and maternal outcomes.	[Haas, David M.; Kirkpatrick, Page; McIntosh, Jennifer J.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA; [Caldwell, Deborah M.; Welton, Nicky J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Indiana University System; Indiana University Bloomington; University of Bristol	Haas, DM (corresponding author), Wishard Mem Hosp, 1001 W 10th St,F5102, Indianapolis, IN 46202 USA.	dahaas@iupui.edu		Welton, Nicky/0000-0003-2198-3205; McIntosh, Jennifer/0000-0002-0299-9589; , Deborah/0000-0001-8014-7480	Indiana University-Purdue University-Indianapolis Signature Center grant; Therapeutics Research in Maternal and Child Health (PREGMED);  [NIH-NICHD K23HD055305]; MRC [G0800800, G0902118, G0802413] Funding Source: UKRI; Medical Research Council [G0802413, G0800800, G0902118] Funding Source: researchfish	Indiana University-Purdue University-Indianapolis Signature Center grant; Therapeutics Research in Maternal and Child Health (PREGMED); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by grants: NIH-NICHD K23HD055305 (DMH) and the Indiana University-Purdue University-Indianapolis Signature Center grant to the Indiana University Center for Pharmacogenetics and Therapeutics Research in Maternal and Child Health (PREGMED). The funding agencies had no role in the study design, implementation, or preparation of results.	Adam G S, 1966, Aust N Z J Obstet Gynaecol, V6, P294, DOI 10.1111/j.1479-828X.1966.tb00392.x; Al-Omari WR, 2006, EUR J OBSTET GYN R B, V128, P129, DOI 10.1016/j.ejogrb.2005.12.010; Al-Qattan F, 2000, MED PRIN PRACT, V9, P164, DOI 10.1159/000054241; American College of Obstetricians and Gynecologists Committee on Practice Bulletins, 2003, OBSTET GYNECOL, V101, P1039; [Anonymous], 2003, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD002255; Anotayanonth S, 2004, Cochrane Database Syst Rev, pCD004352, DOI 10.1002/14651858.CD004352.pub2; BEALL MH, 1985, AM J OBSTET GYNECOL, V153, P854, DOI 10.1016/0002-9378(85)90689-1; BESINGER RE, 1991, AM J OBSTET GYNECOL, V164, P981, DOI 10.1016/0002-9378(91)90569-D; Bisits A, 2004, AM J OBSTET GYNECOL, V191, P683, DOI 10.1016/j.ajog.2004.02.019; Borna S, 2007, J OBSTET GYNAECOL RE, V33, P631, DOI 10.1111/j.1447-0756.2007.00623.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cabrol D, 2001, EUR J OBSTET GYN R B, V98, P177; Caldwell DM, 2007, LANCET, V369, P270, DOI 10.1016/S0140-6736(07)60138-X; Caldwell DM, 2010, J CLIN EPIDEMIOL, V63, P875, DOI 10.1016/j.jclinepi.2009.08.025; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Caldwell DM, 2008, USING MIXED TREATMEN; Cararach V, 2006, EUR J OBSTET GYN R B, V127, P204, DOI 10.1016/j.ejogrb.2005.10.020; CARITIS SN, 1984, AM J OBSTET GYNECOL, V150, P7, DOI 10.1016/S0002-9378(84)80101-5; Caritis SN, 2011, AM J OBSTET GYNECOL, V204, P95, DOI 10.1016/j.ajog.2010.11.041; CHAU AC, 1992, OBSTET GYNECOL, V80, P847; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; COTTON DB, 1984, J REPROD MED, V29, P92; COX SM, 1990, AM J OBSTET GYNECOL, V163, P767, DOI 10.1016/0002-9378(90)91065-K; Crowther CA, 2006, COCHRANE DB SYST REV; CSAPO AI, 1977, AM J OBSTET GYNECOL, V129, P482, DOI 10.1016/0002-9378(77)90084-9; Dakin H, 2011, STAT MED; De Water MV, 2008, ACTA OBSTET GYN SCAN, V87, P340, DOI 10.1080/00016340801913189; Dempster AP, 1997, STAT COMPUT, V7, P247, DOI 10.1023/A:1018598421607; Dias S, 2011, 4 NICE DSU; Dias S, 2011, TECHNICAL SUPPORT DO; El-Sayed YY, 1999, OBSTET GYNECOL, V93, P79, DOI 10.1016/S0029-7844(98)00337-8; ESSED GGM, 1978, EUR J OBSTET GYN R B, V8, P341, DOI 10.1016/0028-2243(78)90046-1; [范玲 Fan Ling], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P87; Fisk NM, 2001, ACTA OBSTET GYN SCAN, V80, P413; FLOYD RC, 1995, J MATERN-FETAL INVES, V5, P25; Garcia-Velasco JA, 1998, INT J GYNECOL OBSTET, V61, P239, DOI 10.1016/S0020-7292(98)00053-8; GLOCK JL, 1993, AM J OBSTET GYNECOL, V169, P960, DOI 10.1016/0002-9378(93)90035-H; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; GOODWIN TM, 1994, AM J OBSTET GYNECOL, V170, P474, DOI 10.1016/S0002-9378(94)70214-4; Goodwin TM, 1996, OBSTET GYNECOL, V88, P331, DOI 10.1016/0029-7844(96)00200-1; Grignaffini A, 2007, Minerva Ginecol, V59, P481; Groom KM, 2005, BJOG-INT J OBSTET GY, V112, P725, DOI 10.1111/j.1471-0528.2005.00539.x; GUMMERUS M, 1983, GEBURTSH FRAUENHEILK, V43, P151, DOI 10.1055/s-2008-1037077; Haas DM, 2012, J MATERN-FETAL NEO M, V25, P1646, DOI 10.3109/14767058.2011.650249; Haas DM, 2009, OBSTET GYNECOL, V113, P585, DOI 10.1097/AOG.0b013e318199924a; Haghighi L, 1999, INT J GYNECOL OBSTET, V66, P297, DOI 10.1016/S0020-7292(99)00095-8; HAMILTON BE, 2010, NATL VITAL STAT REP, V58, P1; Hess LW, 1997, AM J OBSTET GYNECOL, V176, P1169; Higgins J.P.T, 2009, COCHRANE HDB SYSTEMA, P187; HOLLANDER DI, 1987, AM J OBSTET GYNECOL, V156, P631, DOI 10.1016/0002-9378(87)90066-4; Holleboom CAG, 1996, BRIT J OBSTET GYNAEC, V103, P695, DOI 10.1111/j.1471-0528.1996.tb09840.x; How HY, 2006, AM J OBSTET GYNECOL, V194, P976, DOI 10.1016/j.ajog.2006.02.030; Husslein P, 2007, J PERINAT MED, V35, P305, DOI 10.1515/JPM.2007.078; INGEMARSSON I, 1976, AM J OBSTET GYNECOL, V125, P520, DOI 10.1016/0002-9378(76)90369-0; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; JANKY E, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P478; Jannet D, 1997, EUR J OBSTET GYN R B, V73, P11, DOI 10.1016/S0301-2115(97)02701-2; Jimenez Aramayo J F, 1990, Ginecol Obstet Mex, V58, P265; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kashanian M, 2005, INT J GYNECOL OBSTET, V91, P10, DOI 10.1016/j.ijgo.2005.06.005; Kashanian M, 2011, INT J GYNECOL OBSTET, V113, P192, DOI 10.1016/j.ijgo.2010.12.019; King J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub2; Koks CAM, 1998, EUR J OBSTET GYN R B, V77, P171, DOI 10.1016/S0301-2115(97)00255-8; Kramer WB, 1999, AM J OBSTET GYNECOL, V180, P396, DOI 10.1016/S0002-9378(99)70221-8; KUPFERMINC M, 1993, BRIT J OBSTET GYNAEC, V100, P1090, DOI 10.1111/j.1471-0528.1993.tb15171.x; KURKI T, 1991, OBSTET GYNECOL, V78, P1093; Laohapojanart Nisa, 2007, Journal of the Medical Association of Thailand, V90, P2461; Larmon JE, 1999, AM J OBSTET GYNECOL, V181, P1432, DOI 10.1016/S0002-9378(99)70388-1; LARSEN J F, 1980, British Journal of Obstetrics and Gynaecology, V87, P949, DOI 10.1111/j.1471-0528.1980.tb04457.x; LARSEN JF, 1986, OBSTET GYNECOL, V67, P607, DOI 10.1097/00006250-198605000-00001; LAUERSEN NH, 1977, AM J OBSTET GYNECOL, V127, P837, DOI 10.1016/0002-9378(77)90115-6; LEVENO KJ, 1986, LANCET, V1, P1293; Lin CH, 2009, J FORMOS MED ASSOC, V108, P493, DOI 10.1016/S0929-6646(09)60097-8; Lorzadeh N, 2007, J MED SCI, V7, P640; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2007, STAT MED, V26, P3681, DOI 10.1002/sim.2831; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lyell DJ, 2007, OBSTET GYNECOL, V110, P61, DOI 10.1097/01.AOG.0000269048.06634.35; Ma L, 1992, Zhonghua Yi Xue Za Zhi, V72, P158; Ma L, 1992, ZHONGINTA YI XUE ZA, V72, P91; Macones GA, 1998, BRIT J OBSTET GYNAEC, V105, P541, DOI 10.1111/j.1471-0528.1998.tb10156.x; Maitra N, 2007, INT J GYNECOL OBSTET, V97, P147, DOI 10.1016/j.ijgo.2007.01.004; Mawaldi L, 2008, INT J GYNECOL OBSTET, V100, P65, DOI 10.1016/j.ijgo.2007.06.047; McWhorter J, 2004, OBSTET GYNECOL, V103, P923, DOI 10.1097/01.AOG.0000124784.48287.15; MERKATZ IR, 1980, OBSTET GYNECOL, V56, P7; MILLER JM, 1982, J REPROD MED, V27, P348; MITAL P, 1992, J ROY SOC HEALTH, V112, P214, DOI 10.1177/146642409211200502; Mittendorf R, 2002, AM J OBSTET GYNECOL, V186, P1111, DOI 10.1067/mob.2002.123544; MORALES WJ, 1989, OBSTET GYNECOL, V74, P567; MORALES WJ, 1993, AM J OBSTET GYNECOL, V169, P97, DOI 10.1016/0002-9378(93)90138-9; Motazedian S, 2010, ANN SAUDI MED, V30, P370, DOI 10.4103/0256-4947.67079; Moutquin JM, 2000, AM J OBSTET GYNECOL, V182, P1191, DOI 10.1067/mob.2000.104950; MOUTQUIN JM, 1992, NEW ENGL J MED, V327, P308; Nassar AH, 2009, AM J PERINAT, V26, P575, DOI 10.1055/s-0029-1220780; Neri I, 2009, AM J PERINAT, V26, P259, DOI 10.1055/s-0028-1103153; NIEBYL JR, 1980, AM J OBSTET GYNECOL, V136, P1014, DOI 10.1016/0002-9378(80)90629-8; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Panter KR, 1999, BRIT J OBSTET GYNAEC, V106, P467, DOI 10.1111/j.1471-0528.1999.tb08300.x; Papatsonis D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub2; Papatsonis DNM, 1997, OBSTET GYNECOL, V90, P230, DOI 10.1016/S0029-7844(97)00182-8; Parilla BV, 1997, AM J OBSTET GYNECOL, V176, P1166, DOI 10.1016/S0002-9378(97)70330-2; PECKHAM GJ, 1984, J PEDIATR-US, V105, P285, DOI 10.1016/S0022-3476(84)80134-1; Amorim MMR, 2009, REV BRAS GINECOL OBS, V31, P552, DOI 10.1590/S0100-72032009001100005; RASANEN J, 1995, AM J OBSTET GYNECOL, V173, P20, DOI 10.1016/0002-9378(95)90163-9; Raymajhi R, 2003, Kathmandu Univ Med J (KUMJ), V1, P85; READ MD, 1986, BRIT J OBSTET GYNAEC, V93, P933, DOI 10.1111/j.1471-0528.1986.tb08011.x; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Romero R, 2000, AM J OBSTET GYNECOL, V182, P1173, DOI 10.1067/mob.2000.95834; Roy U K, 1993, J Indian Med Assoc, V91, P8; Sawdy RJ, 2003, AM J OBSTET GYNECOL, V188, P1046, DOI 10.1067/mob.2003.255; Schorr SJ, 1998, SOUTHERN MED J, V91, P1028, DOI 10.1097/00007611-199811000-00007; Sekar KC, 2008, J PERINATOL, V28, pS60, DOI 10.1038/jp.2008.52; Shim JY, 2006, BJOG-INT J OBSTET GY, V113, P1228, DOI 10.1111/j.1471-0528.2006.01053.x; Smith GN, 2007, AM J OBSTET GYNECOL, V196, P37, DOI 10.1016/j.ajog.2006.10.868; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; SPEARING G, 1979, OBSTET GYNECOL, V53, P171; SPELLACY WN, 1979, OBSTET GYNECOL, V54, P220; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEER CM, 1977, AM J OBSTET GYNECOL, V129, P1; Stika CS, 2002, AM J OBSTET GYNECOL, V187, P653, DOI 10.1067/mob.2002.125281; Surichamorn Prayong, 2001, Journal of the Medical Association of Thailand, V84, P98; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Taherian AA, 2007, J RES MED SCI, V12, P136; TCHILINGUIRIAN NG, 1984, INT J GYNECOL OBSTET, V22, P117, DOI 10.1016/0020-7292(84)90024-9; Thornton S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.015; Trabelsi Khaled, 2008, Tunis Med, V86, P43; Wang Hongjing, 2000, Journal of West China University of Medical Sciences, V31, P515; Weerakul W, 2002, INT J GYNECOL OBSTET, V76, P311, DOI 10.1016/S0020-7292(01)00547-1; WEINER CP, 1988, AM J OBSTET GYNECOL, V159, P216, DOI 10.1016/0002-9378(88)90524-8; WILKINS IA, 1988, AM J OBSTET GYNECOL, V159, P685, DOI 10.1016/S0002-9378(88)80035-8; Zhu B, 1996, Zhonghua Fu Chan Ke Za Zhi, V31, P721; ZUCKERMAN H, 1984, J PERINAT MED, V12, P25, DOI 10.1515/jpme.1984.12.1.25	137	211	219	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6226	10.1136/bmj.e6226	http://dx.doi.org/10.1136/bmj.e6226			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23048010	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000309907100001
J	Brewer, C				Brewer, Colin			Assisted dying: "all good doctors do it anyway"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.	brewerismo@gmail.com							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 28	2012	345								e6536	10.1136/bmj.e6536	http://dx.doi.org/10.1136/bmj.e6536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014PD	23045318				2022-12-28	WOS:000309387100004
J	Tachibana, M; Amato, P; Sparman, M; Woodward, J; Sanchis, DM; Ma, H; Gutierrez, NM; Tippner-Hedges, R; Kang, E; Lee, HS; Ramsey, C; Masterson, K; Battaglia, D; Lee, D; Wu, D; Jensen, J; Patton, P; Gokhale, S; Stouffer, R; Mitalipov, S				Tachibana, Masahito; Amato, Paula; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Jensen, Jeffrey; Patton, Phillip; Gokhale, Sumita; Stouffer, Richard; Mitalipov, Shoukhrat			Towards germline gene therapy of inherited mitochondrial diseases	NATURE			English	Article							OOCYTE VITRIFICATION; ACTIVATION; COMMON	Mutations in mitochondrial DNA (mtDNA) are associated with severe human diseases and are maternally inherited through the egg's cytoplasm. Here we investigated the feasibility of mtDNA replacement in human oocytes by spindle transfer (ST; also called spindle-chromosomal complex transfer). Of 106 human oocytes donated for research, 65 were subjected to reciprocal ST and 33 served as controls. Fertilization rate in ST oocytes (73%) was similar to controls (75%); however, a significant portion of ST zygotes (52%) showed abnormal fertilization as determined by an irregular number of pronuclei. Among normally fertilized ST zygotes, blastocyst development (62%) and embryonic stem cell isolation (38%) rates were comparable to controls. All embryonic stem cell lines derived from ST zygotes had normal euploid karyotypes and contained exclusively donor mtDNA. The mtDNA can be efficiently replaced in human oocytes. Although some ST oocytes displayed abnormal fertilization, remaining embryos were capable of developing to blastocysts and producing embryonic stem cells similar to controls.	[Tachibana, Masahito; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Jensen, Jeffrey; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Amato, Paula; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Patton, Phillip; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, Portland, OR 97239 USA; [Jensen, Jeffrey] Oregon Hlth & Sci Univ, Ctr Womens Hlth, Portland, OR 97239 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Univ Pathologists LLC, Providence, RI 02908 USA; [Gokhale, Sumita] Roger Williams Med Ctr, Providence, RI 02908 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Boston University; Roger Williams Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224; Melguizo Sanchis, Dario/0000-0002-5728-4345	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation; National Institutes of Health [HD063276, HD057121, HD059946, EY021214, 8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD057121, R01HD059946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Oregon Health & Science University (OHSU) Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and staff at the Women's Health Research Unit at the Center for Women's Health, University Fertility Consultants and Reproductive Endocrinology & Infertility Division at the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of human gametes. The Division of Animal Resources, Surgery Team, Assisted Reproductive Technology & Embryonic Stem Cell Core, Endocrine Technology Core, Imaging & Morphology Core, Flow Cytometry Core and Molecular & Cellular Biology Core at the Oregon National Primate Research Center provided expertise and services for the nonhuman primate research. Hamilton Thorne Inc., donated an XYClone laser system for this study. We are grateful to W. Sanger and D. Zaleski for karyotyping services, C. Penedo for microsatellite analysis and J. Hennebold for consulting on metabolic assays. We are also indebted to A. Steele, R. Cervera Juanes and E. Wolff for their technical support. The human oocyte/embryo research was supported by grants from the OHSU Center for Women's Health Circle of Giving and other OHSU institutional funds, as well as the Leducq Foundation. The nonhuman primate study was supported by grants from the National Institutes of Health HD063276, HD057121, HD059946, EY021214 and 8P51OD011092.	Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Gao SR, 2005, TRENDS BIOTECHNOL, V23, P66, DOI 10.1016/j.tibtech.2004.12.007; Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Smith DG, 2005, COMPARATIVE MED, V55, P227; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100	24	266	284	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					627	631		10.1038/nature11647	http://dx.doi.org/10.1038/nature11647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23103867	Green Accepted			2022-12-28	WOS:000314219600047
J	Burke, CJ; Huetteroth, W; Owald, D; Perisse, E; Krashes, MJ; Das, G; Gohl, D; Silies, M; Certel, S; Waddell, S				Burke, Christopher J.; Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Krashes, Michael J.; Das, Gaurav; Gohl, Daryl; Silies, Marion; Certel, Sarah; Waddell, Scott			Layered reward signalling through octopamine and dopamine in Drosophila	NATURE			English	Article							NEURONS; EXPRESSION; GENE; RECEPTOR; PROTEIN; MEMORY; MARKER; FAMILY; LIGHT; FLIES	Dopamine is synonymous with reward and motivation in mammals(1,2). However, only recently has dopamine been linked to motivated behaviour and rewarding reinforcement in fruitflies(3,4). Instead, octopamine has historically been considered to be the signal for reward in insects(5-7). Here we show, using temporal control of neural function in Drosophila, that only short-term appetitive memory is reinforced by octopamine. Moreover, octopamine-dependent memory formation requires signalling through dopamine neurons. Part of the octopamine signal requires the alpha-adrenergic-like OAMB receptor in an identified subset of mushroom-body-targeted dopamine neurons. Octopamine triggers an increase in intracellular calcium in these dopamine neurons, and their direct activation can substitute for sugar to form appetitive memory, even in flies lacking octopamine. Analysis of the beta-adrenergic-like OCT beta 2R receptor reveals that octopamine-dependent reinforcement also requires an interaction with dopamine neurons that control appetitive motivation. These data indicate that sweet taste engages a distributed octopamine signal that reinforces memory through discrete subsets of mushroom-body-targeted dopamine neurons. In addition, they reconcile previous findings with octopamine and dopamine and suggest that reinforcement systems in flies are more similar to mammals than previously thought.	[Burke, Christopher J.; Krashes, Michael J.; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Das, Gaurav; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England; [Gohl, Daryl; Silies, Marion] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Certel, Sarah] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Certel, Sarah] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford; Stanford University; University of Montana System; University of Montana; University of Montana System; University of Montana	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@cncb.ox.ac.uk	Owald, David/ABB-5432-2020; Huetteroth, Wolf/L-5252-2019; Krashes, Michael/P-7677-2019; Huetteroth, Wolf/I-6661-2015	Huetteroth, Wolf/0000-0003-3421-9935; Das, Gaurav/0000-0002-3564-5621; Owald, David/0000-0001-7747-7884; Perisse, Emmanuel/0000-0002-0830-0687; Gohl, Daryl/0000-0002-4434-2788; Burke, Christopher/0000-0001-7609-1146; Waddell, Scott/0000-0003-4503-6229	EMBO Long-Term Fellowship; Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship [F32EY020040]; Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences; National Institutes of Health [MH069883, MH081982]; Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE [F32EY020040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081982, R01MH069883] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Yoshihara, S. DasGupta, V. Budnik and S. Goodwin for reagents. We thank T. Clandinin and E. Kravitz for collegial exchange. D.O. was supported by an EMBO Long-Term Fellowship and a Sir Henry Wellcome Postdoctoral Fellowship. D.G. was supported by a Ruth L. Kirschstein NRSA Postdoctoral Fellowship (F32EY020040). M.S. was supported by a Jane Coffin Childs Postdoctoral Fellowship. S.W. is funded by a Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences, by grants MH069883 and MH081982 from the National Institutes of Health and by funds from the Gatsby Charitable Foundation and Oxford Martin School.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Han KA, 1998, J NEUROSCI, V18, P3650; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yoshihara M, 2012, JOVE-J VIS EXP, DOI 10.3791/3625	37	330	338	6	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					433	+		10.1038/nature11614	http://dx.doi.org/10.1038/nature11614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23103875	Green Submitted, Green Accepted			2022-12-28	WOS:000312488200057
J	Lafaille, FG; Pessach, IM; Zhang, SY; Ciancanelli, MJ; Herman, M; Abhyankar, A; Ying, SW; Keros, S; Goldstein, PA; Mostoslavsky, G; Ordovas-Montanes, J; Jouanguy, E; Plancoulaine, S; Tu, E; Elkabetz, Y; Al-Muhsen, S; Tardieu, M; Schlaeger, TM; Daley, GQ; Abel, L; Casanova, JL; Studer, L; Notarangelo, LD				Lafaille, Fabien G.; Pessach, Itai M.; Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Ying, Shui-Wang; Keros, Sotirios; Goldstein, Peter A.; Mostoslavsky, Gustavo; Ordovas-Montanes, Jose; Jouanguy, Emmanuelle; Plancoulaine, Sabine; Tu, Edmund; Elkabetz, Yechiel; Al-Muhsen, Saleh; Tardieu, Marc; Schlaeger, Thorsten M.; Daley, George Q.; Abel, Laurent; Casanova, Jean-Laurent; Studer, Lorenz; Notarangelo, Luigi D.			Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells	NATURE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; EMBRYONIC STEM-CELLS; TOLL-LIKE RECEPTOR-3; RETICULAR THALAMIC NEURONS; CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRANDED-RNA; TLR3 DEFICIENCY; HUMAN ES; PROTECTIVE IMMUNITY; VIRUS ENCEPHALITIS	In the course of primary infection with herpes simplex virus 1 (HSV-1), children with inborn errors of toll-like receptor 3 (TLR3) immunity are prone to HSV-1 encephalitis (HSE)(1-3). We tested the hypothesis that the pathogenesis of HSE involves non-haematopoietic CNS-resident cells. We derived induced pluripotent stem cells (iPSCs) from the dermal fibroblasts of TLR3- and UNC-93B-deficient patients and from controls. These iPSCs were differentiated into highly purified populations of neural stem cells (NSCs), neurons, astrocytes and oligodendrocytes. The induction of interferon-beta (IFN-beta) and/or IFN-lambda 1 in response to stimulation by the dsRNA analogue polyinosinic: polycytidylic acid (poly(I:C)) was dependent on TLR3 and UNC-93B in all cells tested. However, the induction of IFN-beta and IFN-lambda 1 in response to HSV-1 infection was impaired selectively in UNC-93B-deficient neurons and oligodendrocytes. These cells were also much more susceptible to HSV-1 infection than control cells, whereas UNC-93B-deficient NSCs and astrocytes were not. TLR3-deficient neurons were also found to be susceptible to HSV-1 infection. The rescue of UNC-93B- and TLR3-deficient cells with the corresponding wild-type allele showed that the genetic defect was the cause of the poly(I:C) and HSV-1 phenotypes. The viral infection phenotype was rescued further by treatment with exogenous IFN-alpha or IFN-beta (IFN-alpha/beta) but not IFN-lambda 1. Thus, impaired TLR3- and UNC-93B-dependent IFN-alpha/beta intrinsic immunity to HSV-1 in the CNS, in neurons and oligodendrocytes in particular, may underlie the pathogenesis of HSE in children with TLR3-pathway deficiencies.	[Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Pessach, Itai M.; Ordovas-Montanes, Jose; Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Div Immunol, Sch Med, Boston, MA 02115 USA; [Pessach, Itai M.] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Hashomer, Israel; [Pessach, Itai M.] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Aviv, Israel; [Zhang, Shen-Ying; Herman, Melina; Jouanguy, Emmanuelle; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Lab Human Genet Infect Dis, Inst Natl Sante & Rech Med, Necker Med Sch,U980, F-75015 Paris, France; [Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, CV Starr Lab Mol Neuropharmacol, Dept Anesthesiol, New York, NY 10065 USA; [Keros, Sotirios] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY 10065 USA; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Sect Gastroenterol, Dept Med, Boston, MA 02118 USA; [Elkabetz, Yechiel] Tel Aviv Univ, Lab Pluripotent & Neural Stem Cell Biol, Dept Cell & Dev Biol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Al-Muhsen, Saleh] King Saud Univ, Prince Naif Ctr Immunol Res, Dept Pediat, Coll Med, Riyadh 11451, Saudi Arabia; [Tardieu, Marc] Hop Bicetre, Assistance Publ Hop Paris, Dept Pediat Neurol, F-94275 Le Kremlin Bicetre, France; [Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Schlaeger, Thorsten M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Cornell University; Boston University; Tel Aviv University; Sackler Faculty of Medicine; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital	Zhang, SY (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	shzh289@rockefeller.edu; jean-laurent.casanova@rockefeller.edu	Jouanguy, Emmanuelle/H-7901-2017; PLANCOULAINE, Sabine/E-2824-2017; Al-muhsen, saleh/E-9315-2014; Studer, Lorenz/ABH-1491-2021; Zhang, Shen-Ying/I-2685-2017; Casanova, Jean-Laurent/I-3418-2017; Abel, Laurent/H-8888-2017; Notarangelo, Luigi D/F-9718-2016	Jouanguy, Emmanuelle/0000-0002-7358-9157; PLANCOULAINE, Sabine/0000-0003-0725-8306; Al-muhsen, saleh/0000-0003-3698-9968; Studer, Lorenz/0000-0003-0741-7987; Zhang, Shen-Ying/0000-0002-9449-3672; Abel, Laurent/0000-0001-7016-6493; Notarangelo, Luigi D/0000-0002-8335-0262; Goldstein, Peter/0000-0002-5973-9104; Casadio, Melina/0000-0003-2389-2243; Casanova, Jean-Laurent/0000-0002-7782-4169; Ciancanelli, Michael/0000-0002-4623-852X; Keros, Sotirios/0000-0001-9264-9824; Mostoslavsky, Gustavo/0000-0002-0784-2169; Schlaeger, Thorsten/0000-0002-1599-9908; Ordovas-Montanes, Jose/0000-0001-5444-5601	National Center for Translational Sciences (NCATS) [8UL1TR000043]; National Institutes of Health (NIH); Rockefeller University; St. Giles Foundation; ANR; INSERM; Paris Descartes University; March of Dimes; NIH [5R01NS072381-02, 1R03AI0883502-01, 1R01NS066390]; Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease [41/11]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI088352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, K12NS066274] Funding Source: NIH RePORTER	National Center for Translational Sciences (NCATS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; St. Giles Foundation; ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank our patients, their families and physicians; and the members of the three laboratories for helpful discussions and critical reading of this manuscript. The work was funded by grant number 8UL1TR000043 from the National Center for Translational Sciences (NCATS), the National Institutes of Health (NIH), the Rockefeller University, the St. Giles Foundation, the ANR, INSERM, Paris Descartes University, the March of Dimes, NIH grant 5R01NS072381-02 (to J.-L.C., L.S. and L.D.N.), NIH grant 1R03AI0883502-01 (to L.D.N.), NIH grant 1R01NS066390 and the Manton Foundation, the Israeli Centers of Research Excellence (I-CORE), and Gene Regulation in Complex Human Disease, Center No 41/11 (to I.M.P.). F.G.L. is supported by the New York Stem Cell Foundation.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jackson AC, 2006, J NEUROVIROL, V12, P229, DOI 10.1080/13550280600848399; JACQUEMONT B, 1975, J VIROL, V15, P707, DOI 10.1128/JVI.15.4.707-713.1975; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1400, DOI 10.1016/j.jaci.2010.11.008; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036	42	234	238	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					769	+		10.1038/nature11583	http://dx.doi.org/10.1038/nature11583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103873	Green Submitted, Green Accepted			2022-12-28	WOS:000311606000048
J	Bell, JC; Plank, JL; Dombrowski, CC; Kowalczykowski, SC				Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.			Direct imaging of RecA nucleation and growth on single molecules of SSB-coated ssDNA	NATURE			English	Article							DNA-BINDING-PROTEIN; STRANDED NUCLEIC-ACIDS; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; E. COLI; FILAMENTS; EXCHANGE; MECHANISM; DYNAMICS; KINETICS	Escherichia coli RecA is the defining member of a ubiquitous class of DNA strand-exchange proteins that are essential for homologous recombination, a pathway that maintains genomic integrity by repairing broken DNA(1). To function, filaments of RecA must nucleate and grow on single-stranded DNA (ssDNA) in direct competition with ssDNA-binding protein (SSB), which rapidly binds and continuously sequesters ssDNA, kinetically blocking RecA assembly(2,3). This dynamic self-assembly on a DNA lattice, in competition with another protein, is unique for the RecA family compared to other filament-forming proteins such as actin and tubulin. The complexity of this process has hindered our understanding of RecA filament assembly because ensemble measurements cannot reliably distinguish between the nucleation and growth phases, despite extensive and diverse attempts(2-5). Previous single-molecule assays have measured the nucleation and growth of RecA-and its eukaryotic homologue RAD51-on naked double-stranded DNA and ssDNA(6-12); however, the template for RecA self-assembly in vivo is SSB-coated ssDNA(3). Using single-molecule microscopy, here we directly visualize RecA filament assembly on single molecules of SSB-coated ssDNA, simultaneously measuring nucleation and growth. We establish that a dimer of RecA is required for nucleation, followed by growth of the filament through monomer addition, consistent with the finding that nucleation, but not growth, is modulated by nucleotide and magnesium ion cofactors. Filament growth is bidirectional, albeit faster in the 5'-> 3' direction. Both nucleation and growth are repressed at physiological conditions, highlighting the essential role of recombination mediators in potentiating assembly in vivo. We define a two-step kinetic mechanism in which RecA nucleates on transiently exposed ssDNA during SSB sliding and/or partial dissociation (DNA unwrapping) and then the RecA filament grows. We further demonstrate that the recombination mediator protein pair, RecOR (RecO and RecR), accelerates both RecA nucleation and filament growth, and that the introduction of RecF further stimulates RecA nucleation.	[Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Bell, Jason C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Biochem & Mol Biol Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Plank, Jody/0000-0002-8025-7935; Bell, Jason/0000-0001-5480-7975	National Institutes of Health (NIH) [T32 GM007377, CA10052159, CA136103, GM62653, GM64745]; NATIONAL CANCER INSTITUTE [F32CA136103, T32CA108459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, R01GM062653, R37GM062653, T32GM007377] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. J.C.B. was funded by a National Institutes of Health (NIH) Predoctoral Training Program in Molecular & Cellular Biology (T32 GM007377); C. C. D. and J.L.P. were funded by the NIH T32 Training Program in Oncogenic Signals and Chromosome Biology (CA10052159); J.L.P. was also funded by a NIH Postdoctoral Fellowship (CA136103); and S. C. K. was supported by the NIH (GM62653 and GM64745).	Bell J. C., 2011, THESIS U CALIFORNIA; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Dillingham MS, 2008, BIOPHYS J, V95, P3330, DOI 10.1529/biophysj.108.133512; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Handa N, 2009, J BIOL CHEM, V284, P18664, DOI 10.1074/jbc.M109.004895; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629	35	109	110	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					274	U144		10.1038/nature11598	http://dx.doi.org/10.1038/nature11598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103864	Green Accepted, Green Submitted			2022-12-28	WOS:000310774300048
J	Greene, MF				Greene, Michael F.			Two Hundred Years of Progress in the Practice of Midwifery	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MATERNAL PLASMA; PRENATAL-DIAGNOSIS; PREGNANCY; DNA; RATES; ERYTHROBLASTOSIS; 1ST-TRIMESTER; TRANSMISSION; TRISOMY-21; MUTATION		[Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA; [Greene, Michael F.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Greene, MF (corresponding author), Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, 55 Fruit St, Boston, MA 02114 USA.	mfgreene@partners.org						Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; [Anonymous], 1990, NEW ENGL J MED, V323, P70; [Anonymous], 2011, MMWR-MORBID MORTAL W, V60, P2; Badger GSC, 1908, BOSTON MED SURG J, V158, P607, DOI 10.1056/NEJM190805071581902; Braxton Hicks J, 1860, LANCET, V76, P28; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; CLEWELL WH, 1981, NEW ENGL J MED, V305, P955; Clifford SH, 1932, NEW ENGL J MED, V207, P105, DOI 10.1056/NEJM193207212070301; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; Dameshek W, 1943, NEW ENGL J MED, V228, P157; Diamond LK, 1942, NEW ENGL J MED, V227, P857, DOI 10.1056/NEJM194212032272301; FREDA VJ, 1967, NEW ENGL J MED, V277, P1022, DOI 10.1056/NEJM196711092771908; Gillette WJ, 1901, BOSTON MED SURG J, V145, P9, DOI 10.1056/NEJM190107041450103; GRANT A, 1991, LANCET, V337, P1491; Green CM, 1909, BOSTON MED SURG J, V161, P803; HAMERTON JL, 1989, LANCET, V1, P1; Hamilton BE, 2012, NATL VITAL STAT REP, P61; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EB, 1981, NEW ENGL J MED, V305, P1410, DOI 10.1056/NEJM198112033052312; Kallen B, 2010, HUM REPROD, V25, P1026, DOI 10.1093/humrep/deq003; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; KAN YW, 1976, NEW ENGL J MED, V294, P1039, DOI 10.1056/NEJM197605062941905; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KERENYI TD, 1981, NEW ENGL J MED, V304, P1525, DOI 10.1056/NEJM198106183042505; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; KOBAYASHI M, 1969, AM J OBSTET GYNECOL, V103, P1131, DOI 10.1016/0002-9378(69)90518-3; Levine P, 1941, J AMER MED ASSOC, V116, P825, DOI 10.1001/jama.1941.02820090025006; Li Y, 2005, JAMA-J AM MED ASSOC, V293, P843, DOI 10.1001/jama.293.7.843; Li Y, 2004, PRENATAL DIAG, V24, P896, DOI 10.1002/pd.1030; LILEY AW, 1961, AM J OBSTET GYNECOL, V82, P1359; LILEY AW, 1963, BRIT MED J, P1107, DOI 10.1136/bmj.2.5365.1107; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Martin JA, 2010, NATL VITAL STAT REP, V59, P3; Martin Joyce A, 2007, Natl Vital Stat Rep, V55, P1; Martin Joyce A, 2012, NCHS Data Brief, P1; Philip L., 1939, JAMA-J AM MED ASSOC, V113, P126; REID DE, 1953, AM J OBSTET GYNECOL, V66, P500, DOI 10.1016/0002-9378(53)90067-2; Reynolds E, 1907, BOSTON MED SURG J, V157, P581, DOI 10.1056/NEJM190710311571801; RHOADS GG, 1989, NEW ENGL J MED, V320, P609, DOI 10.1056/NEJM198903093201001; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Tait L, 1899, LANCET, V153, P364; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Van Voorhis BJ, 2007, NEW ENGL J MED, V356, P379, DOI 10.1056/NEJMcp065743; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Williams JW., 1903, OBSTET TXB USE STUDE, P400; Xu KP, 1999, JAMA-J AM MED ASSOC, V281, P1701, DOI 10.1001/jama.281.18.1701	50	6	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1732	1740		10.1056/NEJMra1209764	http://dx.doi.org/10.1056/NEJMra1209764			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113484				2022-12-28	WOS:000310440800010
J	Rosenbaum, L				Rosenbaum, Lisa			How Much Would You Give to Save a Dying Bird? Patient Advocacy and Biomedical Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIGH-DOSE CHEMOTHERAPY; BREAST-CANCER		[Rosenbaum, Lisa] Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania	Rosenbaum, L (corresponding author), Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.							Dresser R., 2001, SCI OFFERS SALVATION; Howe R, 1999, WASH POST, pC1; Kahneman D., 2011, THINKING FAST SLOW; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mello MM, 2001, HEALTH AFFAIR, V20, P101, DOI 10.1377/hlthaff.20.5.101; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Thaler RH., 2021, NUDGE FINAL EDITION	8	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1755	1759		10.1056/NEJMms1207114	http://dx.doi.org/10.1056/NEJMms1207114			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113489				2022-12-28	WOS:000310440800016
J	Lee, M; Cooper, B; Becker, D				Lee, Michelle; Cooper, Brenda; Becker, Devra			Keeping abreast of axillary masses	LANCET			English	Editorial Material							LARGE-CELL LYMPHOMA; BREAST IMPLANTS		[Lee, Michelle; Cooper, Brenda; Becker, Devra] Univ Hosp Case Med Ctr, Dept Plast & Reconstruct Surg, Cleveland, OH 44106 USA; [Lee, Michelle; Cooper, Brenda; Becker, Devra] Univ Hosp Case Med Ctr, Dept Hematol Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital	Becker, D (corresponding author), Univ Hosp Case Med Ctr, Dept Plast & Reconstruct Surg, 11100 Euclid Ave, Cleveland, OH 44106 USA.	devra.becker@uhhospitals.org	Becker, Devra B/D-3134-2018	Becker, Devra B/0000-0003-2688-2198				Aladily TN, 2012, AM J SURG PATHOL, V36, P1000, DOI 10.1097/PAS.0b013e31825749b1; de Jong D, 2008, JAMA-J AM MED ASSOC, V300, P2030, DOI 10.1001/jama.2008.585; Ferreri AJM, CRIT REV ON IN PRESS; Kim B, 2011, PLAST RECONSTR SURG, V128, P629, DOI 10.1097/PRS.0b013e31821f9f23; Smith TJ, 2012, BREAST, V21, P102, DOI 10.1016/j.breast.2011.07.007	5	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1530	1530		10.1016/S0140-6736(12)61334-8	http://dx.doi.org/10.1016/S0140-6736(12)61334-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101720				2022-12-28	WOS:000310272000033
J	Phrampus, BJ; Hornbach, MJ				Phrampus, Benjamin J.; Hornbach, Matthew J.			Recent changes to the Gulf Stream causing widespread gas hydrate destabilization	NATURE			English	Article							OCEAN; FLOW	The Gulf Stream is an ocean current that modulates climate in the Northern Hemisphere by transporting warm waters from the Gulf of Mexico into the North Atlantic and Arctic oceans(1,2). A changing Gulf Stream has the potential to thaw and convert hundreds of gigatonnes of frozen methane hydrate trapped below the sea floor into methane gas, increasing the risk of slope failure and methane release(3-9). How the Gulf Stream changes with time and what effect these changes have on methane hydrate stability is unclear. Here, using seismic data combined with thermal models, we show that recent changes in intermediate-depth ocean temperature associated with the Gulf Stream are rapidly destabilizing methane hydrate along a broad swathe of the North American margin. The area of active hydrate destabilization covers at least 10,000 square kilometres of the United States eastern margin, and occurs in a region prone to kilometre-scale slope failures. Previous hypothetical studies(3,5) postulated that an increase of five degrees Celsius in intermediate-depth ocean temperatures could release enough methane to explain extreme global warming events like the Palaeocene-Eocene thermal maximum (PETM) and trigger widespread ocean acidification(7). Our analysis suggests that changes in Gulf Stream flow or temperature within the past 5,000 years or so are warming the western North Atlantic margin by up to eight degrees Celsius and are now triggering the destabilization of 2.5 gigatonnes of methane hydrate (about 0.2 per cent of that required to cause the PETM). This destabilization extends along hundreds of kilometres of the margin and may continue for centuries. It is unlikely that the western North Atlantic margin is the only area experiencing changing ocean currents(10-12); our estimate of 2.5 gigatonnes of destabilizing methane hydrate may therefore represent only a fraction of the methane hydrate currently destabilizing globally. The transport from ocean to atmosphere of any methane released-and thus its impact on climate-remains uncertain.	[Phrampus, Benjamin J.; Hornbach, Matthew J.] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA	Southern Methodist University	Phrampus, BJ (corresponding author), So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA.	bphrampus@mail.smu.edu		Phrampus, Benjamin/0000-0002-6405-3625				Archer D, 2004, EARTH PLANET SC LETT, V222, P333, DOI 10.1016/j.epsl.2004.03.011; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; BRYAN GM, 1980, MAR GEOL, V35, P43, DOI 10.1016/0025-3227(80)90021-3; Carpenter G., 1981, GEO-MAR LETT, V1, P29, DOI [10.1007/BF02463298, DOI 10.1007/BF02463298]; DESER C, 1993, J CLIMATE, V6, P1743, DOI 10.1175/1520-0442(1993)006<1743:SCVOTN>2.0.CO;2; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dillon W. P., 1993, US GEOL SURV PROF PA, V1570, P313; Dugan B, 2000, SCIENCE, V289, P288, DOI 10.1126/science.289.5477.288; Evans HK, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001409; Flemings PB, 2003, GEOLOGY, V31, P1057, DOI 10.1130/G19863.1; Holbrook WS, 1996, SCIENCE, V273, P1840, DOI 10.1126/science.273.5283.1840; Hornbach MJ, 2004, NATURE, V427, P142, DOI 10.1038/nature02172; HUTCHISON I, 1985, GEOPHYS J ROY ASTR S, V82, P439, DOI 10.1111/j.1365-246X.1985.tb05145.x; Kennett JP, 2003, SPEC PUBL SER, V54; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Lynch-Stieglitz J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002032; MACKENZIE KV, 1981, J ACOUST SOC AM, V70, P801, DOI 10.1121/1.386919; Milton D. J., 1976, FUTURE SUPPLY NATURE, P927; Paull C. K., 1996, P OCEAN DRILLING PRO, V164, P5; Rajan A, 2012, MAR PETROL GEOL, V32, P36, DOI 10.1016/j.marpetgeo.2011.12.008; Ruppel C, 1997, GEOLOGY, V25, P699, DOI 10.1130/0091-7613(1997)025<0699:ACTOAT>2.3.CO;2; RUPPEL C, 1995, J GEOPHYS RES-SOL EA, V100, P20037, DOI 10.1029/95JB01860; SHIPLEY TH, 1979, AAPG BULL, V63, P2204; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Westbrook CD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038186; Winguth A, 2010, J CLIMATE, V23, P2562, DOI 10.1175/2009JCLI3113.1; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; YAMANO M, 1982, GEOLOGY, V10, P339, DOI 10.1130/0091-7613(1982)10<339:EOHFDF>2.0.CO;2	30	111	115	6	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					527	+		10.1038/nature11528	http://dx.doi.org/10.1038/nature11528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099408				2022-12-28	WOS:000310196200039
J	Scheffer, M; Carpenter, SR; Lenton, TM; Bascompte, J; Brock, W; Dakos, V; van de Koppel, J; van de Leemput, IA; Levin, SA; van Nes, EH; Pascual, M; Vandermeer, J				Scheffer, Marten; Carpenter, Stephen R.; Lenton, Timothy M.; Bascompte, Jordi; Brock, William; Dakos, Vasilis; van de Koppel, Johan; van de Leemput, Ingrid A.; Levin, Simon A.; van Nes, Egbert H.; Pascual, Mercedes; Vandermeer, John			Anticipating Critical Transitions	SCIENCE			English	Review							CRITICAL SLOWING-DOWN; NONEQUILIBRIUM PHASE-TRANSITIONS; COORDINATED BIOLOGICAL MOTION; EARLY-WARNING SIGNALS; REGIME SHIFTS; TIPPING-POINT; CATASTROPHIC SHIFTS; ECOSYSTEMS; RESILIENCE; SYSTEMS	Tipping points in complex systems may imply risks of unwanted collapse, but also opportunities for positive change. Our capacity to navigate such risks and opportunities can be boosted by combining emerging insights from two unconnected fields of research. One line of work is revealing fundamental architectural features that may cause ecological networks, financial markets, and other complex systems to have tipping points. Another field of research is uncovering generic empirical indicators of the proximity to such critical thresholds. Although sudden shifts in complex systems will inevitably continue to surprise us, work at the crossroads of these emerging fields offers new approaches for anticipating critical transitions.	[Scheffer, Marten; Dakos, Vasilis; van de Leemput, Ingrid A.; van Nes, Egbert H.] Wageningen Univ, Dept Environm Sci, NL-6700 AA Wageningen, Netherlands; [Scheffer, Marten] S Amer Inst Resilience & Sustainabil Studies SARA, Maldonado, Uruguay; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Lenton, Timothy M.] Univ Exeter, Hatherly Labs, Coll Life & Environm Sci, Exeter EX4 4PS, Devon, England; [Bascompte, Jordi; Dakos, Vasilis] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain; [Brock, William] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [van de Koppel, Johan] Royal Netherlands Inst Sea Res NIOZ, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [van de Koppel, Johan] Univ Groningen, Ctr Ecol & Evolutionary Studies CEES, Community & Conservat Ecol Grp, NL-9700 CC Groningen, Netherlands; [Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pascual, Mercedes; Vandermeer, John] Univ Michigan, Ann Arbor, MI 48109 USA; [Pascual, Mercedes; Vandermeer, John] Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison; University of Exeter; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Wisconsin System; University of Wisconsin Madison; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; Princeton University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; The Santa Fe Institute	Scheffer, M (corresponding author), Wageningen Univ, Dept Environm Sci, POB 47, NL-6700 AA Wageningen, Netherlands.	marten.scheffer@wur.nl	Scheffer, Marten/C-1852-2012; van Nes, Egbert H/F-2681-2011; Lenton, Tim M/X-1893-2018; Van de Koppel, Johan/E-7266-2010; Levin, Simon A/J-1218-2014; Carpenter, Stephen/AAQ-6404-2020; Bascompte, Jordi/B-7596-2008	Lenton, Tim M/0000-0002-6725-7498; Levin, Simon A/0000-0002-8216-5639; Bascompte, Jordi/0000-0002-0108-6411; van Nes, Egbert/0000-0002-6345-104X; Dakos, Vasilis/0000-0001-8862-718X	European Research Council (ERC); NSF [DEB-1144683]; North Temperate Lakes LTER; Natural Environment Research Council [NE/F005474/1]; NERC [NE/F005474/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); NSF(National Science Foundation (NSF)); North Temperate Lakes LTER; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was partly funded by the European Research Council (ERC) Advanced Grant and Spinoza award (to M. S.) and by ERC Advanced Grant (to J.B.). S.R.C.'s work is funded by NSF DEB-1144683 and North Temperate Lakes LTER. T.M.L.'s work is funded by Natural Environment Research Council NE/F005474/1. M. P. is an investigator of the Howard Hughes Medical Institute.	Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brida J. G., 2003, Structural Change and Economic Dynamics, V14, P159, DOI 10.1016/S0954-349X(02)00050-4; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gorban AN, 2010, PHYSICA A, V389, P3193, DOI 10.1016/j.physa.2010.03.035; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hewitt JE, 2010, MAR ECOL PROG SER, V413, P267, DOI 10.3354/meps08626; Hines P., 2011, P ANN HAW INT C SYST; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; KRAMER J, 1985, J CHEM PHYS, V83, P6234, DOI 10.1063/1.449571; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Kuznetsov Y.A., 1997, ELEMENTS APPL BIFURC; Lenton T. M., 2011, IMA J APPL MATH, V76, P27; Levin S. A., 2000, FRAGILE DOMINION COM; Lim J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016203; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MATSUMOTO G, 1978, J PHYS SOC JPN, V44, P1047, DOI 10.1143/JPSJ.44.1047; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Mayer A. L., 2007, EXPLORATORY DATA ANA, DOI [10.1007/978-1-84628-777-0_7, DOI 10.1007/978-1-84628-777-0{_}]; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Meisel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030371; Neuman Y, 2011, COMPLEXITY, V16, P58, DOI 10.1002/cplx.20347; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Ramos O, 2010, TECTONOPHYSICS, V485, P321, DOI 10.1016/j.tecto.2009.11.007; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Saavedra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026705; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHOLZ JP, 1987, PHYS LETT A, V123, P390, DOI 10.1016/0375-9601(87)90038-7; Sole R. V., 1995, Complexity, V1, P13; Sornette D, 2010, ECONOPHYSICS APPROACHES TO LARGE-SCALE BUSINESS DATA AND FINANCIAL CRISIS, P101, DOI 10.1007/978-4-431-53853-0_6; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tredicce JR, 2004, AM J PHYS, V72, P799, DOI 10.1119/1.1688783; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	67	1175	1195	44	1089	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					344	348		10.1126/science.1225244	http://dx.doi.org/10.1126/science.1225244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087241	Green Published, Green Submitted			2022-12-28	WOS:000309955800032
J	Paniello, RC; Day, JMD; Moynier, F				Paniello, Randal C.; Day, James M. D.; Moynier, Frederic			Zinc isotopic evidence for the origin of the Moon	NATURE			English	Article							GIANT IMPACT; LUNAR-SAMPLES; MARE BASALTS; METEORITES; COPPER; DIFFERENTIATION; GEOCHEMISTRY; ABUNDANCES; ACCRETION; PETROLOGY	Volatile elements have a fundamental role in the evolution of planets. But how budgets of volatiles were set in planets, and the nature and extent of volatile-depletion of planetary bodies during the earliest stages of Solar System formation remain poorly understood(1,2). The Moon is considered to be volatile-depleted and so it has been predicted that volatile loss should have fractionated stable isotopes of moderately volatile elements(3). One such element, zinc, exhibits strong isotopic fractionation during volatilization in planetary rocks(4,5), but is hardly fractionated during terrestrial igneous processes(6), making it a powerful tracer of the volatile histories of planets. Here we present high-precision zinc isotopic and abundance data which show that lunar magmatic rocks are enriched in the heavy isotopes of zinc and have lower zinc concentrations than terrestrial or Martian igneous rocks. Conversely, Earth and Mars have broadly chondritic zinc isotopic compositions. We show that these variations represent large-scale evaporation of zinc, most probably in the aftermath of the Moon-forming event, rather than small-scale evaporation processes during volcanism. Our results therefore represent evidence for volatile depletion of the Moon through evaporation, and are consistent with a giant impact origin for the Earth and Moon.	[Paniello, Randal C.; Moynier, Frederic] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Paniello, Randal C.; Moynier, Frederic] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Diego; Scripps Institution of Oceanography	Moynier, F (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	moynier@levee.wustl.edu	Day, James/A-5099-2010; Moynier, Frederic/AFL-9257-2022; Moynier, Frederic/I-2785-2012; Moynier, Frederic/AAH-1235-2022	Day, James/0000-0001-9520-3465; Moynier, Frederic/0000-0003-4321-5581; Moynier, Frederic/0000-0003-4321-5581	NASA LASER; Cosmochemistry programmes [NNX09AM64G, NNX12AH70G, NNX11AG34G, NNX12AH75G]; Exobiology programme [NNX12AD88G]	NASA LASER; Cosmochemistry programmes; Exobiology programme	We thank the NASA curation staff, CAPTEM and the meteorite working group for samples. This work was supported by grants from the NASA LASER and Cosmochemistry programmes to F. M. (NNX09AM64G, NNX12AH70G) and J.M.D.D. (NNX11AG34G; NNX12AH75G) and from the Exobiology programme (NNX12AD88G) to F.M.	Albarede F, 2004, REV MINERAL GEOCHEM, V55, P409, DOI 10.2138/gsrmg.55.1.409; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Barrat JA, 2012, GEOCHIM COSMOCHIM AC, V83, P79, DOI 10.1016/j.gca.2011.12.011; Ben Othman D, 2006, GEOCHIM COSMOCHIM AC, V70, pA46, DOI 10.1016/j.gca.2006.06.201; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Chou C.-L., 1975, LUNAR PLANET SCI, V6, P1701; Day JMD, 2006, GEOCHIM COSMOCHIM AC, V70, P1581, DOI 10.1016/j.gca.2005.11.015; DING TP, 1983, GEOCHIM COSMOCHIM AC, V47, P491, DOI 10.1016/0016-7037(83)90271-5; Giguere TA, 2000, METEORIT PLANET SCI, V35, P193, DOI 10.1111/j.1945-5100.2000.tb01985.x; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Herzog GF, 2009, GEOCHIM COSMOCHIM AC, V73, P5884, DOI 10.1016/j.gca.2009.05.067; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Luck JM, 2005, GEOCHIM COSMOCHIM AC, V69, P5351, DOI 10.1016/j.gca.2005.06.018; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P6103, DOI 10.1016/j.gca.2006.02.030; Moynier F, 2011, GEOCHIM COSMOCHIM AC, V75, P297, DOI 10.1016/j.gca.2010.09.022; Moynier F, 2010, CHEM GEOL, V276, P374, DOI 10.1016/j.chemgeo.2010.07.005; Moynier F, 2009, EARTH PLANET SC LETT, V277, P482, DOI 10.1016/j.epsl.2008.11.020; NEAL CR, 1991, GEOCHIM COSMOCHIM AC, V55, P3037, DOI 10.1016/0016-7037(91)90472-H; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; Spicuzza MJ, 2007, EARTH PLANET SC LETT, V253, P254, DOI 10.1016/j.epsl.2006.10.030; SYMONDS RB, 1987, GEOCHIM COSMOCHIM AC, V51, P2083, DOI 10.1016/0016-7037(87)90258-4; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Warren P.H., 1991, P NIPR S ANTARCTIC M, V4, P91; Wood B J, 2010, Nature, V467, pE6, DOI 10.1038/nature09484; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	33	183	192	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					376	+		10.1038/nature11507	http://dx.doi.org/10.1038/nature11507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075987				2022-12-28	WOS:000309918500040
J	Andrews, J				Andrews, Jeff			Hormonal contraceptives with ethinyl estradiol were associated with increased thrombotic stroke and MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Nashville, TN USA	Vanderbilt University	Andrews, J (corresponding author), Vanderbilt Univ, Nashville, TN USA.							Centers for Disease Control and Prevention, REPR HLTH MAT INF HL	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-9	10.7326/0003-4819-157-8-201210160-02009	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070511				2022-12-28	WOS:000309906000008
J	Cahill, TJ; Nagaratnam, K; Browning, R; Anthony, S; Dwight, J				Cahill, T. J.; Nagaratnam, K.; Browning, R.; Anthony, S.; Dwight, J.			A case of loin pain: a cause close to the heart	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RENAL INFARCTION; MYOCARDIAL-INFARCTION; THROMBUS		[Cahill, T. J.; Browning, R.; Anthony, S.] John Radcliffe Hosp, Dept Radiol, Oxford OX3 9DU, England	University of Oxford	Cahill, TJ (corresponding author), John Radcliffe Hosp, Dept Radiol, Oxford OX3 9DU, England.	thomas.cahill@cardiov.ox.ac.uk		Nagaratnam, Kiruba/0000-0003-1455-2773				ASINGER RW, 1981, NEW ENGL J MED, V305, P297, DOI 10.1056/NEJM198108063050601; BLUM U, 1993, RADIOLOGY, V189, P549, DOI 10.1148/radiology.189.2.8210388; Carey HB, 1999, AM J KIDNEY DIS, V34, P752, DOI 10.1016/S0272-6386(99)70403-8; Cohn PF, 2003, CIRCULATION, V108, P1263, DOI 10.1161/01.CIR.0000088001.59265.EE; Evangelista A, 2004, HEART, V90, P614, DOI 10.1136/hrt.2003.029868; Frost L, 2001, ARCH INTERN MED, V161, P272, DOI 10.1001/archinte.161.2.272; Lip GYH, 1996, POSTGRAD MED J, V72, P731, DOI 10.1136/pgmj.72.854.731; Nasser NJ, 2007, NAT CLIN PRACT NEPHR, V3, P631, DOI 10.1038/ncpneph0624; NICHOLAS GG, 1984, ARCH SURG-CHICAGO, V119, P278; Osherov AB, 2009, AM HEART J, V157, P1074, DOI 10.1016/j.ahj.2009.03.020; OURIEL K, 1987, J VASC SURG, V5, P348, DOI 10.1067/mva.1987.avs0050348; Salam T A, 1993, Ann Vasc Surg, V7, P21, DOI 10.1007/BF02042655; Schmitt R, 2011, QJM-INT J MED, V104, P885, DOI 10.1093/qjmed/hcq200; Zakaria R, 2009, NAT REV UROL, V6, P568, DOI 10.1038/nrurol.2009.176	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2012	345								e6644	10.1136/bmj.e6644	http://dx.doi.org/10.1136/bmj.e6644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WG	23077323				2022-12-28	WOS:000310140600018
J	Deshmukh, S; Roberts, K; Smith, AM				Deshmukh, Sunita; Roberts, Keith; Smith, Andrew M.			Obstructive jaundice and pancreatic disease	BRITISH MEDICAL JOURNAL			English	Editorial Material							AUTOIMMUNE PANCREATITIS		[Deshmukh, Sunita; Roberts, Keith; Smith, Andrew M.] Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Smith, AM (corresponding author), Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	andrewmalvernsmith@me.com						Frulloni L, 2011, WORLD J GASTROENTERO, V17, P2076, DOI 10.3748/wjg.v17.i16.2076; Pezzilli Raffaele, 2011, Case Rep Gastroenterol, V5, P378, DOI 10.1159/000330291; Sadler R, 2011, EUR J GASTROEN HEPAT, V23, P139, DOI 10.1097/MEG.0b013e3283423486; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Zhang LZ, 2010, INT J CLIN EXP PATHO, V3, P491	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 15	2012	345								e6701	10.1136/bmj.e6701	http://dx.doi.org/10.1136/bmj.e6701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024VX	23069596				2022-12-28	WOS:000310139500008
J	Drife, JO				Drife, James Owen			All together now	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 15	2012	345								e6883	10.1136/bmj.e6883	http://dx.doi.org/10.1136/bmj.e6883			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024VX	23069599				2022-12-28	WOS:000310139500006
J	Simpson, JA; Banerjea, A; Howard, J				Simpson, Jonathan Alastair; Banerjea, Ayan; Howard, John			Management of anal fistula	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPHINCTER-SAVING TECHNIQUE; COMPLEX PERIANAL FISTULA; IN-ANO; CROHNS-DISEASE; LIGATION; SETON; MICROBIOLOGY; POPULATION; INFLIXIMAB; SURGERY		[Simpson, Jonathan Alastair; Banerjea, Ayan; Howard, John] Univ Nottingham Hosp, Div Digest Dis, Nottingham NG7 2UH, England	University of Nottingham	Simpson, JA (corresponding author), Univ Nottingham Hosp, Div Digest Dis, Queens Med Ctr Campus, Nottingham NG7 2UH, England.	alastairsimpson@hotmail.com						Atkin GK, 2011, TECH COLOPROCTOL, V15, P143, DOI 10.1007/s10151-011-0676-6; Becker A, 2006, COLORECTAL DIS, V8, P601, DOI 10.1111/j.1463-1318.2006.01025.x; Bleier JIS, 2010, DIS COLON RECTUM, V53, P43, DOI 10.1007/DCR.0b013e3181bb869f; Bokhari I, 2008, JCPSP-J COLL PHYSICI, V18, P401, DOI 06.2008/JCPSP.401403; CHRISTENSEN A, 1986, DIS COLON RECTUM, V29, P454, DOI 10.1007/BF02561583; Donoghue HD, 2009, CURR OPIN INFECT DIS, V22, P490, DOI 10.1097/QCO.0b013e3283306712; Faucheron JL, 1996, DIS COLON RECTUM, V39, P208, DOI 10.1007/BF02068077; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; GRACE RH, 1982, BRIT J SURG, V69, P401, DOI 10.1002/bjs.1800690715; Halligan S, 2006, RADIOLOGY, V239, P18, DOI 10.1148/radiol.2391041043; Hammond TM, 2006, COLORECTAL DIS, V8, P328, DOI 10.1111/j.1463-1318.2005.00926.x; HELLERS G, 1980, GUT, V21, P525, DOI 10.1136/gut.21.6.525; Jacob TJ, 2010, COCHRANE DB SYST REV, V5; Malik AI, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006827.pub2; MEISLIN HW, 1978, JACEP-J AM COLL EMER, V7, P186, DOI 10.1016/S0361-1124(78)80097-5; O'Riordan JM, 2012, DIS COLON RECTUM, V55, P351, DOI 10.1097/DCR.0b013e318239d1e4; Ortiz H, 2000, BRIT J SURG, V87, P1680, DOI 10.1046/j.1365-2168.2000.01582.x; PARKS AG, 1976, BRIT J SURG, V63, P1, DOI 10.1002/bjs.1800630102; Rojanasakul Arun, 2007, Journal of the Medical Association of Thailand, V90, P581; SAINIO P, 1984, ANN CHIR GYNAECOL FE, V73, P219; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2006, ALIMENT PHARM THERAP, V23, P1127, DOI 10.1111/j.1365-2036.2006.02878.x; Sentovich SM, 2001, J GASTROINTEST SURG, V5, P158, DOI 10.1016/S1091-255X(01)80028-7; Shanwani A, 2010, DIS COLON RECTUM, V53, P39, DOI 10.1007/DCR.0b013e3181c160c4; Shawki S, 2011, WORLD J GASTROENTERO, V17, P3277, DOI 10.3748/wjg.v17.i28.3277; Siddiqui MRS, 2012, DIS COLON RECTUM, V55, P576, DOI 10.1097/DCR.0b013e318249d26c; Sileri P, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-120; Tang LY, 2006, CLIN GASTROENTEROL H, V4, P1130, DOI 10.1016/j.cgh.2006.06.021; Taxonera C, 2009, WORLD J GASTROENTERO, V15, P4263, DOI 10.3748/wjg.15.4263; Toyonaga T, 2007, INT J COLORECTAL DIS, V22, P209, DOI 10.1007/s00384-006-0121-x; Tyler KM, 2007, DIS COLON RECTUM, V50, P1535, DOI 10.1007/s10350-007-9002-9; van der Hagen SJ, 2006, INT J COLORECTAL DIS, V21, P784, DOI 10.1007/s00384-005-0072-7; Whitfford MH, 2005, DIS COLON RECTUM, V48, P1337, DOI 10.1007/s10350-005-0055-3; Wijekoon NS, 2010, COLORECTAL DIS, V12, P94, DOI 10.1111/j.1463-1318.2008.01698.x; Zanotti C, 2007, INT J COLORECTAL DIS, V22, P1459, DOI 10.1007/s00384-007-0334-7	35	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2012	345								e6705	10.1136/bmj.e6705	http://dx.doi.org/10.1136/bmj.e6705			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024VX	23069597				2022-12-28	WOS:000310139500005
J	Fialko, Y; Pearse, J				Fialko, Yuri; Pearse, Jill			Sombrero Uplift Above the Altiplano-Puna Magma Body: Evidence of a Ballooning Mid-Crustal Diapir	SCIENCE			English	Article							LONG-VALLEY CALDERA; ELASTIC HALF-SPACE; CENTRAL ANDES; NEW-MEXICO; RADAR INTERFEROMETRY; VOLCANO GEODESY; DEFORMATION; CALIFORNIA; SOCORRO; INTRUSION	The Altiplano-Puna ultralow-velocity zone in the central Andes, South America, is the largest active magma body in Earth's continental crust. Space geodetic observations reported an uplift in the Altiplano-Puna proper at a rate of similar to 10 mm/year; however, the nature of the inferred inflation source has been uncertain. We present data showing that the uplift has persisted at a nearly constant rate over the past two decades, and is surrounded by a broad zone of subsidence. We show that the ongoing uplift and peripheral subsidence may result from a large mid-crustal diapir fed by partial melt from the Altiplano-Puna Magma Body.	[Fialko, Yuri; Pearse, Jill] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Fialko, Y (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	yfialko@ucsd.edu	Fialko, Yuri/B-9567-2012	Fialko, Yuri/0000-0002-6161-8467; Pearse, Jill/0000-0002-7805-2244	NSF [EAR-0944336]	NSF(National Science Foundation (NSF))	Supported by NSF grant EAR-0944336. SAR data are available from the European Space Agency (eopi.esa.int).	AKE JP, 1988, B SEISMOL SOC AM, V78, P1335; Allmendinger RW, 1997, ANNU REV EARTH PL SC, V25, P139, DOI 10.1146/annurev.earth.25.1.139; Amelung F, 2000, NATURE, V407, P993, DOI 10.1038/35039604; [Anonymous], 2012, ABAQUS SIMULIA GEN P, V6.11; Chang WL, 2007, SCIENCE, V318, P952, DOI 10.1126/science.1146842; Chmielowski J, 1999, GEOPHYS RES LETT, V26, P783, DOI 10.1029/1999GL900078; CLEMENS JD, 1992, TECTONOPHYSICS, V204, P339, DOI 10.1016/0040-1951(92)90316-X; DESILVA SL, 1989, GEOLOGY, V17, P1102, DOI 10.1130/0091-7613(1989)017<1102:APVCOT>2.3.CO;2; DIETERICH JH, 1975, J GEOPHYS RES, V80, P4094, DOI 10.1029/JB080i029p04094; Dvorak JJ, 1997, REV GEOPHYS, V35, P343, DOI 10.1029/97RG00070; Fialko Y, 2001, GEOPHYS J INT, V146, P191, DOI 10.1046/j.1365-246X.2001.00453.x; Fialko Y, 2001, GEOPHYS J INT, V146, P181, DOI 10.1046/j.1365-246X.2001.00452.x; Fialko Y, 2000, J GEOPHYS RES-SOL EA, V105, P21781, DOI 10.1029/2000JB900169; LANGBEIN J, 1993, J GEOPHYS RES-SOL EA, V98, P15851, DOI 10.1029/93JB00558; LANGBEIN J, 1995, J GEOPHYS RES-SOL EA, V100, P12487, DOI 10.1029/95JB01052; LARSEN S, 1986, J GEOPHYS RES-SOLID, V91, P6283, DOI 10.1029/JB091iB06p06283; Lundgren P, 2001, J GEOPHYS RES-SOL EA, V106, P19355, DOI 10.1029/2001JB000194; MARSH BD, 1982, AM J SCI, V282, P808, DOI 10.2475/ajs.282.6.808; Pearse J, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006592; Petford N, 2000, NATURE, V408, P669, DOI 10.1038/35047000; Pritchard ME, 2002, NATURE, V418, P167, DOI 10.1038/nature00872; REILINGER R, 1980, GEOLOGY, V8, P291, DOI 10.1130/0091-7613(1980)8<291:NMOCDO>2.0.CO;2; RUBIN AM, 1995, J GEOPHYS RES-SOL EA, V100, P5911, DOI 10.1029/94JB02942; Sparks RSJ, 2008, AM J SCI, V308, P727, DOI 10.2475/06.2008.01; WEINBERG RF, 1994, J GEOPHYS RES-SOL EA, V99, P9543, DOI 10.1029/93JB03461; YANG XM, 1988, J GEOPHYS RES-SOLID, V93, P4249, DOI 10.1029/JB093iB05p04249; Zandt G, 2003, PURE APPL GEOPHYS, V160, P789, DOI 10.1007/PL00012557	27	65	65	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					250	252		10.1126/science.1226358	http://dx.doi.org/10.1126/science.1226358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066078				2022-12-28	WOS:000309712300044
J	Huxley, RR; Woodward, M				Huxley, Rachel R.; Woodward, Mark			Full hazards of smoking and benefits of stopping for women	LANCET			English	Editorial Material							HEART-DISEASE; MORTALITY		[Huxley, Rachel R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Huxley, Rachel R.; Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	University of Minnesota System; University of Minnesota Twin Cities; George Institute for Global Health; University of Sydney; Johns Hopkins University	Huxley, RR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.	rhuxley@umn.edu	Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017; Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Woodward, Mark/0000-0001-9800-5296				[Anonymous], SMOKING HLTH REPORT; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; Doll R, 1994, MORTALITY SMOKING DE; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Green J, 2012, LANCET; Guindon GE, 2003, 6 WORLD BANK; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Martiniuk ALC, 2006, TOB CONTROL, V15, P181, DOI 10.1136/tc.2005.013284; Peto R, 2010, BIOGR MEMS FELL R SO, V56, P63; Wald N, 1991, UK SMOKING STAT; *WHO, 2007, GEND TOB CONTR POL B; WOODWARD M, 1991, J CLIN EPIDEMIOL, V44, P1405, DOI 10.1016/0895-4356(91)90101-E; World Health Organization, 2008, WHO REP GLOB TOB EP	15	7	7	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					96	98		10.1016/S0140-6736(12)61780-2	http://dx.doi.org/10.1016/S0140-6736(12)61780-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069FO	23107253				2022-12-28	WOS:000313420900007
J	Levesque, BG; Sandborn, WJ				Levesque, Barrett G.; Sandborn, William J.			Infliximab versus ciclosporin in severe ulcerative colitis	LANCET			English	Editorial Material							INTRAVENOUS CYCLOSPORINE; THERAPY; INDUCTION		[Levesque, Barrett G.; Sandborn, William J.] Univ Calif San Diego, Div Gastroenterol, Ctr Inflammatory Bowel Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, Ctr Inflammatory Bowel Dis, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu	Sandborn, William/ABE-8342-2020					Arts J, 2004, INFLAMM BOWEL DIS, V10, P73, DOI 10.1097/00054725-200403000-00002; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Kevans D, 2012, GASTROENTEROLOGY, V142, pS384; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Laharie D, 2012, LANCET; LICHTIGER S, 1990, LANCET, V336, P16, DOI 10.1016/0140-6736(90)91521-B; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Reinisch W, 2012, GASTROENTEROLOGY, V142, pS114; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2010, GUT, V59, P1485, DOI 10.1136/gut.2009.205443; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; TRUELOVE SC, 1974, LANCET, V1, P1067; Van Assche G, 2003, GASTROENTEROLOGY, V125, P1025, DOI 10.1016/S0016-5085(03)01214-9	14	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1887	1888		10.1016/S0140-6736(12)61259-8	http://dx.doi.org/10.1016/S0140-6736(12)61259-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23063315				2022-12-28	WOS:000311758500006
J	Killian, NJ; Jutras, MJ; Buffalo, EA				Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.			A map of visual space in the primate entorhinal cortex	NATURE			English	Article							SPATIAL REPRESENTATION SYSTEM; MONKEY HIPPOCAMPAL-NEURONS; GRID CELLS; THETA OSCILLATIONS; MACAQUE HIPPOCAMPUS; MEMORY; PLACE; ORGANIZATION; PERIODICITY; NAVIGATION	Place-modulated activity among neurons in the hippocampal formation presents a means to organize contextual information in the service of memory formation and recall(1,2). One particular spatial representation, that of grid cells, has been observed in the entorhinal cortex (EC) of rats and bats(3-5), but has yet to be described in single units in primates. Here we examined spatial representations in the EC of head-fixed monkeys performing a free-viewing visual memory task(6,7). Individual neurons were identified in the primate EC that emitted action potentials when the monkey fixated multiple discrete locations in the visual field in each of many sequentially presented complex images. These firing fields possessed spatial periodicity similar to a triangular tiling with a corresponding well-defined hexagonal structure in the spatial auto-correlation. Further, these neurons showed theta-band oscillatory activity and changing spatial scale as a function of distance from the rhinal sulcus, which is consistent with previous findings in rodents(4,8-10). These spatial representations may provide a framework to anchor the encoding of stimulus content in a complex visual scene. Together, our results provide a direct demonstration of grid cells in the primate and suggest that EC neurons encode space during visual exploration, even without locomotion.	[Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Killian, Nathaniel J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Buffalo, Elizabeth A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Buffalo, EA (corresponding author), Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	elizabeth.buffalo@emory.edu	Killian, Nathaniel/B-1914-2013	Killian, Nathaniel/0000-0002-4546-0516	National Institute of Mental Health [R01MH093807, R01MH080007, MH082559]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NSF IGERT program [DGE-0333411]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093807, F31MH082559, R01MH080007] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NSF IGERT program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Potter, C. Erickson, J. Manns, M. Meister and K. Dunne for comments on the manuscript, and M. Tompkins and D. Solyst for assistance with experiments. This project was funded by the National Institute of Mental Health, R01MH093807 (E.A.B.), R01MH080007 (E.A.B.), MH082559 (M.J.J.), the National Center for Research Resources P51RR165, and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. N.J.K. was supported by the NSF IGERT program (DGE-0333411).	Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; TAMURA R, 1992, HIPPOCAMPUS, V2, P307, DOI 10.1002/hipo.450020309; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	30	243	249	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					761	764		10.1038/nature11587	http://dx.doi.org/10.1038/nature11587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103863	Green Accepted			2022-12-28	WOS:000311606000046
J	Dumusque, X; Pepe, F; Lovis, C; Segransan, D; Sahlmann, J; Benz, W; Bouchy, F; Mayor, M; Queloz, D; Santos, N; Udry, S				Dumusque, Xavier; Pepe, Francesco; Lovis, Christophe; Segransan, Damien; Sahlmann, Johannes; Benz, Willy; Bouchy, Francois; Mayor, Michel; Queloz, Didier; Santos, Nuno; Udry, Stephane			An Earth-mass planet orbiting alpha Centauri B	NATURE			English	Article							SOLAR-LIKE OSCILLATIONS; LINE ASYMMETRIES; HABITABLE ZONE; STARS; ROTATION; SEARCH; DWARF; I.	Exoplanets down to the size of Earth have been found, but not in the habitable zone-that is, at a distance from the parent star at which water, if present, would be liquid. There are planets in the habitable zone of stars cooler than our Sun, but for reasons such as tidal locking and strong stellar activity, they are unlikely to harbour water-carbon life as we know it. The detection of a habitable Earth-mass planet orbiting a star similar to our Sun is extremely difficult, because such a signal is overwhelmed by stellar perturbations. Here we report the detection of an Earth-mass planet orbiting our neighbour star alpha Centauri B, a member of the closest stellar system to the Sun. The planet has an orbital period of 3.236 days and is about 0.04 astronomical units from the star (one astronomical unit is the Earth-Sun distance).	[Dumusque, Xavier; Pepe, Francesco; Lovis, Christophe; Segransan, Damien; Sahlmann, Johannes; Bouchy, Francois; Mayor, Michel; Queloz, Didier; Udry, Stephane] Univ Geneva, Observ Geneve, CH-1290 Sauverny, Switzerland; [Dumusque, Xavier; Santos, Nuno] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [Benz, Willy] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Bouchy, Francois] Univ Paris 06, CNRS, Inst Astrophys Paris, UMR7095, F-75014 Paris, France; [Santos, Nuno] Univ Porto, Fac Ciencias, Dept Fis & Astron, P-4169007 Oporto, Portugal	University of Geneva; Universidade do Porto; University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universidade do Porto	Dumusque, X (corresponding author), Univ Geneva, Observ Geneve, 51 Chemin Maillettes, CH-1290 Sauverny, Switzerland.	xavier.dumusque@unige.ch; francesco.pepe@unige.ch	Santos, Nuno C/E-9957-2011	Santos, Nuno C/0000-0003-4422-2919; Bouchy, Francois/0000-0002-7613-393X; udry, Stephane/0000-0001-7576-6236	European Research Council/European Community [239953]; Fundacao para a Ciencia e a Tecnologia (FCT); FCT/MCTES (Portugal); POPH/FSE (EC);  [PTDC/CTE-AST/098528/2008];  [PTDC/CTE-AST/098604/2008]	European Research Council/European Community(European CommissionEuropean Research Council (ERC)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT/MCTES (Portugal)(Portuguese Foundation for Science and Technology); POPH/FSE (EC)(European CommissionEuropean Commission Joint Research CentreEuropean Social Fund (ESF)); ; 	The data presented here were obtained with the ESO 3.6-m telescope at La Silla Paranal Observatory, Chile. We thank the Swiss National Science Foundation (FNRS) for continuous support. We thank R. Mardeling for English revision. N.S. and X. D. acknowledge support by the European Research Council/European Community under FP7 through Starting Grant agreement number 239953, as well as from Fundacao para a Ciencia e a Tecnologia (FCT) through programme Ciencia 2007 funded by FCT/MCTES (Portugal) and POPH/FSE (EC), and in the form of grants PTDC/CTE-AST/098528/2008 and PTDC/CTE-AST/098604/2008.	Barnes JR, 2005, MON NOT R ASTRON SOC, V357, pL1, DOI 10.1111/j.1745-3933.2005.08587.x; BECKERS JM, 1978, SOL PHYS, V58, P243, DOI 10.1007/BF00157270; Boisse I, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014354; Bonfils X., ASTRON ASTROPH UNPUB; BRANDT PN, 1990, ASTRON ASTROPHYS, V231, P221; Carrier F, 2003, ASTRON ASTROPHYS, V406, pL23, DOI 10.1051/0004-6361:20030856; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Del Moro D, 2004, ASTRON ASTROPHYS, V428, P1007, DOI 10.1051/0004-6361:20040466; DeWarf LE, 2010, ASTROPHYS J, V722, P343, DOI 10.1088/0004-637X/722/1/343; DRAVINS D, 1986, ASTRON ASTROPHYS, V158, P83; Dravins D., 1985, IAU C, V88, P311; Dumusque X, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015877; Dumusque X, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014097; Fuhrmann K, 2011, MON NOT R ASTRON SOC, V411, P2311, DOI 10.1111/j.1365-2966.2010.17850.x; Gray D. F, 1992, OBSERVATION ANAL STE; Gray DF, 2009, ASTROPHYS J, V697, P1032, DOI 10.1088/0004-637X/697/2/1032; Howard R., 2000, ENCY ASTRONOMY ASTRO, P3173; KAISIG M, 1982, ASTRON ASTROPHYS, V116, P332; Kervella P, 2003, ASTRON ASTROPHYS, V404, P1087, DOI 10.1051/0004-6361:20030570; Kjeldsen H, 2005, ASTROPHYS J, V635, P1281, DOI 10.1086/497530; Latham DW, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/2/L24; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; LIVINGSTON WC, 1982, NATURE, V297, P208, DOI 10.1038/297208a0; Lovis C, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015577; Lovis C., 2011, ASTRON ASTROPH UNPUB; Mayor M, 2011, ASTRON ASTROPH UNPUB; Meunier N, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913551; Mordasini C, 2009, ASTRON ASTROPHYS, V501, P1161, DOI 10.1051/0004-6361/200810697; NeuforgeVerheecke C, 1997, ASTRON ASTROPHYS, V328, P261; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Pourbaix D, 2002, ASTRON ASTROPHYS, V386, P280, DOI 10.1051/0004-6361:20020287; Santos NC, 2005, ASTRON ASTROPHYS, V437, P1127, DOI 10.1051/0004-6361:20052895; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Thebault P, 2009, MON NOT R ASTRON SOC, V393, pL21, DOI 10.1111/j.1745-3933.2008.00590.x; TITLE AM, 1989, ASTROPHYS J, V336, P475, DOI 10.1086/167026; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; Wolszczan A., 2010, EXOPLANETS, P175; Xie JW, 2010, ASTROPHYS J, V708, P1566, DOI 10.1088/0004-637X/708/2/1566; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296	41	296	299	4	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					207	211		10.1038/nature11572	http://dx.doi.org/10.1038/nature11572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23075844				2022-12-28	WOS:000310774300034
J	Huber, S; Gagliani, N; Zenewicz, LA; Huber, FJ; Bosurgi, L; Hu, B; Hedl, M; Zhang, W; O'Connor, W; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Booth, CJ; Cho, JH; Ouyang, WJ; Abraham, C; Flavell, RA				Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Huber, Francis J.; Bosurgi, Lidia; Hu, Bo; Hedl, Matija; Zhang, Wei; O'Connor, William, Jr.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Booth, Carmen J.; Cho, Judy H.; Ouyang, Wenjun; Abraham, Clara; Flavell, Richard A.			IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine	NATURE			English	Article							SODIUM-INDUCED COLITIS; BINDING-PROTEIN; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTERLEUKIN 22; T-CELLS; IMMUNITY; SULFATE; CLONING; INNATE	Chronic mucosal inflammation and tissue damage predisposes patients to the development of colorectal cancer(1). This association could be explained by the hypothesis that the same factors and pathways important for wound healing also promote tumorigenesis. A sensor of tissue damage should induce these factors to promote tissue repair and regulate their action to prevent development of cancer. Interleukin 22 (IL-22), a cytokine of the IL-10 superfamily, has an important role in colonic epithelial cell repair, and its levels are increased in the blood and intestine of inflammatory bowel disease patients(2,3). This cytokine can be neutralized by the soluble IL-22 receptor, known as the IL-22 binding protein (IL-22BP, also known as IL22RA2); however, the significance of endogenous IL-22BP in vivo and the pathways that regulate this receptor are unknown(4,5). Here we describe that IL-22BP has a crucial role in controlling tumorigenesis and epithelial cell proliferation in the colon. IL-22BP is highly expressed by dendritic cells in the colon in steady-state conditions. Sensing of intestinal tissue damage via the NLRP3 or NLRP6 inflammasomes led to an IL-18-dependent downregulation of IL-22BP, thereby increasing the ratio of IL-22/IL-22BP. IL-22, which is induced during intestinal tissue damage, exerted protective properties during the peak of damage, but promoted tumour development if uncontrolled during the recovery phase. Thus, the IL-22-IL-22BP axis critically regulates intestinal tissue repair and tumorigenesis in the colon.	[Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Bosurgi, Lidia; Hu, Bo; O'Connor, William, Jr.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Huber, Samuel; Huber, Francis J.] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Hedl, Matija; Abraham, Clara] Yale Univ, Sect Digest Dis, Dept Internal Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, Sect Digest Dis, New Haven, CT 06520 USA; [Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; Yale University; Yale University; Regeneron; Yale University; Roche Holding; Genentech; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	shuber@uke.de; richard.flavell@yale.edu	Ouyang, Wenjun/ABA-8763-2020	Bosurgi, Lidia/0000-0002-8775-4950; Zenewicz, Lauren/0000-0002-8787-5955; Ouyang, Wenjun/0000-0002-1811-5864; Gagliani, Nicola/0000-0001-8514-1395; Huber, Samuel/0000-0001-9325-8227; Murphy, Andrew/0000-0003-4152-4081	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO; American Cancer Society; DFG [SFB841];  [R01DK077905];  [DK-P30-34989];  [U19-AI082713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK077905] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO(European Molecular Biology Organization (EMBO)); American Cancer Society(American Cancer Society); DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert administrative assistance, E. Eynon and J. Alderman for managing the mouse program. We also thank T. Taylor and G. Tokmoulina for expert help with the FACS sorting. R. A. F. is an Investigator of the Howard Hughes Medical Institute. S. H. was supported by a post-doctoral fellowship from the Crohn's and Colitis Foundation of America, the 'Stiftung experimentelle Biomedizin' and the Ernst Jung Foundation. N.G. was supported by an EMBO post-doctoral fellowship. L.A.Z. was supported by a post-doctoral fellowship from the American Cancer Society. A. J. M., D. M. V. and G.D.Y. were employees of Regeneron Pharmaceuticals at the time this work was performed. W.O. is an employee of Genentech Inc. This work was supported by R01DK077905, DK-P30-34989 and U19-AI082713 (to C. A. and R. A. F.) and by the DFG, SFB841 (to S.H.).	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wei CC, 2003, GENES IMMUN, V4, P204, DOI 10.1038/sj.gene.6363947; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	35	508	534	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					259	+		10.1038/nature11535	http://dx.doi.org/10.1038/nature11535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23075849	Green Accepted			2022-12-28	WOS:000310774300045
J	Pariser, DM; Meinking, TL; Bell, M; Ryan, WG				Pariser, David M.; Meinking, Terri Lynn; Bell, Margie; Ryan, William G.			Topical 0.5% Ivermectin Lotion for Treatment of Head Lice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL IVERMECTIN; BODY LICE; PEDICULOSIS; CAPITIS; PEDICULIDAE; MALATHION; ANOPLURA; EFFICACY	Background The emergence of resistance to treatment complicates the public health problem of head-louse infestations and drives the need for continuing development of new treatments. There are limited data on the activity of ivermectin as a topical lousicide. Methods In two multisite, randomized, double-blind studies, we compared a single application of 0.5% ivermectin lotion with vehicle control for the elimination of infestations without nit combing in patients 6 months of age or older. A tube of topical ivermectin or vehicle control was dispensed on day 1, to be applied to dry hair, left for 10 minutes, then rinsed with water. The primary end point was the percentage of index patients (youngest household member with >= 3 live lice) in the intention-to-treat population who were louse-free 1 day after treatment (day 2) and remained so through days 8 and 15. Results A total of 765 patients completed the studies. In the intention-to-treat population, significantly more patients receiving ivermectin than patients receiving vehicle control were louse-free on day 2 (94.9% vs. 31.3%), day 8 (85.2% vs. 20.8%), and day 15 (73.8% vs. 17.6%) (P<0.001 for each comparison). The frequency and severity of adverse events were similar in the two groups. Conclusions A single, 10-minute, at-home application of ivermectin was more effective than vehicle control in eliminating head-louse infestations at 1, 7, and 14 days after treatment. (Funded by Topaz Pharmaceuticals [now Sanofi Pasteur]; ClinicalTrials.gov numbers, NCT01066585 and NCT01068158.)	[Pariser, David M.] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA 23501 USA; [Meinking, Terri Lynn] Global Hlth Assoc Miami, Coral Gables, FL USA; [Bell, Margie] Clin Data Serv, Ft Collins, CO USA; [Ryan, William G.] Ryan Mitchell Associates, Westfield, NJ USA	Eastern Virginia Medical School	Ryan, WG (corresponding author), 16 Stoneleigh Pk, Westfield, NJ 07090 USA.	wgryan@yahoo.com			Topaz Pharmaceuticals; Sanofi Pasteur	Topaz Pharmaceuticals; Sanofi Pasteur	Ms. Bell reports receiving consulting fees from Topaz Pharmaceuticals and Sanofi Pasteur. Dr. Ryan reports being a former employee of Topaz Pharmaceuticals, receiving consulting fees and stock or stock options from Topaz Pharmaceuticals, and receiving consulting fees and payment for manuscript preparation from Sanofi Pasteur. No other potential conflict of interest relevant to this article was reported.	Chosidow O, 2010, NEW ENGL J MED, V362, P896, DOI 10.1056/NEJMoa0905471; Colatrella B, 2008, ANN TROP MED PARASIT, V102, P7, DOI 10.1179/136485908X337418; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Foucault C, 2006, J INFECT DIS, V193, P474, DOI 10.1086/499279; Frankowski BL, 2002, PEDIATRICS, V110, P638; Gordon Shirley C, 2007, J Sch Nurs, V23, P283; Halpert OE, 1998, 8 INT C PED DERM PAR; Hazan L, 2010, 36 ANN M SOC PED DER; Ko CJ, 2004, J AM ACAD DERMATOL, V50, P1, DOI 10.1016/S0190-9622(03)02729-4; Meinking T, 2011, PEDIAT DERMATOLOGY, P1535; Meinking TL, 2007, PEDIATR DERMATOL, V24, P405, DOI 10.1111/j.1525-1470.2007.00460.x; Meinking TL, 2010, PEDIATR DERMATOL, V27, P19, DOI 10.1111/j.1525-1470.2009.01059.x; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; Moreno Y, 2010, P NATL ACAD SCI USA, V107, P20120, DOI 10.1073/pnas.1011983107; Stough D, 2009, PEDIATRICS, V124, pE389, DOI 10.1542/peds.2008-3762; Strycharz JP, 2008, J MED ENTOMOL, V45, P75, DOI 10.1603/0022-2585(2008)45[75:ANIFTK]2.0.CO;2; Strycharz JP, 2011, J MED ENTOMOL, V48, P1174, DOI 10.1603/ME11051; Yoon KS, 2011, INSECT MOL BIOL, V20, P687, DOI 10.1111/j.1365-2583.2011.01097.x; Yoon KS, 2003, ARCH DERMATOL, V139, P994, DOI 10.1001/archderm.139.8.994; Youssef MYM, 1995, AM J TROP MED HYG, V53, P652, DOI 10.4269/ajtmh.1995.53.652	20	58	62	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1687	1693		10.1056/NEJMoa1200107	http://dx.doi.org/10.1056/NEJMoa1200107			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113480				2022-12-28	WOS:000310440800005
J	Moynihan, R				Moynihan, Ray			Too much medicine, not enough mirth	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], ONION; [Anonymous], 2002, BMJ, V324; Gotzsche PC, 2002, BRIT MED J, V324, P890; Lenzer J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6230; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Payer L, 2006, DIS MONGERS DOCTORS; Schwarz A., 2012, NY TIMES	9	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7116	10.1136/bmj.e7116	http://dx.doi.org/10.1136/bmj.e7116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114064				2022-12-28	WOS:000310778900009
J	Beets, I; Janssen, T; Meelkop, E; Temmerman, L; Suetens, N; Rademakers, S; Jansen, G; Schoofs, L				Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Rademakers, Suzanne; Jansen, Gert; Schoofs, Liliane			Vasopressin/Oxytocin-Related Signaling Regulates Gustatory Associative Learning in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXYTOCIN RECEPTORS; IDENTIFICATION; PLASTICITY; MOTIVATION; SEROTONIN; DOPAMINE; CUES	Vasopressin- and oxytocin-related neuropeptides are key regulators of animal physiology, including water balance and reproduction. Although these neuropeptides also modulate social behavior and cognition in mammals, the mechanism for influencing behavioral plasticity and the evolutionary origin of these effects are not well understood. Here, we present a functional vasopressin- and oxytocin-like signaling system in the nematode Caenorhabditis elegans. Through activation of its receptor NTR-1, a vasopressin/oxytocin-related neuropeptide, designated nematocin, facilitates the experience-driven modulation of salt chemotaxis, a type of gustatory associative learning in C. elegans. Our study suggests that vasopressin and oxytocin neuropeptides have ancient roles in modulating sensory processing in neural circuits that underlie behavioral plasticity.	[Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Schoofs, Liliane] Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium; [Rademakers, Suzanne; Jansen, Gert] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands	KU Leuven; Erasmus University Rotterdam; Erasmus MC	Schoofs, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium.	liliane.schoofs@bio.kuleuven.be	Meelkop, Ellen/G-3052-2012; Beets, Isabel/I-6386-2012; Janssen, Tom/AAC-1849-2020; schoofs, liliane/ABD-2943-2020; Jansen, Gert/HCI-8852-2022; Schoofs, Liliane/F-2815-2010	Beets, Isabel/0000-0002-0968-4360; Schoofs, Liliane/0000-0002-1673-432X; Jansen, Gert/0000-0002-7524-171X; Temmerman, Liesbet/0000-0002-1249-3995	Fund for Scientific Research-Flanders (FWO); KU Leuven Faculty Research Fund; KU Leuven [GOA/11/002]; FWO [G.0767.09, G.0601.11]	Fund for Scientific Research-Flanders (FWO)(FWO); KU Leuven Faculty Research Fund; KU Leuven(KU Leuven); FWO(FWO)	We thank the Caenorhabditis Genetics Center, S. Mitani, C. Bargmann, and M. Alkema for strains and reagents; L. Vanden Bosch, M. Vanhove, and W. De Haes for technical assistance. I.B., T.J., and L.T. benefit from the Fund for Scientific Research-Flanders (FWO) and E.M. from the KU Leuven Faculty Research Fund. This work was supported by the KU Leuven concerted research grant GOA/11/002 and FWO grants G.0767.09 and G.0601.11. GenBank accession numbers of ntc-1, ntr-1, and ntr-2 sequences are JQ277480, JQ277731, and JQ277479. Strains carrying the tm2385, tm2765, and tm2243 alleles are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement.	Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; CULOTTI JG, 1978, GENETICS, V90, P243; DEWIED D, 1993, FRONT NEUROENDOCRIN, V14, P251, DOI 10.1006/frne.1993.1009; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Izquierdo A, 2012, BEHAV BRAIN RES, V233, P494, DOI 10.1016/j.bbr.2012.05.032; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Janssen T, 2010, ANN NY ACAD SCI, V1200, P1, DOI 10.1111/j.1749-6632.2010.05506.x; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Orcel H, 2009, MOL PHARMACOL, V75, P637, DOI 10.1124/mol.108.049031; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SCHUMACHER M, 1990, SCIENCE, V250, P691, DOI 10.1126/science.2173139; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; VANKESTEREN RE, 1995, NEURON, V15, P897, DOI 10.1016/0896-6273(95)90180-9; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	20	114	117	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					543	545		10.1126/science.1226860	http://dx.doi.org/10.1126/science.1226860			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112336	Green Accepted			2022-12-28	WOS:000310195800062
J	O'Neill, LAJ				O'Neill, Luke A. J.			"Transflammation": When Innate Immunity Meets Induced Pluripotency	CELL			English	Editorial Material							DOUBLE-STRANDED-RNA; STEM-CELLS; INDUCTION; ADAPTER	A surprising link between innate immunity and nuclear reprogramming is reported by Lee et al.; this discovery may boost the efficiency of stem cell production.	Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Pearse St, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	10	9	9	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					471	473		10.1016/j.cell.2012.10.006	http://dx.doi.org/10.1016/j.cell.2012.10.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101619	Bronze			2022-12-28	WOS:000310529300004
J	Elqatni, M; Ghafir, D				Elqatni, Mohamed; Ghafir, Driss			Hibernoma of the Neck	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Elqatni, Mohamed; Ghafir, Driss] Mohammed V Mil Teaching Hosp, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Elqatni, M (corresponding author), Mohammed V Mil Teaching Hosp, Rabat, Morocco.	elqatni@yahoo.fr							0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1636	1636		10.1056/NEJMicm1106191	http://dx.doi.org/10.1056/NEJMicm1106191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094725				2022-12-28	WOS:000310131700010
J	Cohen, D				Cohen, Deborah			EU approval system leaves door open for dangerous devices	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.							Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905	1	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7173	10.1136/bmj.e7173	http://dx.doi.org/10.1136/bmj.e7173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097554				2022-12-28	WOS:000310427600023
J	Kratz, JR; Van den Eeden, SK; He, JX; Jablons, DM; Mann, MJ				Kratz, Johannes R.; Van den Eeden, Stephen K.; He, Jianxing; Jablons, David M.; Mann, Michael J.			A Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CANCER		[Kratz, Johannes R.; Jablons, David M.; Mann, Michael J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Van den Eeden, Stephen K.] No Calif Kaiser Permanente, Dept Res, Oakland, CA USA; [He, Jianxing] Guangzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Francisco; Kaiser Permanente; Guangzhou Medical University	Kratz, JR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	michael.mann@ucsfmedctr.org		Kratz, Johannes R/0000-0003-0696-4073; He, Jianxing/0000-0003-1737-8192				Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	6	23	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1629	1631		10.1001/jama.2012.13551	http://dx.doi.org/10.1001/jama.2012.13551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093159				2022-12-28	WOS:000310434100013
J	Samarasekera, E; Sawyer, L; Parnham, J; Smith, CH				Samarasekera, Eleanor; Sawyer, Laura; Parnham, Jill; Smith, Catherine H.		Guideline Dev Grp	Assessment and management of psoriasis: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTHRITIS; PEOPLE; RISK		[Smith, Catherine H.] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London SE1 7EH, England; [Samarasekera, Eleanor; Sawyer, Laura; Parnham, Jill] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Smith, CH (corresponding author), Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London SE1 7EH, England.	catherine.smith@kcl.ac.uk	Smith, Catherine H./G-5268-2012	Smith, Catherine H./0000-0001-9918-1144; Wonderling, David/0000-0003-0315-6273	Department of Health Funding Source: Medline	Department of Health		Ahlehoff O, 2011, DAN MED BULL, V58; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; Eedy DJ, 2009, BRIT J DERMATOL, V160, P557, DOI 10.1111/j.1365-2133.2008.08987.x; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Ibrahim GH, 2009, CLIN EXP RHEUMATOL, V27, P469; Kurd SK, 2010, ARCH DERMATOL, V146, P891, DOI 10.1001/archdermatol.2010.186; National Collaborating Centre for Primary Care, 2008, CARD RISK ASS MOD BL; National Collaborating Centre for Primary Care National Institute for Health and Clinical Excellence, 2009, MED ADH INV PAT DEC; National Institute for Health and Clinical Excellence, 2012, PSOR MAN PSOR; NHS Scotland, PHOT NAT MAN CLIN NE; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Schofield J., 2009, SKIN CONDITIONS UK H; Spuls PI, 2010, J INVEST DERMATOL, V130, P933, DOI 10.1038/jid.2009.391	14	65	66	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e6712	10.1136/bmj.e6712	http://dx.doi.org/10.1136/bmj.e6712			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MY	23097521				2022-12-28	WOS:000310427600020
J	Smith, M; Halvorson, G; Kaplan, G				Smith, Mark; Halvorson, George; Kaplan, Gary			What's Needed Is a Health Care System That Learns Recommendations From an IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; MEDICARE		[Smith, Mark] Calif HealthCare Fdn, Oakland, CA USA; [Halvorson, George] Kaiser Permanente, Oakland, CA USA; [Kaplan, Gary] Virginia Mason Hlth Syst, Seattle, WA USA	Kaiser Permanente; Virginia Mason Medical Center	Smith, M (corresponding author), Calif HealthCare Fdn, 1438 Webster St,Ste 400, Oakland, CA USA.	msmith@chcf.org						Anderson G, 2010, CHRONIC CARE MAKING; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Donchin Y, 2003, QUAL SAF HEALTH CARE, V12, P143, DOI 10.1136/qhc.12.2.143; *I MED, 1999, ERR IS HUM BUILD SAF; Institute of Medicine, 2012, BEST CAR LOW COST PA; Keehan SP, 2011, HEALTH AFFAIR, V30, P1594, DOI 10.1377/hlthaff.2011.0662; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Yarnall KSH, 2009, PREV CHRONIC DIS, V6	9	22	22	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1637	1638		10.1001/jama.2012.13664	http://dx.doi.org/10.1001/jama.2012.13664			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093161				2022-12-28	WOS:000310434100016
J	Edler, J				Edler, Jakob			Toward Variable Funding for International Science	SCIENCE			English	Editorial Material									Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England	University of Manchester	Edler, J (corresponding author), Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England.	jakob.edler@mbs.ac.uk		Edler, Jakob/0000-0003-0938-1244				Amanatidou E., 2010, ERA NETS STAGE 2010; Boekholt P., 2009, DRIVERS INT COLLABOR; EC Commission, 2008, OP WORLD INT COOP SC; Edler J., 2010, REV HUMAN FRONTIER S; Edler J., 2011, 6 INT COOP R D INT A; Georghiou L, 1998, RES POLICY, V27, P611, DOI 10.1016/S0048-7333(98)00054-7; Glanzel W., 2008, P WIS 2008 BERL 4 IN; Horvat M., 2006, ERA NET REV; IEA (International Energy Agency), 2010, EN TECHN IN IMPL MUL; Laredo P., 2007, WORKSH DICH NAT VS E; Lepori B., 2011, SCI TECHN INN IND C; LEWISON G, 1991, SCIENTOMETRICS, V21, P223, DOI 10.1007/BF02017570; Nielsen K. S., 2011, WORKSH CONT ERA NET; OECD, 2010, MEASURING INNOVATION; OECD, 2012, M GLOB CHALL BETT GO; WHO, 2010, RES DEV COORD FIN RE	16	6	8	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					331	332		10.1126/science.1221970	http://dx.doi.org/10.1126/science.1221970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022JS	23087233				2022-12-28	WOS:000309955800024
J	Carroll, MD; Kit, BK; Lacher, DA; Shero, ST; Mussolino, ME				Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.; Shero, Susan T.; Mussolino, Michael E.			Trends in Lipids and Lipoproteins in US Adults, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES ADULTS; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; NATIONAL-HEALTH; PREVALENCE; PLASMA; RISK; OBESITY	Context Serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) contribute to atherosclerosis and its clinical consequences. Between the periods 1988-1994 and 1999-2002, mean TC and mean LDL-C declined in adults. During this time, there was an increase in the percentage of adults receiving lipid-lowering medications. Geometric mean triglyceride levels increased but mean high-density lipoprotein cholesterol (HDL-C) remained unchanged. Objective To examine trends in serum lipids in adults between 1988 and 2010. Design, Setting, and Participants Three distinct US cross-sectional National Health and Nutrition Examination Surveys, 1988-1994 (n=16 573), 1999-2002 (n=9471), and 2007-2010 (n=11 766). Main Outcome Measures Mean TC, LDL-C, HDL-C, non-HDL-C, and geometric mean triglyceride levels and the prevalence of lipid-lowering medication use. Results Mean TC declined from 206 (95% CI, 205-207) mg/dL in 1988-1994 to 196 (95% CI, 195-198) mg/dL in 2007-2010 (P<.001 for linear trend); mean LDL-C declined from 129 (95% CI, 127-130) mg/dL to 116 (95% CI, 114-117) mg/dL (P<.001 for linear trend). Mean non-HDL-C declined from 155 (95% CI, 153-157) mg/dL in 1988-1994 to 144 (95% CI, 143-145) mg/dL in 2007-2010 (P<.001 for linear trend). Mean HDL-C increased from 50.7 (95% CI, 50.0-51.0) mg/dL during 1988-1994 to 52.5 (95% CI, 51.8-53.2) mg/dL in 2007-2010 (P=.001 for linear trend). Geometric mean serum triglyceride levels increased from 118 (95% CI, 114-121) mg/dL in 1988-1994 to 123 (95% CI, 119-127) mg/dL in 1999-2002 and decreased to 110 (95% CI, 107-113) mg/dL in 2007-2010 (P<.001 for quadratic trend). The prevalence of lipid-lowering medication use increased from 3.4% (95% CI, 2.9%-3.9%) in 1988-1994 to 15.5% (95% CI, 14.7%-16.3%) in 2007-2010 (P<.001 for linear trend). Among adults not receiving lipid-lowering medications, trends in lipids were similar to those reported for adults overall. Among obese adults, mean TC, non-HDL-C, LDL-C, and geometric mean triglycerides declined between 1988 and 2010. Conclusion Between 1988 and 2010, favorable trends in lipid levels have occurred among adults in the United States. JAMA. 2012;308(15):1545-1554 www.jama.com	[Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, Hyattsville, MD 20782 USA; [Shero, Susan T.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD USA; [Mussolino, Michael E.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Carroll, MD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	mdc3@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of lipids was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (intra-agency agreement Y1-HC-8039).	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], EARL REL SEL EST BAS; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 1998, EUR HEART J, V19, pA2; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BACHORIK PS, 1984, CLIN CHEM, V30, P839; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention/Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; Centers for Disease Control and Prevention/National Center for Health Statistic, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TOT CHO; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Ferrieres J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleiss JL., 2003, STAT METHODS RATES P; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULWOOD R, 1987, JAMA-J AM MED ASSOC, V257, P937; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Klein RJ, 2010, AGE ADJUSTMENT USING; National Center for Health Statistics, NAT HLTH NUTR EX SUR; National Heart Lung and Blood Institute Division of blood diseases and resources, 2002, NIH PUBL; Physical Activity Guidelines Advisory Committee, 2008, 12009 PHYS ACT GUID; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wiefeld A, 1974, METHODS ENZYMATIC AN; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winer B.J., 1962, STAT PRINCIPLES EXPT; Wolters KM, 1985, INTRO VARIANCE ESTIM; Wright Jacqueline D, 2010, NCHS Data Brief, P1	38	181	191	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1545	1554		10.1001/jama.2012.13260	http://dx.doi.org/10.1001/jama.2012.13260			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073951				2022-12-28	WOS:000309858100021
J	Fisher, C; Freris, N				Fisher, Caroline; Freris, Nicole			Neuromuscular degeneration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Freris, Nicole] Islington Cent Med Ctr, London N1 1SW, England			c.fisher256@btinternet.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 17	2012	345								e6880	10.1136/bmj.e6880	http://dx.doi.org/10.1136/bmj.e6880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077352	Bronze, Green Submitted			2022-12-28	WOS:000310141900006
J	Wolff, JL				Wolff, Jennifer L.			Family Matters in Health Care Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wolff, JL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 692, Baltimore, MD 21205 USA.	jwolff@jhsph.edu			NIMH NIH HHS [K01MH082885] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH082885] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abadir PM, 2011, J AM GERIATR SOC, V59, P2337, DOI 10.1111/j.1532-5415.2011.03700.x; Cella D, 2012, METHODOLOGICAL ISSUE; Congressional Budget Office, 2004, FINANCING LONG TERM; Institute of Medicine, 2008, RETOOLING FOR AN AGI; LOEB JM, 1993, JAMA-J AM MED ASSOC, V269, P1282; National Priorities Partnership, 2011, PRIORITIES FOR THE N; Wolff JL, 2011, SOC SCI MED, V72, P823, DOI 10.1016/j.socscimed.2011.01.015; Zulman DM, 2011, ANN INTERN MED, V155, P805, DOI 10.7326/0003-4819-155-12-201112200-00002	8	31	31	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1529	1530		10.1001/jama.2012.13366	http://dx.doi.org/10.1001/jama.2012.13366			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073948				2022-12-28	WOS:000309858100017
J	Ginn, S				Ginn, Stephen			Elderly prisoners	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		BMJ, London WC1H 9JR, England		Ginn, S (corresponding author), BMJ, London WC1H 9JR, England.	mail@stephenginn.com						[Anonymous], 2003, TIMES; [Anonymous], 2004, NO PROBL OLD QUIET; [Anonymous], 2008, HM CHIEF INSPECTOR P; Crawley E., 2007, HDB PRISONS, P224; Crawley E., 2005, PRISON SERVICE J, V160; Dochherty LJ, HEALTHCARE CHALLENGE; Fazel S, 2001, AGE AGEING, V30, P403, DOI 10.1093/ageing/30.5.403; Fazel S, 2001, BRIT J PSYCHIAT, V179, P535, DOI 10.1192/bjp.179.6.535; Hayes AJ, 2012, INT J GERIATR PSYCH, V27, P1155, DOI 10.1002/gps.3761; Human Rights Watch, 2012, OLD BEH BARS AG PRIS; Independent Monitoring Board, ANN REP HMP DARTM 20; Manns N, 2012, DOING HARDER TIME; Ministry of Justice, 2012, OFF MAN CAS STAT 201; Philips J., 2006, AGEING CRIME SOC, P53; Prison Reform Trust, 2012, BROML BRIEF PRIS FAC; Prison Reform Trust, 2008, DOING TIM EXP NEEDS; Secretary of State for Health, 2012, CAR OUR FUT REF CAR; Wahadin A, 2010, OLDER WOMEN PRISON I; Wahidin A., 2004, OLDER WOMEN CRIMINAL; Wahidin A, 2011, SAGE HDB SOCIAL GERO, P587; Williams J., 2012, J SOC WORK      0221	21	27	27	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2012	345								e6263	10.1136/bmj.e6263	http://dx.doi.org/10.1136/bmj.e6263			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024VX	23069595				2022-12-28	WOS:000310139500004
J	Munoz, J; Guo, Y				Munoz, Javier; Guo, Yue			Familial History of Bone Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEREDITARY MULTIPLE EXOSTOSES; OSTEOCHONDROMA		[Munoz, Javier; Guo, Yue] Henry Ford Hosp, Dept Hematol & Oncol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Munoz, J (corresponding author), Henry Ford Hosp, Dept Hematol & Oncol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	javier.munoz@me.com						Ezra N, 2010, AM J MED GENET A, V152A, P1264, DOI 10.1002/ajmg.a.33345; Khan I, 2010, J VASC SURG, V51, P1003, DOI 10.1016/j.jvs.2009.10.123; KRIEG JC, 1995, J BONE JOINT SURG AM, V77A, P269, DOI 10.2106/00004623-199502000-00015; Murphey MD, 2000, RADIOGRAPHICS, V20, P1407, DOI 10.1148/radiographics.20.5.g00se171407; Pannier S, 2008, BEST PRACT RES CL RH, V22, P45, DOI 10.1016/j.berh.2007.12.004	5	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1476	1477		10.1001/jama.2012.12909	http://dx.doi.org/10.1001/jama.2012.12909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047362				2022-12-28	WOS:000309579300027
J	Hallan, SI; Matsushita, K; Sang, YY; Mahmoodi, BK; Black, C; Ishani, A; Kleefstra, N; Naimark, D; Roderick, P; Tonelli, M; Wetzels, JFM; Astor, BC; Gansevoort, RT; Levin, A; Wen, CP; Coresh, J				Hallan, Stein I.; Matsushita, Kunihiro; Sang, Yingying; Mahmoodi, Bakhtawar K.; Black, Corri; Ishani, Areef; Kleefstra, Nanne; Naimark, David; Roderick, Paul; Tonelli, Marcello; Wetzels, Jack F. M.; Astor, Brad C.; Gansevoort, Ron T.; Levin, Adeera; Wen, Chi-Pang; Coresh, Josef		Chronic Kidney Dis Prognosis Conso	Age and Association of Kidney Measures With Mortality and End-stage Renal Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; URINARY ALBUMIN EXCRETION; CARDIOVASCULAR RISK; COLLABORATIVE METAANALYSIS; OLDER-ADULTS; CYSTATIN C; OUTCOMES; POPULATION; PROGRESSION	Context Chronic kidney disease (CKD) is prevalent in older individuals, but the risk implications of low estimated glomerular filtration rate (eGFR) and high albuminuria across the full age range are controversial. Objective To evaluate possible effect modification (interaction) by age of the association of eGFR and albuminuria with clinical risk, examining both relative and absolute risks. Design, Setting, and Participants Individual-level meta-analysis including 2 051 244 participants from 33 general population or high-risk (of vascular disease) cohorts and 13 CKD cohorts from Asia, Australasia, Europe, and North/South America, conducted in 1972-2011 with a mean follow-up time of 5.8 years (range, 0-31 years). Main Outcome Measures Hazard ratios (HRs) of mortality and end-stage renal disease (ESRD) according to eGFR and albuminuria were meta-analyzed across age categories after adjusting for sex, race, cardiovascular disease, diabetes, systolic blood pressure, cholesterol, body mass index, and smoking. Absolute risks were estimated using HRs and average incidence rates. Results Mortality (112 325 deaths) and ESRD (8411 events) risks were higher at lower eGFR and higher albuminuria in every age category. In general and high-risk cohorts, relative mortality risk for reduced eGFR decreased with increasing age; eg, adjusted HRs at an eGFR of 45 mL/min/1.73 m(2) vs 80 mL/min/1.73 m(2) were 3.50 (95% CI, 2.55-4.81), 2.21 (95% CI, 2.02-2.41), 1.59 (95% CI, 1.42-1.77), and 1.35 (95% CI, 1.23-1.48) in age categories 18-54, 55-64, 65-74, and >= 75 years, respectively (P < .05 for age interaction). Absolute risk differences for the same comparisons were higher at older age (9.0 [95% CI, 6.0-12.8], 12.2 [95% CI, 10.3-14.3], 13.3 [95% CI, 9.0-18.6], and 27.2 [95% CI, 13.5-45.5] excess deaths per 1000 person-years, respectively). For increased albuminuria, reduction of relative risk with increasing age was less evident, while differences in absolute risk were higher in older age categories (7.5 [95% CI, 4.3-11.9], 12.2 [95% CI, 7.9-17.6], 22.7 [95% CI, 15.3-31.6], and 34.3 [95% CI, 19.5-52.4] excess deaths per 1000 person-years, respectively by age category, at an albumin-creatinine ratio of 300 mg/g vs 10 mg/g). In CKD cohorts, adjusted relative hazards of mortality did not decrease with age. In all cohorts, ESRD relative risks and absolute risk differences at lower eGFR or higher albuminuria were comparable across age categories. Conclusions Both low eGFR and high albuminuria were independently associated with mortality and ESRD regardless of age across a wide range of populations. Mortality showed lower relative risk but higher absolute risk differences at older age.	[Hallan, Stein I.] Norwegian Univ Sci & Technol, Div Nephrol, Dept Med, St Olav Univ Hosp, N-7034 Trondheim, Norway; [Hallan, Stein I.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Fac Med, St Olav Univ Hosp, N-7034 Trondheim, Norway; [Matsushita, Kunihiro; Sang, Yingying; Mahmoodi, Bakhtawar K.; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mahmoodi, Bakhtawar K.; Gansevoort, Ron T.] Univ Groningen, Dept Nephrol, Univ Med Ctr Groningen, Groningen, Netherlands; [Black, Corri] Univ Aberdeen, Aberdeen Appl Renal Res Collaborat, Div Appl Hlth Sci, Aberdeen, Scotland; [Ishani, Areef] Minneapolis VAMC, Ctr Epidemiol & Clin Res, Minneapolis, MN USA; [Ishani, Areef] Univ Minnesota, Minneapolis, MN USA; [Kleefstra, Nanne] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Kleefstra, Nanne] Langerhans Med Res Fdn, Zwolle, Netherlands; [Kleefstra, Nanne] Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Naimark, David] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Roderick, Paul] Univ Southampton, Southampton, Hants, England; [Roderick, Paul] Southampton Univ Hosp, Southampton, Hants, England; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Dept Nephrol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Astor, Brad C.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Astor, Brad C.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Levin, Adeera] Univ British Columbia, Dept Med, St Pauls Hosp, Vancouver, BC, Canada; [Wen, Chi-Pang] Natl Hlth Res Inst, Inst Populat Sci, Zhunan, Taiwan; [Wen, Chi-Pang] China Med Univ Hosp, Taichung, Taiwan	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Groningen; University of Aberdeen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Isala Clinics; Langerhans Medical Research Group; University of Groningen; University of Toronto; University of Southampton; University of Southampton; University of Alberta; Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium Data Coordi, 615 N Wolfe St, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Bello, Aminu K/D-2213-2013; Matsushita, Kunihiro/AAJ-5817-2020; Kikuya, Masahiro/X-5662-2018; Wetzels, Jack F.M./A-1720-2014; Schöttker, Ben/F-8183-2014; de Zeeuw, Dick/E-9080-2014; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Mahmoodi, Bakhtawar/ABA-7050-2020; Kronenberg, Florian/B-1736-2008; Brenner, Hermann/ABE-6383-2020; Marks, Angharad/H-5657-2019; Tonelli, Marcello/B-3028-2009; Matsushita, Kunihiro/B-1021-2018; Brenner, Hermann/B-4627-2017; Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Kikuya, Masahiro/0000-0002-3080-6107; Wetzels, Jack F.M./0000-0002-0650-6921; Schöttker, Ben/0000-0002-1217-4521; de Zeeuw, Dick/0000-0003-3434-7777; Kronenberg, Florian/0000-0003-2229-1120; Brenner, Hermann/0000-0002-6129-1572; Marks, Angharad/0000-0003-1910-462X; Tonelli, Marcello/0000-0002-0846-3187; Matsushita, Kunihiro/0000-0002-7179-718X; Brenner, Hermann/0000-0002-6129-1572; Stengel, Benedicte/0000-0001-9469-0804; Woodward, Mark/0000-0001-9800-5296; Townend, Jonathan/0000-0002-5881-5806; Emberson, Jonathan/0000-0001-7792-9422; Klein, Ronald/0000-0002-4428-6237; rossing, peter/0000-0002-1531-4294; Sairenchi, Toshimi/0000-0001-8896-6501; Rothenbacher, Dietrich/0000-0002-3563-2791; Froissart, Marc/0000-0002-4010-3173; Prescott, Gordon/0000-0002-9156-2361; Metzger, Marie/0000-0003-3597-5409; Kleefstra, Nanne/0000-0003-1473-8519; Naimark, David Malcolm Joseph/0000-0002-0621-0637	National Kidney Foundation (NKF); Amgen; National Institutes of Health; Netherlands Organization for Scientific Research; Dutch Kidney Foundation; CKD-PC/KDIGO; NKF/CKD-PC; College of Physicians and Surgeons of Newfoundland and Labrador; Kidney Research UK; Johns Hopkins University; Pfizer; Sanofi-Genzyme; Otsuka; Bayer; Baxter; Abbott; Roche; Taiwan Department of Public Health Clinical Trial and Research Center of Exellence; Merck; US National Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC025195, N01HC035129, N01HC095169, N01HC045133, N01HC085086, N01HC095159, N01HC015103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140, R01HL080295, R01HL043232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002904, R01DK073217, K23DK067303, R01DK031801, U01DK035073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028507, R01AG023629, R01AG015928, R01AG027058, R01AG007181, R01AG020098] Funding Source: NIH RePORTER; Chief Scientist Office [CZH/4/656] Funding Source: researchfish	National Kidney Foundation (NKF); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; CKD-PC/KDIGO; NKF/CKD-PC; College of Physicians and Surgeons of Newfoundland and Labrador; Kidney Research UK(Kidney Research UK (KRUK)); Johns Hopkins University(Johns Hopkins University); Pfizer(Pfizer); Sanofi-Genzyme(Sanofi-AventisGenzyme Corporation); Otsuka(Otsuka Pharmaceutical); Bayer(Bayer AG); Baxter; Abbott(Abbott Laboratories); Roche(Roche Holding); Taiwan Department of Public Health Clinical Trial and Research Center of Exellence; Merck(Merck & Company); US National Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chief Scientist Office	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Matsushita reports receiving grant support to his institution from the National Kidney Foundation (NKF) and Amgen and to him from the National Institutes of Health; Dr Mahmoodi, grant support from the Netherlands Organization for Scientific Research and the Dutch Kidney Foundation; Dr Black, grant support to her institution from CKD-PC/KDIGO; Dr Ishani, travel support from the NKF; Dr Naimark, a stipend for data analysis from the NKF/CKD-PC and payment for expert testimony from the College of Physicians and Surgeons of Newfoundland and Labrador; Dr Roderick, grant support to his institution from Kidney Research UK, Dr Tonelli, grant support to his institution from Johns Hopkins University; Dr Wetzels, grant support to his institution from Amgen, Pfizer, and Sanofi-Genzyme; Dr Gansevoort, grants and consultancy/lecture fees to his institution from Otsuka, Bayer, Amgen, Baxter, Abbott, and Roche and payment to him for educational materials or travel expenses from Roche, Amgen, and Bayer; Dr Wen, grant support to his institution from the Taiwan Department of Public Health Clinical Trial and Research Center of Exellence; and Dr Coresh, grant support to his institution from the NKF and Amgen and payment to him for consultancy fees from Amgen and Merck. No other disclosures were reported.; The CKD-PC Data Coordinating Center is funded in part by a program grant from the US National Kidney Foundation (National Kidney Foundation funding sources include Abbott and Amgen). A variety of sources have supported enrollment and data collection including laboratory measurements and follow-up in the collaborating cohorts of the CKD-PC. These funding sources include government agencies such as national institutes of health and medical research councils as well as foundations and industry sponsors listed in eAppendix 3.	Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Bilo HJG, 2009, DIABETIC MED, V26, P478, DOI 10.1111/j.1464-5491.2009.02709.x; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Bui AL, 2009, AM J KIDNEY DIS, V53, P389, DOI 10.1053/j.ajkd.2008.06.025; Cao JJ, 2008, ATHEROSCLEROSIS, V197, P806, DOI 10.1016/j.atherosclerosis.2007.07.029; Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; Conway B, 2009, NEPHROL DIAL TRANSPL, V24, P1930, DOI 10.1093/ndt/gfn772; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P41, DOI 10.1093/ndt/gfr669; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2011, KIDNEY INT, V79, P99, DOI 10.1038/ki.2010.291; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gansevoort RT, 2009, J AM SOC NEPHROL, V20, P465, DOI 10.1681/ASN.2008111212; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2007, HYPERTENS RES, V30, P55, DOI 10.1291/hypres.30.55; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Ito H, 2011, AM J EPIDEMIOL, V174, P949, DOI 10.1093/aje/kwr185; Jafar TH, 2009, NEPHROL DIAL TRANSPL, V24, P2111, DOI 10.1093/ndt/gfp042; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Jorsal A, 2008, KIDNEY INT, V74, P649, DOI 10.1038/ki.2008.201; Jurkovitz CT, 2008, AM J KIDNEY DIS, V51, pS3, DOI 10.1053/j.ajkd.2007.12.022; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kilbride HS, 2013, AM J KIDNEY DIS, V61, P57, DOI 10.1053/j.ajkd.2012.06.016; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Landray MJ, 2001, AM J KIDNEY DIS, V38, P537, DOI 10.1053/ajkd.2001.26850; Lee BJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2395; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Marks A, 2012, NEPHROL DIAL TRANSPL, V27, P65, DOI 10.1093/ndt/gfr746; Martin-Ponce E, 2010, CLIN NUTR, V29, P501, DOI 10.1016/j.clnu.2009.12.009; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Mitsuhashi H, 2009, CIRC J, V73, P667, DOI 10.1253/circj.CJ-08-0626; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Muntner P, 2011, CLIN J AM SOC NEPHRO, V6, P2200, DOI 10.2215/CJN.02030311; Nakayama M, 2007, NEPHROL DIAL TRANSPL, V22, P1910, DOI 10.1093/ndt/gfm051; National Institute for Health and Clinical Excellence, 2008, CLIN GUID 73 CHRON K; Noda H, 2009, CIRCULATION, V119, P2136, DOI 10.1161/CIRCULATIONAHA.108.795666; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2010, ARCH INTERN MED, V170, P930, DOI 10.1001/archinternmed.2010.129; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pavkov ME, 2008, AM J KIDNEY DIS, V51, P759, DOI 10.1053/j.ajkd.2008.01.011; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Poggio ED, 2009, NEPHROL DIAL TRANSPL, V24, P698, DOI 10.1093/ndt/gfn704; Prakash S, 2009, SEMIN NEPHROL, V29, P497, DOI 10.1016/j.semnephrol.2009.06.006; Rifkin DE, 2010, NEPHROL DIAL TRANSPL, V25, P1560, DOI 10.1093/ndt/gfp646; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Shimizu Y, 2011, STROKE, V42, P2531, DOI 10.1161/STROKEAHA.110.600759; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Van Pottelbergh G, 2012, NEPHROL DIAL TRANSPL, V27, P2297, DOI 10.1093/ndt/gfr659; van Zuilen AD, 2011, NETH J MED, V69, P517; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	86	399	410	2	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2349	2360		10.1001/jama.2012.16817	http://dx.doi.org/10.1001/jama.2012.16817			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23111824	Bronze, Green Accepted			2022-12-28	WOS:000312132400025
J	Mello, MM; Cohen, IG				Mello, Michelle M.; Cohen, I. Glenn			The Taxing Power and the Public's Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				[Anonymous], 2012, STAT CIG EXC TAX RAT; Mariner WK, 2012, NEW ENGL J MED, V367, P1154, DOI 10.1056/NEJMhle1208437	2	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1777	1779		10.1056/NEJMp1209648	http://dx.doi.org/10.1056/NEJMp1209648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23075142				2022-12-28	WOS:000310773200003
J	Yoshizaki, A; Miyagaki, T; DiLillo, DJ; Matsushita, T; Horikawa, M; Kountikov, EI; Spolski, R; Poe, JC; Leonard, WJ; Tedder, TF				Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Spolski, Rosanne; Poe, Jonathan C.; Leonard, Warren J.; Tedder, Thomas F.			Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions	NATURE			English	Article							B10 CELLS; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; CUTTING EDGE; PLASMA-CELLS; HUMAN CD19; MEMORY B; IN-VIVO; IL-21; IL-10	B cells regulate immune responses by producing antigen-specific antibodies(1). However, specific B-cell subsets can also negatively regulate T-cell immune responses, and have been termed regulatory B cells(2-4). Human and mouse regulatory B cells (B10 cells) with the ability to express the inhibitory cytokine interleukin-10 (IL-10) have been identified(2-5). Although rare, B10 cells are potent negative regulators of antigen-specific inflammation and T-cell-dependent autoimmune diseases in mice(5-7). How B10-cell IL-10 production and regulation of antigen-specific immune responses are controlled in vivo without inducing systemic immunosuppression is unknown. Using a mouse model for multiple sclerosis, here we show that B10-cell maturation into functional IL-10-secreting effector cells that inhibit in vivo autoimmune disease requires IL-21 and CD40-dependent cognate interactions with T cells. Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease. The ex vivo expansion and reinfusion of autologous B10 cells may provide a novel and effective in vivo treatment for severe autoimmune diseases that are resistant to current therapies.	[Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Poe, Jonathan C.; Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	thomas.tedder@duke.edu	Matsushita, Takashi/C-4750-2015; Yoshizaki, Ayumi/AAN-1548-2021; Miyagaki, Tomomitsu/AFP-0003-2022; Leonard, Warren/AAA-1397-2022	Matsushita, Takashi/0000-0002-1617-086X; Yoshizaki, Ayumi/0000-0002-8194-9140; Poe, Jonathan/0000-0002-7789-1564	National Institutes of Health (NIH) [AI56363, AI057157]; Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, U19AI056363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Maseda, E. Weimer, J. Bryant, K. Candando and G. Venturi for help and comments. These studies were supported by grants from the National Institutes of Health (NIH; AI56363 and AI057157), the Lymphoma Research Foundation, and the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH.	Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2011, IMMUNOL REV, V240, P52, DOI 10.1111/j.1600-065X.2010.00991.x; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Tedder T. F., 1995, LEUCOCYTE TYPING 5, V1, P483; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	37	463	491	6	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					264	+		10.1038/nature11501	http://dx.doi.org/10.1038/nature11501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064231	Green Accepted			2022-12-28	WOS:000310774300046
J	Chen, CE; Dhruva, SS; Redberg, RF				Chen, Connie E.; Dhruva, Sanket S.; Redberg, Rita F.			Inclusion of Comparative Effectiveness Data in High-Risk Cardiovascular Device Studies at the Time of Premarket Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chen, Connie E.] Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA; [Dhruva, Sanket S.] Univ Calif Davis, Div Cardiovasc Med, Davis, CA 95616 USA; [Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA	Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco	Chen, CE (corresponding author), Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA.	redberg@medicine.ucsf.edu						Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Food and Drug Administration, DET SAF EFF 860 7 VA; Food and Drug Administration, FDA SUMM SAF EFF DAT; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539	4	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1740	1742		10.1001/jama.2012.14491	http://dx.doi.org/10.1001/jama.2012.14491			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117769	Bronze			2022-12-28	WOS:000310726500015
J	Aronin, N; Moore, M				Aronin, Neil; Moore, Melissa			Hunting Down Huntingtin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, Neurotherapeut Inst, Worcester, MA USA; [Moore, Melissa] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Aronin, N (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.				HHMI Funding Source: Medline	HHMI(Howard Hughes Medical Institute)		Bhide PG, 1996, J NEUROSCI, V16, P5523; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	5	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1753	1754		10.1056/NEJMcibr1209595	http://dx.doi.org/10.1056/NEJMcibr1209595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113488				2022-12-28	WOS:000310440800015
J	Gill, RJ; Ramos-Rodriguez, O; Raine, NE				Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.			Combined pesticide exposure severely affects individual- and colony-level traits in bees	NATURE			English	Article							HONEY-BEES; RISK-ASSESSMENT; SYSTEMIC INSECTICIDES; HYMENOPTERA APIDAE; BOMBUS-TERRESTRIS; FORAGING SUCCESS; APIS-MELLIFERA; POLLINATORS; MITICIDES; TOXICITY	Reported widespread declines of wild and managed insect pollinators have serious consequences for global ecosystem services and agricultural production(1-3). Bees contribute approximately 80% of insect pollination, so it is important to understand and mitigate the causes of current declines in bee populations(4-6). Recent studies have implicated the role of pesticides in these declines, as exposure to these chemicals has been associated with changes in bee behaviour(7-11) and reductions in colony queen production(12). However, the key link between changes in individual behaviour and the consequent impact at the colony level has not been shown. Social bee colonies depend on the collective performance of many individual workers. Thus, although field-level pesticide concentrations can have subtle or sublethal effects at the individual level(8), it is not known whether bee societies can buffer such effects or whether it results in a severe cumulative effect at the colony level. Furthermore, widespread agricultural intensification means that bees are exposed to numerous pesticides when foraging(13-15), yet the possible combinatorial effects of pesticide exposure have rarely been investigated(16,17). Here we show that chronic exposure of bumblebees to two pesticides (neonicotinoid and pyrethroid) at concentrations that could approximate field-level exposure impairs natural foraging behaviour and increases worker mortality leading to significant reductions in brood development and colony success. We found that worker foraging performance, particularly pollen collecting efficiency, was significantly reduced with observed knock-on effects for forager recruitment, worker losses and overall worker productivity. Moreover, we provide evidence that combinatorial exposure to pesticides increases the propensity of colonies to fail.	[Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Gill, RJ (corresponding author), Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	richard.gill@rhul.ac.uk; nigel.raine@rhul.ac.uk	Raine, Nigel/AAK-6425-2020	Raine, Nigel/0000-0001-6343-2829; Gill, Richard/0000-0001-9389-1284	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA); Natural Environment Research Council (NERC) [BB/I000178/1]; Biotechnology and Biological Sciences Research Council [BB/I000178/1] Funding Source: researchfish; BBSRC [BB/I000178/1] Funding Source: UKRI	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M.J.F. Brown, M. Clook, J. Culverhouse, A. Dixon, M. Furst, D. Garthwaite, A. Horsell, V. Jansen and I. Pedroso-Rovira for comments and technical assistance, and Syngenta Bioline Bees for supplying colonies. The study was supported by the Insect Pollinator Initiative (funded under the auspices of the Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Scottish Government, Department for Environment, Food and Rural Affairs (DEFRA) and Natural Environment Research Council (NERC): grant BB/I000178/1).	Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Garthwaite D., 2010, 235 FOOD ENV RES AG; Garthwaite DG, 2008, 224 FOOD ENV RES AG; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	40	595	625	26	1176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					105	U119		10.1038/nature11585	http://dx.doi.org/10.1038/nature11585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23086150	Green Accepted			2022-12-28	WOS:000310434500039
J	King, LY; Tucker, JK; Lee, LS; Levy, BD; Loscalzo, J				King, Lindsay Y.; Tucker, J. Kevin; Lee, Linda S.; Levy, Bruce D.; Loscalzo, Joseph			A Complex Cause of Pleuritic Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; INFLAMMATORY-BOWEL-DISEASE; MEMBRANOUS NEPHROPATHY; NEPHROTIC SYNDROME; COMPLICATIONS; MANAGEMENT; RECEPTOR		[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, Harvard Inst Med Bldg,77 Ave Louis Pasteur HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021	Tucker, John Kevin/0000-0002-5831-3320				Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Lewis JB, 2012, HARRISONS PRINCIPLES, P2347; Lindor KD, 2009, HEPATOLOGY, V50, P808, DOI 10.1002/hep.23082; Lionaki S, 2012, CLIN J AM SOC NEPHRO, V7, P43, DOI 10.2215/CJN.04250511; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; Singhal R, 2006, THROMB RES, V118, P397, DOI 10.1016/j.thromres.2005.03.030; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Venkatesh PGK, 2011, J DIGEST DIS, V12, P245, DOI 10.1111/j.1751-2980.2011.00511.x	12	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1742	1748		10.1056/NEJMcps1208614	http://dx.doi.org/10.1056/NEJMcps1208614			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113486				2022-12-28	WOS:000310440800013
J	Bynum, H				Bynum, Helen			Riding the waves: optimism and realism in the treatment of TB	LANCET			English	Editorial Material												helenjbynum@gmail.com						Coker R. J., 2000, CHAOS COERCION DETEN; Condrau F, 2010, MCGILL QUEENS ASSOC, V35, P1; DANIELS M, 1949, BMJ-BRIT MED J, V2, P1135, DOI 10.1136/bmj.2.4637.1135; Gandy M., 2003, RETURN WHITE PLAGUE; Gradman Christoph, 2009, LAB DIS R KOCHS MED; MacDonald B, 1994, PLAGUE I MAIDSTONE G; Rothman S., 1994, INT J HIST SPORT	7	1	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1465	1466		10.1016/S0140-6736(12)61830-3	http://dx.doi.org/10.1016/S0140-6736(12)61830-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026JJ	23115786				2022-12-28	WOS:000310272000014
J	Green, DJ; Alemseged, Z				Green, David J.; Alemseged, Zeresenay			Australopithecus afarensis Scapular Ontogeny, Function, and the Role of Climbing in Human Evolution	SCIENCE			English	Article							HOMININ SHOULDER; CHIMPANZEE; LOCOMOTION; PRIMATE; EMG; ETHIOPIA; BEHAVIOR; MUSCLES; WALKING; ANGLE	Scapular morphology is predictive of locomotor adaptations among primates, but this skeletal element is scarce in the hominin fossil record. Notably, both scapulae of the juvenile Australopithecus afarensis skeleton from Dikika, Ethiopia, have been recovered. These scapulae display several traits characteristic of suspensory apes, as do the few known fragmentary adult australopith representatives. Many of these traits change significantly throughout modern human ontogeny, but remain stable in apes. Thus, the similarity of juvenile and adult fossil morphologies implies that A. afarensis development was apelike. Additionally, changes in other scapular traits throughout African ape development are associated with shifts in locomotor behavior. This affirms the functional relevance of those characteristics, and their presence in australopith fossils supports the hypothesis that their locomotor repertoire included a substantial amount of climbing.	[Green, David J.] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Alemseged, Zeresenay] Calif Acad Sci, Dept Anthropol, San Francisco, CA 94118 USA	Midwestern University; California Academy of Sciences	Green, DJ (corresponding author), Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA.	dgreen1@midwestern.edu			NSF IGERT grant [9987590]; NSF [BCS-0824552, BCS-0914687]; Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	NSF IGERT grant; NSF(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	We thank C. Kiarie and the staff at the National Museum of Ethiopia for help during the preparation of these fragile fossils. We greatly appreciate critical comments offered by B. Richmond, B. Wood, R. Bernstein, M. Hamrick, L.P. Hernandez, and three anonymous reviewers on this manuscript and A. Gordon for analytical assistance. We thank D. Hunt, L. Gordon, E. Westwig, I. Tattersall, G. Garcia, J. Chupasko, M. Omura, Y. Haile-Selassie, L. Jellema, M. Harman, A. Gill, E. Mbua, S. Muteti, M. Yilma, P.V. Tobias, B. Zipfel, S. Potze, and T. Perregil for coordinating museum visits. We also acknowledge the NSF IGERT grant (9987590), NSF Doctoral Dissertation Improvement Grant (BCS-0824552), NSF (BCS-0914687), The Leakey Foundation, the Wenner-Gren Foundation, The George Washington University, Midwestern University, and the California Academy of Sciences for funding support. This paper was written by D.J.G. and Z.A. Fossil data were collected and described by D.J.G. and Z.A. Extant primate data were collected and analyzed by D.J.G. The data reported in this paper are summarized in the supplementary materials; raw data are available on request to D.J.G.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; ASHTON E. H., 1964, PROC ZOOL SOC LONDON, V142, P49; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; Green D. J., 2012, J EXP ZOOL B; Green D. J., 2010, THESIS G WASHINGTON; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Inouye SE, 1997, INT J PRIMATOL, V18, P629, DOI 10.1023/A:1026319424308; LARSON SG, 1986, AM J ANAT, V176, P171, DOI 10.1002/aja.1001760207; LARSON SG, 1995, AM J PHYS ANTHROPOL, V98, P13, DOI 10.1002/ajpa.1330980103; LARSON SG, 1991, AM J PHYS ANTHROPOL, V85, P71, DOI 10.1002/ajpa.1330850109; LARSON SG, 1987, J ZOOL, V212, P629, DOI 10.1111/j.1469-7998.1987.tb05961.x; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Latimer B., 1991, P169; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; MENSFORTH RP, 1990, AM J PHYS ANTHROPOL, V81, P267; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; OXNARD CE, 1967, AM J PHYS ANTHROPOL, V26, P219, DOI 10.1002/ajpa.1330260209; Roberts D., 1974, P171; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; Susman R.L., 1991, P121; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2002, THESIS HARVARD U	30	88	91	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					514	517		10.1126/science.1227123	http://dx.doi.org/10.1126/science.1227123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112331				2022-12-28	WOS:000310195800054
J	Pace, L; Tempez, A; Arnold-Schrauf, C; Lemaitre, F; Bousso, P; Fetler, L; Sparwasser, T; Amigorena, S				Pace, Luigia; Tempez, Andy; Arnold-Schrauf, Catharina; Lemaitre, Fabrice; Bousso, Philippe; Fetler, Luc; Sparwasser, Tim; Amigorena, Sebastian			Regulatory T Cells Increase the Avidity of Primary CD8(+) T Cell Responses and Promote Memory	SCIENCE			English	Article							DENDRITIC CELLS; IN-VIVO; PEPTIDE; REPERTOIRE; ANTIGEN; MHC; SELECTION; IMMUNITY; AUTOIMMUNITY; TOLERANCE	Although regulatory T cells (T-regs) are known to suppress self-reactive autoimmune responses, their role during T cell responses to nonself antigens is not well understood. We show that T-regs play a critical role during the priming of immune responses in mice. T-reg depletion induced the activation and expansion of a population of low-avidity CD8(+) T cells because of overproduction of CCL-3/4/5 chemokines, which stabilized the interactions between antigen-presenting dendritic cells and low-avidity T cells. In the absence of T-regs, the avidity of the primary immune response was impaired, which resulted in reduced memory to Listeria monocytogenes. These results suggest that T-regs are important regulators of the homeostasis of CD8(+) T cell priming and play a critical role in the induction of high-avidity primary responses and effective memory.	[Pace, Luigia; Tempez, Andy; Amigorena, Sebastian] Inst Curie, INSERM, U932, F-75248 Paris 05, France; [Arnold-Schrauf, Catharina; Sparwasser, Tim] TWINCORE, Ctr Expt & Clin Infect Res, Inst Infect Immunol, D-30625 Hannover, Germany; [Lemaitre, Fabrice; Bousso, Philippe] Inst Pasteur, INSERM, U668, Dept Immunol, F-75015 Paris, France; [Fetler, Luc] Inst Curie, CNRS, UMR 168, Lab Physicochim Curie, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center for Infection Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Sparwasser, Tim/AAF-7085-2019; Fetler, luc/M-9034-2018; Sparwasser, Tim D/AAA-4306-2022; BOUSSO, Philippe/M-6547-2014	Sparwasser, Tim/0000-0001-5645-902X; BOUSSO, Philippe/0000-0002-6362-561X; Amigorena, Sebastian/0000-0001-8583-8416	Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC [ENCITE, Health-F5-2008-201842, SFB 900]; ARC; Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	Institut Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association de Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); EC(European CommissionEuropean Commission Joint Research Centre); ARC(Australian Research Council); Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	We thank all the U932 and TWINCORE Sparwasser members; D. Raulet, A. Dielmann, P. Paul-Gilloteaux, O. Lantz, and M. Albert; the Nikon Imaging Center and flow cytometry platform; and the animal facilities of Institut Curie and TWINCORE for help with the experiments and helpful discussions. rLM-OVA was kindly provided by H. Shen. This work was supported by funding from the Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC grant ENCITE, Health-F5-2008-201842, SFB 900. L.P. has been supported by ARC, A.T. was a fellow of Ministere de l'Education et de la Recherche. C.A.-S. was supported by the Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine. The authors have no conflicting financial interests. The data are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beltman JB, 2009, J IMMUNOL METHODS, V347, P54, DOI 10.1016/j.jim.2009.05.013; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dal Secco V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007696; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, P NATL ACAD SCI USA, V109, P881, DOI 10.1073/pnas.1119763109; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Morlacchi S, 2011, J IMMUNOL, V186, P6807, DOI 10.4049/jimmunol.1003265; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	30	102	104	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					532	536		10.1126/science.1227049	http://dx.doi.org/10.1126/science.1227049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112334	Green Submitted			2022-12-28	WOS:000310195800059
J	Donald, A				Donald, Athene			Throw off the cloak of invisibility	NATURE			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Donald, A (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	amd3@cam.ac.uk						Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109	1	4	4	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					447	447		10.1038/490447a	http://dx.doi.org/10.1038/490447a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NK	23099365	Bronze			2022-12-28	WOS:000310196200004
J	Popat, R; Derodra, J; Vig, S; Lim, E				Popat, Ravi; Derodra, Josh; Vig, Stella; Lim, Eric			A sinister cause of shoulder pain, with numbness and weakness in the ipsilateral hand	BRITISH MEDICAL JOURNAL			English	Editorial Material							SULCUS TUMORS; LUNG-CANCER; ASPIRATION; DIAGNOSIS		[Popat, Ravi] London Deanery, London WC1B 5DN, England; [Derodra, Josh; Vig, Stella] Croydon Hlth Serv NHS Trust, Croydon Univ Hosp, Croydon, England; [Lim, Eric] Royal Brompton & Harefield NHS Fdn Trust, London, England	Croydon University Hospital; Royal Brompton & Harefield NHS Foundation Trust	Popat, R (corresponding author), 20 Weston Dr, Stanmore HA7 2EU, Middx, England.	ravipopat@doctors.org.uk		Lim, Eric/0000-0002-9078-3226				Allgar VL, 2005, BRIT J CANCER, V92, P1959, DOI 10.1038/sj.bjc.6602587; Arcasoy SM, 1997, NEW ENGL J MED, V337, P1370, DOI 10.1056/NEJM199711063371907; CAVANAUGH DG, 1993, MIL MED, V158, P577, DOI 10.1093/milmed/158.8.577; Davis GA, 2008, NEUROSURG CLIN N AM, V19, P545, DOI 10.1016/j.nec.2008.07.002; Kumaran M, 2005, THORAX, V60, P229, DOI 10.1136/thx.2004.029223; Lim E, 2010, THORAX, V65, P1, DOI 10.1136/thx.2010.145938; Medford ARL, 2010, RESPIROLOGY, V15, P71, DOI 10.1111/j.1440-1843.2009.01652.x; National Institute for Health and Clinical Excellence, 2011, CG121; Rusch VW, 2007, J CLIN ONCOL, V25, P313, DOI 10.1200/JCO.2006.08.2826; Sculier JP, 2009, EUR RESPIR J, V33, P915, DOI 10.1183/09031936.00132008	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e6948	10.1136/bmj.e6948	http://dx.doi.org/10.1136/bmj.e6948			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MY	23097551				2022-12-28	WOS:000310427600022
J	Schuetz, GM; Schlattmann, P; Dewey, M				Schuetz, Georg M.; Schlattmann, Peter; Dewey, Marc			Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; DUAL-SOURCE CT; HEART-RATE-VARIABILITY; RADIATION-DOSE REDUCTION; SINGLE-CENTER EXPERIENCE; STABLE ANGINA-PECTORIS; AORTIC-VALVE STENOSIS; ARTERY-DISEASE; NONINVASIVE DETECTION; IMAGE QUALITY	Objective To determine whether a 3x2 table, using an intention to diagnose approach, is better than the "classic" 2x2 table at handling transparent reporting and non-evaluable results, when assessing the accuracy of a diagnostic test. Design Based on a systematic search for diagnostic accuracy studies of coronary computed tomography (CT) angiography, full texts of relevant studies were evaluated to determine whether they could calculate an alternative 3x2 table. To quantify an overall effect, we pooled diagnostic accuracy values according to a meta-analytical approach. Data sources Medline (via PubMed), Embase (via Ovid), and ISI Web of Science electronic databases. Eligibility criteria Prospective English or German language studies comparing coronary CT with conventional coronary angiography in all patients and providing sufficient data for a patient level analysis. Results 120 studies (10 287 patients) were eligible. Studies varied greatly in their approaches to handling non-evaluable findings. We found 26 studies (including 2298 patients) that allowed us to calculate both 2x2 tables and 3x2 tables. Using a bivariate random effects model, we compared the 2x2 table with the 3x2 table, and found significant differences for pooled sensitivity (98.2 (95% confidence interval 96.7 to 99.1) v 92.7 (88.5 to 95.3)), area under the curve (0.99 (0.98 to 1.00) v 0.93 (0.91 to 0.95)), positive likelihood ratio (9.1 (6.2 to 13.3) v 4.4 (3.3 to 6.0)), and negative likelihood ratio (0.02 (0.01 to 0.04) v 0.09 (0.06 to 0.15); (P<0.05)). Conclusion Parameters for diagnostic performance significantly decrease if non-evaluable results are included by a 3x2 table for analysis (intention to diagnose approach). This approach provides a more realistic picture of the clinical potential of diagnostic tests.	[Schuetz, Georg M.; Dewey, Marc] Free Univ Berlin, Humboldt Univ, Charite Univ Med, Dept Radiol, D-10117 Berlin, Germany; [Schlattmann, Peter] Univ Jena, Univ Hosp, Dept Med Stat Informat & Documentat, Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Dewey, M (corresponding author), Free Univ Berlin, Humboldt Univ, Charite Univ Med, Dept Radiol, D-10117 Berlin, Germany.	dewey@charite.de		Dewey, Marc/0000-0002-4402-2733	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [FKZ: 01KG1110]; German Science Foundation (DFG); German Federal Ministry of Education and Research (BMBF); DFG [Schl 3-1]; Bayer-Schering; Heisenberg Program of the German Research Foundation (DFG) [DE 1361/14-1]; European Regional Development Fund [20072013 2/05, 20072013 2/48]; German Heart Foundation/German Foundation of Heart Research [F/23/08, F/27/10]; German Federal Ministry of Education and Research (BMBF) for meta-analyses [01KG1013, 01KG1110]; GE Healthcare, Bracco, Guerbet; Toshiba Medical Systems; Cardiac MR Academy Berlin; Bayer (Schering-Berlex)	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Bayer-Schering(Bayer AG); Heisenberg Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); European Regional Development Fund(European Commission); German Heart Foundation/German Foundation of Heart Research; German Federal Ministry of Education and Research (BMBF) for meta-analyses(Federal Ministry of Education & Research (BMBF)); GE Healthcare, Bracco, Guerbet(General ElectricGE Healthcare); Toshiba Medical Systems; Cardiac MR Academy Berlin; Bayer (Schering-Berlex)	This study was supported by a grant of the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF; FKZ: 01KG1110) for meta-analyses as part of the joint programme "clinical trials" of the BMBF and the German Science Foundation (DFG). The supporting organisation had no involvement in the design, conduct, analysis, or manuscript preparation of this study. Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: PS and MD are supported by a grant of the German Federal Ministry of Education and Research (BMBF) for meta-analyses as part of the joint programme "clinical trials" of the BMBF and the German Science Foundation (DFG); PS is also supported by another grant of the (DFG) (Schl 3-1) and has received lecture fees from Bayer-Schering; MD has received grant support from Heisenberg Program of the German Research Foundation (DFG) for a professorship (DE 1361/14-1), European Regional Development Fund (20072013 2/05, 20072013 2/48), German Heart Foundation/German Foundation of Heart Research (F/23/08, F/27/10), a joint programme from the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF) for meta-analyses (01KG1013, 01KG1110), GE Healthcare, Bracco, Guerbet, and Toshiba Medical Systems; MD has received lecture fees from Toshiba Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer (Schering-Berlex); MD is a consultant to Guerbet and one of the principal investigators of multicentre studies (CORE-64 and 320) on coronary CT angiography sponsored by Toshiba Medical Systems; MD is the editor of Coronary CT Angiography and Cardiac CT, both published by Springer, and offers hands-on workshops on cardiovascular imaging; institutional master research agreements for MD exist with Siemens Medical Solutions, Philips Medical Systems, and Toshiba Medical Systems; GMS is a physician working as a research assistant in MD's working group, whose salary is financed by a BMBF grant for meta-analyses granted to MD; no other relationships or activities that could appear to have influenced the submitted work.	Achenbach S, 2005, EUR HEART J, V26, P1978, DOI 10.1093/eurheartj/ehi326; Alkadhi H, 2008, EUR HEART J, V29, P766, DOI 10.1093/eurheartj/ehn044; Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Altman DG, 2010, J ANTIMICROB CHEMOTH, V65, P1, DOI 10.1093/jac/dkp410; Andreini D, 2007, J AM COLL CARDIOL, V49, P2044, DOI 10.1016/j.jacc.2007.01.086; Andreini D, 2009, CIRC-CARDIOVASC IMAG, V2, P199, DOI 10.1161/CIRCIMAGING.108.822809; [Anonymous], 2010, BMJ-BRIT MED J, V340, pc754; Arends LR, 2008, MED DECIS MAKING, V28, P621, DOI 10.1177/0272989X08319957; Bayrak F, 2008, ACTA CARDIOL, V63, P11, DOI 10.2143/AC.63.1.2025326; Bettencourt N, 2009, CIRC-CARDIOVASC IMAG, V2, P306, DOI 10.1161/CIRCIMAGING.108.827717; Bonmassari R, 2006, J CARDIOVASC MED, V7, P817, DOI 10.2459/01.JCM.0000250870.55907.75; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Boulmier D, 2009, ARCH CARDIOVASC DIS, V102, P685, DOI 10.1016/j.acvd.2009.06.004; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Cademartiri F, 2007, RADIOL MED, V112, P969, DOI 10.1007/s11547-007-0198-5; Cademartiri F, 2009, RADIOL MED, V114, P513, DOI 10.1007/s11547-009-0388-4; Cademartiri F, 2010, EUR RADIOL, V20, P81, DOI 10.1007/s00330-009-1529-9; Carrascosa P, 2010, HEART, V96, P1543, DOI 10.1136/hrt.2009.183699; Carrascosa P, 2010, J CARDIOVASC COMPUT, V4, P197, DOI 10.1016/j.jcct.2010.04.001; Carrascosa Patricia, 2007, J Cardiovasc Comput Tomogr, V1, P86, DOI 10.1016/j.jcct.2007.06.003; Chow BJW, 2007, CAN J CARDIOL, V23, P801, DOI 10.1016/S0828-282X(07)70831-0; Chu H, 2006, J CLIN EPIDEMIOL, V59, P32; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Coles DR, 2007, INT J CARDIOVAS IMAG, V23, P603, DOI 10.1007/s10554-006-9193-5; Cornily JC, 2007, EUR J RADIOL, V61, P84, DOI 10.1016/j.ejrad.2006.08.010; Davin L, 2007, ACTA CARDIOL, V62, P339, DOI 10.2143/AC.62.4.2022276; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deetjen AG, 2007, CLIN CARDIOL, V30, P118, DOI 10.1002/clc.20059; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Diederichsen ACP, 2009, SCAND CARDIOVASC J, V43, P337, DOI 10.1080/14017430902785501; Donati OF, 2010, AM J ROENTGENOL, V194, P920, DOI 10.2214/AJR.09.3225; Dwamena, 2007, MIDAS PROGRAM METAAN; Ehara M, 2006, CIRC J, V70, P564, DOI 10.1253/circj.70.564; Erdogan N, 2006, HEART VESSELS, V21, P278, DOI 10.1007/s00380-005-0903-z; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Garcia MJ, 2006, JAMA-J AM MED ASSOC, V296, P403, DOI 10.1001/jama.296.4.403; Gaudio C, 2009, INT J CARDIOL, V135, P280, DOI 10.1016/j.ijcard.2008.03.091; Ghersin E, 2006, AM J ROENTGENOL, V186, P177, DOI 10.2214/AJR.04.1232; Ghostine S, 2006, J AM COLL CARDIOL, V48, P1929, DOI 10.1016/j.jacc.2006.04.103; Gilard M, 2006, J AM COLL CARDIOL, V47, P2020, DOI 10.1016/j.jacc.2005.11.085; Grosse C, 2007, ACTA RADIOL, V48, P36, DOI 10.1080/02841850601045096; Hacker M, 2007, NUKLEARMED-NUCL MED, V46, P29; Halon DA, 2007, CARDIOLOGY, V108, P200, DOI 10.1159/000096778; Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007; Hausleiter J, 2007, EUR HEART J, V28, P3034, DOI 10.1093/eurheartj/ehm150; Henneman MM, 2006, HEART, V92, P1779, DOI 10.1136/hrt.2006.087874; Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012; Herzog BA, 2008, EUR HEART J, V29, P3037, DOI 10.1093/eurheartj/ehn485; Herzog C, 2007, RADIOLOGY, V244, P112, DOI 10.1148/radiol.2441060332; Herzog C, 2007, RADIOLOGY, V244, P121, DOI 10.1148/radiol.2441060004; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Hoffmann U, 2004, CIRCULATION, V110, P2638, DOI 10.1161/01.CIR.0000145614.07427.9F; Husmann L, 2010, ACAD RADIOL, V17, P201, DOI 10.1016/j.acra.2009.09.007; Jenkins SMM, 2011, QJM-INT J MED, V104, P49, DOI 10.1093/qjmed/hcq163; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Kaiser C, 2005, EUR HEART J, V26, P1987, DOI 10.1093/eurheartj/ehi384; Kefer J, 2005, J AM COLL CARDIOL, V46, P92, DOI 10.1016/j.jacc.2005.03.057; Kolnes K, 2006, ACTA RADIOL, V47, P680, DOI 10.1080/02841850600806332; LaBounty TM, 2010, AM J CARDIOL, V106, P287, DOI 10.1016/j.amjcard.2010.02.038; Laissy JP, 2007, HEART, V93, P1121, DOI 10.1136/hrt.2006.107284; Langer C, 2009, J COMPUT ASSIST TOMO, V33, P179, DOI 10.1097/RCT.0b013e3181839624; Leber AW, 2007, EUR HEART J, V28, P2354, DOI 10.1093/eurheartj/ehm294; Leschka S, 2008, HEART, V94, P1154, DOI 10.1136/hrt.2007.124800; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Lijmer Jeroen G, 2009, Med Decis Making, V29, pE13, DOI 10.1177/0272989X09336144; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Maintz D, 2007, ACTA RADIOL, V48, P967, DOI 10.1080/02841850701630292; Manghat NE, 2007, CLIN RADIOL, V62, P632, DOI 10.1016/j.crad.2007.01.014; Marano R, 2009, EUR RADIOL, V19, P1114, DOI 10.1007/s00330-008-1239-8; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Meijboom WB, 2007, HEART, V93, P1386, DOI 10.1136/hrt.2006.112771; Meijboom WB, 2006, J AM COLL CARDIOL, V48, P1658, DOI 10.1016/j.jacc.2006.06.054; Meng LD, 2009, KOREAN J RADIOL, V10, P347, DOI 10.3348/kjr.2009.10.4.347; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mir-Akbari H, 2009, ACTA RADIOL, V50, P174, DOI 10.1080/02841850802647013; Mollet NR, 2004, J AM COLL CARDIOL, V43, P2265, DOI 10.1016/j.jacc.2004.03.032; Mollet NR, 2005, J AM COLL CARDIOL, V45, P128, DOI 10.1016/j.jacc.2004.09.074; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Moon JY, 2005, YONSEI MED J, V46, P86, DOI 10.3349/ymj.2005.46.1.86; Morgan-Hughes GJ, 2005, HEART, V91, P308, DOI 10.1136/hrt.2004.034892; National Institute for Health and Clinical Excellence, 2012, DG3 COMP TOM CT SCAN; Nazeri I, 2010, ARCH IRAN MED, V13, P373, DOI 010135/AIM.003; Nikolaou K, 2006, AM J ROENTGENOL, V186, P1659, DOI 10.2214/AJR.05.0726; Nikolaou K, 2006, AM J ROENTGENOL, V187, P111, DOI 10.2214/AJR.05.1697; Olivetti L, 2006, RADIOL MED, V111, P1054, DOI 10.1007/s11547-006-0104-6; Oncel D, 2007, RADIOLOGY, V245, P703, DOI 10.1148/radiol.2453070094; Oncel D, 2007, EUR J RADIOL, V62, P394, DOI 10.1016/j.ejrad.2007.01.009; Ovrehus KA, 2010, AM J CARDIOL, V105, P773, DOI 10.1016/j.amjcard.2009.11.006; Pontone G, 2007, CLIN RADIOL, V62, P978, DOI 10.1016/j.crad.2007.02.022; Pontone G, 2007, CORONARY ARTERY DIS, V18, P265, DOI 10.1097/MCA.0b013e328035f8ae; Pontone G, 2009, J AM COLL CARDIOL, V54, P346, DOI 10.1016/j.jacc.2009.04.027; Postel Thomas, 2007, Exp Clin Cardiol, V12, P149; Pouleur AC, 2008, CIRC-CARDIOVASC IMAG, V1, P114, DOI 10.1161/CIRCIMAGING.107.756304; Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0; Pundziute G, 2008, HEART, V94, P48, DOI 10.1136/hrt.2007.116715; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Reant P, 2006, AM J CARDIOL, V97, P1506, DOI 10.1016/j.amjcard.2005.12.039; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rixe J, 2009, CIRC J, V73, P316, DOI 10.1253/circj.CJ-08-0534; Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014; Rodevand O, 2006, SCAND CARDIOVASC J, V40, P76, DOI 10.1080/14017430600686969; Romagnoli A, 2010, RADIOL MED, V115, P341, DOI 10.1007/s11547-009-0482-7; Romeo F, 2007, AM J CARDIOL, V99, P325, DOI 10.1016/j.amjcard.2006.08.029; Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Ropers U, 2007, J AM COLL CARDIOL, V50, P2393, DOI 10.1016/j.jacc.2007.09.017; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Sato A, 2010, J NUCL CARDIOL, V17, P19, DOI 10.1007/s12350-009-9150-5; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Scheffel H, 2007, AM J CARDIOL, V100, P701, DOI 10.1016/j.amjcard.2007.03.087; Scheffel H, 2006, EUR RADIOL, V16, P2739, DOI 10.1007/s00330-006-0474-0; Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092; Shabestari AA, 2007, AM J CARDIOL, V99, P1656, DOI 10.1016/j.amjcard.2007.01.040; Sheikh M, 2009, MED PRIN PRACT, V18, P323, DOI 10.1159/000215732; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stagnaro N, 2009, RADIOL MED, V114, P728, DOI 10.1007/s11547-009-0403-9; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Thomas C, 2010, ACAD RADIOL, V17, P212, DOI 10.1016/j.acra.2009.08.010; Tsai IC, 2007, J COMPUT ASSIST TOMO, V31, P258, DOI 10.1097/01.rct.0000237808.03499.e4; Turkvattan A, 2008, ACTA RADIOL, V49, P400, DOI 10.1080/02841850701870922; Ugolini P, 2009, CAN J CARDIOL, V25, P641, DOI 10.1016/S0828-282X(09)70161-8; Ulimoen GR, 2008, ACTA RADIOL, V49, P1140, DOI 10.1080/02841850802452083; van Werkhoven JM, 2010, AM J CARDIOL, V105, P302, DOI 10.1016/j.amjcard.2009.09.029; VANHOUWELINGEN HC, 1993, STAT MED, V12, P2273, DOI 10.1002/sim.4780122405; Watkins MW, 2007, AM J CARDIOL, V99, P175, DOI 10.1016/j.amjcard.2006.07.081; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xu L, 2011, EUR RADIOL, V21, P936, DOI 10.1007/s00330-010-1987-0; Yang L, 2009, AM J ROENTGENOL, V193, P795, DOI 10.2214/AJR.08.2012; Zhang LJ, 2010, ACTA RADIOL, V51, P727, DOI 10.3109/02841851.2010.492792	144	100	101	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2012	345								e6717	10.1136/bmj.e6717	http://dx.doi.org/10.1136/bmj.e6717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MY	23097549	Green Published, hybrid			2022-12-28	WOS:000310427600002
J	Amack, JD; Manning, ML				Amack, Jeffrey D.; Manning, M. Lisa			Knowing the Boundaries: Extending the Differential Adhesion Hypothesis in Embryonic Cell Sorting	SCIENCE			English	Review							TISSUE SURFACE-TENSION; INTERCELLULAR-ADHESION; CORTICAL TENSION; FORCES; MORPHOGENESIS; ZEBRAFISH; MECHANICS	Successful embryogenesis requires proper sorting and compartmentalization of different cell types. Mechanical interactions between cells help govern these processes. In the past, physics-based theories have guided in vitro studies of cell sorting and tissue surface tension. Recent experiments have challenged this approach, indicating that adhesive molecules also act as signaling molecules that initiate local reorganization of actomyosin and demonstrating that cells at the boundary of a colony of initially identical cells become "mechanically polarized." Extending physical models to account for mechanical polarization helps solve a long-standing paradox about magnitudes of tissue surface tensions and potentially explains discrepancies between recent in vivo and in vitro cell-sorting experiments. New experiments are needed to further explore the connection between mechanical polarization and tissue boundary formation in vivo.	[Amack, Jeffrey D.] SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [Manning, M. Lisa] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Manning, M. Lisa] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University; Syracuse University	Amack, JD (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, 309 Weiskotten Hall, Syracuse, NY 13210 USA.	amackj@upstate.edu; mmanning@syr.edu	Manning, Lisa/B-1746-2012	Manning, Lisa/0000-0001-7682-2324; Amack, Jeffrey/0000-0002-5465-9754	NIH [R01HL095690]; College of Arts and Sciences at Syracuse University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Arts and Sciences at Syracuse University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Amack lab is supported in part by a grant from NIH (R01HL095690). The Manning lab acknowledges support from the College of Arts and Sciences at Syracuse University.	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Krens SFG, 2011, P NATL ACAD SCI USA, V108, pE9, DOI 10.1073/pnas.1010767108; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Laplante C, 2006, DEVELOPMENT, V133, P3255, DOI 10.1242/dev.02492; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Monier B, 2011, CELL MOL LIFE SCI, V68, P1897, DOI 10.1007/s00018-011-0668-8; Ninomiya H, 2012, J CELL SCI, V125, P1877, DOI 10.1242/jcs.095315; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Youssef J, 2011, P NATL ACAD SCI USA, V108, P6993, DOI 10.1073/pnas.1102559108	28	105	106	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					212	215		10.1126/science.1223953	http://dx.doi.org/10.1126/science.1223953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066072				2022-12-28	WOS:000309712300033
J	Furusawa, C; Kaneko, K				Furusawa, Chikara; Kaneko, Kunihiko			A Dynamical-Systems View of Stem Cell Biology	SCIENCE			English	Editorial Material							DIFFERENTIATION; ROBUSTNESS; LANDSCAPE; NETWORKS	During development, cells undergo a unidirectional course of differentiation that progressively decreases the number of cell types they can potentially become. Stem cells, however, keep their potential to both proliferate and differentiate. A very important issue then is to understand the characteristics that distinguish stem cells from other cell types and allow them to conduct stable proliferation and differentiation. Here, we review relevant dynamical-systems approaches to describe the state transition between stem and differentiated cells, with an emphasis on fluctuating and oscillatory gene expression levels, as these represent the specific properties of stem cells. Relevance between recent experimental results and dynamical-systems descriptions of stem cell differentiation is also discussed.	[Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr QBiC, Osaka, Japan	University of Tokyo; RIKEN	Kaneko, K (corresponding author), Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan.	kaneko@complex.c.u-tokyo.ac.jp	Furusawa, Chikara/N-6103-2015; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975	Grants-in-Aid for Scientific Research [23650152] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Furusawa C, 2001, J THEOR BIOL, V209, P395, DOI 10.1006/jtbi.2001.2264; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2012, BIOESSAYS, V34, P149, DOI 10.1002/bies.201100031; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Kauffman S.A., 1993, ORIGINS ORDER; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Suzuki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027232; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Waddington C., 1957, STRATEGY GENES; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108	22	129	130	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					215	217		10.1126/science.1224311	http://dx.doi.org/10.1126/science.1224311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066073				2022-12-28	WOS:000309712300034
J	Link, MS				Link, Mark S.			Evaluation and Initial Treatment of Supraventricular Tachycardia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-ASSOCIATION GUIDELINES; ATRIAL-FIBRILLATION; CARDIOPULMONARY-RESUSCITATION; ADENOSINE; PREVALENCE; RISK	A 24-year-old woman presents to the emergency department with the sole symptom of "a racing heart," which began abruptly while she was eating dinner. She reports having had prior episodes of palpitations that resolved spontaneously. In the emergency room, her blood pressure is 84/60 mm Hg. An electrocardiogram (ECG) reveals a regular narrow-complex tachycardia at a rate of 190 beats per minute without clear atrial activity (P waves). How should this case be managed?	Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Link, MS (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, 800 Washington St,Box 197, Boston, MA 02111 USA.	mlink@tuftsmedicalcenter.org			Lantheus Medical Imaging	Lantheus Medical Imaging	Dr. Link reports receiving consulting fees from Lantheus Medical Imaging and holding patents for a chest-wall protector for sports and a testing model for commotio cordis. No other potential conflict of interest relevant to this article was reported.	Buxton AE, 2006, CIRCULATION, V114, P2534, DOI 10.1161/CIRCULATIONAHA.106.180199; Delaney B, 2011, EUR J EMERG MED, V18, P148, DOI 10.1097/MEJ.0b013e3283400ba2; DIMARCO JP, 1985, J AM COLL CARDIOL, V6, P417, DOI 10.1016/S0735-1097(85)80181-9; FOX SM, 1971, ANN CLIN RES, V3, P404, DOI 10.1016/0091-7435(72)90079-5; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Katritsis DG, 2010, CIRCULATION, V122, P831, DOI 10.1161/CIRCULATIONAHA.110.936591; Link, 2011, CIRCULATION, V123, pE235, DOI 10.1161/CIR.0b013e31820ff4b0; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Link MS, 2007, EP LAB DIGEST, V5, P38; Marill KA, 2009, CRIT CARE MED, V37, P2512, DOI 10.1097/CCM.0b013e3181a93661; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Neumar, 2011, CIRCULATION, V123, pE236, DOI 10.1161/CIR.0b013e31820ff511; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Orejarena LA, 1998, J AM COLL CARDIOL, V31, P150, DOI 10.1016/S0735-1097(97)00422-1; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Strickberger SA, 1997, ANN INTERN MED, V127, P417, DOI 10.7326/0003-4819-127-6-199709150-00001; Strickberger SA, 1998, ANN INTERN MED, V128, P511, DOI 10.7326/0003-4819-127-6-199709150-00001	17	37	39	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1438	1448		10.1056/NEJMcp1111259	http://dx.doi.org/10.1056/NEJMcp1111259			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050527				2022-12-28	WOS:000309652700010
J	Metcalf, B; Henley, W; Wilkin, T				Metcalf, Brad; Henley, William; Wilkin, Terence			Effectiveness of intervention on physical activity of children: systematic review and meta-analysis of controlled trials with objectively measured outcomes (EarlyBird 54)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTION; OPEN-LOOP FEEDBACK; OBESITY PREVENTION; CHILDHOOD OBESITY; PRIMARY-CARE; BODY FATNESS; WEIGHT-GAIN; LOW-INCOME; SCHOOL	Objective To determine whether, and to what extent, physical activity interventions affect the overall activity levels of children. Design Systematic review and meta-analysis. Data sources Electronic databases (Embase, Medline, PsycINFO, SPORTDiscus) and reference lists of included studies and of relevant review articles. Study selection Design: randomised controlled trials or controlled clinical trials (cluster and individual) published in peer reviewed journals. Intervention: incorporated a component designed to increase the physical activity of children/adolescents and was at least four weeks in duration. Outcomes: measured whole day physical activity objectively with accelerometers either before or immediately after the end of the intervention period. Data analysis Intervention effects (standardised mean differences) were calculated for total physical activity, time spent in moderate or vigorous physical activity, or both for each study and pooled using a weighted random effects model. Meta-regression explored the heterogeneity of intervention effects in relation to study participants, design, intervention type, and methodological quality. Results Thirty studies (involving 14 326 participants; 6153 with accelerometer measured physical activity) met the inclusion criteria and all were eligible for meta-analysis/meta-regression. The pooled intervention effect across all studies was small to negligible for total physical activity (standardised mean difference 0.12, 95% confidence interval 0.04 to 0.20; P<0.01) and small for moderate or vigorous activity (0.16, 0.08 to 0.24; P<0.001). Meta-regression indicated that the pooled intervention effect did not differ significantly between any of the subgroups (for example, for total physical activity, standardised mean differences were 0.07 for age <10 years and 0.16 for >= 10 years, P=0.19; 0.07 for body mass index across the entire range and 0.22 for exclusively overweight/obese children, P=0.07; 0.12 for study duration <= 6 months and 0.09 for >6 months, P=0.71; 0.15 for home/family based intervention and 0.10 for school based intervention, P=0.53; and 0.09 for higher quality studies and 0.14 for lower quality studies, P=0.52). Conclusions This review provides strong evidence that physical activity interventions have had only a small effect (approximately 4 minutes more walking or running per day) on children's overall activity levels. This finding may explain, in part, why such interventions have had limited success in reducing the body mass index or body fat of children.	[Metcalf, Brad; Wilkin, Terence] Peninsula Coll Med & Dent, Dept Endocrinol & Metab, Plymouth, Devon, England; [Henley, William] Peninsula Coll Med & Dent, Inst Hlth Serv Res, Exeter, Devon, England	University of Plymouth; University of Exeter; University of Plymouth	Metcalf, B (corresponding author), Peninsula Coll Med & Dent, Dept Endocrinol & Metab, Plymouth Univ Campus, Plymouth, Devon, England.	brad.metcalf@nhs.net		Metcalf, Brad/0000-0002-9142-3732	Bright Future Trust; Kirby Laing Foundation; Peninsula Foundation; EarlyBird Diabetes Trust; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC)	Bright Future Trust; Kirby Laing Foundation; Peninsula Foundation; EarlyBird Diabetes Trust; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC)(National Institute for Health Research (NIHR))	EarlyBird (BM and TW) is currently supported by the Bright Future Trust, the Kirby Laing Foundation, the Peninsula Foundation, and the EarlyBird Diabetes Trust. These funding sources had no role in the study design, data collection, analysis, interpretation of results, or the writing of the report. WH was supported by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Backlund C, 2011, EUR J PHYSIOTHER, V13, P97, DOI 10.3109/14038196.2011.562540; Baranowski T, 2011, AM J PREV MED, V40, P33, DOI 10.1016/j.amepre.2010.09.029; Basterfield L, 2008, ARCH DIS CHILD, V93, P1054, DOI 10.1136/adc.2007.135905; Basterfield L, 2011, J PHYS ACT HEALTH, V8, P543, DOI 10.1123/jpah.8.4.543; Borenstein M., 2009, INTROD MAGN MAT, P277, DOI [DOI 10.1002/9780470743386.CH30, 10.1002/9780470743386.ch30, DOI 10.1002/9780470386323.FMATTER]; Borenstein M, 2009, INTRO METAANALYSIS, P187; Borenstein M., 2009, INTRO META ANAL, P21, DOI DOI 10.1002/9780470743386.CH4; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Cliff DP, 2011, MED SCI SPORT EXER, V43, P90, DOI 10.1249/MSS.0b013e3181e741e8; Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Farpour-Lambert NJ, 2009, J AM COLL CARDIOL, V54, P2396, DOI 10.1016/j.jacc.2009.08.030; Fitzgibbon ML, 2011, OBESITY, V19, P994, DOI 10.1038/oby.2010.314; Fremeaux AE, 2011, INT J OBESITY, V35, P1277, DOI 10.1038/ijo.2011.52; Fulton Janet E., 2011, Morbidity and Mortality Weekly Report, V60, P773; Goldfield GS, 2006, PEDIATRICS, V118, pE157, DOI 10.1542/peds.2005-3052; Goran MI, 2005, OBES RES, V13, P762, DOI 10.1038/oby.2005.86; Gorely T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-5; Guinhouya BC, 2011, INT J PEDIATR OBES, V6, P361, DOI 10.3109/17477166.2011.605896; Haerens L, 2006, HEALTH EDUC RES, V21, P911, DOI 10.1093/her/cyl115; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Harvey-Berino J, 2003, OBES RES, V11, P606, DOI 10.1038/oby.2003.87; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hughes AR, 2008, PEDIATRICS, V121, pE539, DOI 10.1542/peds.2007-1786; Jago R, 2006, PREV MED, V42, P181, DOI 10.1016/j.ypmed.2005.12.010; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Klesges RC, 2010, ARCH PEDIAT ADOL MED, V164, P1007, DOI 10.1001/archpediatrics.2010.196; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Kristensen PL, 2008, SCAND J MED SCI SPOR, V18, P171, DOI 10.1111/j.1600-0838.2006.00622.x; Maddison R, 2011, AM J CLIN NUTR, V94, P156, DOI 10.3945/ajcn.110.009142; Magnusson KT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-138; Marcus C, 2009, INT J OBESITY, V33, P408, DOI 10.1038/ijo.2009.38; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; McCallum Z, 2007, INT J OBESITY, V31, P630, DOI 10.1038/sj.ijo.0803509; Metcalf BS, 2008, ARCH DIS CHILD, V93, P772, DOI 10.1136/adc.2007.135012; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Multiple Outcomes or Time-Points within a Study, 2009, INTRO METAANALYSIS, P225, DOI DOI 10.1002/9780470743386.CH24; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Patrick K, 2006, ARCH PEDIAT ADOL MED, V160, P128, DOI 10.1001/archpedi.160.2.128; Peralta LR, 2009, PREV MED, V48, P537, DOI 10.1016/j.ypmed.2009.04.007; Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Robinson TN, 2010, ARCH PEDIAT ADOL MED, V164, P995, DOI 10.1001/archpediatrics.2010.197; Roemmich JN, 2004, MED SCI SPORT EXER, V36, P668, DOI 10.1249/01.MSS.0000121947.59529.3B; Saavedra JM, 2011, INT J PEDIATR OBES, V6, P169, DOI 10.3109/17477166.2011.579975; Sallis JF, 1996, MED SCI SPORT EXER, V28, P840, DOI 10.1097/00005768-199607000-00011; Salmon J, 2008, INT J OBESITY, V32, P601, DOI 10.1038/sj.ijo.0803805; Salmon J, 2007, EPIDEMIOL REV, V29, P144, DOI 10.1093/epirev/mxm010; Schmitz KH, 2005, MED SCI SPORT EXER, V37, P155, DOI 10.1249/01.MSS.0000150084.97823.F7; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Taber DR, 2009, ANN EPIDEMIOL, V19, P316, DOI 10.1016/j.annepidem.2009.01.001; Taylor RW, 2007, AM J CLIN NUTR, V86, P735, DOI 10.1093/ajcn/86.3.735; Treuth MS, 2005, MED SCI SPORT EXER, V37, P488, DOI 10.1249/01.MSS.0000155392.75790.83; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Verstraete SJ, 2007, PUBLIC HEALTH NUTR, V10, P477, DOI 10.1017/S1368980007223900; Wafa SW, 2011, INT J PEDIATR OBES, V6, pE62, DOI 10.3109/17477166.2011.566340; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Webber LS, 2008, AM J PREV MED, V34, P173, DOI 10.1016/j.amepre.2007.11.018; Weintraub DL, 2008, ARCH PEDIAT ADOL MED, V162, P232, DOI 10.1001/archpediatrics.2007.43; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Wilson DK, 2011, HEALTH PSYCHOL, V30, P463, DOI 10.1037/a0023390; Wilson DK, 2005, ANN BEHAV MED, V30, P119, DOI 10.1207/s15324796abm3002_4	71	408	413	9	135	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2012	345								e5888	10.1136/bmj.e5888	http://dx.doi.org/10.1136/bmj.e5888			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014OZ	23044984	hybrid, Green Submitted			2022-12-28	WOS:000309386700001
J	Rebolj, M; Helmerhorst, T; Habbema, D; Looman, C; Boer, R; van Rosmalen, J; van Ballegooijen, M				Rebolj, Matejka; Helmerhorst, Theo; Habbema, Dik; Looman, Caspar; Boer, Rob; van Rosmalen, Joost; van Ballegooijen, Marjolein			Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM RISK; BRITISH-COLUMBIA COHORT; RETROSPECTIVE COHORT; NATURAL-HISTORY; INVASIVE CANCER; RECORD LINKAGE; OUTCOMES; REGISTRY; GRADE-3; WOMEN	Objective To compare the risk of cervical cancer in women with histologically confirmed cervical intraepithelial neoplasia who returned to routine screening after having completed post-treatment follow-up with consecutive normal smear test results with women with a normal primary smear test result. Design Population based cohort study using data from a nationwide pathology register. Setting The Netherlands, 1994 to 2006. Population 38 956 women with histologically confirmed intraepithelial neoplasia grades 1 to 3 with completed follow-up after treatment. Intervention Routine post-treatment follow-up of cervical intraepithelial neoplasia, recommending smear tests at six, 12, and 24 months. Main outcome measure Incidence of cervical cancer in the period from completed follow-up with negative test results after cervical intraepithelial neoplasia to the next primary test. 10-year hazard ratios were compared with periods after normal results for the primary smear test, adjusted for year in follow-up. Results 20 cervical cancers were diagnosed during 56 956 woman years after completed follow-up of cervical intraepithelial neoplasia, whereas 1613 cervical cancers were diagnosed during 25 020 697 woman years after a normal primary smear test result. The incidence of 35.1 (95% confidence interval 21.4 to 54.2) per 100 000 woman years and 6.4 (6.1 to 6.8) per 100 000 woman years, respectively, led to an adjusted hazard ratio of 4.2 (95% confidence interval 2.7 to 6.5) for periods after completed follow-up compared with periods after normal primary smear test results. This hazard ratio was increased for all ages. No significant difference in risk of cervical cancer was observed by grade of cervical intraepithelial neoplasia. Conclusions An excess risk of cervical cancer previously observed for women treated for cervical intraepithelial neoplasia was also observed in the subgroup of women who completed their post-treatment follow-up with three consecutive normal smear test results. The overall corrected risk of cervical cancer in these women was increased fourfold 35 cases per 100 000 woman years) compared with women with normal primary smear test results (6 per 100 000 woman years).	[Rebolj, Matejka; Habbema, Dik; Looman, Caspar; Boer, Rob; van Rosmalen, Joost; van Ballegooijen, Marjolein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Rebolj, Matejka] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Helmerhorst, Theo] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC	Rebolj, M (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	mare@sund.ku.dk	Boer, Rob/E-6473-2015; Boer, Robert/AAH-2901-2022; Boer, Robert/AFM-0525-2022	Boer, Rob/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Rebolj, Matejka/0000-0001-9597-645X; van Rosmalen, Joost/0000-0002-9187-244X	Dutch National Institute for Public Health and the Environment (RIVM) [3022/07 DG MS/CvB/NvN]; GSK; Health Insurance Executive Board	Dutch National Institute for Public Health and the Environment (RIVM); GSK(GlaxoSmithKline); Health Insurance Executive Board	This study was funded by the Dutch National Institute for Public Health and the Environment (RIVM, grant No 3022/07 DG MS/CvB/NvN). The RIVM had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the report; and the decision to submit the manuscript for publication. The researchers worked independently of the funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: MR is currently involved in a comparative study of new generation human papillomavirus tests, for which Roche Diagnostics, Genomica, Qiagen, and Gen-Probe provided assays and instrumentations. MR did not receive any salary, compensation, or bonuses for work on any of the projects from any of the companies, and does not hold companies' stock. Concerning the present paper, there has been no involvement or support from any of the companies. Since 1989 RB has been participating in the screening research group at the Department of Public Health of Erasmus MC. Between 2009 and 2012 he was also director of health economics at Cerner LifeSciences, which is a consultancy that mainly works for the pharmaceutical industry and is part of Cerner that mainly develops and markets healthcare information technology. This research and article were not funded or supported by Cerner or their clients. RB's institution has received a grant from Health Insurance Executive Board. MvB was the principal investigator until 2008 on a project on the cost effectiveness of human papillomavirus vaccination, financed by GSK (a pharmaceutical company that produces human papillomavirus vaccines against cervical cancer). There has been no collaboration with or support from GSK for the present paper. The authors have no other relationships or activities that could appear to have influenced the submitted work.	Akker-van Marle MEV, 2003, BRIT J CANCER, V88, P1054, DOI 10.1038/sj.bjc.6600843; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Cecchini S, 2009, JNCI-J NATL CANCER I, V101, P1429, DOI 10.1093/jnci/djp307; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Dutch Central Bureau of Statistics, 2011, POP SEX AG MAR STAT; Dutch Comprehensive Cancer Centres, 2011, CANC REG ONL INC CER; Hakama M, 1986, SCREENING CANC UTERI; Hanselaar AGJM, 1996, CISOE A PICTURES; HELMERHORST TJM, 1998, NED TIJDSCHR OBSTET, V111, P264; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Kalliala I, 2007, GYNECOL ONCOL, V105, P228, DOI 10.1016/j.ygyno.2006.12.028; Kjeld Petersen L, 2007, POSTCONISATION FOLLO, P201; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Luesley D, 2010, NHSCSP PUBLICATION, V20; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Melnikow J, 2009, JNCI-J NATL CANCER I, V101, P721, DOI 10.1093/jnci/djp089; NHS Cervical Screening Programme, 2011, HIV TRIAG TEST CUR P; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; PALGA, 2011, DESCR PALGA SYST COM; PETTERSSON F, 1989, RADIOTHER ONCOL, V16, P115, DOI 10.1016/0167-8140(89)90028-5; Prismant, 2007, DUTCH NETW DAT PATH; REBOLJ M, 2008, THESIS DEP PUBLIC HL; Rebolj M, 2007, INT J CANCER, V121, P1529, DOI 10.1002/ijc.22838; Rebolj M, 2007, INT J CANCER, V120, P806, DOI 10.1002/ijc.22167; Rebolj M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1354; Ronco G, 2007, BRIT MED J, V335, P1053, DOI 10.1136/bmj.39364.439444.80; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Strander B, 2007, BMJ-BRIT MED J, V335, P1077, DOI 10.1136/bmj.39363.471806.BE; Swedish Society of Obstetricians and Gynecologists (SFOG), 2011, GUID MAN CERV INTR N; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Ursic-Vrscaj M, 2011, GUIDELINES COMPREHEN; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; Werkgroep Oncologische Gynaecologie, 2011, CERV INTR NEOPL CIN	38	41	41	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2012	345								e6855	10.1136/bmj.e6855	http://dx.doi.org/10.1136/bmj.e6855			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033FG	23117059	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310779000001
J	FitzGerald, GA				FitzGerald, Garret A.			Can Intellectual Property Save Drug Development?	SCIENCE			English	Editorial Material									Translat Res Ctr, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Translat Res Ctr, Perelman Sch Med, Inst Translat Med & Therapeut, 10th Floor,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	garret@upenn.edu						[Anonymous], 2012, NY TIMES; Bubela T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003490; Digg C., 2012, NY TIMES; FitzGerald GA, 2008, SCIENCE, V320, P1563, DOI 10.1126/science.1161006	4	4	4	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					483	484		10.1126/science.1231170	http://dx.doi.org/10.1126/science.1231170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112323				2022-12-28	WOS:000310195800045
J	Larson, S				Larson, Susan			Did Australopiths Climb Trees?	SCIENCE			English	Editorial Material							AFARENSIS; EVOLUTION; ANGLE		SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Larson, S (corresponding author), SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA.	susan.larson@stonybrook.edu	Larson, Susan/AAL-1935-2021					Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Inouye SE, 1997, INT J PRIMATOL, V18, P629, DOI 10.1023/A:1026319424308; Latimer B., 1991, P169; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; MENSFORTH RP, 1990, AM J PHYS ANTHROPOL, V81, P267; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Susman R.L., 1991, P121; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185	11	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					478	479		10.1126/science.1230128	http://dx.doi.org/10.1126/science.1230128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112319				2022-12-28	WOS:000310195800041
J	Lembke, A				Lembke, Anna			Why Doctors Prescribe Opioids to Known Opioid Abusers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University	Lembke, A (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.							[Anonymous], 2011, PUBL SMA; Fassin Didier, 2009, EMPIRE TRAUMA INQUIR; Meldrum ML, 2003, JAMA-J AM MED ASSOC, V290, P2470, DOI 10.1001/jama.290.18.2470; Pizzo PA, 2012, NEW ENGL J MED, V366, P197, DOI 10.1056/NEJMp1109084	4	82	82	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1580	1581		10.1056/NEJMp1208498	http://dx.doi.org/10.1056/NEJMp1208498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094719				2022-12-28	WOS:000310131700002
J	Sakata, R; McGale, P; Grant, EJ; Ozasa, K; Peto, R; Darby, SC				Sakata, R.; McGale, P.; Grant, E. J.; Ozasa, K.; Peto, R.; Darby, S. C.			Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; LARGE-SCALE COHORT; CIGARETTE-SMOKING; CANCER-RISK; TOBACCO SMOKING; STYLE FACTORS; RADIATION; POPULATION; DISEASES; HABITS	Objective To investigate the impact of smoking on overall mortality and life expectancy in a large Japanese population, including some who smoked throughout adult life. Design The Life Span Study, a population-based prospective study, initiated in 1950. Setting Hiroshima and Nagasaki, Japan. Participants Smoking status for 27 311 men and 40 662 women was obtained during 1963-92. Mortality from one year after first ascertainment of smoking status until 1 January 2008 has been analysed. Main outcome measures Mortality from all causes in current, former, and never smokers. Results Smokers born in later decades tended to smoke more cigarettes per day than those born earlier, and to have started smoking at a younger age. Among those born during 1920-45 (median 1933) and who started smoking before age 20 years, men smoked on average 23 cigarettes/day, while women smoked 17 cigarettes/day, and, for those who continued smoking, overall mortality was more than doubled in both sexes (rate ratios versus never smokers: men 2.21 (95% confidence interval 1.97 to 2.48), women 2.61 (1.98 to 3.44)) and life expectancy was reduced by almost a decade (8 years for men, 10 years for women). Those who stopped smoking before age 35 avoided almost all of the excess risk among continuing smokers, while those who stopped smoking before age 45 avoided most of it. Conclusions The lower smoking related hazards reported previously in Japan may have been due to earlier birth cohorts starting to smoke when older and smoking fewer cigarettes per day. In Japan, as elsewhere, those who start smoking in early adult life and continue smoking lose on average about a decade of life. Much of the risk can, however, be avoided by giving up smoking before age 35, and preferably well before age 35.	[McGale, P.; Peto, R.; Darby, S. C.] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Sakata, R.; Grant, E. J.; Ozasa, K.] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan	University of Oxford; Radiation Effects Research Foundation - Japan	Darby, SC (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	sarah.darby@ctsu.ox.ac.uk	OZASA, Kotaro/ABF-3001-2020; Sakata, Ritsu/ABI-1805-2020	OZASA, Kotaro/0000-0002-5637-1383; 	RERF, Hiroshima; RERF, Nagasaki, Japan; Japanese Ministry of Health, Labour, and Welfare (MHLW); US Department of Energy (DOE); DOE [DE-HS0000031]; RERF Research Protocol [RP 3-08]; MHLW International Exchange Program Fund; Cancer Research UK; British Heart Foundation; Medical Research Council; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI	RERF, Hiroshima; RERF, Nagasaki, Japan; Japanese Ministry of Health, Labour, and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); US Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); RERF Research Protocol; MHLW International Exchange Program Fund; Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RS, EJG, and KO are supported by RERF, Hiroshima and Nagasaki, Japan, a private, non-profit foundation funded by the Japanese Ministry of Health, Labour, and Welfare (MHLW) and the US Department of Energy (DOE), partly through DOE award DE-HS0000031 to the National Academy of Sciences which provides support for EJG. This publication was supported by RERF Research Protocol RP 3-08 and by the MHLW International Exchange Program Fund. The views of the authors do not necessarily reflect those of the two governments. PMcG, RP, and SCD are supported by the core funding to CTSU from Cancer Research UK, British Heart Foundation, and Medical Research Council.	AKIBA S, 1994, ENVIRON HEALTH PERSP, V102, P15, DOI 10.1289/ehp.94102s815; Akiba S, 1991, MAIL SURVEY EPIDEMIO; Al Mamun A, 2004, EUR HEART J, V25, P409, DOI 10.1016/j.ehj.2003.12.015; Ando M, 2003, INT J CANCER, V105, P249, DOI 10.1002/ijc.11043; [Anonymous], IARC HDB CANC PREV T; Chief of Epidemiology and Statistics, 1978, MAIL QUEST SURV EP D; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Forey B, 2006, INT SMOKING STAT COL; Free Japan Tobacco, 2005, TOB FREE JAP REC TOB; Furukawa K, 2010, RADIAT RES, V174, P72, DOI 10.1667/RR2083.1; Grant EJ, 2012, RADIAT RES, V178, P86, DOI 10.1667/RR2841.1; Hara M, 2010, J EPIDEMIOL, V20, P128, DOI 10.2188/jea.JE20080093; Hirayama T, 1990, LIFE STYLE MORTALITY; Hozawa A, 2004, J EPIDEMIOL, V14, pS12, DOI 10.2188/jea.14.S12; Inoue M, 2004, PREV MED, V38, P516, DOI 10.1016/j.ypmed.2003.11.026; Japan Health Promotion & Fitness Foundation, 2008, NAT SURV UND SMOK DR; Japan Health Promotion & Fitness Foundation, 2008, JAP TOB INC SURV; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Kato H, 1965, STUDY CARDIOVASCULAR; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Lin YS, 2002, CANCER CAUSE CONTROL, V13, P249, DOI 10.1023/A:1015052710213; Murakami Y, 2007, J EPIDEMIOL, V17, P31, DOI 10.2188/jea.17.31; Murakami Y, 2011, PREV MED, V52, P60, DOI 10.1016/j.ypmed.2010.11.009; Ozasa K., 2007, ASIAN PACIFIC J CA S, V8, ps89; Ozasa K, 2008, J EPIDEMIOL, V18, P111, DOI 10.2188/jea.JE2007416; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pham TM, 2007, EUR J EPIDEMIOL, V22, P599, DOI 10.1007/s10654-007-9161-y; Pirie K, LANCET IN PRESS; Sagan LA, 1963, EPIDEMIOLOGIC SURVEY; Sakata K, 2005, J EPIDEMIOL, V15, pS212, DOI 10.2188/jea.15.S212; Sauvaget C, 2005, CANCER CAUSE CONTROL, V16, P773, DOI 10.1007/s10552-005-5385-x; Uno F, 2005, J EPIDEMIOL, V15, P173, DOI 10.2188/jea.15.173; Wakabayashi T., 1969, MAIL QUESTIONNAIRE S; Yamada M, 2005, DIGESTION, V71, P231, DOI 10.1159/000087048	34	75	77	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 25	2012	345								e7093	10.1136/bmj.e7093	http://dx.doi.org/10.1136/bmj.e7093			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MZ	23100333	hybrid, Green Published			2022-12-28	WOS:000310427800001
J	Astrow, AB				Astrow, Alan B.			Cancer Survivorship and Beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Astrow, AB (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.	aastrow@maimonidesmed.org						[Anonymous], 2006, PION SURV 20 YEARS A, P7; Hoffman B, 2006, J CLIN ONCOL, V24, P5154, DOI 10.1200/JCO.2006.06.5300; Institute of Medicine, 2005, CANC PAT CANC SURV L; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; Mullan F, 1982, VITAL SIGNS YOUNG DO	5	9	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1639	1640		10.1001/jama.2012.13258	http://dx.doi.org/10.1001/jama.2012.13258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093162				2022-12-28	WOS:000310434100017
J	Lotti, F; Imlach, WL; Saieva, L; Beck, ES; Hao, LT; Li, DK; Jiao, W; Mentis, GZ; Beattie, CE; McCabe, BD; Pellizzoni, L				Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Hao, Le T.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; Beattie, Christine E.; McCabe, Brian D.; Pellizzoni, Livio			An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL; NEURON; DEFECTS; PROTEIN; GENE; ZEBRAFISH; MODEL; BIOGENESIS; DEFICIENCY	Spinal muscular atrophy (SMA) is a motor neuron disease caused by deficiency of the ubiquitous survival motor neuron (SMN) protein. To define the mechanisms of selective neuronal dysfunction in SMA, we investigated the role of SMN-dependent U12 splicing events in the regulation of motor circuit activity. We show that SMN deficiency perturbs splicing and decreases the expression of a subset of U12 intron-containing genes in mammalian cells and Drosophila larvae. Analysis of these SMN target genes identifies Stasimon as a protein required for motor circuit function. Restoration of Stasimon expression in the motor circuit corrects defects in neuromuscular junction transmission and muscle growth in Drosophila SMN mutants and aberrant motor neuron development in SMN-deficient zebrafish. These findings directly link defective splicing of critical neuronal genes induced by SMN deficiency to motor circuit dysfunction, establishing a molecular framework for the selective pathology of SMA.	[Lotti, Francesco; Saieva, Luciano; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Imlach, Wendy L.; Beck, Erin S.; Jiao, Wei; McCabe, Brian D.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Hao, Le T.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University	McCabe, BD (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	brian@mccabelab.org; lp2284@columbia.edu	Imlach, Wendy/G-7609-2011; Lotti, Francesco/AAC-3186-2019; Beck, Erin/AAA-8399-2022	Imlach, Wendy/0000-0002-7521-9969; Pellizzoni, Livio/0000-0002-9168-5628; McCabe, Brian/0000-0003-1620-0501	NIH-NINDS [R01NS069601, R21NS077038, R01NS078375, R01NS050414]; DoD [W81XWH-08-1-0009, W81XWH-11-1-0753, W81XWH-11-1-0689]; SMA Foundation; MDA USA; FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069601, R01NS078375, R21NS077038, R01NS050414] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DoD(United States Department of Defense); SMA Foundation; MDA USA(Muscular Dystrophy Association); FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank Chris Henderson for invaluable comments. We are grateful to Spyros Artavanis-Tsakonas and Greg Matera for Drosophila stocks and reagents. This work was supported by grants from NIH-NINDS R01NS069601 and R21NS077038 (L. P.), R01NS078375 (G.Z.M.), and R01NS050414 (C. E. B.); DoD W81XWH-08-1-0009 and W81XWH-11-1-0753 (B. D. M.) and W81XWH-11-1-0689 (G.Z.M.); SMA Foundation (L. P. and C. E. B.); MDA USA (L. P.); FSMA A. Lewis Young Investigator Award (G.Z.M.); and Columbia University Motor Neuron Center (L. P. and B. D. M.).	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	226	235	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					440	454		10.1016/j.cell.2012.09.012	http://dx.doi.org/10.1016/j.cell.2012.09.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063131	Bronze, Green Accepted			2022-12-28	WOS:000309981000020
J	Sharpley, MS; Marciniak, C; Eckel-Mahan, K; McManus, M; Crimi, M; Waymire, K; Lin, CS; Masubuchi, S; Friend, N; Koike, M; Chalkia, D; MacGregor, G; Sassone-Corsi, P; Wallace, DC				Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; McManus, Meagan; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Masubuchi, Satoru; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; MacGregor, Grant; Sassone-Corsi, Paolo; Wallace, Douglas C.			Heteroplasmy of Mouse mtDNA Is Genetically Unstable and Results in Altered Behavior and Cognition	CELL			English	Article							MAMMALIAN MITOCHONDRIAL-DNA; EVOLUTIONARY MEDICINE; SPERM MITOCHONDRIA; RAPID SEGREGATION; SELECTION; TRANSMISSION; BOTTLENECK; MODEL; MICE; REPLICATION	Maternal inheritance of mtDNA is the rule in most animals, but the reasons for this pattern remain unclear. To investigate the consequence of overriding uniparental inheritance, we generated mice containing an admixture (heteroplasmy) of NZB and 129S6 mtDNAs in the presence of a congenic C57BL/6J nuclear background. Analysis of the segregation of the two mtDNAs across subsequent maternal generations revealed that proportion of NZB mtDNA was preferentially reduced. Ultimately, this segregation process produced NZB-129 heteroplasmic mice and their NZB or 129 mtDNA homoplasmic counterparts. Phenotypic comparison of these three mtDNA lines demonstrated that the NZB-129 heteroplasmic mice, but neither homoplasmic counterpart, had reduced activity, food intake, respiratory exchange ratio; accentuated stress response; and cognitive impairment. Therefore, admixture of two normal but different mouse mtDNAs can be genetically unstable and can produce adverse physiological effects, factors that may explain the advantage of uniparental inheritance of mtDNA.	[Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; Marciniak, Christine; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; MacGregor, Grant; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; Sassone-Corsi, Paolo; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Eckel-Mahan, Kristin; Masubuchi, Satoru; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Waymire, Katrina; MacGregor, Grant] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Colket Translat Res Bldg, Philadelphia, PA 19104 USA.	wallaced1@email.chop.edu	Chalkia, Dimitra/J-3793-2016; Crimi, Marco/A-4032-2008; McManus, Meagan J/F-7932-2018	Chalkia, Dimitra/0000-0003-4780-544X; Crimi, Marco/0000-0001-6903-9163; McManus, Meagan J/0000-0001-6064-0665; Eckel-Mahan, Kristin/0000-0001-8201-1675	NIH [HD36437, HD45913, NS21328, NS070298, AG24373, DK73691]; California Institute of Regenerative Medicine [RC1-00353]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036437, U01HD045913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070298, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We express our special appreciation for the technical contributions of Prasanth Potluri, PhD, Marie Lott, Christopher deSolis, Kierstin Keller, Stefanie Navarro, and Paulette Allard. This work was supported by NIH grants HD36437 and HD45913 to G. R. M. and NS21328, NS070298, AG24373, and DK73691, and California Institute of Regenerative Medicine grant RC1-00353 awarded to D. C. W.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; ALONSO SJ, 1991, PHYSIOL BEHAV, V49, P69, DOI 10.1016/0031-9384(91)90232-D; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Flaisher-Grinberg S, 2010, J PSYCHOPHARMACOL, V24, P437, DOI 10.1177/0269881108097905; Gindre C, 2010, ENCEPHALE, V36, pD92, DOI 10.1016/j.encep.2008.09.006; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Hogan B, 1994, MANIPULATING MOUSE E; Isobe Y, 2011, J NEUROSCI RES, V89, P929, DOI 10.1002/jnr.22609; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012; Minassian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024185; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011; Poole JC, 2010, BIOL CHEM, V391, P1115, DOI 10.1515/BC.2010.125; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sartori SB, 2012, NEUROPHARMACOLOGY, V62, P304, DOI 10.1016/j.neuropharm.2011.07.027; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; SOLIGNAC M, 1987, GENETICS, V117, P687; Sportiche N, 2010, NEUROSCIENCE, V170, P247, DOI 10.1016/j.neuroscience.2010.06.038; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808	47	243	249	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					333	343		10.1016/j.cell.2012.09.004	http://dx.doi.org/10.1016/j.cell.2012.09.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063123	Bronze, Green Accepted			2022-12-28	WOS:000309981000012
J	Jahn, R; Fasshauer, D				Jahn, Reinhard; Fasshauer, Dirk			Molecular machines governing exocytosis of synaptic vesicles	NATURE			English	Review							N-TERMINAL PEPTIDE; SNARE COMPLEX; MEMBRANE-FUSION; 3-DIMENSIONAL STRUCTURE; SINGLE-MOLECULE; CA2+ SENSOR; CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN; SYNTAXIN	Calcium-dependent exocytosis of synaptic vesicles mediates the release of neurotransmitters. Important proteins in this process have been identified such as the SNAREs, synaptotagmins, complexins, Munc18 and Munc13. Structural and functional studies have yielded a wealth of information about the physiological role of these proteins. However, it has been surprisingly difficult to arrive at a unified picture of the molecular sequence of events from vesicle docking to calcium-triggered membrane fusion. Using mainly a biochemical and biophysical perspective, we briefly survey the molecular mechanisms in an attempt to functionally integrate the key proteins into the emerging picture of the neuronal fusion machine.	[Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Fasshauer, Dirk] Univ Lausanne, Fac Biol & Med, Dept Basic Neurosci, CH-1005 Lausanne, Switzerland	Max Planck Society; University of Lausanne	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282; Jahn, Reinhard/0000-0003-1542-3498	National Institutes of Health [3P01GM072694-05S1]; Swiss National Fond [31003A_133055]; Deutsche Forschungsgemeinschaft [FA 297/3-1, SFB 803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Fond(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories was supported by grants from the National Institutes of Health (3P01GM072694-05S1) to D. F. and R.J., of the Swiss National Fond to D. F. (31003A_133055) and of the Deutsche Forschungsgemeinschaft to D. F. (FA 297/3-1) and R.J. (SFB 803). The authors thank H. Grubmuller, E. Neher, J. Rissellada, G. van den Bogaart, M. Hernandez, J. Sorensen and J. Rizo for discussions and critical reading of the manuscript. We apologize to all colleagues whose work, although relevant, could not be mentioned and/or cited owing to space limitations.	Aeffner S., P NATL ACAD IN PRESS; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 1997, J BIOL CHEM, V272, P2520; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BRENNER S, 1974, GENETICS, V77, P71; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Diao JJ, 2011, BIOSCIENCE REP, V31, P457, DOI 10.1042/BSR20110011; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez-Busnadiego R, 2011, J ELECTRON MICROSC, V60, pS137, DOI 10.1093/jmicro/dfr018; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Knecht V, 2003, BIOPHYS J, V84, P1527, DOI 10.1016/S0006-3495(03)74965-0; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; KOZLOV MM, 1983, BIOFIZIKA+, V28, P242; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kuo WW, 2011, BIOCHEMISTRY-US, V50, P2633, DOI 10.1021/bi200049c; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lai AL, 2011, J MOL BIOL, V405, P696, DOI 10.1016/j.jmb.2010.11.015; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Lygina AS, 2011, ANGEW CHEM INT EDIT, V50, P8597, DOI 10.1002/anie.201101951; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Marsden HR, 2009, ANGEW CHEM INT EDIT, V48, P2330, DOI 10.1002/anie.200804493; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Moss TJ, 2011, TRENDS CELL BIOL, V21, P416, DOI 10.1016/j.tcb.2011.03.009; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Neher E, 2010, NEURON, V68, P803, DOI 10.1016/j.neuron.2010.11.038; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Qian S, 2012, BIOPHYS J, V102, P48, DOI 10.1016/j.bpj.2011.11.4009; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Sigrist SJ, 2012, CURR OPIN NEUROBIOL, V22, P86, DOI 10.1016/j.conb.2011.10.014; Siksou L, 2011, CURR OPIN NEUROBIOL, V21, P261, DOI 10.1016/j.conb.2010.12.003; Simonsson L, 2010, CHEMPHYSCHEM, V11, P1011, DOI 10.1002/cphc.200901010; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NEURON, V64, P295, DOI 10.1016/j.neuron.2009.10.026; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudhof TC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Walter AM, 2011, TRENDS NEUROSCI, V34, P487, DOI 10.1016/j.tins.2011.07.003; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wang TT, 2009, BIOPHYS J, V96, P4122, DOI 10.1016/j.bpj.2009.02.050; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wiederhold K, 2010, J BIOL CHEM, V285, P21549, DOI 10.1074/jbc.M110.105148; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Xue MS, 2010, NAT STRUCT MOL BIOL, V17, P568, DOI 10.1038/nsmb.1791; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	117	635	641	7	373	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					201	207		10.1038/nature11320	http://dx.doi.org/10.1038/nature11320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060190	Green Published, Green Accepted			2022-12-28	WOS:000309733300038
J	Maercker, M; Mohamed, S; Vlemmings, WHT; Ramstedt, S; Groenewegen, MAT; Humphreys, E; Kerschbaum, F; Lindqvist, M; Olofsson, H; Paladini, C; Wittkowski, M; de Gregorio-Monsalvo, I; Nyman, LA				Maercker, M.; Mohamed, S.; Vlemmings, W. H. T.; Ramstedt, S.; Groenewegen, M. A. T.; Humphreys, E.; Kerschbaum, F.; Lindqvist, M.; Olofsson, H.; Paladini, C.; Wittkowski, M.; de Gregorio-Monsalvo, I.; Nyman, L. -A.			Unexpectedly large mass loss during the thermal pulse cycle of the red giant star R Sculptoris	NATURE			English	Article							DETACHED SHELLS; CIRCUMSTELLAR ENVELOPES; HIGH-RESOLUTION; BRANCH STARS; AGB STARS; NEBULAE; ORIGIN	The asymptotic-giant-branch star R Sculptoris is surrounded by a detached shell of dust and gas(1,2). The shell originates from a thermal pulse during which the star underwent a brief period of increased mass loss(3,4). It has hitherto been impossible to constrain observationally the timescales and mass-loss properties during and after a thermal pulse-parameters that determine the lifetime of the asymptotic giant branch and the amount of elements returned by the star. Here we report observations of CO emission from the circumstellar envelope and shell around R Sculptoris with an angular resolution of 1.3 ''. What was previously thought to be only a thin, spherical shell with a clumpy structure is revealed to also contain a spiral structure. Spiral structures associated with circumstellar envelopes have been previously seen, leading to the conclusion that the systems must be binaries(5-8). Combining the observational data with hydrodynamic simulations, we conclude that R Sculptoris is a binary system that underwent a thermal pulse about 1,800 years ago, lasting approximately 200 years. About 3 x 10(-3) solar masses of material were ejected at a velocity of 14.3 km s(-1) and at a rate around 30 times higher than the pre-pulse mass-loss rate. This shows that about three times more mass was returned to the interstellar medium during and immediately after the pulse than previously thought.	[Maercker, M.; Humphreys, E.; Wittkowski, M.] European So Observ, D-85748 Garching, Germany; [Maercker, M.; Ramstedt, S.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Mohamed, S.] S African Astron Observ, ZA-7935 Cape Town, Western Cape, South Africa; [Vlemmings, W. H. T.; Lindqvist, M.; Olofsson, H.] Chalmers Univ Technol, Dept Earth & Space Sci, Onsala Space Observ, SE-43992 Onsala, Sweden; [Groenewegen, M. A. T.] Royal Observ Belgium, B-1180 Brussels, Belgium; [Kerschbaum, F.; Paladini, C.] Univ Vienna, Dept Astrophys, A-1180 Vienna, Austria; [de Gregorio-Monsalvo, I.; Nyman, L. -A.] Joint ALMA Observ, Santiago, Chile	European Southern Observatory; University of Bonn; National Research Foundation - South Africa; South African Astronomical Observatory; Chalmers University of Technology; University of Vienna	Maercker, M (corresponding author), European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany.	mmaercke@eso.org	Kerschbaum, Franz/AAB-1523-2019; Mohamed, Shazrene/AHA-7739-2022	Kerschbaum, Franz/0000-0001-6320-0980; /0000-0002-2700-9916; /0000-0002-9030-0546; Paladini, Claudia/0000-0003-4974-7239; Mohamed, Shazrene/0000-0002-1856-9225; de Gregorio-Monsalvo, Itziar/0000-0003-4518-407X; Humphreys, Elizabeth/0000-0001-9549-6421; Wittkowski, Markus/0000-0002-7952-9550; Lindqvist, Michael/0000-0002-3669-0715; Groenewegen, Martin/0000-0003-2723-6075	ADS/JAO.ALMA [2011.0.00131.S]; Austrian Science Fund FWF [P23586-N16, I163-N16, P23006-N16]; Austrian Science Fund (FWF) [P 23586, P 23006] Funding Source: researchfish	ADS/JAO.ALMA; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This paper makes use of ALMA data from project no. ADS/JAO.ALMA#2011.0.00131.S. ALMA is a partnership of ESO (representing its member states), the NSF (USA) and NINS (Japan), together with the NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. We gratefully acknowledge the technical expertise and assistance provided by the Spanish Supercomputing Network (Red Espanola de Supercomputacion), as well as the use of the LaPalma Supercomputer, located at the Instituto de Astrofisica de Canarias. F. K. acknowledges funding by the Austrian Science Fund FWF under project numbers P23586-N16 and I163-N16. C. P. acknowledges funding by the Austrian Science Fund FWF under project number P23006-N16.	Brinch C, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201015333; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Cox NLJ, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117910; De Marco O, 2009, PUBL ASTRON SOC PAC, V121, P316, DOI 10.1086/597765; Dinh-V-Trung, 2009, ASTROPHYS J, V701, P292, DOI 10.1088/0004-637X/701/1/292; Karakas A, 2007, PUBL ASTRON SOC AUST, V24, P103, DOI 10.1071/AS07021; Kim H, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/136; Mastrodemos N, 1999, ASTROPHYS J, V523, P357, DOI 10.1086/307717; Mattsson L, 2007, ASTRON ASTROPHYS, V470, P339, DOI 10.1051/0004-6361:20066368; Mauron N, 2006, ASTRON ASTROPHYS, V452, P257, DOI 10.1051/0004-6361:20054739; Mohamed S, 2007, ASTR SOC P, V372, P397; Olofsson H, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913929; OLOFSSON H, 1988, ASTRON ASTROPHYS, V196, pL1; Olofsson H, 2000, ASTRON ASTROPHYS, V353, P583; Politano M, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/5; Schoier FL, 2005, ASTRON ASTROPHYS, V436, P633, DOI 10.1051/0004-6361:20042510; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Steffen M, 2000, ASTRON ASTROPHYS, V357, P180	18	125	125	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					232	234		10.1038/nature11511	http://dx.doi.org/10.1038/nature11511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060194	Green Submitted			2022-12-28	WOS:000309733300043
J	Gunn, S; Gromelski, T				Gunn, Steven; Gromelski, Tomasz			The art of medicine For whom the bell tolls: accidental deaths in Tudor England	LANCET			English	Editorial Material									[Gunn, Steven] Univ Oxford Merton Coll, Oxford OX1 4JD, England; [Gromelski, Tomasz] Univ Oxford Wolfson Coll, Oxford OX2 6UD, England	University of Oxford; University of Oxford	Gunn, S (corresponding author), Univ Oxford Merton Coll, Oxford OX1 4JD, England.	steven.gunn@merton.ox.ac.uk			ESRC [ES/I005218/1] Funding Source: UKRI; Economic and Social Research Council [ES/I005218/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Gunn S, 2011, BBC HISTORY MAGAZINE, V12/13, P46; Gunn S, 2010, PAST PRESENT, P53, DOI 10.1093/pastj/gtq029; Loar C, 2010, SOC HIST MED, V23, P475, DOI 10.1093/shm/hkq010; Towner E, 2008, J EPIDEMIOL COMMUN H, V62, P952, DOI 10.1136/jech.2007.067918	4	0	0	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1222	1223		10.1016/S0140-6736(12)61702-4	http://dx.doi.org/10.1016/S0140-6736(12)61702-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	020NG	23057076	Green Submitted			2022-12-28	WOS:000309817500013
J	Liu, GH; Qu, J; Suzuki, K; Nivet, E; Li, M; Montserrat, N; Yi, F; Xu, XL; Ruiz, S; Zhang, WQ; Wagner, U; Kim, A; Ren, B; Li, Y; Goebl, A; Kim, J; Soligalla, RD; Dubova, I; Thompson, J; Yates, J; Esteban, CR; Sancho-Martinez, I; Belmonte, JCI				Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Montserrat, Nuria; Yi, Fei; Xu, Xiuling; Ruiz, Sergio; Zhang, Weiqi; Wagner, Ulrich; Kim, Audrey; Ren, Bing; Li, Ying; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Thompson, James; Yates, John, III; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos			Progressive degeneration of human neural stem cells caused by pathogenic LRRK2	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; KINASE-ACTIVITY; 14-3-3 BINDING; DISEASE; INHIBITION; MUTATIONS; EFFICIENT; EXPRESSION; NUCLEUS	Nuclear-architecture defects have been shown to correlate with the manifestation of a number of human diseases as well as ageing(1-4). It is therefore plausible that diseases whose manifestations correlate with ageing might be connected to the appearance of nuclear aberrations over time. We decided to evaluate nuclear organization in the context of ageing-associated disorders by focusing on a leucine-rich repeat kinase 2 (LRRK2) dominant mutation (G2019S; glycine-to-serine substitution at amino acid 2019), which is associated with familial and sporadic Parkinson's disease as well as impairment of adult neurogenesis in mice(5). Here we report on the generation of induced pluripotent stem cells (iPSCs) derived from Parkinson's disease patients and the implications of LRRK2 (G2019S) mutation in human neural-stem-cell (NSC) populations. Mutant NSCs showed increased susceptibility to proteasomal stress as well as passage-dependent deficiencies in nuclear-envelope organization, clonal expansion and neuronal differentiation. Disease phenotypes were rescued by targeted correction of the LRRK2 (G2019S) mutation with its wild-type counterpart in Parkinson's disease iPSCs and were recapitulated after targeted knock-in of the LRRK2(G2019S) mutation in human embryonic stem cells. Analysis of human brain tissue showed nuclear-envelope impairment in clinically diagnosed Parkinson's disease patients. Together, our results identify the nucleus as a previously unknown cellular organelle in Parkinson's disease pathology and may help to open new avenues for Parkinson's disease diagnoses as well as for the potential development of therapeutics targeting this fundamental cell structure.	[Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Yi, Fei; Ruiz, Sergio; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Guang-Hui; Qu, Jing; Xu, Xiuling; Zhang, Weiqi; Li, Ying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Wagner, Ulrich; Kim, Audrey; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Salk Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghliu@ibp.ac.cn; belmonte@salk.edu	Li, Mo/J-2090-2014; Li, Mo/AAM-8266-2021; Qu, Jing/ABB-9088-2020; Ruiz, Sergio/G-1561-2016; Montserrat, Nuria/F-3136-2016; Nivet, Emmanuel/C-2729-2014	Li, Mo/0000-0003-0827-8907; Ruiz, Sergio/0000-0002-0177-6965; Montserrat, Nuria/0000-0002-1603-1755; Nivet, Emmanuel/0000-0001-7903-4059; Liu, Guang-Hui/0000-0001-9289-8177; Suzuki, Keiichiro/0000-0001-5603-9105; Zhang, Weiqi/0000-0002-8885-5104; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038	Thousand Young Talents program of China; National Laboratory of Biomacromolecules; Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC) [81271266, 31222039]; Beijing Municipal Natural Science Foundation; AFAR/Ellison Medical Foundation; Uehara Memorial Foundation; F.M. Kirby Foundation; NSFC [31201111]; US National Institute of Health (NIH) [ES017166]; Ludwig Institute for Cancer Research; NIH [P41 RR011823]; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine; Ellison Medical Foundation; Helmsley Charitable Trust; ERA-Net Neuron; MINECO; Fundacion Cellex; (G. Gaslini Institute)-Telethon Genetic Biobank Network [GTB07001]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); F.M. Kirby Foundation; NSFC(National Natural Science Foundation of China (NSFC)); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ERA-Net Neuron; MINECO(Spanish Government); Fundacion Cellex(Foundation CELLEX); (G. Gaslini Institute)-Telethon Genetic Biobank Network(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank K. Mitani, P. Ng, A. Lieber, Y. Imai, M. A. Miyawaki, Filocamo, S. Goldwurm, Telethon Genetic Biobank Network for providing constructs and cells (the fibroblast samples were obtained from the "Cell Line and DNA Biobank from patients affected by Genetic Diseases" (G. Gaslini Institute)-Telethon Genetic Biobank Network (project no. GTB07001)); Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS for providing human brain tissue; F. Gage, M. Hetzer, J. Yao, Y. Mu, D. Yu, E. Gelpi, X. M. Wang, X. Wang, G. Bai and Z. J. Liu for helpful discussions; M. Joens and J. Fitzpatrick of the Waitt Advanced Biophotonics Core Facility for performing TEM analysis; M. Marti for imaging, teratoma and karyotyping analysis; F. Osakada for statistics analysis; and M. Schwarz, P. Schwarz and L. Laricchia-Robbio for administrative help. G.-H.L. is supported by the Thousand Young Talents program of China, the National Laboratory of Biomacromolecules, the Strategic Priority Research Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (NSFC) (81271266 and 31222039), and the Beijing Municipal Natural Science Foundation. J.Q. was partly supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship. K.S. was partly supported by a Uehara Memorial Foundation research fellowship. E.N. was partly supported by an F.M. Kirby Foundation postdoctoral fellowship. X.X. is supported by NSFC (31201111). B.R. was supported by a US National Institute of Health (NIH) grant (ES017166) and the Ludwig Institute for Cancer Research. J.Y. was supported by an NIH grant (P41 RR011823). J.C.I.B. was supported by grants from the Glenn Foundation, G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi, the California Institute of Regenerative Medicine, the Ellison Medical Foundation, the Helmsley Charitable Trust, ERA-Net Neuron, MINECO and Fundacion Cellex.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Chang KH, 2011, MOL BIOL CELL, V22, P1452, DOI 10.1091/mbc.E10-07-0654; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x	30	248	265	1	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					603	607		10.1038/nature11557	http://dx.doi.org/10.1038/nature11557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075850	Green Accepted			2022-12-28	WOS:000311339800054
J	Zaki, AM; van Boheemen, S; Bestebroer, TM; Osterhaus, ADME; Fouchier, RAM				Zaki, Ali Moh; van Boheemen, Sander; Bestebroer, Theo M.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; PCR ASSAYS; IDENTIFICATION; DISEASE; INFLUENZA; GENOMES	A previously unknown coronavirus was isolated from the sputum of a 60-year-old man who presented with acute pneumonia and subsequent renal failure with a fatal outcome in Saudi Arabia. The virus (called HCoV-EMC) replicated readily in cell culture, producing cytopathic effects of rounding, detachment, and syncytium formation. The virus represents a novel betacoronavirus species. The closest known relatives are bat coronaviruses HKU4 and HKU5. Here, the clinical data, virus isolation, and molecular identification are presented. The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.	[Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Virosci Lab, NL-3015 GE Rotterdam, Netherlands; [Zaki, Ali Moh] Dr Soliman Fakeeh Hosp, Jeddah, Saudi Arabia	Erasmus University Rotterdam; Erasmus MC	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, Virosci Lab, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported in part by the European Commission Seventh Framework Program for Research and Technological Development Project EMPERIE.	Corman V. M., 2012, EURO SURVEILL, V17; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kaw G. J. L., 2003, SMJ Singapore Medical Journal, V44, P201; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; The International Committee on Taxonomy of Viruses, 2012, VIRUS TAXONOMY CLASS; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; van Boheemen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034961; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001; Vijgen Leen, 2008, V454, P3, DOI 10.1007/978-1-59745-181-9_1; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2012, NOV COR INF UPD REV	25	3499	3718	15	436	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1814	1820		10.1056/NEJMoa1211721	http://dx.doi.org/10.1056/NEJMoa1211721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23075143	Bronze, Green Published			2022-12-28	WOS:000310773200008
J	McCartney, M				McCartney, Margaret			The assault on the Liverpool care pathway	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2010, DAILY MAIL; [Anonymous], 2004, DAILY MAIL; [Anonymous], 2012, DAILY MAIL; Boggan S., 2009, DAILY MAIL; Catholic Herald, 2010, CATHOLIC HERALD 0423; Christian Medical Comment, 2012, LIVERPOOL CARE PATHW; Clarke N., DIS NHS KILL MY MOTH; Doughty, 2012, DAILY MAIL; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6654; Maes N., 2011, DAILY MAIL; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Phillips M., 2012, DAILY MAIL; Preston M, 2007, END LIFE CARE, V1, P1	13	14	14	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 30	2012	345								e7316	10.1136/bmj.e7316	http://dx.doi.org/10.1136/bmj.e7316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EY	23112122				2022-12-28	WOS:000310778200019
J	Kaufman, F				Kaufman, Frederick			Wall Street's thirst for water	NATURE			English	Editorial Material									CUNY, Grad Sch Journalism, New York, NY 10018 USA	City University of New York (CUNY) System	Kaufman, F (corresponding author), CUNY, Grad Sch Journalism, New York, NY 10018 USA.							Brookshire D. S., 2011, RFF PRESS WATER POLI; Ghosh N, 2010, COMMODITY VISION, V4, P8; Global Water Partnership and International Network of Basin Organizations, 2009, HDB INT WAT RES MAN; Kaufman F., 2011, FOREIGN POLICY; Keim B., 2012, WIRED SCI       0306; Lagi M, 2011, PREPRINT; Moya E., 2010, GUARDIAN; Nguyen A., 2011, BLOOMBERG       1214	8	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					469	471		10.1038/490469a	http://dx.doi.org/10.1038/490469a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NK	23099383	Bronze			2022-12-28	WOS:000310196200012
J	Volpp, KG; Loewenstein, G; Asch, DA				Volpp, Kevin G.; Loewenstein, George; Asch, David A.			Choosing Wisely Low-Value Services, Utilization, and Patient Cost Sharing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE DESIGN; COVERAGE; CARE		[Volpp, Kevin G.; Asch, David A.] Univ Penn, Perelman Sch Med, Ctr Hlth Equity Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Loewenstein, George; Asch, David A.] Univ Penn, Perelman Sch Med, Leonard Davis Inst Ctr Hlth Incent & Behav Econ, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Dept Hlth Care Management, Wharton Sch, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Penn Med Ctr Innovat, Philadelphia, PA USA; [Loewenstein, George] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Carnegie Mellon University	Volpp, KG (corresponding author), Univ Penn, Perelman Sch Med, Ctr Hlth Equity Res & Promot, Philadelphia Vet Affairs Med Ctr, 1120 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599	NIA NIH HHS [P30 AG034546, RC4 AG039114, RC2 AG036592] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RC4AG039114, RC2AG036592, P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Fendrick AM, 2006, AM J MANAG CARE, V12, P18; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; PAULY MV, 1990, J HEALTH ECON, V9, P447, DOI 10.1016/0167-6296(90)90005-N; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500	7	53	54	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1635	1636		10.1001/jama.2012.13616	http://dx.doi.org/10.1001/jama.2012.13616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028PI	23093160	Green Accepted			2022-12-28	WOS:000310434100015
J	Beaudet, AL				Beaudet, Arthur L.			Preventable Forms of Autism?	SCIENCE			English	Editorial Material							AMINO-ACID TRANSPORTER; SPECTRUM DISORDERS; MUTATIONS; CARNITINE; ATB(0,+); DISEASE; RISK; AGE		Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006485, U54HG003273] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000188] Funding Source: Medline; NHGRI NIH HHS [U54 HG003273, U01 HG006485] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Karst JS, 2012, CLIN CHILD FAM PSYCH, V15, P247, DOI 10.1007/s10567-012-0119-6; Karunakaran S, 2011, J BIOL CHEM, V286, P31830, DOI 10.1074/jbc.M111.229518; Keyes KM, 2012, INT J EPIDEMIOL, V41, P495, DOI 10.1093/ije/dyr193; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; Miles JH, 2000, AM J MED GENET, V91, P245, DOI 10.1002/(SICI)1096-8628(20000410)91:4<245::AID-AJMG1>3.3.CO;2-U; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Nordahl CW, 2011, P NATL ACAD SCI USA, V108, P20195, DOI 10.1073/pnas.1107560108; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Srinivasan BS, 2010, REPROD BIOMED ONLINE, V21, P537, DOI 10.1016/j.rbmo.2010.05.012; 2007, MMWR SURVEILL SUMM, V56, P12	15	16	17	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					342	343		10.1126/science.1229178	http://dx.doi.org/10.1126/science.1229178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087240	Green Accepted			2022-12-28	WOS:000309955800031
J	Bottjer, DJ				Bottjer, David J.			Life in the Early Triassic Ocean	SCIENCE			English	Editorial Material							PERMIAN MASS EXTINCTION; ACIDIFICATION; AFTERMATH; REEFS; TIME		Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of Southern California	Bottjer, DJ (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	dbottjer@usc.edu						Algeo TJ, 2010, GEOLOGY, V38, P1023, DOI 10.1130/G31203.1; Baud A, 2007, GLOBAL PLANET CHANGE, V55, P81, DOI 10.1016/j.gloplacha.2006.06.008; Brayard A, 2011, NAT GEOSCI, V4, P693, DOI 10.1038/NGEO1264; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Hinojosa JL, 2012, GEOLOGY, V40, P743, DOI 10.1130/G33048.1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kiehl J, 2011, SCIENCE, V331, P158, DOI 10.1126/science.1199380; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; Marenco PJ, 2012, GEOLOGY, V40, P715, DOI 10.1130/G32936.1; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Payne JL, 2012, ANNU REV EARTH PL SC, V40, P89, DOI 10.1146/annurev-earth-042711-105329; Powers CM, 2008, J PALEONTOL, V82, P362, DOI 10.1666/06-131.1; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126	15	12	13	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					336	337		10.1126/science.1228998	http://dx.doi.org/10.1126/science.1228998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087236				2022-12-28	WOS:000309955800027
J	Newman, SA				Newman, Stuart A.			Physico-Genetic Determinants in the Evolution of Development	SCIENCE			English	Editorial Material							BIOLOGICAL PATTERN-FORMATION; AMPHIMEDON-QUEENSLANDICA; SEGMENTATION CLOCK; GENOME; ORIGIN; COMPLEXITY; DROSOPHILA; EXPLOSION; MODEL; WNT	Animal bodies and the embryos that generate them exhibit an assortment of stereotypic morphological motifs that first appeared more than half a billion years ago. During development, cells arrange themselves into tissues with interior cavities and multiple layers with immiscible boundaries, containing patterned arrangements of cell types. These tissues go on to elongate, fold, segment, and form appendages. Their motifs are similar to the outcomes of physical processes generic to condensed, chemically excitable, viscoelastic materials, although the embryonic mechanisms that generate them are typically much more complex. I propose that the origins of animal development lay in the mobilization of physical organizational effects that resulted when certain gene products of single-celled ancestors came to operate on the spatial scale of multicellular aggregates.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College	Newman, SA (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	newman@nymc.edu	Newman, Stuart/W-1617-2019					Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Harrington MJ, 2009, MOL REPROD DEV, V76, P954, DOI 10.1002/mrd.21085; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Newman SA, 2006, INT J DEV BIOL, V50, P289, DOI 10.1387/ijdb.052049sn; Newman SA, 2011, J EXP ZOOL PART B, V316B, P467, DOI 10.1002/jez.b.21417; Newman SA, 2009, INT J DEV BIOL, V53, P693, DOI 10.1387/ijdb.072481sn; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Reinke H, 2006, TRENDS BIOCHEM SCI, V31, P189, DOI 10.1016/j.tibs.2006.02.001; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shen B, 2008, SCIENCE, V319, P81, DOI 10.1126/science.1150279; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Strogatz S., 2003, SYNC THE EMERGING SC; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Tyson JJ, 2011, CURR BIOL, V21, pR185, DOI 10.1016/j.cub.2011.01.042; Wilkins A., 2002, THE EVOLUTION OF DEV	30	61	66	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					217	219		10.1126/science.1222003	http://dx.doi.org/10.1126/science.1222003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066074	Green Submitted			2022-12-28	WOS:000309712300035
J	Wang, X; Zhang, XL; Dong, XP; Samie, M; Li, XR; Cheng, XP; Goschka, A; Shen, DB; Zhou, YD; Harlow, J; Zhu, MX; Clapham, DE; Ren, DJ; Xu, HX				Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Zhou, Yandong; Harlow, Janice; Zhu, Michael X.; Clapham, David E.; Ren, Dejian; Xu, Haoxing			TPC Proteins Are Phosphoinositide-Activated Sodium-Selective Ion Channels in Endosomes and Lysosomes	CELL			English	Article							CA2+; NAADP; CALCIUM; IDENTIFICATION; RECEPTORS; CATIONS	Mammalian two-pore channel proteins (TPC1, TPC2; TPCN1, TPCN2) encode ion channels in intracellular endosomes and lysosomes and were proposed to mediate endolysosomal calcium release triggered by the second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). By directly recording TPCs in endolysosomes from wild-type and TPC double-knockout mice, here we show that, in contrast to previous conclusions, TPCs are in fact sodium-selective channels activated by PI(3,5)P-2 and are not activated by NAADP. Moreover, the primary endolysosomal ion is Na+, not K+, as had been previously assumed. These findings suggest that the organellar membrane potential may undergo large regulatory changes and may explain the specificity of PI(3,5)P-2 in regulating the fusogenic potential of intracellular organelles.	[Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zhou, Yandong; Harlow, Janice; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Clapham, David E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	xu, hao/GWQ-7394-2022; Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Dong, Xianping/0000-0002-4496-7104	NIH [NS062792, NS055293, GM081658]; Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293, R01NS062792, R01NS074257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 grants (NS062792 to H. X., NS055293 to D. R., GM081658 to M.X.Z., and HHMI to D. E. C.) and a Sloan Research Fellowship (to H. X.). We thank the Gene Manipulation Facility of Children's Hospital Boston (TPC1) and the Transgenic and Chimera Mouse Facility at the University of Pennsylvania (TPC2) for embryonic stem cell injection. The authors are listed in the order of their institutions; X. W. initiated the project; X. W., X.Z., and X.-p. D. performed the electrophysiology experiments; X. W. also performed the Ca<SUP>2+</SUP> imaging experiments; M. S. and A. G. performed the ionic composition experiments; X. L., X. C., D. S., and M. X.Z. contributed the reagents; D. R. and J.H. developed the TPC1, TPC2 knockout mouse lines and the hTPC1, hTPC2, hTPC1 Delta N, and hTPC2 Delta N constructs; Y.Z. measured the glucose- and NAADP-induced Ca<SUP>2+</SUP> responses in the TPC mutant islets compared with wild-type; development of the TPC1 knockout was carried out by D. R. in the laboratory of D. E. C.; and H. X. and D. E. C. wrote the paper with input from all authors. We are grateful to Drs. Susan Slaugenhaupt and James Slama for sharing reagents; Drs. Ted Huston, Hollis Showalter, Yafei Jin, Leslie Satin, Jianhua Ren, Peter Arvan, and Gautam Rajpal for assistance; and Dr. Richard Hume for comments on an earlier version of the manuscript. We appreciate the encouragement and helpful comments from other members of the Xu, Ren, and Clapham laboratories.	ANZAI K, 1993, J BIOCHEM-TOKYO, V114, P487, DOI 10.1093/oxfordjournals.jbchem.a124204; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; COHN DV, 1968, J BIOL CHEM, V243, P1089; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kraayenhof R, 1996, BBA-BIOMEMBRANES, V1282, P293, DOI 10.1016/0005-2736(96)00069-7; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; SCHMIDT R, 1980, NEUROSCIENCE, V5, P625, DOI 10.1016/0306-4522(80)90060-3; Seby F, 2003, ANAL BIOANAL CHEM, V377, P685, DOI 10.1007/s00216-003-2133-5; Shen DB, 2011, BIOESSAYS, V33, P448, DOI 10.1002/bies.201000152; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	350	355	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					372	383		10.1016/j.cell.2012.08.036	http://dx.doi.org/10.1016/j.cell.2012.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063126	Green Accepted, Bronze			2022-12-28	WOS:000309981000015
J	Adesnik, H; Bruns, W; Taniguchi, H; Huang, ZJ; Scanziani, M				Adesnik, Hillel; Bruns, William; Taniguchi, Hiroki; Huang, Z. Josh; Scanziani, Massimo			A neural circuit for spatial summation in visual cortex	NATURE			English	Article							CLASSICAL RECEPTIVE-FIELD; NEURONS; INHIBITION; CONTRAST; V1; CONNECTIONS; GENERATION; RESPONSES; DYNAMICS; SPARSE	The response of cortical neurons to a sensory stimulus is modulated by the context. In the visual cortex, for example, stimulation of a pyramidal cell's receptive-field surround can attenuate the cell's response to a stimulus in the centre of its receptive field, a phenomenon called surround suppression. Whether cortical circuits contribute to surround suppression or whether the phenomenon is entirely relayed from earlier stages of visual processing is debated. Here we show that, in contrast to pyramidal cells, the response of somatostatin-expressing inhibitory neurons (SOMs) in the superficial layers of the mouse visual cortex increases with stimulation of the receptive-field surround. This difference results from the preferential excitation of SOMs by horizontal cortical axons. By perturbing the activity of SOMs, we show that these neurons contribute to pyramidal cells' surround suppression. These results establish a cortical circuit for surround suppression and attribute a particular function to a genetically defined type of inhibitory neuron.	[Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Huang, Z. Josh/0000-0003-0592-028X	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI); Gatsby charitable foundation; US National Institute of Health [NS069010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS069010] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Gatsby charitable foundation; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. Evora for the reconstruction of SOMs and technical assistance. We thank C. Niell and M. Stryker for providing expertise and sharing code used at the initial stages of this project; S. Olsen for providing the firing rates of part of the units isolated under anaesthesia; P. Abelkop and A. Linder for technical assistance; and J. Isaacson and members of the Scanziani laboratory for helpful advice. H. A. was supported by the Helen Hay Whitney Foundation and the Howard Hughes Medical Institute (HHMI). W. B. and M. S. were supported by the HHMI, the Gatsby charitable foundation and US National Institute of Health grant NS069010.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Mareschal I, 2004, VISION RES, V44, P57, DOI 10.1016/j.visres.2003.07.009; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Sceniak MP, 2006, J NEUROPHYSIOL, V96, P3474, DOI 10.1152/jn.00734.2006; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Taniguchi H, 2011, NEURON, V72, P1091, DOI 10.1016/j.neuron.2011.12.010; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	40	397	399	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					226	231		10.1038/nature11526	http://dx.doi.org/10.1038/nature11526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060193	Green Accepted			2022-12-28	WOS:000309733300042
J	Steinbrook, R; Sharfstein, JM				Steinbrook, Robert; Sharfstein, Joshua M.			The FDA Safety and Innovation Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinbrook, Robert] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Yale University; Maryland Department of Health & Mental Hygiene	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	2	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1437	1438		10.1001/jama.2012.12829	http://dx.doi.org/10.1001/jama.2012.12829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047356				2022-12-28	WOS:000309579300020
J	Ko, JH; Shih, YC; Huang, YH; Yang, CH				Ko, Jui-Hung; Shih, Yi-Chin; Huang, Yu-Huei; Yang, Chih-Hsun			Pseudoxanthoma elasticum	LANCET			English	Editorial Material									[Ko, Jui-Hung; Shih, Yi-Chin; Huang, Yu-Huei; Yang, Chih-Hsun] Chang Gung Mem Hosp, Dept Dermatol, Taipei 105, Taiwan; [Ko, Jui-Hung; Shih, Yi-Chin; Huang, Yu-Huei; Yang, Chih-Hsun] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, 199 Tung Hwa N Rd, Taipei 105, Taiwan.	huang3764@mail2000.com.tw							0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					565	565		10.1016/S0140-6736(12)61130-1	http://dx.doi.org/10.1016/S0140-6736(12)61130-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23084479				2022-12-28	WOS:000314927500031
J	Pletsch, HJ; Guillemot, L; Fehrmann, H; Allen, B; Kramer, M; Aulbert, C; Ackermann, M; Ajello, M; de Angelis, A; Atwood, WB; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Bechtol, K; Bellazzini, R; Borgland, AW; Bottacini, E; Brandt, TJ; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Charles, E; Chaves, RCG; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Cutini, S; D'Ammando, F; Dermer, CD; Digel, SW; Drell, PS; Drlica-Wagner, A; Dubois, R; Dumora, D; Favuzzi, C; Ferrara, EC; Franckowiak, A; Fukazawa, Y; Fusco, P; Gargano, F; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; den Hartog, PR; Hayashida, M; Hays, E; Hill, AB; Hou, X; Hughes, RE; Johannesson, G; Jackson, MS; Jogler, T; Johnson, AS; Johnson, WN; Kataoka, J; Kerr, M; Knodlseder, J; Kuss, M; Lande, J; Larsson, S; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Massaro, F; Mayer, M; Mazziotta, MN; McEnery, JE; Mehault, J; Michelson, PF; Mitthumsiri, W; Mizuno, T; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nemmen, R; Nuss, E; Ohno, M; Ohsugi, T; Omodei, N; Orienti, M; Orlando, E; de Palma, F; Paneque, D; Perkins, JS; Piron, F; Pivato, G; Porter, TA; Raino, S; Rando, R; Ray, PS; Razzano, M; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Romani, RW; Romoli, C; Sanchez, DA; Parkinson, PMS; Schulz, A; Sgro, C; Silva, EDE; Siskind, EJ; Smith, DA; Spandre, G; Spinelli, P; Suson, DJ; Takahashi, H; Tanaka, T; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Tinivella, M; Troja, E; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Waite, AP; Winer, BL; Wood, KS; Wood, M; Yang, Z; Zimmer, S				Pletsch, H. J.; Guillemot, L.; Fehrmann, H.; Allen, B.; Kramer, M.; Aulbert, C.; Ackermann, M.; Ajello, M.; de Angelis, A.; Atwood, W. B.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Borgland, A. W.; Bottacini, E.; Brandt, T. J.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Charles, E.; Chaves, R. C. G.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Cutini, S.; D'Ammando, F.; Dermer, C. D.; Digel, S. W.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Dumora, D.; Favuzzi, C.; Ferrara, E. C.; Franckowiak, A.; Fukazawa, Y.; Fusco, P.; Gargano, F.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; den Hartog, P. R.; Hayashida, M.; Hays, E.; Hill, A. B.; Hou, X.; Hughes, R. E.; Johannesson, G.; Jackson, M. S.; Jogler, T.; Johnson, A. S.; Johnson, W. N.; Kataoka, J.; Kerr, M.; Knoedlseder, J.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Massaro, F.; Mayer, M.; Mazziotta, M. N.; McEnery, J. E.; Mehault, J.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nemmen, R.; Nuss, E.; Ohno, M.; Ohsugi, T.; Omodei, N.; Orienti, M.; Orlando, E.; de Palma, F.; Paneque, D.; Perkins, J. S.; Piron, F.; Pivato, G.; Porter, T. A.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Romani, R. W.; Romoli, C.; Sanchez, D. A.; Parkinson, P. M. Saz; Schulz, A.; Sgro, C.; do Couto e Silva, E.; Siskind, E. J.; Smith, D. A.; Spandre, G.; Spinelli, P.; Suson, D. J.; Takahashi, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Tinivella, M.; Troja, E.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Waite, A. P.; Winer, B. L.; Wood, K. S.; Wood, M.; Yang, Z.; Zimmer, S.			Binary Millisecond Pulsar Discovery via Gamma-Ray Pulsations	SCIENCE			English	Article							LARGE-AREA TELESCOPE; BLIND FREQUENCY SEARCHES; FERMI-LAT; SPACE-TELESCOPE; SOURCE CATALOG; POPULATION; PLANET; YOUNG	Millisecond pulsars, old neutron stars spun up by accreting matter from a companion star, can reach high rotation rates of hundreds of revolutions per second. Until now, all such "recycled" rotation-powered pulsars have been detected by their spin-modulated radio emission. In a computing-intensive blind search of gamma-ray data from the Fermi Large Area Telescope (with partial constraints from optical data), we detected a 2.5-millisecond pulsar, PSR J1311-3430. This unambiguously explains a formerly unidentified gamma-ray source that had been a decade-long enigma, confirming previous conjectures. The pulsar is in a circular orbit with an orbital period of only 93 minutes, the shortest of any spin-powered pulsar binary ever found.	[Pletsch, H. J.; Fehrmann, H.; Allen, B.; Aulbert, C.] Albert Einstein Inst, Max Planck Inst Gravitat Phys, D-30167 Hannover, Germany; [Pletsch, H. J.; Fehrmann, H.; Allen, B.; Aulbert, C.] Leibniz Univ Hannover, Inst Gravitat Phys, D-30167 Hannover, Germany; [Guillemot, L.; Kramer, M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Allen, B.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Kramer, M.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 PPL, Lancs, England; [Ackermann, M.; Mayer, M.; Schulz, A.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ajello, M.; Bechtol, K.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Franckowiak, A.; Godfrey, G.; den Hartog, P. R.; Hayashida, M.; Hill, A. B.; Jogler, T.; Johnson, A. S.; Kerr, M.; Lande, J.; Massaro, F.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; do Couto e Silva, E.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Dept Phys, Stanford, CA 94305 USA; [Ajello, M.; Bechtol, K.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Franckowiak, A.; Godfrey, G.; den Hartog, P. R.; Hayashida, M.; Hill, A. B.; Jogler, T.; Johnson, A. S.; Kerr, M.; Lande, J.; Massaro, F.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; do Couto e Silva, E.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [Atwood, W. B.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Chaves, R. C. G.; Grenier, I. A.] Univ Paris Diderot, CEA Saclay, Serv Astrophys, CEA,IRFU,CNRS,Lab AIM, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Pivato, G.; Rando, R.; Romoli, C.; Tibaldo, L.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bellazzini, R.; Bregeon, J.; Kuss, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Brandt, T. J.; Knoedlseder, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [Brandt, T. J.; Knoedlseder, J.] Univ Toulouse, GAHEC, UPS OMP, IRAP, Toulouse, France; [Brigida, M.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; de Palma, F.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; de Palma, F.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; de Palma, F.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.] IEEE CSIC, Inst Ciencies Espai, Barcelona 08193, Spain; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Cecchi, C.; D'Ammando, F.; Germani, S.; Lubrano, P.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Celik, Oe; Ferrara, E. C.; Gehrels, N.; Guiriec, S.; Harding, A. K.; Hays, E.; McEnery, J. E.; Nemmen, R.; Perkins, J. S.; Thompson, D. J.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, Oe; Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Celik, Oe; Perkins, J. S.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, Oe; Perkins, J. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Cheung, C. C.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Ray, P. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ciprini, S.; Cutini, S.] ASI, Sci Data Ctr, I-00044 Rome, Italy; [Cohen-Tanugi, J.; Mehault, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Univers & Particules Montpellier, Montpellier, France; [Conrad, J.; Larsson, S.; Yang, Z.; Zimmer, S.] Stockholm Univ, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Larsson, S.; Yang, Z.; Zimmer, S.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [D'Ammando, F.] IASF Palermo, I-90146 Palermo, Italy; [D'Ammando, F.] INAF Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; [Dumora, D.; Hou, X.; Lemoine-Goumard, M.; Reposeur, T.; Smith, D. A.] Univ Bordeaux 1, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Fukazawa, Y.; Hanabata, Y.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Giroletti, M.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Grondin, M. -H.; Sanchez, D. A.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Grondin, M. -H.] Heidelberg Univ, Landessternwarte, D-69117 Heidelberg, Germany; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hill, A. B.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Jackson, M. S.] Royal Inst Technol KTH, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Kataoka, J.; Nakamori, T.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [McEnery, J. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McEnery, J. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Ohno, M.] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Perkins, J. S.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Vianello, G.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy	Max Planck Society; Leibniz University Hannover; Max Planck Society; University of Wisconsin System; University of Wisconsin Milwaukee; University of Manchester; Jodrell Bank Centre for Astrophysics; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Stockholm University; Oskar Klein Centre; Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Hiroshima University; Istituto Nazionale Astrofisica (INAF); Max Planck Society; Ruprecht Karls University Heidelberg; Kyoto University; University of Southampton; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iceland; Royal Institute of Technology; Waseda University; Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Hiroshima University; Istituto Nazionale di Fisica Nucleare (INFN); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Innsbruck; University of Innsbruck; Purdue University System; Purdue University; University of Rome Tor Vergata	Pletsch, HJ (corresponding author), Albert Einstein Inst, Max Planck Inst Gravitat Phys, D-30167 Hannover, Germany.	holger.pletsch@aei.mpg.de	Hadasch, Daniela/N-7819-2016; Morselli, Aldo/G-6769-2011; Troja, Eleonora/AAB-3604-2020; Moskalenko, Igor V/A-1301-2007; Cutini, Sara/ABB-1787-2020; Rando, Riccardo/O-1302-2019; Parkinson, Pablo Miguel Saz/I-7980-2013; Gargano, Fabio/O-8934-2015; Gargano, Fabio/AAD-5121-2021; Massaro, Francesco/L-9102-2016; Orlando, Elena/R-5594-2016; Reimer, Olaf/A-3117-2013; Bastieri, Denis/AAC-5917-2020; Mazziotta, Mario N/O-8867-2015; Allen, Bruce/K-2327-2012; Fukazawa, Yasushi/G-2081-2017; Takahashi, Hiromitsu H/T-2713-2017; Harding, Alice K/D-3160-2012; Jóhannesson, Guðlaugur/O-8741-2015; Hays, Elizabeth/D-3257-2012; Troja, Eleonora/I-5282-2017; giglietto, nicola/I-8951-2012; Giglietto, Nicola/Y-2425-2019; Jóhannesson, Guðlaugur/ABC-7216-2020; cohen-tanugi, Johann/ABB-1481-2021; Caraveo, Patrizia/AAL-5708-2020; Loparco, Francesco/O-8847-2015; Nemmen, Rodrigo/O-6841-2014; Johnson, Neil/G-3309-2014; Sgrò, Carmelo/K-3395-2016; Reimer, Anita/K-5822-2015; Rando, Riccardo/M-7179-2013	Hadasch, Daniela/0000-0001-8663-6461; Morselli, Aldo/0000-0002-7704-9553; Troja, Eleonora/0000-0002-1869-7817; Moskalenko, Igor V/0000-0001-6141-458X; Cutini, Sara/0000-0002-1271-2924; Rando, Riccardo/0000-0001-6992-818X; Gargano, Fabio/0000-0002-5055-6395; Gargano, Fabio/0000-0002-5055-6395; Massaro, Francesco/0000-0002-1704-9850; Orlando, Elena/0000-0001-6406-9910; Reimer, Olaf/0000-0001-6953-1385; Bastieri, Denis/0000-0002-6954-8862; Mazziotta, Mario N/0000-0001-9325-4672; Allen, Bruce/0000-0003-4285-6256; Fukazawa, Yasushi/0000-0002-0921-8837; Takahashi, Hiromitsu H/0000-0001-6314-5897; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Troja, Eleonora/0000-0002-1869-7817; giglietto, nicola/0000-0002-9021-2888; Giglietto, Nicola/0000-0002-9021-2888; Jóhannesson, Guðlaugur/0000-0003-1458-7036; cohen-tanugi, Johann/0000-0001-9022-4232; Caraveo, Patrizia/0000-0003-2478-8018; Loparco, Francesco/0000-0002-1173-5673; Nemmen, Rodrigo/0000-0003-3956-0331; Reimer, Anita/0000-0001-8604-7077; Hill, Adam/0000-0003-3470-4834; de Palma, Francesco/0000-0001-5898-2834; Ray, Paul/0000-0002-5297-5278; Kramer, Michael/0000-0002-4175-2271; Sgro', Carmelo/0000-0001-5676-6214; orienti, monica/0000-0003-4470-7094; Giroletti, Marcello/0000-0002-8657-8852; Ajello, Marco/0000-0002-6584-1703; SPINELLI, Paolo/0000-0001-6688-8864; Charles, Eric/0000-0002-3925-7802; Monzani, Maria Elena/0000-0002-8254-5308; Vianello, Giacomo/0000-0002-2553-0839; Giordano, Francesco/0000-0002-8651-2394; Grenier, Isabelle/0000-0003-3274-674X; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Spandre, Gloria/0000-0003-0802-3453; Ciprini, Stefano/0000-0002-0712-2479; Aulbert, Carsten/0000-0002-1481-8319; Fusco, Piergiorgio/0000-0002-9383-2425; Casandjian, Jean-Marc/0000-0003-1404-0524; Kerr, Matthew/0000-0002-0893-4073; Tanaka, Takaaki/0000-0002-4383-0368; D'Ammando, Filippo/0000-0001-7618-7527; Buehler, Rolf/0000-0003-4425-6641; Tibaldo, Luigi/0000-0001-7523-570X; Baldini, Luca/0000-0002-9785-7726; Omodei, Nicola/0000-0002-5448-7577; Cheung, Chi (Teddy)/0000-0002-4377-0174; Ackermann, Markus/0000-0001-8952-588X; Porter, Troy/0000-0002-2621-4440; Cecchi, Claudia/0000-0002-2192-8233; Buson, Sara/0000-0002-3308-324X; Cameron, Robert/0000-0003-0942-2747; Murgia, Simona/0000-0003-0516-9422; Larsson, Stefan/0000-0003-0716-107X; Romoli, Carlo/0000-0003-2541-4499; De Angelis, Alessandro/0000-0002-3288-2517; Raino', Silvia/0000-0002-9181-0345	Max-Planck-Gesellschaft	Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the Max-Planck-Gesellschaft. The Fermi LAT Collaboration acknowledges support from several agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and Department of Energy (United States), CEA/Irfu and IN2P3/CNRS (France), ASI and INFN (Italy), MEXT, KEK, and JAXA (Japan), and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board (Sweden). Additional support from INAF in Italy and CNES in France for science analysis during the operations phase is also gratefully acknowledged. Fermi LAT data are available from the Fermi Science Support Center (http://fermi.gsfc.nasa.gov/ssc).	Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Abdo AA, 2009, SCIENCE, V325, P848, DOI 10.1126/science.1176113; Ackermann M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/83; Atwood WB, 2006, ASTROPHYS J, V652, pL49, DOI 10.1086/510018; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Bailes M, 2011, SCIENCE, V333, P1717, DOI 10.1126/science.1208890; Benvenuto OG, 2012, ASTROPHYS J LETT, V753, DOI 10.1088/2041-8205/753/2/L33; Brady PR, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.082001; DEJAGER OC, 1989, ASTRON ASTROPHYS, V221, P180; FICHTEL CE, 1994, ASTROPHYS J SUPPL S, V94, P551, DOI 10.1086/192082; FRANK J, 1985, ACCRETION POWER ASTR; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Hessels JWT, 2006, SCIENCE, V311, P1901, DOI 10.1126/science.1123430; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Kerr M, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/38; Messenger C, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.083003; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; Parkinson PMS, 2010, ASTROPHYS J, V725, P571, DOI 10.1088/0004-637X/725/1/571; Pletsch HJ, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L20; Pletsch HJ, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/105; Pletsch HJ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.122003; Pletsch HJ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.042002; Pletsch HJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.181102; Ransom SM, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/1/L16; Ray PS, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/17; Romani RW, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L25; Romani RW, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/2/L26; Smith DA, 2008, ASTRON ASTROPHYS, V492, P923, DOI 10.1051/0004-6361:200810285; van Haaften LM, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201218798; Watters KP, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/123	32	78	78	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1314	1317		10.1126/science.1229054	http://dx.doi.org/10.1126/science.1229054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23112297	Green Submitted, Green Published			2022-12-28	WOS:000311991200058
J	Klein, F; Halper-Stromberg, A; Horwitz, JA; Gruell, H; Scheid, JF; Bournazos, S; Mouquet, H; Spatz, LA; Diskin, R; Abadir, A; Zang, T; Dorner, M; Billerbeck, E; Labitt, RN; Gaebler, C; Marcovecchio, PM; Incesu, RB; Eisenreich, TR; Bieniasz, PD; Seaman, MS; Bjorkman, PJ; Ravetch, JV; Ploss, A; Nussenzweig, MC				Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Bournazos, Stylianos; Mouquet, Hugo; Spatz, Linda A.; Diskin, Ron; Abadir, Alexander; Zang, Trinity; Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Gaebler, Christian; Marcovecchio, Paola M.; Incesu, Reha-Baris; Eisenreich, Thomas R.; Bieniasz, Paul D.; Seaman, Michael S.; Bjorkman, Pamela J.; Ravetch, Jeffrey V.; Ploss, Alexander; Nussenzweig, Michel C.			HIV therapy by a combination of broadly neutralizing antibodies in humanized mice	NATURE			English	Article							MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; B-CELLS; INFECTION; PROTECTION; GENERATION; VIREMIA; GENE; PCR	Human antibodies to human immunodeficiency virus-1 (HIV-1) can neutralize a broad range of viral isolates in vitro and protect non-human primates against infection(1,2). Previous work showed that antibodies exert selective pressure on the virus but escape variants emerge within a short period of time(3,4). However, these experiments were performed before the recent discovery of more potent anti-HIV-1 antibodies and their improvement by structure-based design(5-9). Here we re-examine passive antibody transfer as a therapeutic modality in HIV-1-infected humanized mice. Although HIV-1 can escape from antibody monotherapy, combinations of broadly neutralizing antibodies can effectively control HIV-1 infection and suppress viral load to levels below detection. Moreover, in contrast to antiretroviral therapy(10-12), the longer half-life of antibodies led to control of viraemia for an average of 60 days after cessation of therapy. Thus, combinations of potent monoclonal antibodies can effectively control HIV-1 replication in humanized mice, and should be re-examined as a therapeutic modality in HIV-1-infected individuals.	[Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Mouquet, Hugo; Spatz, Linda A.; Abadir, Alexander; Gaebler, Christian; Incesu, Reha-Baris; Eisenreich, Thomas R.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gruell, Henning] Univ Munster, Fak Med, D-48149 Munster, Germany; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Spatz, Linda A.] CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Microbiol & Immunol, New York, NY 10031 USA; [Diskin, Ron; Marcovecchio, Paola M.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Ploss, Alexander] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Gaebler, Christian] Tech Univ Dresden, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Bieniasz, Paul D.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Rockefeller University; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; California Institute of Technology; Rockefeller University; Rockefeller University; Technische Universitat Dresden; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; California Institute of Technology; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Ploss, Alexander/ABG-2330-2020; Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019; Mouquet, Hugo/M-2750-2014; Gaebler, Christian/GWZ-2628-2022; Bournazos, Stylianos/ABH-1578-2021	Ploss, Alexander/0000-0001-9322-7252; Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Gaebler, Christian/0000-0001-7295-8128; Dorner, Marcus/0000-0003-0321-4226; Grull, Henning/0000-0002-0725-7138; Dorner, Marcus/0000-0001-7936-1527	German Research Foundation (DFG) [KL 2389/1-1, DO 1450/1-1, BI 1422/1-1]; German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation [OPP1033115]; NIAID [1UM1AI100663]; NIH [AI081677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081677, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kaiser for analysing viral loads of reference HIV-1 samples and N. N. Freund for producing YU2 gp120. We thank B. Flatley, T. Friling, H. Gao, S. Sell and S. Hinklein for assistance and technical support, M. Suarez-Farinas for advice on statistical analysis, and M. Babayeva for helping with antibody t<INF>1/2</INF> estimation. M. C. N. and F. K. have a pending patent application for the antibody 3BC176 and M. C. N., P.J.B. and H. M. for the antibody 10-1074 with the United States Patent and Trademark Office. These reagents are available with a Material Transfer Agreement. F. K. (KL 2389/1-1), M. D. (DO 1450/1-1) and E. B. (BI 1422/1-1) were supported by the German Research Foundation (DFG). H. G., C. G. and R.-B.I. were supported by The German National Academic Foundation. M. S. S. was supported by the Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium, grant number 1032144. A. P. is a recipient of a Liver Scholar Award from the American Liver Foundation. This work was supported in part by CAVD grant OPP1033115 from the Bill and Melinda Gates Foundation to M. C. N., in part by NIAID 1UM1AI100663 to M. C. N. and NIH grant AI081677 to M. C. N. M. C. N., P.J.B. and P. D. B. are HHMI investigators.	Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ince WL, 2010, J VIROL, V84, P2740, DOI 10.1128/JVI.02180-09; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H., P NATL ACAD IN PRESS; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	36	393	406	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					118	+		10.1038/nature11604	http://dx.doi.org/10.1038/nature11604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23103874	Green Accepted			2022-12-28	WOS:000311893400057
J	Canup, RM				Canup, Robin M.			Forming a Moon with an Earth-like Composition via a Giant Impact	SCIENCE			English	Article							ORIGIN	In the giant impact theory, the Moon formed from debris ejected into an Earth-orbiting disk by the collision of a large planet with the early Earth. Prior impact simulations predict that much of the disk material originates from the colliding planet. However, Earth and the Moon have essentially identical oxygen isotope compositions. This has been a challenge for the impact theory, because the impactor's composition would have likely differed from that of Earth. We simulated impacts involving larger impactors than previously considered. We show that these can produce a disk with the same composition as the planet's mantle, consistent with Earth-Moon compositional similarities. Such impacts require subsequent removal of angular momentum from the Earth-Moon system through a resonance with the Sun as recently proposed.	SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA		Canup, RM (corresponding author), SW Res Inst, Planetary Sci Directorate, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	robin@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458	NASA Lunar Science Institute; NASA's LASER program	NASA Lunar Science Institute; NASA's LASER program	SPH simulation data are contained in tables S2 to S5 of the supplementary materials. Financial support for this project was provided by the NASA Lunar Science Institute and by NASA's LASER program.	Belbruno E, 2005, ASTRON J, V129, P1724, DOI 10.1086/427539; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; Cuk M., 2012, EARLY SOLAR SYSTEM I; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Kokubo E, 2000, ICARUS, V148, P419, DOI 10.1006/icar.2000.6496; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Meier M. M. M., 2011, ANN M MET SOC; Melosh HJ, 2007, METEORIT PLANET SCI, V42, P2079, DOI 10.1111/j.1945-5100.2007.tb01009.x; Melosh H.J., 2009, METEORIT PLANET SC S, V72, P5104; O'Brien DP, 2006, ICARUS, V184, P39, DOI 10.1016/j.icarus.2006.04.005; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Reufer A., 2011, LUNAR PLANET SCI, VXLII, P1136; Salmon J. J., 2012, LUNAR PLANET SCI, V43, P2540; Thompson S. L., 1972, SCRR710714; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wood J. A., 1984, ORIGIN MOON, P17; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	24	343	350	19	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1052	1055		10.1126/science.1226073	http://dx.doi.org/10.1126/science.1226073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23076098	Green Accepted			2022-12-28	WOS:000311390600036
J	Choy, A; Dancourt, J; Mugo, B; O'Connor, TJ; Isberg, RR; Melia, TJ; Roy, CR				Choy, Augustine; Dancourt, Julia; Mugo, Brian; O'Connor, Tamara J.; Isberg, Ralph R.; Melia, Thomas J.; Roy, Craig R.			The Legionella Effector RavZ Inhibits Host Autophagy Through Irreversible Atg8 Deconjugation	SCIENCE			English	Article							PNEUMOPHILA GENOME; SYSTEM; PATHWAY	Eukaryotic cells can use the autophagy pathway to defend against microbes that gain access to the cytosol or reside in pathogen-modified vacuoles. It remains unclear if pathogens have evolved specific mechanisms to manipulate autophagy. Here, we found that the intracellular pathogen Legionella pneumophila could interfere with autophagy by using the bacterial effector protein RavZ to directly uncouple Atg8 proteins attached to phosphatidylethanolamine on autophagosome membranes. RavZ hydrolyzed the amide bond between the carboxyl-terminal glycine residue and an adjacent aromatic residue in Atg8 proteins, producing an Atg8 protein that could not be reconjugated by Atg7 and Atg3. Thus, intracellular pathogens can inhibit autophagy by irreversibly inactivating Atg8 proteins during infection.	[Dancourt, Julia; Mugo, Brian; Melia, Thomas J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Choy, Augustine; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Yale University; Yale University; Howard Hughes Medical Institute; Tufts University; Tufts University	Melia, TJ (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	thomas.melia@yale.edu; craig.roy@yale.edu	Dancourt, Julia/U-1533-2017	Dancourt, Julia/0000-0002-6237-1566; Roy, Craig/0000-0003-4490-440X	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute; NIH [AI007019, NS063973, AI041699, AI048770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI048770, R01AI041699, R37AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973] Funding Source: NIH RePORTER	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Mizushima and A. Iwasaki for providing GFP-LC3 and Atg5-deficient mice and S. Shin for providing the plasmid encoding BlaM-RalF. Support for this research came from the Science, Technology and Research Scholars Program at Yale University (B. M.); the Howard Hughes Medical Institute (T.J.O. and R. R. I.); and NIH Awards AI007019 (A. C.), NS063973 (T.J.M.), AI041699, and AI048770 (C. R. R.). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Hayward AP, 2011, ANNU REV PHYTOPATHOL, V49, P557, DOI 10.1146/annurev-phyto-072910-095333; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jotwani A, 2012, METHOD CELL BIOL, V108, P93, DOI 10.1016/B978-0-12-386487-1.00005-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	15	315	327	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1072	1076		10.1126/science.1227026	http://dx.doi.org/10.1126/science.1227026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112293	Green Accepted			2022-12-28	WOS:000311390600042
J	Chaneton, B; Hillmann, P; Zheng, L; Martin, ACL; Maddocks, ODK; Chokkathukalam, A; Coyle, JE; Jankevics, A; Holding, FP; Vousden, KH; Frezza, C; O'Reilly, M; Gottlieb, E				Chaneton, Barbara; Hillmann, Petra; Zheng, Liang; Martin, Agnes C. L.; Maddocks, Oliver D. K.; Chokkathukalam, Achuthanunni; Coyle, Joseph E.; Jankevics, Andris; Holding, Finn P.; Vousden, Karen H.; Frezza, Christian; O'Reilly, Marc; Gottlieb, Eyal			Serine is a natural ligand and allosteric activator of pyruvate kinase M2	NATURE			English	Article							MASS-SPECTROMETRY DATA; X-RAY DATA; TUMOR-GROWTH; CANCER; CRYSTALLOGRAPHY; CONTRIBUTES; GLYCOLYSIS; METABOLISM; PATHWAY; QUALITY	Cancer cells exhibit several unique metabolic phenotypes that are critical for cell growth and proliferation(1). Specifically, they overexpress the M2 isoform of the tightly regulated enzyme pyruvate kinase (PKM2), which controls glycolytic flux, and are highly dependent on de novo biosynthesis of serine and glycine(2). Here we describe a new rheostat-like mechanistic relationship between PKM2 activity and serine biosynthesis. We show that serine can bind to and activate human PKM2, and that PKM2 activity in cells is reduced in response to serine deprivation. This reduction in PKM2 activity shifts cells to a fuel-efficient mode in which more pyruvate is diverted to the mitochondria and more glucose-derived carbon is channelled into serine biosynthesis to support cell proliferation.	[Chaneton, Barbara; Zheng, Liang; Maddocks, Oliver D. K.; Vousden, Karen H.; Frezza, Christian; Gottlieb, Eyal] Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hillmann, Petra; Martin, Agnes C. L.; Coyle, Joseph E.; Holding, Finn P.; O'Reilly, Marc] Astex Pharmaceut, Cambridge CB4 0QA, England; [Chokkathukalam, Achuthanunni; Jankevics, Andris] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Jankevics, Andris] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, NL-9747 AG Groningen, Netherlands	Beatson Institute; Cancer Research UK; Astex Pharmaceuticals; University of Glasgow; University of Groningen	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	marc.oreilly@astx.com; e.gottlieb@beatson.gla.ac.uk	Frezza, Christian/G-2174-2010; Maddocks, Oliver/K-5410-2012; Gottlieb, Eyal/G-6450-2010	Frezza, Christian/0000-0002-3293-7397; Maddocks, Oliver/0000-0002-5551-9091; Gottlieb, Eyal/0000-0002-9770-0956; Hillmann, Petra/0000-0001-8642-7109; Zheng, Liang/0000-0002-5346-4111; Jankevics, Andris/0000-0003-2095-6846	Cancer Research UK	Cancer Research UK(Cancer Research UK)	The work performed at the Beatson Institute for Cancer Research was supported by Cancer Research UK. We thank D. Sumpton for technical support with two-dimensional gel electrophoresis and N. Thompson, N. Wallis and M. Jones for comments provided during manuscript preparation. We would also like to thank D. M. Sabatini for the Scramble shRNA plasmid used as a control (shCntrla) and the Structural Genomics Consortium for providing us with the PKM2 expression plasmid from their collection. We thank A. King for editorial work and S. Tardito for graphical help.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; EIGENBRODT E, 1983, BIOMED BIOCHIM ACTA, V42, pS278; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARQUEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P667, DOI 10.1016/0003-9861(89)90335-4; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MEDINA MA, 1992, BIOCHEM MED METAB B, V48, P1, DOI 10.1016/0885-4505(92)90041-V; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Salituro F. G., 2010, Preparation of Pyridinyl or Pyrimidinyl Imidazoles, Pyrroles and Pyrazoles as PKM2 Modulators Useful in Treating Cancer, Patent No. [2010118063 A2, 2010118063]; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SPELLMAN CM, 1973, FEBS LETT, V37, P281, DOI 10.1016/0014-5793(73)80478-8; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	39	396	415	8	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					458	+		10.1038/nature11540	http://dx.doi.org/10.1038/nature11540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064226	Green Accepted			2022-12-28	WOS:000311031600049
J	Stevenson, DG				Stevenson, David G.			Growing Pains for the Medicare Hospice Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PALLIATIVE CARE		Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							Byock I, 1998, J Palliat Med, V1, P165, DOI 10.1089/jpm.1998.1.165; Groninger H, 2012, HEALTH AFFAIR, V31, P452, DOI [10.1377/hlthaff.2011.0473, 10.1377/HLTHAFF.2011.0473]; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Waldman P, 2011, WASHINGTON POST	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1683	1685		10.1056/NEJMp1208465	http://dx.doi.org/10.1056/NEJMp1208465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113479				2022-12-28	WOS:000310440800004
J	Hawkes, N				Hawkes, Nigel			Bright lights and big city health problems	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7226	10.1136/bmj.e7226	http://dx.doi.org/10.1136/bmj.e7226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109328				2022-12-28	WOS:000310778000003
J	Jia, JL; Zheng, XB; Hu, GQ; Cui, KR; Zhang, JQ; Zhang, AY; Jiang, H; Lu, BW; Yates, J; Liu, CY; Zhao, KJ; Zheng, YX				Jia, Junling; Zheng, Xiaobin; Hu, Gangqing; Cui, Kairong; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Lu, Bingwen; Yates, John, III; Liu, Chengyu; Zhao, Keji; Zheng, Yixian			Regulation of Pluripotency and Self-Renewal of ESCs through Epigenetic-Threshold Modulation and mRNA Pruning	CELL			English	Article							EMBRYONIC STEM-CELLS; CORE TRANSCRIPTIONAL NETWORK; DEVELOPMENTAL REGULATORS; TROPHECTODERM DIFFERENTIATION; GENE-EXPRESSION; POLYMERASE-II; TARGET GENES; CHROMATIN; POLYCOMB; PROTEIN	Embryonic stem cell (ESC) pluripotency requires bivalent epigenetic modifications of key developmental genes regulated by various transcription factors and chromatin-modifying enzymes. How these factors coordinate with one another to maintain the bivalent chromatin state so that ESCs can undergo rapid self-renewal while retaining pluripotency is poorly understood. We report that Utf1, a target of Oct4 and Sox2, is a bivalent chromatin component that buffers poised states of bivalent genes. By limiting PRC2 loading and histone 3 lysine-27 trimethylation, Utf1 sets proper activation thresholds for bivalent genes. It also promotes nuclear tagging of messenger RNAs (mRNAs) transcribed from insufficiently silenced bivalent genes for cytoplasmic degradation through mRNA decapping. These opposing functions of Utf1 promote coordinated differentiation. The mRNA degradation function also ensures rapid cell proliferation by blocking the Myc-Arf feedback control. Thus, Utf1 couples the core pluripotency factors with Myc and PRC2 networks to promote the pluripotency and proliferation of ESCs.	[Jia, Junling; Zheng, Xiaobin; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Jia, Junling; Zheng, Yixian] NHLBI, Howard Hughes Med Inst, NIH, Bethesda, MD 20892 USA; [Hu, Gangqing; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, NIH, Bethesda, MD 20892 USA; [Lu, Bingwen; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Zhang, An/GRS-5852-2022; Hu, Gangqing/ABA-3507-2020; HU, GANGQING/K-5849-2012; Zheng, Xiaobin/AAD-7564-2019	HU, GANGQING/0000-0001-5453-6888; 	NIH [GM56312, MH067880, P41 RR011823]; NHLBI; HHMI [P41 RR011823, R01 HL079442-08]; Cystic Fibrosis Foundation Therapeutics, Inc. [BALCH05X5];  [R01 GM056312]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZICHL006058, ZIAHL005801, R01HL079442, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); HHMI(Howard Hughes Medical Institute); Cystic Fibrosis Foundation Therapeutics, Inc.; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Allison Pinder for deep-seq; Nick Ingolia for advice on data analyses; and Chen-ming Fan, Nick Ingolia, Xin Chen, Haiqing Zhao, Dong Yang, Ma Wan, Max Guo, and members of the Zheng lab for comments. This work was supported by NIH (GM56312 to Y. Z.; MH067880 and P41 RR011823 to J. R. Y.) and by NHLBI intramural research (G. H., K. C., C. L., and K. Z.). This work was also supported by R01 GM056312 (Y. Z., J. Z., A. Z.), HHMI (J. J., Y. Z.), P41 RR011823 and R01 HL079442-08 (J. Y.), and Cystic Fibrosis Foundation Therapeutics, Inc. BALCH05X5 (B.L.).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fukushima A, 1998, J BIOL CHEM, V273, P25840, DOI 10.1074/jbc.273.40.25840; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Vong QP, 2010, STEM CELLS, V28, P1030, DOI 10.1002/stem.428; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	57	57	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					576	589		10.1016/j.cell.2012.09.023	http://dx.doi.org/10.1016/j.cell.2012.09.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101626	Green Accepted, Bronze			2022-12-28	WOS:000310529300014
J	Blendon, RJ; Benson, JM; Brule, A				Blendon, Robert J.; Benson, John M.; Brule, Amanda			Understanding Health Care in the 2012 Election	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Blendon, Robert J.; Benson, John M.; Brule, Amanda] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Blendon RJ, 2008, NEW ENGL J MED, V359, P2050, DOI 10.1056/NEJMsr0807717; Congressional Budget Office, 2012, 2012 LONG TERM BUDG; Popkin SL, 2012, CANDIDATE WHAT IT TA, P133	3	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1658	1661		10.1056/NEJMsr1211472	http://dx.doi.org/10.1056/NEJMsr1211472			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23050512				2022-12-28	WOS:000310131700018
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Prostate Cancer Screening - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		D'Amico AV, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMclde1209426; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135	2	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17								10.1056/NEJMclde1212034	http://dx.doi.org/10.1056/NEJMclde1212034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094752				2022-12-28	WOS:000310131700016
J	Weeks, JC; Catalano, PJ; Cronin, A; Finkelman, MD; Mack, JW; Keating, NL; Schrag, D				Weeks, Jane C.; Catalano, Paul J.; Cronin, Angel; Finkelman, Matthew D.; Mack, Jennifer W.; Keating, Nancy L.; Schrag, Deborah			Patients' Expectations about Effects of Chemotherapy for Advanced Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; ADVANCED COLORECTAL-CANCER; CARE OUTCOMES RESEARCH; QUALITY-OF-LIFE; SURVEILLANCE CONSORTIUM; MULTIPLE IMPUTATION; RANDOMIZED-TRIAL; PALLIATIVE CARE; SUPPORTIVE CARE; TREATMENT GOALS	Background Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. Methods We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. Results Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. Conclusions Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.)	[Weeks, Jane C.; Cronin, Angel; Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Catalano, Paul J.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Finkelman, Matthew D.] Tufts Univ, Sch Dent Med, Dept Publ Hlth & Community Serv, Boston, MA 02111 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Keating, Nancy L.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Tufts University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Weeks, JC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	jane_weeks@dfci.harvard.edu	Maslov, Victor Pavlovich/M-9068-2015; Keating, Nancy L/I-9968-2019	Maslov, Victor Pavlovich/0000-0003-2599-5086; Keating, Nancy L/0000-0002-8274-4681	National Cancer Institute (NCI) [U01 CA093344]; NCI; Dana-Farber Cancer Institute/Cancer Research Network [U01 CA093332]; Harvard Medical School/Northern California Cancer Center [U01 CA093324, RAND/UCLA U01 CA093348]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA093339]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [CRS 02-164]; NATIONAL CANCER INSTITUTE [U01CA093324, U01CA093348, U01CA093329, U01CA093339, U01CA093332, U01CA093344, U01CA093326] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana-Farber Cancer Institute/Cancer Research Network; Harvard Medical School/Northern California Cancer Center; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (NCI) to the Statistical Coordinating Center (U01 CA093344) and the NCI-supported Primary Data Collection and Research Centers, Dana-Farber Cancer Institute/Cancer Research Network (U01 CA093332), Harvard Medical School/Northern California Cancer Center (U01 CA093324, RAND/UCLA U01 CA093348), University of Alabama at Birmingham (U01 CA093329), University of Iowa (U01 CA093339), and University of North Carolina (U01 CA093326); and by a Department of Veterans Affairs grant to the Durham Veterans Affairs Medical Center (CRS 02-164).	[Anonymous], 2004, J PALLIAT MED, V7, P637; Ayanian JZ, 2010, J CLIN ONCOL, V28, P4154, DOI 10.1200/JCO.2009.27.3268; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Catalano P, 2012, MED CARE APPL M 0307; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen JY, 2008, MED CARE, V46, P1157, DOI 10.1097/MLR.0b013e31817924bc; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Gabrijel S, 2008, J CLIN ONCOL, V26, P297, DOI 10.1200/JCO.2007.13.0609; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; GLIMELIUS B, 1994, CANCER, V73, P556, DOI 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO;2-8; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003; He Y, 2010, STAT METHODS MED RES, V19, P653, DOI 10.1177/0962280208101273; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; Keating NL, 2010, J CLIN ONCOL, V28, P4364, DOI 10.1200/JCO.2009.26.8870; Leighl NB, 2011, J CLIN ONCOL, V29, P2077, DOI 10.1200/JCO.2010.32.0754; LIDZ CW, 1988, ARCH INTERN MED, V148, P1385, DOI 10.1001/archinte.148.6.1385; Mack JW, 2007, J CLIN ONCOL, V25, P1357, DOI 10.1200/JCO.2006.08.3170; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; MCQUELLON RP, 1995, J CLIN ONCOL, V13, P858, DOI 10.1200/JCO.1995.13.4.858; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Smith Thomas J, 2011, J Support Oncol, V9, P79; Smith TJ, 2010, CLIN CANCER RES, V16, P5981, DOI 10.1158/1078-0432.CCR-10-1278; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; von Gunten Charles F, 2004, J Palliat Med, V7, P209, DOI 10.1089/109662104773709332; von Roenn JH, 2003, J CLIN ONCOL, V21, P570, DOI 10.1200/JCO.2003.10.161; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	39	770	775	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1616	1625		10.1056/NEJMoa1204410	http://dx.doi.org/10.1056/NEJMoa1204410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094723	Green Accepted			2022-12-28	WOS:000310131700008
J	Adashi, EY; McDonough, JE; Venkatesh, KK				Adashi, Eli Y.; McDonough, John E.; Venkatesh, Kartik K.			Health Care Policy under President Romney	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adashi, Eli Y.; Venkatesh, Kartik K.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McDonough, John E.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy, Boston, MA 02115 USA	Brown University; Harvard University; Harvard T.H. Chan School of Public Health	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							Holahan J, 2011, HOUSE REPUBLICAN BUD; MittRomney.com, HLTH CAR; Romney M, 2012, NEW ENGL J MED, V367, P1377, DOI 10.1056/NEJMp1211516; [No title captured]	4	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1477	1479		10.1056/NEJMp1210265	http://dx.doi.org/10.1056/NEJMp1210265			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23050513				2022-12-28	WOS:000309904500002
J	McCartney, M				McCartney, Margaret			Online health checks may obscure effective advice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Bishop DVM, 2007, J PAEDIATR CHILD H, V43, P653, DOI 10.1111/j.1440-1754.2007.01225.x; Channel 4, EMB BOD CHECK YOUR V; Channel 4, EMB BOD MY HEALTHCH; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; NHS Choices, US ED POL; NHS Choices, WELLB SELF ASS; NHS Choices, TEST CANC PREV; NHS Choices, DEPR SELF ASS; NHS Choices, WHAT SHOULD MY TEST; Reynolds WM, 2010, EVID-BASED MENT HEAL, V13, P96, DOI 10.1136/ebmh.13.3.96; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; TheFamilyGP.com, SELF EX VID	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2012	345								e6745	10.1136/bmj.e6745	http://dx.doi.org/10.1136/bmj.e6745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024VX	23069598				2022-12-28	WOS:000310139500003
J	Ackman, JB; Burbridge, TJ; Crair, MC				Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.			Retinal waves coordinate patterned activity throughout the developing visual system	NATURE			English	Article							RETINOTOPIC MAP REFINEMENT; LATERAL GENICULATE-NUCLEUS; MOUSE SUPERIOR COLLICULUS; EYE-SPECIFIC SEGREGATION; IMAGING IN-VIVO; GANGLION-CELLS; ACTIVITY TRANSIENTS; RETINOGENICULATE PROJECTIONS; DIRECTION SELECTIVITY; ACTION-POTENTIALS	The morphological and functional development of the vertebrate nervous system is initially governed by genetic factors and subsequently refined by neuronal activity. However, fundamental features of the nervous system emerge before sensory experience is possible. Thus, activity-dependent development occurring before the onset of experience must be driven by spontaneous activity, but the origin and nature of activity in vivo remains largely untested. Here we use optical methods to show in live neonatal mice that waves of spontaneous retinal activity are present and propagate throughout the entire visual system before eye opening. This patterned activity encompassed the visual field, relied on cholinergic neurotransmission, preferentially initiated in the binocular retina and exhibited spatiotemporal correlations between the two hemispheres. Retinal waves were the primary source of activity in the midbrain and primary visual cortex, but only modulated ongoing activity in secondary visual areas. Thus, spontaneous retinal activity is transmitted through the entire visual system and carries patterned information capable of guiding the activity-dependent development of complex intra-and inter-hemispheric circuits before the onset of vision.	[Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Crair, MC (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	michael.crair@yale.edu		Ackman, James/0000-0003-0802-6080	US National Institutes of Health (NIH) [P30 EY000785, R01 EY015788, T32 NS007224, T15 LM070506, T32 EY017353]; family of William Ziegler III; NATIONAL EYE INSTITUTE [R01EY023105, P30EY000785, T32EY022312, R01EY015788, R01EY017353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of William Ziegler III; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Sachdev and D. McCormick for Emx1-Cre:Ai38 mice, C. Chen for helpful advice on ganglion cell loading with calcium indicators and Y. Zhang for technical support. We would like to thank M. Colonnese and members of the Crair laboratory for valuable comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grants P30 EY000785 and R01 EY015788 (to M. C. C.), T32 NS007224 (to J.A.), and T15 LM070506 and T32 EY017353 (to T. B.). This work was also supported by the family of William Ziegler III.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dhande OS, 2011, JOVE-J VIS EXP, DOI 10.3791/2678; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gastinger MJ, 2006, CURR EYE RES, V31, P655, DOI 10.1080/02713680600776119; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; MULLER M, 1988, EXP BRAIN RES, V71, P611, DOI 10.1007/BF00248754; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Tolonen M, 2007, NEUROSCIENCE, V145, P997, DOI 10.1016/j.neuroscience.2006.12.070; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007	59	276	277	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					219	+		10.1038/nature11529	http://dx.doi.org/10.1038/nature11529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060192	Green Accepted			2022-12-28	WOS:000309733300041
J	Nestler, EJ				Nestler, Eric J.			Stress makes its molecular mark	NATURE			English	Editorial Material							MOUSE NUCLEUS-ACCUMBENS; HISTONE METHYLATION; DEPRESSION		[Nestler, Eric J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu			NIMH NIH HHS [R01 MH051399, P50 MH096890] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Caldji C, 2011, FEBS LETT, V585, P2049, DOI 10.1016/j.febslet.2011.03.032; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Sun H, 2012, NEUROPSYCHOPHARMACOL; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	10	53	53	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					171	172		10.1038/490171a	http://dx.doi.org/10.1038/490171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060173	Green Accepted			2022-12-28	WOS:000309733300024
J	Bobrow, RS				Bobrow, Robert S.			Big Hearts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									SUNY Stony Brook, Dept Family Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bobrow, RS (corresponding author), SUNY Stony Brook, Dept Family Med, Stony Brook, NY 11794 USA.	robert.bobrow@stonybrookmedicine.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1441	1442		10.1001/2012.jama.12268	http://dx.doi.org/10.1001/2012.jama.12268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047358				2022-12-28	WOS:000309579300022
J	Lasalvia, A; Zoppei, S; Van Bortel, T; Bonetto, C; Cristofalo, D; Wahlbeck, K; Bacle, SV; Van Audenhove, C; van Weeghel, J; Reneses, B; Germanavicius, A; Economou, M; Lanfredi, M; Ando, S; Sartorius, N; Lopez-Ibor, JJ; Thornicroft, G				Lasalvia, Antonio; Zoppei, Silvia; Van Bortel, Tine; Bonetto, Chiara; Cristofalo, Doriana; Wahlbeck, Kristian; Bacle, Simon Vasseur; Van Audenhove, Chantal; van Weeghel, Jaap; Reneses, Blanca; Germanavicius, Arunas; Economou, Marina; Lanfredi, Mariangela; Ando, Shuntaro; Sartorius, Norman; Lopez-Ibor, Juan J.; Thornicroft, Graham		ASPEN INDIGO Study Grp	Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey	LANCET			English	Article							MENTAL-HEALTH-SERVICES; SELF-STIGMA; PERCEIVED STIGMA; ILLNESS STIGMA; HELP-SEEKING; SCHIZOPHRENIA; LIFE; INTENTIONS; WORKPLACE; ATTITUDES	Background Depression is the third leading contributor to the worldwide burden of disease. We assessed the nature and severity of experienced and anticipated discrimination reported by adults with major depressive disorder worldwide. Moreover, we investigated whether experienced discrimination is related to clinical history, provision of health care, and disclosure of diagnosis and whether anticipated discrimination is associated with disclosure and previous experiences of discrimination. Methods In a cross-sectional survey, people with a diagnosis of major depressive disorder were interviewed in 39 sites (35 countries) worldwide with the discrimination and stigma scale (version 12; DISC-12). Other inclusion criteria were ability to understand and speak the main local language and age 18 years or older. The DISC-12 subscores assessed were reported discrimination and anticipated discrimination. Multivariable regression was used to analyse the data. Findings 1082 people with depression completed the DISC-12. Of these, 855 (79%) reported experiencing discrimination in at least one life domain. 405 (37%) participants had stopped themselves from initiating a close personal relationship, 271 (25%) from applying for work, and 218 (20%) from applying for education or training. We noted that higher levels of experienced discrimination were associated with several lifetime depressive episodes (negative binomial regression coefficient 0.20 [95% CI 0.09-0.32], p = 0.001); at least one lifetime psychiatric hospital admission (0.29 [0.15-0.42], p = 0.001); poorer levels of social functioning (widowed, separated, or divorced 0.10 [0.01-0.19], p = 0.032; unpaid employed 0.34 [0.09-0.60], p = 0.007; looking for a job 0.26 [0.09-0.43], p = 0.002; and unemployed 0.22 [0.03-0.41], p = 0.022). Experienced discrimination was also associated with lower willingness to disclose a diagnosis of depression (mean discrimination score 4.18 [SD 3.68] for concealing depression vs 2.25 [2.65] for disclosing depression; p<0.0001). Anticipated discrimination is not necessarily associated with experienced discrimination because 147 (47%) of 316 participants who anticipated discrimination in finding or keeping a job and 160 (45%) of 353 in their intimate relationships had not experienced discrimination. Interpretation Discrimination related to depression acts as a barrier to social participation and successful vocational integration. Non-disclosure of depression is itself a further barrier to seeking help and to receiving effective treatment. This finding suggests that new and sustained approaches are needed to prevent stigmatisation of people with depression and reduce the effects of stigma when it is already established.	[Lasalvia, Antonio] Univ Verona, Policlin GB Rossi, Dept Publ Hlth & Community Med, Sect Psychiat, I-37134 Verona, Italy; [Van Bortel, Tine; Thornicroft, Graham] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Wahlbeck, Kristian] Natl Inst Hlth & Welf, Helsinki, Vasa, Finland; [Bacle, Simon Vasseur] Etab Publ Sante Mentale Lille Metropole, Armentieres, France; [Van Audenhove, Chantal] Katholieke Univ Leuven, Louvain, Belgium; [van Weeghel, Jaap] Stichting Kennisctr Phrenos, Utrecht, Netherlands; [Reneses, Blanca; Lopez-Ibor, Juan J.] Hosp Clin San Carlos, Ctr Invest Biomed Red Salud Mental, Inst Invest Sanitaria, Inst Psiquiatria, Madrid, Spain; [Germanavicius, Arunas] Vilnius State Univ, Vilnius, Lithuania; [Economou, Marina] Univ Mental Hlth Inst, Athens, Greece; [Lanfredi, Mariangela] Ctr San Giovanni Dio Fatebenefratelli, Ist Ricovero & Cura Carattere Sci, Brescia, Italy; [Sartorius, Norman] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland; Univ Sydney, Sydney, NSW, Australia	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of London; King's College London; Finland National Institute for Health & Welfare; KU Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Clinico San Carlos; Vilnius University; IRCCS Fatebenefratelli; University of Sydney	Lasalvia, A (corresponding author), Univ Verona, Policlin GB Rossi, Dept Publ Hlth & Community Med, Sect Psychiat, Ple Scuro 10, I-37134 Verona, Italy.	antonio.lasalvia@univr.it	Economou, Marina/AAB-5079-2020; R, JOHNSON-PRADEEP/G-5359-2014; Milev, Roumen/F-4521-2012; Rose, Diana S/D-1387-2010; Pedrini, Laura/J-7275-2016; Thornicroft, Graham/B-4027-2010; Germanavicius, Arunas/A-5084-2017; Lanfredi, Mariangela/M-3345-2016; Abdulmalik, Jibril/R-5840-2019; Ola, Bolanle/D-4455-2019; Germanavicius, Arunas/A-6149-2016; Tófoli, Luís Fernando/F-9221-2012; Csukly, Gabor/J-8244-2017; Rossi, Giuseppe/G-6158-2017; Wahlbeck, Kristian/F-8394-2011; Reneses, Blanca/AAG-9590-2019; Lasalvia, Antonio/E-5932-2010; Ouali, Uta/P-6837-2017	Economou, Marina/0000-0002-6742-4348; R, JOHNSON-PRADEEP/0000-0003-0758-1664; Milev, Roumen/0000-0001-6884-171X; Rose, Diana S/0000-0002-6393-6389; Pedrini, Laura/0000-0001-9662-881X; Thornicroft, Graham/0000-0003-0662-0879; Germanavicius, Arunas/0000-0002-1226-1449; Lanfredi, Mariangela/0000-0001-5968-8952; Abdulmalik, Jibril/0000-0001-9486-5408; Ola, Bolanle/0000-0002-9828-3365; Tófoli, Luís Fernando/0000-0003-2262-8272; Rossi, Giuseppe/0000-0002-5902-2568; Wahlbeck, Kristian/0000-0003-3754-3933; Reneses, Blanca/0000-0003-0721-758X; Lasalvia, Antonio/0000-0001-9963-6081; Jayaram, Geetha/0000-0002-6369-237X; Ouali, Uta/0000-0001-6916-2110; Van Audenhove, Chantal/0000-0002-5504-5439; Csukly, Gabor/0000-0002-5006-9407; Glozier, Nick/0000-0002-0476-9146; Nyqvist, Fredrica/0000-0001-6554-8040; Van Bortel, Tine/0000-0003-0467-6393; Quinn, Neil/0000-0003-3361-7552; Brohan, Elaine/0000-0001-7400-6884; Melone, Arturo/0000-0002-8030-7197	European Commission; Directorate General for Health and Consumers, Public Health Executive Agency; European Union; National Institute for Health Research, London; National Institute for Health Research [RP-PG-0606-1053] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Directorate General for Health and Consumers, Public Health Executive Agency; European Union(European Commission); National Institute for Health Research, London(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding European Commission, Directorate General for Health and Consumers, Public Health Executive Agency.; This report arises from the project Anti Stigma Programme European Network (ASPEN), which has received funding from the European Union in the framework of the Public Health Programme. GT is a member of the National Institute for Health Research Biomedical Research Centre, and Maudsley National Health Service Foundation Trust/Institute of Psychiatry (King's College London, London), and receives support for an applied research programme from the National Institute for Health Research, London. He is also an honorary professor at the University of KwaZulu Natal, Durban, South Africa. TVB is the ASPEN/INDIGO scientific coordinator and senior researcher and is affiliated with King's College London. KW, FN, EA, and CH are affiliated with the National Institute for Health and Welfare, Vaasa, Finland.	Alonso J, 2009, J AFFECT DISORDERS, V118, P180, DOI 10.1016/j.jad.2009.02.006; Angermeyer MC, 2004, INT J SOC PSYCHIATR, V50, P153, DOI 10.1177/0020764004043115; Aromaa E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-52; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Brohan E, PSYCHIAT RE IN PRESS; Brohan E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-11; Brohan E, 2011, J AFFECT DISORDERS, V129, P56, DOI 10.1016/j.jad.2010.09.001; Chee CYI, 2005, SOC PSYCH PSYCH EPID, V40, P648, DOI 10.1007/s00127-005-0932-z; Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P481, DOI 10.1093/oxfordjournals.schbul.a007096; Griffiths KM, 2011, J AFFECT DISORDERS, V132, P413, DOI 10.1016/j.jad.2011.03.012; Hayward P, 2002, J AFFECT DISORDERS, V69, P61, DOI 10.1016/S0165-0327(00)00380-3; Henderson C, 2012, PSYCHIAT SERV, V63, P451, DOI 10.1176/appi.ps.201100422; Holzinger A, 2011, EPIDEMIOL PSYCH SCI, V20, P163, DOI 10.1017/S2045796011000266; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Little K, 2011, EPIDEMIOL PSYCH SCI, V20, P73, DOI 10.1017/S204579601100014X; Lundberg B, 2007, SOC PSYCH PSYCH EPID, V42, P295, DOI 10.1007/s00127-007-0160-9; Marcussen K, 2010, PSYCHIAT SERV, V61, P489, DOI 10.1176/ps.2010.61.5.489; NICE, 2009, NICE CLIN GUID; Perlick DA, 2001, PSYCHIAT SERV, V52, P1627, DOI 10.1176/appi.ps.52.12.1627; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Rose D, 2011, EPIDEMIOL PSYCH SCI, V20, P193, DOI 10.1017/S2045796011000254; Rosenfield S, 1997, AM SOCIOL REV, V62, P660, DOI 10.2307/2657432; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI [10.1176/appi.ps.62.6.675, 10.1176/ps.62.6.pss6206_0675]; Rusch N, 2009, SCHIZOPHR RES, V110, P65, DOI 10.1016/j.schres.2009.01.005; Rusch LC, 2008, J NERV MENT DIS, V196, P919, DOI 10.1097/NMD.0b013e31818ec5d9; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Thornicroft G, 2007, BRIT J PSYCHIAT, V190, P192, DOI 10.1192/bjp.bp.106.025791; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Ucok A, 2012, ACTA PSYCHIAT SCAND, V125, P77, DOI 10.1111/j.1600-0447.2011.01772.x; Vazquez GH, 2011, J AFFECT DISORDERS, V130, P323, DOI 10.1016/j.jad.2010.10.012; Vega WA, 2010, GEN HOSP PSYCHIAT, V32, P182, DOI 10.1016/j.genhosppsych.2009.10.008; Verhaeghe M, 2008, INT J SOC PSYCHIATR, V54, P206, DOI 10.1177/0020764008090422; Werner P, 2009, INT PSYCHOGERIATR, V21, P1180, DOI 10.1017/S1041610209990470; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2018, MENT HLTH ATL 2017	36	266	268	7	166	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					55	62		10.1016/S0140-6736(12)61379-8	http://dx.doi.org/10.1016/S0140-6736(12)61379-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23083627				2022-12-28	WOS:000313044300027
J	Marmot, MG; Altman, DG; Cameron, DA; Dewar, JA; Thompson, SG; Wilcox, M				Marmot, M. G.; Altman, D. G.; Cameron, D. A.; Dewar, J. A.; Thompson, S. G.; Wilcox, Maggie		Independent UK Panel Breast Canc S	The benefits and harms of breast cancer screening: an independent review	LANCET			English	Review							RANDOMIZED-TRIAL; FOLLOW-UP; MAMMOGRAPHY; OVERDIAGNOSIS; WOMEN; DIAGNOSIS; MORTALITY; IMPACT	Whether breast cancer screening does more harm than good has been debated extensively. The main questions are how large the benefit of screening is in terms of reduced breast cancer mortality and how substantial the harm is in terms of overdiagnosis, which is defined as cancers detected at screening that would not have otherwise become clinically apparent in the woman's lifetime. An independent Panel was convened to reach conclusions about the benefits and harms of breast screening on the basis of a review of published work and oral and written evidence presented by experts in the subject. To provide estimates of the level of benefits and harms, the Panel relied mainly on findings from randomised trials of breast cancer screening that compared women invited to screening with controls not invited, but also reviewed evidence from observational studies. The Panel focused on the UK setting, where women aged 50-70 years are invited to screening every 3 years. In this Review, we provide a summary of the full report on the Panel's findings and conclusions. In a meta-analysis of 11 randomised trials, the relative risk of breast cancer mortality for women invited to screening compared with controls was 0.80 (95% CI 0.73-0.89), which is a relative risk reduction of 20%. The Panel considered the internal biases in the trials and whether these trials, which were done a long time ago, were still relevant; they concluded that 20% was still a reasonable estimate of the relative risk reduction. The more reliable and recent observational studies generally produced larger estimates of benefit, but these studies might be biased. The best estimates of overdiagnosis are from three trials in which women in the control group were not invited to be screened at the end of the active trial period. In a meta-analysis, estimates of the excess incidence were 11% (95% CI 9-12) when expressed as a proportion of cancers diagnosed in the invited group in the long term, and 19% (15-23) when expressed as a proportion of the cancers diagnosed during the active screening period. Results from observational studies support the occurrence of overdiagnosis, but estimates of its magnitude are unreliable. The Panel concludes that screening reduces breast cancer mortality but that some overdiagnosis occurs. Since the estimates provided are from studies with many limitations and whose relevance to present-day screening programmes can be questioned, they have substantial uncertainty and should be regarded only as an approximate guide. If these figures are used directly, for every 10 000 UK women aged 50 years invited to screening for the next 20 years, 43 deaths from breast cancer would be prevented and 129 cases of breast cancer, invasive and non-invasive, would be overdiagnosed; that is one breast cancer death prevented for about every three overdiagnosed cases identified and treated. Of the roughly 307 000 women aged 50-52 years who are invited to begin screening every year, just over 1% would have an overdiagnosed cancer in the next 20 years. Evidence from a focus group organised by Cancer Research UK and attended by some members of the Panel showed that many women feel that accepting the off er of breast screening is worthwhile, which agrees with the results of previous similar studies. Information should be made available in a transparent and objective way to women invited to screening so that they can make informed decisions.	[Marmot, M. G.] UCL, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Altman, D. G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Cameron, D. A.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh EH8 9YL, Midlothian, Scotland; [Dewar, J. A.] Ninewells Med Sch, Dept Surg & Oncol, Dundee, Scotland; [Thompson, S. G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England	University of London; University College London; University of Oxford; University of Edinburgh; University of Dundee; University of Cambridge	Marmot, MG (corresponding author), UCL, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019; wang, edwin/G-5372-2010	Marmot, M G/0000-0002-2431-6419; 	Department of Health; British Heart Foundation [RG/07/008/23674, RG/08/014/24067] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G1000616, G0902037, G8802774] Funding Source: researchfish	Department of Health; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Review was commissioned by Professor Sir Mike Richards (National Cancer Director, England) and Dr Harpal Kumar (Chief Executive, Cancer Research UK). The Department of Health provided funding to the Independent Breast Screening Review, which supported the additional resources needed to undertake the Review. The Panel is very grateful to the experts, listed in the full report, who provided verbal or written evidence, or both, for the Review.	[Anonymous], 2012, AUD SCREEN DET BREAS, V13, P2010; Beral V, 2011, J MED SCREEN, V18, P210, DOI 10.1258/jms.2011.011134; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Blamey RW, 2002, EUR J CANCER, V38, P1458; Bond Mary, 2013, Evid Based Med, V18, P54, DOI 10.1136/eb-2012-100608; Cancer Research UK, BREAST SCREEN REV; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Duffy SW, 2012, BREAST CANC MANAGEME, V1, P31; FALLOWFIELD LJ, 1991, BRIT MED BULL, V47, P388, DOI 10.1093/oxfordjournals.bmb.a072478; Forrest APM., 1987, BREAST CANC SCREENIN; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Harris R, 2011, PREV MED, V53, P108, DOI 10.1016/j.ypmed.2011.07.004; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Nelson HD, 2009, ANN INTERN MED, V151, p[727, W237]; NHS Breast Screening Programme, 2011, ANN REV 2011, V13; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Puliti D, 2011, PREV MED, V53, P131, DOI 10.1016/j.ypmed.2011.05.012; Schunemann HJ, 2009, GRADE HDB GRADING QU; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; The Sloane Project, 2012, UK PROSP AUD SCREEN; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG., 2006, MUCH OVERDIAGNOSIS; Woolf SH, 2010, JAMA-J AM MED ASSOC, V303, P162, DOI 10.1001/jama.2009.1989; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	32	904	926	10	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1778	1786		10.1016/S0140-6736(12)61611-0	http://dx.doi.org/10.1016/S0140-6736(12)61611-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23117178	Green Published			2022-12-28	WOS:000311153700035
J	Myburgh, JA; Finfer, S; Bellomo, R; Billot, L; Cass, A; Gattas, D; Glass, P; Lipman, J; Liu, B; McArthur, C; McGuinness, S; Rajbhandari, D; Taylor, CB; Webb, SAR				Myburgh, John A.; Finfer, Simon; Bellomo, Rinaldo; Billot, Laurent; Cass, Alan; Gattas, David; Glass, Parisa; Lipman, Jeffrey; Liu, Bette; McArthur, Colin; McGuinness, Shay; Rajbhandari, Dorrilyn; Taylor, Colman B.; Webb, Steven A. R.		CHEST Investigators; Australian New Zealand Intensive	Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; RENAL-FUNCTION; MULTICENTER; TRIAL; REPLACEMENT; THERAPY; UNITS	BACKGROUND The safety and efficacy of hydroxyethyl starch (HES) for fluid resuscitation have not been fully evaluated, and adverse effects of HES on survival and renal function have been reported. METHODS We randomly assigned 7000 patients who had been admitted to an intensive care unit (ICU) in a 1:1 ratio to receive either 6% HES with a molecular weight of 130 kD and a molar substitution ratio of 0.4 (130/0.4, Voluven) in 0.9% sodium chloride or 0.9% sodium chloride (saline) for all fluid resuscitation until ICU discharge, death, or 90 days after randomization. The primary outcome was death within 90 days. Secondary outcomes included acute kidney injury and failure and treatment with renal-replacement therapy. RESULTS A total of 597 of 3315 patients (18.0%) in the HES group and 566 of 3336 (17.0%) in the saline group died (relative risk in the HES group, 1.06; 95% confidence interval [CI], 0.96 to 1.18; P = 0.26). There was no significant difference in mortality in six predefined subgroups. Renal-replacement therapy was used in 235 of 3352 patients (7.0%) in the HES group and 196 of 3375 (5.8%) in the saline group (relative risk, 1.21; 95% CI, 1.00 to 1.45; P = 0.04). In the HES and saline groups, renal injury occurred in 34.6% and 38.0% of patients, respectively (P = 0.005), and renal failure occurred in 10.4% and 9.2% of patients, respectively (P = 0.12). HES was associated with significantly more adverse events (5.3% vs. 2.8%, P < 0.001). CONCLUSIONS In patients in the ICU, there was no significant difference in 90-day mortality between patients resuscitated with 6% HES (130/0.4) or saline. However, more patients who received resuscitation with HES were treated with renal-replacement therapy. (Funded by the National Health and Medical Research Council of Australia and others; CHEST ClinicalTrials.gov number, NCT00935168.)	[Myburgh, John A.] George Inst Global Hlth, Div Crit Care & Trauma, Sydney, NSW 2000, Australia; [Myburgh, John A.; Liu, Bette] Univ New S Wales, Sydney, NSW, Australia; [Myburgh, John A.] St George Hosp, Sydney, NSW, Australia; [Myburgh, John A.; Finfer, Simon; Cass, Alan; Gattas, David; Taylor, Colman B.] Univ Sydney, Sydney, NSW 2006, Australia; [Finfer, Simon] Royal N Shore Hosp, Sydney, NSW, Australia; [Gattas, David; Rajbhandari, Dorrilyn] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Lipman, Jeffrey] Univ Queensland, Brisbane, Qld, Australia; [Lipman, Jeffrey] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Webb, Steven A. R.] Univ Western Australia, Perth, WA 6009, Australia; [Webb, Steven A. R.] Royal Perth Hosp, Perth, WA, Australia; [McArthur, Colin; McGuinness, Shay] Auckland City Hosp, Auckland, New Zealand	George Institute for Global Health; University of Sydney; University of New South Wales Sydney; St George Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Queensland; Royal Brisbane & Women's Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; Auckland City Hospital	Myburgh, JA (corresponding author), George Inst Global Hlth, Div Crit Care & Trauma, Level 13,321 Kent St, Sydney, NSW 2000, Australia.	jmyburgh@georgeinstitute.org.au	Liu, Bette C/A-7581-2013; Billot, Laurent/Y-1241-2019; Gattas, David/AAN-9668-2020; Lipman, Jeffrey/G-2211-2010; Leditschke, Isabel A/M-1186-2015; Presneill, Jeffrey J/B-4894-2012	Liu, Bette C/0000-0002-0787-5825; Billot, Laurent/0000-0002-4975-9793; Gattas, David/0000-0002-9282-7093; Lipman, Jeffrey/0000-0002-5965-9876; Leditschke, Isabel A/0000-0003-2212-2140; Presneill, Jeffrey J/0000-0001-7177-7667; Jan, Stephen/0000-0003-2839-1405; Cass, Alan/0000-0002-3923-3173; Venkatesh, Bala/0000-0002-3234-5244; Myburgh, John/0000-0003-4088-7016; Whitehead, Christina/0000-0003-4561-7082; Bompoint, Severine/0000-0001-5226-4321; Bellomo, Rinaldo/0000-0002-1650-8939; Glass, Parisa/0000-0002-1334-7156; SHEHABI, Yahya/0000-0003-4707-7462; Micallef, Sharon/0000-0002-8496-2324; Thompson, Kelly/0000-0003-2304-8931; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Aneman, Anders/0000-0003-2096-5304; McGuinness, Shay/0000-0003-0620-4787; Finfer, Simon/0000-0002-2785-5864	National Health and Medical Research Council of Australia; Ministry of Health, New South Wales Government, Australia; Fresenius Kabi; Practitioner Fellowship from the National Health and Medical Research Council of Australia; Principal Research Fellowship from the National Health and Medical Research Council of Australia; Practitioner Fellowship from the Medical Research Foundation of the Royal Perth Hospital	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Health, New South Wales Government, Australia; Fresenius Kabi; Practitioner Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Practitioner Fellowship from the Medical Research Foundation of the Royal Perth Hospital	Supported by the National Health and Medical Research Council of Australia; the Ministry of Health, New South Wales Government, Australia; and Fresenius Kabi; and by a Practitioner Fellowship from the National Health and Medical Research Council of Australia (to Drs. Myburgh and Bellomo), by a Principal Research Fellowship from the National Health and Medical Research Council of Australia (to Dr. Cass), and by a Practitioner Fellowship from the Medical Research Foundation of the Royal Perth Hospital (to Dr. Webb).; Funded by the National Health and Medical Research Council of Australia and others; CHEST ClinicalTrials.gov number, NCT00935168.	[Anonymous], COCHRANE DATABASE SY; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bunn F, 2012, COCHRANE DB SYST REV, V7; Christidis C, 2001, J HEPATOL, V35, P726, DOI 10.1016/S0168-8278(01)00200-8; Cohen J, 2001, CRIT CARE MED, V29, P880, DOI 10.1097/00003246-200104000-00039; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Jover JL, 2009, REV ESP ANEST REANIM, V56, P27, DOI 10.1016/S0034-9356(09)70317-2; Kamann Stefanie, 2007, J Dtsch Dermatol Ges, V5, P204, DOI 10.1111/j.1610-0387.2007.06239.x; Kellum JA, 2007, CONTRIB NEPHROL, V156, P10; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Myburgh J, 2012, CRIT CARE RESUSC, V14, P44; Myburgh J, 2011, INTENS CARE MED, V37, P816, DOI 10.1007/s00134-010-2117-9; Ostermann M, 2012, NEPHROL DIAL TRANSPL, V27, P2242, DOI 10.1093/ndt/gfr707; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016	24	1064	1146	2	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1901	1911		10.1056/NEJMoa1209759	http://dx.doi.org/10.1056/NEJMoa1209759			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23075127	Green Published, Bronze			2022-12-28	WOS:000311029300006
J	Nishimasu, H; Ishizu, H; Saito, K; Fukuhara, S; Kamatani, MK; Bonnefond, L; Matsumoto, N; Nishizawa, T; Nakanaga, K; Aoki, J; Ishitani, R; Siomi, H; Siomi, MC; Nureki, O				Nishimasu, Hiroshi; Ishizu, Hirotsugu; Saito, Kuniaki; Fukuhara, Satoshi; Kamatani, Miharu K.; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Nakanaga, Keita; Aoki, Junken; Ishitani, Ryuichiro; Siomi, Haruhiko; Siomi, Mikiko C.; Nureki, Osamu			Structure and function of Zucchini endoribonuclease in piRNA biogenesis	NATURE			English	Article							PHOSPHOLIPASE-D FAMILY; CRYSTAL-STRUCTURE; NUAGE FORMATION; SMALL RNAS; DROSOPHILA; GERMLINE; GENOME; PIWI; REPLACEMENT; MECHANISM	PIWI-interacting RNAs (piRNAs) silence transposons to maintain genome integrity in animal germ lines(1-4). piRNAs are classified as primary and secondary piRNAs, depending on their biogenesis machinery(5-10). Primary piRNAs are processed from long non-coding RNA precursors transcribed from piRNA clusters in the genome through the primary processing pathway(5,8-10). Although the existence of a ribonuclease participating in this pathway has been predicted, its molecular identity remained unknown. Here we show that Zucchini (Zuc), a mitochondrial phospholipase D (PLD) superfamily member(11), is an endoribonuclease essential for primary piRNA biogenesis. We solved the crystal structure of Drosophila melanogaster Zuc (DmZuc) at 1.75 angstrom resolution. The structure revealed that DmZuc has a positively charged, narrow catalytic groove at the dimer interface, which could accommodate a single-stranded, but not a double-stranded, RNA. DmZuc and the mouse homologue MmZuc (also known as Pld6 and MitoPLD)(12-14) showed endoribonuclease activity for single-stranded RNAs in vitro. The RNA cleavage products bear a 5'-monophosphate group, a hallmark of mature piRNAs. Mutational analyses revealed that the conserved active-site residues of DmZuc are critical for the ribonuclease activity in vitro, and for piRNA maturation and transposon silencing in vivo. We propose a model for piRNA biogenesis in animal germ lines, in which the Zuc endoribonuclease has a key role in primary piRNA maturation.	[Nishimasu, Hiroshi; Ishizu, Hirotsugu; Fukuhara, Satoshi; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Siomi, Mikiko C.; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Ishizu, Hirotsugu; Saito, Kuniaki; Kamatani, Miharu K.; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Nakanaga, Keita; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Siomi, Mikiko C.; Nureki, Osamu] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan	University of Tokyo; Keio University; Tohoku University; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	siomim@biochem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015; ISHIZU, HIROTSUGU/G-4991-2014; Bonnefond, Luc/P-3926-2016; NUREKI, OSAMU/G-4960-2014	Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822; Bonnefond, Luc/0000-0002-1164-742X; Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [11J05211] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Kurabayashi, H. Kotani and Y. Tamaki for technical assistance; other members of the Siomi laboratory for discussions and comments on the manuscript; the beamline staff at BL32XU of SPring-8 for assistance in data collection; and T. Suzuki and H. Suga for technical suggestions and comments. This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program' to O.N., by the Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST) to O.N. and M. C. S., and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H.N., H. I., H. S., M. C. S. and O.N.. K.S. is supported by the JSPS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuhara S, ACTA CRYS F IN PRESS; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAAE AJ, 1975, EUR J BIOCHEM, V60, P437, DOI 10.1111/j.1432-1033.1975.tb21021.x; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Zhao Y, 1997, PROTEIN SCI, V6, P2655	33	229	243	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					284	U157		10.1038/nature11509	http://dx.doi.org/10.1038/nature11509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064230				2022-12-28	WOS:000310774300050
J	Vaidya, N; Manapat, ML; Chen, IA; Xulvi-Brunet, R; Hayden, EJ; Lehman, N				Vaidya, Nilesh; Manapat, Michael L.; Chen, Irene A.; Xulvi-Brunet, Ramon; Hayden, Eric J.; Lehman, Niles			Spontaneous network formation among cooperative RNA replicators	NATURE			English	Article							NATURAL SELF-ORGANIZATION; EVOLUTION; RIBOZYME; ORIGIN; HYPERCYCLE; PRINCIPLE; LIFE; EMERGENCE; SELECTION; SYSTEMS	The origins of life on Earth required the establishment of self-replicating chemical systems capable of maintaining and evolving biological information. In an RNA world, single self-replicating RNAs would have faced the extreme challenge of possessing a mutation rate low enough both to sustain their own information and to compete successfully against molecular parasites with limited evolvability. Thus theoretical analyses suggest that networks of interacting molecules were more likely to develop and sustain life-like behaviour. Here we show that mixtures of RNA fragments that self-assemble into self-replicating ribozymes spontaneously form cooperative catalytic cycles and networks. We find that a specific three-membered network has highly cooperative growth dynamics. When such cooperative networks are competed directly against selfish autocatalytic cycles, the former grow faster, indicating an intrinsic ability of RNA populations to evolve greater complexity through cooperation. We can observe the evolvability of networks through in vitro selection. Our experiments highlight the advantages of cooperative behaviour even at the molecular stages of nascent life.	[Vaidya, Nilesh; Lehman, Niles] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Manapat, Michael L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Chen, Irene A.; Xulvi-Brunet, Ramon] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hayden, Eric J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Portland State University; Harvard University; Harvard University; Harvard University; Stanford University	Lehman, N (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	niles@pdx.edu	Lehman, Niles/ABF-7609-2021	Lehman, Niles/0000-0002-9056-6600; Xulvi-Brunet, Ramon/0000-0002-6013-4831; Chen, Irene/0000-0001-6040-7927	NASA [NNX10AR15G]; Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization; Direct For Biological Sciences [0963548] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization(Human Frontier Science Program); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank A. Burton, R. Ghadiri, P. Higgs, B. Larson, K. Chacon and A. Lopez Garcia de Lomana for help during preparation of this manuscript. This work was supported by NASA grant NNX10AR15G to N.L., the Center for Life in Extreme Environments at Portland State University, and a fellowship from the Human Frontier Science Program Organization to R.X.-B.	BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; Draper WE, 2008, NUCLEIC ACIDS RES, V36, P520, DOI 10.1093/nar/gkm1055; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Hayden EJ, 2008, ANGEW CHEM INT EDIT, V47, P8424, DOI 10.1002/anie.200802177; Hayden EJ, 2006, CHEM BIOL, V13, P909, DOI 10.1016/j.chembiol.2006.06.014; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Kauffman S.A., 1993, ORIGINS ORDER; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; Lee DH, 1997, CURR OPIN CHEM BIOL, V1, P491, DOI 10.1016/S1367-5931(97)80043-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Levy M, 2001, NAT STRUCT BIOL, V8, P580, DOI 10.1038/89601; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2008, P NATL ACAD SCI USA, V105, P14924, DOI 10.1073/pnas.0806714105; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	32	232	235	6	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					72	77		10.1038/nature11549	http://dx.doi.org/10.1038/nature11549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23075853				2022-12-28	WOS:000310434500032
J	Zhang, YT; Baik, SH; Fendrick, AM; Baicker, K				Zhang, Yuting; Baik, Seo Hyon; Fendrick, A. Mark; Baicker, Katherine			Comparing Local and Regional Variation in Health Care Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GEOGRAPHIC-VARIATION; MEDICARE; QUALITY	BACKGROUND Wide geographic variation in health care spending has generated both concern about inefficiency and policy debate about geographic-based payment reform. Evidence regarding variation has focused on hospital referral regions (HRRs), which incorporate numerous local hospital service areas (HSAs). If there is substantial variation across local areas within HRRs, then policies focusing on HRRs may be poorly targeted. METHODS Using prescription drug and medical claims data from a 5% random sample of Medicare beneficiaries from 2006 through 2009, we compared variation in health care spending and utilization among 306 HRRs and 3436 HSAs. We adjusted for beneficiary-level demographic characteristics, insurance status, and clinical characteristics. RESULTS There was substantial local variation in health care (drug and nondrug) utilization and spending. Furthermore, many of the low-spending HSAs were located in high-spending HRRs, and many of the high-spending HSAs were in low-spending HRRs. For drug spending, only 50.7% of the HSAs located within the borders of the highest-spending quintile of HRRs were in the highest-spending quintile of HSAs; conversely, only 51.5% of the highest-spending HSAs were located within the borders of the highest-spending HRRs. Similar patterns were observed for nondrug spending. CONCLUSIONS The effectiveness of payment reforms in reducing overutilization while maintaining access to high-quality care depends on the effectiveness of targeting. Our analysis suggests that HRR-based policies may be too crudely targeted to promote the best use of health care resources. (Funded by the Institute of Medicine and others.)	[Zhang, Yuting; Baik, Seo Hyon] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Fendrick, A. Mark] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Fendrick, A. Mark] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, YT (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, 130 De Soto St,Crabtree Hall A664, Pittsburgh, PA 15261 USA.	ytzhang@pitt.edu		Zhang, Yuting/0000-0002-6460-6779	Institute of Medicine [HHSP22320042509XI]; National Institute of Mental Health [RC1 MH088510]; Agency for Healthcare Research and Quality [R01 HS018657]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088510] Funding Source: NIH RePORTER	Institute of Medicine; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants (to Dr. Zhang) from the Institute of Medicine (HHSP22320042509XI), National Institute of Mental Health (RC1 MH088510), and Agency for Healthcare Research and Quality (R01 HS018657).	[Anonymous], 2009, C MEAS REG VAR SERV; [Anonymous], 2011, RISK ADJ 2011 RXHCC; [Anonymous], 2010, DARTM ATL HLTH CAR; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Doyle JJ, 2011, AM ECON J-APPL ECON, V3, P221, DOI 10.1257/app.3.3.221; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Medicare Payment Advisory Commission, 2011, C REG VAR MED SERV U; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	13	95	95	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1724	1731		10.1056/NEJMsa1203980	http://dx.doi.org/10.1056/NEJMsa1203980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113483	Green Accepted			2022-12-28	WOS:000310440800009
J	Orozco, LD; Bennett, BJ; Farber, CR; Ghazalpour, A; Pan, C; Che, N; Wen, PZ; Qi, HX; Mutukulu, A; Siemers, N; Neuhaus, I; Yordanova, R; Gargalovic, P; Pellegrini, M; Kirchgessner, T; Lusis, AJ				Orozco, Luz D.; Bennett, Brian J.; Farber, Charles R.; Ghazalpour, Anatole; Pan, Calvin; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Mutukulu, Adonisa; Siemers, Nathan; Neuhaus, Isaac; Yordanova, Roumyana; Gargalovic, Peter; Pellegrini, Matteo; Kirchgessner, Todd; Lusis, Aldons J.			Unraveling Inflammatory Responses using Systems Genetics and Gene-Environment Interactions in Macrophages	CELL			English	Article							PPAR-GAMMA; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS; CHOLESTEROL; EXPRESSION; RECEPTORS; IMMUNITY; ABCA1; ALPHA	Many common diseases have an important inflammatory component mediated in part by macrophages. Here we used a systems genetics strategy to examine the role of common genetic variation in macrophage responses to inflammatory stimuli. We examined genome-wide transcript levels in macrophages from 92 strains of the Hybrid Mouse Diversity Panel. We exposed macrophages to control media, bacterial lipopolysaccharide (LPS), or oxidized phospholipids. We performed association mapping under each condition and identified several thousand expression quantitative trait loci (eQTL), gene-by-environment interactions, and eQTL "hot spots" that specifically control LPS responses. We used siRNA knockdown of candidate genes to validate an eQTL hot spot in chromosome 8 and identified the gene 2310061C15Rik as a regulator of inflammatory responses in macrophages. We have created a public database where the data presented here can be used as a resource for understanding many common inflammatory traits that are modeled in the mouse and for the dissection of regulatory relationships between genes.	[Orozco, Luz D.; Pan, Calvin; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bennett, Brian J.; Ghazalpour, Anatole; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mutukulu, Adonisa] Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Farber, Charles R.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Siemers, Nathan; Neuhaus, Isaac] Bristol Myers Squibb Co, Dept Bioinformat & Proteom, Pennington, NJ 08534 USA; [Yordanova, Roumyana] Bristol Myers Squibb Co, Dept Appl Genom, Pennington, NJ 08534 USA; [Gargalovic, Peter; Kirchgessner, Todd] Bristol Myers Squibb Co, Dept Atherosclerosis Drug Discovery, Pennington, NJ 08534 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Virginia; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Orozco, LD (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	ldorozco@mednet.ucla.edu	Yordanova, Roumyana/AAR-2275-2021	Pellegrini, Matteo/0000-0001-9355-9564; Farber, Charles/0000-0002-6748-4711; bennett, brian/0000-0002-0766-3195	NIH [HL30568, HL28481, D094311, K99 HL102223]; Ruth L. Kirschstein NIH F32 Fellowship [5F32DK074317]; USPHS National Research Service Award [GM07104, T32-HG002536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102223, P01HL030568, R00HL102223, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK074317, DP3DK094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095656, T32GM007104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NIH F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.L. and this work were supported by the NIH grants HL30568, HL28481, and D094311. B. J. B. was supported by the NIH grant K99 HL102223. C. R. F. was supported by the Ruth L. Kirschstein NIH F32 Fellowship 5F32DK074317. L. D. O. was supported by USPHS National Research Service Award GM07104 and USPHS National Research Service Award T32-HG002536. N. S., I. N., R. Y., P. G., and T. K. are employees of Bristol-Myers Squibb.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Edgel KA, 2010, ATHEROSCLEROSIS, V209, P387, DOI 10.1016/j.atherosclerosis.2009.10.019; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Rojo L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73976; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	21	92	95	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					658	670		10.1016/j.cell.2012.08.043	http://dx.doi.org/10.1016/j.cell.2012.08.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101632	Green Accepted, Bronze			2022-12-28	WOS:000310529300020
J	Breen, MS; Kemena, C; Vlasov, PK; Notredame, C; Kondrashov, FA				Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.			Epistasis as the primary factor in molecular evolution	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPENSATORY EVOLUTION; ADAPTIVE EVOLUTION; PROTEIN EVOLUTION; NATURAL-SELECTION; GENETIC-VARIATION; PERSPECTIVE; DROSOPHILA; MUTATIONS; LANDSCAPE	The main forces directing long-term molecular evolution remain obscure. A sizable fraction of amino-acid substitutions seem to be fixed by positive selection(1-4), but it is unclear to what degree long-term protein evolution is constrained by epistasis, that is, instances when substitutions that are accepted in one genotype are deleterious in another. Here we obtain a quantitative estimate of the prevalence of epistasis in long-term protein evolution by relating data on amino-acid usage in 14 organelle proteins and 2 nuclear-encoded proteins to their rates of short-term evolution. We studied multiple alignments of at least 1,000 orthologues for each of these 16 proteins from species from a diverse phylogenetic background and found that an average site contained approximately eight different amino acids. Thus, without epistasis an average site should accept two-fifths of all possible amino acids, and the average rate of amino-acid substitutions should therefore be about three-fifths lower than the rate of neutral evolution. However, we found that the measured rate of amino-acid substitution in recent evolution is 20 times lower than the rate of neutral evolution and an order of magnitude lower than that expected in the absence of epistasis. These data indicate that epistasis is pervasive throughout protein evolution: about 90 per cent of all amino-acid substitutions have a neutral or beneficial impact only in the genetic backgrounds in which they occur, and must therefore be deleterious in a different background of other species. Our findings show that most amino-acid substitutions have different fitness effects in different species and that epistasis provides the primary conceptual framework to describe the tempo and mode of long-term protein evolution.	[Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Kondrashov, Fyodor A.] 23 Passeig Lluis Co, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, 88 Dr Aiguader, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Vlasov, Peter/O-6392-2015; Kondrashov, Fyodor Alexeevich/H-6331-2015; notredame, cedric/G-3868-2010	Vlasov, Peter/0000-0003-0489-4200; Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Kemena, Carsten/0000-0002-2416-9842; notredame, cedric/0000-0003-1461-0988	Spanish Ministry of Science and Innovation; European Union [KBBE2A222664]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); ICREA(ICREA)	The work was supported by Plan Nacional grants from the Spanish Ministry of Science and Innovation, to F.A.K. and C.N. C.K. was supported by the European Union FP7 project Quantomics (KBBE2A222664). F.A.K. is a European Molecular Biology Organization Young Investigator and Howard Hughes Medical Institute International Early Career Scientist. We thank B. Lehner and T. Warnecke for input and a critical reading of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; GILLESPIE JH, 1986, MOL BIOL EVOL, V3, P138; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li W. H., 1997, MOL EVOLUTION, P419; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Poon AFY, 2006, EVOLUTION, V60, P2032, DOI 10.1111/j.0014-3820.2006.tb01841.x; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	237	244	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					535	+		10.1038/nature11510	http://dx.doi.org/10.1038/nature11510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23064225				2022-12-28	WOS:000310196200041
J	Mesotten, D; Gielen, M; Sterken, C; Claessens, K; Hermans, G; Vlasselaers, D; Lemiere, J; Lagae, L; Gewillig, M; Eyskens, B; Vanhorebeek, I; Wouters, PJ; Van den Berghe, G				Mesotten, Dieter; Gielen, Marijke; Sterken, Caroline; Claessens, Kirsten; Hermans, Greet; Vlasselaers, Dirk; Lemiere, Jurgen; Lagae, Lieven; Gewillig, Marc; Eyskens, Benedicte; Vanhorebeek, Ilse; Wouters, Pieter J.; Van den Berghe, Greet			Neurocognitive Development of Children 4 Years After Critical Illness and Treatment With Tight Glucose Control A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYPOTHERMIC CIRCULATORY ARREST; PEDIATRIC INTENSIVE-CARE; NEURODEVELOPMENTAL OUTCOMES; PERSISTENT HYPERGLYCEMIA; COGNITIVE FUNCTION; D-TRANSPOSITION; NERVOUS-SYSTEM; HEART-SURGERY; HYPOGLYCEMIA; ADOLESCENTS	Context A large randomized controlled trial revealed that tight glucose control (TGC) to age-adjusted normoglycemia (50-80 mg/dL at age <1 year and 70-100 mg/dL at age 1-16 years) reduced intensive care morbidity and mortality compared with usual care (UC), but increased hypoglycemia (<= 40 mg/dL) (25% vs 1%). Objective As both hyperglycemia and hypoglycemia may adversely affect the developing brain, long-term follow-up was required to exclude harm and validate short-term benefits of TGC. Design, Setting, and Patients A prospective, randomized controlled trial of 700 patients aged 16 years or younger who were admitted to the pediatric intensive care unit (ICU) of the University Hospitals in Leuven, Belgium, between October 2004 and December 2007. Follow-up was scheduled after 3 years with infants assessed at 4 years old between August 2008 and January 2012. Assessment was performed blinded for treatment allocation, in-hospital (83%) or at home/school (17%). For comparison, 216 healthy siblings and unrelated children were tested. Main Outcome Measures Intelligence (full-scale intelligence quotient [IQ]), as assessed with age-adjusted tests (Wechsler IQ scales). Further neurodevelopmental testing encompassed tests for visual-motor integration (Beery-Buktenica Developmental Test of Visual-Motor Integration); attention, motor coordination, and executive functions (Amsterdam Neuropsychological Tasks); memory (Children's Memory Scale); and behavior (Child Behavior Checklist). Results Sixteen percent of patients declined participation or could not be reached (n=113), resulting in 569 patients being alive and testable at follow-up. At a median (interquartile range [IQR]) of 3.9 (3.8-4.1) years after randomization, TGC in the ICU did not affect full-scale IQ score (median [IQR], 88.0 [74.0-100.0] vs 88.5 [74.3-99.0] for UC; P=.73) and had not increased incidence of poor outcomes (death or severe disability precluding neurocognitive testing: 19% [68/349] vs 18% [63/351] with UC; risk-adjusted odds ratio, 0.93; 95% CI, 0.60-1.46; P=.72). Other scores for intelligence, visual-motor integration, and memory also did not differ between groups. Tight glucose control improved motor coordination( 9% [95% CI, 0%-18%] to 20% [95% CI, 5%-35%] better, all P <= .03) and cognitive flexibility (19% [95% CI, 5%-33%] better, P=.02). Brief hypoglycemia evoked by TGC was not associated with worse neurocognitive outcome. Conclusion At follow-up, children who had been treated with TGC during an ICU admission did not have a worse measure of intelligence than those who had received UC.	[Mesotten, Dieter; Gielen, Marijke; Sterken, Caroline; Claessens, Kirsten; Hermans, Greet; Vlasselaers, Dirk; Vanhorebeek, Ilse; Wouters, Pieter J.; Van den Berghe, Greet] Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium; [Lemiere, Jurgen] Catholic Univ Louvain, Dept Child & Adolescent Psychiat, B-3000 Louvain, Belgium; [Lagae, Lieven] Catholic Univ Louvain, Dept Pediat Neurol, B-3000 Louvain, Belgium; [Gewillig, Marc; Eyskens, Benedicte] Catholic Univ Louvain, Dept Pediat & Congenital Cardiol, B-3000 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Van den Berghe, G (corresponding author), Catholic Univ Louvain, Dept Intens Care Med, Herestr 49, B-3000 Louvain, Belgium.	greet.vandenberghe@med.kuleuven.be	Van den Berghe, Greet/J-6788-2018; Hermans, Greet M/E-6234-2018; Lemiere, Jurgen/A-2515-2017; Mesotten, Dieter/ABE-4176-2020	Van den Berghe, Greet/0000-0002-5320-1362; Hermans, Greet M/0000-0001-5340-1500; Lemiere, Jurgen/0000-0002-1575-0889; Mesotten, Dieter/0000-0002-3258-4720; Gewillig, Marc/0000-0002-4595-5922; Vanhorebeek, Ilse/0000-0002-5261-5192	Institute for Science and Technology, Flanders, Belgium (via Catholic University of Leuven) [IWT/070695/TBM]; Methusalem Program of the Flemish Government (via Catholic University of Leuven) [METH08/07]; FWO Research Foundation-Flanders, Belgium; Clinical Research Fund of the Leuven University Hospital; Viropharma; Cyberonics	Institute for Science and Technology, Flanders, Belgium (via Catholic University of Leuven); Methusalem Program of the Flemish Government (via Catholic University of Leuven); FWO Research Foundation-Flanders, Belgium; Clinical Research Fund of the Leuven University Hospital; Viropharma; Cyberonics	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lagae reported having board membership and receiving consultancy fees and payment for lectures from Viropharma and Cyberonics, and receiving payment for lectures from Eisai and UCB. No other authors reported any disclosures.; This research was fully supported by official research grants IWT/070695/TBM from the Institute for Science and Technology, Flanders, Belgium (via Catholic University of Leuven to Drs Van den Berghe, Mesotten, and Vanhorebeek); METH08/07 from the Methusalem Program of the Flemish Government (via Catholic University of Leuven to Dr Van den Berghe); from the FWO Research Foundation-Flanders, Belgium (PhD fellowship to Dr Gielen and postdoctoral fellowship to Dr Mesotten); and from the Clinical Research Fund of the Leuven University Hospital (postdoctoral fellowship to Dr Hermans).	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adams J., 2011, YALE J SOCIOLOGY, V8, P11; Agus MS, 2012, N ENGL J MED; Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Beery K. E, 2006, BEERY VMI BEERY BUKT; Bellinger DC, 2011, CIRCULATION, V124, P1361, DOI 10.1161/CIRCULATIONAHA.111.026963; Bellinger DC, 1999, CIRCULATION, V100, P526, DOI 10.1161/01.CIR.100.5.526; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Beyerlein A, 2010, AM J CLIN NUTR, V92, P585, DOI 10.3945/ajcn.2009.29116; Bjorgaas M, 1997, ACTA PAEDIATR, V86, P148, DOI 10.1111/j.1651-2227.1997.tb08856.x; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; BROWN TCK, 1980, AUST PAEDIATR J, V16, P28; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Cohen MJ., 1997, CHILDRENS MEMORY SCA; De Sonneville L.M.J., 2011, AMSTERDAM NEUROPSYCH; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, 2007, NEW ENGL J MED, V356, P1842; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Duning T, 2010, DIABETES CARE, V33, P639, DOI 10.2337/dc09-1740; Elison S, 2008, INTENS CARE MED, V34, P1289, DOI 10.1007/s00134-008-1093-9; Ellerbeck KA, 1998, J DEV BEHAV PEDIATR, V19, P335, DOI 10.1097/00004703-199810000-00003; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hadders-Algra M, 2005, MENT RETARD DEV D R, V11, P180, DOI 10.1002/mrdd.20069; Halsey C, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-42; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hirsch IB, 2012, NEW ENGL J MED, V367, P1150, DOI 10.1056/NEJMe1208208; Hollingshead AB., 2011, YJS, V8, P21, DOI DOI 10.1016/J.MATERRESBULL.2011.04.018; Jaber L, 1998, Community Genet, V1, P12, DOI 10.1159/000016130; Kalff AC, 2005, J INT NEUROPSYCH SOC, V11, P173; Knoester H, 2007, EUR J PEDIATR, V166, P1119, DOI 10.1007/s00431-007-0573-1; Koekkoek S, 2006, J NEUROL, V253, P1615, DOI 10.1007/s00415-006-0277-x; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mennes M, 2005, PEDIATR BLOOD CANCER, V44, P479, DOI 10.1002/pbc.20147; Miatton M, 2006, NEUROPSYCHOL REV, V16, P65, DOI 10.1007/s11065-006-9005-7; Musen G, 2008, DIABETES CARE, V31, P1933, DOI 10.2337/dc08-0607; Perantie DC, 2007, DIABETES CARE, V30, P2331, DOI 10.2337/dc07-0351; Peters LHJ, 2008, EUR J PAEDIATR NEURO, V12, P328, DOI 10.1016/j.ejpn.2007.09.006; Rommelse NNJ, 2007, J ABNORM CHILD PSYCH, V35, P957, DOI 10.1007/s10802-007-9146-z; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Schittekatte M., 2005, NEDERLANDSE BEWERKIN; Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; Smith AB, 2004, HUM BRAIN MAPP, V21, P247, DOI 10.1002/hbm.20007; Sonneville R, 2012, J CLIN ENDOCR METAB, V97, P2113, DOI 10.1210/jc.2011-2971; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Thoemmes F, PROPENSITY SCORE MAT; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2009, J CLIN ENDOCR METAB, V94, P3163, DOI 10.1210/jc.2009-0663; Vander Steene G, 1997, WPPSI R VLAAMS NEDER; Vanhorebeek I, 2010, J CLIN ENDOCR METAB, V95, P4669, DOI 10.1210/jc.2010-0805; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Watkinson PJ, 2012, ANN CLIN BIOCHEM, V49, P144, DOI 10.1258/acb.2011.011162; Wechsler D, 2004, WAIS 3 NEDERLANDSTAL; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98	69	112	115	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1641	1650		10.1001/jama.2012.12424	http://dx.doi.org/10.1001/jama.2012.12424			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23101118	Bronze, Green Accepted			2022-12-28	WOS:000310434100018
J	Kappagoda, S; Ioannidis, JPA				Kappagoda, Shanthi; Ioannidis, John P. A.			Neglected tropical diseases: survey and geometry of randomised evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSMITTED HELMINTH INFECTIONS; EFLORNITHINE COMBINATION THERAPY; GLOBAL BURDEN; VISCERAL LEISHMANIASIS; LYMPHATIC FILARIASIS; NEMATODE INFECTIONS; AMPHOTERICIN-B; HEALTH-POLICY; EFFICACY; ALBENDAZOLE	Objective To assess the quantity and distribution of evidence from randomised controlled trials for the treatment of the major neglected tropical diseases and to identify gaps in the evidence with network analysis. Design Systematic review and network analysis. Data sources Cochrane Central Register of Controlled Trials and PubMed from inception to 31 August 2011. Study selection Randomised controlled trials that examined treatment of 16 neglected tropical diseases or complications thereof published in English, French, Spanish, Portuguese, German, or Dutch. Results We identified 971 eligible randomised trials. Leishmaniasis (184 trials, 23 039 participants) and geohelminth infections; 160 trials, 46 887 participants) were the most studied, while dracunculiasis (nine trials, 798 participants) and Buruli ulcer (five trials, 337 participants) were least studied. Relative to its global burden of disease, lymphatic filariasis had the fewest trials and participants. Only 11% of trials were industry funded. Either a single trial or trials with fewer than 100 participants comprised the randomised evidence for first or second line treatments for Buruli ulcer, human African trypanosomiasis, American trypanosomiasis, cysticercosis, rabies, echinococcosis, New World cutaneous leishmaniasis, and each of the foodborne trematode infections. Among the 10 disease categories with more than 40 trials, five lacked sufficient head to head comparisons between first or second line treatments. Conclusions There is considerable variation in the amount of evidence from randomised controlled trials for each of the 16 major neglected tropical diseases. Even in diseases with substantial evidence, such as leishmaniasis and geohelminth infections, some recommended treatments have limited supporting data and lack head to head comparisons.	[Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Kappagoda, Shanthi] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Kappagoda, Shanthi] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Dept Med, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011		Agency for Healthcare Research and Quality [HS000028]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028, F32HS000028] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	SK was supported in part by grant HS000028 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funding source had no role in the design or implementation of the study or the decision to publish.	Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; [Anonymous], 1982, World Health Organ Tech Rep Ser, V675, P1; [Anonymous], 2007, MED LETT, V5, pe1; ARCHIBALD LK, 1993, Q J MED, V86, P191; ARJONA R, 1995, MEDICINE, V74, P13, DOI 10.1097/00005792-199501000-00002; AZIZ MA, 1986, REV INFECT DIS, V8, P500; BACQ Y, 1991, HEPATOLOGY, V14, P1066, DOI 10.1002/hep.1840140620; BARTOLONI A, 1993, TROP GEOGR MED, V45, P114; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bill and Melinda Gates Foundation, 2006, GRANT ANN; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; BUNNAG D, 1983, Southeast Asian Journal of Tropical Medicine and Public Health, V14, P216; Calvopina M, 1998, T ROY SOC TROP MED H, V92, P566, DOI 10.1016/S0035-9203(98)90919-1; Cao WC, 1997, TROP MED INT HEALTH, V2, P393; Davidson RN, 1998, DRUGS, V56, P1009, DOI 10.2165/00003495-199856060-00005; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; den Boer Margriet, 2006, Expert Rev Anti Infect Ther, V4, P187, DOI 10.1586/14787210.4.2.187; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; DUKE BOL, 1972, BRIT MED BULL, V28, P66, DOI 10.1093/oxfordjournals.bmb.a070896; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Estellat C, 2012, ARCH INTERN MED, V172, P237, DOI 10.1001/archinternmed.2011.1209; EVANS TG, 1993, INFECT DIS CLIN N AM, V7, P527; FARAG HF, 1988, J TROP MED HYG, V91, P240; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Flohr C, 2007, AM J TROP MED HYG, V76, P732, DOI 10.4269/ajtmh.2007.76.732; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002; Grencis RK, 1996, GASTROENTEROL CLIN N, V25, P579, DOI 10.1016/S0889-8553(05)70264-8; HALL A, 1994, T ROY SOC TROP MED H, V88, P110, DOI 10.1016/0035-9203(94)90525-8; HARINASUTA T, 1993, INFECT DIS CLIN N AM, V7, P699; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296; Hoerauf A, 2008, CURR OPIN INFECT DIS, V21, P673, DOI 10.1097/QCO.0b013e328315cde7; Hopkins Donald R., 2011, Morbidity and Mortality Weekly Report, V60, P1450; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Igual-Adell R, 2004, EXPERT OPIN PHARMACO, V5, P2615, DOI 10.1517/14656566.5.12.2615; JONG EC, 1985, J INFECT DIS, V152, P637, DOI 10.1093/infdis/152.3.637; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Legesse M, 2004, East Afr Med J, V81, P134; Lwin K, 2005, LEPROSY REV, V76, P77; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; MOST H, 1972, NEW ENGL J MED, V287, P495, DOI 10.1056/NEJM197209072871006; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; NAQUIRA C, 1989, AM J TROP MED HYG, V40, P304, DOI 10.4269/ajtmh.1989.40.304; Norhayati M., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P563; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6; OTTESEN EA, 1994, J ANTIMICROB CHEMOTH, V34, P195, DOI 10.1093/jac/34.2.195; Priotto G, 2007, CLIN INFECT DIS, V45, P1435, DOI 10.1086/522982; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Pungpak Swangjai, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P246; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Ribeiro-dos-Santos G, 2006, PARASITOL RES, V99, P505, DOI 10.1007/s00436-006-0175-2; RIPERT C, 1992, T ROY SOC TROP MED H, V86, P417, DOI 10.1016/0035-9203(92)90247-A; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; ROSSIGNOL JF, 1984, ANN TROP MED PARASIT, V78, P135, DOI 10.1080/00034983.1984.11811787; Sacko M, 1999, T ROY SOC TROP MED H, V93, P195, DOI 10.1016/S0035-9203(99)90306-1; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Thase Michael E, 2008, Curr Psychiatry Rep, V10, P487; Tisch DJ, 2005, LANCET INFECT DIS, V5, P514, DOI 10.1016/S1473-3099(05)70192-4; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; WHO, 2006, TRACH CONTR GUID PRO; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, BUR ULC PROV GUID RO; World Health Organization, 2012, WHO METR DIS ADJ YEA; World Health Organization, 2000, GUID EL LEPR PUBL HL; Zhang Liangfen, 2003, Nihon Hansenbyo Gakkai Zasshi, V72, P209	93	29	29	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2012	345								e6512	10.1136/bmj.e6512	http://dx.doi.org/10.1136/bmj.e6512			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MR	23089149	hybrid, Green Published			2022-12-28	WOS:000310426900001
J	Devanand, DP; Mintzer, J; Schultz, SK; Andrews, HF; Sultzer, DL; de la Pena, D; Gupta, S; Colon, S; Schimming, C; Pelton, GH; Levin, B				Devanand, D. P.; Mintzer, Jacobo; Schultz, Susan K.; Andrews, Howard F.; Sultzer, David L.; de la Pena, Danilo; Gupta, Sanjay; Colon, Sylvia; Schimming, Corbett; Pelton, Gregory H.; Levin, Bruce			Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATYPICAL ANTIPSYCHOTIC MEDICATIONS; PLACEBO-CONTROLLED TRIALS; NURSING-HOME RESIDENTS; DOUBLE-BLIND; CATIE-AD; NEUROPSYCHIATRIC INVENTORY; COGNITIVE DECLINE; RANDOMIZED TRIAL; ELDERLY-PATIENTS; DEMENTIA	BACKGROUND Among patients with Alzheimer's disease who have had a response to antipsychotic medication for psychosis or agitation-aggression, the risk of a recurrence of symptoms after discontinuation of the medication has not been established. METHODS Patients with Alzheimer's disease and psychosis or agitation-aggression received open-label treatment with risperidone for 16 weeks. Those who had a response to risperidone therapy were then randomly assigned, in a double-blind fashion, to one of three regimens: continued risperidone therapy for 32 weeks (group 1), risperidone therapy for 16 weeks followed by placebo for 16 weeks (group 2), or placebo for 32 weeks (group 3). The primary outcome was the time to relapse of psychosis or agitation. RESULTS A total of 180 patients received open-label risperidone (mean dose, 0.97 mg daily). The severity of psychosis and agitation were reduced, although there was a mild increase in extrapyramidal signs; 112 patients met the criteria for response to treatment, of whom 110 underwent randomization. In the first 16 weeks after randomization, the rate of relapse was higher in the group that received placebo than in the groups that received risperidone (60% [24 of 40 patients in group 3] vs. 33% [23 of 70 in groups 1 and 2]; P = 0.004; hazard ratio with placebo, 1.94; 95% confidence interval [CI], 1.09 to 3.45; P = 0.02). During the next 16 weeks, the rate of relapse was higher in the group that was switched from risperidone to placebo than in the group that continued to receive risperidone (48% [13 of 27 patients in group 2] vs. 15% [2 of 13 in group 1]; P = 0.02; hazard ratio, 4.88; 95% CI, 1.08 to 21.98; P = 0.02). The rates of adverse events and death after randomization did not differ significantly among the groups, although comparisons were based on small numbers of patients, especially during the final 16 weeks. CONCLUSIONS In patients with Alzheimer's disease who had psychosis or agitation that had responded to risperidone therapy for 4 to 8 months, discontinuation of risperidone was associated with an increased risk of relapse. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00417482.)	[Devanand, D. P.; Pelton, Gregory H.] Columbia Univ, New York State Psychiat Inst, Div Geriatr Psychiat, New York, NY 10032 USA; [Devanand, D. P.; Andrews, Howard F.; Pelton, Gregory H.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Devanand, D. P.; Andrews, Howard F.; Pelton, Gregory H.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Devanand, D. P.; Andrews, Howard F.; Pelton, Gregory H.] Columbia Univ, Coll Physicians & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Andrews, Howard F.; Levin, Bruce] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA; [Gupta, Sanjay] Global Res & Consulting, Buffalo, NY USA; [Schimming, Corbett] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Mintzer, Jacobo] Med Univ S Carolina, Dept Neurosci, Div Translat Res, Charleston, SC USA; [Mintzer, Jacobo] Ralph H Johnson Vet Affairs VA Med Ctr, Charleston, SC USA; [Schultz, Susan K.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA USA; [Sultzer, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Sultzer, David L.] VA Greater Angeles Hlth Syst, Los Angeles, CA USA; [de la Pena, Danilo] Res Ctr Clin Studies, Norwalk, CT USA; [Colon, Sylvia] VA Med Ctr, Dept Psychiat, Tuscaloosa, AL USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Devanand, DP (corresponding author), Columbia Univ, New York State Psychiat Inst, Div Geriatr Psychiat, 1051 Riverside Dr,Unit 126, New York, NY 10032 USA.	dpd3@columbia.edu	Schultz, Susan K./M-3516-2019; gupta, sanjay/T-2462-2019		National Institutes of Health [R01 AG021488, R01 AG17761]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [R01AG021488, P01AG007232, R01AG017761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (R01 AG021488 and R01 AG17761) and the Department of Veterans Affairs.	AVORN J, 1992, NEW ENGL J MED, V327, P168, DOI 10.1056/NEJM199207163270306; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P114; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2009, AM J GERIAT PSYCHIAT, V17, P726, DOI 10.1097/JGP.0b013e3181b0f8c0; BridgesParlet S, 1997, J GERIATR PSYCH NEUR, V10, P119, DOI 10.1177/089198879701000306; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Chan TC, 2011, INT PSYCHOGERIATR, V23, P1640, DOI 10.1017/S104161021100175X; Cohen-Mansfield J, 1999, ARCH INTERN MED, V159, P1733, DOI 10.1001/archinte.159.15.1733; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Devanand DP, 2012, AM J GERIAT PSYCHIAT, V20, P362, DOI 10.1097/JGP.0b013e3182110563; Devanand DP, 2011, AM J PSYCHIAT, V168, P767, DOI 10.1176/appi.ajp.2011.11040629; Devanand DP, 2011, INT J GERIATR PSYCH, V26, P937, DOI 10.1002/gps.2630; Devanand DP, 1997, ARCH GEN PSYCHIAT, V54, P257; Fitz D, 1992, J Appl Gerontol, V11, P50, DOI 10.1177/073346489201100105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Holm A, 1999, GERONTOLOGIST, V39, P668, DOI 10.1093/geront/39.6.668; HORWITZ GJ, 1995, AM J GERIAT PSYCHIAT, V3, P290, DOI 10.1097/00019442-199503040-00003; Jeste DV, 2000, AM J PSYCHIAT, V157, P1150, DOI 10.1176/appi.ajp.157.7.1150; Katz I, 2007, INT J GERIATR PSYCH, V22, P475, DOI 10.1002/gps.1792; Kong EH, 2009, AGING MENT HEALTH, V13, P512, DOI 10.1080/13607860902774394; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Maher AR, 2012, JAMA-J AM MED ASSOC, V307, P147, DOI 10.1001/jama.2011.1988; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McShane R, 1997, BMJ-BRIT MED J, V314, P266, DOI 10.1136/bmj.314.7076.266; Mulsant BH, 2004, J CLIN PSYCHIAT, V65, P1708, DOI 10.4088/JCP.v65n1217; Raivio MM, 2007, AM J GERIAT PSYCHIAT, V15, P416, DOI 10.1097/JGP.0b013e31802d0b00; Rovner BW, 1996, J AM GERIATR SOC, V44, P7, DOI 10.1111/j.1532-5415.1996.tb05631.x; Ruths S, 2004, J AM GERIATR SOC, V52, P1737, DOI 10.1111/j.1532-5415.2004.52470.x; Scarmeas N, 2007, ARCH NEUROL-CHICAGO, V64, P1755, DOI 10.1001/archneur.64.12.1755; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Shorr Ronald I., 1994, JAMA (Journal of the American Medical Association), V271, P358, DOI 10.1001/jama.271.5.358; Simoni-Wastila L, 2009, AM J GERIAT PSYCHIAT, V17, P417, DOI 10.1097/JGP.0b013e31819b8936; Sultzer DL, 2008, AM J PSYCHIAT, V165, P844, DOI 10.1176/appi.ajp.2008.07111779; THAPA PB, 1994, J AM GERIATR SOC, V42, P280, DOI 10.1111/j.1532-5415.1994.tb01752.x; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Zheng L, 2009, AM J PSYCHIAT, V166, P583, DOI 10.1176/appi.ajp.2008.08081218	39	114	117	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1497	1507		10.1056/NEJMoa1114058	http://dx.doi.org/10.1056/NEJMoa1114058			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23075176	Green Accepted			2022-12-28	WOS:000309904500007
J	Abubakar, I; Griffiths, C; Ormerod, P				Abubakar, Ibrahim; Griffiths, Chris; Ormerod, Peter		Guideline Dev Grp	Diagnosis of active and latent tuberculosis: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Abubakar, Ibrahim] UCL, Res Dept Infect & Populat Hlth, London, England; [Griffiths, Chris] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Ormerod, Peter] Royal Blackburn Hosp, Blackburn, Lancs, England	University of London; University College London; University of London; Queen Mary University London	Abubakar, I (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	i.abubakar@ucl.ac.uk		Abubakar, Ibrahim/0000-0002-0370-1430				Abubakar I, 2011, BRIT MED J, V3, P4281; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; KRUIJSHAAR ME, 2007, TUBERCULOSIS UK ANN; National Institute for Health and Clinical Excellence, 2012, PUBL HLTH GUID; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T, V117; National Institute for Health and Clinical Excellence, 2006, CLIN GUID NICE; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Pareek M, 2011, THORAX, V66, P1010, DOI 10.1136/thx.2010.152280; Salisbury D, 2008, IMMUNISATION INFECT	10	21	25	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 17	2012	345								e6828	10.1136/bmj.e6828	http://dx.doi.org/10.1136/bmj.e6828			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077351				2022-12-28	WOS:000310141900005
J	Takasaki, Y; Kawachi, I; Brunner, EJ				Takasaki, Yohsuke; Kawachi, Ichiro; Brunner, Eric J.			Japan's answer to the economic demands of an ageing population	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Brunner, Eric J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London		takasaki@yoh.jp	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474				Cabinet Office, 2012, WHIT PAP AG SOC; Headquarters of the Government and Ruling Parties for Social Security Reform, 2011, DEF PLAN COMPR REF S; International Monetary Fund, 2011, RAIS CONS TAX JAP WH; Japan Federation of Economic Organizations, 2012, YON COMM EN BILLS CO; Ministry of Finance, 2011, HIGHL BUDG FY2012; Ministry of Finance, ROL CONS TAX OTH COU; Ministry of Health Labor and welfare, DEM STAT; Ministry of Health Labour and Welfare, 2011, ABR LIF TABL 2011; Ministry of Internal Affairs and Communications, 2012, ANN REP LAB FORC SUR; Ministry of Internal Affairs and Communications Statistics Bureau Director General for Policy Planning and Statistical Research and Training Institute, 2012, POP EST; National Institute of Population and Social Security Research, 2012, EST FUT POP JAP; Nikkei Business On Line, 2011, M SAND ACCL JAP SPIR; OECD, 2011, TAX CONS; Office of Budget Responsibility, 2012, FISC SUST REP; Organisation for Economic Cooperation and Development, OECD HLTH DAT 2012; United Nations, WORLDP PROSP 2010 RE; World Health Organization, 2000, WORLD HLTH REP 2000	17	1	1	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 16	2012	345								e6632	10.1136/bmj.e6632	http://dx.doi.org/10.1136/bmj.e6632			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WG	23077322				2022-12-28	WOS:000310140600015
J	Ou, HD; Kwiatkowski, W; Deerinck, TJ; Noske, A; Blain, KY; Land, HS; Soria, C; Powers, CJ; May, AP; Shu, XK; Tsien, RY; Fitzpatrick, JAJ; Long, JA; Ellisman, MH; Choe, S; O'Shea, CC				Ou, Horng D.; Kwiatkowski, Witek; Deerinck, Thomas J.; Noske, Andrew; Blain, Katie Y.; Land, Hannah S.; Soria, Conrado; Powers, Colin J.; May, Andrew P.; Shu, Xiaokun; Tsien, Roger Y.; Fitzpatrick, James A. J.; Long, Jeff A.; Ellisman, Mark H.; Choe, Senyon; O'Shea, Clodagh C.			A Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor Suppressors	CELL			English	Article							E4 ORF3 PROTEIN; DNA-BINDING DOMAIN; ADENOVIRUS INFECTION; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; MRE11 COMPLEX; REPLICATION; E1A; 3D; MICROSCOPY	Evolution of minimal DNA tumor virus' genomes has selected for small viral oncoproteins that hijack critical cellular protein interaction networks. The structural basis for the multiple and dominant functions of adenovirus oncoproteins has remained elusive. E4-ORF3 forms a nuclear polymer and simultaneously inactivates p53, PML, TRIM24, and MRE11/RAD50/NBS1 (MRN) tumor suppressors. We identify oligomerization mutants and solve the crystal structure of E4-ORF3. E4-ORF3 forms a dimer with a central beta core, and its structure is unrelated to known polymers or oncogenes. E4-ORF3 dimer units coassemble through reciprocal and nonreciprocal exchanges of their C-terminal tails. This results in linear and branched oligomer chains that further assemble in variable arrangements to form a polymer network that partitions the nuclear volume. E4-ORF3 assembly creates avidity-driven interactions with PML and an emergent MRN binding interface. This reveals an elegant structural solution whereby a small protein forms a multivalent matrix that traps disparate tumor suppressors.	[Ou, Horng D.; Soria, Conrado; Powers, Colin J.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Kwiatkowski, Witek; Blain, Katie Y.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Land, Hannah S.; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Fitzpatrick, James A. J.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Deerinck, Thomas J.; Noske, Andrew; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Shu, Xiaokun] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Shu, Xiaokun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu	Fitzpatrick, James/C-2268-2009	Fitzpatrick, James/0000-0002-7907-3602; Lipton, Stuart/0000-0002-3490-1259; shu, Xiaokun/0000-0001-9248-7095	NIH [CA137094, CA009370, P30CA014195, P30NS057096, 5P41RR004050, P41GM103412-24, RO1GM086197]; William Scandling Developmental Chair; American Cancer Society; Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE [R01CA137094, T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Scandling Developmental Chair; American Cancer Society(American Cancer Society); Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. McCormick, T. Hunter, J. Chory, V. Lundblad, J. Young, I. Verma, and members of the C.C.O. laboratory for all of their support, insights, and helpful comments. We thank S. Phan and M. Terada for help with EM tomography. This work was supported by the following NIH grants awarded to the Salk Institute: CA137094 to C.C.O., a T32 fellowship (CA009370) to H.D.O., P30CA014195 provides support for the Salk Cancer Center, P30NS057096 supports in part the Salk X-ray equipment. The National Center for Microscopy contributions were supported by NIH awards 5P41RR004050 and P41GM103412-24 to M. H. E. The MiniSOG probe development was supported under RO1GM086197 (to R.Y.T. and M. H. E.). C.C.O. is also supported by the William Scandling Developmental Chair and young investigator awards from the American Cancer Society, the Sontag Foundation, the Arnold and Mabel Beckman Foundation, and the Anna Fuller Fund.	AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Berk AJ, 2007, FIELDS VIROLOGY, P2355; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; DeLano W.L, PYMOL MOL GRAPHICS S; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Evans JD, 2003, J VIROL, V77, P5295, DOI 10.1128/JVI.77.9.5295-5304.2003; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martos V, 2008, CURR OPIN CHEM BIOL, V12, P698, DOI 10.1016/j.cbpa.2008.08.024; MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; Ou HD, 2011, WIRES SYST BIOL MED, V3, P48, DOI 10.1002/wsbm.88; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Ponstingl H, 2000, PROTEINS, V41, P47; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seeliger MA, 2005, J BIOL CHEM, V280, P30448, DOI 10.1074/jbc.M501450200; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	55	61	64	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					304	319		10.1016/j.cell.2012.08.035	http://dx.doi.org/10.1016/j.cell.2012.08.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063122	Green Accepted, Bronze			2022-12-28	WOS:000309981000010
J	Borro, JM				Borro, Jose M.			New methods to facilitate lung transplantation	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; EX-VIVO; SINGLE; PERFUSION; DONORS		Univ Hosp A Coruna, Dept Thorac Surg & Lung Transplantat, La Coruna 15006, Spain	Complejo Hospitalario Universitario A Coruna	Borro, JM (corresponding author), Univ Hosp A Coruna, Dept Thorac Surg & Lung Transplantat, La Coruna 15006, Spain.	jbormat@sergas.es						Aigner C, 2012, AM J TRANSPLANT, V12, P1839, DOI 10.1111/j.1600-6143.2012.04027.x; Botha P, 2006, TRANSPLANTATION, V82, P1273, DOI 10.1097/01.tp.0000236099.52382.74; Coll E, 2012, ARCH BRONCONEUMOL; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Cypel M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000266; Delgado M, 2009, TRANSPL P, V41, P2207, DOI 10.1016/j.transproceed.2009.05.017; Matesanz R, 2011, TRANSPL INT, V24, P333, DOI 10.1111/j.1432-2277.2010.01204.x; Munson JC, 2011, AM J RESP CRIT CARE, V184, P1282, DOI 10.1164/rccm.201104-0695OC; Rodriguez DA, 2011, ARCH BRONCONEUMOL, V47, P403, DOI 10.1016/j.arbres.2011.04.009; Steen S, 2003, ANN THORAC SURG, V76, P244, DOI 10.1016/S0003-4975(03)00191-7; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Warnecke G, 2012, LANCET; Zych B, 2012, J HEART LUNG TRANSPL, V31, P274, DOI 10.1016/j.healun.2011.10.008	14	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1799	1801		10.1016/S0140-6736(12)61691-2	http://dx.doi.org/10.1016/S0140-6736(12)61691-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23063318				2022-12-28	WOS:000311435000008
J	Soerjomataram, I; Lortet-Tieulent, J; Parkin, DM; Ferlay, J; Mathers, C; Forman, D; Bray, F				Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Parkin, D. Maxwell; Ferlay, Jacques; Mathers, Colin; Forman, David; Bray, Freddie			Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions	LANCET			English	Article							MORTALITY; SURVIVAL; OVERDIAGNOSIS; OUTCOMES; DISEASE; EUROPE; TRENDS	Background Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008. Methods We used population-based data, mostly from cancer registries, for incidence, mortality, life expectancy, disease duration, and age at onset and death, alongside proportions of patients who were treated and living with sequelae or regarded as cured, to calculate years of life lost (YLLs) and years lived with disability (YLDs). We used YLLs and YLDs to derive DALYs for 27 sites of cancers in 184 countries in 12 world regions. Estimates were grouped into four categories based on a country's human development index (HDI). We applied zero discounting and uniform age weighting, and age-standardised rates to enable cross-country and regional comparisons. Findings Worldwide, an estimated 169.3 million years of healthy life were lost because of cancer in 2008. Colorectal, lung, breast, and prostate cancers were the main contributors to total DALYs in most world regions and caused 18-50% of the total cancer burden. We estimated an additional burden of 25% from infection-related cancers (liver, stomach, and cervical) in sub-Saharan Africa, and 27% in eastern Asia. We noted substantial global differences in the cancer profile of DALYs by country and region; however, YLLs were the most important component of DALYs in all countries and for all cancers, and contributed to more than 90% of the total burden. Nonetheless, low-resource settings had consistently higher YLLs (as a proportion of total DALYs) than did high-resource settings. Interpretation Age-adjusted DALYs lost from cancer are substantial, irrespective of world region. The consistently larger proportions of YLLs in low HDI than in high HDI countries indicate substantial inequalities in prognosis after diagnosis, related to degree of human development. Therefore, radical improvement in cancer care is needed in low-resource countries.	[Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Ferlay, Jacques; Forman, David; Bray, Freddie] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Parkin, D. Maxwell] Univ Oxford, Dept Med, Clin Trial Serv Unit, Oxford, England; [Mathers, Colin] WHO, Dept Evidence & Policy Cluster, CH-1211 Geneva, Switzerland	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; World Health Organization	Soerjomataram, I (corresponding author), Int Agcy Res Canc, Sect Canc Informat, 150 Cours Albert Thomas, F-69372 Lyon, France.	soerjomatarami@iarc.fr	Ferlay, Jacques/ABD-5058-2021; Lortet-Tieulent, Joannie/AAE-9099-2019	Lortet-Tieulent, Joannie/0000-0002-8816-7475; Bray, Freddie/0000-0002-3248-7787; Mathers, Colin/0000-0002-0617-6731	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society, Erasmus University Rotterdam, and International Agency for research on Cancer.	Albreht T, 2008, EUR J CANCER, V44, P1451, DOI 10.1016/j.ejca.2008.02.015; [Anonymous], 2004, LANCET, V364, P2153; [Anonymous], 2009, HUMAN DEV REPORT; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Cvancarova M, 2012, INT J CANC, DOI 10.1002/ijc.27802; de Larrea-Baz NF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-42; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francisci S, 2009, EUR J CANCER, V45, P1067, DOI 10.1016/j.ejca.2008.11.034; International Agency for Research on Cancer WHO, 2010, GLOBOCAN 2008 CANC I; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kerr DJ, 2010, NEW ENGL J MED, V363, P801, DOI 10.1056/NEJMp1002812; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murthy NS, 2010, ASIAN PAC J CANCER P, V11, P633; National Cancer Institute, SURV EP END RES; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Public Health Group of the Department of Human Services, 2005, VICT BURD DIS STUD M; Sankaranarayanan R, 2011, IARC Sci Publ, P257; Sankaranarayanan R, 2011, IARC Sci Publ, P1; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Sankaranarayanan R, 1998, IARC SCI PUBL, V145, P1; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Soerjomataram I, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-125; Stouthard MEA, 1997, DISABILITY WEIGHTS D; United Nations, 2009, WORLD POP PROSP 2008; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; Verhoeven RHA, 2007, EUR J CANCER, V43, P2553, DOI 10.1016/j.ejca.2007.08.022; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; World Health Organization, 2008, GLOB BURD DIS 2004 U	44	410	448	4	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1840	1850		10.1016/S0140-6736(12)60919-2	http://dx.doi.org/10.1016/S0140-6736(12)60919-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23079588				2022-12-28	WOS:000311435000029
J	Adashi, EY; Lee, E				Adashi, Eli Y.; Lee, Eric			The President's Global Health Initiative at Midterm Progress in the Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Lee, Eric] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu		Lee, Eric/0000-0002-1347-2635				Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Romney M., 2011, MY PROL PLEDG; The Henry J. Kaiser Family Foundation Kaiser Family Foundation, 2012, BUDG TRACK STAT US F; The United States government Global Health Initiative: strategy document, 2011, STRAT DOC PRES EM PL; The US Global Health Initiative (GHI), 2012, FACT SHEET; US Department of State, 2010, 1 QUADR DIPL DEV QDD; US Global Health Initiative, 2011, LEADERSHIP; US Global Health Initiative, 2012, GLOB HLTH IN NEXT ST; *WHIT HOUS, 2009, STAT PRES GLOB HLTH	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1977	1978		10.1001/jama.2012.14287	http://dx.doi.org/10.1001/jama.2012.14287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23060258				2022-12-28	WOS:000311291400018
J	Ipsaro, JJ; Haase, AD; Knott, SR; Joshua-Tor, L; Hannon, GJ				Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.			The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis	NATURE			English	Article							SMALL RNAS; NUAGE FORMATION; MESSENGER-RNA; PROTEIN; RECOGNITION; MECHANISM; ELEMENTS; MITOPLD; PATHWAY	PIWI-family proteins and their associated small RNAs (piRNAs) act in an evolutionarily conserved innate immune mechanism to provide essential protection for germ-cell genomes against the activity of mobile genetic elements(1). piRNA populations comprise a molecular definition of transposons, which permits them to distinguish transposons from host genes and selectively silence them. piRNAs can be generated in two distinct ways, forming either primary or secondary piRNAs. Primary piRNAs come from discrete genomic loci, termed piRNA clusters, and seem to be derived from long, single-stranded precursors(2). The biogenesis of primary piRNAs involves at least two nucleolytic steps. An unknown enzyme cleaves piRNA cluster transcripts to generate monophosphorylated piRNA 5' ends. piRNA 3' ends are probably formed by exonucleolytic trimming, after a piRNA precursor is loaded into its PIWI partner(1,3). Secondary piRNAs arise during the adaptive 'ping-pong' cycle, with their 5' termini being formed by the activity of PIWIs themselves(2,4). A number of proteins have been implicated genetically in primary piRNA biogenesis. One of these, Drosophila melanogaster Zucchini, is a member of the phospholipase-D family of phosphodiesterases, which includes both phospholipases and nucleases(5-7). Here we produced a dimeric, soluble fragment of the mouse Zucchini homologue (mZuc; also known as PLD6) and show that it possesses single-strand-specific nuclease activity. A crystal structure of mZuc at 1.75 angstrom resolution indicates greater architectural similarity to phospholipase-D family nucleases than to phospholipases. Together, our data suggest that the Zucchini proteins act in primary piRNA biogenesis as nucleases, perhaps generating the 5' ends of primary piRNAs.	[Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Ipsaro, Jonathan J.; Joshua-Tor, Leemor] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu; hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019; @haase_astrid, Astrid D/HHS-1635-2022	@haase_astrid, Astrid D/0000-0003-1120-9013; Ipsaro, Jonathan/0000-0002-2743-3776; Joshua-Tor, Leemor/0000-0001-8185-8049	National Cancer Institute Cancer Center Support Grant [CA045508]; Department of Energy, Office of Basic Energy Sciences; Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) [F32GM97888]; NIH [R01GM062534]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097888, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Filipowicz, R. MacDonald and members of the G.J.H. and L.J. laboratories for discussions; G. Bencze, K. Rivera and D. Pappin of the Cold Spring Harbor Laboratory proteomics facility, which is funded in part by an National Cancer Institute Cancer Center Support Grant (CA045508), for support with mass spectrometry; and H. Robinson for help at the National Synchrotron Light Source, which is supported by the Department of Energy, Office of Basic Energy Sciences. J.J.I. was supported by the Harvey L. Karp award and by a Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) fellowship F32GM97888. This work was supported by NIH grant R01GM062534. G.J.H. and L.J. are Howard Hughes Medical Institute Investigators.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Pozharski EV, 2001, ANAL BIOCHEM, V291, P158, DOI 10.1006/abio.2001.5012; SCHUPBACH T, 1991, GENETICS, V129, P1119; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005	44	216	227	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					279	U151		10.1038/nature11502	http://dx.doi.org/10.1038/nature11502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064227	Green Accepted			2022-12-28	WOS:000310774300049
J	Ryan, A; O'Toole, L				Ryan, Andrea; O'Toole, Louise			Ochronosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryan, Andrea; O'Toole, Louise] Mater Private Hosp, Dublin, Ireland	Mater Private Hospital	Ryan, A (corresponding author), Mater Private Hosp, Dublin, Ireland.	andrearyan11@gmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					E26	E26		10.1056/NEJMicm1111515	http://dx.doi.org/10.1056/NEJMicm1111515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113505				2022-12-28	WOS:000310440800012
J	Lee, G; Sanders, P; Kalman, JM				Lee, Geoffrey; Sanders, Prashanthan; Kalman, Jonathan M.			Catheter ablation of atrial arrhythmias: state of the art	LANCET			English	Article							PULMONARY VEIN ISOLATION; LONG-TERM; RADIOFREQUENCY ABLATION; FOLLOW-UP; ANTIARRHYTHMIC-DRUGS; INTRACARDIAC ECHOCARDIOGRAPHY; FIBRILLATION ABLATION; FOCAL IMPULSE; HEART-DISEASE; SINGLE-CENTER	Catheter ablation is at the forefront of the management of a range of atrial arrhythmias. In this Series paper, we discuss the underlying mechanisms and the current role of catheter ablation for the three most common atrial arrhythmias encountered in clinical practice: focal atrial tachycardia, atrial flutter, and atrial fibrillation. The mechanisms of focal atrial tachycardia and atrial flutter are well understood, and these arrhythmias are amenable to curative catheter ablation with high success rates. In most cases, paroxysmal atrial fibrillation is initiated by triggers located within pulmonary vein musculature. Circumferential ablation to isolate this musculature is associated with high success rates for elimination of paroxysmal atrial fibrillation in selected populations. Because of the problem of recurrent pulmonary vein connection, more than one procedure will be needed in about 30% of patients, and new technologies are being developed to reduce this occurrence. The mechanisms that sustain persistent atrial fibrillation are not well understood and are the subject of continuing investigation. As such, ablation approaches and technologies for this arrhythmia are still evolving.	[Lee, Geoffrey; Kalman, Jonathan M.] Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic 3050, Australia; [Lee, Geoffrey; Kalman, Jonathan M.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Sanders, Prashanthan] Royal Adelaide Hosp, Ctr Heart Rhythm Disorders, Adelaide, SA 5000, Australia; [Sanders, Prashanthan] Univ Adelaide, Adelaide, SA, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Adelaide Hospital; University of Adelaide	Kalman, JM (corresponding author), Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic 3050, Australia.	jon.kalman@mh.org.au	Sanders, Prashanthan/D-7641-2013	Sanders, Prashanthan/0000-0003-3803-8429	Bard Electrophysiology; Biosense-Webster; Medtronic; St Jude Medical; Johnson & Johnson Medical; National Health and Medical Research Council of Australia (NHMRC); NHMRC [604908]	Bard Electrophysiology; Biosense-Webster; Medtronic(Medtronic); St Jude Medical(St. Jude Medical); Johnson & Johnson Medical(Johnson & JohnsonJohnson & Johnson USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	PS has served on the advisory board of Bard Electrophysiology, Biosense-Webster, Medtronic, St Jude Medical, Merck, and Sanofi-Aventis, and has received lecture fees or research funding from Bard Electrophysiology, Biosense-Webster, Medtronic, and St Jude Medical. JMK is the recipient of research funding and fellowship support from Medtronic, St Jude Medical, and Johnson & Johnson Medical. GL declares that he has no conflicts of interest.; GL is the recipient of a research scholarship from the National Health and Medical Research Council of Australia (NHMRC). JMK is the recipient of a grant from NHMRC (604908).	ALLESSIE MA, 1973, CIRC RES, V33, P54, DOI 10.1161/01.RES.33.1.54; Arora R, 2003, CIRCULATION, V107, P1816, DOI 10.1161/01.CIR.0000058461.86339.7E; Arya A, 2010, EUROPACE, V12, P173, DOI 10.1093/europace/eup331; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Bonanno C, 2010, J CARDIOVASC MED, V11, P408, DOI 10.2459/JCM.0b013e328332e926; Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Chan DP, 2000, CIRCULATION, V102, P1283, DOI 10.1161/01.CIR.102.11.1283; CHEN SA, 1994, CIRCULATION, V90, P1262, DOI 10.1161/01.CIR.90.3.1262; Chen YJ, 2001, CIRCULATION, V104, P2849, DOI 10.1161/hc4801.099736; Cheng J, 1999, CIRCULATION, V99, P1700, DOI 10.1161/01.CIR.99.13.1700; COSIO FG, 1988, AM J CARDIOL, V61, P775, DOI 10.1016/0002-9149(88)91065-X; COX JL, 1991, J THORAC CARDIOV SUR, V101, P406, DOI 10.1016/s0022-5223(19)36723-6; Da Costa A, 2004, CIRCULATION, V110, P1030, DOI 10.1161/01.CIR.0000139845.40818.75; Da Costa A, 2002, EUR HEART J, V23, P498, DOI 10.1053/euhj.2001.2819; Daoud EG, 2006, J CARDIOVASC ELECTR, V17, P157, DOI 10.1111/j.1540-8167.2006.00312.x; Gerstenfeld ER, 2003, J CARDIOVASC ELECTR, V14, P685, DOI 10.1046/j.1540-8167.2003.03013.x; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Hoyt H, 2011, HEART RHYTHM, V8, P1869, DOI 10.1016/j.hrthm.2011.07.025; Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572; Jais P, 2000, CIRCULATION, V101, P2928, DOI 10.1161/01.CIR.101.25.2928; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Kall JG, 2000, CIRCULATION, V101, P270, DOI 10.1161/01.CIR.101.3.270; Kalman JM, 1996, CIRCULATION, V94, P398, DOI 10.1161/01.CIR.94.3.398; Kalman JM, 1998, J AM COLL CARDIOL, V31, P451, DOI 10.1016/S0735-1097(97)00492-0; Kalman JM, 1997, J CARDIOVASC ELECTR, V8, P121, DOI 10.1111/j.1540-8167.1997.tb00775.x; Kalman JM, 1996, CIRCULATION, V93, P502, DOI 10.1161/01.CIR.93.3.502; Kerst G, 2012, HEART RHYTHM, V9, P709, DOI 10.1016/j.hrthm.2011.12.025; Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058; Kong MH, 2011, EUROPACE, V13, P193, DOI 10.1093/europace/euq384; Kuck KH, 2012, HEART RHYTHM, V9, P18, DOI 10.1016/j.hrthm.2011.08.021; Lee G, 2012, HEART LUNG CIRC S1, V21, pS117; Lee G, 2011, J CARDIOVASC ELECTR, V22, P163, DOI 10.1111/j.1540-8167.2010.01870.x; Linhart M, 2009, J CARDIOVASC ELECTR, V20, P1343, DOI 10.1111/j.1540-8167.2009.01560.x; Medi C, 2009, J AM COLL CARDIOL, V53, P1791, DOI 10.1016/j.jacc.2009.02.014; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Moubarak G, 2009, ARCH CARDIOVASC DIS, V102, P525, DOI 10.1016/j.acvd.2009.04.002; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; Natale A, 1998, AM J CARDIOL, V82, P989, DOI 10.1016/S0002-9149(98)00522-0; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Neumann T, 2008, J AM COLL CARDIOL, V52, P273, DOI 10.1016/j.jacc.2008.04.021; OLGIN JE, 1995, CIRCULATION, V92, P1839, DOI 10.1161/01.CIR.92.7.1839; Olshansky B, 2004, J AM COLL CARDIOL, V43, P1201, DOI 10.1016/j.jacc.2003.11.032; OLSHANSKY B, 1990, J AM COLL CARDIOL, V16, P1639, DOI 10.1016/0735-1097(90)90314-F; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Patterson E, 2007, J CARDIOVASC ELECTR, V18, P1067, DOI 10.1111/j.1540-8167.2007.00909.x; Porter MJ, 2004, HEART RHYTHM, V1, P393, DOI 10.1016/j.hrthm.2004.05.007; Reithmann C, 2000, EUR HEART J, V21, P565, DOI 10.1053/euhj.1999.1865; Sahadevan J, 2004, CIRCULATION, V110, P3293, DOI 10.1161/01.CIR.0000147781.02738.13; Saoudi N, 1998, PACE, V21, P2105, DOI 10.1111/j.1540-8159.1998.tb01131.x; Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658; Scharf C, 2009, J AM COLL CARDIOL, V54, P1450, DOI 10.1016/j.jacc.2009.07.009; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schumacher B, 1998, J CARDIOVASC ELECTR, V9, P152, DOI 10.1111/j.1540-8167.1998.tb00896.x; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; Tai CT, 2002, J AM COLL CARDIOL, V40, P746, DOI 10.1016/S0735-1097(02)02036-3; Vaitkevicius R, 2009, HEART RHYTHM, V6, P221, DOI 10.1016/j.hrthm.2008.10.027; Van Belle Y, 2008, EUROPACE, V10, P1271, DOI 10.1093/europace/eun218; Verma A, 2011, CAN J CARDIOL, V27, P60, DOI 10.1016/j.cjca.2010.11.011; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Waldo AL, 1997, J CARDIOVASC ELECTR, V8, P337, DOI 10.1111/j.1540-8167.1997.tb00798.x; Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; Willems S, 2000, J CARDIOVASC ELECTR, V11, P1223, DOI 10.1046/j.1540-8167.2000.01223.x; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Yang YF, 2001, CIRCULATION, V103, P3092, DOI 10.1161/01.CIR.103.25.3092	74	100	109	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1509	1519		10.1016/S0140-6736(12)61463-9	http://dx.doi.org/10.1016/S0140-6736(12)61463-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101718				2022-12-28	WOS:000310272000031
J	Mathur, R; Oh, H; Zhang, DK; Park, SG; Seo, J; Koblansky, A; Hayden, MS; Ghosh, S				Mathur, Ramkumar; Oh, Hyunju; Zhang, Dekai; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar			A Mouse Model of Salmonella Typhi Infection	CELL			English	Article							TOLL-LIKE RECEPTOR-5; ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL FLAGELLIN; DENDRITIC CELLS; GENE-EXPRESSION; HUMANIZED MICE; FEVER; VACCINE; TOLL-LIKE-RECEPTOR-5; PATHOGENESIS	Salmonella spp. are gram-negative flagellated bacteria that can cause food- and waterborne gastroenteritis and typhoid fever in humans. We now report that flagellin from Salmonella spp. is recognized in mouse intestine by Toll-like receptor 11 (TLR11). Absence of TLR11 renders mice more susceptible to infection by S. Typhimurium, with increased dissemination of the bacteria and enhanced lethality. Unlike S. Typhimurium, S. Typhi, a human obligatory pathogen that causes typhoid fever, is normally unable to infect mice. TLR11 is expressed in mice, but not in humans, and remarkably, we find that tlr11(-/-) mice are efficiently infected with orally administered S. Typhi. We also find that tlr11(-/-) mice can be immunized against S. Typhi. Therefore, tlr11(-/-) mice represent a small-animal model for the study of the immune response to S. Typhi and for the development of vaccines against this important human pathogen.	[Mathur, Ramkumar; Oh, Hyunju; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA; [Hayden, Matthew S.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Dekai] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA	Columbia University; Columbia University; Yale University	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA.	sg2715@columbia.edu	Park, Sung-Gyoo/H-8652-2019; Mathur, Ramkumar/AAZ-4314-2020	mathur, Ramkumar/0000-0002-9317-2631; Park, Sung-Gyoo/0000-0003-3702-5765; Hayden, Matthew/0000-0003-1670-6430	NIH [RO1-AI59440, R37-AI33443]; ARRA [P30 AR058886-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443, R01AI059440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this manuscript was supported by grants from NIH (RO1-AI59440 and R37-AI33443) and by institutional support from Columbia University. M. S. H. is supported by ARRA P30 AR058886-01. We would like to thank Ms. Crystal Bussey for help managing our animal colony and Dr. Suneeta Krishnareddy for help evaluating histology.	Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; COLLINS FM, 1978, INFECT IMMUN, V21, P41, DOI 10.1128/IAI.21.1.41-47.1978; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Levine MM, 2007, CLIN INFECT DIS, V45, pS24, DOI 10.1086/518141; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Mestecky J, 2008, CURR OPIN GASTROEN, V24, P713, DOI 10.1097/MOG.0b013e32830d58be; Mian MF, 2011, VIRULENCE, V2, P248, DOI 10.4161/viru.2.3.16133; Mian MF, 2011, CELL MOL IMMUNOL, V8, P83, DOI 10.1038/cmi.2010.52; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; West AP, 2005, J BIOL CHEM, V280, P9482, DOI 10.1074/jbc.M411875200; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Woc-Colburn Laila, 2009, Curr Infect Dis Rep, V11, P120, DOI 10.1007/s11908-009-0018-2; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	38	134	141	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					590	602		10.1016/j.cell.2012.08.042	http://dx.doi.org/10.1016/j.cell.2012.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101627	Green Accepted, Bronze			2022-12-28	WOS:000310529300015
J	Livio, M				Livio, Mario			Why symmetry matters	NATURE			English	Editorial Material									Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Livio, M (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	mlivio@stsci.edu							0	23	23	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					472	473		10.1038/490472a	http://dx.doi.org/10.1038/490472a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NK	23099384	Bronze			2022-12-28	WOS:000310196200013
J	Lawrence, R; Lawrie, SM				Lawrence, Rebecca; Lawrie, Stephen M.			Psychotic depression	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lawrence, Rebecca] Royal Edinburgh & Associated Hosp, Ritson Clin, Edinburgh EH10 5HF, Midlothian, Scotland; [Lawrie, Stephen M.] Univ Edinburgh, Sch Clin Sci, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland	Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Lawrence, R (corresponding author), Royal Edinburgh & Associated Hosp, Ritson Clin, Edinburgh EH10 5HF, Midlothian, Scotland.	Rebecca.Lawrence@nhslothian.scot.nhs.uk	Lawrie, Stephen MacGregor/AAD-1607-2021	Lawrie, Stephen MacGregor/0000-0002-2444-5675					0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e6994	10.1136/bmj.e6994	http://dx.doi.org/10.1136/bmj.e6994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097553	Bronze			2022-12-28	WOS:000310427600018
J	Doherty, CJ; Kay, SA				Doherty, Colleen J.; Kay, Steve A.			Circadian Surprise-It's Not All About Transcription	SCIENCE			English	Editorial Material							CLOCK; IDENTIFICATION		[Doherty, Colleen J.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA; [Kay, Steve A.] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; University of Southern California	Doherty, CJ (corresponding author), Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA.	cdoherty@ucsd.edu; stevekay@dornsife.usc.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; doherty, colleen/0000-0003-1126-5592				Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	15	11	12	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					338	340		10.1126/science.1230008	http://dx.doi.org/10.1126/science.1230008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087238				2022-12-28	WOS:000309955800029
J	Roskar, R; Debattista, VP				Roskar, Rok; Debattista, Victor P.			Galactic Archaeology	SCIENCE			English	Editorial Material									[Roskar, Rok] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Debattista, Victor P.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England	University of Zurich; University of Central Lancashire	Roskar, R (corresponding author), Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland.	roskar@physik.uzh.ch; vpdebattista@uclan.ac.uk		Roskar, Rok/0000-0001-9962-0389	STFC [ST/J001341/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001341/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		[Anonymous], 2012, STARS BORDERS RADIAL; Bland-Hawthorn J, 2010, ASTROPHYS J, V713, P166, DOI 10.1088/0004-637X/713/1/166; Gilmore G, 2012, MESSENGER, V147, P25; Meidt SE, 2009, ASTROPHYS J, V702, P277, DOI 10.1088/0004-637X/702/1/277; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Sellwood JA, 2011, MON NOT R ASTRON SOC, V410, P1637, DOI 10.1111/j.1365-2966.2010.17545.x; Sellwood JA, 2002, MON NOT R ASTRON SOC, V336, P785, DOI 10.1046/j.1365-8711.2002.05806.x; Wielen R, 1996, ASTRON ASTROPHYS, V314, P438	8	0	0	3	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					333	334		10.1126/science.1227302	http://dx.doi.org/10.1126/science.1227302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087234				2022-12-28	WOS:000309955800025
J	Moreira, L; Balaguer, F; Lindor, N; de la Chapelle, A; Hampel, H; Aaltonen, LA; Hopper, JL; Le Marchand, L; Gallinger, S; Newcomb, PA; Haile, R; Thibodeau, SN; Gunawardena, S; Jenkins, MA; Buchanan, DD; Potter, JD; Baron, JA; Ahnen, DJ; Moreno, V; Andreu, M; de Leon, MP; Rustgi, AK; Castells, A				Moreira, Leticia; Balaguer, Francesc; Lindor, Noralane; de la Chapelle, Albert; Hampel, Heather; Aaltonen, Lauri A.; Hopper, John L.; Le Marchand, Loic; Gallinger, Steven; Newcomb, Polly A.; Haile, Robert; Thibodeau, Stephen N.; Gunawardena, Shanaka; Jenkins, Mark A.; Buchanan, Daniel D.; Potter, John D.; Baron, John A.; Ahnen, Dennis J.; Moreno, Victor; Andreu, Montserrat; de Leon, Maurizio Ponz; Rustgi, Anil K.; Castells, Antoni		EPICOLON Consortium	Identification of Lynch Syndrome Among Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REVISED BETHESDA GUIDELINES; POPULATION-BASED COHORT; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; COST-EFFECTIVENESS; CLINICAL-CRITERIA; COLON-CANCER; RISK; MLH1; PREDICTION	Context Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of gene carriers currently relies on germline analysis in patients with MMR-deficient tumors, but criteria to select individuals in whom tumor MMR testing should be performed are unclear. Objective To establish a highly sensitive and efficient strategy for the identification of MMR gene mutation carriers among CRC probands. Design, Setting, and Patients Pooled-data analysis of 4 large cohorts of newly diagnosed CRC probands recruited between 1994 and 2010 (n=10 206) from the Colon Cancer Family Registry, the EPICOLON project, the Ohio State University, and the University of Helsinki examining personal, tumor-related, and family characteristics, as well as microsatellite instability, tumor MMR immunostaining, and germline MMR mutational status data. Main Outcome Measures Performance characteristics of selected strategies (Bethesda guidelines, Jerusalem recommendations, and those derived from a bivariate/multivariate analysis of variables associated with Lynch syndrome) were compared with tumor MMR testing of all CRC patients (universal screening). Results Of 10 206 informative, unrelated CRC probands, 312 (3.1%) were MMR gene mutation carriers. In the population-based cohorts (n=3671 probands), the universal screening approach (sensitivity, 100%; 95% CI, 99.3%-100%; specificity, 93.0%; 95% CI, 92.0%-93.7%; diagnostic yield, 2.2%; 95% CI, 1.7%-2.7%) was superior to the use of Bethesda guidelines (sensitivity, 87.8%; 95% CI, 78.9%-93.2%; specificity, 97.5%; 95% CI, 96.9%-98.0%; diagnostic yield, 2.0%; 95% CI, 1.5%-2.4%; P<.001), Jerusalem recommendations (sensitivity, 85.4%; 95% CI, 77.1%-93.6%; specificity, 96.7%; 95% CI, 96.0%-97.2%; diagnostic yield, 1.9%; 95% CI, 1.4%-2.3%; P<.001), and a selective strategy based on tumor MMR testing of cases with CRC diagnosed at age 70 years or younger and in older patients fulfilling the Bethesda guidelines (sensitivity, 95.1%; 95% CI, 89.8%-99.0%; specificity, 95.5%; 95% CI, 94.7%-96.1%; diagnostic yield, 2.1%; 95% CI, 1.6%-2.6%; P<.001). This selective strategy missed 4.9% of Lynch syndrome cases but resulted in 34.8% fewer cases requiring tumor MMR testing and 28.6% fewer cases undergoing germline mutational analysis than the universal approach. Conclusion Universal tumor MMR testing among CRC probands had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the increase in the diagnostic yield was modest. JAMA. 2012;308(15):1555-1565 www.jama.com	[Moreira, Leticia; Balaguer, Francesc; Castells, Antoni] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, E-08036 Barcelona, Catalonia, Spain; [Lindor, Noralane; Thibodeau, Stephen N.; Gunawardena, Shanaka] Mayo Clin, Mayo Colorectal Canc Family Registry, Rochester, MN USA; [de la Chapelle, Albert; Hampel, Heather] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Le Marchand, Loic] Univ Hawaii, Hawaii Family Registry Colon Canc, Honolulu, HI 96822 USA; [Gallinger, Steven] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Newcomb, Polly A.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle Familial Colorectal Canc Registry, Seattle, WA 98104 USA; [Haile, Robert] Univ So Calif Consortium, Los Angeles, CA USA; [Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Ahnen, Dennis J.] Vet Affairs Med Ctr, Denver Dept, Dept Med, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Moreno, Victor] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Unit Biomarkers & Susceptibil,Catalan Inst Oncol, E-08036 Barcelona, Catalonia, Spain; [Andreu, Montserrat] Pompeu Fabra Univ, IMIM, Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [de Leon, Maurizio Ponz] Univ Modena, Dept Med Genet, I-41100 Modena, Italy; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Genet, Philadelphia, PA 19104 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Mayo Clinic; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Helsinki; University of Helsinki; University of Melbourne; University of Hawaii System; Cancer Care Ontario; Fred Hutchinson Cancer Center; QIMR Berghofer Medical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universita di Modena e Reggio Emilia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Castells, A (corresponding author), Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, Villarroel 170, E-08036 Barcelona, Catalonia, Spain.	castells@clinic.ub.es	Gallinger, Steven/E-4575-2013; Moreira, Leticia/AAN-9863-2021; Andreu, Montserrat/D-9911-2015; Castells, Antoni/ABC-1002-2021; Hampel, Heather/AAV-4041-2020; Balaguer, Francesc/GPX-7801-2022; BALAGUER, FRANCESC/G-2389-2016; de Leon, Maurizio Ponz/A-9356-2015; Moreno, Victor/A-1697-2010; Aaltonen, Lauri/A-5375-2010; Jenkins, Mark/P-7803-2015	Moreira, Leticia/0000-0002-4518-8591; Andreu, Montserrat/0000-0003-4286-1098; Castells, Antoni/0000-0001-8431-2033; Hampel, Heather/0000-0001-7558-9794; de Leon, Maurizio Ponz/0000-0003-4465-1043; Moreno, Victor/0000-0002-2818-5487; Aaltonen, Lauri/0000-0001-6839-4286; Jenkins, Mark/0000-0002-8964-6160; Balaguer, Francesc/0000-0002-0206-0539; Potter, John/0000-0001-5439-1500; Buchanan, Daniel/0000-0003-2225-6675	Ministerio de Economia y Competividad [SAF2010-19273]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 849]; Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III [PI10/00384]; National Cancer Institute [CA67941, CA16058]; National Institutes of Health [5R01DK056645, RFA CA-95-011]; National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE [U01CA074800, U01CA074799, P30CA016058, K22CA095011, U01CA074806, U01CA074794, U01CA097735, U01CA074783, R01CA067941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056645] Funding Source: NIH RePORTER	Ministerio de Economia y Competividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Ministerio de Economia y Competividad (SAF2010-19273), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 849), Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona), Hospital Clinic of Barcelona (Josep Font grant), and Instituto de Salud Carlos III (PI10/00384). CIBEREHD and CIBERESP are funded by the Instituto de Salud Carlos III. The research at the Ohio State University Comprehensive Cancer Center was supported by National Cancer Institute grants CA67941 and CA16058. The research at the University of Pennsylvania was supported by the National Institutes of Health under 5R01DK056645, the National Colon Cancer Research Alliance, and the Hansen Foundation. This work was also supported by the National Cancer Institute, by the National Institutes of Health under RFA CA-95-011, and through cooperative agreements with members of the Colon Cancer Family Registry and Principal Investigators. Collaborating centers include Australasian Colorectal Cancer Family Registry (U01 CA097735), Familial Colorectal Neoplasia Collaborative Group (U01 CA074799) (University of Southern California), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), Seattle Colorectal Cancer Family Registry (U01 CA074794), and University of Hawaii Colorectal Cancer Family Registry (U01 CA074806). The work was carried out in part at the Esther Koplowitz Center, Barcelona.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; [Anonymous], BREAST COL CANC FAM; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balmana J, 2008, J MED GENET, V45, P557, DOI 10.1136/jmg.2008.059311; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Boland CR, 1998, CANCER RES, V58, P5248; Boland CR, 2010, GASTROENTEROLOGY, V138, P2197, DOI [10.1053/j.gastro.2010.04.024, DOI 10.1053/J.GASTRO.2010.04.024]; Boland CR, 2010, GASTROENTEROLOGY, V138, pe1; Chen SN, 2006, JAMA-J AM MED ASSOC, V296, P1479, DOI 10.1001/jama.296.12.1479; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Cicek MS, 2011, J MOL DIAGN, V13, P271, DOI 10.1016/j.jmoldx.2010.12.004; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kastrinos F, 2011, CANCER J, V17, P405, DOI 10.1097/PPO.0b013e318237e408; Kastrinos F, 2011, GASTROENTEROLOGY, V140, P73, DOI 10.1053/j.gastro.2010.08.021; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Loughrey MB, 2007, FAM CANCER, V6, P301, DOI 10.1007/s10689-007-9124-1; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Paya A, 2009, CLIN CANCER RES, V15, P3156, DOI 10.1158/1078-0432.CCR-08-3116; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; Rodriguez-Moranta F, 2006, AM J GASTROENTEROL, V101, P1104, DOI 10.1111/j.1572-0241.2006.00522.x; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Stoffel EM, 2010, GASTROENTEROLOGY, V139, P1436, DOI 10.1053/j.gastro.2010.09.018; Therneau TM, R PORT; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2005, JAMA-J AM MED ASSOC, V293, P2028, DOI 10.1001/jama.293.16.2028; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	40	350	365	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1555	1565		10.1001/jama.2012.13088	http://dx.doi.org/10.1001/jama.2012.13088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073952	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000309858100022
J	Grosse-Sundrup, M; Henneman, JP; Sandberg, WS; Bateman, BT; Uribe, JV; Nguyen, NT; Ehrenfeld, JM; Martinez, EA; Kurth, T; Eikermann, M				Grosse-Sundrup, Martina; Henneman, Justin P.; Sandberg, Warren S.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Ehrenfeld, Jesse M.; Martinez, Elizabeth A.; Kurth, Tobias; Eikermann, Matthias			Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHEAL INTUBATION; MUSCLE-ACTIVITY; CARE-UNIT; ANESTHESIA; MORBIDITY; BLOCKADE; REVERSAL; NEOSTIGMINE; PREDICTORS; SURGERY	Objective To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design Prospective, propensity score matched cohort study. Setting General teaching hospital in Boston, Massachusetts, United States, 2006-10. Participants 18 579 surgical patients who received intermediate acting neuromuscular blocking agents during surgery were matched by propensity score to 18 579 reference patients who did not receive such agents. Main outcome measures The main outcome measures were oxygen desaturation after extubation (hemoglobin oxygen saturation <90% with a decrease in oxygen saturation after extubation of >3%) and reintubations requiring unplanned admission to an intensive care unit within seven days of surgery. We also evaluated effects on these outcome variables of qualitative monitoring of neuromuscular transmission (train-of-four ratio) and reversal of neuromuscular blockade with neostigmine to prevent residual postoperative neuromuscular blockade. Results The use of intermediate acting neuromuscular blocking agents was associated with an increased risk of postoperative desaturation less than 90% after extubation (odds ratio 1.36, 95% confidence interval 1.23 to 1.51) and reintubation requiring unplanned admission to an intensive care unit (1.40, 1.09 to 1.80). Qualitative monitoring of neuromuscular transmission did not decrease this risk and neostigmine reversal increased the risk of postoperative desaturation less than 90% (1.32, 1.20 to 1.46) and reintubation (1.76, 1.38 to 2.26). Conclusion The use of intermediate acting neuromuscular blocking agents during anesthesia was associated with an increased risk of clinically meaningful respiratory complications. Our data suggest that the strategies used in our trial to prevent residual postoperative neuromuscular blockade should be revisited.	[Grosse-Sundrup, Martina; Henneman, Justin P.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Martinez, Elizabeth A.; Eikermann, Matthias] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Sandberg, Warren S.; Ehrenfeld, Jesse M.] Vanderbilt Univ, Sch Med, Dept Anaesthesiol, Nashville, TN 37212 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA; [Kurth, Tobias] INSERM, Unit Neuroepidemio 708, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France; [Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02114 USA; [Eikermann, Matthias] Univ Klinikum Essen, Klin Anaesthesie & Intens Med, Essen, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen	Eikermann, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	meikermann@partners.org	Ehrenfeld, Jesse/AAI-2951-2020; Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Ehrenfeld, Jesse/0000-0003-3427-0140	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency; US National Institutes of Health; Migraine Research Foundation; Parkinson's Disease Foundation; Merck; Pfizer; ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Migraine Research Foundation; Parkinson's Disease Foundation; Merck(Merck & Company); Pfizer(Pfizer); ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	This study was funded by the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that this study has been funded only by academic research funds; TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, the Migraine Research Foundation, and the Parkinson's Disease Foundation. He has received honorariums from Allergan, the American Academy of Neurology, and Merck for educational lectures, from the BMJ for editorial services, and from MAP Pharmaceutical for contributing to a scientific advisory panel. ME has received investigator initiated research funding from Merck, Pfizer, and the ResMed Foundation, as well as the Department of Anesthesia and Critical Care and Pain Medicine of the Massachusetts General Hospital. He has received honorariums from Hill-Rom for giving advise, and from the American Thoracic Society, Brown University, Michigan University, and Vanderbilt University for educational lectures, and from the Journal Anesthesiology for editorial services; the authors have no financial relationships with any organisation or company that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	ABAJIAN J, 1955, ANN SURG, V142, P138; Alfille PH, 2009, CURR OPIN ANESTHESIO, V22, P730, DOI 10.1097/ACO.0b013e328331d545; Arbous MS, 2005, ANESTHESIOLOGY, V102, P257, DOI 10.1097/00000542-200502000-00005; BEECHER HK, 1954, ANN SURG, V140, P2, DOI 10.1097/00000658-195407000-00001; BEEMER GH, 1991, BRIT J ANAESTH, V66, P469, DOI 10.1093/bja/66.4.469; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Butterly A, 2010, BRIT J ANAESTH, V105, P304, DOI 10.1093/bja/aeq157; CALDWELL JE, 1995, ANESTH ANALG, V80, P1168, DOI 10.1097/00000539-199506000-00018; Chan KS, 2009, SURG TODAY, V39, P295, DOI 10.1007/s00595-008-3876-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claudius C, 2008, ANESTHESIOLOGY, V108, P1117, DOI 10.1097/ALN.0b013e318173f62f; Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004; Eikermann M, 2008, BRIT J ANAESTH, V101, P344, DOI 10.1093/bja/aen176; Eikermann M, 2005, CHEST, V127, P1703, DOI 10.1378/chest.127.5.1703; Eikermann M, 2002, BRIT J ANAESTH, V89, P277, DOI 10.1093/bja/aef177; Eikermann M, 2007, ANESTHESIOLOGY, V107, P621, DOI 10.1097/01.anes.0000281928.88997.95; Eikermann M, 2007, AM J RESP CRIT CARE, V175, P9, DOI 10.1164/rccm.200512-1862OC; Evers AS, 2005, CLIN ANESTH, P111; HARRISON GG, 1978, BRIT J ANAESTH, V50, P1041, DOI 10.1093/bja/50.10.1041; Hayes AH, 2001, ANAESTHESIA, V56, P312, DOI 10.1046/j.1365-2044.2001.01921.x; Herbstreit F, 2010, ANESTHESIOLOGY, V113, P1280, DOI 10.1097/ALN.0b013e3181f70f3d; Johnson RG, 2007, J AM COLL SURGEONS, V204, P1188, DOI 10.1016/j.jamcollsurg.2007.02.070; Kopman AF, 2009, ANAESTHESIA, V64, P22, DOI 10.1111/j.1365-2044.2008.05867.x; Krodel DJ, 2010, ANESTHESIOLOGY, V113, P200, DOI 10.1097/ALN.0b013e3181e32e68; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; LUNN JN, 1983, ANAESTHESIA, V38, P1090, DOI 10.1111/j.1365-2044.1983.tb12486.x; Mencke T, 2003, ANESTHESIOLOGY, V98, P1049, DOI 10.1097/00000542-200305000-00005; Mencke T, 2006, ANESTH ANALG, V102, P306, DOI 10.1213/01.ANE.0000181290.37527.CE; Murphy GS, 2006, MINERVA ANESTESIOL, V72, P97; Murphy GS, 2008, ANESTHESIOLOGY, V109, P389, DOI 10.1097/ALN.0b013e318182af3b; Murphy GS, 2008, ANESTH ANALG, V107, P130, DOI 10.1213/ane.0b013e31816d1268; Murphy GS, 2010, ANESTH ANALG, V111, P120, DOI 10.1213/ANE.0b013e3181da832d; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Parsons L., SAS I P 26 ANN SAS U; Paton F, 2010, BRIT J ANAESTH, V105, P558, DOI 10.1093/bja/aeq269; PAYNE JP, 1980, BRIT J ANAESTH, V52, P69, DOI 10.1093/bja/52.1.69; PEDERSEN T, 1992, ACTA ANAESTH SCAND, V36, P812, DOI 10.1111/j.1399-6576.1992.tb03570.x; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; ROSE DK, 1994, ANESTHESIOLOGY, V81, P410, DOI 10.1097/00000542-199408000-00020; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; Sprung J, 2003, ANESTHESIOLOGY, V99, P259, DOI 10.1097/00000542-200308000-00006; Srivastava A, 2009, BRIT J ANAESTH, V103, P115, DOI 10.1093/bja/aep093; Sundman E, 2000, ANESTHESIOLOGY, V92, P977, DOI 10.1097/00000542-200004000-00014; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67; Williams MT, 2003, ANAESTHESIA, V58, P574, DOI 10.1046/j.1365-2044.2003.03150.x	46	164	169	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2012	345								e6329	10.1136/bmj.e6329	http://dx.doi.org/10.1136/bmj.e6329			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WG	23077290	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000310140600001
J	Brooks, BA				Brooks, Benjamin A.			Seeing Is Believing	SCIENCE			English	Editorial Material							CENTRAL ANDES; DEFORMATION		Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of Hawaii System	Brooks, BA (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA.	bbrooks@hawaii.edu						Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; DESILVA SL, 1989, GEOLOGY, V17, P1102, DOI 10.1130/0091-7613(1989)017<1102:APVCOT>2.3.CO;2; Fialko Y, 2012, SCIENCE, V338, P250, DOI 10.1126/science.1226358; Fournier TJ, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002558; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Pritchard ME, 2002, NATURE, V418, P167, DOI 10.1038/nature00872; RUBIN AM, 1995, J GEOPHYS RES-SOL EA, V100, P5911, DOI 10.1029/94JB02942; SCHWERDTNER WM, 1990, CAN J EARTH SCI, V27, P387, DOI 10.1139/e90-035; Sparks RSJ, 2008, AM J SCI, V308, P727, DOI 10.2475/06.2008.01; Yuan X, 2000, NATURE, V408, P958, DOI 10.1038/35050073; Zandt G, 2003, PURE APPL GEOPHYS, V160, P789, DOI 10.1007/PL00012557	12	1	1	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					207	208		10.1126/science.1228953	http://dx.doi.org/10.1126/science.1228953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066069				2022-12-28	WOS:000309712300030
J	Haak, LL; Baker, D; Ginther, DK; Gordon, GJ; Probus, MA; Kannankutty, N; Weinberg, BA				Haak, Laurel L.; Baker, David; Ginther, Donna K.; Gordon, Gregg J.; Probus, Matthew A.; Kannankutty, Nirmala; Weinberg, Bruce A.			Standards and Infrastructure for Innovation Data Exchange	SCIENCE			English	Editorial Material									[Haak, Laurel L.] ORCID, Bethesda, MD 20817 USA; [Baker, David] CASRAI, Ottawa, ON K1R 7X6, Canada; [Ginther, Donna K.] Univ Kansas, Lawrence, KS 66045 USA; [Gordon, Gregg J.] SSRN, Rochester, NY 14618 USA; [Probus, Matthew A.] Thomson Reuters Intellectual Property & Sci, Rockville, MD 20850 USA; [Kannankutty, Nirmala] Natl Sci Fdn, NCSES, Rockville, MD 20850 USA; [Weinberg, Bruce A.] Ohio State Univ, Columbus, OH 43210 USA; [Weinberg, Bruce A.] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of Kansas; Clarivate; National Science Foundation (NSF); Ohio State University; National Bureau of Economic Research	Haak, LL (corresponding author), ORCID, Bethesda, MD 20817 USA.	l.haak@orcid.org	Haak, Laurel L./C-4986-2008; Ginther, Donna/W-9055-2019; Ginther, Donna K/F-7317-2016	Haak, Laurel L./0000-0001-5109-3700; Ginther, Donna/0000-0002-0881-7969; Ginther, Donna K/0000-0002-0881-7969; Gordon, Gregory/0000-0002-0432-0816; Weinberg, Bruce/0000-0001-8856-1803	NIA NIH HHS [R01 AG036820, 1R01AG036820] Funding Source: Medline; SBE Off Of Multidisciplinary Activities [1064220] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG036820] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2010, M1102 OFF MAN BUDG; Boyd AD, 2007, INT J MED INFORM, V76, P407, DOI 10.1016/j.ijmedinf.2006.09.004; Dhir R, 2008, CANCER-AM CANCER SOC, V113, P1705, DOI 10.1002/cncr.23768; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; National Research Council, 2005, EXP ACC RES DAT REC	5	9	9	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					196	197		10.1126/science.1221840	http://dx.doi.org/10.1126/science.1221840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066063	Green Accepted			2022-12-28	WOS:000309712300023
J	Imlach, WL; Beck, ES; Choi, BJ; Lotti, F; Pellizzoni, L; McCabe, BD				Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.			SMN Is Required for Sensory-Motor Circuit Function in Drosophila	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; NEUROMUSCULAR-JUNCTIONS; ELECTRICAL-PROPERTIES; SINGLE NUCLEOTIDE; NEURON PROTEIN; MOUSE MODEL; GENE; SURVIVAL; MICE; MUSCLE	Spinal muscular atrophy (SMA) is a lethal human disease characterized by motor neuron dysfunction and muscle deterioration due to depletion of the ubiquitous survival motor neuron (SMN) protein. Drosophila SMN mutants have reduced muscle size and defective locomotion, motor rhythm, and motor neuron neurotransmission. Unexpectedly, restoration of SMN in either muscles or motor neurons did not alter these phenotypes. Instead, SMN must be expressed in proprioceptive neurons and interneurons in the motor circuit to nonautonomously correct defects in motor neurons and muscles. SMN depletion disrupts the motor system subsequent to circuit development and can be mimicked by the inhibition of motor network function. Furthermore, increasing motor circuit excitability by genetic or pharmacological inhibition of K+ channels can correct SMN-dependent phenotypes. These results establish sensory-motor circuit dysfunction as the origin of motor system deficits in this SMA model and suggest that enhancement of motor neural network activity could ameliorate the disease.	[Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA; [Imlach, Wendy L.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Beck, Erin S.; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	McCabe, BD (corresponding author), Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA.	brian@mccabelab.org	Imlach, Wendy/G-7609-2011; Beck, Erin/AAA-8399-2022; Lotti, Francesco/AAC-3186-2019	Imlach, Wendy/0000-0002-7521-9969; Choi, Ben Jiwon/0000-0001-9155-8445; McCabe, Brian/0000-0003-1620-0501; Pellizzoni, Livio/0000-0002-9168-5628	NIH-NINDS [R01NS069601]; Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry;  [DoD-W81XWH-08-1-0009];  [DoD-W81XWH-11-1-0753]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069601, R21NS075572] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are very grateful to Spyros Artavanis-Tsakonas and Greg Matera for smn stocks and reagents. We also thank Haig Keshishian, James Hodge, Cynthia Hughes, John Thomas, Michael Nitabach, Andrea Pizzo, Jonathan Javitch, Graeme Davis, Julie Simpson, and Wesley Grueber for additional stocks and advice. We thank George Mentis and especially Chris Henderson for critical reading of this manuscript. L. P. was supported by NIH-NINDS R01NS069601 and with B. D. M. by the Columbia University Motor Neuron Center. B. D. M. was supported by DoD-W81XWH-08-1-0009, DoD-W81XWH-11-1-0753, and the Gatsby Initiative in Brain Circuitry.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baines RA, 2006, INT REV NEUROBIOL, V75, P91, DOI 10.1016/S0074-7742(06)75005-X; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chwieduk CM, 2010, CNS DRUGS, V24, P883, DOI 10.2165/11205910-000000000-00000; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hayes Keith C, 2007, Expert Rev Neurother, V7, P453, DOI 10.1586/14737175.7.5.453; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imlach Wendy, 2009, J Vis Exp, DOI 10.3791/1109; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pinter MJ, 1997, J NEUROSCI, V17, P4500; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Renault F, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P301, DOI 10.1016/S0370-4475(83)80042-2; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	57	139	140	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					427	439		10.1016/j.cell.2012.09.011	http://dx.doi.org/10.1016/j.cell.2012.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063130	Green Accepted, Bronze			2022-12-28	WOS:000309981000019
J	Zaratiegui, M; Martienssen, RA				Zaratiegui, Mikel; Martienssen, Robert A.			SnapShot: Small RNA-Mediated Epigenetic Modifications	CELL			English	Editorial Material							GERMLINE; PIRNAS; MEMORY		[Zaratiegui, Mikel] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zaratiegui, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.			Zaratiegui, Mikel/0000-0002-0342-0268	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM076396-05, R01 GM076396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	10	4	4	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					456	+		10.1016/j.cell.2012.10.001	http://dx.doi.org/10.1016/j.cell.2012.10.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063132	Green Accepted, Bronze			2022-12-28	WOS:000309981000022
J	Moran, PJ; Geoghegan, P; Sexton, DJ; O'Regan, A				Moran, Peter J.; Geoghegan, Pierce; Sexton, Donal J.; O'Regan, Anthony			A skin rash to remember	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							KAPOSIS VARICELLIFORM ERUPTION; HERPES-SIMPLEX-VIRUS; ATOPIC-DERMATITIS; ECZEMA HERPETICUM; INCREASING INCIDENCE; INFECTIONS; RECURRENT; THERAPY		[Moran, Peter J.; Geoghegan, Pierce; Sexton, Donal J.] Univ Coll Hosp Galway, Galway, Ireland; [O'Regan, Anthony] Galway Univ Hosp, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Moran, PJ (corresponding author), Univ Coll Hosp Galway, Galway, Ireland.	petermoran@hotmail.com		Sexton, Donal/0000-0001-8262-632X				Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V118, P40, DOI 10.1016/j.jaci.2006.04.044; BORK K, 1988, J AM ACAD DERMATOL, V19, P1024, DOI 10.1016/S0190-9622(88)70267-4; Brook I, 1998, J AM ACAD DERMATOL, V38, P627, DOI 10.1016/S0190-9622(98)70130-6; Chan Lawrence S., 2008, V10, P76, DOI 10.1159/000131450; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Erlich KS, 1997, WESTERN J MED, V166, P211; Hata TR, 2008, SEMIN CUTAN MED SURG, V27, P144, DOI 10.1016/j.sder.2008.04.002; Hoare C, 2000, Health Technol Assess, V4, P1; JAWITZ JC, 1985, ARCH DERMATOL, V121, P274, DOI 10.1001/archderm.121.2.274; Kimata H, 2008, INDIAN J DERMATOL VE, V74, P260, DOI 10.4103/0378-6323.41376; LAFFERTY WE, 1987, NEW ENGL J MED, V316, P1444, DOI 10.1056/NEJM198706043162304; Langan SM, 2006, BRIT J DERMATOL, V155, P504, DOI 10.1111/j.1365-2133.2006.07381.x; Lubbe J, 2003, ARCH DERMATOL, V139, P670, DOI 10.1001/archderm.139.5.670; MOONEY MA, 1994, CUTIS, V53, P243; SPRUANCE SL, 1977, NEW ENGL J MED, V297, P69, DOI 10.1056/NEJM197707142970201; Strick LB, 2006, MOL DIAGN THER, V10, P17, DOI 10.1007/BF03256439; WHEELER CE, 1966, ARCH DERMATOL, V93, P162, DOI 10.1001/archderm.93.2.162; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1	18	0	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2012	345								e6625	10.1136/bmj.e6625	http://dx.doi.org/10.1136/bmj.e6625			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SV	23044694				2022-12-28	WOS:000309906600005
J	Wilson, LE; Blythe, D; Sharfstein, JM				Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.			Fungal Meningitis From Injection of Contaminated Steroids A Compounding Problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD 21202 USA	Maryland Department of Health & Mental Hygiene	Sharfstein, JM (corresponding author), Maryland Dept Hlth & Mental Hyg, 201 W Preston St, Baltimore, MD 21202 USA.	joshua.sharfstein@maryland.gov						[Anonymous], 2002, KANSAS CITY STA 1006; Centers for Disease Control and Prevention (CDC), MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), CAS DEF MEN SEPT ART; Food and Drug Administration (FDA), FUNG MEN OUTBR ARCH; Hallissy E, 2002, SAN FRANCISCO CHRONI; Kliff S, 2012, WASHINGTON POST; Professional Compounding Centers of America (PCCA), COMP PHARM PHARM AR	7	15	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2461	2462		10.1001/jama.2012.47932	http://dx.doi.org/10.1001/jama.2012.47932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23104261				2022-12-28	WOS:000312441400019
J	Kraemer, JD; Gostin, LO				Kraemer, John D.; Gostin, Lawrence O.			The Power to Block the Affordable Care Act What Are the Limits?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kraemer, John D.; Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA; [Kraemer, John D.] Georgetown Univ, Dept Hlth Syst Adm, Sch Nursing & Hlth Studies, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Gostin LO, 2012, JAMA FORUM; Jost Timothy, 2012, HLTH AFFAIRS BLOG; Pear Robert, 2012, NY TIMES        0316, pA14; Redhead CS, 2011, C RES SERV REP C FEB	4	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1975	1976		10.1001/jama.2012.51175	http://dx.doi.org/10.1001/jama.2012.51175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23108675				2022-12-28	WOS:000311291400017
J	Cho, J; Chang, H; Kwon, SC; Kim, B; Kim, Y; Choe, J; Ha, M; Kim, YK; Kim, VN				Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Choe, Junho; Ha, Minju; Kim, Yoon Ki; Kim, V. Narry			LIN28A Is a Suppressor of ER-Associated Translation in Embryonic Stem Cells	CELL			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; MICRORNA BIOGENESIS; LET-7 MICRORNA; BINDING-SITES; CROSS-LINKING; IN-VIVO; CLIP; LIN-28; PROTEINS	LIN28 plays a critical role in developmental transition, glucose metabolism, and tumorigenesis. At the molecular level, LIN28 is known to repress maturation of let-7 microRNAs and enhance translation of certain mRNAs. In this study, we obtain a genome-wide view of the molecular function of LIN28A in mouse embryonic stem cells by carrying out RNA crosslinking-immunoprecipitation-sequencing (CLIP-seq) and ribosome footprinting. We find that, in addition to let-7 precursors, LIN28A binds to a large number of spliced mRNAs. LIN28A recognizes AAGNNG, AAGNG, and less frequently UGUG, which are located in the terminal loop of a small hairpin. LIN28A is localized to the periendo-plasmic reticulum (ER) area and inhibits translation of mRNAs that are destined for the ER, reducing the synthesis of transmembrane proteins, ER or Golgi lumen proteins, and secretory proteins. Our study suggests a selective regulatory mechanism for ER-associated translation and reveals an unexpected role of LIN28A as a global suppressor of genes in the secretory pathway.	[Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Choe, Junho; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Korea University	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kim, Yoosik/B-9009-2016; Kwon, S. Chul/ABG-9415-2020; Choe, Junho/E-3410-2019; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Kim, Yoosik/0000-0003-3064-4643; Choe, Junho/0000-0002-2365-3755; Ha, Minju/0000-0003-2328-415X; Kim, Yoon Ki/0000-0003-1303-072X; Kim, Baekgyu/0000-0002-6681-6198; Chang, Hyeshik/0000-0002-9812-8015	Research Center Program of IBS (Institute for Basic Science) [EM1202]; BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF)	We are grateful to Huili Guo for advice on ribosome profiling and Daehyun Baek for critical comments on the manuscript. We also thank Ahyoung Cho and Yun Cheng Chang for technical help and members of our laboratory for discussion. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J.C., H. C., S. C. K., and B. K.) from the Ministry of Education, Science and Technology of Korea; the TJ Park Postdoctoral Fellowship (Y.K.); and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hamilton RL, 1999, J LIPID RES, V40, P1140; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	43	171	176	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					765	777		10.1016/j.cell.2012.10.019	http://dx.doi.org/10.1016/j.cell.2012.10.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23102813	Bronze			2022-12-28	WOS:000310921200009
J	Woloshin, S; Schwartz, LM; Black, WC; Kramer, BS				Woloshin, Steven; Schwartz, Lisa M.; Black, William C.; Kramer, Barnett S.			Cancer Screening Campaigns - Getting Past Uninformative Persuasion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woloshin, Steven; Schwartz, Lisa M.] VA Outcomes Grp, White River Jct, VT USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA; [Woloshin, Steven; Schwartz, Lisa M.; Black, William C.] Norris Cotton Canc Ctr, Lebanon, NH USA; [Black, William C.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Kramer, Barnett S.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Woloshin, S (corresponding author), VA Outcomes Grp, White River Jct, VT USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Lerner Barron H, 2001, BREAST CANC WARS HOP; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106	5	62	66	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1677	1679		10.1056/NEJMp1209407	http://dx.doi.org/10.1056/NEJMp1209407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113476				2022-12-28	WOS:000310440800001
J	Emmons, SW				Emmons, Scott W.			The Mood of a Worm	SCIENCE			English	Editorial Material							CONNECTOME		Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	scott.emmons@einstein.yu.edu						Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	10	5	5	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					475	476		10.1126/science.1230251	http://dx.doi.org/10.1126/science.1230251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112317				2022-12-28	WOS:000310195800039
J	Heo, I; Ha, M; Lim, J; Yoon, MJ; Park, JE; Kwon, SC; Chang, H; Kim, VN				Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry			Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-7 MicroRNAs	CELL			English	Article							RNA-INTERFERENCE; C-ELEGANS; POLY(A) POLYMERASES; NUCLEAR EXPORT; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; DROSHA-DGCR8 COMPLEX; MOLECULAR-BASIS; 3' ADENYLATION; MESSENGER-RNA	RNase III Drosha initiates microRNA (miRNA) maturation by cleaving a primary miRNA transcript and releasing a pre-miRNA with a 2 nt 3' overhang. Dicer recognizes the 2 nt 3' overhang structure to selectively process pre-miRNAs. Here, we find that, unlike prototypic pre-miRNAs (group I), group II pre-miRNAs acquire a shorter (1 nt) 3' overhang from Drosha processing and therefore require a 3'-end mono-uridylation for Dicer processing. The majority of let-7 and miR-105 belong to group II. We identify TUT7/ZCCHC6, TUT4/ZCCHC11, and TUT2/PAPD4/GLD2 as the terminal uridylyl transferases responsible for pre-miRNA mono-uridylation. The TUTs act specifically on dsRNAs with a 1 nt 3' overhang, thereby creating a 2 nt 3' overhang. Depletion of TUTs reduces let-7 levels and disrupts let-7 function. Although the let-7 suppressor, Lin28, induces inhibitory oligo-uridylation in embryonic stem cells, mono-uridylation occurs in somatic cells lacking Lin28 to promote let-7 biogenesis. Our study reveals functional duality of uridylation and introduces TUT7/4/2 as components of the miRNA biogenesis pathway.	[Heo, Inha; Ha, Minju; Lim, Jaechul; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Chang, Hyeshik/0000-0002-9812-8015; Ha, Minju/0000-0003-2328-415X	Research Center Program of IBS (Institute for Basic Science) [EM1202]; Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	We are grateful to the members of our laboratory, particularly Joha Park, Hyerim Yi, Dr. Kyu-Hyeon Yeom, Dr. Yoosik Kim, Ahyoung Cho, and Yun Cheng Chang for discussion and technical help. We thank Dr. Yun-jeong Kim and Dr. Daehyun Baek for help in preparation of mRNA sequencing libraries. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J. L., J.-E. P., and H. C.) from the Ministry of Education, Science and Technology of Korea; and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MENEELY PM, 1979, GENETICS, V92, P99; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	65	215	221	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					521	532		10.1016/j.cell.2012.09.022	http://dx.doi.org/10.1016/j.cell.2012.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063654	Bronze			2022-12-28	WOS:000310529300010
J	McBain, CJ				McBain, Chris J.			Decoding the Neuronal Tower of Babel	SCIENCE			English	Editorial Material							EXPRESSION; RELEASE		Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Porter Neurosci Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Porter Neurosci Ctr, Room 3C903,Lincoln Dr, Bethesda, MD 20892 USA.	mcbainc@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD001205-21] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Pelkey KA, 2008, J PHYSIOL-LONDON, V586, P1495, DOI 10.1113/jphysiol.2007.148635; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x	6	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					482	483		10.1126/science.1230338	http://dx.doi.org/10.1126/science.1230338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112322	Green Accepted			2022-12-28	WOS:000310195800044
J	Camilleri, M				Camilleri, Michael			Peripheral Mechanisms in Irritable Bowel Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; BILE-ACID MALABSORPTION; CHAIN FATTY-ACIDS; GLUTEN-FREE DIET; CELIAC-DISEASE; COLONIC TRANSIT; CHROMOGRANIN-A; MACROMOLECULAR PERMEABILITY; VISCERAL HYPERSENSITIVITY; ENTEROENDOCRINE CELLS		Mayo Clin, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Camilleri, M (corresponding author), Mayo Clin, Coll Med, Charlton 8-110,200 1st St SW, Rochester, MN 55905 USA.	camilleri.michael@mayo.edu			Takeda Pharmaceuticals USA; Albany Molecular Research; BioKier; Theravance; Alkermes; ARYx Therapeutics; AstraZeneca; Domain Therapeutics; Ironwood Pharmaceuticals; Tranzyme; NPS Pharmaceuticals; Rose Pharma; Albireo; Tsumura; Second Genome; SK Life Science; Salix Pharmaceuticals; Rhythm	Takeda Pharmaceuticals USA; Albany Molecular Research; BioKier; Theravance; Alkermes; ARYx Therapeutics; AstraZeneca(AstraZeneca); Domain Therapeutics; Ironwood Pharmaceuticals; Tranzyme; NPS Pharmaceuticals; Rose Pharma; Albireo; Tsumura(Tsumura & Company); Second Genome; SK Life Science; Salix Pharmaceuticals; Rhythm	Dr. Camilleri reports receiving consulting fees from Takeda Pharmaceuticals USA, Albany Molecular Research, BioKier, Theravance, Alkermes, ARYx Therapeutics, AstraZeneca, Domain Therapeutics, Ironwood Pharmaceuticals, Tranzyme, and NPS Pharmaceuticals; receiving grant support from Rose Pharma, Albireo, Tsumura, Second Genome, SK Life Science, Salix Pharmaceuticals, and Rhythm through his institution; being a coinventor of a patent related to enteric delivery of chenodeoxycholic acid for constipation; and receiving royalties from EnteroMedics for licensed technology related to vagal-stimulation treatment of obesity. No other potential conflict of interest relevant to this article was reported.	Aerssens J, 2008, CLIN GASTROENTEROL H, V6, P194, DOI 10.1016/j.cgh.2007.11.012; Alonso C, 2012, NEUROGASTROENT MOTIL, V24, P740, DOI 10.1111/j.1365-2982.2012.01928.x; Bampton PA, 2002, AM J PHYSIOL-GASTR L, V282, pG443, DOI 10.1152/ajpgi.00194.2001; Barbara Giovanni, 2011, Curr Gastroenterol Rep, V13, P308, DOI 10.1007/s11894-011-0195-7; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bouchoucha M, 2009, TECH COLOPROCTOL, V13, P103; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P23; Camilleri M, 2012, CLIN PHARMACOL THER, V91, P44, DOI 10.1038/clpt.2011.261; Camilleri M, 2011, NEUROGASTROENT MOTIL, V23, P935, DOI 10.1111/j.1365-2982.2011.01749.x; Camilleri M, 2009, NEUROGASTROENT MOTIL, V21, P734, DOI 10.1111/j.1365-2982.2009.01288.x; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V295, pG219, DOI 10.1152/ajpgi.90202.2008; Camilleri M, 2008, CLIN GASTROENTEROL H, V6, P772, DOI 10.1016/j.cgh.2008.02.060; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V294, pG13, DOI 10.1152/ajpgi.00371.2007; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V302, pG1075, DOI 10.1152/ajpgi.00537.2011; Camilleri M, 2012, AM J GASTROENTEROL, V107, P448, DOI 10.1038/ajg.2011.465; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; Cash BD, 2011, GASTROENTEROLOGY, V141, P1187, DOI [10.1053/J.GASTRO.2011.06.084, 10.1053/j.gastro.2011.06.084]; CHADWICK VS, 1979, J LAB CLIN MED, V94, P661; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Chiarioni G, 2005, GASTROENTEROLOGY, V129, P86, DOI 10.1053/j.gastro.2005.05.015; Deiteren A, 2010, DIGEST DIS SCI, V55, P384, DOI 10.1007/s10620-009-1041-8; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; El-Salhy M, 2011, MOL MED REP, V4, P603, DOI 10.3892/mmr.2011.492; Farup PG, 2004, SCAND J GASTROENTERO, V39, P645, DOI 10.1080/00365520410005405; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Horwitz BJ, 2001, NEW ENGL J MED, V344, P1846, DOI 10.1056/NEJM200106143442407; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Johnston Ian, 2011, Curr Gastroenterol Rep, V13, P418, DOI 10.1007/s11894-011-0219-3; KAMATH PS, 1987, AM J PHYSIOL, V253, pG427, DOI 10.1152/ajpgi.1987.253.4.G427; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Karaki S, 2011, PFLUG ARCH EUR J PHY, V461, P141, DOI 10.1007/s00424-010-0889-y; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Keely SJ, 2007, AM J PHYSIOL-GASTR L, V292, pG290, DOI 10.1152/ajpgi.00076.2006; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Kim HJ, 2003, ALIMENT PHARM THER, V17, P895, DOI 10.1046/j.1365-2036.2003.01543.x; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Lillestol K, 2010, ALIMENT PHARM THER, V31, P1112, DOI 10.1111/j.1365-2036.2010.04261.x; Ludidi S, 2012, NEUROGASTROENT MOTIL, V24, P47, DOI 10.1111/j.1365-2982.2011.01802.x; LYNN RB, 1994, NEW ENGL J MED, V330, P228; LYNN RB, 1993, NEW ENGL J MED, V329, P1940, DOI 10.1056/NEJM199312233292608; Mayer EA, 2008, NEW ENGL J MED, V358, P1692, DOI 10.1056/NEJMcp0801447; Mitsui R, 2005, NEUROGASTROENT MOTIL, V17, P585, DOI 10.1111/j.1365-2982.2005.00669.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Montagnani M, 2001, SCAND J GASTROENTERO, V36, P1077, DOI 10.1080/003655201750422693; Montagnani M, 2006, WORLD J GASTROENTERO, V12, P7710, DOI 10.3748/wjg.v12.i47.7710; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; MOYANA TN, 1991, MODERN PATHOL, V4, P419; NELIS GF, 1990, GASTROENTEROLOGY, V99, P1016, DOI 10.1016/0016-5085(90)90621-7; ODDSSON E, 1978, SCAND J GASTROENTERO, V13, P409, DOI 10.3109/00365527809181914; Odunsi-Shiyanbade ST, 2010, CLIN GASTROENTEROL H, V8, P159, DOI 10.1016/j.cgh.2009.10.020; Ohman L, 2012, AM J GASTROENTEROL, V107, P440, DOI 10.1038/ajg.2011.458; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Ong DK, 2010, J GASTROEN HEPATOL, V25, P1366, DOI 10.1111/j.1440-1746.2010.06370.x; Parkes GC, 2012, NEUROGASTROENT MOTIL, V24, P31, DOI 10.1111/j.1365-2982.2011.01803.x; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Peregrin AT, 1999, BRIT J PHARMACOL, V127, P887, DOI 10.1038/sj.bjp.0702615; PIETROLETTI R, 1986, GUT, V27, P838, DOI 10.1136/gut.27.7.838; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Prott G, 2010, NEUROGASTROENT MOTIL, V22, P764, DOI 10.1111/j.1365-2982.2010.01503.x; Ragnarsson G, 1998, EUR J GASTROEN HEPAT, V10, P415, DOI 10.1097/00042737-199805000-00011; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Rao AS, 2011, AM J PHYSIOL-GASTR L, V301, pG919, DOI 10.1152/ajpgi.00168.2011; Rao AS, 2010, GASTROENTEROLOGY, V139, P1549, DOI 10.1053/j.gastro.2010.07.052; Rosenstiel P, 2009, SEMIN IMMUNOL, V21, P334, DOI 10.1016/j.smim.2009.10.001; RUMESSEN JJ, 1988, GASTROENTEROLOGY, V95, P694, DOI 10.1016/S0016-5085(88)80016-7; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; Saps M, 2008, J PEDIATR-US, V152, P812, DOI 10.1016/j.jpeds.2007.11.042; Saps M, 2011, J PEDIATR GASTR NUTR, V52, P166, DOI 10.1097/MPG.0b013e3181e85b55; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058; Shooshtarizadeh P, 2010, REGUL PEPTIDES, V165, P102, DOI 10.1016/j.regpep.2009.11.014; Shulman RJ, 2008, J PEDIATR-US, V153, P646, DOI 10.1016/j.jpeds.2008.04.062; Simren M, 2007, NEUROGASTROENT MOTIL, V19, P20, DOI 10.1111/j.1365-2982.2006.00849.x; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Spiller R, 2010, CLIN GASTROENTEROL H, V8, P125, DOI 10.1016/j.cgh.2009.12.018; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; STEPHEN AM, 1983, GASTROENTEROLOGY, V85, P589; Swan C, 2012, GUT; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Tornblom H, 2012, AM J GASTROENTEROL, V107, P754, DOI 10.1038/ajg.2012.5; Traub RJ, 2008, GASTROENTEROLOGY, V135, P2075, DOI 10.1053/j.gastro.2008.08.051; Treem WR, 1996, J PEDIATR GASTR NUTR, V23, P280, DOI 10.1097/00005176-199610000-00013; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Voderholzer WA, 1997, AM J GASTROENTEROL, V92, P95; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Walters JRF, 2009, CLIN GASTROENTEROL H, V7, P1189, DOI 10.1016/j.cgh.2009.04.024; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Wong BS, 2012, CLIN GASTROENTEROL H, V10, P1009, DOI 10.1016/j.cgh.2012.05.006; Wong BS, 2011, GASTROENTEROLOGY, V140, P1934, DOI 10.1053/j.gastro.2011.02.063; Zhou QQ, 2011, NAT REV GASTRO HEPAT, V8, P349, DOI 10.1038/nrgastro.2011.83; Zucchelli M, 2011, GUT, V60, P1671, DOI 10.1136/gut.2011.241877	101	218	245	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1626	1635		10.1056/NEJMra1207068	http://dx.doi.org/10.1056/NEJMra1207068			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094724				2022-12-28	WOS:000310131700009
J	Lane, R				Lane, Richard			Jimmy Volmink: shaping the evidence base in South Africa	LANCET			English	Biographical-Item																		VOLMINK J, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1377	1377		10.1016/S0140-6736(12)61788-7	http://dx.doi.org/10.1016/S0140-6736(12)61788-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	23084443				2022-12-28	WOS:000310196500012
J	Wesolowski, A; Eagle, N; Tatem, AJ; Smith, DL; Noor, AM; Snow, RW; Buckee, CO				Wesolowski, Amy; Eagle, Nathan; Tatem, Andrew J.; Smith, David L.; Noor, Abdisalan M.; Snow, Robert W.; Buckee, Caroline O.			Quantifying the Impact of Human Mobility on Malaria	SCIENCE			English	Article							ELIMINATION STRATEGIES; TRANSMISSION; KENYA; NAIROBI; SETTLEMENT; ZANZIBAR	Human movements contribute to the transmission of malaria on spatial scales that exceed the limits of mosquito dispersal. Identifying the sources and sinks of imported infections due to human travel and locating high-risk sites of parasite importation could greatly improve malaria control programs. Here, we use spatially explicit mobile phone data and malaria prevalence information from Kenya to identify the dynamics of human carriers that drive parasite importation between regions. Our analysis identifies importation routes that contribute to malaria epidemiology on regional spatial scales.	[Eagle, Nathan; Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15221 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15221 USA; [Eagle, Nathan] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.; Smith, David L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Collaborat Programme, KEMRI Wellcome Trust, Malaria Publ Hlth & Epidemiol Grp,Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Carnegie Mellon University; Carnegie Mellon University; Northeastern University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Buckee, CO (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	cbuckee@hsph.harvard.edu	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X	National Science Foundation Graduate Research Fellowship program [0750271]; Bill & Melinda Gates Foundation [49446, OPP1032350]; National Institute of Allergy and Infectious Disease, NIH [U19AI089674]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH; Wellcome Trust [095127, 079080]; Wellcome Trust Major Overseas Programme grant [092654]; Models of Infectious Disease Agent Study program [1U54GM088558]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1005075] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1216345] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Disease, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Major Overseas Programme grant(Wellcome Trust); Models of Infectious Disease Agent Study program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	A.W. was supported by the National Science Foundation Graduate Research Fellowship program (0750271). D. L. S. and A.J.T. acknowledge support from Bill & Melinda Gates Foundation grants (49446 and OPP1032350); National Institute of Allergy and Infectious Disease, NIH, grant (U19AI089674); and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; and the Fogarty International Center, NIH. A.M.N. is supported by the Wellcome Trust as an Intermediate Research Fellow (095127). R. W. S. is supported by the Wellcome Trust as Principal Research Fellow (079080). A.M.N. and R. W. S. also acknowledge programmatic support provided by the Wellcome Trust Major Overseas Programme grant to the Kenya Medical Research Institute-Wellcome Trust Programme (092654). C.O.B. was supported by the Models of Infectious Disease Agent Study program (cooperative agreement 1U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. Mobile phone data were provided by an anonymous service provider in Kenya and are not available for distribution.	Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Dolgin E, 2010, NAT MED, V16, P1055, DOI 10.1038/nm1010-1055; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Kasili S, 2009, J VECTOR DIS, V46, P273; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; Moonen B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-322; Mudhune SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-138; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Rapuoda B., 1984, P KEMRI KETRI 5 ANN, P115; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	20	539	549	11	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					267	270		10.1126/science.1223467	http://dx.doi.org/10.1126/science.1223467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066082	Green Accepted			2022-12-28	WOS:000309712300049
J	Lee, GM; Kleinman, K; Soumerai, SB; Tse, A; Cole, D; Fridkin, SK; Horan, T; Platt, R; Gay, C; Kassler, W; Goldmann, DA; Jernigan, J; Jha, AK				Lee, Grace M.; Kleinman, Ken; Soumerai, Stephen B.; Tse, Alison; Cole, David; Fridkin, Scott K.; Horan, Teresa; Platt, Richard; Gay, Charlene; Kassler, William; Goldmann, Donald A.; Jernigan, John; Jha, Ashish K.			Effect of Nonpayment for Preventable Infections in US Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-ASSOCIATED INFECTIONS; PAY-FOR-PERFORMANCE; URINARY-TRACT-INFECTIONS; QUALITY-OF-CARE; SAFETY-NET HOSPITALS; HEALTH-CARE; MEDICARE POLICY; PAYMENT POLICY; UNINTENDED CONSEQUENCES; ACQUIRED CONDITIONS	Background In October 2008, the Centers for Medicare and Medicaid Services (CMS) discontinued additional payments for certain hospital-acquired conditions that were deemed preventable. The effect of this policy on rates of health care-associated infections is unknown. Methods Using a quasi-experimental design with interrupted time series with comparison series, we examined changes in trends of two health care-associated infections that were targeted by the CMS policy (central catheter-associated bloodstream infections and catheter-associated urinary tract infections) as compared with an outcome that was not targeted by the policy (ventilator-associated pneumonia). Hospitals participating in the National Healthcare Safety Network and reporting data on at least one health care-associated infection before the onset of the policy were eligible to participate. Data from January 2006 through March 2011 were included. We used regression models to measure the effect of the policy on changes in infection rates, adjusting for base-line trends. Results A total of 398 hospitals or health systems contributed 14,817 to 28,339 hospital unit-months, depending on the type of infection. We observed decreasing secular trends for both targeted and nontargeted infections long before the policy was implemented. There were no significant changes in quarterly rates of central catheter-associated bloodstream infections (incidence-rate ratio in the postimplementation vs. preimplementation period, 1.00; P = 0.97), catheter-associated urinary tract infections (incidence-rate ratio, 1.03; P = 0.08), or ventilator-associated pneumonia (incidence-rate ratio, 0.99; P = 0.52) after the policy implementation. Our findings did not differ for hospitals in states without mandatory reporting, nor did it differ according to the quartile of percentage of Medicare admissions or hospital size, type of ownership, or teaching status. Conclusions We found no evidence that the 2008 CMS policy to reduce payments for central catheter-associated bloodstream infections and catheter-associated urinary tract infections had any measurable effect on infection rates in U.S. hospitals. (Funded by the Agency for Healthcare Research and Quality.)	[Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, Boston, MA 02215 USA; [Lee, Grace M.] Harvard Univ, Sch Med, Div Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicare Serv, Boston, MA 02115 USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicaid Serv, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Inst Healthcare Improvement, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fridkin, Scott K.; Horan, Teresa; Jernigan, John] Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA	Lee, GM (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.	grace.lee@childrens.harvard.edu		Kawai, Alison/0000-0002-2923-2169; Kleinman, Ken/0000-0002-5600-5834; Jernigan, John/0000-0001-8163-925X	Agency for Healthcare Research and Quality [5R01HS018414-03]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018414] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant from the Agency for Healthcare Research and Quality (5R01HS018414-03, to Dr. Lee).	Agency for Healthcare Research and Quality, HEALTHC ASS INF; American Hospital Association, 2011, MED NONP HEALTHC ASS; [Anonymous], STAT BAS HAI PREV; [Anonymous], RED HEALTHC INF; [Anonymous], 2011, HOSP ACQ COND PRES A; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Department of Health and Human Services, 2011, COMMUNICATION    071; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Emmert M, 2011, EUR J HLTH EC; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Hartmann CW, 2012, MED CARE RES REV, V69, P45, DOI 10.1177/1077558711413606; Health Forum LLC, 2010, AM HOSP ASS ANN SURV; Healthcare-associated infections (HAI), HEALTHC ASS INF HAI; Hoff T, 2011, J HEALTHC MANAG, V56, P319, DOI 10.1097/00115514-201109000-00007; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Karve AM, 2008, AM HEART J, V155, P571, DOI 10.1016/j.ahj.2007.10.043; Krein SL, 2012, J GEN INTERN MED, V27, P773, DOI 10.1007/s11606-011-1935-y; Lee GM, 2012, AM J INFECT CONTROL, V40, P314, DOI 10.1016/j.ajic.2011.11.003; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McClellan M., 2009, MOVING ACCOUNT ABLE; McHugh M, 2011, MED CARE RES REV, V68, P667, DOI 10.1177/1077558711408326; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; McNutt Robert, 2010, Qual Manag Health Care, V19, P17, DOI 10.1097/QMH.0b013e3181ccbd07; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections, METH RES STAPH AURC; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Sherman ER, 2006, INFECT CONT HOSP EP, V27, P332, DOI 10.1086/502684; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f; Teufack SG, 2010, J NEUROSURG, V112, P249, DOI 10.3171/2009.7.JNS09753; The Joint Commission, INF CONTR; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700; Zhan CL, 2009, MED CARE, V47, P364, DOI 10.1097/MLR.0b013e31818af83d; Zrelak Patricia A, 2011, J Healthc Qual, V33, P29, DOI 10.1111/j.1945-1474.2010.00114.x	53	161	166	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1428	1437		10.1056/NEJMsa1202419	http://dx.doi.org/10.1056/NEJMsa1202419			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050526	Green Published, Green Submitted			2022-12-28	WOS:000309652700009
J	Masood, E				Masood, Ehsan			Expert assessments can work if lessons are learned	NATURE			English	Editorial Material												ehm@researchresearch.com							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					145	145		10.1038/490145a	http://dx.doi.org/10.1038/490145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23060151				2022-12-28	WOS:000309733300012
J	Al-Hadithy, N; Panagiotidou, A				Al-Hadithy, Nada; Panagiotidou, Anna			The management of open tibial shaft fractures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LONG-BONE FRACTURES; INFECTED NONUNION; TRAUMA; CLASSIFICATION; EPIDEMIOLOGY; FIXATION; COVERAGE; TRIAL; FLAP; ROOM		[Al-Hadithy, Nada] St Johns Hosp, Dept Plast Surg, Livingston EH54 6PP, Scotland; [Panagiotidou, Anna] Stanmore Natl Orthopaed Hosp, Stanmore, Middx, England		Al-Hadithy, N (corresponding author), St Johns Hosp, Dept Plast Surg, Livingston EH54 6PP, Scotland.	nadaucl@yahoo.com						Arnez ZM, 1999, BRIT J PLAST SURG, V52, P280, DOI 10.1054/bjps.1999.3080; Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74; BEHRENS F, 1986, J BONE JOINT SURG BR, V68, P246, DOI 10.1302/0301-620X.68B2.3514629; Bhandari M, 2011, J TRAUMA, V71, P596, DOI 10.1097/TA.0b013e3181f6f2e8; Bhattacharyya T, 2008, PLAST RECONSTR SURG, V121, P1263, DOI 10.1097/01.prs.0000305536.09242.a6; Bhoi Sanjeev, 2012, J Emerg Trauma Shock, V5, P28, DOI 10.4103/0974-2700.93107; Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; BYRD HS, 1985, PLAST RECONSTR SURG, V76, P719, DOI 10.1097/00006534-198511000-00011; Chua WL, 2012, SINGAP MED J, V53, P385; Court-Brown CM, 1998, INJURY, V29, P529, DOI 10.1016/S0020-1383(98)00125-9; De Buck F, 2012, CURR OPIN ANESTHESIO, V25, P501, DOI 10.1097/ACO.0b013e3283556f58; Department of Health, 2009, IMM INF DIS GREEN BO, P367; FACKLER ML, 1989, SURGERY, V105, P576; GODINA M, 1986, PLAST RECONSTR SURG, V78, P285, DOI 10.1097/00006534-198609000-00001; Gopal S, 2000, J BONE JOINT SURG BR, V82B, P959, DOI 10.1302/0301-620X.82B7.10482; Gopal S, 2004, J BONE JOINT SURG BR, V86B, P861, DOI 10.1302/0301-620X.86B6.13400; Gosselin RA, 2004, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003764.pub2, DOI 10.1002/14651858.CD003764.PUB2]; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; GUSTILO RB, 1995, J BONE JOINT SURG AM, V77A, P1291, DOI 10.2106/00004623-199508000-00024; Hannon M, 2009, J TRAUMA, V67, P1384, DOI 10.1097/TA.0b013e31819ea3e0; Ma CH, 2011, J TRAUMA, V71, P614, DOI 10.1097/TA.0b013e3182041175; Martin JS, 1997, J ORTHOP TRAUMA, V11, P477, DOI 10.1097/00005131-199710000-00004; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P99, DOI 10.1302/0301-620X.78B1.0780099; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; Nanchahal J, 2009, STANDARDS MANAGEMENT; Parker P, 2011, J ROY ARMY MED CORPS, V157, pS293, DOI 10.1136/jramc-157-03s-07; Patzakis MJ, 2005, J AM ACAD ORTHOP SUR, V13, P417, DOI 10.5435/00124635-200510000-00006; Rainer TH, 2000, BMJ-BRIT MED J, V321, P1247, DOI 10.1136/bmj.321.7271.1247; Reed LK, 2008, OPER TECH ORTHOP, V18, P128, DOI 10.1053/j.oto.2008.09.002; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Stannard JP, 2010, INJURY, V41, P780, DOI 10.1016/j.injury.2009.08.011; Stephen Robert, 2012, J Opioid Manag, V8, P237, DOI 10.5055/jom.2012.0121; Sudkamp NP, CLASSIFICATION SOFT; TOH CL, 1995, CLIN ORTHOP RELAT R, P176; Yang JS, 2011, SPRINT STUDY PROSPEC	36	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 28	2012	345								e6348	10.1136/bmj.e6348	http://dx.doi.org/10.1136/bmj.e6348			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014PD	23045317				2022-12-28	WOS:000309387100002
J	Hill, A; Fisher, P; Yeomanson, D				Hill, Andrew; Fisher, Patricia; Yeomanson, Dan			Non-small cell lung cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yeomanson, Dan] Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; [Fisher, Patricia] Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Weston Park Hospital	Yeomanson, D (corresponding author), Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England.	daniel.yeomanson@sch.nhs.uk							0	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6443	10.1136/bmj.e6443	http://dx.doi.org/10.1136/bmj.e6443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044990	Bronze			2022-12-28	WOS:000309386700012
J	Gayathri, P; Fujii, T; Moller-Jensen, J; van den Ent, F; Namba, K; Lowe, J				Gayathri, P.; Fujii, T.; Moller-Jensen, J.; van den Ent, F.; Namba, K.; Loewe, J.			A Bipolar Spindle of Antiparallel ParM Filaments Drives Bacterial Plasmid Segregation	SCIENCE			English	Article							DYNAMIC INSTABILITY; STRUCTURAL BASIS; DNA SEGREGATION; F-ACTIN; VISUALIZATION; MECHANISM	To ensure their stable inheritance by daughter cells during cell division, bacterial low-copy-number plasmids make simple DNA segregating machines that use an elongating protein filament between sister plasmids. In the ParMRC system of the Escherichia coli R1 plasmid, ParM, an actinlike protein, forms the spindle between ParRC complexes on sister plasmids. By using a combination of structural work and total internal reflection fluorescence microscopy, we show that ParRC bound and could accelerate growth at only one end of polar ParM filaments, mechanistically resembling eukaryotic formins. The architecture of ParM filaments enabled two ParRC-bound filaments to associate in an antiparallel orientation, forming a bipolar spindle. The spindle elongated as a bundle of at least two antiparallel filaments, thereby pushing two plasmid clusters toward the poles.	[Gayathri, P.; Moller-Jensen, J.; van den Ent, F.; Loewe, J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fujii, T.; Namba, K.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Namba, K.] Riken Quantitat Biol Ctr, Suita, Osaka 5650871, Japan	MRC Laboratory Molecular Biology; Osaka University; RIKEN	Lowe, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jyl@mrc-lmb.cam.ac.uk	Namba, Keiichi/A-9406-2016; Møller-Jensen, Jakob/AAO-8480-2020; Löwe, Jan/X-6998-2019	Møller-Jensen, Jakob/0000-0002-6008-3771; Lowe, Jan/0000-0002-5218-6615; Gayathri, Pananghat/0000-0002-2242-4619	MRC [U105184326]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21227006]; FP7-IIF-2008 fellowship; MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FP7-IIF-2008 fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge N. Barry and C. Johnson (MRC-LMB, help with TIRF microscopy and isothermal titration calorimetry); T. Kato (Osaka University, technical support with cryo-EM); beamline support at ID29, ID14-2 (European Synchrotron Radiation Facility, France), and I02 (Diamond Light Source, UK); L. Amos, S. Bullock, A. Carter, and R. Gasper-Schonenbrucher (MRC-LMB, critical reading of the manuscript); and K. Gerdes (Newcastle University) and A. Toste Rego (MRC-LMB) (provision of reagents). Support by the MRC (U105184326 to J.L.), Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (21227006 to K. N.), and FP7-IIF-2008 fellowship (P. G.) is acknowledged. Protein Data Bank (PDB) accession codes: ParM-AMPPNP, 4A61; ParM-AMPPNP-ParR<INF>pept</INF>, 4A62. The EM reconstruction has been deposited in the Electron Microscopy Data Bank (EMD-1980), fitted coordinates in the PDB (4A6J).	Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	22	63	65	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1334	1337		10.1126/science.1229091	http://dx.doi.org/10.1126/science.1229091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23112295	Green Accepted			2022-12-28	WOS:000311991200064
J	Jakola, AS; Myrmel, KS; Kloster, R; Torp, SH; Lindal, S; Unsgard, G; Solheim, O				Jakola, Asgeir S.; Myrmel, Kristin S.; Kloster, Roar; Torp, Sverre H.; Lindal, Sigurd; Unsgard, Geirmund; Solheim, Ole			Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAOPERATIVE 3-DIMENSIONAL ULTRASOUND; LONG-TERM SURVIVAL; STEREOTACTIC BIOPSY; PROGNOSTIC-FACTORS; ADULT PATIENTS; EXTENT; NEURONAVIGATION; ASTROCYTOMA; MANAGEMENT; TUMORS	Context There are no controlled studies on surgical treatment of diffuse low-grade gliomas (LGGs), and management is controversial. Objective To examine survival in population-based parallel cohorts of LGGs from 2 Norwegian university hospitals with different surgical treatment strategies. Design, Setting, and Patients Both neurosurgical departments are exclusive providers in adjacent geographical regions with regional referral practices. In hospital A diagnostic biopsies followed by a "wait and scan" approach has been favored (biopsy and watchful waiting), while early resections have been advocated in hospital B (early resection). Thus, the treatment strategy in individual patients has been highly dependent on the patient's residential address. Histopathology specimens from all adult patients diagnosed with LGG from 1998 through 2009 underwent a blinded histopathological review to ensure uniform classification and inclusion. Follow-up ended April 11, 2011. There were 153 patients (66 from the center favoring biopsy and watchful waiting and 87 from the center favoring early resection) with diffuse LGGs included. Main Outcome Measure The prespecified primary end point was overall survival based on regional comparisons without adjusting for administered treatment. Results Initial biopsy alone was carried out in 47 (71%) patients served by the center favoring biopsy and watchful waiting and in 12 (14%) patients served by the center favoring early resection (P < .001). Median follow-up was 7.0 years (interquartile range, 4.5-10.9) at the center favoring biopsy and watchful waiting and 7.1 years (interquartile range, 4.2-9.9) at the center favoring early resection (P = .95). The 2 groups were comparable with respect to baseline parameters. Overall survival was significantly better with early surgical resection (P = .01). Median survival was 5.9 years (95% CI, 4.5-7.3) with the approach favoring biopsy only while median survival was not reached with the approach favoring early resection. Estimated 5-year survival was 60% (95% CI, 48%-72%) and 74% (95% CI, 64%-84%) for biopsy and watchful waiting and early resection, respectively. In an adjusted multivariable analysis the relative hazard ratio was 1.8 (95% CI, 1.1-2.9, P = .03) when treated at the center favoring biopsy and watchful waiting. Conclusions For patients in Norway with LGG, treatment at a center that favored early surgical resection was associated with better overall survival than treatment at a center that favored biopsy and watchful waiting. This survival benefit remained after adjusting for validated prognostic factors. JAMA. 2012;308(18):1881-1888 Published online October 25, 2012. doi:10.1001/jama.2012.12807 www.jama.com	[Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Torp, Sverre H.] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway; [Myrmel, Kristin S.; Lindal, Sigurd] Univ Hosp N Norway, Dept Pathol, Tromso, Norway; [Kloster, Roar] Univ Hosp N Norway, Dept Ophthalmol & Neurosurg, Tromso, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] Natl Ctr Competence Ultrasound & Image Guided Sur, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Torp, Sverre Helge/AAN-4229-2020; Jakola, Asgeir S/J-1738-2018	Torp, Sverre Helge/0000-0001-8345-6852; Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817				Aldape K, 2000, CANCER-AM CANCER SOC, V88, P2342, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X; Berntsen EM, 2010, NEUROSURGERY, V67, P251, DOI 10.1227/01.NEU.0000371731.20246.AC; Brommeland T, 2000, ACTA NEUROCHIR, V142, P443, DOI 10.1007/s007010050455; Brommeland T, 2000, ACTA NEUROCHIR, V142, P449, DOI 10.1007/s007010050456; Brommeland T, 2002, SURG NEUROL, V57, P190, DOI 10.1016/S0090-3019(01)00700-5; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Chaichana KL, 2009, J NEUROSURG, V112, P10; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Duffau H, 2008, J NEUROSURG, V109, P461, DOI 10.3171/JNS/2008/109/9/0461; Gronningsaeter A, 2000, NEUROSURGERY, V47, P1373, DOI 10.1097/00006123-200012000-00021; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Johannesen TB, 2003, EUR J CANCER, V39, P2355, DOI 10.1016/S0959-8049(03)00603-8; Johannesen TB, 2003, J NEUROSURG, V99, P854, DOI 10.3171/jns.2003.99.5.0854; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McGirt MJ, 2003, SURG NEUROL, V59, P277, DOI 10.1016/S0090-3019(03)00048-X; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Pouratian N, 2007, NAT CLIN PRACT NEURO, V3, P628, DOI 10.1038/ncpneuro0634; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; RECHT LD, 1992, ANN NEUROL, V31, P431, DOI 10.1002/ana.410310413; Reijneveld JC, 2001, NEUROLOGY, V56, P618, DOI 10.1212/WNL.56.5.618; Rezvan A, 2009, ACTA NEUROCHIR, V151, P1359, DOI 10.1007/s00701-009-0435-x; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Seiz M, 2011, CENT EUR NEUROSURG, V72, P186, DOI 10.1055/s-0031-1275351; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Shaw EG, 2003, NEURO-ONCOLOGY, V5, P153, DOI 10.1215/S1152851702000601; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Solheim O, 2012, J NEUROSURG, V116, P825, DOI 10.3171/2011.12.JNS11339; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Unsgaard G, 2002, NEUROSURGERY, V50, P804, DOI 10.1097/00006123-200204000-00022; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; van Veelen MLC, 1998, J NEUROL NEUROSUR PS, V64, P581, DOI 10.1136/jnnp.64.5.581; Veeravagu A, 2011, COCHRANE DB SYST REV; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wessels PH, 2003, LANCET NEUROL, V2, P395, DOI 10.1016/S1474-4422(03)00434-4	45	388	395	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1881	1888		10.1001/jama.2012.12807	http://dx.doi.org/10.1001/jama.2012.12807			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23099483				2022-12-28	WOS:000310952700024
J	Bascom-Slack, CA; Arnold, AE; Strobel, SA				Bascom-Slack, Carol A.; Arnold, A. Elizabeth; Strobel, Scott A.			Student-Directed Discovery of the Plant Microbiome and Its Products	SCIENCE			English	Editorial Material							ENDOPHYTES; DIVERSITY		[Bascom-Slack, Carol A.; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA	Yale University; University of Arizona	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	scott.strobel@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Stone JK, 2000, BOOK SOIL P, P3; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356	8	44	46	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					485	486		10.1126/science.1215227	http://dx.doi.org/10.1126/science.1215227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112324				2022-12-28	WOS:000310195800046
J	Cohen, D				Cohen, Deborah			How a fake hip showed up failings in European device regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Cohen D, 2012, BRIT MED J, V342, pd2748; Coombes R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6303; Farrell G, 2011, BLOOMBERG NEWS  0511; House of Commons Science and Technology Company, HC 163 REG MED IMPL; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126	5	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7090	10.1136/bmj.e7090	http://dx.doi.org/10.1136/bmj.e7090			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097541				2022-12-28	WOS:000310427600026
J	Pereira, TV; Horwitz, RI; Ioannidis, JPA				Pereira, Tiago V.; Horwitz, Ralph I.; Ioannidis, John P. A.			Empirical Evaluation of Very Large Treatment Effects of Medical Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURROGATE END-POINTS; CLINICAL-TRIALS; HEART-FAILURE; GRADE; METAANALYSIS; QUALITY	Context Most medical interventions have modest effects, but occasionally some clinical trials may find very large effects for benefits or harms. Objective To evaluate the frequency and features of very large effects in medicine. Data Sources Cochrane Database of Systematic Reviews (CDSR, 2010, issue 7). Study Selection We separated all binary-outcome CDSR forest plots with comparisons of interventions according to whether the first published trial, a subsequent trial (not the first), or no trial had a nominally statistically significant (P<.05) very large effect (odds ratio [OR], >= 5). We also sampled randomly 250 topics from each group for further in-depth evaluation. Data Extraction We assessed the types of treatments and outcomes in trials with very large effects, examined how often large-effect trials were followed up by other trials on the same topic, and how these effects compared against the effects of the respective meta-analyses. Results Among 85 002 forest plots (from 3082 reviews), 8239 (9.7%) had a significant very large effect in the first published trial, 5158 (6.1%) only after the first published trial, and 71 605 (84.2%) had no trials with significant very large effects. Nominally significant very large effects typically appeared in small trials with median number of events: 18 in first trials and 15 in subsequent trials. Topics with very large effects were less likely than other topics to address mortality (3.6% in first trials, 3.2% in subsequent trials, and 11.6% in no trials with significant very large effects) and were more likely to address laboratory-defined efficacy (10% in first trials, 10.8% in subsequent, and 3.2% in no trials with significant very large effects). First trials with very large effects were as likely as trials with no very large effects to have subsequent published trials. Ninety percent and 98% of the very large effects observed in first and subsequently published trials, respectively, became smaller in meta-analyses that included other trials; the median odds ratio decreased from 11.88 to 4.20 for first trials, and from 10.02 to 2.60 for subsequent trials. For 46 of the 500 selected topics (9.2%; first and subsequent trials) with a very large-effect trial, the meta-analysis maintained very large effects with P<.001 when additional trials were included, but none pertained to mortality-related outcomes. Across the whole CDSR, there was only 1 intervention with large beneficial effects on mortality, P<.001, and no major concerns about the quality of the evidence (for a trial on extracorporeal oxygenation for severe respiratory failure in newborns). Conclusions Most large treatment effects emerge from small studies, and when additional trials are performed, the effect sizes become typically much smaller. Well-validated large effects are uncommon and pertain to nonfatal outcomes. JAMA. 2012;308(16):1676-1684 www.jama.com	[Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Dept Med & Hlth & Res, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Policy, Sch Med, Stanford, CA 94305 USA; [Pereira, Tiago V.] German Hosp Oswaldo Cruz, Hlth Technol Assessment Unit, Inst Educ & Sci, Sao Paulo, Brazil; [Horwitz, Ralph I.] GlaxoSmithKline, King Of Prussia, PA USA; [Horwitz, Ralph I.] Yale Univ, Sch Med, New Haven, CT USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; GlaxoSmithKline; Yale University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Dept Med & Hlth & Res, Sch Med, Off Bldg,1265 Welch Rd,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation, FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Dr Pereira was supported in part by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation, FAPESP)	Albert JM, 1998, STAT MED, V17, P2435, DOI 10.1002/(SICI)1097-0258(19981115)17:21&lt;2435::AID-SIM994&gt;3.3.CO;2-7; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djulbegovic B, 2009, CANCER CONTROL, V16, P342, DOI 10.1177/107327480901600409; Durrheim DN, 2010, J EPIDEMIOL COMMUN H, V64, P387, DOI 10.1136/jech.2009.103226; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; Farmer AJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e486; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gan T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005096.pub2; Giljaca V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004385.pub3; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Gong Y, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006000; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hemila H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006665.pub2; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kent DM, 2009, JAMA-J AM MED ASSOC, V302, P2254, DOI 10.1001/jama.2009.1679; Krum H, 2003, J CARD FAIL, V9, P364, DOI 10.1054/S1071-9164(03)00018-6; Lede R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002857.pub2; Mugford M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001340.pub2; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Prasad V, 2011, ARCH INTERN MED, V171, P1675, DOI 10.1001/archinternmed.2011.295; Ram FSF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004403.pub2; Salvador DRK, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003178.pub3; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Swingler GH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001729.pub3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Tiong LU, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD0010001.pub2; Wang XH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007563.pub2; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Yang XZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006765.pub2	36	161	162	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1676	1684		10.1001/jama.2012.13444	http://dx.doi.org/10.1001/jama.2012.13444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093165				2022-12-28	WOS:000310434100022
J	Cals, JWL; de Bont, EGPM				Cals, Jochen W. L.; de Bont, Eefje G. P. M.			10-MINUTE CONSULTATION Minor incised traumatic laceration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cals, Jochen W. L.; de Bont, Eefje G. P. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands	Maastricht University	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@maastrichtuniversity.nl	Cals, Jochen WL/A-1262-2007	Cals, Jochen WL/0000-0001-9550-5674; de Bont, Eefje/0000-0002-2700-4752					0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 23	2012	345								e6824	10.1136/bmj.e6824	http://dx.doi.org/10.1136/bmj.e6824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MT	23092899				2022-12-28	WOS:000310427100017
J	Adams, J				Adams, Jonathan			The rise of research networks	NATURE			English	Editorial Material							COLLABORATION		Thomson Reuters, Leeds, W Yorkshire, England	Clarivate	Adams, J (corresponding author), Thomson Reuters, Leeds, W Yorkshire, England.	jonathan.adams@thomsonreuters.com	Adams, Jonathan/A-5224-2009	Adams, Jonathan/0000-0002-0325-4431				Adams J, 1998, NATURE, V396, P615, DOI 10.1038/25219; Adams J., 2006, INT PARTNERSHIPS RES; Bound K, 2012, OUR FRUGAL FUTURE LE; Evidence, 2003, FUND RES DIV; Greene M, 2007, NATURE, V450, P1165, DOI 10.1038/4501165a; King C., 2012, SCIENCEWATCH, P1; Leydesdorff L, 2008, J INFORMETR, V2, P317, DOI 10.1016/j.joi.2008.07.003; Ministry of Education Singapore, 2012, ED STAT DIG; Universities UK, 2010, FUTURE RES; Whitfield J, 2008, NATURE, V455, P720, DOI 10.1038/455720a	10	240	255	4	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					335	336		10.1038/490335a	http://dx.doi.org/10.1038/490335a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	021XI	23075965				2022-12-28	WOS:000309918500017
J	Clevers, H				Clevers, Hans			The Paneth Cell, Caloric Restriction, and Intestinal Integrity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.							CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	4	5	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1560	1561		10.1056/NEJMcibr1208353	http://dx.doi.org/10.1056/NEJMcibr1208353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075184				2022-12-28	WOS:000309904500015
J	Ebo, DG; Bridts, CH				Ebo, Didier G.; Bridts, Chris H.			Disfiguring Angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ebo, Didier G.; Bridts, Chris H.] Univ Antwerp, Antwerp, Belgium	University of Antwerp	Ebo, DG (corresponding author), Univ Antwerp, Antwerp, Belgium.		BRIDTS, Chris HM/M-7933-2016; EBO, Didier/H-4894-2016	BRIDTS, Chris HM/0000-0002-3324-7320; EBO, Didier/0000-0003-0672-7529					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1539	1539		10.1056/NEJMicm1200960	http://dx.doi.org/10.1056/NEJMicm1200960			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075180				2022-12-28	WOS:000309904500011
J	Gage, BF; Andrade, A				Gage, Brian F.; Andrade, Ambar			Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gage, Brian F.; Andrade, Ambar] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Gage, BF (corresponding author), Washington Univ, St Louis, MO 63130 USA.							Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Shah SV, 2011, CIRCULATION, V123, P2562, DOI 10.1161/CIRCULATIONAHA.110.985655	4	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-13	10.7326/0003-4819-157-8-201210160-02013	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070515				2022-12-28	WOS:000309906000012
J	Hirsch, C				Hirsch, Calvin			The Mini-Cog had sensitivity similar to the longer 3MS for detecting cognitive impairment or dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Lessig MC, 2008, INT PSYCHOGERIATR, V20, P459, DOI 10.1017/S1041610207006035; McCarten JR, 2011, J AM GERIATR SOC, V59, P309, DOI 10.1111/j.1532-5415.2010.03249.x; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964	4	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-8	10.7326/0003-4819-157-8-201210160-02008	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070510				2022-12-28	WOS:000309906000007
J	Darley, E; Weeks, J; Jones, L; Daniels, V; Wootton, M; MacGowan, A; Walsh, T				Darley, Elizabeth; Weeks, Janis; Jones, Lim; Daniels, Victoria; Wootton, Mandy; MacGowan, Alasdair; Walsh, Timothy			NDM-1 polymicrobial infections including Vibrio cholerae	LANCET			English	Editorial Material									[Darley, Elizabeth; MacGowan, Alasdair] N Bristol NHS Trust, Bristol, Avon, England; [Weeks, Janis; Jones, Lim; Walsh, Timothy] Cardiff Univ, Cardiff, S Glam, Wales; [Daniels, Victoria; Wootton, Mandy] Publ Heath Wales, Specialist Antimicrobial Chemotherapy Unit, Cardiff, S Glam, Wales	North Bristol NHS Trust; Cardiff University	Walsh, T (corresponding author), Cardiff Inst Infect & Immun, UHW Main Bldg,Hlth Pk, Cardiff CF14 4XN, S Glam, Wales.	walshtr@cf.ac.uk	Jones, Lim/K-7357-2013; MacGowan, Alasdair/AAM-1582-2020	MacGowan, Alasdair/0000-0002-6720-5268; Walsh, Timothy/0000-0003-4315-4096	MRC [G1100135] Funding Source: UKRI; Medical Research Council [G1100135] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrews JM, 2011, J ANTIMICROB CHEMOTH, V66, P2726, DOI 10.1093/jac/dkr359; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Jabeen K, 2010, T ROY SOC TROP MED H, V104, P563, DOI 10.1016/j.trstmh.2010.04.004; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Magnusson MR, 1996, BURNS, V22, P44, DOI 10.1016/0305-4179(95)00077-1	5	36	37	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1358	1358		10.1016/S0140-6736(12)60911-8	http://dx.doi.org/10.1016/S0140-6736(12)60911-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	23063285				2022-12-28	WOS:000309931400035
J	Mullan, Z				Mullan, Zoe			Gamal Serour: leader and collaborator in reproductive health	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1301	1301		10.1016/S0140-6736(12)61674-2	http://dx.doi.org/10.1016/S0140-6736(12)61674-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	23051716	Bronze			2022-12-28	WOS:000309931400013
J	Fu, RR; Weiss, BP; Shuster, DL; Gattacceca, J; Grove, TL; Suavet, C; Lima, EA; Li, LY; Kuan, AT				Fu, Roger R.; Weiss, Benjamin P.; Shuster, David L.; Gattacceca, Jerome; Grove, Timothy L.; Suavet, Clement; Lima, Eduardo A.; Li, Luyao; Kuan, Aaron T.			An Ancient Core Dynamo in Asteroid Vesta	SCIENCE			English	Article							PARENT BODY; MAGNETIC-PROPERTIES; METEORITES; EUCRITES; ORIGIN; FIELDS; DIFFERENTIATION; PLANETESIMALS; DIOGENITES; ACCRETION	The asteroid Vesta is the smallest known planetary body that has experienced large-scale igneous differentiation. However, it has been previously uncertain whether Vesta and similarly sized planetesimals formed advecting metallic cores and dynamo magnetic fields. Here we show that remanent magnetization in the eucrite meteorite Allan Hills A81001 formed during cooling on Vesta 3.69 billion years ago in a surface magnetic field of at least 2 microteslas. This field most likely originated from crustal remanence produced by an earlier dynamo, suggesting that Vesta formed an advecting liquid metallic core. Furthermore, the inferred present-day crustal fields can account for the lack of solar wind ion-generated space weathering effects on Vesta.	[Fu, Roger R.; Weiss, Benjamin P.; Grove, Timothy L.; Suavet, Clement; Lima, Eduardo A.; Li, Luyao] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Shuster, David L.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Shuster, David L.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Gattacceca, Jerome] Univ Aix Marseille 3, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13628 Aix En Provence, France; [Kuan, Aaron T.] Harvard Univ, Dept Appl Phys, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Berkeley Geochronolgy Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University	Fu, RR (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rogerfu@mit.edu	Gattacceca, Jerome/AAG-5651-2019; Grove, Timothy/M-9638-2013; Shuster, David/A-4838-2011	Gattacceca, Jerome/0000-0002-1639-7140; Grove, Timothy/0000-0003-0628-1969; Lima, Eduardo/0000-0002-5667-0033; Suavet, Clement/0000-0001-9970-0864; /0000-0003-3635-2676	Ann and Gordon Getty Foundation; NASA Origins Program; NSF Graduate Research Fellowship program; NASA Lunar Science Institute	Ann and Gordon Getty Foundation; NASA Origins Program(National Aeronautics & Space Administration (NASA)); NSF Graduate Research Fellowship program(National Science Foundation (NSF)); NASA Lunar Science Institute	We thank the Johnson Space Center staff and the Meteorite Working Group for allocating ALHA81001, A. Bevan at the Western Australia Museum for allocating Millbillillie, P. Rochette for helpful discussions, N. Chatterjee for help with the microprobe analyses, S. Chu for help with the MPMS-XL analyses, and B. Carbone for administrative help. D. L. S. thanks W. S. Cassata for helpful discussions and the Ann and Gordon Getty Foundation for support. B. P. W. thanks the NASA Origins Program and Thomas F. Peterson for support. R. R. F. thanks the NSF Graduate Research Fellowship program for support. B. P. W. and C. S. thank the NASA Lunar Science Institute for support. Paleomagnetic and thermochronology data are found in the supplementary materials.	Asphaug E, 1997, METEORIT PLANET SCI, V32, P965, DOI 10.1111/j.1945-5100.1997.tb01584.x; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; BISCHOFF A, 1992, EUR J MINERAL, V4, P707; Carporzen L, 2011, P NATL ACAD SCI USA, V108, P6386, DOI 10.1073/pnas.1017165108; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; CISOWSKI SM, 1991, EARTH PLANET SC LETT, V107, P173, DOI 10.1016/0012-821X(91)90053-K; COLLINSON DW, 1994, EARTH PLANET SC LETT, V126, P421, DOI 10.1016/0012-821X(94)90122-8; Crawford DA, 1999, INT J IMPACT ENG, V23, P169, DOI 10.1016/S0734-743X(99)00070-6; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Dunlop DJ, 2000, EARTH PLANET SC LETT, V176, P107, DOI 10.1016/S0012-821X(99)00309-X; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V305, P1, DOI 10.1016/j.epsl.2011.03.010; Fechtig H., 1966, POTASSIUM ARGON DATI, P68, DOI DOI 10.1007/978-3-642-87895-4_4; Garrick-Bethell I, 2010, EARTH PLANET SC LETT, V294, P1, DOI 10.1016/j.epsl.2010.02.013; Gattacceca J, 2004, EARTH PLANET SC LETT, V227, P377, DOI 10.1016/j.epsl.2004.09.013; Greenwood RC, 2006, SCIENCE, V313, P1763, DOI 10.1126/science.1128865; GROVE TL, 1982, AM MINERAL, V67, P251; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hood L. L., 1984, P LUN PLAN SCI C 15, pC211; Hood LL, 2001, J GEOPHYS RES-PLANET, V106, P14601, DOI 10.1029/2000JE001304; Hood LL, 2008, ICARUS, V193, P485, DOI 10.1016/j.icarus.2007.08.023; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Kletetschka G, 2006, PHYS EARTH PLANET IN, V154, P290, DOI 10.1016/j.pepi.2005.07.005; Miyamoto M., 1994, 57 M MET SOC PRAG; Nagata T., 1980, MEM NATL I POLAR RES, V17, P233; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Rochette P, 2009, METEORIT PLANET SCI, V44, P405, DOI 10.1111/j.1945-5100.2009.tb00741.x; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Scott ERD, 2009, GEOCHIM COSMOCHIM AC, V73, P5835, DOI 10.1016/j.gca.2009.06.024; STEPHENSON A, 1974, EARTH PLANET SC LETT, V23, P220, DOI 10.1016/0012-821X(74)90196-4; Sterenborg M. G., 2012, 43 LUN PLAN SCI C HO; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; Turner NJ, 2008, ASTROPHYS J LETT, V679, pL131, DOI 10.1086/589540; Vernazza P, 2006, ASTRON ASTROPHYS, V451, pL43, DOI 10.1051/0004-6361:20065176; WALKER D, 1978, P LUN PLAN SCI C 9, P1369; Weiss BP, 2008, SCIENCE, V322, P713, DOI 10.1126/science.1162459; Weiss BP, 2010, SPACE SCI REV, V152, P341, DOI 10.1007/s11214-009-9580-z; Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773	40	66	67	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					238	241		10.1126/science.1225648	http://dx.doi.org/10.1126/science.1225648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066077				2022-12-28	WOS:000309712300041
J	Milstein, A; Shortell, S				Milstein, Arnold; Shortell, Stephen			Innovations in Care Delivery to Slow Growth of US Health Spending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL		[Milstein, Arnold] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Shortell, Stephen] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Milstein, A (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, 366 Galvez St,334, Stanford, CA 94305 USA.	amilstein@stanford.edu						[Anonymous], IMPR PAT FLOW THROUG; [Anonymous], HLTH AFFAIRS; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Orszag P, FOREIGN AFFAIRS; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Zuvekas SH, 2007, HEALTH AFFAIR, V26, P249, DOI 10.1377/hlthaff.26.1.249	10	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1439	1440		10.1001/jama.2012.12659	http://dx.doi.org/10.1001/jama.2012.12659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	017GY	23047357				2022-12-28	WOS:000309579300021
J	Tren, R; Nchabi, R; Attaran, A				Tren, Richard; Nchabi, Richard; Attaran, Amir			The UN is premature in trying to ban DDT for malaria control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Tren, Richard] Africa Fighting Malaria, Washington, DC USA	University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						African Leaders Malaria Alliance, 2010, 2010 REP ALMA HEADS; Attaran A, 2000, BRIT MED J, V321, P1403, DOI 10.1136/bmj.321.7273.1403; Mckay B, 2006, WALL STREET J; Office of Senator Tom Coburn US Senate, 2012, OV ACT MULT BIL MAL; PATH Malaria Vaccine Initiative, 2011, STAY COURS MAL RES D; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Southern African Development Community Secretariat, NOT SADC COUNTR RESP; Stockholm Convention on Persistent Organic Pollutants, 2010, 2 M INT STEER COMM; Stockholm Convention on Persistent Organic Pollutants, 2010, 3 EXP GROUP M DDT; Stockholm Convention on Persistent Organic Pollutants, PRINC ORG; Stockholm Convention on Persistent Organic Pollutants, 2009, CONV TEXT; Stockholm Convention on Persistent Organic Pollutants, 2011, 1 ASS GLOB ALL ALT D; Stockholm Convention on Persistent Organic Pollutants, 2007, FUT PLANS WORK DDT E; WHO, 2010, WORLD MALARIA REPORT 2010, P1; [WHO World Health Organization (WHO)], 2011, US DDT MAL VECT CONT; WHO, 2011, DDT IND RES SPRAY HU	18	1	1	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6801	10.1136/bmj.e6801	http://dx.doi.org/10.1136/bmj.e6801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054354				2022-12-28	WOS:000309907400009
J	Pirie, K; Peto, R; Reeves, GK; Green, J; Beral, V				Pirie, Kirstin; Peto, Richard; Reeves, Gillian K.; Green, Jane; Beral, Valerie		Million Women Study Collaborators	The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK	LANCET			English	Article							MORTALITY; SMOKERS	Background Women born around 1940 in countries such as the UK and USA were the first generation in which many smoked substantial numbers of cigarettes throughout adult life. Hence, only in the 21st century can we observe directly the full effects of prolonged smoking, and of prolonged cessation, on mortality among women in the UK. Methods For this prospective study, 1.3 million UK women were recruited in 1996-2001 and resurveyed postally about 3 and 8 years later. All were followed to Jan 1, 2011, through national mortality records (mean 12 woman-years, SD 2). Participants were asked at entry whether they were current or ex-smokers, and how many cigarettes they currently smoked. Those who were ex-smokers at both entry and the 3-year resurvey and had stopped before the age of 55 years were categorised by the age they had stopped smoking. We used Cox regression models to obtain adjusted relative risks that compared categories of smokers or ex-smokers with otherwise similar never-smokers. Findings After excluding 0.1 million women with previous disease, 1.2 million women remained, with median birth year 1943 (IQR 1938-46) and age 55 years (IQR 52-60). Overall, 6% (66 489/1 180 652) died, at mean age 65 years (SD 6). At baseline, 20% (232 461) were current smokers, 28% (328 417) were ex-smokers, and 52% (619 774) were never-smokers. For 12-year mortality, those smoking at baseline had a mortality rate ratio of 2.76 (95% CI 2.71-2.81) compared with never-smokers, even though 44% (37 240/85 256) of the baseline smokers who responded to the 8-year resurvey had by then stopped smoking. Mortality was tripled, largely irrespective of age, in those still smoking at the 3-year resurvey (rate ratio 2.97, 2.88-3.07). Even for women smoking fewer than ten cigarettes per day at baseline, 12-year mortality was doubled (rate ratio 1.98, 1.91-2.04). Of the 30 most common causes of death, 23 were increased signifi cantly in smokers; for lung cancer, the rate ratio was 21.4 (19.7-23.2). The excess mortality among smokers (in comparison with neversmokers) was mainly from diseases that, like lung cancer, can be caused by smoking. Among ex-smokers who had stopped permanently at ages 25-34 years or at ages 35-44 years, the respective relative risks were 1.05 (95% CI 1.00-1.11) and 1.20 (1.14-1.26) for all-cause mortality and 1.84 (1.45-2.34) and 3.34 (2.76-4.03) for lung cancer mortality. Thus, although some excess mortality remains among these long-term ex-smokers, it is only 3% and 10% of the excess mortality among continuing smokers. If combined with 2010 UK national death rates, tripled mortality rates among smokers indicate 53% of smokers and 22% of never-smokers dying before age 80 years, and an 11-year lifespan difference. Interpretation Among UK women, two-thirds of all deaths of smokers in their 50s, 60s, and 70s are caused by smoking; smokers lose at least 10 years of lifespan. Although the hazards of smoking until age 40 years and then stopping are substantial, the hazards of continuing are ten times greater. Stopping before age 40 years (and preferably well before age 40 years) avoids more than 90% of the excess mortality caused by continuing smoking; stopping before age 30 years avoids more than 97% of it.	[Pirie, Kirstin; Reeves, Gillian K.; Green, Jane; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England	University of Oxford; University of Oxford; University of Oxford	Pirie, K (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	kirstin.pirie@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245; Pirie, Kirstin/0000-0002-0561-4904	Cancer Research UK; Medical Research Council; British Heart Foundation; Medical Research Council [MC_U137686857, G9900923, G0700474] Funding Source: researchfish; MRC [MC_U137686857, G9900923, G0700474] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This report is dedicated to Richard Doll, who would have turned 100 on Oct 28, 2012. He died on July 24, 2005, but discussed preliminary results from this study with some authors a few days beforehand. Our short illustrated account of his life and science is available online.<SUP>24,25</SUP> The study was supported by Cancer Research UK, the British Heart Foundation, and the Medical Research Council. We thank Adrian Goodill (Cancer Epidemiology Unit, Oxford University) for help in preparing the figures. The chief acknowledgment is to the women who took part, the project staff, the screening centres, and the remarkable services routinely provided to UK medical research by the availability of automatic notification of all deaths and incident cancers (and, more recently, episodes of NHS treatment).	DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; International Agency for Research on Cancer, 2007, IARC HDB CANC PREV T, V11; International Agency for Research on Cancer, 2012, INT AG RES CANC IA E; International Agency for Research on Cancer, 2004, MON EV CARC RISKS HU, V83; Jarvis MJ, 2001, THORAX, V56, P960, DOI 10.1136/thorax.56.12.960; Jha P, N ENGL J ME IN PRESS; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Office for National Statistics, GEN LIF SURV TECHN A; Peto R, 2005, OXFORD TODAY OXFORD; Peto R, 2010, BIOGR MEMS FELL R SO, V56, P63; Peto R, 2010, NEW ENGL J MED, V362, P855, DOI 10.1056/NEJMc1000079; Sakata R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7093; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; The NHS information centre for health and social care, 2011, STAT SMOK ENGL; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Thun MJ, N ENGL J ME IN PRESS; Townsend PP., 1988, HLTH DEPRIVATION INE; Wald N, 1991, UK SMOKING STAT; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	24	486	495	2	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					133	141		10.1016/S0140-6736(12)61720-6	http://dx.doi.org/10.1016/S0140-6736(12)61720-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23107252	Green Published			2022-12-28	WOS:000313420900029
J	Cook, DE; Lee, TG; Guo, XL; Melito, S; Wang, K; Bayless, AM; Wang, JP; Hughes, TJ; Willis, DK; Clemente, TE; Diers, BW; Jiang, JM; Hudson, ME; Bent, AF				Cook, David E.; Lee, Tong Geon; Guo, Xiaoli; Melito, Sara; Wang, Kai; Bayless, Adam M.; Wang, Jianping; Hughes, Teresa J.; Willis, David K.; Clemente, Thomas E.; Diers, Brian W.; Jiang, Jiming; Hudson, Matthew E.; Bent, Andrew F.			Copy Number Variation of Multiple Genes at Rhg1 Mediates Nematode Resistance in Soybean	SCIENCE			English	Article							PLANT-PATHOGEN; EXPRESSION; CLUSTERS; ROOTS	The rhg1-b allele of soybean is widely used for resistance against soybean cyst nematode (SCN), the most economically damaging pathogen of soybeans in the United States. Gene silencing showed that genes in a 31-kilobase segment at rhg1-b, encoding an amino acid transporter, an a-SNAP protein, and a WI12 (wound-inducible domain) protein, each contribute to resistance. There is one copy of the 31-kilobase segment per haploid genome in susceptible varieties, but 10 tandem copies are present in an rhg1-b haplotype. Overexpression of the individual genes in roots was ineffective, but overexpression of the genes together conferred enhanced SCN resistance. Hence, SCN resistance mediated by the soybean quantitative trait locus Rhg1 is conferred by copy number variation that increases the expression of a set of dissimilar genes in a repeated multigene segment.	[Cook, David E.; Guo, Xiaoli; Melito, Sara; Bayless, Adam M.; Hughes, Teresa J.; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lee, Tong Geon; Wang, Jianping; Diers, Brian W.; Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wang, Kai; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, USDA ARS, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Clemente, Thomas E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Hudson, Matthew E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln; University of Illinois System; University of Illinois Urbana-Champaign	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016; Jiang, Jiming/V-6060-2019; Lee, Tong Geon/H-1812-2014; Cook, David E./AAM-9348-2021; Jiang, Jiming/A-9614-2009; Hudson, Matthew E/A-4438-2008; Wang, Kai/A-2143-2011	Bent, Andrew/0000-0001-6610-9525; Jiang, Jiming/0000-0002-6435-6140; Lee, Tong Geon/0000-0003-1672-4356; Cook, David E./0000-0002-2719-4701; Jiang, Jiming/0000-0002-6435-6140; Hudson, Matthew E/0000-0002-4737-0936; Wang, Kai/0000-0002-1074-0438; Guo, Xiaoli/0000-0002-5407-6911; Melito, Sara/0000-0002-4910-2353	United Soybean Board; USDA CSREES; Illinois Soybean Association; NSF [DBI-0922703]; Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation	United Soybean Board; USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Illinois Soybean Association; NSF(National Science Foundation (NSF)); Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by the United Soybean Board (A.F.B.), USDA CSREES (M.E.H.), Illinois Soybean Association (M.E.H. and B.W.D.), NSF grant DBI-0922703 (J.J.), Wisconsin Experiment Station Hatch Award (A.F.B.), and the Pioneer Fellowship in Plant Pathology awarded to D.E.C. by the American Phytopathological Society through a gift from Pioneer Hi-Bred. We thank A. E. MacGuidwin for suggestions regarding SCN experiments and J. M. Palmer for assistance with RNA blots. DNA sequence data are available at NCBI GenBank under accession codes JX907804 to JX907808 and at the NCBI Short Read Archive, study no. SRA059285. A.F.B., M.E.H., B.W.D., D.E.C., T.G.L., X.G., S.M., T.J.H., and J.W. are listed as inventors on a provisional patent application filed by Wisconsin Alumni Research Foundation that covers the findings reported herein.	Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Frey NFD, 2009, CURR OPIN PLANT BIOL, V12, P437, DOI 10.1016/j.pbi.2009.06.002; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim M, 2011, CROP SCI, V51, P934, DOI 10.2135/cropsci2010.08.0459; Kim M, 2010, PLANT GENOME-US, V3, P81, DOI 10.3835/plantgenome2010.02.0001; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Narayanan RA, 1999, CROP SCI, V39, P1680, DOI 10.2135/cropsci1999.3961680x; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Okumoto S, 2011, MOL PLANT, V4, P453, DOI 10.1093/mp/ssr003; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schmutz J, 2010, NATURE, V465, P120, DOI 10.1038/nature08957; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wingen LU, 2012, P NATL ACAD SCI USA, V109, P7115, DOI 10.1073/pnas.1111670109; Yen ShyiKae, 1999, Plant Physiology, V119, P1147, DOI 10.1104/pp.119.3.1147; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	31	391	442	9	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1206	1209		10.1126/science.1228746	http://dx.doi.org/10.1126/science.1228746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23065905				2022-12-28	WOS:000311666200045
J	Cuk, M; Stewart, ST				Cuk, Matija; Stewart, Sarah T.			Making the Moon from a Fast-Spinning Earth: A Giant Impact Followed by Resonant Despinning	SCIENCE			English	Article							TERRESTRIAL PLANETS; LUNAR ORIGIN; DISK; ACCRETION; EVOLUTION; DIFFERENTIATION; COLLISIONS; SYSTEM; PROTOPLANETS; HYPOTHESIS	A common origin for the Moon and Earth is required by their identical isotopic composition. However, simulations of the current giant impact hypothesis for Moon formation find that most lunar material originated from the impactor, which should have had a different isotopic signature. Previous Moon-formation studies assumed that the angular momentum after the impact was similar to that of the present day; however, Earth-mass planets are expected to have higher spin rates at the end of accretion. Here, we show that typical last giant impacts onto a fast-spinning proto-Earth can produce a Moon-forming disk derived primarily from Earth's mantle. Furthermore, we find that a faster-spinning early Earth-Moon system can lose angular momentum and reach the present state through an orbital resonance between the Sun and Moon.	[Cuk, Matija; Stewart, Sarah T.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Cuk, M (corresponding author), SETI Inst, Carl Sagan Ctr, 189 N Bernardo Ave, Mountain View, CA 94043 USA.	cuk@eps.harvard.edu		Stewart, Sarah/0000-0001-9606-1593; Cuk, Matija/0000-0003-1226-7960	NASA's Origins of Solar Systems program	NASA's Origins of Solar Systems program(National Aeronautics & Space Administration (NASA))	This work, which was supported by NASA's Origins of Solar Systems program and Harvard's Daly and Smithosonian's Clay Fellowships, was improved by helpful discussions with S. Jacobsen, J. Melosh, D. Minton, S. Mukhopadhyay, D. Stevenson, J. Wisdom, and comments from the anonymous reviewers. The impact simulations were run on the Odyssey cluster supported by the Harvard Faculty of Arts and Sciences Research Computing Group. S. T. S. conducted the impact simulations, M. C. calculated the tidal evolution, and both wrote the paper. Numerical codes are available as supplementary materials.	Cameron A. G. W., 1976, P LUNAR PLANET SCI C, V7, P120; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Darwin GH., 1879, PHILOS T ROY SOC LON, V170, P447, DOI [10.1098/rstl.1879.0073, DOI 10.1098/RSTL.1879.0073]; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Kaula W. M., 1976, P LUNAR PLANET SCI C, V7, P440; Kokubo E, 2000, ICARUS, V148, P419, DOI 10.1006/icar.2000.6496; Kokubo E, 2007, ASTROPHYS J, V671, P2082, DOI 10.1086/522364; Kraus RG, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004082; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Machida R, 2004, ASTROPHYS J, V617, P633, DOI 10.1086/425209; Marcus RA, 2009, ASTROPHYS J LETT, V700, pL118, DOI 10.1088/0004-637X/700/2/L118; Meier MMM, 2012, NAT GEOSCI, V5, P240, DOI 10.1038/ngeo1434; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Pahlevan K, 2011, EARTH PLANET SC LETT, V301, P433, DOI 10.1016/j.epsl.2010.10.036; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; RINGWOOD AE, 1989, EARTH PLANET SC LETT, V95, P208, DOI 10.1016/0012-821X(89)90097-6; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Stewart ST, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/32; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; TOUMA J, 1994, ASTRON J, V108, P1943, DOI 10.1086/117209; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Ward WR, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/140; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; Weber RC, 2011, SCIENCE, V331, P309, DOI 10.1126/science.1199375; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Yu G, 2011, P NATL ACAD SCI USA, V108, P17604, DOI 10.1073/pnas.1108544108; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	39	363	370	7	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1047	1052		10.1126/science.1225542	http://dx.doi.org/10.1126/science.1225542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23076099				2022-12-28	WOS:000311390600035
J	Shin, HN; Iwasaki, A				Shin, Haina; Iwasaki, Akiko			A vaccine strategy that protects against genital herpes by establishing local memory T cells	NATURE			English	Article							REPLICATION-DEFECTIVE MUTANT; SIMPLEX-VIRUS TYPE-2; IMMUNE-RESPONSES; DENDRITIC CELLS; VIRAL-INFECTION; RESIDENT MEMORY; RM CELLS; MIGRATION; MUCOSAL; HSV-2	Most successful existing vaccines rely on neutralizing antibodies, which may not require specific anatomical localization of B cells. However, efficacious vaccines that rely on T cells for protection have been difficult to develop, as robust systemic memory T-cell responses do not necessarily correlate with host protection(1). In peripheral sites, tissue-resident memory T cells provide superior protection compared to circulating memory T cells(2,3). Here we describe a simple and non-inflammatory vaccine strategy that enables the establishment of a protective memory T-cell pool within peripheral tissue. The female genital tract, which is a portal of entry for sexually transmitted infections, is an immunologically restrictive tissue that prevents entry of activated T cells in the absence of inflammation or infection(4). To overcome this obstacle, we developed a vaccine strategy that we term 'prime and pull' to establish local tissue-resident memory T cells at a site of potential viral exposure. This approach relies on two steps: conventional parenteral vaccination to elicit systemic T-cell responses (prime), followed by recruitment of activated T cells by means of topical chemokine application to the restrictive genital tract (pull), where such T cells establish a long-term niche and mediate protective immunity. In mice, prime and pull protocol reduces the spread of infectious herpes simplex virus 2 into the sensory neurons and prevents development of clinical disease. These results reveal a promising vaccination strategy against herpes simplex virus 2, and potentially against other sexually transmitted infections such as human immunodeficiency virus.	[Shin, Haina; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Shin, Haina/0000-0002-1014-1451	NIAID [F32AI091024]; NIH [AI054359, AI062428]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI091024, R56AI062428, R01AI062428, R01AI054359] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Foxman and R. Medzhitov for critical reading of the manuscript, and N. Iijima, H. Dong and B. Yordy for technical support. H. S. is supported by NIAID grant F32AI091024. This work is supported by NIH grants AI054359 and AI062428 to A.I.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gill N, 2008, AM J REPROD IMMUNOL, V59, P35, DOI 10.1111/j.1600-0897.2007.00558.x; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Parr MB, 2003, J NEUROVIROL, V9, P594, DOI 10.1080/714044481; PARR MB, 1994, LAB INVEST, V70, P369; Perkins N, 2011, SEX TRANSM INFECT, V87, P292, DOI 10.1136/sti.2010.047431; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soderberg KA, 2004, J IMMUNOL, V173, P1908, DOI 10.4049/jimmunol.173.3.1908; SPANG AE, 1983, J VIROL, V45, P332, DOI 10.1128/JVI.45.1.332-342.1983; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	30	414	427	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					463	+		10.1038/nature11522	http://dx.doi.org/10.1038/nature11522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23075848	Green Accepted			2022-12-28	WOS:000311031600050
J	Marcia, M; Pyle, AM				Marcia, Marco; Pyle, Anna Marie			Visualizing Group II Intron Catalysis through the Stages of Splicing	CELL			English	Article							SMALL NUCLEAR-RNA; METAL-ION COORDINATION; STRUCTURE VALIDATION; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; 2ND STEP; IN-VIVO; SPLICEOSOME; NUCLEOTIDES	Group II introns are self-splicing ribozymes that share a reaction mechanism and a common ancestor with the eukaryotic spliceosome, thereby providing a model system for understanding the chemistry of pre-mRNA splicing. Here we report 14 crystal structures of a group II intron at different stages of catalysis. We provide a detailed mechanism for the first step of splicing, we describe a reversible conformational change between the first and the second steps of splicing, and we present the ligand-free intron structure after splicing in an active state that corresponds to the retrotransposable form of the intron. During each reaction, the reactants are aligned and activated by a heteronuclear four-metal-ion center that contains a metal cluster and obligate monovalent cations, and they adopt a structural arrangement similar to that of protein endonucleases. Based on our data, we propose a model for the splicing cycle and show that it is applicable to the eukaryotic spliceosome.	[Marcia, Marco; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	anna.pyle@yale.edu	Marcia, Marco/M-2887-2014	Marcia, Marco/0000-0003-2430-0713	National Institute of Health [RO1GM50313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline scientists at 24-ID-C and E, NE-CAT, APS, Argonne (IL), USA for their thorough support during data collection. We acknowledge all members of the Pyle lab, and in particular Dr. Olga Fedorova for synthesizing the oligonucleotide fragment, Dr. Maximilian Bailor for cloning the OiD1-5 construct, Gabriele Drews for cloning the Oi5eD1-5 construct, Dr. Kevin Keating for the analysis of the backbone kink at the 50 splice junction (Table S2), Dr. Srinivas Somarowthu for calculating the model of intron domain 6 in the silent conformation (Figure S4), Dr. Laura Murray for sharing preliminary unpublished results, Dr. Dahai Luo and Dr. Patrick Lombardi for valuable discussion, and Dr. Isabel Chillon Gazquez for constructive criticism and help preparing the figures. Additionally, we acknowledge Dr. John Abelson, Dr. John Stahley, Dr. Magda Konarska, Dr. Patrick Cramer, Dr. Giovanni Capranico, Dr. Ulrich Ermler, and Tanja Hedderich for insightful discussion. This project was supported by the National Institute of Health (RO1GM50313). Prof. Pyle is a Howard Hughes Medical Institute Investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BOULANGER SC, 1995, MOL CELL BIOL, V15, P4479; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; CHANFREAU G, 1993, EMBO J, V12, P5173, DOI 10.1002/j.1460-2075.1993.tb06212.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn GL, 2002, J MOL BIOL, V318, P963, DOI 10.1016/S0022-2836(02)00147-X; Cotton AF, 1980, ADV ORGANIC CHEM COM, P58; Dai LX, 2002, RNA, V8, P1294, DOI 10.1017/S1355838202023014; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; De Lencastre A, 2008, RNA, V14, P11, DOI 10.1261/rna.774008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erat MC, 2008, J BIOL INORG CHEM, V13, P1025, DOI 10.1007/s00775-008-0390-7; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; HARDY SF, 1984, NATURE, V308, P375, DOI 10.1038/308375a0; Ho Faix P., 1998, THESIS U PITTSBURGH; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Lambert D, 2009, J MOL BIOL, V390, P791, DOI 10.1016/j.jmb.2009.04.083; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; Messerschmidt A., 2001, HDB METALLOPROTEINS; Mikheeva S, 2000, RNA, V6, P1509, DOI 10.1017/S1355838200000972; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PADGETT RA, 1994, SCIENCE, V266, P1685, DOI 10.1126/science.7527587; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Podar M, 1998, RNA, V4, P890, DOI 10.1017/S1355838298971643; PODAR M, 1995, MOL CELL BIOL, V15, P4466; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Schmidt U, 1996, RNA, V2, P1161; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2010, RNA, V16, P57, DOI 10.1261/rna.1844010; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617	57	123	123	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					497	507		10.1016/j.cell.2012.09.033	http://dx.doi.org/10.1016/j.cell.2012.09.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101623	Bronze, Green Accepted			2022-12-28	WOS:000310529300008
J	Joosten, MM; Pai, JK; Bertoia, ML; Rimm, EB; Spiegelman, D; Mittleman, MA; Mukamal, KJ				Joosten, Michel M.; Pai, Jennifer K.; Bertoia, Monica L.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.; Mukamal, Kenneth J.			Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANKLE-BRACHIAL INDEX; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; INTERMITTENT CLAUDICATION; NUTRITION EXAMINATION; ALCOHOL-CONSUMPTION; FUNCTIONAL DECLINE; SMOKING-CESSATION; PHYSICAL-ACTIVITY; NATIONAL-HEALTH	Context Previous studies have examined the associations of individual clinical risk factors with risk of peripheral artery disease (PAD), but the combined effects of these risk factors are largely unknown. Objective To estimate the degree to which the 4 conventional cardiovascular risk factors of smoking, hypertension, hypercholesterolemia, and type 2 diabetes are associated with the risk of PAD among men. Design, Setting, and Participants Prospective study of 44 985 men in the United States without a history of cardiovascular disease at baseline in 1986; participants in the Health Professionals Follow-up Study were followed up for 25 years until January 2011. The presence of risk factors was updated biennially during follow-up. Main Outcome Measure Clinically significant PAD defined as limb amputation or revascularization, angiogram reporting vascular obstruction of 50% or greater, ankle-brachial index of less than 0.90, or physician-diagnosed PAD. Results During a median follow-up of 24.2 years (interquartile range, 20.8-24.7 years), there were 537 cases of incident PAD. Each risk factor was significantly and independently associated with a higher risk of PAD after adjustment for the other 3 risk factors and confounders. The age-adjusted incidence rates were 9 (95% CI, 6-14) cases/100 000 person-years (n=19 incident cases) for 0 risk factors, 23 (95% CI, 18-28) cases/100 000 person-years (n=99 incident cases) for 1 risk factor, 47 (95% CI, 39-56) cases/100 000 person-years (n=176 incident cases) for 2 risk factors, 92(95% CI, 76-111) cases/100 000 person-years (n=180 incident cases) for 3 risk factors, and 186(95% CI, 141-246) cases/100 000 person-years (n=63 incident cases) for 4 risk factors. The multivariable-adjusted hazard ratio for each additional risk factor was 2.06 (95% CI, 1.88-2.26). Men without any of the 4 risk factors had a hazard ratio of PAD of 0.23 (95% CI, 0.14-0.36) compared with all other men in the cohort. In 96% of PAD cases (95% CI, 94%-98%), at least 1 of the 4 risk factors was present at the time of PAD diagnosis. The population-attributable risk associated with these 4 risk factors was 75% (95% CI, 64%-87%). The absolute incidence of PAD among men with all 4 risk factors was 3.5/1000 person-years. Conclusion Among men in this cohort, smoking, hypertension, hypercholesterolemia, and type 2 diabetes account for the majority of risk associated with development of clinically significant PAD. JAMA. 2012;308(16):1660-1667 www.jama.com	[Joosten, Michel M.; Bertoia, Monica L.; Mukamal, Kenneth J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Cardiovasc Epidemiol Res Unit, Sch Med,Dept Med, Boston, MA 02215 USA; [Joosten, Michel M.; Bertoia, Monica L.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joosten, Michel M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Joosten, Michel M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna] Harvard Univ, Channing Div Network Med, Brigham & Womens Hosp, Sch Med,Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Top Institute Food & Nutrition; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Joosten, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,Bldg 2, Boston, MA 02115 USA.	hpmmj@channing.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274; Joosten, Michel Marinus/0000-0002-0039-6629	National Institutes of Health [R01 HL091874, HL35464, CA55075]; National Heart, Lung, and Blood Institute; Environmental Protection Agency; Health Effects Institute; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091874, R01HL035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Environmental Protection Agency(United States Environmental Protection Agency); Health Effects Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mittleman reported institutional grant support from the National Heart, Lung, and Blood Institute; and receiving or having institutional grants pending from the National Institutes of Health, the Environmental Protection Agency, and Health Effects Institute. Dr Mukamal reported institutional grant support from the National Heart, Lung, and Blood Institute and the National Institutes of Health; and institutional support in the form of active and placebo capsules provided from the Martek Corporation to Harvard Medical School for a trial of docosahexaenoic acid for periodontitis. No other author reported disclosures.; This work was supported by National Institutes of Health grants R01 HL091874, HL35464, and CA55075.	Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Al-Delaimy WK, 2004, AM J MED, V116, P236, DOI 10.1016/j.amjmed.2003.09.038; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Bonow RO, 2011, BRAUNWALDS HEART DIS, P1338; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Dhaliwal G, 2007, INT J ANGIOL, V16, P36, DOI 10.1055/s-0031-1278244; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gentil A, 2009, J NEUROL NEUROSUR PS, V80, P1006, DOI 10.1136/jnnp.2009.172551; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hussein AA, 2011, J AM COLL CARDIOL, V57, P1220, DOI 10.1016/j.jacc.2010.10.034; JONASON T, 1987, ACTA MED SCAND, V221, P253; Joosten MM, 2011, DIABETES, V60, P74, DOI 10.2337/db10-1052; KANNEL WB, 1985, J AM GERIATR SOC, V33, P13, DOI 10.1111/j.1532-5415.1985.tb02853.x; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kennedy M, 2005, ARCH INTERN MED, V165, P1896, DOI 10.1001/archinte.165.16.1896; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mehler PS, 2003, CIRCULATION, V107, P753, DOI 10.1161/01.CIR.0000049640.46039.52; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Therneau TM, 2000, MODELING SURVIVAL DA; West AM, 2011, J AM COLL CARDIOL, V58, P1068, DOI 10.1016/j.jacc.2011.04.034	46	177	187	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1660	1667		10.1001/jama.2012.13415	http://dx.doi.org/10.1001/jama.2012.13415			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093164	Green Accepted			2022-12-28	WOS:000310434100020
J	Yunos, NM; Bellomo, R; Hegarty, C; Story, D; Ho, L; Bailey, M				Yunos, Nor'azim Mohd; Bellomo, Rinaldo; Hegarty, Colin; Story, David; Ho, Lisa; Bailey, Michael			Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL CONSENSUS CONFERENCE; RENAL-REPLACEMENT THERAPY; HYPERONCOTIC COLLOIDS; SALINE RESUSCITATION; 0.9-PERCENT SALINE; CODE RATES; BLOOD-FLOW; ACID-BASE; MORTALITY; ALBUMIN	Context Administration of traditional chloride-liberal intravenous fluids may precipitate acute kidney injury (AKI). Objective To assess the association of a chloride-restrictive (vs chloride-liberal) intravenous fluid strategy with AKI in critically ill patients. Design, Setting, and Patients Prospective, open-label, sequential period pilot study of 760 patients admitted consecutively to the intensive care unit (ICU) during the control period (February 18 to August 17, 2008) compared with 773 patients admitted consecutively during the intervention period (February 18 to August 17, 2009) at a university-affiliated hospital in Melbourne, Australia. Interventions During the control period, patients received standard intravenous fluids. After a 6-month phase-out period (August 18, 2008, to February 17, 2009), any use of chloride-rich intravenous fluids (0.9% saline, 4% succinylated gelatin solution, or 4% albumin solution) was restricted to attending specialist approval only during the intervention period; patients instead received a lactated solution (Hartmann solution), a balanced solution (Plasma-Lyte 148), and chloride-poor 20% albumin. Main Outcome Measures The primary outcomes included increase from baseline to peak creatinine level in the ICU and incidence of AKI according to the risk, injury, failure, loss, end-stage (RIFLE) classification. Secondary post hoc analysis outcomes included the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival. Results Chloride administration decreased by 144 504 mmol (from 694 to 496 mmol/patient) from the control period to the intervention period. Comparing the control period with the intervention period, the mean serum creatinine level increase while in the ICU was 22.6 mu mol/L (95% CI, 17.5-27.7 mu mol/L) vs 14.8 mu mol/L (95% CI, 9.8-19.9 mu mol/L) (P=.03), the incidence of injury and failure class of RIFLE-defined AKI was 14%(95% CI, 11%-16%; n=105) vs 8.4% (95% CI, 6.4%-10%; n=65) (P<.001), and the use of RRT was 10% (95% CI, 8.1%-12%; n=78) vs 6.3% (95% CI, 4.6%-8.1%; n=49) (P=.005). After adjustment for covariates, this association remained for incidence of injury and failure class of RIFLE-defined AKI (odds ratio, 0.52 [95% CI, 0.37-0.75]; P<.001) and use of RRT (odds ratio, 0.52 [95% CI, 0.33-0.81]; P=.004). There were no differences in hospital mortality, hospital or ICU length of stay, or need for RRT after hospital discharge. Conclusion The implementation of a chloride-restrictive strategy in a tertiary ICU was associated with a significant decrease in the incidence of AKI and use of RRT.	[Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia; [Hegarty, Colin] Austin Hosp, Dept Lab Med, Melbourne, Vic 3084, Australia; [Story, David] Austin Hosp, Dept Anaesthesia, Melbourne, Vic 3084, Australia; [Ho, Lisa] Austin Hosp, Dept Pharm, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo; Bailey, Michael] Monash Univ, Dept Epidemiol & Prevent Med, Australia & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Bellomo, R (corresponding author), Austin Hlth, Heidelberg, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au	Bailey, Michael J/A-4499-2012; Yunos, Nor'azim Mohd/U-3994-2017	Bailey, Michael J/0000-0002-5551-1401; Yunos, Nor'azim Mohd/0000-0002-5890-4825; Story, David/0000-0002-6479-1310; Bellomo, Rinaldo/0000-0002-1650-8939	Baxter Healthcare	Baxter Healthcare	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Story reported receiving an unconditional research grant from Baxter Healthcare to fund other fluid studies. No other authors reported disclosures.	Bagshaw SM, 2007, CRIT CARE, V11, DOI 10.1186/cc5949; Bagshaw SM, 2011, CRIT CARE RESUSC, V13, P201; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; BULLIVANT EMA, 1989, AM J PHYSIOL, V256, pF152, DOI 10.1152/ajprenal.1989.256.1.F152; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; HALL JE, 1976, AM J PHYSIOL, V231, P1550, DOI 10.1152/ajplegacy.1976.231.5.1550; Hashimoto S, 2004, KIDNEY BLOOD PRESS R, V27, P35, DOI 10.1159/000075621; Jacob M, 2008, CRIT CARE, V12, DOI 10.1186/cc6812; McIntyre LA, 2007, CRIT CARE, V11, DOI 10.1186/cc5962; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; QUILLEY CP, 1993, BRIT J PHARMACOL, V108, P106, DOI 10.1111/j.1476-5381.1993.tb13447.x; RENAL Study Investigators, 2008, Crit Care Resusc, V10, P225; SALOMONSSON M, 1993, ACTA PHYSIOL SCAND, V147, P305, DOI 10.1111/j.1748-1716.1993.tb09503.x; Saw MM, 2012, ANAESTH INTENS CARE, V40, P17, DOI 10.1177/0310057X1204000104; SCHNERMANN J, 1976, PFLUG ARCH EUR J PHY, V362, P229, DOI 10.1007/BF00581175; Schortgen F, 2008, INTENS CARE MED, V34, P2157, DOI 10.1007/s00134-008-1225-2; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Smith RJ, 2010, CRIT CARE RESUSC, V12, P235; Srisawat N, 2010, CRIT CARE, V14, DOI 10.1186/cc8933; STOCKWELL MA, 1992, ANAESTHESIA, V47, P7, DOI 10.1111/j.1365-2044.1992.tb01942.x; WAKIM KG, 1970, J AMER MED ASSOC, V214, P1710, DOI 10.1001/jama.1970.03180090074027; Wan L, 2011, CRIT CARE RESUSC, V13, P262; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; Yunos NM, 2011, CRIT CARE MED, V39, P2419, DOI 10.1097/CCM.0b013e31822571e5; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052; Zavada J, 2010, NEPHROL DIAL TRANSPL, V25, P3911, DOI 10.1093/ndt/gfp766	39	746	785	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1566	1572		10.1001/jama.2012.13356	http://dx.doi.org/10.1001/jama.2012.13356			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073953	Bronze			2022-12-28	WOS:000309858100023
J	Brito, JP; Montori, VM				Brito, Juan P.; Montori, Victor M.			Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-PRESSURE CONTROL		[Brito, Juan P.; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Brito, JP (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-7	10.7326/0003-4819-157-8-201210160-02007	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070509				2022-12-28	WOS:000309906000006
J	Dinneen, SF; O'Donnell, M				Dinneen, Sean F.; O'Donnell, Maire			Review: Quality improvement strategies reduce HbA(1c), LDL cholesterol, and BP in diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dinneen, Sean F.; O'Donnell, Maire] NUI Galway, Galway, Ireland		Dinneen, SF (corresponding author), NUI Galway, Galway, Ireland.							Colagiuri R, 2009, DIABETIC MED, V26, P442, DOI 10.1111/j.1464-5491.2009.02700.x	1	2	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-11	10.7326/0003-4819-157-8-201210160-02011	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070513				2022-12-28	WOS:000309906000010
J	Jin, J; Sison, K; Li, CJ; Tian, RJ; Wnuk, M; Sung, HK; Jeansson, M; Zhang, CJ; Tucholska, M; Jones, N; Kerjaschki, D; Shibuya, M; Fantus, IG; Nagy, A; Gerber, HP; Ferrara, N; Pawson, T; Quaggin, SE				Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Jones, Nina; Kerjaschki, Dontscho; Shibuya, Masabumi; Fantus, I. George; Nagy, Andras; Gerber, Hans-Peter; Ferrara, Napoleone; Pawson, Tony; Quaggin, Susan E.			Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function	CELL			English	Article							GROWTH-FACTOR RECEPTOR-1; TYROSINE KINASE; NEPHRIN PHOSPHORYLATION; MASS-SPECTROMETRY; HEPARIN-BINDING; VEGF RECEPTOR; RAFTS; LOCALIZATION; ANGIOGENESIS; GANGLIOSIDES	Vascular endothelial growth factor and its receptors, FLK1/KDR and FLT1, are key regulators of angiogenesis. Unlike FLK1/KDR, the role of FLT1 has remained elusive. FLT1 is produced as soluble (sFLT1) and full-length isoforms. Here, we show that pericytes from multiple tissues produce sFLT1. To define the biologic role of sFLT1, we chose the glomerular microvasculature as a model system. Deletion of Flt1 from specialized glomerular pericytes, known as podocytes, causes reorganization of their cytoskeleton with massive proteinuria and kidney failure, characteristic features of nephrotic syndrome in humans. The kinase-deficient allele of Flt1 rescues this phenotype, demonstrating dispensability of the full-length isoform. Using cell imaging, proteomics, and lipidomics, we show that sFLT1 binds to the glycosphingolipid GM3 in lipid rafts on the surface of podocytes, promoting adhesion and rapid actin reorganization. sFLT1 also regulates pericyte function in vessels outside of the kidney. Our findings demonstrate an autocrine function for sFLT1 to control pericyte behavior.	[Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Nagy, Andras; Pawson, Tony; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Shibuya, Masabumi] Jobu Univ, Inst Physiol & Med, Takasaki, Gunma 3701393, Japan; [Fantus, I. George] Toronto Gen Res Hosp, Toronto, ON M5G 1L7, Canada; [Fantus, I. George] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fantus, I. George] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5S 1A8, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON M5S 1A8, Canada; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5S 1A8, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gerber, Hans-Peter] Pfizer Worldwide Res & Dev, BioConjugate Vasc Biol, Oncol Res Unit E, Pearl River, NY 10965 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Quaggin, Susan E.] St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Guelph; Medical University of Vienna; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Pfizer; Roche Holding; Genentech; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Quaggin, SE (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@lunenfeld.ca	Sung, Hoon-Ki/G-3049-2013; Nagy, Andras/G-6465-2013; Tian, Ruijun/B-5629-2009; Pawson, Tony J/E-4578-2013; Sung, Hoon-Ki/A-1922-2016; Tian, Ruijun/J-3019-2014	Nagy, Andras/0000-0003-4311-0413; Tian, Ruijun/0000-0001-9521-5124; Sung, Hoon-Ki/0000-0001-6677-9385; Jeansson, Marie/0000-0003-1075-8563	CIHR [MOP62931]; TF grant [016002]; Gabor-Zellerman Chair [CIHR-MOP57793, HFSP-RGP0039/2009-C]; CCRI [2010-700465]; CIHR Postdoctoral Fellowship; KRES-CENT Award; Swiss NSF Postdoctoral Grant;  [CIHR- MOP-49409]	CIHR(Canadian Institutes of Health Research (CIHR)); TF grant; Gabor-Zellerman Chair; CCRI; CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); KRES-CENT Award; Swiss NSF Postdoctoral Grant; 	We thank Doug Holmyard and Ken Harpal for EM and histology; Sarang Kulkarni, Steffen Lawo, and Laurence Pelletier for microscopy and imaging; Gerry Gish for peptide synthesis and lipid assays; Rick Bagshaw for mass spec advice and providing Lys-N enzyme; Moin Saleem for human podocyte cells; Jim Dennis, Andras Kapus, Johan van der Vlag, Roy Zent, Jin Gyoon Park, and Sergio Grinstein for helpful discussions; and Vivian Nguyen, Bret Larsen, and Lorne Taylor for technical assistance. This work was funded by CIHR grant MOP62931, TF grant 016002 to S. E. Q., who holds the Gabor-Zellerman Chair, CIHR-MOP57793 and HFSP-RGP0039/2009-C grants to T. P., CIHR- MOP-49409 to I. G. F., and TF grant 016002, CCRI grant 2010-700465 to A.N. J.J. received a CIHR Postdoctoral Fellowship, N.J. received a KRES-CENT Award, and M.W. a Swiss NSF Postdoctoral Grant.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Balreira A, 2008, HUM MOL GENET, V17, P2238, DOI 10.1093/hmg/ddn124; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kwak DH, 2003, LIFE SCI, V72, P1997, DOI 10.1016/S0024-3205(03)00090-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maezawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040547; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rhainds D, 2004, J CELL SCI, V117, P3095, DOI 10.1242/jcs.01182; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zobiack N, 2002, J CELL SCI, V115, P91	40	108	110	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					384	399		10.1016/j.cell.2012.08.037	http://dx.doi.org/10.1016/j.cell.2012.08.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063127	Bronze			2022-12-28	WOS:000309981000016
J	Xhemalce, B; Robson, SC; Kouzarides, T				Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony			Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing	CELL			English	Article							TARGETS; EXPRESSION; COMPLEX	MicroRNAs (miRNAs) regulate key biological processes and their aberrant expression may lead to cancer. The primary transcript of canonical miRNAs is sequentially cleaved by the RNase III enzymes, Drosha and Dicer, which generate 5' monophosphate ends that are important for subsequent miRNA functions. In particular, the recognition of the 5' monophosphate of pre-miRNAs by Dicer is important for precise and effective biogenesis of miRNAs. Here, we identify a RNA-methyltransferase, BCDIN3D, that O-methylates this 5' monophosphate and negatively regulates miRNA maturation. Specifically, we show that BCDIN3D phospho-dimethylates pre-miR-145 both in vitro and in vivo and that phospho-dimethylated pre-miR-145 displays reduced processing by Dicer in vitro. Consistently, BCDIN3D depletion leads to lower pre-miR-145 and concomitantly increased mature miR-145 levels in breast cancer cells, which suppresses their tumorigenic phenotypes. Together, our results uncover a miRNA methylation pathway potentially involved in cancer that antagonizes the Dicer-dependent processing of miR-145 as well as other miRNAs.	[Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Xhemalce, Blerta] Univ Texas Austin, Coll Nat Sci, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Cambridge; University of Texas System; University of Texas Austin	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Xhemalce, Blerta/0000-0002-0517-9607	ICMB at the University of Texas at Austin; Cancer Research UK; CRUK; European Union	ICMB at the University of Texas at Austin; Cancer Research UK(Cancer Research UK); CRUK(Cancer Research UK); European Union(European Commission)	We thank Dr. Till Bartke for the recombinant nucleosomes and the parental Hela-S3-FlpIn cell line, Dr. Kyle M. Miller for help with the xCELLigence system, the DNA core facility at the Institute of Cellular and Molecular Biology (ICMB) at the University of Texas at Austin for use of equipment, and Dr. Andrew J. Bannister for helpful discussions. B. X. was funded by a start-up grant from ICMB at the University of Texas at Austin and a Cancer Research UK project grant. The T. K. laboratory was funded by grants from CRUK and the 6th Research Framework Program of the European Union (Epitron, SMARTER and HEROIC). Tony Kouzarides is a director of Abcam.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gunther T, 2006, MAGNESIUM RES, V19, P225; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawamata T, 2011, EMBO REP, V12, P944, DOI 10.1038/embor.2011.128; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Xhemalce B., 2011, HISTONE MODIFICATION; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	29	107	111	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					278	288		10.1016/j.cell.2012.08.041	http://dx.doi.org/10.1016/j.cell.2012.08.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063121	Green Accepted, Bronze			2022-12-28	WOS:000309981000008
J	Cohen, DA; Babey, SH				Cohen, Deborah A.; Babey, Susan H.			Candy at the Cash Register - A Risk Factor for Obesity and Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, Deborah A.] RAND Hlth, Santa Clara, CA USA; [Babey, Susan H.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles	Cohen, DA (corresponding author), RAND Hlth, Santa Clara, CA USA.			Babey, Susan/0000-0001-8113-1739				CURHAN RC, 1974, J MARKETING RES, V11, P286, DOI 10.2307/3151144; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Sorenson H, 2009, INSIDE MIND SHOPPER; Thomas M, 2011, J CONSUM RES, V38, P126, DOI 10.1086/657331; Wedel M, 2008, VISUAL MARKETING ATT	5	37	36	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1381	1383		10.1056/NEJMp1209443	http://dx.doi.org/10.1056/NEJMp1209443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050524				2022-12-28	WOS:000309652700003
J	Mather, J; Mao, M				Mather, John; Mao, Minnie			ASTRONOMY A conversation about observation	NATURE			English	Editorial Material									[Mao, Minnie] Natl Radio Astron Observ, Socorro, NM 87801 USA	National Radio Astronomy Observatory (NRAO)	Mather, J (corresponding author), NASA, Washington, DC 20546 USA.								0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S5	S7		10.1038/490S5a	http://dx.doi.org/10.1038/490S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051770	Bronze			2022-12-28	WOS:000309733300003
J	Grynbaum, MM				Grynbaum, Michael M.			Will soda restrictions help New York win the war on obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									New York Times Co, New York, NY 10036 USA	New York Times	Grynbaum, MM (corresponding author), New York Times Co, New York, NY 10036 USA.	grynbaum@nytimes.com						City of New York, 2012, REV EP NEW YORK CIT; de Ruyter JC, 2012, N ENGL J MED; Ebbeling CB, 2012, N ENGL J MED; KATAN M, NEW ENG J MEDI; Nestle M, FIGHTING FOOD GIANTS; Rabin Roni Caryn, 2012, NY TIMES; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	7	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6768	10.1136/bmj.e6768	http://dx.doi.org/10.1136/bmj.e6768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054050				2022-12-28	WOS:000309907400019
J	Ellegren, H; Smeds, L; Burri, R; Olason, PI; Backstrom, N; Kawakami, T; Kunstner, A; Makinen, H; Nadachowska-Brzyska, K; Qvarnstrom, A; Uebbing, S; Wolf, JBW				Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Qvarnstrom, Anna; Uebbing, Severin; Wolf, Jochen B. W.			The genomic landscape of species divergence in Ficedula flycatchers	NATURE			English	Article							WILD BIRD POPULATION; FEMALE MEIOTIC DRIVE; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; HYBRID STERILITY; EVOLUTION; CONSEQUENCES; HITCHHIKING; CHICKEN	Unravelling the genomic landscape of divergence between lineages is key to understanding speciation(1). The naturally hybridizing collared flycatcher and pied flycatcher are important avian speciation models(2-7) that show pre- as well as postzygotic isolation(8,9). We sequenced and assembled the 1.1-Gb flycatcher genome, physically mapped the assembly to chromosomes using a low-density linkage map(10) and re-sequenced population samples of each species. Here we show that the genomic landscape of species differentiation is highly heterogeneous with approximately 50 'divergence islands' showing up to 50-fold higher sequence divergence than the genomic background. These non-randomly distributed islands, with between one and three regions of elevated divergence per chromosome irrespective of chromosome size, are characterized by reduced levels of nucleotide diversity, skewed allele-frequency spectra, elevated levels of linkage disequilibrium and reduced proportions of shared polymorphisms in both species, indicative of parallel episodes of selection. Proximity of divergence peaks to genomic regions resistant to sequence assembly, potentially including centromeres and telomeres, indicate that complex repeat structures may drive species divergence. A much higher background level of species divergence of the Z chromosome, and a lower proportion of shared polymorphisms, indicate that sex chromosomes and autosomes are at different stages of speciation. This study provides a roadmap to the emerging field of speciation genomics.	[Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Uebbing, Severin; Wolf, Jochen B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Qvarnstrom, Anna] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75263 Uppsala, Sweden	Uppsala University; Uppsala University	Ellegren, H (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	Hans.Ellegren@ebc.uu.se	Kawakami, Takeshi/B-9060-2009; Nadachowska-Brzyska, Krystyna/ABB-7632-2020; Uebbing, Severin/K-5046-2012; Wolf, Jochen/U-2243-2017	Kawakami, Takeshi/0000-0002-9204-6852; Nadachowska-Brzyska, Krystyna/0000-0002-8457-310X; Uebbing, Severin/0000-0003-2439-6946; Wolf, Jochen/0000-0002-2958-5183; Smeds, Linnea/0000-0002-8415-9259; Qvarnstrom, Anna/0000-0002-1178-4053; Kunstner, Axel/0000-0003-0692-2105	European Research Council; Knut and Alice Wallenberg Scholar Grant; Swedish Research Council; Swiss National Science Foundation [PBLAB3-134299, PBLAB1-140171]; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing (SNIC)	European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Scholar Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing (SNIC)	Financial support was obtained from a European Research Council Advanced Investigator Grant (NEXTGENMOLECOL), a Knut and Alice Wallenberg Scholar Grant, and from the Swedish Research Council to H.E. R.B. was funded by the Swiss National Science Foundation (grants PBLAB3-134299 and PBLAB1-140171). We are grateful to M. Lascoux, M. Noor and T. Slotte for helpful discussion and comments. We thank the Uppsala University SNP and SEQ Technology Platform for help with DNA sequencing, and the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX), and the associated Next generation sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing (SNIC), for computer resources.	[Anonymous], 1861, ORIGIN SPECIES MEANS; Axelsson E, 2010, HEREDITY, V105, P290, DOI 10.1038/hdy.2009.193; Backstrom N, 2008, GENETICS, V179, P1479, DOI 10.1534/genetics.108.088195; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Coyne J.A., 2004, SPECIATION; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Delany ME, 2007, CYTOGENET GENOME RES, V117, P54, DOI 10.1159/000103165; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; SHIELDS GF, 1982, CONDOR, V84, P45, DOI 10.2307/1367820; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Wiley C, 2009, EVOLUTION, V63, P1731, DOI 10.1111/j.1558-5646.2009.00674.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	30	428	436	8	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					756	760		10.1038/nature11584	http://dx.doi.org/10.1038/nature11584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103876	hybrid			2022-12-28	WOS:000311606000045
J	Farrell, L				Farrell, Liam			Breaking good news	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7355	10.1136/bmj.e7355	http://dx.doi.org/10.1136/bmj.e7355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114076				2022-12-28	WOS:000310778900019
J	Ah-See, KL; MacKenzie, J; Ah-See, KW				Ah-See, Kim Lawrence; MacKenzie, Jane; Ah-See, Kim Wong			Management of chronic rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENDOSCOPIC SINUS SURGERY; NASAL POLYPOSIS; PARANASAL SINUSES; PREVALENCE; DIAGNOSIS; EPIDEMIOLOGY; BIOFILMS; DELIVERY; ALLERGY		[Ah-See, Kim Lawrence] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [MacKenzie, Jane] Skene Med Practice, Aberdeen, Scotland; [Ah-See, Kim Wong] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland	University of Edinburgh; University of Aberdeen	Ah-See, KL (corresponding author), Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland.	kim.ah-see@nhs.net						Aggarwal R, 2004, CLIN OTOLARYNGOL, V29, P201, DOI 10.1111/j.1365-2273.2004.00797.x; Ah-See KW, 2007, BMJ-BRIT MED J, V334, P358, DOI 10.1136/bmj.39092.679722.BE; Ahmed J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008515.pub2; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Benninger MS, 2008, ENT-EAR NOSE THROAT, V87, P463, DOI 10.1177/014556130808700812; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P147, DOI 10.1016/j.otohns.2010.04.012; Cannady SB, 2005, OTOLARYNG HEAD NECK, V133, P735, DOI 10.1016/j.otohns.2005.07.039; Chan Y, 2009, CURR OPIN OTOLARYNGO, V17, P204, DOI 10.1097/MOO.0b013e32832ac393; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Clifton NJ, 2007, J LARYNGOL OTOL, V121, P345, DOI 10.1017/S0022215106002647; Ede MPN, 2006, BRIT J GEN PRACT, V56, P141; Fahy C, 2001, CLIN OTOLARYNGOL, V26, P510, DOI 10.1046/j.1365-2273.2001.00514.x; Fokkens WJ, 2012, RHINOLOGY, V50, P225; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Goetzel RZ, 2003, J OCCUP ENVIRON MED, V45, P5, DOI 10.1097/00043764-200301000-00007; Grobler A, 2008, LARYNGOSCOPE, V118, P2078, DOI 10.1097/MLG.0b013e31818208c1; Hadfield PJ, 2000, CLIN OTOLARYNGOL, V25, P19, DOI 10.1046/j.1365-2273.2000.00241.x; Harvey R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006394; Harvey RJ, 2008, OTOLARYNG HEAD NECK, V139, P137, DOI 10.1016/j.otohns.2008.04.020; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Kaliner M, 1998, ALLERGY ASTHMA PROC, V19, P181, DOI 10.2500/108854198778557818; KENNEDY DW, 1985, ARCH OTOLARYNGOL, V111, P643, DOI 10.1001/archotol.1985.00800120037003; Khalil HS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004458.pub2; Kim JE, 2007, ENT-EAR NOSE THROAT, V86, P396, DOI 10.1177/014556130708600715; KLEMI P J, 1980, Rhinology (Utrecht), V18, P19; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Krause HF, 2003, OTOLARYNG HEAD NECK, V128, P14, DOI 10.1067/mhn.2003.3; Lim M, 2007, RHINOLOGY, V45, P144; LLOYD GAS, 1990, J LARYNGOL OTOL, V104, P477, DOI 10.1017/S0022215100112927; Meltzer EO, 2011, MAYO CLIN PROC, V86, P427, DOI 10.4065/mcp.2010.0392; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mullol J, 1997, CLIN EXP ALLERGY, V27, P1432, DOI 10.1111/j.1365-2222.1997.tb02988.x; MYGIND N, 1978, ACTA OTO-LARYNGOL, V85, P437; Newton Jonathan Ray, 2008, Ther Clin Risk Manag, V4, P507; Pawankar R, 2003, CURR OPIN ALLERGY CL, V3, P1, DOI 10.1097/01.all.0000053260.61007.d6; Pleis John R, 2006, Vital Health Stat 10, P1; Poetker DM, 2007, AM J RHINOL, V21, P84, DOI 10.2500/ajr.2007.21.2978; Ragab S, 2001, CLIN EXP ALLERGY, V31, P1385, DOI 10.1046/j.1365-2222.2001.01160.x; Royal College of Radiologists, 2003, MAK BEST US DEP CLIN, V5th; Sasama Jan, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P2, DOI 10.1097/00020840-200502000-00003; Settipane GA, 1996, ALLERGY ASTHMA PROC, V17, P231, DOI 10.2500/108854196778662246; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Suh JD, 2010, CURR OPIN OTOLARYNGO, V18, P27, DOI 10.1097/MOO.0b013e328334f670; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Wallwork B, 2006, LARYNGOSCOPE, V116, P189, DOI 10.1097/01.mlg.0000191560.53555.08; Wormald PJ, 2004, LARYNGOSCOPE, V114, P2224, DOI 10.1097/01.mlg.0000149463.95950.c5	47	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2012	345								e7054	10.1136/bmj.e7054	http://dx.doi.org/10.1136/bmj.e7054			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033EY	23111434				2022-12-28	WOS:000310778200003
J	John, RM; Tedrow, UB; Koplan, BA; Albert, CM; Epstein, LM; Sweeney, MO; Miller, AL; Michaud, GF; Stevenson, WG				John, Roy M.; Tedrow, Usha B.; Koplan, Bruce A.; Albert, Christine M.; Epstein, Laurence M.; Sweeney, Michael O.; Miller, Amy Leigh; Michaud, Gregory F.; Stevenson, William G.			Ventricular arrhythmias and sudden cardiac death	LANCET			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ASSOCIATION TASK-FORCE; GUIDELINES WRITING COMMITTEE; CATHETER ABLATION; MYOCARDIAL-INFARCTION; HYPERTROPHIC CARDIOMYOPATHY; AMERICAN-COLLEGE; HEART-DISEASE; RESYNCHRONIZATION THERAPY; PROPHYLACTIC IMPLANTATION	Management strategies for ventricular arrhythmias are guided by the risk of sudden death and severity of symptoms. Patients with a substantial risk of sudden death usually need an implantable cardioverter defibrillator (ICD). Although ICDs effectively end most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in specific populations of patients, they have inherent risks and limitations. Generally, antiarrhythmic drugs do not provide sufficient protection from sudden death, but do have a role in reducing arrhythmias that cause symptoms. Catheter ablation is likewise important for reducing the frequency of spontaneous arrhythmias and is curative for some patients, usually those with idiopathic arrhythmias and no heart disease. Arrhythmia surgery is now infrequent, offered by only a few specialised centres for refractory arrhythmias. Advances in understanding of genetic arrhythmia syndromes and in technology for mapping and ablation of ventricular arrhythmias, and enhanced algorithms in implantable devices for rhythm management, have contributed to improved outcomes.	[John, Roy M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiol,Cardiac Arrhythmia Serv, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	John, RM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiol,Cardiac Arrhythmia Serv, SH 5, Boston, MA 02115 USA.	rjohn2@partners.org	Tedrow, Usha/AFV-2528-2022; Epstein, Laurence/ABB-1592-2020; Koplan, Bruce/AAK-8363-2021; Epstein, Laurence/AAQ-7571-2021	Epstein, Laurence/0000-0001-5410-0291; Albert, Christine/0000-0002-2081-1121				Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098; Anter E, 2011, CIRC-ARRHYTHMIA ELEC, V4, P494, DOI 10.1161/CIRCEP.111.962555; Arya A, 2010, PACE, V33, P1504, DOI 10.1111/j.1540-8159.2010.02835.x; Bai R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P478, DOI 10.1161/CIRCEP.111.963066; Baman TS, 2010, HEART RHYTHM, V7, P865, DOI 10.1016/j.hrthm.2010.03.036; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barsheshet Alon, 2011, Curr Cardiol Rep, V13, P364, DOI 10.1007/s11886-011-0209-y; Benito B, 2010, J AM COLL CARDIOL, V56, P1177, DOI 10.1016/j.jacc.2010.05.037; Bhavani SS, 2007, J CARDIAC SURG, V22, P533, DOI 10.1111/j.1540-8191.2007.00468.x; Bogun FM, 2009, J AM COLL CARDIOL, V53, P1138, DOI 10.1016/j.jacc.2008.11.052; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Cerrone M, 2011, EUR HEART J, V32, P2109, DOI 10.1093/eurheartj/ehr082; Cesario DA, 2011, J CARDIOVASC ELECTR, V22, P359, DOI 10.1111/j.1540-8167.2010.01911.x; Christiaans I, 2011, EUR HEART J, V32, P1161, DOI 10.1093/eurheartj/ehr092; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; Crawford T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P624, DOI 10.1161/CIRCEP.110.945295; Della Bella P, 2011, CIRC-ARRHYTHMIA ELEC, V4, P653, DOI 10.1161/CIRCEP.111.962217; Derval N, 2011, J AM COLL CARDIOL, V58, P722, DOI 10.1016/j.jacc.2011.04.022; Dewland TA, 2011, J AM COLL CARDIOL, V58, P1007, DOI 10.1016/j.jacc.2011.04.039; Dorian P, 2010, CIRCULATION, V122, P2645, DOI 10.1161/CIRCULATIONAHA.109.924225; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; Eckart RE, 2008, ANN INTERN MED, V149, P451, DOI 10.7326/0003-4819-149-7-200810070-00005; Eckart RE, 2007, CIRCULATION, V116, P2005, DOI 10.1161/CIRCULATIONAHA.107.703157; Ellenbogen KA, 2006, CIRCULATION, V113, P776, DOI 10.1161/CIRCULATIONAHA.105.561571; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Goldenberg I, 2012, HEART RHYTHM, V9, P49, DOI 10.1016/j.hrthm.2011.08.020; Haines DE, 2011, CIRCULATION, V123, P2069, DOI 10.1161/CIRCULATIONAHA.110.959676; Hsieh CHC, 2010, CIRC-ARRHYTHMIA ELEC, V3, P178, DOI 10.1161/CIRCEP.109.906628; Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260; Junttila MJ, 2012, ANN MED, V44, P717, DOI 10.3109/07853890.2011.594807; Knecht S, 2009, J AM COLL CARDIOL, V54, P522, DOI 10.1016/j.jacc.2009.03.065; Knight BP, 1999, NEW ENGL J MED, V341, P1270, DOI 10.1056/NEJM199910213411704; Koneru JN, 2011, CIRC-ARRHYTHMIA ELEC, V4, P778, DOI 10.1161/CIRCEP.110.961243; Kosmidou I, 2011, HEART RHYTHM, V8, P1516, DOI 10.1016/j.hrthm.2011.06.021; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Kumar S, 2011, HEART RHYTHM, V8, P493, DOI 10.1016/j.hrthm.2010.11.046; Kumar S, 2010, HEART RHYTHM, V7, P1589, DOI 10.1016/j.hrthm.2010.07.019; Leonardi RA, 2010, CIRC-CARDIOVASC INTE, V3, P97, DOI 10.1161/CIRCINTERVENTIONS.109.916676; Mallidi J, 2011, HEART RHYTHM, V8, P503, DOI 10.1016/j.hrthm.2010.12.015; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Mehta RH, 2009, JAMA-J AM MED ASSOC, V301, P1779, DOI 10.1001/jama.2009.600; Michowitz Y, 2010, HEART RHYTHM, V7, P1635, DOI 10.1016/j.hrthm.2010.07.009; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Morshedi-Meibodi A, 2004, CIRCULATION, V109, P2417, DOI 10.1161/01.CIR.0000129762.41889.41; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Olshansky B, 2008, J AM COLL CARDIOL, V51, P1277, DOI 10.1016/j.jacc.2007.11.065; Packer DL, 2009, CIRCULATION, V120, P2170, DOI 10.1161/CIRCULATIONAHA.109.853689; Perez-David E, 2011, J AM COLL CARDIOL, V57, P184, DOI 10.1016/j.jacc.2010.07.043; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Pouleur AC, 2010, CIRCULATION, V122, P597, DOI 10.1161/CIRCULATIONAHA.110.940619; Roberts-Thomson KC, 2009, CIRCULATION, V120, P1465, DOI 10.1161/CIRCULATIONAHA.109.870790; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633; Schmidt B, 2010, HEART RHYTHM, V7, P1746, DOI 10.1016/j.hrthm.2010.08.010; Sesselberg HW, 2007, HEART RHYTHM, V4, P1395, DOI 10.1016/j.hrthm.2007.07.013; Shimizu W, 2009, HEART RHYTHM, V6, P1507, DOI 10.1016/j.hrthm.2009.06.017; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Sweeney MO, 2010, CIRCULATION, V122, P2638, DOI 10.1161/CIRCULATIONAHA.110.000208; Teodorescu C, 2010, CIRCULATION, V122, P2116, DOI 10.1161/CIRCULATIONAHA.110.966333; Theuns DAMJ, 2010, EUROPACE, V12, P1564, DOI 10.1093/europace/euq329; Tokuda M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P889, DOI 10.1161/CIRCEP.111.966283; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Varma N, 2012, CIRC-ARRHYTHMIA ELEC, V3, P428; Vereckei A, 2008, HEART RHYTHM, V5, P89, DOI 10.1016/j.hrthm.2007.09.020; Vincent GM, 2009, CIRCULATION, V119, P215, DOI 10.1161/CIRCULATIONAHA.108.772533; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070; Wijnmaalen AP, 2012, HEART RHYTHM, V9, P10, DOI 10.1016/j.hrthm.2011.07.037; Wilde AAM, 2008, NEW ENGL J MED, V358, P2024, DOI 10.1056/NEJMoa0708006; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Yamada T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P616, DOI 10.1161/CIRCEP.110.939744; Zeppenfeld K, 2007, CIRCULATION, V116, P2241, DOI 10.1161/CIRCULATIONAHA.107.723551; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	85	146	154	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1520	1529		10.1016/S0140-6736(12)61413-5	http://dx.doi.org/10.1016/S0140-6736(12)61413-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101719				2022-12-28	WOS:000310272000032
J	Sansom, M				Sansom, Mark			Louise Johnson (1940-2012) OBITUARY	NATURE			English	Biographical-Item									Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Sansom, M (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	mark.sansom@bioch.ox.ac.uk	Sansom, Mark S.P./C-5157-2009	Sansom, Mark S.P./0000-0001-6360-7959				JOHNSON LC, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					488	488		10.1038/490488a	http://dx.doi.org/10.1038/490488a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099399	Bronze			2022-12-28	WOS:000310196200027
J	Shcheka, SS; Keppler, H				Shcheka, Svyatoslav S.; Keppler, Hans			The origin of the terrestrial noble-gas signature	NATURE			English	Article							MAGNESIUM-SILICATE PEROVSKITE; ALUMINUM SUBSTITUTION; XENON; WATER; ATMOSPHERES; EVOLUTION; MGSIO3; ARGON; LASER; EARTH	In the atmospheres of Earth and Mars, xenon is strongly depleted relative to argon, when compared to the abundances in chondritic meteorites(1,2). The origin of this depletion is poorly understood(3-13). Here we show that more than one weight per cent of argon may be dissolved in MgSiO3 perovskite, the most abundant phase of Earth's lower mantle, whereas the xenon solubility in MgSiO3 perovskite is orders of magnitude lower. We therefore suggest that crystallization of perovskite from a magma ocean in the very early stages of Earth's history concentrated argon in the lower mantle. After most of the primordial atmosphere had been lost, degassing of the lower mantle replenished argon and krypton, but not xenon, in the atmosphere. Our model implies that the depletion of xenon relative to argon indicates that perovskite crystallized from a magma ocean in the early history of Earth and perhaps also Mars.	[Shcheka, Svyatoslav S.; Keppler, Hans] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	Shcheka, SS (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	svyatoslav.shcheka@uni-bayreuth.de		Shcheka, Svyatoslav/0000-0003-0865-0828	German Science Foundation (DFG) [SPP 1236]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG, SPP 1236). We thank A. Audetat for measurements of Kr and Xe by laser-ablation ICP-MS, N. Miyajima for help with TEM studies of the samples and T. Boffa-Ballaran for preliminary X-ray data of Ar-bearing perovskite.	ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; BOETTCHER SL, 1989, AM MINERAL, V74, P1383; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Brooker RA, 2003, NATURE, V423, P738, DOI 10.1038/nature01708; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Gunther D, 1997, J ANAL ATOM SPECTROM, V12, P939, DOI 10.1039/a701423f; Heber VS, 2007, GEOCHIM COSMOCHIM AC, V71, P1041, DOI 10.1016/j.gca.2006.11.010; Jephcoat AP, 1998, NATURE, V393, P355, DOI 10.1038/30712; Kojitani H, 2007, PHYS CHEM MINER, V34, P257, DOI 10.1007/s00269-007-0144-z; Lauterbach S, 2000, CONTRIB MINERAL PETR, V138, P17, DOI 10.1007/PL00007658; Lee KKM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003781; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; MATSUDA J, 1989, GEOPHYS RES LETT, V16, P81, DOI 10.1029/GL016i001p00081; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; Navrotsky A, 1999, SCIENCE, V284, P1788, DOI 10.1126/science.284.5421.1788; Navrotsky A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002055; Nishio-Hamane D, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041953; Pepin RO, 2002, REV MINERAL GEOCHEM, V47, P191, DOI 10.2138/rmg.2002.47.7; Pepin RO, 1997, ICARUS, V126, P148, DOI 10.1006/icar.1996.5639; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; Porcelli D, 2001, EARTH PLANET SC LETT, V193, P237, DOI 10.1016/S0012-821X(01)00493-9; Pujol M, 2011, EARTH PLANET SC LETT, V308, P298, DOI 10.1016/j.epsl.2011.05.053; Sanloup C, 2005, SCIENCE, V310, P1174, DOI 10.1126/science.1119070; SILL GT, 1978, ICARUS, V33, P13, DOI 10.1016/0019-1035(78)90020-9; Stashans A, 2010, PHYSICA B, V405, P4350, DOI 10.1016/j.physb.2010.07.041; Stebbins JF, 2006, AM MINERAL, V91, P337, DOI 10.2138/am.2006.1988; WACKER JF, 1984, GEOCHIM COSMOCHIM AC, V48, P2373, DOI 10.1016/0016-7037(84)90232-1; Yang HX, 2001, AM MINERAL, V86, P1483; ZHANG YX, 1995, AM MINERAL, V80, P670	32	41	43	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					531	+		10.1038/nature11506	http://dx.doi.org/10.1038/nature11506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23051754				2022-12-28	WOS:000310196200040
J	Allotey, P; Amazigo, U; Adjei, S; Seddoh, A; Lusamba-Dikassa, PS				Allotey, Pascale; Amazigo, Uche; Adjei, Sam; Seddoh, Anthony; Lusamba-Dikassa, Paul-Samson			15 years of APOC-a lifetime of public health evidence	LANCET			English	Editorial Material							ONCHOCERCIASIS CONTROL; ELIMINATION; AFRICA; DISEASES; LOIASIS; REALITY; IMPACT; CARE		[Allotey, Pascale] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway 46150, Selangor DE, Malaysia; [Amazigo, Uche; Lusamba-Dikassa, Paul-Samson] APOC, Ouagadougou, Burkina Faso; [Adjei, Sam; Seddoh, Anthony] Ctr Hlth & Social Serv, Accra, Ghana	Monash University; Monash University Sunway	Allotey, P (corresponding author), Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Bandar Sunway 46150, Selangor DE, Malaysia.	pascale.allotey@monash.edu		Allotey, Pascale/0000-0002-6942-5774				Adjei S, 2010, REPORT EXTERNAL MIDT; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Boatin B, 1997, J HELMINTHOL, V71, P91, DOI 10.1017/S0022149X00015741; DFID, BRIT PROT MOR 140 MI; Heymann DL, NEGLECTED INFECT DIS; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Molyneux DH, 2005, TRENDS PARASITOL, V21, P525, DOI 10.1016/j.pt.2005.08.027; RIFKIN SB, 1986, SOC SCI MED, V23, P559, DOI 10.1016/0277-9536(86)90149-8; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Tekle AH, 2011, ACTA TROP, V120, pS81, DOI 10.1016/j.actatropica.2010.05.008; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Waters HR, 2004, TROP MED INT HEALTH, V9, pA16, DOI 10.1111/j.1365-3156.2004.01210.x; WHO APOC, 2011, WHO YEAR 2011 PROGR; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	15	2	2	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1361	1363		10.1016/S0140-6736(12)60723-5	http://dx.doi.org/10.1016/S0140-6736(12)60723-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084441				2022-12-28	WOS:000310196500005
J	Haroche, S				Haroche, Serge			The secrets of my prizewinning research	NATURE			English	Editorial Material									[Haroche, Serge] Coll France, F-75231 Paris, France; [Haroche, Serge] Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Haroche, S (corresponding author), Coll France, F-75231 Paris, France.	serge.haroche@lkb.ens.fr							0	3	3	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					311	311		10.1038/490311a	http://dx.doi.org/10.1038/490311a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	021XI	23075943	Bronze			2022-12-28	WOS:000309918500004
J	O'Driscoll, R				O'Driscoll, Ronan			Emergency oxygen use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ARTERIAL HYPEROXIA; MORTALITY; RESUSCITATION; ASSOCIATION; THERAPY; DISEASE	This is one of a series of occasional articles on therapeutics for common or serious conditions, covering new drugs and old drugs with important new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham and Birmingham City Hospital, and Albert Ferro, professor of cardiovascular clinical pharmacology, King's College London. To suggest a topic for this series, please email us at practice@bmj.com.	Univ Manchester, Salford Royal Univ Hosp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester	O'Driscoll, R (corresponding author), Univ Manchester, Salford Royal Univ Hosp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England.	ronan.o'driscoll@srft.nhs.uk						Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Downs John B, 2003, Respir Care, V48, P611; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hale KE, 2008, EMERG MED J, V25, P773, DOI 10.1136/emj.2008.059287; HOFFMAN CE, 1946, AM J PHYSIOL, V145, P685, DOI 10.1152/ajplegacy.1946.145.5.685; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Murphy R, 2001, EMERG MED J, V18, P333, DOI 10.1136/emj.18.5.333; National Patient Safety Agency, 2009, 2009RRR2006 NPAS NPS; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; O'Driscoll BR, 2011, THORAX, V66, P734, DOI 10.1136/thoraxjnl-2011-200078; O'Driscoll BR, 2012, CLIN MED, V12, P79, DOI 10.7861/clinmedicine.12-1-79; O'Driscoll BR, 2008, EMERGENCY OXYGEN USE; Pedersen T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002013.pub2; Perrin K, 2011, THORAX, V66, P937, DOI 10.1136/thx.2010.155259; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Smith J L, 1899, J Physiol, V24, P19; Wijesinghe M, 2012, J ROY SOC MED, V105, P208, DOI 10.1258/jrsm.2012.110084; Wijesinghe M, 2011, CHEST, V139, P1018, DOI 10.1378/chest.10-1280	21	7	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2012	345								e6856	10.1136/bmj.e6856	http://dx.doi.org/10.1136/bmj.e6856			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WU	23078806				2022-12-28	WOS:000310142300009
J	Zhu, GZ; Radtke, G; Botton, GA				Zhu, Guo-zhen; Radtke, Guillaume; Botton, Gianluigi A.			Bonding and structure of a reconstructed (001) surface of SrTiO3 from TEM	NATURE			English	Article							ELECTRON; MICROSCOPY	The determination of the atomic structure and the retrieval of information about reconstruction and bonding of metal oxide surfaces is challenging owing to the highly defective structure and insulating properties of these surfaces. Transmission electron microscopy (TEM) offers extremely high spatial resolution (less than one angstrom) and the ability to provide systematic information from both real and reciprocal space. However, very few TEM studies(1-3) have been carried out on surfaces because the information from the bulk dominates the very weak signals originating from surfaces. Here we report an experimental approach to extract surface information effectively from a thickness series of electron energy-loss spectra containing different weights of surface signals, using a wedge-shaped sample. Using the (001) surface of the technologically important compound strontium titanate, SrTiO3 (refs 4-6), as a model system for validation, our method shows that surface spectra are sensitive to the atomic reconstruction and indicate bonding and crystal-field changes surrounding the surface Ti cations. Very good agreement can be achieved between the experimental surface spectra and crystal-field multiplet calculations based on the proposed atomic surface structure optimized by density functional calculations(3). The distorted TiO6-x units indicated by the proposed model can be viewed directly in our high-resolution scanning TEM images. We suggest that this approach be used as a general method to extract valuable spectroscopic information from surface atoms in parallel with high-resolution images in TEM.	[Zhu, Guo-zhen; Botton, Gianluigi A.] McMaster Univ, Canadian Ctr Electron Microscopy, Hamilton, ON L8S 4M1, Canada; [Zhu, Guo-zhen; Botton, Gianluigi A.] McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4M1, Canada; [Radtke, Guillaume] Aix Marseille Univ, Fac Sci St Jerome, CNRS, IM2NP,UMR 7334,Case 262, F-13397 Marseille 20, France	McMaster University; McMaster University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Botton, GA (corresponding author), McMaster Univ, Canadian Ctr Electron Microscopy, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	gbotton@mcmaster.ca	Radtke, Guillaume/F-7650-2019; Zhu, Guo-zhen/D-8913-2015	Radtke, Guillaume/0000-0002-4738-7332; Zhu, Guo-zhen/0000-0002-2910-2786	NSERC; McMaster University	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University	We are grateful to NSERC for Discovery and Strategic Grants supporting this work. The microscopy was carried out at the Canadian Centre for Electron Microscopy, a National Facility supported by NSERC and McMaster University. G.-z.Z. thanks J. LeBeau for help and advice on the simulations of the PACBEDs.	Castell MR, 2002, SURF SCI, V505, P1, DOI 10.1016/S0039-6028(02)01393-6; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Cowan R.D., 1981, THEORY ATOMIC STRUCT; COWLEY JM, 1986, PROG SURF SCI, V21, P209, DOI 10.1016/0079-6816(86)90006-7; DEGROOT FMF, 1993, PHYS REV B, V48, P2074, DOI 10.1103/PhysRevB.48.2074; DOMEN K, 1986, J CATAL, V102, P92, DOI 10.1016/0021-9517(86)90143-0; Enterkin JA, 2010, NAT MATER, V9, P245, DOI [10.1038/nmat2636, 10.1038/NMAT2636]; Erdman N, 2003, J AM CHEM SOC, V125, P10050, DOI 10.1021/ja034933h; Erdman N, 2002, NATURE, V419, P55, DOI 10.1038/nature01010; Hoche T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205111; Inada H, 2011, ULTRAMICROSCOPY, V111, P865, DOI 10.1016/j.ultramic.2010.10.002; JIANG QD, 1995, SURF SCI, V338, pL882, DOI 10.1016/0039-6028(95)00643-5; Kirkland E. J., 2010, ADV COMPUTING ELECT, P289; LeBeau JM, 2010, ULTRAMICROSCOPY, V110, P118, DOI 10.1016/j.ultramic.2009.10.001; Muller DA, 2004, NATURE, V430, P657, DOI 10.1038/nature02756; PEARSON DH, 1993, PHYS REV B, V47, P8471, DOI 10.1103/PhysRevB.47.8471; Radtke G., 2011, SCANNING TRANSMISSIO, P207; Sefat AS, 2005, J SOLID STATE CHEM, V178, P1008, DOI 10.1016/j.jssc.2004.12.027; Silly F, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133909; Uldry A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.125133; UNSER M, 1987, J MICROSC-OXFORD, V145, P245	21	90	91	6	278	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					384	387		10.1038/nature11563	http://dx.doi.org/10.1038/nature11563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23051749				2022-12-28	WOS:000309918500042
J	Hashkes, PJ; Spalding, SJ; Giannini, EH; Huang, B; Johnson, A; Park, G; Barron, KS; Weisman, MH; Pashinian, N; Reiff, AO; Samuels, J; Wright, DA; Kastner, DL; Lovell, DJ				Hashkes, Philip J.; Spalding, Steven J.; Giannini, Edward H.; Huang, Bin; Johnson, Anne; Park, Grace; Barron, Karyl S.; Weisman, Michael H.; Pashinian, Noune; Reiff, Andreas O.; Samuels, Jonathan; Wright, Dowain A.; Kastner, Daniel L.; Lovell, Daniel J.			Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							DOUBLE-BLIND; ANAKINRA; THERAPY; PYRIN; MUTATIONS; EFFICACY; PROTEIN; AMYLOIDOSIS; ADOLESCENT; PATIENT	Background: Currently, there is no proven alternative therapy for patients with familial Mediterranean fever (FMF) that is resistant to or intolerant of colchicine. Interleukin-1 is a key proinflammatory cytokine in FMF. Objective: To assess the efficacy and safety of rilonacept, an interleukin-1 decoy receptor, in treating patients with colchicine-resistant or -intolerant FMF. Design: Randomized, double-blind, single-participant alternating treatment study. (ClinicalTrials.gov number: NCT00582907). Setting: 6 U. S. sites. Patients: Patients with FMF aged 4 years or older with 1 or more attacks per month. Intervention: One of 4 treatment sequences that each included two 3-month courses of rilonacept, 2.2 mg/kg (maximum, 160 mg) by weekly subcutaneous injection, and two 3-month courses of placebo. Measurements: Differences in the frequency of FMF attacks and adverse events between rilonacept and placebo. Results: 8 males and 6 females with a mean age of 24.4 years (SD, 11.8) were randomly assigned. Among 12 participants who completed 2 or more treatment courses, the rilonacept-placebo attack risk ratio was 0.59 (SD, 0.12) (equal-tail 95% credible interval, 0.39 to 0.85). The median number of attacks per month was 0.77 (0.18 and 1.20 attacks in the first and third quartiles, respectively) with rilonacept versus 2.00 (0.90 and 2.40, respectively) with placebo (median difference, -1.74 [95% CI, -3.4 to -0.1]; P = 0.027). There were more treatment courses of rilonacept without attacks (29% vs. 0%; P = 0.004) and with a decrease in attacks of greater than 50% compared with the baseline rate during screening (75% vs. 35%; P = 0.006) than with placebo. However, the duration of attacks did not differ between placebo and rilonacept (median difference, 1.2 days [-0.5 and 2.4 days in the first and third quartiles, respectively]; P = 0.32). Injection site reactions were more frequent with rilonacept (median difference, 0 events per patient treatment month [medians of -4 and 0 in the first and third quartiles, respectively]; P = 0.047), but no differences were seen in other adverse events. Limitation: Small sample size, heterogeneity of FMF mutations, age, and participant indication (colchicine resistance or intolerance) were study limitations. Conclusion: Rilonacept reduces the frequency of FMF attacks and seems to be a treatment option for patients with colchicine-resistant or -intolerant FMF.	[Hashkes, Philip J.] Shaare Zedek Med Ctr, Pediat Rheumatol Unit, IL-91031 Jerusalem, Israel; Cleveland Clin Fdn, Cleveland, OH USA; Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; NIAID, NIAMSD, Bethesda, MD 20892 USA; NHGRI, Bethesda, MD 20892 USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Childrens Hosp Cent Calif, Madera, CA USA; NYU, Langone Hosp Joint Dis, New York, NY USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Cleveland Clinic Foundation; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's Hospital Los Angeles; Cedars Sinai Medical Center; New York University	Hashkes, PJ (corresponding author), Shaare Zedek Med Ctr, Pediat Rheumatol Unit, POB 3235, IL-91031 Jerusalem, Israel.	hashkesp@szmc.org.il	Huang, Bin/U-2867-2019; Huang, Bin/G-2468-2014	Huang, Bin/0000-0001-9724-675X; samuels, jonathan/0000-0002-1513-770X	U.S. Food and Drug Administration, Office of Orphan Products Development; U.S. Food and Drug Administration, Office of Orphan Products Development [R01 FD003435]; Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Cleveland Clinic Foundation; FOOD AND DRUG ADMINISTRATION [R01FD003435] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372] Funding Source: NIH RePORTER	U.S. Food and Drug Administration, Office of Orphan Products Development; U.S. Food and Drug Administration, Office of Orphan Products Development; Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cleveland Clinic Foundation; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	U.S. Food and Drug Administration, Office of Orphan Products Development.; Grant Support: By the U.S. Food and Drug Administration, Office of Orphan Products Development (R01 FD003435). This trial was also supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Human Genome Research Institute, and the Cleveland Clinic Foundation. Rilonacept and placebo were supplied by Regeneron Pharmaceuticals. Target Health provided and partially subsidized the electronic data capture system and electronic database.	Aksentijevich I, 1997, CELL, V90, P797; Alpay N, 2010, RHEUMATOL INT; Amaryan G, 2003, PHYTOMEDICINE, V10, P271, DOI 10.1078/094471103322004767; Arcalyst (rilonacept) Injection for Subcutaneous Use, 2009, ARC RIL INJ SUBC US, V14; Belkhir R, 2007, ANN INTERN MED, V146, P825, DOI 10.7326/0003-4819-146-11-200706050-00023; Ben-Chetrit E, 2008, CLIN EXP RHEUMATOL, V26, pS49; Ben-Chetrit E, 2009, ARTHRIT CARE RES, V61, P1447, DOI 10.1002/art.24458; Bernot A, 1997, NAT GENET, V17, P25; Bilginer Y, 2010, CLIN RHEUMATOL, V29, P209, DOI 10.1007/s10067-009-1279-8; Bowyer S, 1996, J RHEUMATOL, V23, P1968; Calligaris L, 2008, EUR J PEDIATR, V167, P695, DOI 10.1007/s00431-007-0547-3; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; DINARELLO CA, 1974, NEW ENGL J MED, V291, P934, DOI 10.1056/NEJM197410312911804; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Gattringer R, 2007, EUR J CLIN INVEST, V37, P912, DOI 10.1111/j.1365-2362.2007.01868.x; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; GOLDSTEIN RC, 1974, ANN INTERN MED, V81, P792, DOI 10.7326/0003-4819-81-6-792; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Kuijk LM, 2007, ANN RHEUM DIS, V66, P1545, DOI 10.1136/ard.2007.071498; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Landgraf JM, 1996, CHQ USERS MANUAL; Lidar M, 2004, SEMIN ARTHRITIS RHEU, V33, P273, DOI 10.1053/S0049-0172(03)00137-9; Livneh A, 1996, SEMIN ARTHRITIS RHEU, V26, P612, DOI 10.1016/S0049-0172(96)80012-6; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lovell DJ, 2009, ARTHRITIS RHEUM S10, V60, pS2053; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Meinzer U, 2011, SEMIN ARTHRITIS RHEU, V41, P265, DOI 10.1016/j.semarthrit.2010.11.003; Mitroulis I, 2008, NETH J MED, V66, P489; Ozen S, 2011, J RHEUMATOL, V38, P516, DOI 10.3899/jrheum.100718; Ozgocmen S, 2011, MOD RHEUMATOL, V21, P684, DOI 10.1007/s10165-011-0463-2; Petropoulou AD, 2010, TRANSPLANTATION, V90, P102, DOI 10.1097/TP.0b013e3181d84cc3; PUTTERMAN C, 1991, SEMIN ARTHRITIS RHEU, V21, P143, DOI 10.1016/0049-0172(91)90003-I; Roldan R, 2008, JOINT BONE SPINE, V75, P504, DOI 10.1016/j.jbspin.2008.04.001; Ryan JG, 2010, ANN RHEUM DIS, V69, P1383, DOI 10.1136/ard.2009.113415; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Stojanovic KS, 2012, NEPHROL DIAL TRANSPL, V27, P1898, DOI 10.1093/ndt/gfr528; WRIGHT DG, 1977, ANN INTERN MED, V86, P162, DOI 10.7326/0003-4819-86-2-162; ZEMER D, 1974, NEW ENGL J MED, V291, P932, DOI 10.1056/NEJM197410312911803; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	46	132	136	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					533	+		10.7326/0003-4819-157-8-201210160-00003	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070486				2022-12-28	WOS:000309906000013
J	Henne, WM; Buchkovich, NJ; Zhao, YY; Emr, SD				Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.			The Endosomal Sorting Complex ESCRT-II Mediates the Assembly and Architecture of ESCRT-III Helices	CELL			English	Article							STRUCTURAL BASIS; FTSZ; AUTOINHIBITION; ENDOCYTOSIS; CARGO	The endosomal sorting complexes required for transport (ESCRTs) constitute hetero-oligomeric machines that mediate topologically similar membrane-sculpting processes, including cytokinesis, retroviral egress, and multivesicular body (MVB) biogenesis. Although ESCRT-III drives membrane remodeling that creates MVBs, its structure and the mechanism of vesicle formation are unclear. Using electron microscopy, we visualize an ESCRT-II: ESCRT-III supercomplex and propose how it mediates vesicle formation. We define conformational changes that activate ESCRT-III subunit Snf7 and show that it assembles into spiraling similar to 9 nm protofilaments on lipid monolayers. A high-content flow cytometry assay further demonstrates that mutations halting ESCRT-III assembly block ESCRT function. Strikingly, the addition of Vps24 and Vps2 transforms flat Snf7 spirals into membrane-sculpting helices. Finally, we show that ESCRT-II and ESCRT-III coassemble into similar to 65 nm diameter rings indicative of a cargo-sequestering supercomplex. We propose that ESCRT-III has distinct architectural stages that are modulated by ESCRT-II to mediate cargo capture and vesicle formation by ordered assembly.	[Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu			Sam and Nancy Fleming Research Fellowship; American Cancer Society [PF-12-062-01-DMC]	Sam and Nancy Fleming Research Fellowship; American Cancer Society(American Cancer Society)	W. M. H. is supported by a Sam and Nancy Fleming Research Fellowship. N.J.B. is supported by an American Cancer Society Postdoctoral Fellowship (PF-12-062-01-DMC). We thank Beverly Wendland for the Mup1-pHluorin integration plasmid and Roger Williams for the ESCRT-II expression construct. The authors also thank Neil Adige and Bret Judson for all technical expertise. We also thank Chris Stefan, Jason MacGurn, Jeremy Thorner, Tony Bretscher, Chris Fromme, Gerald Feigenson, David Teis, Suraj Saksena, Jeanne Quirit, and Abbie Davies for helpful discussions.	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	27	144	146	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					356	371		10.1016/j.cell.2012.08.039	http://dx.doi.org/10.1016/j.cell.2012.08.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063125	Bronze			2022-12-28	WOS:000309981000014
J	Wimmer, GE; Shohamy, D				Wimmer, G. Elliott; Shohamy, Daphna			Preference by Association: How Memory Mechanisms in the Hippocampus Bias Decisions	SCIENCE			English	Article							REACTIVATION; COMPETITION; CHOICE; MIND	Every day people make new choices between alternatives that they have never directly experienced. Yet, such decisions are often made rapidly and confidently. Here, we show that the hippocampus, traditionally known for its role in building long-term declarative memories, enables the spread of value across memories, thereby guiding decisions between new choice options. Using functional brain imaging in humans, we discovered that giving people monetary rewards led to activation of a preestablished network of memories, spreading the positive value of reward to nonrewarded items stored in memory. Later, people were biased to choose these nonrewarded items. This decision bias was predicted by activity in the hippocampus, reactivation of associated memories, and connectivity between memory and reward regions in the brain. These findings explain how choices among new alternatives emerge automatically from the associative mechanisms by which the brain builds memories. Further, our findings demonstrate a previously unknown role for the hippocampus in value-based decisions.	[Wimmer, G. Elliott; Shohamy, Daphna] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Shohamy, D (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	shohamy@psych.columbia.edu	Wimmer, G. Elliott/AAJ-8537-2020	Wimmer, G. Elliott/0000-0002-2227-119X; Shohamy, Daphna/0000-0003-4239-4960	NSF Career Development Award; National Institutes of Drug Abuse [R03-DA026957]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026957] Funding Source: NIH RePORTER	NSF Career Development Award; National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by a NSF Career Development Award and National Institutes of Drug Abuse grant R03-DA026957 to D. S. We thank E. K. Braun, L. Davachi, R. Hassin, and E. Weber for helpful comments on an earlier draft of the manuscript; L. Atlas and T. Wager for guidance with the mediation analyses; and N. Daw and R. Hassin for insightful conversations.	Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Houwer J., 2007, IMPLICIT MEASURES AT, P179; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; KIMMEL HD, 1977, AM J PSYCHOL, V90, P319, DOI 10.2307/1422055; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Wimmer GE, 2011, DECISION MAKING AFFE, P281, DOI 10.1093/acprof:oso/9780199600434.003.0013	33	291	292	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					270	273		10.1126/science.1223252	http://dx.doi.org/10.1126/science.1223252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019BQ	23066083				2022-12-28	WOS:000309712300050
J	Hoye, TR; Baire, B; Niu, DW; Willoughby, PH; Woods, BP				Hoye, Thomas R.; Baire, Beeraiah; Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.			The hexadehydro-Diels-Alder reaction	NATURE			English	Article							ORGANIC-SYNTHESIS; ARYNE CHEMISTRY; GENERATION; BENZYNE; CYCLOAROMATIZATION; CYCLOHEXYNE; SYSTEM	Arynes (aromatic systems containing, formally, a carbon-carbon triple bond) are among the most versatile of all reactive intermediates in organic chemistry. They can be 'trapped' to give products that are used as pharmaceuticals, agrochemicals, dyes, polymers and other fine chemicals. Here we explore a strategy that unites the de novo generation of benzynes-through a hexadehydro-Diels-Alder reaction-with their in situ elaboration into structurally complex benzenoid products. In the hexadehydro-Diels-Alder reaction, a 1,3-diyne is engaged in a [4+2] cycloisomerization with a 'diynophile' to produce the highly reactive benzyne intermediate. The reaction conditions for this simple, thermal transformation are notable for being free of metals and reagents. The subsequent and highly efficient trapping reactions increase the power of the overall process. Finally, we provide examples of how this de novo benzyne generation approach allows new modes of intrinsic reactivity to be revealed.	[Hoye, Thomas R.; Baire, Beeraiah; Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hoye, TR (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hoye@umn.edu	Baire, Beeraiah/Q-1284-2019; Niu, Dawen/M-4910-2013	Baire, Beeraiah/0000-0001-8810-1620; Willoughby, Patrick/0000-0001-5163-0502; Niu, Dawen/0000-0002-5114-4413	National Science Foundation; National Institutes of Health [GM65597, CA76497]; NATIONAL CANCER INSTITUTE [R01CA076497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065597] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P.H.W. thanks the National Science Foundation for a graduate research fellowship. Financial support from the National Institutes of Health (GM65597 and CA76497) is acknowledged. This work was carried out in part using hardware and software provided by the University of Minnesota Supercomputing Institute.	Ajaz A, 2011, J ORG CHEM, V76, P9320, DOI 10.1021/jo201567d; Bradley AZ, 1997, J AM CHEM SOC, V119, P9917, DOI 10.1021/ja972141f; Chang W.-T. T., 2011, ORGANIC REACTIONS, P213; Chen Y, 2009, MODERN ARYLATION METHODS, P401, DOI 10.1002/9783527627325.ch12; Cheong PHY, 2010, J AM CHEM SOC, V132, P1267, DOI 10.1021/ja9098643; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; Dyke AM, 2006, SYNTHESIS-STUTTGART, P4093, DOI 10.1055/s-2006-950370; Gampe CM, 2012, ANGEW CHEM INT EDIT, V51, P3766, DOI 10.1002/anie.201107485; Garr AN, 2010, ORG LETT, V12, P96, DOI 10.1021/ol902415s; Gilchrist T. L, 2008, SCI SYNTH, V43, P151; Hoffmann R. W., 1967, ORGANIC CHEM SERIES, V11; JOHNSON RP, 1995, J AM CHEM SOC, V117, P362, DOI 10.1021/ja00106a040; Kimura H, 2008, CHEM LETT, V37, P662, DOI 10.1246/cl.2008.662; Kitamura T, 2010, AUST J CHEM, V63, P987, DOI 10.1071/CH10072; Liu ZJ, 2004, ORG LETT, V6, P99, DOI 10.1021/ol0361406; Michael A., 1898, CHEM ZENTRBLT, P731; Miyawaki K, 1997, TETRAHEDRON LETT, V38, P3943, DOI 10.1016/S0040-4039(97)00785-5; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Onishchenko A. S., 1964, DIENE SYNTHESIS; Pellissier H, 2003, TETRAHEDRON, V59, P701, DOI 10.1016/S0040-4020(02)01563-6; Sanz R, 2008, ORG PREP PROCED INT, V40, P215, DOI 10.1080/00304940809458089; STILES M, 1963, J AM CHEM SOC, V85, P1792, DOI 10.1021/ja00895a022; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Tsui JA, 2009, ORGANOMETALLICS, V28, P4906, DOI 10.1021/om900578d; Uchiyama M, 2002, J AM CHEM SOC, V124, P8514, DOI 10.1021/ja0202199; Wenk HH, 2003, ANGEW CHEM INT EDIT, V42, P502, DOI 10.1002/anie.200390151; Wessig P, 2008, CHEM REV, V108, P2051, DOI 10.1021/cr0783986; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	28	323	323	11	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					208	212		10.1038/nature11518	http://dx.doi.org/10.1038/nature11518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060191	Green Accepted			2022-12-28	WOS:000309733300039
J	Kermani, TA; Warrington, KJ				Kermani, Tanaz A.; Warrington, Kenneth J.			Polymyalgia rheumatica	LANCET			English	Article							GIANT-CELL ARTERITIS; ERYTHROCYTE SEDIMENTATION-RATE; DISTAL MUSCULOSKELETAL MANIFESTATIONS; PROVISIONAL CLASSIFICATION CRITERIA; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; TERM-FOLLOW-UP; TEMPORAL ARTERITIS; DOUBLE-BLIND; RHEUMATISM/AMERICAN COLLEGE	Polymyalgia rheumatica is a chronic, inflammatory disorder of unknown cause that affects people over age 50 years. Classic symptoms include pain and long-term morning stiffness of the neck, shoulders, hips, upper arms, and thighs. Although markers of inflammation are often raised, no specific laboratory test exists for the disorder and the diagnosis is based on clinical assessment. Provisional classification criteria were published in April, 2012, by a collaborative initiative of the European League Against Rheumatism and the American College of Rheumatology. Several other disorders can mimic polymyalgia rheumatica. In particular, clinical manifestations can be difficult to differentiate from other forms of inflammatory arthritis such as spondyloarthritis and rheumatoid arthritis. Imaging studies such as ultrasonography and MRI typically show a predominantly periarticular inflammatory process. A subset of patients has an associated inflammatory vasculopathy affecting large arteries (giant cell arteritis). The standard treatment is low-dose glucocorticoids, which provide symptomatic relief for most patients. However, disease relapses are common, and treatment with glucocorticoids is associated with substantial morbidity. Improved understanding of disease pathogenesis might allow for more targeted immunotherapy.	[Kermani, Tanaz A.; Warrington, Kenneth J.] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN 55905 USA; [Kermani, Tanaz A.] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Santa Monica, CA USA	Mayo Clinic; University of California System; University of California Los Angeles	Warrington, KJ (corresponding author), Mayo Clin, Dept Internal Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA.	warrington.kenneth@mayo.edu	Warrington, Kenneth/CAG-1626-2022	Warrington, Kenneth/0000-0001-7708-2487	Vasculitis Clinical Research Consortium (VCRC); US National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319]; US National Center for Research Resources [U54RR019497]; Office of Rare Diseases Research of the US National Institutes of Health (NIH); NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR057319] Funding Source: NIH RePORTER	Vasculitis Clinical Research Consortium (VCRC); US National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Rare Diseases Research of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Wolfgang A Schmidt at the Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, for kindly providing us with the ultrasound images for this report. TAK was supported by the Vasculitis Clinical Research Consortium (VCRC), which has received support from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the US National Center for Research Resources (U54RR019497), and the Office of Rare Diseases Research of the US National Institutes of Health (NIH). The VCRC is part of the NIH-funded Rare Diseases Clinical Research Network.	Alvarez-Rodriguez L, 2010, ANN RHEUM DIS, V69, P263, DOI 10.1136/ard.2008.103663; Alvarez-Rodriguez L, 2009, HUM IMMUNOL, V70, P49, DOI 10.1016/j.humimm.2008.10.011; Barraclough K, 2008, FAM PRACT, V25, P328, DOI 10.1093/fampra/cmn044; Bernatsky S, 2009, ARTHRIT RHEUM-ARTHR, V61, P1264, DOI 10.1002/art.24793; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Blockmans D, 2009, CURR OPIN RHEUMATOL, V21, P19, DOI 10.1097/BOR.0b013e32831cec7b; BOESEN P, 1987, ARTHRITIS RHEUM, V30, P294, DOI 10.1002/art.1780300308; Boiardi L, 2006, J RHEUMATOL, V33, P703; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Cantini F, 2005, CLIN EXP RHEUMATOL, V23, P462; Cantini F, 2004, J RHEUMATOL, V31, P120; Cantini F, 2001, ARTHRITIS RHEUM, V44, P1155, DOI 10.1002/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N; Cantini F, 2001, J RHEUMATOL, V28, P1049; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Caporali R, 2001, ANN RHEUM DIS, V60, P1021, DOI 10.1136/ard.60.11.1021; Ceccato F, 2006, CLIN RHEUMATOL, V25, P854, DOI 10.1007/s10067-005-0188-8; Ceccato F, 2006, JCR-J CLIN RHEUMATOL, V12, P167, DOI 10.1097/01.rhu.0000231381.21179.e6; CHAKRAVARTY K, 1994, BRIT J RHEUMATOL, V33, P152; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Cimmino MA, 2008, CLIN EXP RHEUMATOL, V26, P395; CIMMINO MA, 1990, ANN RHEUM DIS, V49, P521, DOI 10.1136/ard.49.7.521; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Cutolo M, 2006, ANN RHEUM DIS, V65, P1438, DOI 10.1136/ard.2006.051979; Cutolo M, 2002, J RHEUMATOL, V29, P748; Dasgupta B, 2008, ANN RHEUM DIS, V67, P903, DOI 10.1136/ard.2007.081935; Dasgupta B, 2007, CLIN EXP RHEUMATOL, V25, pS130; Dasgupta B, 1998, BRIT J RHEUMATOL, V37, P189; Dasgupta B, 2012, ARTHRITIS RHEUM-US, V64, P943, DOI 10.1002/art.34356; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Demir H, 2006, SCAND J RHEUMATOL, V35, P217, DOI 10.1080/03009740500474586; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; Doran MF, 2002, J RHEUMATOL, V29, P1694; Elling P, 1996, J RHEUMATOL, V23, P112; ELLIS ME, 1983, ANN RHEUM DIS, V42, P168, DOI 10.1136/ard.42.2.168; Falsetti P, 2011, SCAND J RHEUMATOL, V40, P57, DOI 10.3109/03009742.2010.486766; Falsetti P, 2002, J RHEUMATOL, V29, P123; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Gonzalez-Gay MA, 1999, J RHEUMATOL, V26, P1326; Gonzalez-Gay MA, 2000, J RHEUMATOL, V27, P2179; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P317, DOI 10.1001/archinte.157.3.317; Gran JT, 2000, RHEUMATOLOGY, V39, P283, DOI 10.1093/rheumatology/39.3.283; Gran JT, 1997, J RHEUMATOL, V24, P1739; Gran JT, 2001, RHEUMATOLOGY, V40, P1238, DOI 10.1093/rheumatology/40.11.1238; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Helfgott SM, 1996, ARTHRITIS RHEUM, V39, P304, DOI 10.1002/art.1780390220; Hernandez-Rodriguez J, 2009, ARCH INTERN MED, V169, P1839, DOI 10.1001/archinternmed.2009.352; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Jimenez-Palop M, 2010, ANN RHEUM DIS, V69, P879, DOI 10.1136/ard.2009.113555; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; Kalke S, 2000, RHEUMATOLOGY, V39, P883, DOI 10.1093/rheumatology/39.8.883; KOSKI JM, 1992, BRIT J RHEUMATOL, V31, P201; Kreiner F, 2010, ARTHRITIS RHEUM-US, V62, P3768, DOI 10.1002/art.27728; Kremers HM, 2007, ARTHRIT RHEUM-ARTHR, V57, P279, DOI 10.1002/art.22548; Kremers HM, 2005, ARTHRIT RHEUM-ARTHR, V53, P578, DOI 10.1002/art.21311; Kremers HM, 2005, ARTHRIT RHEUM-ARTHR, V53, P395, DOI 10.1002/art.21160; Kremers HM, 2005, J RHEUMATOL, V32, P65; KYLE V, 1989, ANN RHEUM DIS, V48, P667, DOI 10.1136/ard.48.8.667; KYLE V, 1991, CLIN RHEUMATOL, V10, P294, DOI 10.1007/BF02208693; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liozon E, 2009, CLIN EXP RHEUMATOL, V27, pS89; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Matteson EL, 2012, J RHEUMATOL, V39, P795, DOI 10.3899/jrheum.110977; McGonagle D, 2001, J RHEUMATOL, V28, P1837; Meliconi R, 1996, ARTHRITIS RHEUM-US, V39, P1199, DOI 10.1002/art.1780390719; Michet CJ, 2008, BRIT MED J, V336, P765, DOI 10.1136/bmj.39514.653588.80; Moosig F, 2004, ANN RHEUM DIS, V63, P870, DOI 10.1136/ard.2003.011692; Myklebust G, 1996, BRIT J RHEUMATOL, V35, P1161; Narvaez J, 2006, J RHEUMATOL, V33, P1293; Olsson AT, 1997, ARTHRITIS RHEUM, V40, P191, DOI 10.1002/art.1780400128; Pamuk ON, 2009, CLIN EXP RHEUMATOL, V27, P830; Pease CT, 2009, RHEUMATOLOGY, V48, P123, DOI 10.1093/rheumatology/ken343; Pease CT, 2005, J RHEUMATOL, V32, P1043; Perfetto F, 2005, ANN RHEUM DIS, V64, P1662, DOI 10.1136/ard.2005.038901; Proven A, 1999, J RHEUMATOL, V26, P1333; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; Salvarani C, 2008, ANN RHEUM DIS, V67, P758, DOI 10.1136/ard.2007.084723; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; Salvarani C, 1997, ANN INTERN MED, V127, P27, DOI 10.7326/0003-4819-127-1-199707010-00005; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 1999, J RHEUMATOL, V26, P517; SALVARANI C, 1991, ARTHRITIS RHEUM, V34, P351, DOI 10.1002/art.1780340313; Salvarani C, 2000, CLIN EXP RHEUMATOL, V18, pS51; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; SCHAUFELBERGER C, 1995, BRIT J RHEUMATOL, V34, P261; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Spies CM, 2010, CLIN EXP RHEUMATOL, V28, pS172; Straub RH, 2006, J RHEUMATOL, V33, P1219; Straub RH, 2000, RHEUMATOLOGY, V39, P624, DOI 10.1093/rheumatology/39.6.624; Tsigos C, 1997, NEUROENDOCRINOLOGY, V66, P54, DOI 10.1159/000127219; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; Warrington KJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2664; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7	103	86	92	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					63	72		10.1016/S0140-6736(12)60680-1	http://dx.doi.org/10.1016/S0140-6736(12)60680-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23051717				2022-12-28	WOS:000313044300028
J	Pettit, AC; Kropski, JA; Castilho, JL; Schmitz, JE; Rauch, CA; Mobley, BC; Wang, XJ; Spires, SS; Pugh, ME				Pettit, April C.; Kropski, Jonathan A.; Castilho, Jessica L.; Schmitz, Jonathan E.; Rauch, Carol A.; Mobley, Bret C.; Wang, Xuan J.; Spires, Steven S.; Pugh, Meredith E.			The Index Case for the Fungal Meningitis Outbreak in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; INVASIVE ASPERGILLOSIS	Persistent neutrophilic meningitis presents a diagnostic challenge, because the differential diagnosis is broad and includes atypical infectious causes. We describe a case of persistent neutrophilic meningitis due to Aspergillus fumigatus in an immunocompetent man who had no evidence of sinopulmonary or cutaneous disease. An epidural glucocorticoid injection was identified as a potential route of entry for this organism into the central nervous system, and the case was reported to the state health department.	[Pettit, April C.] Vanderbilt Univ, Sch Med, Med Ctr N A2200, Div Infect Dis, Nashville, TN 37232 USA; [Kropski, Jonathan A.; Pugh, Meredith E.] Vanderbilt Univ, Sch Med, Div Allergy Pulmonary & Crit Care Med, Nashville, TN 37232 USA; [Schmitz, Jonathan E.; Rauch, Carol A.; Mobley, Bret C.; Wang, Xuan J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Schmitz, Jonathan E.; Rauch, Carol A.; Mobley, Bret C.; Wang, Xuan J.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pettit, AC (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N A2200, Div Infect Dis, 1161 21st Ave S, Nashville, TN 37232 USA.	april.pettit@vanderbilt.edu		Mobley, Bret/0000-0002-8138-5330				Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; DENNING DW, 1991, REV INFECT DIS, V13, P345; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Larone D.H., 2011, MED IMPORTANT FUNGI; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; MCGINNIS MR, 1983, AM J MED, V75, P129, DOI 10.1016/0002-9343(83)90084-0; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; PEACOCK JE, 1984, MEDICINE, V63, P379, DOI 10.1097/00005792-198411000-00004; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; WALSH TJ, 1985, ANN NEUROL, V18, P574, DOI 10.1002/ana.410180511	14	63	67	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2119	2125		10.1056/NEJMoa1212292	http://dx.doi.org/10.1056/NEJMoa1212292			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23083311				2022-12-28	WOS:000311624400009
J	Dowell, D; Farley, TA				Dowell, Deborah; Farley, Thomas A.			Prevention of non-communicable diseases in New York City	LANCET			English	Editorial Material							RESTAURANTS; HEALTH; SMOKE		[Dowell, Deborah; Farley, Thomas A.] New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Dowell, D (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8-62, Long Isl City, NY 11101 USA.	ddowell1@health.nyc.gov						Angell SY, 2009, ANN INTERN MED, V151, P129, DOI 10.7326/0003-4819-151-2-200907210-00010; [Anonymous], 2012, COMMUNICATION 0920; [Anonymous], 2012, COMMUNICATION   0913; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bartosch W J, 1999, J Public Health Manag Pract, V5, P53; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P370; Chang C, 2004, AM J IND MED, V46, P188, DOI 10.1002/ajim.20030; Dumanovsky T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4464; Farley TA, 2009, HEALTH AFFAIR, V28, pW1098, DOI 10.1377/hlthaff.28.6.w1098; Frieden TR, 2005, AM J PUBLIC HEALTH, V95, P1016, DOI 10.2105/AJPH.2004.058164; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Glantz SA, 1997, AM J PUBLIC HEALTH, V87, P1687, DOI 10.2105/AJPH.87.10.1687; Goldberg JP, 2009, PREV CHRONIC DIS, V6; Gunn Janelle P., 2012, Morbidity and Mortality Weekly Report, V61, P89; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; New York City Department of Health and Mental Hygiene, SUMM VIT STAT 2010 C; New York City Department of Health and Mental Hygiene, 2002, NYC COMM HLTH SURV 2; New York City Department of Health and Mental Hygiene, 2002, SUMM VIT STAT 2000 C; New York City Department of Transportation, COMM CYCL IND 2010; Shea S, 1990, Am J Health Promot, V4, P203; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Summers C, 2012, TAKE CARE NEW YORK 2; [No title captured]	25	16	16	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2012	380	9855					1787	1789		10.1016/S0140-6736(12)60733-8	http://dx.doi.org/10.1016/S0140-6736(12)60733-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23063239				2022-12-28	WOS:000311153700036
J	Singh, G; Kucukural, A; Cenik, C; Leszyk, JD; Shaffer, SA; Weng, ZP; Moore, MJ				Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.			The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus	CELL			English	Article							EXON JUNCTION COMPLEX; RNA-BINDING PROTEINS; MESSENGER-RNA; NONSENSE; DECAY; TRANSLATION; CORE; EIF4AIII; SURVEILLANCE; ARCHITECTURE	In addition to sculpting eukaryotic transcripts by removing introns, pre-mRNA splicing greatly impacts protein composition of the emerging mRNP. The exon junction complex (EJC), deposited upstream of exon-exon junctions after splicing, is a major constituent of spliced mRNPs. Here, we report comprehensive analysis of the endogenous human EJC protein and RNA interactomes. We confirm that the major "canonical" EJC occupancy site in vivo lies 24 nucleotides upstream of exon junctions and that the majority of exon junctions carry an EJC. Unexpectedly, we find that endogenous EJCs multimerize with one another and with numerous SR proteins to form megadalton sized complexes in which SR proteins are super-stoichiometric to EJC core factors. This tight physical association may explain known functional parallels between EJCs and SR proteins. Further, their protection of long mRNA stretches from nuclease digestion suggests that endogenous EJCs and SR proteins cooperate to promote mRNA packaging and compaction.	[Singh, Guramrit; Kucukural, Alper; Cenik, Can; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu	Kucukural, Alper/AAJ-7758-2020; Kucukural, Alper/T-3563-2018	Kucukural, Alper/0000-0001-9983-394X; Kucukural, Alper/0000-0001-9983-394X; Singh, Guramrit/0000-0002-5283-9540; Cenik, Can/0000-0001-6370-0889	HHMI; NIH [RO1-GM53007]; Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053007] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For valuable antibodies, we thank Elisa Izaurralde (alpha-Magoh), Jens Lykke-Andersen (alpha-Upf1, -Upf2, -Upf3, -Y14, and -eIF4AIII), Akila Mayeda (alpha-RNPS1), and John Blenis (alpha-SKAR). Frederick Roth and Hon Nian Chua generously provided a modified AlignACE algorithm. Ellie Kittler and the deep sequencing core are thanked for generating the deep sequencing data. We thank members of the Moore lab for discussions and critiques and Herve Le Hir for communicating results prior to publication. This work was supported by funding from HHMI and NIH RO1-GM53007 (to M.J.M.). G. S. was partially supported by the Charles A. King trust postdoctoral fellowship program. M.J.M. is an HHMI Investigator. G. S. and M.J.M. originally conceived the project, and G. S. executed all wet bench experiments. A. K. implemented all computational analyses with input from C. C. and Z.W. on computational method design and statistical analysis. J.D.L and S. A. S. performed mass spec. All authors contributed to data analysis and interpretation. With input from all authors, G. S. and M.J.M. were primarily responsible for writing the paper.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barbosa I, 2012, NAT STRUCT MOL BIOL, V19, P983, DOI 10.1038/nsmb.2380; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Bjork P, 2009, J CELL BIOL, V184, P555, DOI 10.1083/jcb.200806156; Bono F, 2011, RNA BIOL, V8, P24, DOI 10.4161/rna.8.1.13618; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Michelle L, 2012, MOL CELL BIOL, V32, P954, DOI 10.1128/MCB.06130-11; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mishler DM, 2008, RNA, V14, P2657, DOI 10.1261/rna.1312808; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sauliere J, 2010, NAT STRUCT MOL BIOL, V17, P1269, DOI 10.1038/nsmb.1890; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; SKOGLUND U, 1983, CELL, V34, P847, DOI 10.1016/0092-8674(83)90542-1; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Stroupe ME, 2006, J MOL BIOL, V360, P743, DOI 10.1016/j.jmb.2006.05.049; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	54	224	226	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					750	764		10.1016/j.cell.2012.10.007	http://dx.doi.org/10.1016/j.cell.2012.10.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23084401	Green Accepted, Bronze			2022-12-28	WOS:000310921200008
J	Baicker, K; Levy, H				Baicker, Katherine; Levy, Helen			The Insurance Value of Medicare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Levy, Helen] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.				NIA NIH HHS [K01 AG034232] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG034232] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Finkelstein A, 2008, J PUBLIC ECON, V92, P1644, DOI 10.1016/j.jpubeco.2007.10.005; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Kelley AS, 2012, J GEN INTERN MED; Medicare Payment Advisory Commission, 2012, MED HLTH CAR DEL SYS; Newhouse JP, 1993, FREE ALL LESSONS RAN	5	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1773	1775		10.1056/NEJMp1210789	http://dx.doi.org/10.1056/NEJMp1210789			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23113834	Green Accepted			2022-12-28	WOS:000310773200001
J	Patel, AJ; Som, R; Soppa, GK; Smith, EEJ				Patel, A. J.; Som, R.; Soppa, G. K.; Smith, E. E. J.			A woman with periodic chest pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONTANEOUS PNEUMOTHORAX; MANAGEMENT; EXPERIENCE		[Patel, A. J.] Maidstone Hlth Author, Maidstone, Kent, England; [Som, R.] John Radcliffe Hosp, Oxford OX3 9DU, England; [Soppa, G. K.; Smith, E. E. J.] St George Hosp, Dept Cardiothorac Surg, London, England	University of Oxford; St Georges University London	Som, R (corresponding author), 46 Whitehouse Way, London N14 7LT, England.	rsom@doctors.org.uk						INDERBITZI RGC, 1994, J THORAC CARDIOV SUR, V107, P1410, DOI 10.1016/S0022-5223(94)70415-5; Ingolfsson Ingimar, 2006, Interact Cardiovasc Thorac Surg, V5, P602, DOI 10.1510/icvts.2006.129676; Ingram RJH, 1996, CLIN INFECT DIS, V23, P624, DOI 10.1093/clinids/23.3.624; Joseph J, 1996, AM J MED, V100, P164, DOI 10.1016/S0002-9343(97)89454-5; KONDO T, 1994, AM J RESP CRIT CARE, V149, P178, DOI 10.1164/ajrccm.149.1.8111579; LIPPERT HL, 1991, EUR RESPIR J, V4, P324; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Peikert T, 2005, MAYO CLIN PROC, V80, P677, DOI 10.4065/80.5.677; PRIMROSE WR, 1984, SCOT MED J, V29, P15, DOI 10.1177/003693308402900105; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Schramel F M, 1995, Diagn Ther Endosc, V2, P1, DOI 10.1155/DTE.2.1; TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807; Weissberg D, 2000, CHEST, V117, P1279, DOI 10.1378/chest.117.5.1279	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e6869	10.1136/bmj.e6869	http://dx.doi.org/10.1136/bmj.e6869			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109326				2022-12-28	WOS:000310778000001
J	Loven, J; Orlando, DA; Sigova, AA; Lin, CY; Rahl, PB; Burge, CB; Levens, DL; Lee, TI; Young, RA				Loven, Jakob; Orlando, David A.; Sigova, Alla A.; Lin, Charles Y.; Rahl, Peter B.; Burge, Christopher B.; Levens, David L.; Lee, Tong Ihn; Young, Richard A.			Revisiting Global Gene Expression Analysis	CELL			English	Article							C-MYC; MOLECULAR CLASSIFICATION; BREAST-CANCER; RNA-SEQ; NORMALIZATION; ARRAYS; PREDICTION; DISCOVERY; ADENOCARCINOMA; MICROARRAYS	Gene expression analysis is a widely used and powerful method for investigating the transcriptional behavior of biological systems, for classifying cell states in disease, and for many other purposes. Recent studies indicate that common assumptions currently embedded in experimental and analytical practices can lead to misinterpretation of global gene expression data. We discuss these assumptions and describe solutions that should minimize erroneous interpretation of gene expression data from multiple analysis platforms.	[Loven, Jakob; Orlando, David A.; Sigova, Alla A.; Lin, Charles Y.; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Burge, Christopher B.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Levens, David L.] NCI, Gene Regulat Sect, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, TI (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	tlee@wi.mit.edu; young@wi.mit.edu	Burge, Christopher B./AAH-2177-2020; Levens, David/C-9216-2009; Young, Richard A/F-6495-2012	Levens, David/0000-0002-7616-922X; Young, Richard A/0000-0001-8855-8647	National Institutes of Health [HG002668, CA146445]; American Cancer Society [PF-11-042-01-DMC]; Swedish Research Council [VR-B0086301]; NATIONAL CANCER INSTITUTE [R01CA146445, ZIABC011465] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, R01HG002439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Tom Volkert, Jeong-Ah Kwen, Jennifer Love, and Sumeet Gupta at the Whitehead Genome Technologies Core for Solexa sequencing and microarray processing and Ziv Bar-Joseph for critical comments. This work was supported by National Institutes of Health grants HG002668 (R. A. Y.) and CA146445 (R. A. Y., T. I. L.), an American Cancer Society Postdoctoral Fellowship PF-11-042-01-DMC (P. B. R.) and a Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Benes V, 2003, TRENDS BIOCHEM SCI, V28, P244, DOI 10.1016/S0968-0004(03)00068-9; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HARTEMINK AJ, 2001, P SOC PHOTO-OPT INS, V2, P132; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hill AA, 2001, GENOME BIOL, V2; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalocsai P, 2001, Methods Mol Biol, V170, P223; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Reimers M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000786; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schulze A, 2001, NAT CELL BIOL, V3, pE190, DOI 10.1038/35087138; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Su AI, 2001, CANCER RES, V61, P7388; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	44	377	391	2	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					476	482		10.1016/j.cell.2012.10.012	http://dx.doi.org/10.1016/j.cell.2012.10.012			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101621	Green Accepted, Bronze			2022-12-28	WOS:000310529300006
J	Legge, D				Legge, David			Future of WHO hangs in the balance	BRITISH MEDICAL JOURNAL			English	Editorial Material							WORLD-HEALTH-ORGANIZATION		La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia	La Trobe University	Legge, D (corresponding author), La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia.	d.legge@latrobe.edu.au						Chisholm Brock., 2008, WHO COLD WAR; Faunce T, 2012, MED J AUSTRALIA, V196, P1; GODLEE F, 1994, BRIT MED J, V309, P1491, DOI 10.1136/bmj.309.6967.1491; GODLEE F, 1995, BRIT MED J, V310, P178, DOI 10.1136/bmj.310.6973.178a; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; International Health Conference, CONST WHO; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; STENSON B, 1994, HEALTH POLICY, V28, P235, DOI 10.1016/0168-8510(94)90063-9; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Tienhaara K, 2010, INVESTOR STATE DISPU; United Nation, 2012, MILL DEV GOALS REP; Vaughan JP, 1996, HEALTH POLICY, V35, P229, DOI 10.1016/0168-8510(95)00786-5; WALT G, 1993, HEALTH POLICY, V24, P125, DOI 10.1016/0168-8510(93)90030-S; WHO, STAT COLL ASS CONTR; WHO, FIN REP AUD FIN STAT; WHO, 1958, INT HLTH C 1 10 WHO; WHO, VOL CONTR FUND DON F; WHO Director General, 2012, A65 5 WHO REF; WHO Director General, 2011, A64 4 FUT FIN WHO; WHO Watch, 13 1 PREV CONTR NCDS; World Health Assembly, 2012, WHA65 9 WHO REF; World Health Organization, 3 5 IN	22	10	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 25	2012	345								e6877	10.1136/bmj.e6877	http://dx.doi.org/10.1136/bmj.e6877			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MZ	23100330				2022-12-28	WOS:000310427800007
J	Cohen, D				Cohen, Deborah			Notified bodies: are they fit for purpose?	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Cohen D, 2012, BRIT MED J, V342, pd2748	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7177	10.1136/bmj.e7177	http://dx.doi.org/10.1136/bmj.e7177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097555				2022-12-28	WOS:000310427600024
J	George, SMC; Sen, M; Elliman, D				George, Susannah M. C.; Sen, Milly; Elliman, David			CASE REPORT Rash in a 15 month old girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEASLES-VIRUS INFECTION; KOPLIK SPOTS; LABORATORY DIAGNOSIS; MMR VACCINE; RUBELLA; OUTBREAK; CHILDREN		[George, Susannah M. C.] Brighton & Sussex Univ Hosp NHS Trust, Brighton Gen Hosp, Brighton BN2 3EW, E Sussex, England; [Sen, Milly] Univ Coll London Hosp NHS Fdn Trust, Univ Coll Hosp, London, England; [Elliman, David] Whittington Hlth, London, England	Brighton and Sussex University Hospitals NHS Trust; Brighton General Hospital; University of Brighton; University College London Hospitals NHS Foundation Trust; University of London; University College London	George, SMC (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Brighton Gen Hosp, Brighton BN2 3EW, E Sussex, England.	susannah@susannahgeorge.net	Elliman, David/AAK-4595-2020					Akiyoshi K, 2010, JPN J INFECT DIS, V63, P225; ANNUNZIATO D, 1987, NEW YORK STATE J MED, V87, P667; Arenz S, 2009, PEDIATR INFECT DIS J, V28, P1030, DOI 10.1097/INF.0b013e3181aa6a29; Bassetti Matteo, 2011, Infez Med, V19, P16; Battegay R, 2012, DERMATOLOGY, V224, P1, DOI 10.1159/000335091; Bellini WJ, 2003, J INFECT DIS, V187, pS283, DOI 10.1086/368040; BROWN DWG, 1994, BRIT MED J, V308, P1015, DOI 10.1136/bmj.308.6935.1015; Calza L, 2009, Infez Med, V17, P28; CDC, 1991, MMWR 40, P369; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Chen SSP, 2011, MEASLES; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; du Chatelet IP, 2010, EUROSURVEILLANCE, V15, P2; EMC, PREV SUMM PROD CHAR; EVANS LM, 1992, J AM ACAD DERMATOL, V27, P466, DOI 10.1016/S0190-9622(08)80888-2; Filia A, 2011, EUROSURVEILLANCE, V16, P18; FREEMAN TR, 1993, CAN MED ASSOC J, V149, P1669; Friederichs V, 2006, ARCH DIS CHILD, V91, P465, DOI 10.1136/adc.2005.085944; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; Gellin BG, 2000, PEDIATRICS, V106, P1097, DOI 10.1542/peds.106.5.1097; Goon P, 2001, VACCINE, V19, P3816, DOI 10.1016/S0264-410X(01)00122-0; Health Protection Agency, 2010, HPA NAT MEASL GUID L; Health Protection Agency, 1989, MEASL NOT ENGL WAL R; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; HETHCOTE HW, 1983, AM J EPIDEMIOL, V117, P2, DOI 10.1093/oxfordjournals.aje.a113511; *HLTH PROT AG, MEASL NOT CONF CAS E; Hutse V, 2010, INT J INFECT DIS, V14, pE991, DOI 10.1016/j.ijid.2010.06.009; Hyde TB, 2009, B WORLD HEALTH ORGAN, V87, P93, DOI 10.2471/BLT.07.045484; Information Centre for Health and Social Care, 2005, NHS IMM STAT ENGL 20; KOPLIK H, 1896, ARCH PEDIATR, V13, P918; LeBaron CW, 2006, PEDIATRICS, V118, P1422, DOI 10.1542/peds.2006-0678; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lynn TV, 2004, J INFECT DIS, V189, pS86, DOI 10.1086/377699; Mantadakis E, 2010, J PEDIATR-US, V156, P623, DOI 10.1016/j.jpeds.2009.10.015; Miller C, 2004, ARCH DIS CHILD, V89, P1145, DOI 10.1136/adc.2003.038489; Mosquera MM, 2005, J CLIN MICROBIOL, V43, P5117, DOI 10.1128/JCM.43.10.5117-5121.2005; NHS Brighton and Hove, 2009, NHS URG PAR PROT CHI; Oliveira SA, 2001, EPIDEMIOL INFECT, V127, P509, DOI 10.1017/S0950268801005908; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Ramsay M, 2002, ARCH DIS CHILD, V87, P202, DOI 10.1136/adc.87.3.202; Ratnam S, 2000, J CLIN MICROBIOL, V38, P99; RIORDAN FAI, 1995, POSTGRAD MED J, V71, P745, DOI 10.1136/pgmj.71.842.745; Sheppeard Vicky, 2009, N S W Public Health Bull, V20, P81, DOI 10.1071/NB08014; Slifka MK, 2003, J CLIN INVEST, V111, P805, DOI 10.1172/JCI200313603; Steichen O, 2009, CAN MED ASSOC J, V180, P583, DOI 10.1503/cmaj.080724; Wakefield AJ, 2010, LANCET, V375, P445, DOI 10.1016/S0140-6736(10)60175-4; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; Woo GKS, 2010, J MED VIROL, V82, P1773, DOI 10.1002/jmv.21888; World Health Organization, 2012, MEASL; Yasunaga H, 2010, INTERNAL MED, V49, P1965, DOI 10.2169/internalmedicine.49.3843; Zenner D, 2012, J INFECT DEV COUNTR, V6, P271, DOI 10.3855/jidc.1756	51	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2012	345								e6973	10.1136/bmj.e6973	http://dx.doi.org/10.1136/bmj.e6973			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MT	23092900				2022-12-28	WOS:000310427100004
J	Brayne, C; Davis, D				Brayne, Carol; Davis, Daniel			Making Alzheimer's and dementia research fit for populations	LANCET			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; DISEASE; PREVALENCE; DIAGNOSIS; CRITERIA		[Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Robinson Way, Cambridge CB2 0SR, England.	cb105@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Davis, Daniel/F-9995-2012	Brayne, Carol/0000-0001-5307-663X; Davis, Daniel/0000-0002-1560-1955	National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; Wellcome Trust [090661] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ablin R, 2010, NY TIMES; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; BRAYNE C, 1993, PSYCHOL MED, V23, P287, DOI 10.1017/S003329170002835X; BRAYNE C, 1993, BRIT J PSYCHIAT, V162, P439, DOI 10.1192/bjp.162.4.439; BRAYNE C, 1988, LANCET, V2, P514, DOI 10.1016/S0140-6736(88)90166-3; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Muniz-Terrera G, 2011, INT J GERIATR PSYCH, V26, P584, DOI 10.1002/gps.2566; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Yip AG, 2006, AGE AGEING, V35, P154, DOI 10.1093/ageing/afj030; Zimmern RL, 2009, CLIN MED, V9, P68, DOI 10.7861/clinmedicine.9-1-68	22	69	69	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1441	1443		10.1016/S0140-6736(12)61803-0	http://dx.doi.org/10.1016/S0140-6736(12)61803-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084456	Green Accepted			2022-12-28	WOS:000310196500034
J	Suresh, S				Suresh, Subra			Global challenges need global solutions	NATURE			English	Editorial Material									Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Suresh, S (corresponding author), Natl Sci Fdn, Arlington, VA 22230 USA.	ssuresh@nsf.gov	Suresh, Subra/B-8289-2008	Suresh, Subra/0000-0002-6223-6831				Grueber M., 2011, R D             1216; National Science Board, 2012, SCI ENG IND 2012	2	27	32	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					337	338		10.1038/490337a	http://dx.doi.org/10.1038/490337a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	021XI	23075966	Bronze			2022-12-28	WOS:000309918500018
J	Arie, S				Arie, Sophie			Ending the French love affair with drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						Benkimoun P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6882; Debre B, 2012, GUIDE 4000 MED UTILE; OECD, 2012, HLTH KEY TABL PHARM; OECD, 2011, HLTH GLANC 2011 PHAR	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 17	2012	345								e6996	10.1136/bmj.e6996	http://dx.doi.org/10.1136/bmj.e6996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077372				2022-12-28	WOS:000310141900016
J	Pavri, BB; Lokhandwala, Y; Kulkarni, GV; Shah, M; Kantharia, BK; Mascarenhas, DAN				Pavri, Behzad B.; Lokhandwala, Yash; Kulkarni, Gaurav V.; Shah, Mandar; Kantharia, Bharat K.; Mascarenhas, Daniel A. N.			Reuse of Explanted, Resterilized Implantable Cardioverter-Defibrillators A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PACEMAKER REUSE; NATIONS; EFFICACY; SAFETY; WORLD; DEATH	Background: Implantable cardioverter-defibrillators (ICDs) often have clinically useful battery life remaining when explanted because of upgrades, infection, or patient death. Objective: To show that explanted ICDs can be resterilized and reused. Design: Retrospective cohort study. Setting: Multicenter ICD acquisition and single-center ICD reimplantation. Patients: Indigent persons in India who had class I indications for cardiac resynchronization therapy with an ICD and were unable to afford such a device. Measurements: Device longevity after reimplantation, device-related complications, number of appropriate therapies, patient clinical characteristics, and deaths. Results: Eighty-one consecutive consenting patients (mean age, 52.6 years; 66 male patients) received 106 explanted devices. Twenty-two patients received a second device and 3 patients received a third device after the prior one reached replacement voltage. Mean time to ICD replacement was 1287.4 days. Follow-up data were available for 75 of 81 (92.6%) patients. Mean follow-up duration for all devices was 824.9 days. No infectious complications occurred; 1 lead dislodgement and 1 lead fracture required repeated surgery. Appropriate therapy (shocks or antitachycardia pacing) was delivered by 64 of 106 (60.4%) devices in 44 of 81 (54.3%) patients. Nine of 81 (11.1%) patients died; mean time from implantation to death was 771.3 days. Limitations: This is a retrospective report of a single-center experience with a modest number of patients and devices. Follow-up data were missing for 6 patients. No records were kept of the number of devices obtained through postmortem versus antemortem explantation or whether explantation was due to infection or upgrade. Complete data were not available on exact battery voltage at the time of reimplantation, left ventricular ejection fraction, or number of inappropriate shocks. A control group was not possible. Conclusion: Explanted ICDs with 3 or more years of estimated remaining battery life can be reused after they are cleaned and resterilized. These devices functioned normally and delivered life-saving therapies, without an increased risk for complications. These preliminary data deserve further validation and, if confirmed, could have important societal and economic implications.	[Pavri, Behzad B.] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; Drexel Univ, Sch Med, Philadelphia, PA 19104 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Holy Family Hosp, Bombay, Maharashtra, India; Univ Texas Hlth Sci Ctr Houston, Houston, TX USA	Jefferson University; Drexel University; Loyola University Chicago; University of Texas System; University of Texas Health Science Center Houston	Pavri, BB (corresponding author), Thomas Jefferson Univ Hosp, 925 Chestnut St,Suite 200, Philadelphia, PA 19107 USA.		Pavri, Behzad/AAP-2156-2020; Lokhandwala, Yash/AAQ-5985-2020; mascarenhas, daniel/R-6259-2019	Kantharia, Bharat/0000-0002-4207-0387; Lokhandwala, Yash/0000-0002-1147-7926				[Anonymous], 2011, WORLD POP PROSP 2010; Balachander J, 2003, STIMUCOEUR, V31, P190; Baman TS, 2012, HEART RHYTHM, V9, P211, DOI 10.1016/j.hrthm.2011.09.067; Baman TS, 2010, CIRCULATION, V122, P1649, DOI 10.1161/CIRCULATIONAHA.110.970483; Baman TS, 2009, J AM COLL CARDIOL, V54, P1557, DOI 10.1016/j.jacc.2009.04.096; Delacretaz E, 2000, AM J CARDIOL, V86, p52K, DOI 10.1016/S0002-9149(00)01292-3; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Ghosh D, 1997, HEART, V77, P484, DOI 10.1136/hrt.77.5.484; Hasan R, 2011, PACE, V34, P653, DOI 10.1111/j.1540-8159.2011.03061.x; Hidden hazards of cremation [Editorial], 1977, BR MED J, V2, P1620; Kantharia BK, 2012, AM J CARDIOL, V109, P238, DOI 10.1016/j.amjcard.2011.08.036; Karch M, 1996, J CARDIOVASC SURG, V37, P67; Kirkpatrick JN, 2007, J CARDIOVASC ELECTR, V18, P478, DOI 10.1111/j.1540-8167.2007.00773.x; Kirkpatrick JN, 2010, HEART RHYTHM, V7, P1623, DOI 10.1016/j.hrthm.2010.04.027; Linde CL, 1998, EUR HEART J, V19, P154, DOI 10.1053/euhj.1997.0728; Logani S, 2011, PACE, V34, P659, DOI 10.1111/j.1540-8159.2011.03032.x; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Namboodiri K K N, 2004, Indian Pacing Electrophysiol J, V4, P3; National Funeral Directors Association, 2007, LEG ADV FUN HOM TRAN; Nelson OL, 2006, J VET INTERN MED, V20, P1232, DOI 10.1892/0891-6640(2006)20[1232:TUOAIC]2.0.CO;2; Pellegrini CN, 2008, EUROPACE, V10, P1296, DOI 10.1093/europace/eun253; Romero J, 2010, QUAL CAR OUTC RES CA; Suvarna SK, 1999, J CLIN PATHOL, V52, P677, DOI 10.1136/jcp.52.9.677; U.S. Food and Drug Administration, 2009, CPG SEC 310 100 PAC; U.S. Food and Drug Administration, 2010, CPG SEC 300 500 REPR	25	22	22	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					542	+		10.7326/0003-4819-157-8-201210160-00004	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070487				2022-12-28	WOS:000309906000014
J	Rabinowitz, I				Rabinowitz, Ian			Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Rabinowitz, I (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.							Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-3	10.7326/0003-4819-157-8-201210160-02003	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070505				2022-12-28	WOS:000309906000002
J	Hinrichs, KU; Inagaki, F				Hinrichs, Kai-Uwe; Inagaki, Fumio			Downsizing the Deep Biosphere	SCIENCE			English	Editorial Material							SUBSURFACE SEDIMENTS		[Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Hinrichs, Kai-Uwe] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Kochi 7838502, Japan	University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hinrichs, KU (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	khinrichs@uni-bremen.de; inagaki@jamstec.go.jp	Hinrichs, Kai-Uwe/C-7675-2009; Inagaki, Fumio/AAI-1156-2019	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Inagaki, Fumio/0000-0003-2887-6525				D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Hoehler TM, 2004, GEOBIOLOGY, V2, P205, DOI 10.1111/j.1472-4677.2004.00033.x; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Kallmeyer J, 2008, LIMNOL OCEANOGR-METH, V6, P236, DOI 10.4319/lom.2008.6.236; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lipp JS, 2009, GEOCHIM COSMOCHIM AC, V73, P6816, DOI 10.1016/j.gca.2009.08.003; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Rebata-Landa V, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001355; Schouten S, 2010, GEOCHIM COSMOCHIM AC, V74, P3806, DOI 10.1016/j.gca.2010.03.029; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	12	28	29	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					204	205		10.1126/science.1229296	http://dx.doi.org/10.1126/science.1229296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066067				2022-12-28	WOS:000309712300028
J	Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Complex brain and optic lobes in an early Cambrian arthropod	NATURE			English	Article							GROUND PATTERN; NERVOUS-SYSTEM; SISTER GROUP; EVOLUTION; CRUSTACEAN; INSECTS; HEAD; VIEW; ORGANIZATION; FUXIANHUIA	The nervous system provides a fundamental source of data for understanding the evolutionary relationships between major arthropod groups(1,2). Fossil arthropods rarely preserve neural tissue. As a result, inferring sensory and motor attributes of Cambrian taxa has been limited to interpreting external features, such as compound eyes(3) or sensilla decorating appendages(4), and early-diverging arthropods have scarcely been analysed in the context of nervous system evolution. Here we report exceptional preservation of the brain and optic lobes of a stem-group arthropod from 520 million years ago (Myr ago), Fuxianhuia protensa(5), exhibiting the most compelling neuroanatomy known from the Cambrian. The protocerebrum of Fuxianhuia is supplied by optic lobes evidencing traces of three nested optic centres serving forward-viewing eyes. Nerves from uniramous antennae define the deutocerebrum, and a stout pair of more caudal nerves indicates a contiguous tritocerebral component. Fuxianhuia shares a tripartite pre-stomodeal brain and nested optic neuropils with extant Malacostraca and Insecta(2,6), demonstrating that these characters were present in some of the earliest derived arthropods. The brain of Fuxianhuia impacts molecular analyses that advocate either a branchiopod-like ancestor of Hexapoda(7,8) or remipedes and possibly cephalocarids as sister groups of Hexapoda(9,10). Resolving arguments about whether the simple brain of a branchiopod approximates an ancestral insect brain or whether it is the result of secondary simplification has until now been hindered by lack of fossil evidence. The complex brain of Fuxianhuia accords with cladistic analyses on the basis of neural characters, suggesting that Branchiopoda derive from a malacostracan-like ancestor but underwent evolutionary reduction and character reversal of brain centres that are common to hexapods and malacostracans(2). The early origin of sophisticated brains provides a probable driver for versatile visual behaviours, a view that accords with compound eyes from the early Cambrian that were, in size and resolution, equal to those of modern insects and malacostracans(3).	[Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Ma, XY (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	x.ma@nhm.ac.uk	Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [40730211]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona	This account is dedicated to J. Bergstrom, who was first in suggesting a brain in YKLP 15006. The present work was supported by the National Natural Science Foundation of China (40730211), a Leverhulme Trust Research Project Grant (F/00 696/T), and the Center for Insect Science, University of Arizona. We thank A. Ball and J. Spratt for their assistance with scanning electron microscopy imagery and energy-dispersive X-ray spectroscopy, respectively.	Andrew DR, 2012, J COMP NEUROL, V520, P3446, DOI 10.1002/cne.23099; Bergstrom J, 2008, GFF, V130, P189; Boyan G. S., 2006, EVOLUTION NERVOUS SY, P249; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; ELOFSSON R, 1970, Z ZELLFORSCH MIK ANA, V107, P343, DOI 10.1007/BF00336672; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Hanstr_om B., 1926, K SVEN VETENSKAPSAKA, V4, P1; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2004, LETHAIA, V37, P235, DOI 10.1080/00241160410006555; Kirsch R, 2007, ARTHROPOD STRUCT DEV, V36, P143, DOI 10.1016/j.asd.2006.08.013; Land M.F., 1989, P90; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Sandeman D. C., 1995, NERVOUS SYSTEMS INVE, P329; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Sombke A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-1; Stegner MEJ, 2011, ARTHROPOD STRUCT DEV, V40, P221, DOI 10.1016/j.asd.2011.04.001; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Strausfeld Nicholas J., 2011, Palaeontographica Canadiana, V31, P157; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wolff G, 2012, J COMP NEUROL, V520, P2824, DOI 10.1002/cne.23059	30	139	143	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					258	+		10.1038/nature11495	http://dx.doi.org/10.1038/nature11495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060195				2022-12-28	WOS:000309733300049
J	Orchard, J				Orchard, John			Plantar fasciitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SHOCK-WAVE THERAPY; INTRALESIONAL CORTICOSTEROID INJECTION; PLATELET-RICH PLASMA; BOTULINUM-TOXIN-A; HEEL PAIN; FOOT ORTHOSES; RISK-FACTORS; SHORT-TERM; DIAGNOSIS; INTERVENTION		Univ Sydney, Sports Clin, Sydney, NSW 2006, Australia	University of Sydney	Orchard, J (corresponding author), Univ Sydney, Sports Clin, Sydney, NSW 2006, Australia.	johnorchard@msn.com.au	Orchard, John W/AAY-7216-2020	Orchard, John W/0000-0003-3530-1711				Abbassian A, 2012, FOOT ANKLE INT, V33, P14, DOI 10.3113/FAI.2012.0014; Akfirat M, 2003, CLIN IMAG, V27, P353, DOI 10.1016/S0899-7071(02)00591-0; Aksahin E, 2012, ARCH ORTHOP TRAUM SU, V132, P781, DOI 10.1007/s00402-012-1488-5; Babcock MS, 2005, AM J PHYS MED REHAB, V84, P649, DOI 10.1097/01.phm.0000176339.73591.d7; Barry Lance D, 2002, J Foot Ankle Surg, V41, P221; Bazaz R, 2007, FOOT ANKLE INT, V28, P549, DOI 10.3113/FAI.2007.0549; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Chang KV, 2012, ARCH PHYS MED REHAB, V93, P1259, DOI 10.1016/j.apmr.2012.02.023; Cole C, 2005, AM FAM PHYSICIAN, V72, P2237; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Crawford F, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000416; De Garceau D, 2003, FOOT ANKLE INT, V24, P251, DOI 10.1177/107110070302400309; DiGiovanni BF, 2006, J BONE JOINT SURG AM, V88A, P1775, DOI 10.2106/JBJS.E.01281; Huang YC, 2010, J REHABIL MED, V42, P136, DOI 10.2340/16501977-0491; Irving DB, 2006, J SCI MED SPORT, V9, P11, DOI 10.1016/j.jsams.2006.02.004; Irving DB, 2008, J AM PODIAT MED ASSN, V98, P283, DOI 10.7547/0980283; Janisse DJ, 2008, J AM ACAD ORTHOP SUR, V16, P152, DOI 10.5435/00124635-200803000-00006; Khan KM, 2002, BRIT MED J, V324, P626, DOI 10.1136/bmj.324.7338.626; Labovitz Jonathan M, 2011, Foot Ankle Spec, V4, P141, DOI 10.1177/1938640010397341; Landorf KB, 2006, ARCH INTERN MED, V166, P1305, DOI 10.1001/archinte.166.12.1305; Lee SY, 2009, PHYS THER SPORT, V10, P12, DOI 10.1016/j.ptsp.2008.09.002; Marafko C, 2007, ACTA CHIR ORTHOP TR, V74, P406; Maskill JD, 2010, FOOT ANKLE INT, V31, P19, DOI 10.3113/FAI.2010.0019; Metzner G, 2010, FOOT ANKLE INT, V31, P790, DOI 10.3113/FAI.2010.0790; Neve L, 2010, OPEN ACCESS J SPORTS, V1, P183, DOI [10.2147/AJSMS10622, 10.2147/OAJSM.S10622]; Orchard JW, 2004, J SCI MED SPORT, V7, P424, DOI 10.1016/S1440-2440(04)80259-7; Orchard JW, 2004, BRIT J SPORT MED, V38, P502, DOI 10.1136/bjsm.2003.011346; Orchard JW, 2002, BRIT J SPORT MED, V36, P209, DOI 10.1136/bjsm.36.3.209; Othman AMA, 2010, ARCH ORTHOP TRAUM SU, V130, P1343, DOI 10.1007/s00402-009-1034-2; Peerbooms JC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-69; Peerbooms JC, 2010, AM J SPORT MED, V38, P255, DOI 10.1177/0363546509355445; Peplinski SL, 2010, J GERIATR PHYS THER, V33, P141, DOI 10.1097/JPT.0b013e3181eda48f; Placzek R, 2005, ANN RHEUM DIS, V64, P1659, DOI 10.1136/ard.2005.035840; Porter MD, 2005, CLIN J SPORT MED, V15, P119, DOI 10.1097/01.jsm.0000164039.91787.dc; Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872, DOI 10.2106/00004623-200305000-00015; Rompe JD, 2007, BRIT MED BULL, V81-82, P183, DOI 10.1093/bmb/ldm005; Roos E, 2006, FOOT ANKLE INT, V27, P606, DOI 10.1177/107110070602700807; Scher DL, 2009, J BONE JOINT SURG AM, V91A, P2867, DOI 10.2106/JBJS.I.00257; Sinnaeve F, 2008, ACTA ORTHOP BELG, V74, P483; Sorrentino F, 2008, RADIOL MED, V113, P486, DOI 10.1007/s11547-008-0277-2; Tatli YZ, 2009, CURR REV MUSCULOSKE, V2, P3, DOI 10.1007/s12178-008-9036-1; Thomas JL, 2010, J FOOT ANKLE SURG, V49, pS1, DOI 10.1053/j.jfas.2010.01.001; Toomey EP, 2009, FOOT ANKLE CLIN, V14, P229, DOI 10.1016/j.fcl.2009.02.001; Tsai CT, 2010, J MUSCULOSKELET PAIN, V18, P71, DOI 10.3109/10582450903495882; Tsai WC, 2006, J CLIN ULTRASOUND, V34, P12, DOI 10.1002/jcu.20177; van de Water ATM, 2010, J AM PODIAT MED ASSN, V100, P41, DOI 10.7547/1000041; Werner RA, 2010, PM&R, V2, P110, DOI 10.1016/j.pmrj.2009.11.012; WOLGIN M, 1994, FOOT ANKLE INT, V15, P97, DOI 10.1177/107110079401500303; Yucel I, 2010, J AM PODIAT MED ASSN, V100, P105, DOI 10.7547/1000105	49	51	52	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6603	10.1136/bmj.e6603	http://dx.doi.org/10.1136/bmj.e6603			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TD	23054045				2022-12-28	WOS:000309907400008
J	de Gage, SB; Begaud, B; Bazin, F; Verdoux, H; Dartigues, JF; Peres, K; Kurth, T; Pariente, A				de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine			Benzodiazepine use and risk of dementia: prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NESTED CASE-CONTROL; MINI-MENTAL-STATE; COGNITIVE DECLINE; ALZHEIMER-DISEASE; ELDERLY-PEOPLE; PSYCHOTROPIC MEDICATION; HUMAN-MEMORY; COMMUNITY; EPIDEMIOLOGY; IMPAIRMENT	Objective To evaluate the association between use of benzodiazepines and incident dementia. Design Prospective, population based study. Setting PAQUID study, France. Participants 1063 men and women (mean age 78.2 years) who were free of dementia and did not start taking benzodiazepines until at least the third year of follow-up. Main outcome measures Incident dementia, confirmed by a neurologist. Results During a 15 year follow-up, 253 incident cases of dementia were confirmed. New use of benzodiazepines was associated with an increased risk of dementia (multivariable adjusted hazard ratio 1.60, 95% confidence interval 1.08 to 2.38). Sensitivity analysis considering the existence of depressive symptoms showed a similar association (hazard ratio 1.62, 1.08 to 2.43). A secondary analysis pooled cohorts of participants who started benzodiazepines during follow-up and evaluated the association with incident dementia. The pooled hazard ratio across the five cohorts of new benzodiazepine users was 1.46 (1.10 to 1.94). Results of a complementary nested case-control study showed that ever use of benzodiazepines was associated with an approximately 50% increase in the risk of dementia (adjusted odds ratio 1.55, 1.24 to 1.95) compared with never users. The results were similar in past users (odds ratio 1.56, 1.23 to 1.98) and recent users (1.48, 0.83 to 2.63) but reached significance only for past users. Conclusions In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzodiazepines throughout the study and in a complementary case-control study. Considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects of this drug class in the general population, indiscriminate widespread use should be cautioned against.	[de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine] Univ Bordeaux Segalen, F-33000 Bordeaux, France; [de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Pariente, Antoine] INSERM, U657, F-33000 Bordeaux, France; [Begaud, Bernard; Dartigues, Jean-Francois; Pariente, Antoine] CHU Bordeaux, F-33000 Bordeaux, France; [Verdoux, Helene] Ctr Hosp Charles Perrens, F-33000 Bordeaux, France; [Dartigues, Jean-Francois; Peres, Karine] INSERM, U897, F-33000 Bordeaux, France; [Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, F-33000 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Gage, SB (corresponding author), Univ Bordeaux Segalen, INSERM, U657, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	sophie.billiotidegage@u-bordeaux2.fr; bernard.begaud@u-bordeaux2.fr	Verdoux, Helene/T-1996-2019; Kurth, Tobias/A-9243-2012; DARTIGUES, Jean François/T-4513-2019; PERES, Karine/T-4128-2019; Pariente, Antoine/S-9231-2019	Verdoux, Helene/0000-0003-2948-3782; Kurth, Tobias/0000-0001-7169-2620; PERES, Karine/0000-0002-0720-0684; Pariente, Antoine/0000-0002-7873-5483	INSERM (Institut National de la Sante et de la Recherche Medicale); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	This research was conducted by the INSERM U657 research team co-funded by INSERM (Institut National de la Sante et de la Recherche Medicale) and Universite Bordeaux Segalen. Additional support was provided by a 2010 grant from IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); by a 2011 grant from the French Ministry of Health (Direction Generale de la Sante); and by Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie, and Institut National de Prevention et d'Education pour la Sante.	Allard J, 2003, INT J GERIATR PSYCH, V18, P874, DOI 10.1002/gps.891; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BENTON AL, 1972, J PSYCHOL, V80, P189, DOI 10.1080/00223980.1972.9924794; Boeuf-Cazou O, 2011, EUR J CLIN PHARMACOL, V67, P1045, DOI 10.1007/s00228-011-1047-y; Briot M, 2006, BON USAGE MEDICAMENT; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; CURRAN HV, 1986, BIOL PSYCHOL, V23, P179, DOI 10.1016/0301-0511(86)90081-5; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; Dealberto MJ, 1997, INT J GERIATR PSYCH, V12, P567, DOI 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V; Dell'osso B, 2012, EUR PSYCHIAT; Egan M, 2000, J AM GERIATR SOC, V48, P811, DOI 10.1111/j.1532-5415.2000.tb04758.x; European Medicines Agency, 2012, SUMM PROD CHAR BENZ; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hanlon JT, 1998, CLIN PHARMACOL THER, V64, P684, DOI 10.1016/S0009-9236(98)90059-5; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hogan David B, 2003, Can J Clin Pharmacol, V10, P72; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Jorm AF, 2000, AUST NZ J PUBL HEAL, V24, P7, DOI 10.1111/j.1467-842X.2000.tb00715.x; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lagnaoui R, 2009, AGE AGEING, V38, P226, DOI 10.1093/ageing/afn277; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Pariente A, 2008, DRUG AGING, V25, P61, DOI 10.2165/00002512-200825010-00007; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sonnenberg CM, 2012, SOC PSYCH PSYCH EPID, V47, P293, DOI 10.1007/s00127-011-0344-1; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Verdoux H, 2005, PSYCHOL MED, V35, P307, DOI 10.1017/S0033291704003897; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Windle A, 2007, AUST NZ J PUBL HEAL, V31, P379, DOI 10.1111/j.1753-6405.2007.00091.x; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	50	181	187	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2012	345								e6231	10.1136/bmj.e6231	http://dx.doi.org/10.1136/bmj.e6231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23045258	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309386700007
J	Zalaudek, I; Argenziano, G				Zalaudek, Iris; Argenziano, Giuseppe			Dermoscopy of Nits and Pseudonits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zalaudek, Iris] Med Univ Graz, Graz, Austria; [Argenziano, Giuseppe] Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy	Medical University of Graz; IRCCS Arcispedale S. Maria Nuova	Zalaudek, I (corresponding author), Med Univ Graz, Graz, Austria.	iris.zalaudek@gmail.com	Zalaudek, Iris/AAL-5436-2020; Zalaudek, Iris/E-5910-2010; Argenziano, Giuseppe/E-5926-2010	Zalaudek, Iris/0000-0002-7878-4955; Zalaudek, Iris/0000-0002-7878-4955; Argenziano, Giuseppe/0000-0003-1413-8214					0	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1741	1741		10.1056/NEJMicm1103059	http://dx.doi.org/10.1056/NEJMicm1103059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113485				2022-12-28	WOS:000310440800011
J	Evrony, GD; Cai, XY; Lee, E; Hills, LB; Elhosary, PC; Lehmann, HS; Parker, JJ; Atabay, KD; Gilmore, EC; Poduri, A; Park, PJ; Walsh, CA				Evrony, Gilad D.; Cai, Xuyu; Lee, Eunjung; Hills, L. Benjamin; Elhosary, Princess C.; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Gilmore, Edward C.; Poduri, Annapurna; Park, Peter J.; Walsh, Christopher A.			Single-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain	CELL			English	Article							HUMAN GENOMES; EVOLUTION; CELLS; NEUN; GENERATION; LANDSCAPE; GERMLINE; TUMOR; GENE; AKT3	A major unanswered question in neuroscience is whether there exists genomic variability between individual neurons of the brain, contributing to functional diversity or to an unexplained burden of neurological disease. To address this question, we developed a method to amplify genomes of single neurons from human brains. Because recent reports suggest frequent LINE-1 (L1) retrotransposition in human brains, we performed genome-wide L1 insertion profiling of 300 single neurons from cerebral cortex and caudate nucleus of three normal individuals, recovering >80% of germline insertions from single neurons. While we find somatic L1 insertions, we estimate <0.6 unique somatic insertions per neuron, and most neurons lack detectable somatic insertions, suggesting that L1 is not a major generator of neuronal diversity in cortex and caudate. We then genotyped single cortical cells to characterize the mosaicism of a somatic AKT3 mutation identified in a child with hemimegalencephaly. Single-neuron sequencing allows systematic assessment of genomic diversity in the human brain.	[Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Poduri, Annapurna; Walsh, Christopher A.] Harvard Univ, Dept Neurol, Sch Med, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Elhosary, Princess C.; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Park, Peter J.] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gilmore, Edward C.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Case Western Reserve University	Walsh, CA (corresponding author), Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		Walsh, Christopher/0000-0002-0156-2238; Parker, John James/0000-0002-6769-5922; Park, Peter/0000-0001-9378-960X; Evrony, Gilad/0000-0001-7621-2630	NIH MSTP grant [T32GM007753]; NIH NIGMS grant [T32GM007726]; Manton Center for Orphan Disease Research; NINDS [R01 NS079277, R01 NS035129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS079277] Funding Source: NIH RePORTER	NIH MSTP grant; NIH NIGMS grant; Manton Center for Orphan Disease Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Peter V. Kharchenko, Tim W. Yu, Vijay S. Ganesh, and Nathan C. Silberman for helpful discussions; Hal Schneider, Richard Bennett, R. Sean Hill, and Christina Kourkoulis for technical assistance; Robert Johnson from the NICHD Brain and Tissue Bank; the Orchestra research computing support team (Harvard Medical School); and the Hematologic Neoplasia Flow Cytometry Core (Dana-Farber Cancer Institute). Brain image in Figure 1A adapted with permission from http://brainmuseum.org, supported by the US National Science Foundation. G. D. E. is supported, in part, by NIH MSTP grant T32GM007753. X. C. is supported, in part, by NIH NIGMS grant T32GM007726. C. A. W. is supported by the Manton Center for Orphan Disease Research and grants from the NINDS (R01 NS079277 and R01 NS035129). C. A. W. is an Investigator of the Howard Hughes Medical Institute.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Flores-Sarnat L, 2003, J CHILD NEUROL, V18, P776, DOI 10.1177/08830738030180111101; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Matevossian A., 2008, JOVE-J VIS EXP, V20, pe914, DOI DOI 10.3791/914; MIKI Y, 1992, CANCER RES, V52, P643; Mills SE, 2007, HISTOLOGY PATHOLOGIS; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	42	364	370	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					483	496		10.1016/j.cell.2012.09.035	http://dx.doi.org/10.1016/j.cell.2012.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101622	Green Accepted, Bronze			2022-12-28	WOS:000310529300007
J	Mallilankaraman, K; Doonan, P; Cardenas, C; Chandramoorthy, HC; Muller, M; Miller, R; Hoffman, NE; Gandhirajan, RK; Molgo, J; Birnbaum, MJ; Rothberg, BS; Mak, DOD; Foskett, JK; Madesh, M				Mallilankaraman, Karthik; Doonan, Patrick; Cardenas, Cesar; Chandramoorthy, Harish C.; Mueller, Marioly; Miller, Russell; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Molgo, Jordi; Birnbaum, Morris J.; Rothberg, Brad S.; Mak, Don-On Daniel; Foskett, J. Kevin; Madesh, Muniswamy			MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival	CELL			English	Article							CALCIUM-UPTAKE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; TRANSPORT; ACTIVATION; MECHANISMS; APOPTOSIS; SUPEROXIDE; UNIPORTER; MEMBRANE	Mitochondrial Ca2+ (Ca-m(2+)) uptake is mediated by an inner membrane Ca2+ channel called the uniporter. Ca2+ uptake is driven by the considerable voltage present across the inner membrane (Delta psi(m)) generated by proton pumping by the respiratory chain. Mitochondrial matrix Ca2+ concentration is maintained five to six orders of magnitude lower than its equilibrium level, but the molecular mechanisms for how this is achieved are not clear. Here, we demonstrate that the mitochondrial protein MICU1 is required to preserve normal [Ca2+](m) under basal conditions. In its absence, mitochondria become constitutively loaded with Ca2+, triggering excessive reactive oxygen species generation and sensitivity to apoptotic stress. MICU1 interacts with the uniporter pore-forming subunit MCU and sets a Ca2+ threshold for Ca-m(2+) uptake without affecting the kinetic properties of MCU-mediated Ca2+ uptake. Thus, MICU1 is a gatekeeper of MCU-mediated Ca-m(2+) uptake that is essential to prevent [Ca2+](m) overload and associated stress.	[Cardenas, Cesar; Mueller, Marioly; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Miller, Russell; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Rothberg, Brad S.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Cardenas, Cesar] Univ Chile, Anat & Dev Biol Program, Inst Biomed Sci, Santiago 8380453, Chile; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol & Dev,UPR 3294, F-91198 Gif Sur Yvette, France	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu; madeshm@temple.edu	Muller, Marioly/J-5420-2014; Foskett, Kevin/R-2549-2019; Rothberg, Brad/AAD-1260-2022	Foskett, J. Kevin/0000-0002-8854-0268; Chinna Konda Chandramoorthy, Harish/0000-0002-8780-8971; Rothberg, Brad/0000-0003-1982-2269; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050; Birnbaum, Morris/0000-0001-9972-8680; Gandhirajan, Rajesh/0000-0002-0039-771X	NIH [HL086699, HL086699-01A2S1, 1S10RR027327-01]; American Heart Association; NRSA Fellowship;  [GM56328];  [MH059937]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK056886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R37GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants HL086699, HL086699-01A2S1, and 1S10RR027327-01 to M. Madesh and by GM56328 and MH059937 to J. K. F. We thank Jun Yang for biochemistry assistance and the University of Pennsylvania IDOM (P30-DK19535) for assistance. C. C. was supported by the American Heart Association. R. M. was supported by an NRSA Fellowship.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; FELICEAZZONE G, 1977, BIOCHIM BIOPHYS ACTA, V459, P96, DOI 10.1016/0005-2728(77)90012-3; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jacobson J, 2002, J CELL SCI, V115, P1175; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mallilankaraman K., 2011, J VIS EXP, V58, pe3511; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; ROTTENBERG H, 1974, BIOCHEMISTRY-US, V13, P4811, DOI 10.1021/bi00720a020; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200	54	436	447	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					630	644		10.1016/j.cell.2012.10.011	http://dx.doi.org/10.1016/j.cell.2012.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101630	Green Accepted, Bronze			2022-12-28	WOS:000310529300018
J	Wang, HG; Glorius, F				Wang, Honggen; Glorius, Frank			Lending Handedness to the Cyclopentadienyl Ligand	SCIENCE			English	Editorial Material							ACTIVATION		[Wang, Honggen; Glorius, Frank] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany	University of Munster	Wang, HG (corresponding author), Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	honggen.wang@uni-muenster.de; glorius@uni-muenster.de	Glorius, Frank/K-6385-2015; wang, honggen/B-1260-2015; wang, honggen/E-7249-2013	Glorius, Frank/0000-0002-0648-956X; wang, honggen/0000-0002-9648-6759; 				Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Gutnov A, 2004, ANGEW CHEM INT EDIT, V43, P3795, DOI 10.1002/anie.200454164; Hartwig J., 2010, ORGANOMETALLIC TRANS; Hoveyda A. H., 1996, ANGEW CHEM INT EDIT, V35, P1262; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; Wasa M, 2011, J AM CHEM SOC, V133, P19598, DOI 10.1021/ja207607s; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Werner H, 2012, ANGEW CHEM INT EDIT, V51, P6052, DOI 10.1002/anie.201201598; Ye BH, 2012, SCIENCE, V338, P504, DOI 10.1126/science.1226938	13	7	7	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					479	480		10.1126/science.1229830	http://dx.doi.org/10.1126/science.1229830			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112320				2022-12-28	WOS:000310195800042
J	Naqvi, J; Watts, G; Rudralingham, V; Duff, S				Naqvi, Jawad; Watts, Gill; Rudralingham, Velauthan; Duff, Sarah			An abnormality at the hepatic flexure	BRITISH MEDICAL JOURNAL			English	Editorial Material							OCCULT BLOOD-TEST; METASTATIC COLORECTAL-CANCER; BARIUM ENEMA EXAMINATION; APPLE-CORE LESION; COLON-CANCER; ADJUVANT CHEMOTHERAPY; CONTROLLED-TRIALS; LIVER METASTASES; PLUS IRINOTECAN; LEUCOVORIN		[Naqvi, Jawad; Watts, Gill; Rudralingham, Velauthan; Duff, Sarah] Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Naqvi, J (corresponding author), Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	naqvi.jawad@gmail.com	Duff, Sarah E/AAW-3795-2021					Alzaraa Ahmed, 2009, Cases J, V2, P7275, DOI 10.4076/1757-1626-2-7275; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andreoni Bruno, 2007, World J Surg Oncol, V5, P73, DOI 10.1186/1477-7819-5-73; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; BOKEY EL, 1995, DIS COLON RECTUM, V38, P480, DOI 10.1007/BF02148847; BOKEY EL, 1995, DIS COLON RECTUM, V38, P486; British National Formulary, 2012, BRIT NAT FORM 63; Burnand KG, 2005, NEW AIRDS COMPANION; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Cappell MS, 2008, GASTROENTEROL CLIN N, V37, P1, DOI 10.1016/j.gtc.2007.12.002; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Department of Health, 2011, BOW CANC SCREEN FACT; DiazGonzalez VM, 1997, J HEART LUNG TRANSPL, V16, P1171; Edge SB, 2010, AJCC CANC STAGING MA; Ekelund G, 2010, INT J COLORECTAL DIS, V25, P1269, DOI 10.1007/s00384-010-1027-1; Freeman AH, 2001, BRIT J RADIOL, V74, P4, DOI 10.1259/bjr.74.877.740004; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Gertig DM, 1998, SEMIN CANCER BIOL, V8, P285, DOI 10.1006/scbi.1998.0078; Gollub MJ, 2007, RADIOL CLIN N AM, V45, P85, DOI 10.1016/j.rcl.2006.10.003; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Hassan I, 2011, MEDSCAPE; Heresbach D, 2006, EUR J GASTROEN HEPAT, V18, P427, DOI 10.1097/00042737-200604000-00018; HERMANEK P, 1994, CHIRURG, V65, P287; Hewett PJ, 2008, ANN SURG, V248, P728, DOI 10.1097/SLA.0b013e31818b7595; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Horton KM, 2000, RADIOGRAPHICS, V20, P419, DOI 10.1148/radiographics.20.2.g00mc14419; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; Jass JR, 2002, SURG CLIN N AM, V82, P891, DOI 10.1016/S0039-6109(02)00047-6; Karoui M, 2011, DIS COLON RECTUM, V54, P930, DOI 10.1097/DCR.0b013e31821cced0; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Lamont EB, 1999, CLIN CANCER RES, V5, P2289; Leslie A, 2002, POSTGRAD MED J, V78, P473, DOI 10.1136/pmj.78.922.473; Levine MS, 2000, RADIOLOGY, V216, P11, DOI 10.1148/radiology.216.1.r00jl3311; Lin CC, 2009, INT J COLORECTAL DIS, V24, P665, DOI 10.1007/s00384-009-0634-1; MCCARTHY PA, 1995, RADIOLOGY, V197, P683, DOI 10.1148/radiology.197.3.7480739; National Institute for Health and Clinical Excellence, 2011, DIAGN MAN COL CANC C; Panchabhai TS, 2011, J GLOB INFECT DIS, V3, P195, DOI 10.4103/0974-777X.81700; Popov I, 2008, EUR J CANCER, V44, P2204, DOI 10.1016/j.ejca.2008.07.002; Roche CJ, 2002, RADIOGRAPHICS, V22, P1369, DOI 10.1148/rg.226025521; Scemla R, 2006, PANCREAS, V32, P332, DOI 10.1097/01.mpa.0000202954.95364.9c; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; Scottish Intercollegiate Guidelines Network, 2011, DIAGN MAN COL CANC S; Sjo OH, 2009, COLORECTAL DIS, V11, P733, DOI 10.1111/j.1463-1318.2008.01613.x; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; The Association of Coloproctology of Great Britain and Ireland, 2007, GUID MAN COL CANC; THOENI RF, 1991, AM J ROENTGENOL, V156, P909, DOI 10.2214/ajr.156.5.2017950; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Watt AM, 2007, ANN SURG, V246, P24, DOI 10.1097/01.sla.0000261124.72687.72; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu YZ, 2011, WORLD J GASTROENTERO, V17, P4143, DOI 10.3748/wjg.v17.i36.4143	52	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 25	2012	345								e7035	10.1136/bmj.e7035	http://dx.doi.org/10.1136/bmj.e7035			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MZ	23100331				2022-12-28	WOS:000310427800009
J	Neto, AS; Cardoso, SO; Manetta, JA; Pereira, VGM; Esposito, DC; Pasqualucci, MDP; Damasceno, MCT; Schultz, MJ				Neto, Ary Serpa; Cardoso, Sergio Oliveira; Manetta, Jose Antonio; Moura Pereira, Victor Galvao; Esposito, Daniel Crepaldi; Prado Pasqualucci, Manoela de Oliveira; Toledo Damasceno, Maria Cecilia; Schultz, Marcus J.			Association Between Use of Lung-Protective Ventilation With Lower Tidal Volumes and Clinical Outcomes Among Patients Without Acute Respiratory Distress Syndrome A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; MECHANICAL VENTILATION; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; INFLAMMATORY RESPONSES; GENERAL-ANESTHESIA; CANCER SURGERY; RISK-FACTOR; INJURY; PULMONARY	Context Lung-protective mechanical ventilation with the use of lower tidal volumes has been found to improve outcomes of patients with acute respiratory distress syndrome (ARDS). It has been suggested that use of lower tidal volumes also benefits patients who do not have ARDS. Objective To determine whether use of lower tidal volumes is associated with improved outcomes of patients receiving ventilation who do not have ARDS. Data Sources MEDLINE, CINAHL, Web of Science, and Cochrane Central Register of Controlled Trials up to August 2012. Study Selection Eligible studies evaluated use of lower vs higher tidal volumes in patients without ARDS at onset of mechanical ventilation and reported lung injury development, overall mortality, pulmonary infection, atelectasis, and biochemical alterations. Data Extraction Three reviewers extracted data on study characteristics, methods, and outcomes. Disagreement was resolved by consensus. Data Synthesis Twenty articles (2822 participants) were included. Meta-analysis using a fixed-effects model showed a decrease in lung injury development (risk ratio [RR], 0.33; 95% CI, 0.23 to 0.47; I-2, 0%; number needed to treat [NNT], 11), and mortality (RR, 0.64; 95% CI, 0.46 to 0.89; I-2, 0%; NNT, 23) in patients receiving ventilation with lower tidal volumes. The results of lung injury development were similar when stratified by the type of study (randomized vs nonrandomized) and were significant only in randomized trials for pulmonary infection and only in nonrandomized trials for mortality. Meta-analysis using a random-effects model showed, in protective ventilation groups, a lower incidence of pulmonary infection (RR, 0.45; 95% CI, 0.22 to 0.92; I-2, 32%; NNT, 26), lower mean (SD) hospital length of stay (6.91 [2.36] vs 8.87 [2.93] days, respectively; standardized mean difference [SMD], 0.51; 95% CI, 0.20 to 0.82; I-2, 75%), higher mean (SD) PaCO2 levels (41.05 [3.79] vs 37.90 [4.19] mm Hg, respectively; SMD, -0.51; 95% CI, -0.70 to -0.32; I-2, 54%), and lower mean (SD) pH values (7.37 [0.03] vs 7.40 [0.04], respectively; SMD, 1.16; 95% CI, 0.31 to 2.02; I-2, 96%) but similar mean (SD) ratios of PaO2 to fraction of inspired oxygen (304.40 [65.7] vs 312.97 [68.13], respectively; SMD, 0.11; 95% CI, -0.06 to 0.27; I-2, 60%). Tidal volume gradients between the 2 groups did not influence significantly the final results. Conclusions Among patients without ARDS, protective ventilation with lower tidal volumes was associated with better clinical outcomes. Some of the limitations of the meta-analysis were the mixed setting of mechanical ventilation (intensive care unit or operating room) and the duration of mechanical ventilation. JAMA. 2012;308(16):1651-1659 www.jama.com	[Neto, Ary Serpa; Cardoso, Sergio Oliveira; Manetta, Jose Antonio; Moura Pereira, Victor Galvao; Esposito, Daniel Crepaldi; Toledo Damasceno, Maria Cecilia] ABC Med Sch, Dept Crit Care Med, Sao Paulo, Brazil; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [Toledo Damasceno, Maria Cecilia] Univ Sao Paulo, Dept Internal Med, Hosp Clin, Sao Paulo, Brazil; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	Faculdade de Medicina do ABC; University of Amsterdam; Academic Medical Center Amsterdam; Universidade de Sao Paulo; University of Amsterdam; Academic Medical Center Amsterdam	Neto, AS (corresponding author), Av Lauro Gomes, BR-2000 Sao Paulo, Brazil.	aryserpa@terra.com.br	Schultz, Marcus/AAB-6379-2021; Serpa Neto, Ary/D-1927-2012; Schultz, Marcus J/K-6147-2012	Schultz, Marcus/0000-0003-3969-7792; Serpa Neto, Ary/0000-0003-1520-9387; 				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Baudouin SV, 2001, THORAX, V56, P50; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Cai HW, 2007, J CLIN ANESTH, V19, P125, DOI 10.1016/j.jclinane.2006.08.008; Carney David, 2005, Crit Care Med, V33, pS122, DOI 10.1097/01.CCM.0000155928.95341.BC; Chaney MA, 2000, J CARDIOTHOR VASC AN, V14, P514, DOI 10.1053/jcan.2000.9487; Checkley W, 2008, AM J RESP CRIT CARE, V177, P1215, DOI 10.1164/rccm.200709-1424OC; de Oliveira RP, 2010, CRIT CARE, V14, DOI 10.1186/cc8919; de Prost N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-28; Determann RM, 2008, AM J PHYSIOL-LUNG C, V294, pL344, DOI 10.1152/ajplung.00268.2007; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fernandez-Bustamante A, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-22; Fernandez-Perez ER, 2006, ANESTHESIOLOGY, V105, P14, DOI 10.1097/00000542-200607000-00007; Gajic O, 2005, INTENS CARE MED, V31, P922, DOI 10.1007/s00134-005-2625-1; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Koner O, 2004, INTENS CARE MED, V30, P620, DOI 10.1007/s00134-003-2104-5; LEE PC, 1990, CHEST, V97, P430, DOI 10.1378/chest.97.2.430; Lellouche F, 2012, ANESTHESIOLOGY, V116, P1072, DOI 10.1097/ALN.0b013e3182522df5; Licker M, 2009, CRIT CARE, V13, DOI 10.1186/cc7762; Lin Wen-Qian, 2008, Ai Zheng, V27, P870; Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011; Mikkelsen ME, 2008, RESP CARE, V53, P455; Plotz FB, 2004, INTENS CARE MED, V30, P1865, DOI 10.1007/s00134-004-2363-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Sundar S, 2011, ANESTHESIOLOGY, V114, P1102, DOI 10.1097/ALN.0b013e318215e254; Weingarten TN, 2010, BRIT J ANAESTH, V104, P16, DOI 10.1093/bja/aep319; Wolthuis EK, 2007, CRIT CARE, V11, DOI 10.1186/cc5969; Wrigge H, 2004, ANESTH ANALG, V98, P775; Wrigge H, 2005, INTENS CARE MED, V31, P1379, DOI 10.1007/s00134-005-2767-1; Yang M, 2011, CHEST, V139, P530, DOI 10.1378/chest.09-2293; Yilmaz M, 2007, CRIT CARE MED, V35, P1660, DOI 10.1097/01.CCM.0000269037.66955.F0; Zupancich E, 2005, J THORAC CARDIOV SUR, V130, P378, DOI 10.1016/j.jtcvs.2004.11.061	38	519	534	4	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1651	1659		10.1001/jama.2012.13730	http://dx.doi.org/10.1001/jama.2012.13730			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093163	Bronze			2022-12-28	WOS:000310434100019
J	Jutel, A; McBain, L				Jutel, Annemarie; McBain, Lynn			Do We Really Need to Know?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jutel, Annemarie] Victoria Univ Wellington, Grad Sch Nursing Midwifery & Hlth, Wellington, New Zealand; [McBain, Lynn] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand	Victoria University Wellington; University of Otago	Jutel, A (corresponding author), Victoria Univ Wellington, Grad Sch Nursing Midwifery & Hlth, Wellington, New Zealand.	annemarie.jutel@vuw.ac.nz	Jutel, Annemarie/I-2616-2019	Jutel, Annemarie/0000-0001-7131-3838				Balint M., 1964, DOCTOR HIS PATIENT I; BROWN P, 1995, J HEALTH SOC BEHAV, V35, P34, DOI 10.2307/2626956; Cassell EJ, 1991, NATURE SUFFERING GOA; Conrad P, 2007, MED SOC; Healy D, 2006, PLOS MED, V3, P441, DOI 10.1371/journal.pmed.0030185; Jutel A., 2011, PUTTING NAME IT DIAG; LEDER D, 1990, THEOR MED, V11, P9, DOI 10.1007/BF00489234; Lillrank A, 2003, SOC SCI MED, V57, P1045, DOI 10.1016/S0277-9536(02)00479-3; Nettleton S, 2004, SOCIOLOGY, V38, P661, DOI 10.1177/0038038504045857; PARRY V, 2007, PHARM EXEC S     OCT, P22; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Welch H, 2011, OVERDIAGNOSED MAKING	12	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1533	1534		10.1001/2012.jama.12266	http://dx.doi.org/10.1001/2012.jama.12266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073949				2022-12-28	WOS:000309858100019
J	McCarthy, M				McCarthy, Michael			Fact and fiction in the US election healthcare debate	BRITISH MEDICAL JOURNAL			English	Editorial Material									LocalHealthGuide Com, Seattle, WA USA		McCarthy, M (corresponding author), LocalHealthGuide Com, Seattle, WA USA.	mxmc@mac.com						[Anonymous], 2012, COMMUNICATION, P1; [Anonymous], 2012, HLTH CAR 2012 PRES E; Independent Payment Advisory Board, 2011, NEW APPR CONTR MED S	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 16	2012	345								e7007	10.1136/bmj.e7007	http://dx.doi.org/10.1136/bmj.e7007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WG	23077344				2022-12-28	WOS:000310140600022
J	Behrndt, M; Salbreux, G; Campinho, P; Hauschild, R; Oswald, F; Roensch, J; Grill, SW; Heisenberg, CP				Behrndt, Martin; Salbreux, Guillaume; Campinho, Pedro; Hauschild, Robert; Oswald, Felix; Roensch, Julia; Grill, Stephan W.; Heisenberg, Carl-Philipp			Forces Driving Epithelial Spreading in Zebrafish Gastrulation	SCIENCE			English	Article							MORPHOGENESIS; DROSOPHILA; MOVEMENT	Contractile actomyosin rings drive various fundamental morphogenetic processes ranging from cytokinesis to wound healing. Actomyosin rings are generally thought to function by circumferential contraction. Here, we show that the spreading of the enveloping cell layer (EVL) over the yolk cell during zebrafish gastrulation is driven by a contractile actomyosin ring. In contrast to previous suggestions, we find that this ring functions not only by circumferential contraction but also by a flow-friction mechanism. This generates a pulling force through resistance against retrograde actomyosin flow. EVL spreading proceeds normally in situations where circumferential contraction is unproductive, indicating that the flow-friction mechanism is sufficient. Thus, actomyosin rings can function in epithelial morphogenesis through a combination of cable-constriction and flow-friction mechanisms.	[Salbreux, Guillaume; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Behrndt, Martin; Oswald, Felix; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Behrndt, Martin; Campinho, Pedro; Hauschild, Robert; Roensch, Julia; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria	Max Planck Society; Max Planck Society; Institute of Science & Technology - Austria	Grill, SW (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	grill@mpi-cbg.de; heisenberg@ist.ac.at	Grill, Stephan/D-9427-2012; Ladoux, Benoit/A-9879-2013	Heisenberg, Carl-Philipp/0000-0002-0912-4566; Campinho, Pedro/0000-0002-8526-5416; Salbreux, Guillaume/0000-0001-7041-1292	Fonds zur Forderung der wissenschaftlichen Forschung (FWF); Deutsche Forschungsgemeinschaft (DFG) [I930-B20]; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. Sixt, T. Bollenbach, and E. Martin-Blanco for advice and the service facilities of the IST Austria and MPI-CBG for continuous help. M. B., G. S., S. W. G., and C.-P. H. synergistically and equally developed the presented ideas and the experimental and theoretical approaches. M. B. and P. C. performed the experiments; G. S. developed the theory; and R. H., F.O., and J.R. contributed to the experimental work. This work was supported by a grant from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) and the Deutsche Forschungsgemeinschaft (DFG) (I930-B20) to C.-P. H., S. W. G., and G.S.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Holloway BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000413; Howard J., 2001, MECH MOTOR PROTEINS; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Kane DA, 1996, DEVELOPMENT, V123, P47; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Siddiqui M, 2010, DEV DYNAM, V239, P715, DOI 10.1002/dvdy.22172	18	266	268	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					257	260		10.1126/science.1224143	http://dx.doi.org/10.1126/science.1224143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066079				2022-12-28	WOS:000309712300046
J	Lane, N				Lane, Nick			The Problem with Mixing Mitochondria	CELL			English	Editorial Material							OXIDATIVE-PHOSPHORYLATION; SELECTION; DNA		UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk		Lane, Nick/0000-0002-5433-3973				Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026297	10	36	36	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					246	248		10.1016/j.cell.2012.09.028	http://dx.doi.org/10.1016/j.cell.2012.09.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063117	Bronze			2022-12-28	WOS:000309981000003
J	Michalopoulos, NV; Keshtgar, MR				Michalopoulos, Nikolaos V.; Keshtgar, Mohammed R.			Gynecomastia Induced by Prostate-Cancer Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Michalopoulos, Nikolaos V.; Keshtgar, Mohammed R.] UCL, Royal Free London NHS Fdn Trust, London, England	University of London; University College London; Royal Free London NHS Foundation Trust	Michalopoulos, NV (corresponding author), UCL, Royal Free London NHS Fdn Trust, London, England.	m.keshtgar@ucl.ac.uk							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1449	1449		10.1056/NEJMicm1209166	http://dx.doi.org/10.1056/NEJMicm1209166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050528				2022-12-28	WOS:000309652700011
J	Biankin, AV; Waddell, N; Kassahn, KS; Gingras, MC; Muthuswamy, LB; Johns, AL; Miller, DK; Wilson, PJ; Patch, AM; Wu, JM; Chang, DK; Cowley, MJ; Gardiner, BB; Song, S; Harliwong, I; Idrisoglu, S; Nourse, C; Nourbakhsh, E; Manning, S; Wani, S; Gongora, M; Pajic, M; Scarlett, CJ; Gill, AJ; Pinho, AV; Rooman, I; Anderson, M; Holmes, O; Leonard, C; Taylor, D; Wood, S; Xu, QY; Nones, K; Fink, JL; Christ, A; Bruxner, T; Cloonan, N; Kolle, G; Newell, F; Pinese, M; Mead, RS; Humphris, JL; Kaplan, W; Jones, MD; Colvin, EK; Nagrial, AM; Humphrey, ES; Chou, A; Chin, VT; Chantrill, LA; Mawson, A; Samra, JS; Kench, JG; Lovell, JA; Daly, RJ; Merrett, ND; Toon, C; Epari, K; Nguyen, NQ; Barbour, A; Zeps, N; Kakkar, N; Zhao, FM; Wu, YQ; Wang, M; Muzny, DM; Fisher, WE; Brunicardi, FC; Hodges, SE; Reid, JG; Drummond, J; Chang, K; Han, Y; Lewis, LR; Dinh, H; Buhay, CJ; Beck, T; Timms, L; Sam, M; Begley, K; Brown, A; Pai, D; Panchal, A; Buchner, N; De Borja, R; Denroche, RE; Yung, CK; Serra, S; Onetto, N; Mukhopadhyay, D; Tsao, MS; Shaw, PA; Petersen, GM; Gallinger, S; Hruban, RH; Maitra, A; Iacobuzio-Donahue, CA; Schulick, RD; Wolfgang, CL; Morgan, RA; Lawlor, RT; Capelli, P; Corbo, V; Scardoni, M; Tortora, G; Tempero, MA; Mann, KM; Jenkins, NA; Perez-Mancera, PA; Adams, DJ; Largaespada, DA; Wessels, LFA; Rust, AG; Stein, LD; Tuveson, DA; Copeland, NG; Musgrove, EA; Scarpa, A; Eshleman, JR; Hudson, TJ; Sutherland, RL; Wheeler, DA; Pearson, JV; McPherson, JD; Gibbs, RA; Grimmond, SM				Biankin, Andrew V.; Waddell, Nicola; Kassahn, Karin S.; Gingras, Marie-Claude; Muthuswamy, Lakshmi B.; Johns, Amber L.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Kolle, Gabriel; Newell, Felicity; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Fisher, William E.; Brunicardi, F. Charles; Hodges, Sally E.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Serra, Stefano; Onetto, Nicole; Mukhopadhyay, Debabrata; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Gallinger, Steven; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Schulick, Richard D.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Capelli, Paola; Corbo, Vincenzo; Scardoni, Maria; Tortora, Giampaolo; Tempero, Margaret A.; Mann, Karen M.; Jenkins, Nancy A.; Perez-Mancera, Pedro A.; Adams, David J.; Largaespada, David A.; Wessels, Lodewyk F. A.; Rust, Alistair G.; Stein, Lincoln D.; Tuveson, David A.; Copeland, Neal G.; Musgrove, Elizabeth A.; Scarpa, Aldo; Eshleman, James R.; Hudson, Thomas J.; Sutherland, Robert L.; Wheeler, David A.; Pearson, John V.; McPherson, John D.; Gibbs, Richard A.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes	NATURE			English	Article							SOMATIC MUTATIONS; TUMOR; INSTABILITY; EXPRESSION; RESECTION; ROLES	Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n=142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.	[Waddell, Nicola; Kassahn, Karin S.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Newell, Felicity; Pearson, John V.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Biankin, Andrew V.; Chang, David K.; Merrett, Neil D.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.; Chang, David K.] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Liverpool, NSW 2170, Australia; [Gingras, Marie-Claude; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gingras, Marie-Claude; Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Muthuswamy, Lakshmi B.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Onetto, Nicole; Stein, Lincoln D.; Hudson, Thomas J.; McPherson, John D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Gill, Anthony J.; Samra, Jaswinder S.] Royal N Shore Hosp, Dept Anat Pathol, Sydney, NSW 2065, Australia; [Gill, Anthony J.; Kench, James G.] Univ Sydney, Sydney, NSW 2006, Australia; [Kolle, Gabriel] Life Technol, Brisbane, Qld 4000, Australia; [Mead, R. Scott; Chou, Angela] St Vincents Hosp, Dept Anat Pathol, Sydney, NSW 2010, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, Sydney, NSW 2065, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fremantle Hosp, Dept Surg, Fremantle, WA 6160, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia; [Barbour, Andrew] Univ Queensland, Princess Alexandra Hosp, Dept Surg, Woollongabba, Qld 4102, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg M507, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, Subiaco, WA 6008, Australia; [Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Serra, Stefano; Tsao, Ming-Sound; Shaw, Patricia A.; Gallinger, Steven] Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Mukhopadhyay, Debabrata; Petersen, Gloria M.] Mayo Clin, Rochester, MN 55905 USA; [Gallinger, Steven] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Morgan, Richard A.; Eshleman, James R.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Schulick, Richard D.; Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Lawlor, Rita T.; Corbo, Vincenzo; Scarpa, Aldo] Univ & Hosp Trust Verona, ARC NET Ctr Appl Res Canc, I-37134 Verona, Italy; [Capelli, Paola; Scardoni, Maria; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Dept Surg & Oncol, I-37134 Verona, Italy; [Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94115 USA; [Mann, Karen M.; Jenkins, Nancy A.; Copeland, Neal G.] Methodist Hosp, Res Inst, Canc Res Program, Houston, TX 77030 USA; [Perez-Mancera, Pedro A.; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Perez-Mancera, Pedro A.; Tuveson, David A.] Dept Oncol, Cambridge CB2 0RE, England; [Adams, David J.; Rust, Alistair G.] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Musgrove, Elizabeth A.; Sutherland, Robert L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia	University of Queensland; Garvan Institute of Medical Research; University of New South Wales Sydney; Baylor College of Medicine; Baylor College of Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; Thermo Fisher Scientific; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Western Sydney University; University of Western Australia; Royal Adelaide Hospital; University of Queensland; University of Western Australia; St John of God Health Care; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Johns Hopkins University; Johns Hopkins University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of California System; University of California San Francisco; The Methodist Hospital System; The Methodist Hospital - Houston; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; University of New South Wales Sydney	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia.	s.grimmond@imb.uq.edu.au	Wheeler, David A/M-9740-2018; Newell, Felicity/AAN-1253-2020; Drummond, Jennifer/AAG-1654-2020; Fink, Lynn/C-2031-2008; Cloonan, Nicole/B-5272-2008; Merrett, Neil/H-8033-2019; Waddell, Nicola/H-4929-2015; Chantrill, Lorraine/GXF-5117-2022; Zeps, Nikolajs/C-4180-2013; Pearson, John/AAT-4211-2020; McPherson, John D/D-2633-2017; Barbour, Andrew/F-4717-2010; Wolfgang, Christopher/HGD-0863-2022; Tortora, Giampaolo/AAA-1252-2019; Cowley, Mark/K-8731-2019; Grimmond, Sean M/J-5304-2016; Gardiner, Brooke B/C-7773-2011; scarpa, aldo/K-6832-2016; Corbo, Vincenzo/J-7754-2016; Tsao, Ming Sound/AFQ-7332-2022; Gallinger, Steven/E-4575-2013; Patch, Ann-Marie/C-4201-2018; Nones, Katia/AAX-6453-2021; Tsao, Ming-Sound/M-3503-2017; Merrett, Neil/ABB-4342-2021; Zeps, Nikolajs/AAF-3186-2021; Leonard, Conrad/AAD-2587-2020; Gill, Anthony J./M-5015-2019; Iacobuzio-Donahue, Christine/ABF-1295-2020; Pearson, John V/F-2249-2011; Grimmond, Sean/K-3246-2019; Mann, Karen/AAW-8323-2020; Largaespada, David/C-9832-2014; Gill, Anthony/D-4215-2015; Wu, Jianmin/G-3629-2010	Wheeler, David A/0000-0002-9056-6299; Drummond, Jennifer/0000-0002-2612-5958; Fink, Lynn/0000-0003-2912-6048; Cloonan, Nicole/0000-0001-7802-6647; Merrett, Neil/0000-0002-8370-0293; Waddell, Nicola/0000-0002-3950-2476; Zeps, Nikolajs/0000-0002-6404-6839; McPherson, John D/0000-0001-8049-9347; Cowley, Mark/0000-0002-9519-5714; Grimmond, Sean M/0000-0002-8102-7998; Gardiner, Brooke B/0000-0003-3740-3244; scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Tsao, Ming Sound/0000-0002-9160-5405; Patch, Ann-Marie/0000-0001-6121-4019; Nones, Katia/0000-0003-1925-5196; Merrett, Neil/0000-0002-8370-0293; Zeps, Nikolajs/0000-0002-6404-6839; Leonard, Conrad/0000-0002-4131-2065; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Pearson, John V/0000-0003-0904-4598; Grimmond, Sean/0000-0002-8102-7998; Gill, Anthony/0000-0002-9447-1967; Chin, Venessa/0000-0002-4630-4451; Kench, James Geoffrey/0000-0001-8687-4988; Chou, Angela/0000-0001-9212-6927; Bruxner, Timothy/0000-0002-8088-316X; Barbour, Andrew/0000-0002-0991-7662; Yung, Christina/0000-0003-2958-150X; Christ, Angelika/0000-0002-8680-2367; Pinese, Mark/0000-0001-5078-6687; Daly, Roger/0000-0002-5739-8027; Rust, Alistair/0000-0001-7287-192X; Pinho, Andreia V./0000-0003-0647-4015; Chang, Kyle/0000-0001-5295-9676; Beck, Timothy/0000-0003-0145-3557; Nikfarjam, Mehrdad/0000-0003-4866-276X; Spry, Nigel/0000-0001-8659-5065; Biankin, Andrew/0000-0002-0362-5597; Adams, David/0000-0001-9490-0306; Kassahn, Karin/0000-0002-1662-3355; lawlor, Rita/0000-0003-3160-0634; Christophi, Christopher/0000-0002-1349-0884; Wong, Rachel/0000-0001-6760-0463; Jones, Marc/0000-0002-3078-8359; Pajic, Marina/0000-0002-3871-3829; Brancato, Mary-Anne/0000-0002-5439-4549; Rooman, Ilse/0000-0001-7264-2246; Wu, Jianmin/0000-0002-8876-128X; Tortora, Giampaolo/0000-0002-1378-4962; Colvin, Emily/0000-0002-5435-5902; Chang, David/0000-0002-4821-3078; Scarlett, Christopher/0000-0002-4140-7785; serra, stefano/0000-0002-3258-2637; Chantrill, Lorraine/0000-0002-5790-0208	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601, 535914]; Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW [SRP06-01, ICGC09-01, SRP11-01]; Cancer Institute NSW [06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI [U54 HG003273]; CPRIT [RP101353-P7]; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH [R01 CA97075]; Agency for Science, Technology, and Research (Singapore); University of Verona; Italian Ministry of University, Rome, Italy [FIRB RBAP10AHJB]; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH [P50CA062924, P01CA134292]; Sol Goldman Pancreatic Cancer Research Center; NCI [R01 CA97075, P50 CA102701]; NIH SPORE grant [2P50CA101955]; AIRC (Associazione Italiana Ricerca sul Cancro), Italy [12182]; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA062924, P50CA101955, P50CA102701, R01CA113636, R01CA097075, P01CA134292] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland(University of Queensland); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI; CPRIT; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Pancreatic Cancer Genetic Epidemiology Consortium, NIH; Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); University of Verona; Italian Ministry of University, Rome, Italy; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); CPRIT (Cancer Prevention Research Institute of Texas); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sol Goldman Pancreatic Cancer Research Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH SPORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC (Associazione Italiana Ricerca sul Cancro), Italy(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This paper is dedicated to Robert L. Sutherland who died on 10 October 2012 of pancreatic cancer. We would like to thank C. Axford, D. Gwynne, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; and W. Waterson, J. Shepperd, E. Campbell and E. Glasov for their efforts at the Queensland Centre for Medical Genomics. We also thank M. B. Hodgin, M. Debeljak and D. Trusty for technical assistance at Johns Hopkins University, and J. Lau, M. Karaus, K. Rabe, L. Zhang and T. Smyrk at the Mayo Clinic. We acknowledge the following funding support: National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601, 535914); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW (SRP06-01; ICGC09-01; SRP11-01); Cancer Institute NSW (06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI U54 HG003273; CPRIT grant RP101353-P7 (Tumor Banking for Genomic Research and Clinical Translation Site 1); The Ontario Institute for Cancer Research; The Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH grant R01 CA97075; The Agency for Science, Technology, and Research (Singapore); University of Verona and Italian Ministry of University (FIRB RBAP10AHJB), Rome, Italy; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH P50CA062924 (SPORE) and P01CA134292 (PPG); The Sol Goldman Pancreatic Cancer Research Center; NCI grant P50 CA102701 (Mayo Clinic SPORE in Pancreatic Cancer) and NCI grant R01 CA97075 (Pancreatic Cancer Genetic Epidemiology Consortium); NIH SPORE grant 2P50CA101955 (UMN/UAB), and AIRC (Associazione Italiana Ricerca sul Cancro) 5xmille grant 12182, Italy.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Butturini G, 2008, ARCH SURG-CHICAGO, V143, P75, DOI 10.1001/archsurg.2007.17; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao Y, 2011, NAT REV CANCER, V11, P749, DOI 10.1038/nrc3138; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Chang DK, 2009, J CLIN ONCOL, V27, P2855, DOI 10.1200/JCO.2008.20.5104; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jamieson NB, 2011, ANN SURG ONCOL, V18, P2318, DOI 10.1245/s10434-011-1560-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kikuchi K, 2003, J BIOL CHEM, V278, P42985, DOI 10.1074/jbc.M302395200; Kris M. G., 2011, ACCELERATING PROGR C; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Samuel N, 2012, NAT REV GASTRO HEPAT, V9, P77, DOI 10.1038/nrgastro.2011.215; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111	38	1411	1453	8	270	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					399	405		10.1038/nature11547	http://dx.doi.org/10.1038/nature11547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23103869	Green Accepted			2022-12-28	WOS:000311031600037
J	Lammel, S; Lim, BK; Ran, C; Huang, KW; Betley, MJ; Tye, KM; Deisseroth, K; Malenka, RC				Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Tye, Kay M.; Deisseroth, Karl; Malenka, Robert C.			Input-specific control of reward and aversion in the ventral tegmental area	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; LATERAL HABENULA; GABA NEURONS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; RABIES VIRUS; RAT; ACTIVATION; STIMULATION	Ventral tegmental area (VTA) dopamine neurons have important roles in adaptive and pathological brain functions related to reward and motivation. However, it is unknown whether subpopulations of VTA dopamine neurons participate in distinct circuits that encode different motivational signatures, and whether inputs to the VTA differentially modulate such circuits. Here we show that, because of differences in synaptic connectivity, activation of inputs to the VTA from the laterodorsal tegmentum and the lateral habenula elicit reward and aversion in mice, respectively. Laterodorsal tegmentum neurons preferentially synapse on dopamine neurons projecting to the nucleus accumbens lateral shell, whereas lateral habenula neurons synapse primarily on dopamine neurons projecting to the medial prefrontal cortex as well as on GABAergic (gamma-aminobutyric-acid-containing) neurons in the rostromedial tegmental nucleus. These results establish that distinct VTA circuits generate reward and aversion, and thereby provide a new framework for understanding the circuit basis of adaptive and pathological motivated behaviours.	[Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; Stanford University; Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Ran, Chen/N-3007-2017; Tye, Kay/J-6158-2013; Lammel, Stephan/O-8295-2018	Tye, Kay/0000-0002-2435-0182; Lammel, Stephan/0000-0002-3350-3208; Ran, Chen/0000-0002-6632-2366; Lim, Byungkook/0000-0002-3766-5415	National Institutes of Health [NIH NS069375]; Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Stanford Neuroscience Imaging Core, the Stanford Neuroscience Behavior Phenotyping and Pharmacology Core and the Stanford Neuroscience Gene Vector and Virus Core (all supported by National Institutes of Health grant NIH NS069375). This work was supported by grants from the Simons Foundation and NIH (to R. C. M.). K. D. is supported by the NIH, the DARPA REPAIR program, and the Wiegers Family Fund. S. L. is supported by a fellowship from the German Academy of Sciences Leopoldina. B. K. L. is supported by a Davis Foundation Postdoctoral Fellowship in Eating Disorders Research. K. M. T. is supported by the JPB Foundation and NIMH.	ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vertes RP, 1999, J COMP NEUROL, V407, P555; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	42	854	904	5	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					212	+		10.1038/nature11527	http://dx.doi.org/10.1038/nature11527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064228	Green Submitted, Green Accepted			2022-12-28	WOS:000310774300035
J	Kesselheim, AS; Avorn, J; Greene, JA				Kesselheim, Aaron S.; Avorn, Jerry; Greene, Jeremy A.			Risk, Responsibility, and Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AHRQ HHS [K08 HS018465] Funding Source: Medline; NLM NIH HHS [G13 LM010890] Funding Source: Medline; AHRQ [5K08HS018465-04] Funding Source: Federal RePORTER; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G13LM010890] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Duke J, PHARMACOEPI IN PRESS; Glantz LH, 2011, NEW ENGL J MED, V365, P681, DOI 10.1056/NEJMp1107832; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Madigan D, 2012, AM HEART J, V164, P186, DOI 10.1016/j.ahj.2012.05.002; Thomas K., 2012, NY TIMES	5	6	6	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1679	1681		10.1056/NEJMp1208781	http://dx.doi.org/10.1056/NEJMp1208781			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113477	Green Accepted			2022-12-28	WOS:000310440800002
J	Ell, B; Kang, YB				Ell, Brian; Kang, Yibin			SnapShot: Bone Metastasis	CELL			English	Editorial Material							BREAST-CANCER		[Ell, Brian; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Ell, B (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Kang, Yibin/0000-0002-1626-6730				Bidwell B. N., 2012, NAT MED; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	10	81	83	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3							690.e1	10.1016/j.cell.2012.10.005	http://dx.doi.org/10.1016/j.cell.2012.10.005			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101634	Bronze			2022-12-28	WOS:000310529300024
J	Brennan, MD; Cheong, R; Levchenko, A				Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre			How Information Theory Handles Cell Signaling and Uncertainty	SCIENCE			English	Editorial Material							DYNAMICS; BIOLOGY; NOISE; FLOW		[Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Brennan, MD (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	alev@jhu.edu		Brennan, Matthew/0000-0003-3992-713X	NCI NIH HHS [CA65145, R01 CA065145] Funding Source: Medline; NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [GM072024, U54 GM103520, R01 GM072024, GM084322] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, R01GM072024] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alberts B, 2008, MOL BIOL CELL; Andrews BW, 2007, PLOS COMPUT BIOL, V3, P1489, DOI 10.1371/journal.pcbi.0030153; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BERGER T, 2003, IEEE INF THEORY SOC, V53, P1; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bowsher CG, 2012, P NATL ACAD SCI USA, V109, pE1320, DOI 10.1073/pnas.1119407109; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; de Ronde W, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048101; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mian IS, 2011, INTEGR BIOL-UK, V3, P350, DOI 10.1039/c0ib00117a; Milenkovic O, 2010, IEEE T INFORM THEORY, V56, P649, DOI 10.1109/TIT.2009.2036971; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Polani D, 2009, HFSP J, V3, P307, DOI 10.2976/1.3171566; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MC, 2006, ELEMENTS INFORM THEO; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	25	50	51	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					334	335		10.1126/science.1227946	http://dx.doi.org/10.1126/science.1227946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022JS	23087235	Green Accepted			2022-12-28	WOS:000309955800026
J	Sun, LF; Zeng, X; Yan, CY; Sun, XY; Gong, XQ; Rao, Y; Yan, NE				Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng			Crystal structure of a bacterial homologue of glucose transporters GLUT1-4	NATURE			English	Article							DEFICIENCY SYNDROME GLUT1DS; MOLECULAR-BASIS; CLASSIFICATION DATABASE; SUBSTRATE RECOGNITION; LACTOSE PERMEASE; BINDING-SITE; MECHANISM; PROTEINS; GENE; SEQUENCE	Glucose transporters are essential for metabolism of glucose in cells of diverse organisms from microbes to humans, exemplified by the disease-related human proteins GLUT1, 2, 3 and 4. Despite rigorous efforts, the structural information for GLUT1-4 or their homologues remains largely unknown. Here we report three related crystal structures of XylE, an Escherichia coli homologue of GLUT1-4, in complex with D-xylose, D-glucose and 6-bromo-6-deoxy-D-glucose, at resolutions of 2.8, 2.9 and 2.6 angstrom, respectively. The structure consists of a typical major facilitator superfamily fold of 12 transmembrane segments and a unique intracellular four-helix domain. XylE was captured in an outward-facing, partly occluded conformation. Most of the important amino acids responsible for recognition of D-xylose or D-glucose are invariant in GLUT1-4, suggesting functional and mechanistic conservations. Structure-based modelling of GLUT1-4 allows mapping and interpretation of disease-related mutations. The structural and biochemical information reported here constitutes an important framework for mechanistic understanding of glucose transporters and sugar porters in general.	[Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Zeng, Xin/0000-0003-4207-2902	Ministry of Science and Technology [2009CB918802, 2011CB910501]; National Natural Science Foundation of China [31125009, 91017011]; Tsinghua University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	We thank J. He, L. Tang, F. Yu and S. Huang at Shanghai Synchrotron Radiation Facility, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), projects 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DAVIS EO, 1984, J BIOL CHEM, V259, P1520; DAVIS EO, 1987, J BIOL CHEM, V262, P13928; DeLano W.L, PYMOL MOL GRAPHICS S; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Ho YY, 2001, PEDIATR RES, V50, P254, DOI 10.1203/00006450-200108000-00015; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; LAM VMS, 1980, J BACTERIOL, V143, P396, DOI 10.1128/JB.143.1.396-402.1980; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Mueckler Mike, 1993, Journal of Diabetes and its Complications, V7, P130, DOI 10.1016/1056-8727(93)90038-Z; Nelson D. L., 2008, LEHNINGER PRINCIPLES, P1158; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pascual JM, 2004, EUR J ENDOCRINOL, V150, P627, DOI 10.1530/eje.0.1500627; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Scheffer IE, 2012, NEUROLOGY, V78, P524, DOI 10.1212/WNL.0b013e318248a245; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Snider C., 2011, MEMBRANE PROTEINS KN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Xiang ZX, 2007, PROTEINS, V66, P814, DOI 10.1002/prot.21099; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	62	327	350	29	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					361	+		10.1038/nature11524	http://dx.doi.org/10.1038/nature11524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075985				2022-12-28	WOS:000309918500037
J	James, AH				James, Andra H.			Contraceptive transdermal patches or vaginal rings were associated with increased venous thrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia, Charlottesville, VA USA	University of Virginia	James, AH (corresponding author), Univ Virginia, Charlottesville, VA USA.			James, Andra/0000-0003-4570-6595				Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; World Health Organization (WHO), 2010, MED EL CONTR US	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-10	10.7326/0003-4819-157-8-201210160-02010	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070512				2022-12-28	WOS:000309906000009
J	Shivkumar, S; Peeling, R; Jafari, Y; Joseph, L; Pai, NP				Shivkumar, Sushmita; Peeling, Rosanna; Jafari, Yalda; Joseph, Lawrence; Pai, Nitika Pant			Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DIAGNOSTIC-ACCURACY; VIRUS-INFECTION; STATISTICS NOTES; WHOLE-BLOOD; ANTIBODIES; HIV; COINFECTION; ASSAYS; EPIDEMIOLOGY; PERFORMANCE	170 million persons worldwide are infected with hepatitis C, many of whom are undiagnosed. Although rapid diagnostic tests (RDTs) and point-of-care tests (POCTs) provide a time-and cost-saving alternative to conventional laboratory tests, their global uptake partly depends on their performance. To meta-analyze the diagnostic accuracy of POCTs and RDTs to screen for hepatitis C. MEDLINE, EMBASE, BIOSIS, and Web of Science (1992 to 2012) and bibliographies of included articles. All studies evaluating the diagnostic accuracy of POCTs and RDTs for hepatitis C in adults (aged >= 18 years). Two independent reviewers extracted data and critiqued study quality. Of 19 studies reviewed, 18 were meta-analyzed and stratified by specimen type (whole blood, serum, plasma, or oral fluid) or test type (POCT or RDT). Sensitivity was similarly high in POCTs of whole blood (98.9% [95% CI, 94.5% to 99.8%]) and serum or plasma (98.9% [CI, 96.8% to 99.6%]), followed by RDTs of serum or plasma (98.4% [CI, 88.9% to 99.8%]) and POCTs of oral fluid (97.1% [CI, 94.7% to 98.4%]). Specificity was also high in POCTs of whole blood (99.5% [CI, 97.5% to 99.9%]) and serum or plasma (99.7% [CI, 99.3% to 99.9%]), followed by RDTs of serum or plasma (98.6% [CI, 94.9% to 99.6%]) and POCTs of oral fluid (98.2% [CI, 92.2% to 99.6%]). Lack of data prevented sensitivity analyses of specific tests. Data suggest that POCTs of blood (serum, plasma, or whole blood) have the highest accuracy, followed by RDTs of serum or plasma and POCTs of oral fluids. Given their accuracy, convenience, and quick turnaround time, RDTs and POCTs may be useful in expanding first-line screening for hepatitis C.	[Shivkumar, Sushmita; Jafari, Yalda] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Peeling, Rosanna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Joseph, Lawrence] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Pai, Nitika Pant] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol,Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University; University of London; London School of Hygiene & Tropical Medicine; McGill University; McGill University; Royal Victoria Hospital	Shivkumar, S (corresponding author), McGill Univ, Dept Med, Ctr Hlth, V Bldg,Room V1-04,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.			Jafari, Yalda/0000-0002-8922-3387; Pant Pai, Nitika/0000-0002-4672-0500	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Alter M.J., 2003, MMWR RECOMM REP, V52, P1; Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Alter MJ., 2003, MMWR RECOMM REP, V52, P1; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Daniel HDJ, 2005, J CLIN MICROBIOL, V43, P1977, DOI 10.1128/JCM.43.4.1977-1978.2005; De Cock L, 2004, J VIROL METHODS, V122, P179, DOI 10.1016/j.jviromet.2004.09.001; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Department of Blood Safety and Clinical Technology, 2001, 1 WHO DEP BLOOD SAF; Department of Blood Safety and Clinical Technology, 2002, WHO EV PHAS IN PRESS; Deparument of Blood Safety and Clinical Technology, 2001, 2 WHO DEP BLOOD SAF; Downing M, 2001, AIDS CARE, V13, P561, DOI 10.1080/09540120120063205; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Harbord R, 2009, METAANALYSIS STATA U; Hui AY, 2002, ACTA VIROL, V46, P47; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kaur H, 2000, Indian J Med Sci, V54, P432; Lee SR, 2010, J CLIN VIROL, V48, P15, DOI 10.1016/j.jcv.2010.02.018; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Mabey D, 2001, SEX TRANSM INFECT, V77, P397, DOI 10.1136/sti.77.6.397; Montebugnoli L, 1999, CLIN CHIM ACTA, V288, P91, DOI 10.1016/S0009-8981(99)00146-1; Mvere D, 1996, B WORLD HEALTH ORGAN, V74, P19; Nelson DR, 2009, HEPATOLOGY, V50, P997, DOI 10.1002/hep.23208; Njouom R, 2006, J VIROL METHODS, V133, P223, DOI 10.1016/j.jviromet.2005.11.001; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Ivantes CAP, 2010, BRAZ J INFECT DIS, V14, P483, DOI 10.1590/S1413-86702010000500010; Poovorawan Yong, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P647; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smith BD, 2011, CLIN INFECT DIS, V53, P780, DOI 10.1093/cid/cir499; Smith BD, 2011, J INFECT DIS, V204, P825, DOI 10.1093/infdis/jir422; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953; Torane VP, 2008, INDIAN J MED MICROBI, V26, P284, DOI 10.4103/0255-0857.42071; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yuen MF, 2001, AM J GASTROENTEROL, V96, P838, DOI 10.1111/j.1572-0241.2001.03628.x	40	117	121	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					558	+		10.7326/0003-4819-157-8-201210160-00006	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070489				2022-12-28	WOS:000309906000016
J	Grabovskij, GJ; Peichl, T; Lisenfeld, J; Weiss, G; Ustinov, AV				Grabovskij, Grigorij J.; Peichl, Torben; Lisenfeld, Juergen; Weiss, Georg; Ustinov, Alexey V.			Strain Tuning of Individual Atomic Tunneling Systems Detected by a Superconducting Qubit	SCIENCE			English	Article								In structurally disordered solids, some atoms or small groups of atoms are able to quantum mechanically tunnel between two nearly equivalent sites. These atomic tunneling systems have been identified as the cause of various low-temperature anomalies of bulk glasses and as a source of decoherence of superconducting qubits where they are sparsely present in the disordered oxide barrier of Josephson junctions. We demonstrated experimentally that minute deformation of the oxide barrier changes the energies of the atomic tunneling systems, and we measured these changes by microwave spectroscopy of the superconducting qubit through coherent interactions between these two quantum systems. By measuring the dependence of the energy splitting of atomic tunneling states on external strain, we verify a central hypothesis of the two-level tunneling model for disordered solids.	[Weiss, Georg] Karlsruhe Inst Technol, Inst Phys, D-76128 Karlsruhe, Germany; Karlsruhe Inst Technol, Deutsch Forsch Gemeinschaft DFG Ctr Funct Nanostr, D-76128 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Weiss, G (corresponding author), Karlsruhe Inst Technol, Inst Phys, D-76128 Karlsruhe, Germany.	georg.weiss@kit.edu; alexey.ustinov@kit.edu	Lisenfeld, Juergen/O-7449-2014; Ustinov, Alexey/J-4663-2015	Lisenfeld, Juergen/0000-0001-8605-4373; Ustinov, Alexey/0000-0002-1202-1787	DFG; State of Baden-Wurttemberg through the DFG CFN; European Union project SOLID	DFG(German Research Foundation (DFG)); State of Baden-Wurttemberg through the DFG CFN; European Union project SOLID	We thank M. Ansmann and J. M. Martinis (University of California, Santa Barbara) for providing the sample we measured in this work and J. H. Cole, E. Demler, Y. M. Galperin, M. D. Lukin, J. M. Martinis, R. McDermott, J. E. Mooij, C. Muller, A. Shnirman, and J. Wrachtrup for fruitful discussions. This work was supported by the DFG and the State of Baden-Wurttemberg through the DFG CFN, as well as by the European Union project SOLID.	ANDERSON PW, 1972, PHILOS MAG, V25, P1, DOI 10.1080/14786437208229210; Arcizet O, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.021803; Ashhab S, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/103; Birge NO, 1996, CZECH J PHYS, V46, P2343, DOI 10.1007/BF02571163; Brouer S, 2001, EUROPHYS LETT, V54, P654, DOI 10.1209/epl/i2001-00342-y; Cole JH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529457; Enss C., 2005, LOW TEMPERATURE PHYS; Faoro L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.046805; Faoro L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.132505; Grabovskij GJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063015; Heinrich G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214536; Hoehne F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184112; Lisenfeld J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230504; Lisenfeld J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100511; Lupascu A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.172506; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; Neeley M, 2008, NAT PHYS, V4, P523, DOI 10.1038/nphys972; Palomaki TA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144503; Phillips WA, 1972, J LOW TEMP PHYS, V7, P351, DOI 10.1007/BF00660072; Phillips W.A., 1981, AMORPHOUS SOLIDS LOW; Sun GZ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1050; Zagoskin AM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.077001; ZELLER RC, 1971, PHYS REV B, V4, P2029, DOI 10.1103/PhysRevB.4.2029	26	82	82	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					232	234		10.1126/science.1226487	http://dx.doi.org/10.1126/science.1226487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066075				2022-12-28	WOS:000309712300039
J	Lee, KY; Kahn, CR				Lee, Kevin Y.; Kahn, C. Ronald			Turning on Brown Fat and Muscle Metabolism: Hedging Your Bets	CELL			English	Editorial Material							ADIPOGENESIS; THERMOGENESIS		[Lee, Kevin Y.; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R21DK090762, RC1DK087317, R01DK082659] Funding Source: NIH RePORTER; NIDDK NIH HHS [RC1 DK087317, P30 DK036836, R21 DK090762, R01 DK082659] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zeve D, 2012, CELL METAB, V15, P492, DOI 10.1016/j.cmet.2012.03.010	10	1	1	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					248	250		10.1016/j.cell.2012.09.025	http://dx.doi.org/10.1016/j.cell.2012.09.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063118	Green Accepted, Bronze			2022-12-28	WOS:000309981000004
J	Dodwell, E; Snyder, B; Wright, J				Dodwell, Emily; Snyder, Brian; Wright, James			Off-Label Use of Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Dodwell, Emily] Hosp Special Surg, New York, NY 10021 USA; [Snyder, Brian] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wright, James] Childrens Hosp, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital	Dodwell, E (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	dodwelle@hss.edu		Dodwell, Emily/0000-0001-8424-4341				Agency for Healthcare Research and Quality, 2009, HEALTHC COST UT PROJ; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Dewald R, 2003, SPINAL DEFORMITIES C, P644; HCUP central distributor SID California file composition, 2006, HEALTHC COST UT PROJ; Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2; US Food and Drug Administration, OP 1 H010002; US Food and Drug Administration, F INFUSE BON GRAFT L	7	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1429	1432		10.1001/jama.2012.12929	http://dx.doi.org/10.1001/jama.2012.12929			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047351	Bronze			2022-12-28	WOS:000309579300015
J	Schierbeck, LL; Rejnmark, L; Tofteng, CL; Stilgren, L; Eiken, P; Mosekilde, L; Kober, L; Jensen, JEB				Schierbeck, Louise Lind; Rejnmark, Lars; Tofteng, Charlotte Landbo; Stilgren, Lis; Eiken, Pia; Mosekilde, Leif; Kober, Lars; Jensen, Jens-Erik Beck			Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; SECONDARY PREVENTION; RISK; ATHEROSCLEROSIS; YOUNGER; 17-BETA-ESTRADIOL; MORTALITY; BENEFITS	Objective To investigate the long term effect of hormone replacement therapy on cardiovascular outcomes in recently postmenopausal women. Design Open label, randomised controlled trial. Setting Denmark, 1990-93. Participants 1006 healthy women aged 45-58 who were recently postmenopausal or had perimenopausal symptoms in combination with recorded postmenopausal serum follicle stimulating hormone values. 502 women were randomly allocated to receive hormone replacement therapy and 504 to receive no treatment (control). Women who had undergone hysterectomy were included if they were aged 45-52 and had recorded values for postmenopausal serum follicle stimulating hormone. Interventions In the treatment group, women with an intact uterus were treated with triphasic estradiol and norethisterone acetate and women who had undergone hysterectomy received 2 mg estradiol a day. Intervention was stopped after about 11 years owing to adverse reports from other trials, but participants were followed for death, cardiovascular disease, and cancer for up to 16 years. Sensitivity analyses were carried out on women who took more than 80% of the prescribed treatment for five years. Main outcome measure The primary endpoint was a composite of death, admission to hospital for heart failure, and myocardial infarction. Results At inclusion the women on average were aged 50 and had been postmenopausal for seven months. After 10 years of intervention, 16 women in the treatment group experienced the primary composite endpoint compared with 33 in the control group (hazard ratio 0.48, 95% confidence interval 0.26 to 0.87; P=0.015) and 15 died compared with 26 (0.57, 0.30 to 1.08; P=0.084). The reduction in cardiovascular events was not associated with an increase in any cancer (36 in treated group v 39 in control group, 0.92, 0.58 to 1.45; P=0.71) or in breast cancer (10 in treated group v 17 in control group, 0.58, 0.27 to 1.27; P=0.17). The hazard ratio for deep vein thrombosis (2 in treated group v 1 in control group) was 2.01 (0.18 to 22.16) and for stroke (11 in treated group v 14 in control group) was 0.77 (0.35 to 1.70). After 16 years the reduction in the primary composite outcome was still present and not associated with an increase in any cancer. Conclusions After 10 years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure, or myocardial infarction, without any apparent increase in risk of cancer, venous thromboembolism, or stroke.	[Schierbeck, Louise Lind; Tofteng, Charlotte Landbo; Jensen, Jens-Erik Beck] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Rejnmark, Lars; Mosekilde, Leif] Arhus Univ Hosp, Dept Med, Aarhus, Denmark; [Rejnmark, Lars; Mosekilde, Leif] Arhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Stilgren, Lis] Svendborg Hosp, Dept Endocrinol, Svendborg, Denmark; [Eiken, Pia] Cent Hosp Hillerod, Dept Cardiol Nephrol & Endocrinol, Hillerod, Denmark; [Kober, Lars] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen	Schierbeck, LL (corresponding author), Hvidovre Univ Hosp, Dept Endocrinol, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	louise.schierbeck@gmail.com		Rejnmark, Lars/0000-0002-2152-4247; Kober, Lars/0000-0002-6635-1466; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Eiken, Pia/0000-0001-7278-5968; Schierbeck, Louise/0000-0002-1263-8875	University of Aarhus; Karen Elise Jensen's Foundation; Novo Nordic; Novartis; LEO Pharma	University of Aarhus; Karen Elise Jensen's Foundation; Novo Nordic; Novartis(Novartis); LEO Pharma(LEO Pharma)	This study was funded by the University of Aarhus, Karen Elise Jensen's Foundation, Novo Nordic, Novartis, and LEO Pharma. None of the funders had any influence on the study design, interpretation of data, or the decision to publish the results.	Alexandersen P, 1998, ARTERIOSCL THROM VAS, V18, P902, DOI 10.1161/01.ATV.18.6.902; Andersen TF, 1999, DAN MED BULL, V46, P263; Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; GABRIEL SR, 2005, COCHRANE DB SYST REV; Grodstein F, 1998, MATURITAS, V30, P19, DOI 10.1016/S0378-5122(98)00055-3; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Guzic-Salobir B, 2001, J INTERN MED, V250, P508, DOI 10.1046/j.1365-2796.2001.00910.x; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis HN, 2011, BRAIN RES, V1379, P244, DOI 10.1016/j.brainres.2010.10.076; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jayachandran M, 2005, AM J PHYSIOL-HEART C, V288, pH2355, DOI 10.1152/ajpheart.01108.2004; Jensen L, 2003, J BONE MINER RES, V18, P333, DOI 10.1359/jbmr.2003.18.2.333; Kristensen K, 1999, J ENDOCRINOL, V163, P55, DOI 10.1677/joe.0.1630055; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Leng XH, 2005, CIRC RES, V97, P415, DOI 10.1161/01.RES.0000181025.43762.cf; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosekilde L, 1999, MATURITAS, V31, P207, DOI 10.1016/S0378-5122(99)00006-7; Mosekilde L, 2000, MATURITAS, V36, P181, DOI 10.1016/S0378-5122(00)00158-4; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Norris LA, 2002, MATURITAS, V43, P125, DOI 10.1016/S0378-5122(02)00202-5; Novensa L, 2010, HYPERTENSION, V56, P405, DOI 10.1161/HYPERTENSIONAHA.110.151969; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Rosano GMC, 2000, J AM COLL CARDIOL, V36, P2154, DOI 10.1016/S0735-1097(00)01007-X; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Salpeter SR, 2006, J GEN INTERN MED, V21, P363, DOI 10.1111/j.1525-1497.2006.00389.x; Salpeter SR, 2004, J GEN INTERN MED, V19, P791, DOI 10.1111/j.1525-1497.2004.30281.x; Sare GM, 2008, EUR HEART J, V29, P2031, DOI 10.1093/eurheartj/ehn299; Simoncini T, 2003, STEROIDS, V68, P831, DOI 10.1016/j.steroids.2003.08.006; Taner MZ, 2006, MATURITAS, V53, P267, DOI 10.1016/j.maturitas.2005.05.010; Vestergaard P, 1997, MATURITAS, V28, P137, DOI 10.1016/S0378-5122(97)00076-5	39	406	438	3	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6409	10.1136/bmj.e6409	http://dx.doi.org/10.1136/bmj.e6409			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23048011	Green Submitted			2022-12-28	WOS:000309907100002
J	Bolla, M; van Poppel, H; Tombal, B; Vekemans, K; Da Pozzo, L; de Reijke, TM; Verbaeys, A; Bosset, JF; van Velthoven, R; Colombel, M; van de Beek, C; Verhagen, P; van den Bergh, A; Sternberg, C; Gasser, T; van Tienhoven, G; Scalliet, P; Haustermans, K; Collette, L				Bolla, Michel; van Poppel, Hein; Tombal, Bertrand; Vekemans, Kris; Da Pozzo, Luigi; de Reijke, Theo M.; Verbaeys, Antony; Bosset, Jean-Francois; van Velthoven, Roland; Colombel, Marc; van de Beek, Cees; Verhagen, Paul; van den Bergh, Alphonsus; Sternberg, Cora; Gasser, Thomas; van Tienhoven, Geertjan; Scalliet, Pierre; Haustermans, Karin; Collette, Laurence		European Org Res Treatment Canc	Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)	LANCET			English	Article							ADJUVANT RADIOTHERAPY; BIOCHEMICAL RECURRENCE; MULTIVARIATE-ANALYSIS; RADIATION-THERAPY; PROGRESSION; DEFINITION; GUIDELINES; BENEFIT; VOLUME	Background We report the long-term results of a trial of immediate postoperative irradiation versus a wait-and-see policy in patients with prostate cancer extending beyond the prostate, to confirm whether previously reported progression-free survival was sustained. Methods This randomised, phase 3, controlled trial recruited patients aged 75 years or younger with untreated cT0-3 prostate cancer (WHO performance status 0 or 1) from 37 institutions across Europe. Eligible patients were randomly assigned centrally (1:1) to postoperative irradiation (60 Gy of conventional irradiation to the surgical bed for 6 weeks) or to a wait-and-see policy until biochemical progression (increase in prostate-specific antigen >0.2 mu g/L confirmed twice at least 2 weeks apart). We analysed the primary endpoint, biochemical progression-free survival, by intention to treat (two-sided test for difference at alpha=0.05, adjusted for one interim analysis) and did exploratory analyses of heterogeneity of effect. This trial is registered with ClinicalTrials.gov, number NCT00002511. Findings 1005 patients were randomly assigned to a wait-and-see policy (n=503) or postoperative irradiation (n=502) and were followed up for a median of 10.6 years (range 2 months to 16.6 years). Postoperative irradiation significantly improved biochemical progression-free survival compared with the wait-and-see policy (198 [39.4%] of 502 patients in postoperative irradiation group vs 311 [61.8%] of 503 patients in wait-and-see group had biochemical or clinical progression or died; HR 0.49 [95% CI 0.41-0.59]; p<0.0001). Late adverse effects (any type of any grade) were more frequent in the postoperative irradiation group than in the wait-and-see group (10 year cumulative incidence 70.8% [66.6-75.0] vs 59.7% [55.3-64.1]; p=0.001). Interpretation Results at median follow-up of 10.6 years show that conventional postoperative irradiation significantly improves biochemical progression-free survival and local control compared with a wait-and-see policy, supporting results at 5 year follow-up; however, improvements in clinical progression-free survival were not maintained. Exploratory analyses suggest that postoperative irradiation might improve clinical progression-free survival in patients younger than 70 years and in those with positive surgical margins, but could have a detrimental effect in patients aged 70 years or older.	[Bolla, Michel] Ctr Hosp Univ A Michallon, Dept Radiat Oncol, F-38043 Grenoble 9, France; [van Poppel, Hein] Univ Ziekenhuis Gasthuisberg, Leuven Canc Inst, Dept Urol, Louvain, Belgium; [Haustermans, Karin] Univ Ziekenhuis Gasthuisberg, Leuven Canc Inst, Dept Radiat Oncol, Louvain, Belgium; [Tombal, Bertrand] Clin Univ St Luc, Dept Urol, B-1200 Brussels, Belgium; [Scalliet, Pierre] Clin Univ St Luc, Dept Radiat Oncol, B-1200 Brussels, Belgium; [Vekemans, Kris] Virga Jesse Ziekenhuis, Dept Urol, Hasselt, Belgium; [Da Pozzo, Luigi] Univ Milan, Osped San Raffaele, Dept Urol, I-20127 Milan, Italy; [de Reijke, Theo M.] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands; [van Tienhoven, Geertjan] Univ Amsterdam, Acad Med Ctr, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands; [Verbaeys, Antony] Ghent Univ Hosp, Dept Urol, Ghent, Belgium; [Bosset, Jean-Francois] Hop Jean Minjoz, Dept Radiat Oncol, F-25030 Besancon, France; [van Velthoven, Roland] Inst Jules Bordet, Dept Urol, B-1000 Brussels, Belgium; [Colombel, Marc] Hop Edouard Herriot, Dept Urol, Lyon, France; [van de Beek, Cees] Acad Ziekenhuis Maastricht, Dept Urol, Maastricht, Netherlands; [Verhagen, Paul] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [van den Bergh, Alphonsus] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, NL-9713 AV Groningen, Netherlands; [Sternberg, Cora] San Camillo Forlanini Hosp, Dept Oncol, Rome, Italy; [Gasser, Thomas] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland; [Collette, Laurence] European Org Res & Treatment Canc Headquarters, Dept Stat, Brussels, Belgium	CHU Grenoble Alpes; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; Ghent University Hospital; Universite de Franche-Comte; CHU Besancon; Institut Jules Bordet; CHU Lyon; Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC; University of Groningen; Azienda Ospedaliera San Camillo-Forlanini; University of Basel; European Organisation for Research & Treatment of Cancer	Bolla, M (corresponding author), Ctr Hosp Univ A Michallon, Dept Radiat Oncol, BP 217, F-38043 Grenoble 9, France.	mbolla@chu-grenoble.fr	Deville, Curtiland/B-2819-2013; Haustermans, Karin/AAB-5912-2021	Deville, Curtiland/0000-0003-4846-6486; Haustermans, Karin/0000-0003-0364-682X; TOMBAL, Bertrand/0000-0002-0093-8408; Collette, Laurence/0000-0003-2518-7281; colombel, marc/0000-0002-0152-8021; van Tienhoven, Geertjan/0000-0002-2516-2263; Da Pozzo, Luigi Filippo/0000-0002-7051-6980	Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France); European Organisation for Research and Treatment of Cancer (EORTC) Charitable Trust; Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France) through the EORTC Charitable Trust	Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France); European Organisation for Research and Treatment of Cancer (EORTC) Charitable Trust; Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France) through the EORTC Charitable Trust	Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France) and the European Organisation for Research and Treatment of Cancer (EORTC) Charitable Trust.; This publication was supported by a grant from Ligue Nationale contre le Cancer (Comite de l'Isere, Grenoble, France) through the EORTC Charitable Trust. Its content is solely the responsibility of the authors and does not necessarily represent the official views of the Ligue Nationale contre le Cancer.	Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Collette L, 2005, EUR J CANCER, V41, P2662, DOI 10.1016/j.ejca.2005.06.024; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Davis JB, 2002, RADIOTHER ONCOL, V64, P65, DOI 10.1016/S0167-8140(02)00143-3; Early Breast Cancer Trialists' Collaborative Group, 1992, LANCET, V339, P1; EPSTEIN JI, 1993, J UROLOGY, V149, P1478, DOI 10.1016/S0022-5347(17)36421-2; International Commission of Radiation Units and Measurements, 1978, 29 ICRU; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, P163; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King CR, 2011, INT J RADIAT ONCOL, V80, P1, DOI 10.1016/j.ijrobp.2010.10.073; Kupelian PA, 1997, INT J RADIAT ONCOL, V37, P1043, DOI 10.1016/S0360-3016(96)00590-1; Morgan SC, 2008, RADIOTHER ONCOL, V88, P1, DOI 10.1016/j.radonc.2008.04.013; MYERS RP, 1983, PROSTATE, V4, P461, DOI 10.1002/pros.2990040505; National Institutes of Health Consensus Development Panel, 1988, NCI MON, P3; Ost P, 2009, EUR UROL, V56, P669, DOI 10.1016/j.eururo.2009.05.041; Parker C, 2007, BJU INT, V99, P1376, DOI 10.1111/j.1464-410X.2007.06844.x; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Poortmans P, 2007, RADIOTHER ONCOL, V84, P121, DOI 10.1016/j.radonc.2007.07.017; Shipley WU, 2011, 2011 GEN CANC S ORL; Spiessl B, 1989, TNM ATLAS ILLUSTRATE; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Trabulsi EJ, 2008, UROLOGY, V72, P1298, DOI 10.1016/j.urology.2008.05.057; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Van der Kwast TH, 2007, J CLIN ONCOL, V25, P4178, DOI 10.1200/JCO.2006.10.4067; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Yossepowitch O, 2009, EUR UROL, V55, P87, DOI 10.1016/j.eururo.2008.09.051	28	628	642	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					2018	2027		10.1016/S0140-6736(12)61253-7	http://dx.doi.org/10.1016/S0140-6736(12)61253-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23084481				2022-12-28	WOS:000312124900032
J	Cohen, IG; Feigenbaum, J; Adashi, EY				Cohen, I. Glenn; Feigenbaum, Jeremy; Adashi, Eli Y.			Sherley v Sebelius and the Future of Stem Cell Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	Brown University; Harvard University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						[Anonymous], 2001, STEM CELL INF NIH EM; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342	2	1	1	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2087	2088		10.1001/jama.2012.36633	http://dx.doi.org/10.1001/jama.2012.36633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23097016				2022-12-28	WOS:000311537200019
J	Calcagno, V; Demoinet, E; Gollner, K; Guidi, L; Ruths, D; de Mazancourt, C				Calcagno, V.; Demoinet, E.; Gollner, K.; Guidi, L.; Ruths, D.; de Mazancourt, C.			Flows of Research Manuscripts Among Scientific Journals Reveal Hidden Submission Patterns	SCIENCE			English	Article							SCIENCE; IMPACT; PUBLICATION; NETWORKS; QUALITY; METRICS	The study of science-making is a growing discipline that builds largely on online publication and citation databases, while prepublication processes remain hidden. Here, we report on results from a large-scale survey of the submission process, covering 923 scientific journals from the biological sciences in years 2006 to 2008. Manuscript flows among journals revealed a modular submission network, with high-impact journals preferentially attracting submissions. However, about 75% of published articles were submitted first to the journal that would publish them, and high-impact journals published proportionally more articles that had been resubmitted from another journal. Submission history affected post-publication impact: Resubmissions from other journals received significantly more citations than first-intent submissions, and resubmissions between different journal communities received significantly fewer citations.	[Calcagno, V.] Inst Sophia Agrobiotech, French Natl Inst Agr Res, F-06903 Sophia Antipolis, France; [Calcagno, V.; Demoinet, E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Calcagno, V.; Gollner, K.; de Mazancourt, C.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Guidi, L.] Univ Hawaii, Ctr Microbial Oceanog, Honolulu, HI 96822 USA; [Ruths, D.] McGill Univ, Dept Comp Sci, Montreal, PQ, Canada	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; McGill University; McGill University; University of Hawaii System; McGill University	Calcagno, V (corresponding author), Inst Sophia Agrobiotech, Sophia Antipolis Res Ctr, INRA, 400 Route Chappes,BP 167, F-06903 Sophia Antipolis, France.	vincent.calcagno@sophia.inra.fr	calcagno, vincent/B-1456-2015; Guidi, Lionel/B-3977-2012	calcagno, vincent/0000-0002-5781-967X; Guidi, Lionel/0000-0002-6669-5744; de Mazancourt, Claire/0000-0002-3721-1069; Gollner, Kathleen/0000-0002-1753-5461	Centre for Applied Mathematics in Bioscience and Medicine of McGill University; INRA; Natural Sciences and Engineering Research Council of Canada	Centre for Applied Mathematics in Bioscience and Medicine of McGill University; INRA; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank all participants of the survey. M. Fromont-Racine and D. Pike provided decisive input. V. C. received funding from the Centre for Applied Mathematics in Bioscience and Medicine of McGill University, an INRA startup grant, and a Natural Sciences and Engineering Research Council of Canada discovery grant to C.d.M. This research was approved by the Research Ethics Board of McGill. V. C. conceived the project, performed the survey, and processed the data. V. C. analyzed the data with inputs from E. D., K. G., D. R., and C.d.M. and wrote the manuscript with all authors.	Aarssen L.W., 2008, OPEN ECOL J, V1, P14, DOI [10.2174/1874213000801010014, DOI 10.2174/1874213000801010014]; BAKANIC V, 1987, AM SOCIOL REV, V52, P631, DOI 10.2307/2095599; Bergstrom C., 2007, COLL RES LIBR NEWS, V68, P314, DOI DOI 10.5860/crln.68.5.7804; Bollen J, 2005, INFORM PROCESS MANAG, V41, P1419, DOI 10.1016/j.ipm.2005.03.024; Bollen J, 2006, SCIENTOMETRICS, V69, P227, DOI 10.1007/s11192-006-0151-8; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Braun T, 2010, NATURE, V465, P870, DOI 10.1038/465870a; Cassey P, 2003, TRENDS ECOL EVOL, V18, P375, DOI 10.1016/S0169-5347(03)00160-5; Clapham P, 2005, BIOSCIENCE, V55, P390, DOI 10.1641/0006-3568(2005)055[0390:POP]2.0.CO;2; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Garfield E, 2006, INT J EPIDEMIOL, V35, P1127, DOI 10.1093/ije/dyl190; Giles CL, 2004, P NATL ACAD SCI USA, V101, P17599, DOI 10.1073/pnas.0407743101; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; PRICE DJD, 1965, SCIENCE, V149, P510; Rowland F, 2002, LEARN PUBL, V15, P247, DOI 10.1087/095315102760319206; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Shi X., 2010, P ACM INT C DIG LIB, V2010, P58; SMITH R, 1994, BRIT MED J, V309, P143, DOI 10.1136/bmj.309.6948.143; Weber EJ, 2002, JAMA-J AM MED ASSOC, V287, P2790, DOI 10.1001/jama.287.21.2790; ZUCKERMAN H, 1971, MINERVA, V9, P66, DOI 10.1007/BF01553188	25	77	79	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1065	1069		10.1126/science.1227833	http://dx.doi.org/10.1126/science.1227833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23065906				2022-12-28	WOS:000311390600040
J	Chowdhury, R; Stevens, S; Gorman, D; Pan, A; Warnakula, S; Chowdhury, S; Ward, H; Johnson, L; Crowe, F; Hu, FB; Franco, OH				Chowdhury, Rajiv; Stevens, Sarah; Gorman, Donal; Pan, An; Warnakula, Samantha; Chowdhury, Susmita; Ward, Heather; Johnson, Laura; Crowe, Francesca; Hu, Frank B.; Franco, Oscar H.			Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SERUM MAGNESIUM; STROKE; PREVENTION; GUIDELINES; CANCER; MEN; BLOOD	Objective To clarify associations of fish consumption and long chain omega 3 fatty acids with risk of cerebrovascular disease for primary and secondary prevention. Design Systematic review and meta-analysis. Data sources Studies published before September 2012 identified through electronic searches using Medline, Embase, BIOSIS, and Science Citation Index databases. Eligibility criteria Prospective cohort studies and randomised controlled trials reporting on associations of fish consumption and long chain omega 3 fatty acids (based on dietary self report), omega 3 fatty acids biomarkers, or supplementations with cerebrovascular disease (defined as any fatal or non-fatal ischaemic stroke, haemorrhagic stroke, cerebrovascular accident, or transient ischaemic attack). Both primary and secondary prevention studies (comprising participants with or without cardiovascular disease at baseline) were eligible. Results 26 prospective cohort studies and 12 randomised controlled trials with aggregate data on 794 000 non-overlapping people and 34 817 cerebrovascular outcomes were included. In cohort studies comparing categories of fish intake the pooled relative risk for cerebrovascular disease for 2-4 servings a week versus <= 1 servings a week was 0.94 (95% confidence intervals 0.90 to 0.98) and for >= 5 servings a week versus 1 serving a week was 0.88 (0.81 to 0.96). The relative risk for cerebrovascular disease comparing the top thirds of baseline long chain omega 3 fatty acids with the bottom thirds for circulating biomarkers was 1.04 (0.90 to 1.20) and for dietary exposures was 0.90 (0.80 to 1.01). In the randomised controlled trials the relative risk for cerebrovascular disease in the long chain omega 3 supplement compared with the control group in primary prevention trials was 0.98 (0.89 to 1.08) and in secondary prevention trials was 1.17 (0.99 to 1.38). For fish or omega 3 fatty acids the estimates for ischaemic and haemorrhagic cerebrovascular events were broadly similar. Evidence was lacking of heterogeneity and publication bias across studies or within subgroups. Conclusions Available observational data indicate moderate, inverse associations of fish consumption and long chain omega 3 fatty acids with cerebrovascular risk. Long chain omega 3 fatty acids measured as circulating biomarkers in observational studies or supplements in primary and secondary prevention trials were not associated with cerebrovascular disease. The beneficial effect of fish intake on cerebrovascular risk is likely to be mediated through the interplay of a wide range of nutrients abundant in fish.	[Chowdhury, Rajiv; Gorman, Donal; Warnakula, Samantha; Johnson, Laura; Franco, Oscar H.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Pan, An; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Crowe, Francesca] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford OX1 2JD, England; [Ward, Heather] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London SW7 2AZ, England; [Stevens, Sarah] NHS Midlands & E, Publ Hlth Directorate, Cambridge, England; [Chowdhury, Susmita] Publ Hlth Genom Fdn, Cambridge, England; [Franco, Oscar H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Imperial College London; Erasmus University Rotterdam; Erasmus MC	Franco, OH (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England.	o.franco@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Pan, An/C-5572-2011; Chowdhury, Rajiv/AHB-1253-2022	Franco, Óscar H/0000-0002-4606-4929; Pan, An/0000-0002-1089-7945; Ward, Heather/0000-0002-2721-2404; Crowe, Francesca/0000-0003-4026-1726; Johnson, Laura/0000-0001-8985-3154	Gates Cambridge PhD scholarship; MRC; Pfizer Nutrition to establish a new centre on aging research focused on nutrition and lifestyle	Gates Cambridge PhD scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer Nutrition to establish a new centre on aging research focused on nutrition and lifestyle	RC is recipient of a Gates Cambridge PhD scholarship, DG and SW are supported by funding from MRC studentships, and OHF is the recipient of a grant from Pfizer Nutrition to establish a new centre on aging research focused on nutrition and lifestyle.	Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Bernstein AM, 2012, STROKE, V43, P637, DOI 10.1161/STROKEAHA.111.633404; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Burillo E, 2012, CURR VASC PHARMACOL, V10, P432, DOI 10.2174/157016112800812845; Candela M, 1998, J AGR FOOD CHEM, V46, P2793, DOI 10.1021/jf9709616; Cann SAH, 2006, J AM COLL NUTR, V25, P1; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford ES, 1999, INT J EPIDEMIOL, V28, P645, DOI 10.1093/ije/28.4.645; Gidding SS, 2009, CIRCULATION, V119, P1161, DOI 10.1161/CIRCULATIONAHA.109.191856; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hansen J C, 1994, Arctic Med Res, V53, P4; Harris K, 2011, J FOOD COMPOS ANAL, V24, P1168, DOI 10.1016/j.jfca.2011.03.019; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; He K, 2009, PROG CARDIOVASC DIS, V52, P95, DOI 10.1016/j.pcad.2009.06.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Larsson SC, 2011, STROKE, V42, P3621, DOI 10.1161/STROKEAHA.111.630319; Larsson SC, 2011, AM J CLIN NUTR, V93, P487, DOI 10.3945/ajcn.110.002287; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Militante JD, 2002, AMINO ACIDS, V23, P381, DOI 10.1007/s00726-002-0212-0; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Montonen J, 2009, BRIT J NUTR, V102, P750, DOI 10.1017/S0007114509274782; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116; Myint PK, 2006, PUBLIC HEALTH NUTR, V9, P882, DOI 10.1017/PHN2006942; NICE, 2007, NICE SEC PREV PRIM S; Pilz S, 2011, CURR DRUG TARGETS, V12, P88, DOI 10.2174/138945011793591563; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; US Department of Agriculture, 2012, COMP FOODS RAW PROC; van Mierlo LAJ, 2006, J HUM HYPERTENS, V20, P571, DOI 10.1038/sj.jhh.1002038; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Welch AA, 2006, AM J CLIN NUTR, V84, P1330, DOI 10.1093/ajcn/84.6.1330; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; YAMORI Y, 1978, JPN HEART J, V19, P624	50	238	249	1	77	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2012	345								e6698	10.1136/bmj.e6698	http://dx.doi.org/10.1136/bmj.e6698			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033EY	23112118	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000310778200001
J	Fukunaga, R; Han, BW; Hung, JH; Xu, J; Weng, ZP; Zamore, PD				Fukunaga, Ryuya; Han, Bo W.; Hung, Jui-Hung; Xu, Jia; Weng, Zhiping; Zamore, Phillip D.			Dicer Partner Proteins Tune the Length of Mature miRNAs in Flies and Mammals	CELL			English	Article							DOUBLE-STRANDED-RNA; SMALL-INTERFERING RNA; SMALL SILENCING RNAS; ENDOGENOUS SIRNAS; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MICRORNA MATURATION; SOMATIC-CELLS; MOUSE OOCYTES; DROSOPHILA	Drosophila Dicer-1 produces microRNAs (miRNAs) from pre-miRNA, whereas Dicer-2 generates small interfering RNAs (siRNAs) from long dsRNA. Alternative splicing of the loquacious (loqs) mRNA generates three distinct Dicer partner proteins. To understand the function of each, we constructed flies expressing Loqs-PA, Loqs-PB, or Loqs-PD. Loqs-PD promotes both endo-and exo-siRNA production by Dicer-2. Loqs-PA or Loqs-PB is required for viability, but the proteins are not fully redundant: a specific subset of miRNAs requires Loqs-PB. Surprisingly, Loqs-PB tunes where Dicer-1 cleaves pre-miR-307a, generating a longer miRNA isoform with a distinct seed sequence and target specificity. The longer form of miR-307a represses glycerol kinase and taranis mRNA expression. The mammalian Dicer-partner TRBP, a Loqs-PB homolog, similarly tunes where Dicer cleaves pre-miR-132. Thus, Dicer-binding partner proteins change the choice of cleavage site by Dicer, producing miRNAs with target specificities different from those made by Dicer alone or Dicer bound to alternative protein partners.	[Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA; [Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Fukunaga, Ryuya/AAK-8609-2020; Zamore, Phillip D/A-8941-2013; Hung, Jui-Hung/G-2673-2012; Xu, Jia/F-7750-2012	Fukunaga, Ryuya/0000-0002-5814-8206; Hung, Jui-Hung/0000-0003-2208-9213; Xu, Jia/0000-0003-3921-018X; Zamore, Phillip/0000-0002-4505-9618; Han, Bo/0000-0001-9501-8702	National Institutes of Health [GM62862, GM65236]; JSPS; Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R37GM062862, R01GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Haruhiko and Mikiko Siomi for strains and antibodies; Richard Carthew, Qinghua Liu, and the Bloomington Stock Center for strains; Ganes Sen and Robert Braun for MEF cells; Ian MacRae for human Dicer plasmid; Lin Wang and Lauren Dedow for RNA-Seq library protocols; Chengjian Li for help with small RNA libraries; Wei Wang for bioinformatics help; Alicia Boucher, Cindy Tipping, and Shengmei Ma for fly husbandry; and Traci Hall, Gang Lu, and members of the Zamore laboratory for discussion, advice, and comments on the manuscript. This work was supported in part by the National Institutes of Health (GM62862 and GM65236) and a JSPS Research Fellowship for Research Abroad and a Charles A. King Trust Postdoctoral Fellowship to R. F. P. D. Z. is a member of the scientific advisory board of Regulus Therapeutics.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	62	139	141	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					533	546		10.1016/j.cell.2012.09.027	http://dx.doi.org/10.1016/j.cell.2012.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063653	Green Accepted, Bronze			2022-12-28	WOS:000310529300011
J	Ginsberg, M; James, D; Ding, BS; Nolan, D; Geng, FQ; Butler, JM; Schachterle, W; Pulijaal, VR; Mathew, S; Chasen, ST; Xiang, J; Rosenwaks, Z; Shido, K; Elemento, O; Rabbany, SY; Rafii, S				Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Pulijaal, Venkat R.; Mathew, Susan; Chasen, Stephen T.; Xiang, Jenny; Rosenwaks, Zev; Shido, Koji; Elemento, Olivier; Rabbany, Sina Y.; Rafii, Shahin			Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGF beta Suppression	CELL			English	Article							TRANSCRIPTION FACTOR ERG; HEMATOPOIETIC STEM-CELLS; ANGIOCRINE SIGNALS; DIFFERENTIATION; ANGIOGENESIS; FAMILY; GROWTH; GENE; FLI1; ERYTHROLEUKEMIA	ETS transcription factors ETV2, FLI1, and ERG1 specify pluripotent stem cells into induced vascular endothelial cells (iVECs). However, iVECs are unstable and drift toward nonvascular cells. We show that human midgestation c-Kit(-) lineage-committed amniotic cells (ACs) can be reprogrammed into vascular endothelial cells (rAC-VECs) without transitioning through a pluripotent state. Transient ETV2 expression in ACs generates immature rAC-VECs, whereas coexpression with FLI1/ERG1 endows rAC-VECs with a vascular repertoire and morphology matching mature endothelial cells (ECs). Brief TGF beta-inhibition functionalizes VEGFR2 signaling, augmenting specification of ACs into rAC-VECs. Genome-wide transcriptional analyses showed that rAC-VECs are similar to adult ECs in which vascular-specific genes are expressed and nonvascular genes are silenced. Functionally, rAC-VECs form stable vasculature in Matrigel plugs and regenerating livers. Therefore, short-term ETV2 expression and TGF beta inhibition with constitutive ERG1/FLI1 coexpression reprogram mature ACs into durable rAC-VECs with clinical-scale expansion potential. Banking of HLA-typed rAC-VECs establishes a vascular inventory for treatment of diverse disorders.	[Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Chasen, Stephen T.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Xiang, Jenny] Weill Cornell Med Coll, Genom Resources Core Facil, New York, NY 10065 USA; [Pulijaal, Venkat R.; Mathew, Susan] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [James, Daylon; Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Cornell University; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu			Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI [R01s HL097797, DK095039]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar foundation BioMedical Research Program (BMRP); New York State Department of Health (NYSTEM) [C024180, C026438, C026878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities Research Foundation; Qatar foundation BioMedical Research Program (BMRP)(Qatar National Research Fund (QNRF)); New York State Department of Health (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S.R. is supported by Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board and New York State Department of Health grants (NYSTEM, C024180, C026438, C026878); NHLBI R01s HL097797 and DK095039; Qatar National Priorities Research Foundation NPRP08-663-3-140; and Qatar foundation BioMedical Research Program (BMRP). The authors acknowledge Agnes Stachnik and Pooja Rana for their technical contribution to this work.	Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Benavides OM, 2012, TISSUE ENG PT A, V18, P1123, DOI [10.1089/ten.tea.2011.0392, 10.1089/ten.TEA.2011.0392]; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cui JW, 2009, LEUKEMIA, V23, P1311, DOI 10.1038/leu.2009.20; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; McLaughlin F, 2001, BLOOD, V98, P3332, DOI 10.1182/blood.V98.12.3332; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; ZHANG LQ, 1993, ONCOGENE, V8, P1621; Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331	39	153	158	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					559	575		10.1016/j.cell.2012.09.032	http://dx.doi.org/10.1016/j.cell.2012.09.032			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23084400	Green Accepted, Bronze			2022-12-28	WOS:000310529300013
J	Kannan, K; Vazquez-Laslop, N; Mankin, AS				Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.			Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; NASCENT PEPTIDE; TRANSFER-RNA; TRANSLATION ELONGATION; MOLECULAR-MECHANISM; STRUCTURAL INSIGHT; HMR 3647; ANTIBIOTICS	The polypeptide exit tunnel is an important functional compartment of the ribosome where the newly synthesized proteins are surveyed. The tunnel is the target of clinically important macrolide antibiotics. Macrolides plug the tunnel and are believed to stop production of all proteins. Contrary to this view, we show that drug-bound ribosomes can synthesize a distinct subset of cellular polypeptides. The structure of a protein defines its ability to thread through the antibiotic-obstructed tunnel. Synthesis of certain polypeptides that initially bypass translational arrest can be stopped at later stages of elongation while translation of some proteins goes to completion. Our findings reveal that small-molecule effectors can accentuate the discriminatory properties of the ribosomal exit tunnel and that macrolide antibiotics reshape the cellular proteome rather than block global protein synthesis.	[Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave, Chicago, IL 60607 USA.	shura@uic.edu		Kannan, Krishna/0000-0002-2301-7900	National Science Foundation [MCB-0824739]; Div Of Molecular and Cellular Bioscience [0824739] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Anusha Rethi Paul Raj, Dorota Klepacki, Anna Ochabowicz, and Jacqueline M. LaMarre for help with experiments, Teymur Kazakov for advice, Prabha Fernandez for providing solithromycin and CEM-112, and Kirk Hevener for advice on using Chimera software. We are grateful to Peter Moore, Harry Noller, and Ada Yonath for their comments on the manuscript. This work was supported by grant MCB-0824739 from the National Science Foundation.	Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; ANDERSSON S, 1987, BIOCHIMIE, V69, P901, DOI 10.1016/0300-9084(87)90218-5; APIRION D, 1967, J MOL BIOL, V30, P255; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BROCK TD, 1959, BIOCHIM BIOPHYS ACTA, V33, P274, DOI 10.1016/0006-3002(59)90535-9; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; ENNIS HL, 1972, ANTIMICROB AGENTS CH, V1, P197, DOI 10.1128/AAC.1.3.197; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; GRAHAM MY, 1979, J BACTERIOL, V137, P1464, DOI 10.1128/JB.137.3.1464-1467.1979; Hamilton-Miller JMT, 1998, J ANTIMICROB CHEMOTH, V41, P649, DOI 10.1093/jac/41.6.649; HARDESTY B, 1990, BIOCHIM BIOPHYS ACTA, V1050, P197, DOI 10.1016/0167-4781(90)90166-Y; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HORINOUCHI S, 1980, P NATL ACAD SCI-BIOL, V77, P7079, DOI 10.1073/pnas.77.12.7079; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lovmar M, 2006, J BIOL CHEM, V281, P6742, DOI 10.1074/jbc.M511918200; Lovmar M, 2009, EMBO J, V28, P736, DOI 10.1038/emboj.2009.17; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; MAYFORD M, 1989, J MOL BIOL, V206, P69, DOI 10.1016/0022-2836(89)90524-X; MENNINGER JR, 1994, MOL GEN GENET, V243, P225, DOI 10.1007/BF00280320; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Moore SD, 2008, P NATL ACAD SCI USA, V105, P18261, DOI 10.1073/pnas.0810357105; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; ODOM OW, 1991, EUR J BIOCHEM, V198, P713, DOI 10.1111/j.1432-1033.1991.tb16071.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oleinick N.L., 1975, ANTIBIOTICS, P397; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; OTAKA T, 1975, P NATL ACAD SCI USA, V72, P2649, DOI 10.1073/pnas.72.7.2649; Peltz SW, 2009, RNA BIOL, V6, P329, DOI 10.4161/rna.6.3.8953; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Starosta AL, 2010, CHEM BIOL, V17, P504, DOI 10.1016/j.chembiol.2010.04.008; TAI PC, 1974, BIOCHEMISTRY-US, V13, P4653, DOI 10.1021/bi00719a029; TAUBMAN S B, 1963, Antimicrob Agents Chemother (Bethesda), V161, P395; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Tenson T, 1997, J BIOL CHEM, V272, P17425, DOI 10.1074/jbc.272.28.17425; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Tenson T, 2001, PEPTIDES, V22, P1661, DOI 10.1016/S0196-9781(01)00501-0; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; VAZQUEZ D, 1966, BIOCHIM BIOPHYS ACTA, V114, P289, DOI 10.1016/0005-2787(66)90310-8; Vazquez D., 1979, INHIBITORS PROTEIN B; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P377; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P10496, DOI 10.1073/pnas.1103474108; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Yao S, 2008, MOL MICROBIOL, V69, P1439, DOI 10.1111/j.1365-2958.2008.06370.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Zaporojets D, 2003, J BACTERIOL, V185, P6921, DOI 10.1128/JB.185.23.6921-6927.2003; Zhanel George G, 2002, Expert Opin Pharmacother, V3, P277	70	105	106	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					508	520		10.1016/j.cell.2012.09.018	http://dx.doi.org/10.1016/j.cell.2012.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101624	Bronze			2022-12-28	WOS:000310529300009
J	Morlot, S; Galli, V; Klein, M; Chiaruttini, N; Manzi, J; Humbert, F; Dinis, L; Lenz, M; Cappello, G; Roux, A				Morlot, Sandrine; Galli, Valentina; Klein, Marius; Chiaruttini, Nicolas; Manzi, John; Humbert, Frederic; Dinis, Luis; Lenz, Martin; Cappello, Giovanni; Roux, Aurelien			Membrane Shape at the Edge of the Dynamin Helix Sets Location and Duration of the Fission Reaction	CELL			English	Article							MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; LIPID-BILAYERS; CURVATURE; MODEL; CONSTRICTION; TENSION; AMPHIPHYSIN; RINGS	The GTPase dynamin polymerizes into a helical coat that constricts membrane necks of endocytic pits to promote their fission. However, the dynamin mechanism is still debated because constriction is necessary but not sufficient for fission. Here, we show that fission occurs at the interface between the dynamin coat and the uncoated membrane. At this location, the considerable change in membrane curvature increases the local membrane elastic energy, reducing the energy barrier for fission. Fission kinetics depends on tension, bending rigidity, and the dynamin constriction torque. Indeed, we experimentally find that the fission rate depends on membrane tension in vitro and during endocytosis in vivo. By estimating the energy barrier from the increased elastic energy at the edge of dynamin and measuring the dynamin torque, we show that the mechanical energy spent on dynamin constriction can reduce the energy barrier for fission sufficiently to promote spontaneous fission.	[Morlot, Sandrine; Galli, Valentina; Chiaruttini, Nicolas; Humbert, Frederic; Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Morlot, Sandrine; Klein, Marius; Manzi, John; Cappello, Giovanni] Univ Paris 06, Inst Curie, Ctr Rech, CNRS,UMR Physicochim Curie 168, F-75248 Paris, France; [Dinis, Luis] Univ Complutense Madrid, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain; [Dinis, Luis] GISC, Madrid 28040, Spain; [Lenz, Martin] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Lenz, Martin] Univ Paris 11, CNRS, UMR LPTMS 8626, F-91405 Orsay, France; [Roux, Aurelien] Swiss Natl Ctr Competence Res, Programme Chem Biol, CH-1211 Geneva, Switzerland	University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Complutense University of Madrid; University of Chicago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roux, A (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	Aurelien.roux@unige.ch	Cappello, Giovanni/D-4876-2013; Manzi, John/AAI-8253-2021; Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021; Dinis, Luis/B-8820-2011; Lenz, Martin/B-3329-2013; Dinis, Luis/AAN-6969-2021	Manzi, John/0000-0003-2574-4260; Roux, Aurelien R/0000-0002-6088-0711; Dinis, Luis/0000-0003-2064-2396; Lenz, Martin/0000-0002-2307-1106; Dinis, Luis/0000-0003-2064-2396; Morlot, Sandrine/0000-0002-0326-6694	Agence Nationale de la Recherche [JC08-317536, 0061/2008, RGY0076/2009-C, 31003A-130520/1]; Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government [FIS2011-22644]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government(Spanish GovernmentEuropean Commission)	We thank David Drubin for sharing with us the SKML-2 cells. We thank Marcos Gonzalez-Gaitan, for inspiring discussions and critical reading of the manuscript. We thank Pietro De Camilli, Jacques Prost, and Jean-Francois Joanny for thoughtful comments on this study. This work was supported by the Agence Nationale de la Recherche (Young Investigator Program Award No. JC08-317536 to A. R. and G. C.), Human Frontier Science Program Career Development Award No. 0061/2008 (to A. R.), Young Investigator Research Grant No. RGY0076/2009-C (to A. R.), Swiss National Fund for Research Grant No. 31003A-130520/1 (to A. R.), the Societe Academique de Geneve, and the Swiss National Centre for Competence in Research Programme Chemical Biology. L. D. acknowledges financial support from Grant ENFASIS (FIS2011-22644, from the Spanish Government).	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Happel, 2012, LOW REYNOLDS NUMBER; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lenz M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011911; Lipfert J, 2010, NAT METHODS, V7, P977, DOI 10.1038/NMETH.1520; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Morlot S, 2010, BIOPHYS J, V99, P3580, DOI 10.1016/j.bpj.2010.10.015; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	41	118	119	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					619	629		10.1016/j.cell.2012.09.017	http://dx.doi.org/10.1016/j.cell.2012.09.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101629	Green Accepted, Bronze			2022-12-28	WOS:000310529300017
J	Pikitch, EK				Pikitch, Ellen K.			The Risks of Overfishing	SCIENCE			English	Editorial Material							MANAGEMENT; FISHERIES		SUNY Stony Brook, Inst Ocean Conservat Sci, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Pikitch, EK (corresponding author), SUNY Stony Brook, Inst Ocean Conservat Sci, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	ellen.pikitch@stonybrook.edu						Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Pikitch E, 2012, LITTLE FISH BIG IMPA; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Punt AE, 2012, ICES J MAR SCI, V69, P624, DOI 10.1093/icesjms/fss047; Restrepo V.R., 1998, NOAA TECHNICAL MEMOR, V56; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	10	29	30	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					474	475		10.1126/science.1229965	http://dx.doi.org/10.1126/science.1229965			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112316				2022-12-28	WOS:000310195800038
J	Ye, BH; Cramer, N				Ye, Baihua; Cramer, Nicolai			Chiral Cyclopentadienyl Ligands as Stereocontrolling Element in Asymmetric C-H Functionalization	SCIENCE			English	Article							2+2+2 CYCLOADDITION; COMPLEXES; REACTIVITY; OLEFINS	Metal complexes coordinated by a single cyclopentadienyl (Cp) ligand are widely used, versatile catalysts, but their application to asymmetric reactions has been hindered by the difficulty of designing Cp substituents that effectively bias the coordination sphere. Here, we report on a class of simple C-2-symmetric Cp derivatives that finely control the spatial arrangement of the transiently coordinated reactants around the central metal atom. Rhodium(III) complexes bearing these ligands proved to be highly enantioselective catalysts for directed carbon-hydrogen (C-H) bond functionalizations of hydroxamic acid derivatives.	[Ye, Baihua; Cramer, Nicolai] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lab Asymmetr Catalysis & Synth,BCH 4305, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cramer, N (corresponding author), Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lab Asymmetr Catalysis & Synth,BCH 4305, CH-1015 Lausanne, Switzerland.	nicolai.cramer@epfl.ch		Cramer, Nicolai/0000-0001-5740-8494	European Research Council (ERC) under the European Community [257891]	European Research Council (ERC) under the European Community(European Research Council (ERC))	This work is supported by the European Research Council (ERC) under the European Community's Seventh Framework Program (FP7 2007-2013)/ERC Grant agreement 257891. We thank R. Scopelliti for x-ray crystallographic analysis of 1c. CCDC 898196 contains the crystallographic data for 1c. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre, www.ccdc.cam.ac.uk/data_request/cif.	Bauer EB, 2012, CHEM SOC REV, V41, P3153, DOI 10.1039/c2cs15234g; Bolig AD, 2007, J AM CHEM SOC, V129, P14544, DOI 10.1021/ja075694r; Brunner H, 1999, ANGEW CHEM INT EDIT, V38, P1195, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1194::AID-ANIE1194>3.0.CO;2-X; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Crabtree R. H., 2001, ORGANOMETALLIC CHEM; Davis FA, 1999, J ORG CHEM, V64, P8627, DOI 10.1021/jo991119x; Gladysz JA, 1997, ANGEW CHEM INT EDIT, V36, P551; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Gutnov A, 2004, ANGEW CHEM INT EDIT, V43, P3795, DOI 10.1002/anie.200454164; Gutnov A, 2004, ORGANOMETALLICS, V23, P1002, DOI 10.1021/om030357m; Gutnov A, 2003, ORGANOMETALLICS, V22, P1550, DOI 10.1021/om020982b; Halterman RL, 2003, TETRAHEDRON LETT, V44, P2907, DOI 10.1016/S0040-4039(03)00430-1; HALTERMAN RL, 1988, ORGANOMETALLICS, V7, P883, DOI 10.1021/om00094a015; HALTERMAN RL, 1992, CHEM REV, V92, P965, DOI 10.1021/cr00013a011; Hapke M, 2010, J ORG CHEM, V75, P3993, DOI 10.1021/jo100122d; Hartwig JF, 2005, J AM CHEM SOC, V127, P2538, DOI 10.1021/ja045090c; Heller B, 2007, CHEM-EUR J, V13, P1117, DOI 10.1002/chem.200600826; Hoveyda AH, 1996, ANGEW CHEM INT EDIT, V35, P1263; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Lenges CP, 1997, J AM CHEM SOC, V119, P3165, DOI 10.1021/ja9639776; McGlacken GP, 2007, ORGANOMETALLICS, V26, P3722, DOI 10.1021/om700393b; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Roy AH, 2007, J AM CHEM SOC, V129, P2082, DOI 10.1021/ja066509x; Schumann H, 2002, EUR J INORG CHEM, P211; Siemeling U, 2000, CHEM REV, V100, P1495, DOI 10.1021/cr990287m; Song GY, 2012, CHEM SOC REV, V41, P3651, DOI 10.1039/c2cs15281a; Tran DN, 2011, ANGEW CHEM INT EDIT, V50, P11098, DOI 10.1002/anie.201105766; Tran DN, 2010, ANGEW CHEM INT EDIT, V49, P8181, DOI 10.1002/anie.201004179; Trost BM, 2005, ANGEW CHEM INT EDIT, V44, P6630, DOI 10.1002/anie.200500136; Xu L, 2012, J ORG CHEM, V77, P3017, DOI 10.1021/jo202431q; Zhou M, 2010, J AM CHEM SOC, V132, P12550, DOI 10.1021/ja1058247	32	431	431	5	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					504	506		10.1126/science.1226938	http://dx.doi.org/10.1126/science.1226938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112328				2022-12-28	WOS:000310195800051
J	Ferriman, A				Ferriman, Annabel			Finding the smoking gun: a speech by Richard Peto	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7119	10.1136/bmj.e7119	http://dx.doi.org/10.1136/bmj.e7119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097544				2022-12-28	WOS:000310427600016
J	McCartney, M				McCartney, Margaret			Calorie restriction and longevity: fast and loose?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				YouTube, BBC HOR 2012 EAT FAS	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e6872	10.1136/bmj.e6872	http://dx.doi.org/10.1136/bmj.e6872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097550				2022-12-28	WOS:000310427600014
J	Williams, AR; Caplan, AL				Williams, Arthur R.; Caplan, Arthur L.			Thomas Szasz: rebel with a questionable cause	LANCET			English	Editorial Material									[Williams, Arthur R.] NYU, Bellevue Hosp Ctr, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Caplan, Arthur L.] NYU, Langone Med Ctr, Dept Populat Hlth, Div Med Eth, New York, NY 10016 USA	Bellevue Hospital Center; New York University; New York University; NYU Langone Medical Center	Williams, AR (corresponding author), NYU, Bellevue Hosp Ctr, Sch Med, Dept Psychiat, New York, NY 10016 USA.	arthur.caplan@nyumc.org	Williams, Arthur Robin/H-8511-2019	Williams, Arthur Robin/0000-0002-7380-6203				Appelbaum P S, 1979, Bull Am Acad Psychiatry Law, V7, P306; Appelbaum Paul S, 1994, ALMOST REVOLUTION ME, P17; Caplan AL, 2012, J MED ETHICS; GAYLIN W, 2003, PERVERSION AUTONOMY; Isaac RJ, 1990, MADNESS STREETS PSYC; James JD, 2006, 213600 NCJ US DEP JU; Lamb RH, 1992, TREATING HOMELESS ME	7	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1378	1379		10.1016/S0140-6736(12)61789-9	http://dx.doi.org/10.1016/S0140-6736(12)61789-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23091833				2022-12-28	WOS:000310196500013
J	Kicheva, A; Cohen, M; Briscoe, J				Kicheva, Anna; Cohen, Michael; Briscoe, James			Developmental Pattern Formation: Insights from Physics and Biology	SCIENCE			English	Review							MORPHOGEN GRADIENT FORMATION; GENE REGULATORY NETWORKS; EARLY DROSOPHILA EMBRYO; POSITIONAL INFORMATION; MECHANISM; DIFFUSION; DYNAMICS; EXPRESSION; UNDERLIES; PRECISION	The spatial organization of cell fates during development involves the interpretation of morphogen gradients by cellular signaling cascades and transcriptional networks. Recent studies use biophysical models, genetics, and quantitative imaging to unravel how tissue-level morphogen behavior arises from subcellular events. Moreover, data from several systems show that morphogen gradients, downstream signaling, and the activity of cell-intrinsic transcriptional networks change dynamically during pattern formation. Studies from Drosophila and now also vertebrates suggest that transcriptional network dynamics are central to the generation of gene expression patterns. Together, this leads to the view that pattern formation is an emergent behavior that results from the coordination of events occurring across molecular, cellular, and tissue scales. The development of novel approaches to study this complex process remains a challenge.	[Kicheva, Anna; Cohen, Michael; Briscoe, James] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Briscoe, J (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jbrisco@nimr.mrc.ac.uk		Briscoe, James/0000-0002-1020-5240; Kicheva, Anna/0000-0003-4509-4998	Medical Research Council (UK)	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Baum and Manu for helpful comments. Funding provided by the Medical Research Council (UK).	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Ben-Zvi D, 2011, CURR BIOL, V21, P1391, DOI 10.1016/j.cub.2011.07.015; Bollenbach T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011901; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Corson F, 2012, P NATL ACAD SCI USA, V109, P5568, DOI 10.1073/pnas.1201505109; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Drocco JA, 2011, BIOPHYS J, V101, P1807, DOI 10.1016/j.bpj.2011.07.025; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Francois P, 2010, DEVELOPMENT, V137, P2385, DOI 10.1242/dev.048033; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grieneisen VA, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-37; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; Irons DJ, 2010, DEV BIOL, V342, P180, DOI 10.1016/j.ydbio.2010.03.022; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Sample C, 2010, P NATL ACAD SCI USA, V107, P10092, DOI 10.1073/pnas.1001139107; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	42	68	68	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					210	212		10.1126/science.1225182	http://dx.doi.org/10.1126/science.1225182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066071				2022-12-28	WOS:000309712300032
J	Purnell, BA				Purnell, Beverly A.			Forceful Thinking INTRODUCTION	SCIENCE			English	Editorial Material																			0	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					209	209		10.1126/science.338.6104.209	http://dx.doi.org/10.1126/science.338.6104.209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066070				2022-12-28	WOS:000309712300031
J	Vo, TT; Ryan, J; Carrasco, R; Neuberg, D; Rossi, DJ; Stone, RM; DeAngelo, DJ; Frattini, MG; Letai, A				Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Rossi, Derrick J.; Stone, Richard M.; DeAngelo, Daniel J.; Frattini, Mark G.; Letai, Anthony			Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; BCL-2 FAMILY; BH3-ONLY PROTEINS; CYTOCHROME-C; APOPTOSIS; DEATH; MCL-1; BAX; INHIBITOR	Despite decades of successful use of cytotoxic chemotherapy in acute myelogenous leukemia (AML), the biological basis for its differential success among individuals and for the existence of a therapeutic index has remained obscure. Rather than taking a genetic approach favored by many, we took a functional approach to ask how differential mitochondrial readiness for apoptosis ("priming") might explain individual variation in clinical behavior. We found that mitochondrial priming measured by BH3 profiling was a determinant of initial response to induction chemotherapy, relapse after remission, and requirement for allogeneic bone marrow transplantation. Differential priming between malignant myeloblasts and normal hematopoietic stem cells supports a mitochondrial basis to the therapeutic index for chemotherapy. BH3 profiling identified BCL-2 inhibition as a targeted strategy likely to have a useful therapeutic index. BH3 profiling refines predictive information provided by conventional biomarkers currently in use and thus may itself have utility as a clinical predictive biomarker.	[Thanh-Trang Vo; Letai, Anthony] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Stone, Richard M.; DeAngelo, Daniel J.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Letai, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	anthony_letai@dfci.harvard.edu		Ryan, Jeremy/0000-0002-3327-1283	NIH [F31 CA150562, P01 CA139980, R01CA129974]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [F31CA150562, P01CA139980, R01CA129974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the following sources: NIH grants F31 CA150562, P01 CA139980, and R01CA129974, Gabrielle's Angel Foundation for Cancer Research. A. L. is a Leukemia and Lymphoma Society Scholar. We thank Abbott Laboratories for providing ABT-737. We thank Martha Wadleigh, MD, and Ilene Galinsky, RN, and the Pasquarello Tissue Bank for help with clinical data and samples. A. L. was a cofounder and formerly served on the scientific advisory board of Eutropics Pharmaceuticals, which has a license for BH3 profiling.	Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Sekeres Mikkael A, 2002, Curr Oncol Rep, V4, P403, DOI 10.1007/s11912-002-0034-y; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	251	272	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					344	355		10.1016/j.cell.2012.08.038	http://dx.doi.org/10.1016/j.cell.2012.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063124	Green Accepted, Bronze			2022-12-28	WOS:000309981000013
J	Joynt, KE; Blumenthal, DM; Orav, EJ; Resnic, FS; Jha, AK				Joynt, Karen E.; Blumenthal, Daniel M.; Orav, E. John; Resnic, Frederic S.; Jha, Ashish K.			Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR DATA REGISTRY; MORTALITY RISK PREDICTION; UNINTENDED CONSEQUENCES; HEART-ASSOCIATION; BYPASS-SURGERY; MANAGEMENT; UPDATE	Context Public reporting of patient outcomes is an important tool to improve quality of care, but some observers worry that such efforts will lead clinicians to avoid high-risk patients. Objective To determine whether public reporting for percutaneous coronary intervention (PCI) is associated with lower rates of PCI for patients with acute myocardial infarction (MI) or with higher mortality rates in this population. Design, Setting, and Patients Retrospective observational study conducted using data from fee-for-service Medicare patients (49 660 from reporting states and 48 142 from nonreporting states) admitted with acute MI to US acute care hospitals between 2002 and 2010. Logistic regression was used to compare PCI and mortality rates between reporting states (New York, Massachusetts, and Pennsylvania) and regional nonreporting states (Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware). Changes in PCI rates over time in Massachusetts compared with nonreporting states were also examined. Main Outcome Measures Risk-adjusted PCI and mortality rates. Results In 2010, patients with acute MI were less likely to receive PCI in public reporting states than in nonreporting states (unadjusted rates, 37.7% vs 42.7%, respectively; risk-adjusted odds ratio [OR], 0.82 [95% CI, 0.71-0.93]; P=.003). Differences were greatest among the 6708 patients with ST-segment elevation MI (61.8% vs 68.0%; OR, 0.73 [95% CI, 0.59-0.89]; P=.002) and the 2194 patients with cardiogenic shock or cardiac arrest (41.5% vs 46.7%; OR, 0.79 [95% CI, 0.64-0.98]; P=.03). There were no differences in overall mortality among patients with acute MI in reporting vs nonreporting states. In Massachusetts, odds of PCI for acute MI were comparable with odds in nonreporting states prior to public reporting (40.6% vs 41.8%; OR, 1.00 [95% CI, 0.71-1.41]). However, after implementation of public reporting, odds of undergoing PCI in Massachusetts decreased compared with nonreporting states (41.1% vs 45.6%; OR, 0.81 [95% CI, 0.47-1.38]; P=.03 for difference in differences). Differences were most pronounced for the 6081 patients with cardiogenic shock or cardiac arrest (prereporting: 44.2% vs 36.6%; OR, 1.40 [95% CI, 0.85-2.32]; postreporting: 43.9% vs 44.8%; OR, 0.92 [95% CI, 0.38-2.22]; P=.03 for difference in differences). Conclusions Among Medicare beneficiaries with acute MI, the use of PCI was lower for patients treated in 3 states with public reporting of PCI outcomes compared with patients treated in 7 regional control states without public reporting. However, there was no difference in overall acute MI mortality between states with and without public reporting. JAMA. 2012;308(14):1460-1468 www.jama.com	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.; Resnic, Frederic S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital	Joynt, KE (corresponding author), 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute.	Apolito RA, 2008, AM HEART J, V155, P267, DOI 10.1016/j.ahj.2007.10.013; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Resnic FS, 2011, J AM COLL CARDIOL, V57, P904, DOI 10.1016/j.jacc.2010.09.057; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034; Ritley D, 2011, STATE CARDIAC REVASC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e	16	153	155	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1460	1468		10.1001/jama.2012.12922	http://dx.doi.org/10.1001/jama.2012.12922			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047360	Green Accepted			2022-12-28	WOS:000309579300025
J	Walden, AP; Bonten, MJ; Wise, MP				Walden, Andrew P.; Bonten, Marc J.; Wise, Matt P.			Should selective digestive decontamination be used in critically ill patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; TRACT; OROPHARYNX		[Walden, Andrew P.] Royal Berkshire Hosp, Wantage OX12 8HG, England; [Bonten, Marc J.] Univ Med Ctr, Utrecht, Netherlands; [Wise, Matt P.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Royal Berkshire Hospital; Utrecht University; Utrecht University Medical Center; Cardiff University	Walden, AP (corresponding author), Royal Berkshire Hosp, Wantage OX12 8HG, England.	apwalden@hotmail.com		Wise, Matt/0000-0002-2763-4316				Bastin AJ, 2009, ANAESTHESIA, V64, P46, DOI 10.1111/j.1365-2044.2008.05676.x; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; de Smet AMGA, 2009, INTENS CARE MED, V35, P1609, DOI 10.1007/s00134-009-1554-9; GASTINNE H, 1992, NEW ENGL J MED, V326, P594, DOI 10.1056/NEJM199202273260903; Health Protection Agency, 2012, ENGL NAT POINT PREV; Julius Center, UMC UTR R GNOSIS; Liberati A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000022.pub3; Lingnau W, 1998, J HOSP INFECT, V39, P195, DOI 10.1016/S0195-6701(98)90258-4; Melsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Oostdijk EAN, 2010, AM J RESP CRIT CARE, V181, P452, DOI 10.1164/rccm.200908-1210OC; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5	15	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6697	10.1136/bmj.e6697	http://dx.doi.org/10.1136/bmj.e6697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23047967				2022-12-28	WOS:000309907100011
J	Piel, FB; Patil, AP; Howes, RE; Nyangiri, OA; Gething, PW; Dewi, M; Temperley, WH; Williams, TN; Weatherall, DJ; Hay, SI				Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Nyangiri, Oscar A.; Gething, Peter W.; Dewi, Mewahyu; Temperley, William H.; Williams, Thomas N.; Weatherall, David J.; Hay, Simon I.			Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates	LANCET			English	Article							CELL-DISEASE; MALARIA; DISORDERS; GENE; COUNTRIES; BURDEN	Background Reliable estimates of populations affected by diseases are necessary to guide efficient allocation of public health resources. Sickle haemoglobin (HbS) is the most common and clinically significant haemoglobin structural variant, but no contemporary estimates exist of the global populations affected. Moreover, the precision of available national estimates of heterozygous (AS) and homozygous (SS) neonates is unknown. We aimed to provide evidence-based estimates at various scales, with uncertainty measures. Methods Using a database of sickle haemoglobin surveys, we created a contemporary global map of HbS allele frequency distribution within a Bayesian geostatistical model. The pairing of this map with demographic data enabled calculation of global, regional, and national estimates of the annual number of AS and SS neonates. Subnational estimates were also calculated in data-rich areas. Findings Our map shows subnational spatial heterogeneities and high allele frequencies across most of sub-Saharan Africa, the Middle East, and India, as well as gene flow following migrations to western Europe and the eastern coast of the Americas. Accounting for local heterogeneities and demographic factors, we estimated that the global number of neonates affected by HbS in 2010 included 5 476 000 (IQR 5 291 000-5 679 000) AS neonates and 312 000 (294 000-330 000) SS neonates. These global estimates are higher than previous conservative estimates. Important differences predicted at the national level are discussed. Interpretation HbS will have an increasing effect on public health systems. Our estimates can help countries and the international community gauge the need for appropriate diagnoses and genetic counselling to reduce the number of neonates affected. Similar mapping and modelling methods could be used for other inherited disorders.	[Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Gething, Peter W.; Temperley, William H.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Nyangiri, Oscar A.; Williams, Thomas N.] Kilifi Dist Hosp, Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Programme, Kilifi, Kenya; [Dewi, Mewahyu] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Williams, Thomas N.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PS, England; [Weatherall, David J.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; Eijkman Institute; University of Oxford; University of Oxford	Piel, FB (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	fred.piel@zoo.ox.ac.uk	Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020; Hay, Simon Iain/F-8967-2015	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Piel, Frederic B./0000-0001-8131-7728	Kenyan Medical Research Institute (KEMRI); Wellcome Trust [085406, 079091, 091758]; Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC); MRC [MC_UU_12009/13] Funding Source: UKRI; Medical Research Council [MC_UU_12009/13] Funding Source: researchfish	Kenyan Medical Research Institute (KEMRI); Wellcome Trust(Wellcome TrustEuropean Commission); Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kevin Baird and Sunetra Gupta for providing comments on the report. We also thank the following people for sharing unpublished data: Anabel Arends and Gilberto Gomez for Venezuela data; Marcelo Urbano Ferreira for Brazil data; Rick Fairhurst, Carole Long, and Mahamadou Diakite for Mali data; Rick Fairhurst and Duong Socheat for Cambodia data. Data from the MalariaGEN Consortium have been shared for inclusion in the database. We acknowledge all its contributing collaborators and members for collecting, preparing, and genotyping the samples. We thank Andy Tatem for providing modified Global Rural Urban Mapping Project data and members of the Malaria Atlas Project (MAP) including Katherine Battle, Catherine Moyes, and Marianne Sinka who have contributed their expertise and to Janey Messina and David Pigott for proofreading. We acknowledge the support of the Kenyan Medical Research Institute (KEMRI). FBP, REH, and OAN were funded by a Biomedical Resources Grant (#085406) from the Wellcome Trust (to SIH) and acknowledge contributions from their Technical Advisory Group: Kevin Baird, Suthat Fucharoen, Dominic Kwiatkowski, Kevin Marsh, Kirk Rockett, Graham Serjeant, David J Weatherall, Tom N Williams, and Bill Wood. SIH is supported by a Senior Research Fellowship from the Wellcome Trust (#079091), which also supported APP and PWG. TNW is supported by a Senior Fellowship from the Wellcome Trust (#091758). MD acknowledges the support of the Li Ka Shing Foundation. We are also grateful for support from the Philippe Wiener-Maurice Anspach Foundation and the European Research Council (ERC Advanced Grant-Diversity).	Akinyanju O, 2010, NATL BURDEN SICKLE C; Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Balgir RS, 2000, CURR SCI INDIA, V79, P1536; Bittles AH, 2005, COMMUNITY GENET, V8, P17, DOI 10.1159/000083332; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Dyson S. M., 2012, GENETICS GLOBAL PUBL; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; LIVINGSTONE FB, 1964, AM J HUM GENET, V16, P435; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Panepinto JA, 2000, J PEDIATR-US, V136, P201, DOI 10.1016/S0022-3476(00)70102-8; Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003; Penman BS, 2009, P NATL ACAD SCI USA, V106, P21242, DOI 10.1073/pnas.0910840106; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Streetly A, 2000, BRIT MED J, V320, P1353, DOI 10.1136/bmj.320.7246.1353; *UN, 2003, DEM YB; WEATHERALL D, 2006, INHERITED DISORDERS, P663; Weatherall DJ, 2011, BRIT J HAEMATOL, V154, P736, DOI 10.1111/j.1365-2141.2011.08742.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2010, BRIT J HAEMATOL, V149, P635, DOI 10.1111/j.1365-2141.2010.08118.x; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; Williams TN, 2011, TRENDS PARASITOL, V27, P315, DOI 10.1016/j.pt.2011.02.004; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; World Health Organization Regional Office for Africa, 2010, SICKL CELL DIS STRAT	35	567	572	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					142	151		10.1016/S0140-6736(12)61229-X	http://dx.doi.org/10.1016/S0140-6736(12)61229-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23103089	Green Published			2022-12-28	WOS:000313420900030
J	Hare, JM; Fishman, JE; Gerstenblith, G; Velazquez, DLD; Zambrano, JP; Suncion, VY; Tracy, M; Ghersin, E; Johnston, PV; Brinker, JA; Breton, E; Davis-Sproul, J; Schulman, IH; Byrnes, J; Mendizabal, AM; Lowery, MH; Rouy, D; Altman, P; Foo, CWP; Ruiz, P; Amador, A; Da Silva, J; McNiece, IK; Heldman, AW				Hare, Joshua M.; Fishman, Joel E.; Gerstenblith, Gary; Velazquez, Darcy L. DiFede; Zambrano, Juan P.; Suncion, Viky Y.; Tracy, Melissa; Ghersin, Eduard; Johnston, Peter V.; Brinker, Jeffrey A.; Breton, Elayne; Davis-Sproul, Janice; Schulman, Ivonne H.; Byrnes, John; Mendizabal, Adam M.; Lowery, Maureen H.; Rouy, Didier; Altman, Peter; Foo, Cheryl Wong Po; Ruiz, Phillip; Amador, Alexandra; Da Silva, Jose; McNiece, Ian K.; Heldman, Alan W.			Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy The POSEIDON Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-FAILURE QUESTIONNAIRE; LEFT-VENTRICULAR SHAPE; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; DOUBLE-BLIND; TRANSCORONARY TRANSPLANTATION; INTRAMYOCARDIAL INJECTION; THERAPY; REGENERATION; IMPROVEMENT	Context Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. Objective To test whether allogeneic MSCs are as safe and effective as autologous MSCs in patients with left ventricular (LV) dysfunction due to ICM. Design, Setting, and Patients A phase 1/2 randomized comparison (POSEIDON study) in a US tertiary-care referral hospital of allogeneic and autologous MSCs in 30 patients with LV dysfunction due to ICM between April 2, 2010, and September 14, 2011, with 13-month follow-up. Intervention Twenty million, 100 million, or 200 million cells (5 patients in each cell type per dose level) were delivered by transendocardial stem cell injection into 10 LV sites. Main Outcome Measures Thirty-day postcatheterization incidence of predefined treatment-emergent serious adverse events (SAEs). Efficacy assessments included 6-minute walk test, exercise peak (V)over dotO(2), Minnesota Living with Heart Failure Questionnaire (MLHFQ), New York Heart Association class, LV volumes, ejection fraction (EF), early enhancement defect (EED; infarct size), and sphericity index. Results Within 30 days, 1 patient in each group (treatment-emergent SAE rate, 6.7%) was hospitalized for heart failure, less than the prespecified stopping event rate of 25%. The 1-year incidence of SAEs was 33.3% (n=5) in the allogeneic group and 53.3% (n=8) in the autologous group (P=.46). At 1 year, there were no ventricular arrhythmia SAEs observed among allogeneic recipients compared with 4 patients (26.7%) in the autologous group (P=.10). Relative to baseline, autologous but not allogeneic MSC therapy was associated with an improvement in the 6-minute walk test and the MLHFQ score, but neither improved exercise (V)over dotO(2) max. Allogeneic and autologous MSCs reduced mean EED by -33.21% (95% CI, -43.61% to -22.81%; P < .001) and sphericity index but did not increase EF. Allogeneic MSCs reduced LV end-diastolic volumes. Low-dose concentration MSCs (20 million cells) produced greatest reductions in LV volumes and increased EF. Allogeneic MSCs did not stimulate significant donor-specific alloimmune reactions. Conclusions In this early-stage study of patients with ICM, transendocardial injection of allogeneic and autologous MSCs without a placebo control were both associated with low rates of treatment-emergent SAEs, including immunologic reactions. In aggregate, MSC injection favorably affected patient functional capacity, quality of life, and ventricular remodeling.	[Hare, Joshua M.; Velazquez, Darcy L. DiFede; Zambrano, Juan P.; Suncion, Viky Y.; Schulman, Ivonne H.; Da Silva, Jose; McNiece, Ian K.; Heldman, Alan W.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Hare, Joshua M.; Zambrano, Juan P.; Tracy, Melissa; Schulman, Ivonne H.; Byrnes, John; Lowery, Maureen H.; McNiece, Ian K.; Heldman, Alan W.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33101 USA; [Fishman, Joel E.; Ghersin, Eduard] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33101 USA; [Ruiz, Phillip; Amador, Alexandra] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33101 USA; [Gerstenblith, Gary; Johnston, Peter V.; Brinker, Jeffrey A.; Breton, Elayne; Davis-Sproul, Janice] Johns Hopkins Univ, Sch Med, Div Cardiovasc, Baltimore, MD USA; [Schulman, Ivonne H.] Miami Vet Affairs Healthcare Syst, Miami, FL USA; [Mendizabal, Adam M.] EMMES Corp, Rockville, MD USA; [Rouy, Didier; Altman, Peter; Foo, Cheryl Wong Po] Biocardia Inc, San Carlos, CA USA	University of Miami; University of Miami; University of Miami; University of Miami; Johns Hopkins University; Emmes Corporation	Hare, JM (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Biomed Res Bldg,Room 908,POB 016960,R-125, Miami, FL 33101 USA.	jhare@med.miami.edu	Johnston, Peter V/AAX-5573-2021; Heldman, Alan W./K-8784-2012; Schulman, Ivonne H./K-6436-2019	Johnston, Peter V/0000-0002-4258-6981; Heldman, Alan W./0000-0002-1615-3883; Schulman, Ivonne H./0000-0002-2814-2321	US National Heart, Lung, and Blood Institute (NHLBI) of the Specialized Centers for Cell-Based Therapy [U54HL081028-01]; National Institutes of Health (NIH) [RO1 HL094849, P20 HL101443, RO1 HL084275, RO1 HL107110, RO1 HL110737, UM1HL113460]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107110, U54HL081028, R01HL094849, UM1HL113460, R01HL084275, P20HL101443, R01HL110737] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute (NHLBI) of the Specialized Centers for Cell-Based Therapy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the US National Heart, Lung, and Blood Institute (NHLBI) as part of the Specialized Centers for Cell-Based Therapy U54 grant (U54HL081028-01). Dr Hare is also supported by National Institutes of Health (NIH) grants RO1 HL094849, P20 HL101443, RO1 HL084275, RO1 HL107110, RO1 HL110737, and UM1HL113460. The NHLBI provided oversight of the clinical trial through the independent Gene and Cell Therapy Data and Safety Monitoring Board (DSMB). Biocardia Inc provided the Helical Infusion Catheters for the conduct of POSEIDON.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amado LC, 2006, J AM COLL CARDIOL, V48, P2116, DOI 10.1016/j.jacc.2006.06.073; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bray RA, 2011, METHOD CELL BIOL, V103, P285, DOI 10.1016/B978-0-12-385493-3.00012-7; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; Choi SI, 2009, INT J CARDIOVAS IMAG, V25, P23, DOI 10.1007/s10554-009-9443-4; de la Fuente LM, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.04.051; Ganame J, 2011, EUR RADIOL, V21, P693, DOI 10.1007/s00330-010-1963-8; Hamamoto H, 2009, ANN THORAC SURG, V87, P794, DOI 10.1016/j.athoracsur.2008.11.057; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Junttila MJ, 2011, HEART, V97, P1852, DOI 10.1136/heartjnl-2011-300153; Karantalis V, 2012, AM J PHYSIOL-HEART C, V303, pH256, DOI 10.1152/ajpheart.00221.2012; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kinkaid HYM, 2010, J CARDIAC SURG, V25, P359, DOI 10.1111/j.1540-8191.2009.00984.x; KONO T, 1992, J AM COLL CARDIOL, V20, P1594, DOI 10.1016/0735-1097(92)90455-V; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; LAMAS GA, 1989, AM J CARDIOL, V63, P1167, DOI 10.1016/0002-9149(89)90173-2; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Lessick J, 2007, RADIOLOGY, V244, P736, DOI 10.1148/radiol.2443061397; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Lupon J, 2012, EUR J HEART FAIL; Mahnken AH, 2005, J AM COLL CARDIOL, V45, P2042, DOI 10.1016/j.jacc.2005.03.035; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Middel B, 2001, CLIN REHABIL, V15, P489, DOI 10.1191/026921501680425216; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; Williams AR, 2011, CIRCULATION, V124; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Zhuo Y, 2010, J THORAC CARDIOVASC, V139, P1294; Zhuo Y, 2010, J THORAC CARDIOVASC, V139, pe1; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	46	819	849	2	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2369	2379		10.1001/jama.2012.25321	http://dx.doi.org/10.1001/jama.2012.25321			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23117550	Bronze, Green Accepted			2022-12-28	WOS:000312132400027
J	Thomas, MK; Kremer, CT; Klausmeier, CA; Litchman, E				Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena			A Global Pattern of Thermal Adaptation in Marine Phytoplankton	SCIENCE			English	Article							CLIMATE-CHANGE; BIODIVERSITY LOSS; IMPACTS; PRODUCTIVITY; TERRESTRIAL	Rising ocean temperatures will alter the productivity and composition of marine phytoplankton communities, thereby affecting global biogeochemical cycles. Predicting the effects of future ocean warming on biogeochemical cycles depends critically on understanding how existing global temperature variation affects phytoplankton. Here we show that variation in phytoplankton temperature optima over 150 degrees of latitude is well explained by a gradient in mean ocean temperature. An eco-evolutionary model predicts a similar relationship, suggesting that this pattern is the result of evolutionary adaptation. Using mechanistic species distribution models, we find that rising temperatures this century will cause poleward shifts in species' thermal niches and a sharp decline in tropical phytoplankton diversity in the absence of an evolutionary response.	[Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Thomas, Mridul K.; Litchman, Elena] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Kremer, Colin T.; Klausmeier, Christopher A.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Thomas, MK (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	thomasmr@msu.edu	Klausmeier, Christopher A/J-9339-2012	Litchman, Elena/0000-0001-7736-6332; Thomas, Mridul/0000-0002-5089-5610; Klausmeier, Christopher/0000-0002-6987-5871	NSF [DEB-0845932, DEB-0845825, OCE-0928819]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; Graduate Research Fellowship; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; Graduate Research Fellowship; James S. McDonnell Foundation	This research was supported by NSF (grants DEB-0845932, DEB-0845825, and OCE-0928819), including the BEACON Center for the Study of Evolution in Action (grant DBI-0939454) and a Graduate Research Fellowship to C. T. K., as well as a grant from the James S. McDonnell Foundation. K. Edwards and N. Swenson provided statistical advice, and J. Lennon, G. Mittelbach, and.. Miller provided comments on the manuscript. The trait data presented are shown in table S5, and the collated growth rate data are in table S6. Also thanks to NOAA/OAR/ESRL PSD, Boulder, CO, USA, for NOAA_OI_SST_V2 data provided at their Web site, www.esrl.noaa.gov/psd/. This is W. K. Kellogg Biological Station contribution number 1694. E. L. and M. K. T. conceived the original idea; M. K. T. collected the growth-temperature data; M. K. T. and C. T. K. analyzed the data; C. T. K. and C. A. K. developed and C. T. K. analyzed the eco-evolutionary model; M. K. T. and C. T. K. ran the mechanistic species distribution models; and M. K. T., C. T. K., and E. L. wrote and C. A. K. commented on the manuscript.	Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett A. F., 2007, LIGHT EVOLUTION, V1, P225; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Knies JL, 2006, PLOS BIOL, V4, P1257, DOI 10.1371/journal.pbio.0040201; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; REDFIELD AC, 1958, AM SCI, V46, P205; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Solomon S., 2007, PHYS SCI BASIS WORKI; Stegen JC, 2012, P ROY SOC B-BIOL SCI, V279, P1051, DOI 10.1098/rspb.2011.1733; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0	33	445	452	45	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1085	1088		10.1126/science.1224836	http://dx.doi.org/10.1126/science.1224836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112294				2022-12-28	WOS:000311390600045
J	Badrinarayanan, A; Reyes-Lamothe, R; Uphoff, S; Leake, MC; Sherratt, DJ				Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Uphoff, Stephan; Leake, Mark C.; Sherratt, David J.			In Vivo Architecture and Action of Bacterial Structural Maintenance of Chromosome Proteins	SCIENCE			English	Article							ESCHERICHIA-COLI; ATP HYDROLYSIS; CONDENSIN; DNA; COMPLEX; COHESIN; MUKB; SMC; STOICHIOMETRY; ORGANIZATION	SMC (structural maintenance of chromosome) proteins act ubiquitously in chromosome processing. In Escherichia coli, the SMC complex MukBEF plays roles in chromosome segregation and organization. We used single-molecule millisecond multicolor fluorescence microscopy of live bacteria to reveal that a dimer of dimeric fluorescent MukBEF molecules acts as the minimal functional unit. On average, 8 to 10 of these complexes accumulated as "spots" in one to three discrete chromosome-associated regions of the cell, where they formed higher-order structures. Functional MukBEF within spots exchanged with freely diffusing complexes at a rate of one complex about every 50 seconds in reactions requiring adenosine triphosphate (ATP) hydrolysis. Thus, by functioning in pairs, MukBEF complexes may undergo multiple cycles of ATP hydrolysis without being released from DNA, analogous to the behavior of well-characterized molecular motors.	[Uphoff, Stephan; Leake, Mark C.] Univ Oxford, Dept Phys, Oxford OX1 2JD, England; [Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Leake, MC (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 2JD, England.	m.leake1@physics.ox.ac.uk; david.sherratt@bioch.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Sherratt, David/0000-0002-2104-5430; Uphoff, Stephan/0000-0002-3579-0888; Badrinarayanan, Anjana/0000-0001-5520-2134	New College (Oxford University); Mathworks scholarship; Royal Society; Engineering and Physical Sciences Research Council [EP/G061009]; Wellcome Trust [WT083469MA]	New College (Oxford University); Mathworks scholarship; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust)	R.R.-L. held the Todd-Bird Junior Research Fellowship of New College (Oxford University). S.U. was supported by a Mathworks scholarship. M.C.L. was supported by a Royal Society University Research Fellowship. We thank R. Oliveira for assistance with FRAP experiments and A. Kapanidis for discussions and provision of the PALM equipment. The experimental work was funded by an Engineering and Physical Sciences Research Council grant to M.C.L. (EP/G061009) and by a Wellcome Trust program grant to D.J.S. (WT083469MA). All data are presented in the supplementary materials, and bacterial strains are available on request. The authors declare that they have no competing financial interests. The project was conceived by all authors, each of whom contributed to writing the manuscript. A.B., R.R.-L., and S.U. performed the experiments, M.C.L. developed the millisecond microscopy and biophysical/analytical methods, and S.U. implemented live-cell PALM. M.C.L., A.B., and S.U. did the analysis. D.J.S. and M.C.L. contributed equally.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Gloyd M, 2011, J MOL BIOL, V412, P578, DOI 10.1016/j.jmb.2011.08.009; Gruber S, 2011, MOL MICROBIOL, V81, P855, DOI 10.1111/j.1365-2958.2011.07764.x; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Yamanaka K, 1996, MOL GEN GENET, V250, P241	26	163	163	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					528	531		10.1126/science.1227126	http://dx.doi.org/10.1126/science.1227126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112333	Green Accepted			2022-12-28	WOS:000310195800058
J	Hyster, TK; Knorr, L; Ward, TR; Rovis, T				Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.; Rovis, Tomislav			Biotinylated Rh(III) Complexes in Engineered Streptavidin for Accelerated Asymmetric C-H Activation	SCIENCE			English	Article							ARTIFICIAL METALLOENZYMES; PROTEIN; HYDROGENATION; DESIGN; EVOLUTION; CATALYST; ENZYMES; ALKYNES	Enzymes provide an exquisitely tailored chiral environment to foster high catalytic activities and selectivities, but their native structures are optimized for very specific biochemical transformations. Designing a protein to accommodate a non-native transition metal complex can broaden the scope of enzymatic transformations while raising the activity and selectivity of small-molecule catalysis. Here, we report the creation of a bifunctional artificial metalloenzyme in which a glutamic acid or aspartic acid residue engineered into streptavidin acts in concert with a docked biotinylated rhodium(III) complex to enable catalytic asymmetric carbon-hydrogen (C-H) activation. The coupling of benzamides and alkenes to access dihydroisoquinolones proceeds with up to nearly a 100-fold rate acceleration compared with the activity of the isolated rhodium complex and enantiomeric ratios as high as 93:7.	[Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland; [Hyster, Todd K.; Rovis, Tomislav] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	University of Basel; Colorado State University	Ward, TR (corresponding author), Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.	thomas.ward@unibas.ch; rovis@lamar.colostate.edu	Ward, Thomas R/K-6419-2012	Ward, Thomas R/0000-0001-8602-5468	National Institute of General Medical Sciences [GM80442]; Swiss National Science Foundation [200020-126366]; National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network [FP7-ITN-238434]; Amgen; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network(European Commission); Amgen(Amgen); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (GM80442), the Swiss National Science Foundation (grant 200020-126366), the National Center of Competence in Research Nanoscale Sciences, the Marie Curie Training Network (FP7-ITN-238434), Amgen, and Roche for support. We thank Johnson Matthey for a loan of rhodium salts and C. R. Cantor for the Sav gene. We thank M. J. Zimbron for providing an initial sample of [RhCp*<SUP>biotin</SUP>Cl<INF>2</INF>]<INF>2</INF> and for stimulating discussions.	Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c; Collot J, 2004, J ORGANOMET CHEM, V689, P4868, DOI 10.1016/j.jorganchem.2004.09.032; Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646; GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026; Hyster TK, 2010, J AM CHEM SOC, V132, P10565, DOI 10.1021/ja103776u; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Lin CC, 1999, TETRAHEDRON-ASYMMETR, V10, P1887, DOI 10.1016/S0957-4166(99)00193-7; Lin YW, 2010, J AM CHEM SOC, V132, P9970, DOI 10.1021/ja103516n; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Reiner T, 2009, J ORGANOMET CHEM, V694, P1934, DOI 10.1016/j.jorganchem.2009.01.056; Roelfes G, 2011, CHEMCATCHEM, V3, P647, DOI 10.1002/cctc.201000413; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Skander M, 2004, J AM CHEM SOC, V126, P14411, DOI 10.1021/ja0476718; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Xu L, 2012, J ORG CHEM, V77, P3017, DOI 10.1021/jo202431q; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620	30	561	573	9	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					500	503		10.1126/science.1226132	http://dx.doi.org/10.1126/science.1226132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112327	Green Accepted			2022-12-28	WOS:000310195800050
J	Zelenitsky, DK; Therrien, F; Erickson, GM; DeBuhr, CL; Kobayashi, Y; Eberth, DA; Hadfield, F				Zelenitsky, Darla K.; Therrien, Francois; Erickson, Gregory M.; DeBuhr, Christopher L.; Kobayashi, Yoshitsugu; Eberth, David A.; Hadfield, Frank			Feathered Non-Avian Dinosaurs from North America Provide Insight into Wing Origins	SCIENCE			English	Article							THEROPOD DINOSAUR; EVOLUTIONARY ORIGIN; SOFT-TISSUE; ARCHAEOPTERYX	Previously described feathered dinosaurs reveal a fascinating record of feather evolution, although substantial phylogenetic gaps remain. Here we report the occurrence of feathers in ornithomimosaurs, a clade of non-maniraptoran theropods for which fossilized feathers were previously unknown. The Ornithomimus specimens, recovered from Upper Cretaceous deposits of Alberta, Canada, provide new insights into dinosaur plumage and the origin of the avian wing. Individuals from different growth stages reveal the presence of a filamentous feather covering throughout life and winglike structures on the forelimbs of adults. The appearance of winglike structures in older animals indicates that they may have evolved in association with reproductive behaviors. These specimens show that primordial wings originated earlier than previously thought, among non-maniraptoran theropods.	[Zelenitsky, Darla K.; DeBuhr, Christopher L.] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada; [Therrien, Francois; Eberth, David A.] Royal Tyrrell Museum Palaeontol, Drumheller, AB TOJ OYO, Canada; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Hadfield, Frank] Palcoprep, Drumheller, AB TOJ OYO, Canada	University of Calgary; State University System of Florida; Florida State University; Hokkaido University	Zelenitsky, DK (corresponding author), Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada.	dkzeleni@ucalgary.ca; francois.therrien@gov.ab.ca			Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada; University of Calgary; NSF Division of Earth Sciences [EAR 0959029]	Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary; NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. Andrew (landowner), D. Brinkman (logistical support), J. Csotonyi (artwork), D. MacLeod (specimen preparation), M. Newbrey (discussions), D. Sloan (technical illustrations), and K. Womble (graphics). Research was funded by the Royal Tyrrell Museum of Palaeontology, a Natural Sciences and Engineering Research Council of Canada Discovery grant (D.K.Z.), the University of Calgary Start-up Fund (D.K.Z.), and an NSF Division of Earth Sciences grant (EAR 0959029) (G.M.E.). TMP 1995.110.1, TMP 2008.70.1, and TMP 2009.110.1 are permanently deposited at the Royal Tyrrell Museum, Drumheller, Alberta, Canada.	BOCK WALTER J., 1965, SYST ZOOL, V14, P272, DOI 10.2307/2411681; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Cho P., 1984, Zoo Biology, V3, P133, DOI 10.1002/zoo.1430030205; Dal Sasso C, 1998, NATURE, V392, P383; Davies S.J.J.F., 2002, RATITES TINAMOUS; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Duerden J. E., 1911, AGR J UNION S AFRICA, V1, P29; Fastovsky D. E., 1989, AGE DINOSAURS, V2, P22; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; GILL FB, 2007, ORNITHOLOGY; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner Alexander W.A., 2002, P389; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Lucas A.M., 1972, AVIAN ANATOMY INTE 1; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; WRAY R. S., 1887, P ZOOL SOC LONDON, V1887, P343; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	36	66	69	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					510	514		10.1126/science.1225376	http://dx.doi.org/10.1126/science.1225376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112330				2022-12-28	WOS:000310195800053
J	Carroll, AE; Frakt, AB				Carroll, Aaron E.; Frakt, Austin B.			The Health Policy Election	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Carroll, Aaron E.] Indiana Univ Sch Med, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Frakt, Austin B.] VA Boston Healthcare Syst, Dept Vet Affairs, Boston, MA USA; [Frakt, Austin B.] Boston Univ, Boston, MA 02215 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Carroll, AE (corresponding author), Indiana Univ Sch Med, Childrens Hlth Serv Res, 410W10th St,HITS Bldg,Ste 1020, Indianapolis, IN 46202 USA.	aaecarro@iupui.edu		Frakt, Austin/0000-0002-0795-5462				Aaron HJ, 2012, NEW ENGL J MED, V366, P877, DOI 10.1056/NEJMp1200448; Congressional Budget Office, 2012, UPD EST INS COV PROV; Congressional Budget Office, 2012, LONG TERM BUDG IMP P; Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds The Boards of Trustees, 2012, 2012 ANN REP BOARDS; The Henry J. Kaiser Family Foundation, 2008, PRIV HLTH COV WORKS; The Henry J. Kaiser Family Foundation. Raising the Age of Medicare Eligibility, 2011, KAIS FAM FDN MED POL	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1633	1634		10.1001/jama.2012.13667	http://dx.doi.org/10.1001/jama.2012.13667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23060272	Bronze			2022-12-28	WOS:000310434100014
J	Mehanna, H; McQueen, A; Robinson, M; Paleri, V				Mehanna, Hisham; McQueen, Andrew; Robinson, Max; Paleri, Vinidh			Salivary gland swellings	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIAGNOSTIC-ACCURACY; SJOGRENS-SYNDROME; MR SIALOGRAPHY; MANAGEMENT; LESIONS; CALCULI; SIALOLITHIASIS; PAROTIDECTOMY; MALIGNANCIES; METAANALYSIS		[Mehanna, Hisham] Univ Birmingham, Coll Med & Dent, Sch Canc Sci, Inst Head & Neck Studies & Educ InHANSE, Birmingham B15 2TT, W Midlands, England; [McQueen, Andrew] Newcastle Univ, Newcastle upon Tyne Hosp NHS Trust, Dept Radiol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Robinson, Max] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Paleri, Vinidh] Newcastle Univ, Newcastle upon Tyne Hosp NHS Trust, Dept Otolaryngol Head & Neck Surg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Paleri, Vinidh] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Birmingham; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Mehanna, H (corresponding author), Univ Birmingham, Coll Med & Dent, Sch Canc Sci, Inst Head & Neck Studies & Educ InHANSE, Birmingham B15 2TT, W Midlands, England.	Hisham.Mehanna@inhanse.org	; Robinson, Max/R-5280-2018	Mehanna, Hisham/0000-0002-5544-6224; Robinson, Max/0000-0003-4491-6865				Blodgett TM, 2005, RADIOGRAPHICS, V25, P897, DOI 10.1148/RG.254035156; Bradley PJ, 2012, CONTROVERSIES MANAGE; Bron LP, 1997, ARCH OTOLARYNGOL, V123, P1091; Brook I, 2002, J MED MICROBIOL, V51, P526, DOI 10.1099/0022-1317-51-6-526; Capaccio P, 2007, Acta Otorhinolaryngol Ital, V27, P161; Capaccio P, 2004, LARYNGOSCOPE, V114, P1069, DOI 10.1097/00005537-200406000-00021; Drage NA, 2002, CARDIOVASC INTER RAD, V25, P356, DOI 10.1007/s00270-002-1951-8; Friedrich RE, 2005, ANTICANCER RES, V25, P1703; Glastonbury CM, 2005, AMIRSYS, P7; Greenspan JS, 2002, ORAL DIS, V8, P34, DOI 10.1034/j.1601-0825.2002.00009.x; Hanna E, 2007, ARCH OTOLARYNGOL, V133, P541, DOI 10.1001/archotol.133.6.541; Harada Hiroshi, 2000, Kurume Medical Journal, V47, P307; Iro H, 2009, LARYNGOSCOPE, V119, P263, DOI 10.1002/lary.20008; Jager L, 2000, RADIOLOGY, V216, P665; Kalinowski M, 2002, AM J NEURORADIOL, V23, P1485; Kocjan G, DIAGN CYTOPATHOL, V3; Marchal F, 2001, ANN OTO RHINOL LARYN, V110, P464, DOI 10.1177/000348940111000513; Marchal F, 2007, SALIVARY GLAND DISOR, P169; McGurk M, 2005, BRIT J SURG, V92, P107, DOI 10.1002/bjs.4789; MILTON CM, 1986, ANN ROY COLL SURG, V68, P148; Munir N, 2008, ORAL ONCOL, V44, P251, DOI 10.1016/j.oraloncology.2007.02.004; Nahlieli O, 2003, ORAL SURG ORAL MED O, V95, P396, DOI 10.1067/moe.2003.145; Nahlieli O, 2006, J AM DENT ASSOC, V137, P1394, DOI 10.14219/jada.archive.2006.0051; Oxford Cancer Intelligence Unit, 2010, PROF HEAD NECK CANC; Razfar A, 2010, LARYNGOSCOPE, V120, P734, DOI 10.1002/lary.20829; Robinson IA, 1999, CLIN RADIOL, V54, P312, DOI 10.1016/S0009-9260(99)90561-5; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P516, DOI 10.1309/AJCP5LTQ4RVOQAIT; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P45, DOI 10.1309/AJCPOIE0CZNAT6SQ; Sood S, 1999, CLIN OTOLARYNGOL, V24, P365, DOI 10.1046/j.1365-2273.1999.00283.x; Speight PM, 2002, ORAL DIS, V8, P229, DOI 10.1034/j.1601-0825.2002.02870.x; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	32	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2012	345								e6794	10.1136/bmj.e6794	http://dx.doi.org/10.1136/bmj.e6794			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MT	23092898				2022-12-28	WOS:000310427100016
J	Sun, YD; Joachimski, MM; Wignall, PB; Yan, CB; Chen, YL; Jiang, HS; Wang, LN; Lai, XL				Sun, Yadong; Joachimski, Michael M.; Wignall, Paul B.; Yan, Chunbo; Chen, Yanlong; Jiang, Haishui; Wang, Lina; Lai, Xulong			Lethally Hot Temperatures During the Early Triassic Greenhouse	SCIENCE			English	Article							END-PERMIAN EXTINCTION; THERMAL TOLERANCE; DEPENDENT BIOGEOGRAPHY; OXYGEN LIMITATION; NANPANJIANG BASIN; CLIMATE-CHANGE; SOUTH CHINA; BOUNDARY; RECOVERY; PALEOENVIRONMENTS	Global warming is widely regarded to have played a contributing role in numerous past biotic crises. Here, we show that the end-Permian mass extinction coincided with a rapid temperature rise to exceptionally high values in the Early Triassic that were inimical to life in equatorial latitudes and suppressed ecosystem recovery. This was manifested in the loss of calcareous algae, the near-absence of fish in equatorial Tethys, and the dominance of small taxa of invertebrates during the thermal maxima. High temperatures drove most Early Triassic plants and animals out of equatorial terrestrial ecosystems and probably were a major cause of the end-Smithian crisis.	[Sun, Yadong; Yan, Chunbo; Jiang, Haishui; Wang, Lina; Lai, Xulong] China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China; [Sun, Yadong; Wignall, Paul B.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Joachimski, Michael M.] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Chen, Yanlong] Graz Univ, Inst Earth Sci Geol & Paleontol, A-8010 Graz, Austria	China University of Geosciences; University of Leeds; University of Erlangen Nuremberg; University of Graz	Sun, YD (corresponding author), China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China.	eeys@leeds.ac.uk	Joachimski, Michael M./B-9477-2011; Sun, Yadong/AAG-8781-2019; Sun, Yadong/N-6907-2013	Sun, Yadong/0000-0003-4032-2082; Sun, Yadong/0000-0003-4032-2082; Joachimski, Michael/0000-0001-6088-3261; Chen, Yanlong/0000-0003-1110-9020; Lai, Xulong/0000-0002-2837-0885	Chinese 973 Program [2011CB808800]; Natural Science Foundation of China [41172024, 40830212]	Chinese 973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	D. Lutz, F. Nenning, B. Yang, and X. Liu are acknowledged for lab and field assistance. This study was supported by Chinese 973 Program (2011CB808800) and the Natural Science Foundation of China (41172024 and 40830212). Y.S. acknowledges China University of Geosciences and China Scholarship Council for split-site Ph.D. at Wuhan, Leeds, and Erlangen.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Borsuk-Bialynicka M, 1999, ACTA PALAEONTOL POL, V44, P167; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; CALLAWAY JM, 1989, CAN J EARTH SCI, V26, P1491, DOI 10.1139/e89-126; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chen J., 2004, MASS EXTINCTION RECO, VII, P647; CLARK DL, 1986, SCIENCE, V233, P984, DOI 10.1126/science.233.4767.984; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; Ellis RJ, 2010, NATURE, V463, P164, DOI 10.1038/463164a; Frank T. D., 2000, P ODP SCI RESULTS, V166, P137; Galfetti T, 2008, SEDIMENT GEOL, V204, P36, DOI 10.1016/j.sedgeo.2007.12.008; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Hallam A., 1997, MASS EXTINCTIONS THE; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Lehrmann DJ, 2003, PALAIOS, V18, P138, DOI 10.1669/0883-1351(2003)18<138:PBSFSC>2.0.CO;2; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Looy CV, 1999, P NATL ACAD SCI USA, V96, P13857, DOI 10.1073/pnas.96.24.13857; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Muttoni G, 2009, GEOARABIA, V14, P17; O'Dogherty L, 2009, GEODIVERSITAS, V31, P213, DOI 10.5252/g2009n2a3; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Pan H., 1994, PALAEOWORLD, V4, P249; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reichow MK, 2009, EARTH PLANET SC LETT, V277, P9, DOI 10.1016/j.epsl.2008.09.030; Retallack GJ, 1999, AUST J EARTH SCI, V46, P785, DOI 10.1046/j.1440-0952.1999.00745.x; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Schneebeli-Hermann E, 2012, PALAEOGEOGR PALAEOCL, V339, P12, DOI 10.1016/j.palaeo.2012.04.010; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Song HJ, 2011, GEOLOGY, V39, P739, DOI 10.1130/G32191.1; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; Stanley SM, 2009, P NATL ACAD SCI USA, V106, P15264, DOI 10.1073/pnas.0907992106; Sues H.-D., 2010, TRIASSIC LIFE LAND; Sun D., 2004, MASS EXTINCTION RECO, VII, P543; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Ziegler A.M., 1997, LATE GLACIAL POSTGLA, P111	51	700	767	36	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					366	370		10.1126/science.1224126	http://dx.doi.org/10.1126/science.1224126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087244				2022-12-28	WOS:000309955800037
J	Greene, JA; Podolsky, SH				Greene, Jeremy A.; Podolsky, Scott H.			HISTORY OF MEDICINE Reform, Regulation, and Pharmaceuticals - The Kefauver-Harris Amendments at 50	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD 21205 USA; [Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Podolsky, Scott H.] Francis Countway Lib Med, Ctr Hist Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.				NATIONAL LIBRARY OF MEDICINE [G13LM010890] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 1961, C RECORD, V107, P5639; [Anonymous], 1961, NEW ENGL J MED, V265, P1015; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Tobbell DA, 2012, CAL MILBANK BOOK HEA, V23, P1	4	59	63	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1481	1483		10.1056/NEJMp1210007	http://dx.doi.org/10.1056/NEJMp1210007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075174	Green Accepted			2022-12-28	WOS:000309904500004
J	Dmochowski, R				Dmochowski, Roger			Review: Drugs for urgency urinary incontinence improve continence in women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Nashville, TN 37203 USA	Vanderbilt University	Dmochowski, R (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37203 USA.		Ramakrishnan, Rema/AAE-1742-2022	Ramakrishnan, Rema/0000-0002-6784-8319				Madhuvrata P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005429.pub2	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-4	10.7326/0003-4819-157-8-201210160-02004	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070506				2022-12-28	WOS:000309906000003
J	Liman, ER				Liman, Emily R.			Putting the Squeeze on Phototransduction	SCIENCE			English	Editorial Material							DROSOPHILA PHOTORECEPTORS; CHANNELS; TRP; RECEPTOR		Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Liman, ER (corresponding author), Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA.	liman@usc.edu	Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2012, SCIENCE, V338, P260, DOI 10.1126/science.1222376; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005	16	4	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					200	201		10.1126/science.1229909	http://dx.doi.org/10.1126/science.1229909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066065				2022-12-28	WOS:000309712300025
J	Novoselov, KS; Fal'ko, VI; Colombo, L; Gellert, PR; Schwab, MG; Kim, K				Novoselov, K. S.; Fal'ko, V. I.; Colombo, L.; Gellert, P. R.; Schwab, M. G.; Kim, K.			A roadmap for graphene	NATURE			English	Review							SATURABLE ABSORBER; HIGH-QUALITY; GRAPHITE; FEMTOSECOND; TRANSPARENT; TRANSISTORS; EXFOLIATION; FABRICATION; GENERATION; PHOTONICS	Recent years have witnessed many breakthroughs in research on graphene (the first two-dimensional atomic crystal) as well as a significant advance in the mass production of this material. This one-atom-thick fabric of carbon uniquely combines extreme mechanical strength, exceptionally high electronic and thermal conductivities, impermeability to gases, as well as many other supreme properties, all of which make it highly attractive for numerous applications. Here we review recent progress in graphene research and in the development of production methods, and critically analyse the feasibility of various graphene applications.	[Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Fal'ko, V. I.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Colombo, L.] Texas Instruments Inc, Dallas, TX 75243 USA; [Gellert, P. R.] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England; [Schwab, M. G.] BASF SE, Carbon Mat Innovat Ctr, D-67056 Ludwigshafen, Germany; [Kim, K.] Samsung Elect, Samsung Adv Inst Technol SAIT, Yongin 446712, Gyeonggi Do, South Korea	University of Manchester; Lancaster University; Texas Instruments; AstraZeneca; BASF; Samsung	Novoselov, KS (corresponding author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.	kostya@manchester.ac.uk	Colombo, Luigi/T-4677-2018; Novoselov, Kostya S/G-9581-2014	Colombo, Luigi/0000-0002-9048-3565; Novoselov, Kostya S/0000-0003-4972-5371; hai yan, he/0000-0003-0366-6185; Fal'ko, Vladimir/0000-0003-0828-0310	EC Supporting Coordinated Action "Graphene-CA" Flagship Preparatory Action	EC Supporting Coordinated Action "Graphene-CA" Flagship Preparatory Action	We are grateful to the graphene community for years of intensive research and discussions. In particular, A. Geim, F. Bonaccorso, I. Kinloch, R. J. Young, R. Dryfe, A. Tzalenchuk, D. Clarke, J. Kinaret and L. Eaves have commented on this paper. K.S.N. and V. I. F. acknowledge the EC Supporting Coordinated Action "Graphene-CA" Flagship Preparatory Action for financial support.	Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Bao QL, 2011, NAT PHOTONICS, V5, P411, DOI [10.1038/NPHOTON.2011.102, 10.1038/nphoton.2011.102]; Bao QL, 2009, ADV FUNCT MATER, V19, P3077, DOI 10.1002/adfm.200901007; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Blake P, 2008, NANO LETT, V8, P1704, DOI 10.1021/nl080649i; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/NPHOTON.2010.186, 10.1038/nphoton.2010.186]; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Crassee I, 2011, NAT PHYS, V7, P48, DOI [10.1038/nphys1816, 10.1038/NPHYS1816]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; DESOUZA EA, 1995, OPT LETT, V20, P1166, DOI 10.1364/OL.20.001166; Dhar S, 2011, AIP ADV, V1, DOI 10.1063/1.3584204; Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221; Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P9336, DOI 10.1002/anie.201003024; Echtermeyer TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1464; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Forbeaux I, 1998, PHYS REV B, V58, P16396, DOI 10.1103/PhysRevB.58.16396; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Geim AK, 2011, REV MOD PHYS, V83, P851, DOI 10.1103/RevModPhys.83.851; Giesbers AJM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3043426; Hackley J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3242029; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Han SJ, 2011, NANO LETT, V11, P3690, DOI 10.1021/nl2016637; Han TH, 2012, NAT PHOTONICS, V6, P105, DOI [10.1038/NPHOTON.2011.318, 10.1038/nphoton.2011.318]; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Ishibashi T, 2000, IEICE T ELECTRON, VE83C, P938; Ishikawa Y, 2010, IEEE PHOTONICS J, V2, P306, DOI 10.1109/JPHOT.2010.2046026; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Keller U, 1996, IEEE J SEL TOP QUANT, V2, P435, DOI 10.1109/2944.571743; Kim K, 2011, NATURE, V479, P338, DOI 10.1038/nature10680; Koch BR, 2009, LASER PHOTONICS REV, V3, P355, DOI 10.1002/lpor.200810033; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Kuila T, 2011, BIOSENS BIOELECTRON, V26, P4637, DOI 10.1016/j.bios.2011.05.039; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li GL, 2011, OPT EXPRESS, V19, P20435, DOI 10.1364/OE.19.020435; Li SS, 2010, ACS NANO, V4, P3169, DOI 10.1021/nn100551j; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Liao L, 2007, ELECTRON LETT, V43, P1196, DOI 10.1049/el:20072253; Liao L, 2010, NANO LETT, V10, P3952, DOI 10.1021/nl101724k; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Liu F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064120; Liu M, 2011, NATURE, V474, P64, DOI 10.1038/nature10067; Liu X, 1997, IEEE J QUANTUM ELECT, V33, P1706, DOI 10.1109/3.631270; Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Meric I, 2011, HIGH FREQUENCY PERFO, P15; Meric I, 2011, NANO LETT, V11, P1093, DOI 10.1021/nl103993z; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Morozov SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016602; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Mueller T, 2010, NAT PHOTONICS, V4, P297, DOI 10.1038/NPHOTON.2010.40; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Nair RR, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492845; Nair RR, 2010, SMALL, V6, P2877, DOI 10.1002/smll.201001555; Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Prechtel L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1656; Ramakrishnan G, 2009, OPT EXPRESS, V17, P16092, DOI 10.1364/OE.17.016092; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Reed GT, 2010, NAT PHOTONICS, V4, P518, DOI [10.1038/nphoton.2010.179, 10.1038/NPHOTON.2010.179]; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Segal M, 2009, NAT NANOTECHNOL, V4, P611, DOI 10.1038/nnano.2009.279; Sensale-Rodriguez B, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3636435; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Stampfer C, 2008, NANO LETT, V8, P2378, DOI 10.1021/nl801225h; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Sun ZP, 2010, ACS NANO, V4, P803, DOI 10.1021/nn901703e; Tan WD, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292018; Tang YB, 2011, OPT EXPRESS, V19, P5811, DOI 10.1364/OE.19.005811; Tzalenchuk A, 2010, NAT NANOTECHNOL, V5, P186, DOI [10.1038/NNANO.2009.474, 10.1038/nnano.2009.474]; Virojanadara C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245403; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Xia FN, 2009, NAT NANOTECHNOL, V4, P839, DOI [10.1038/nnano.2009.292, 10.1038/NNANO.2009.292]; Xia FN, 2009, NANO LETT, V9, P1039, DOI 10.1021/nl8033812; Xu JL, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3672213; Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u; Yang SB, 2010, ANGEW CHEM INT EDIT, V49, P8408, DOI 10.1002/anie.201003485; Yoo E, 2008, NANO LETT, V8, P2277, DOI 10.1021/nl800957b; Yoo E, 2009, NANO LETT, V9, P2255, DOI 10.1021/nl900397t; Young RJ, 2012, COMPOS SCI TECHNOL, V72, P1459, DOI 10.1016/j.compscitech.2012.05.005; Zhang H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3367743	97	6807	6983	208	6615	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					192	200		10.1038/nature11458	http://dx.doi.org/10.1038/nature11458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060189				2022-12-28	WOS:000309733300037
J	Davis, JM; Connor, EM; Wood, AJJ				Davis, Jonathan M.; Connor, Edward M.; Wood, Alastair J. J.			The Need for Rigorous Evidence on Medication Use in Preterm Infants Is It Time for a Neonatal Rule?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AGE		[Davis, Jonathan M.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Boston, MA 02111 USA; [Connor, Edward M.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Wood, Alastair J. J.] Symphony Capital LLC, New York, NY USA; [Wood, Alastair J. J.] Weill Cornell Med Coll, Dept Med & Pharmacol, New York, NY USA	Floating Hospital For Children; Tufts Medical Center; Children's National Health System; Cornell University	Davis, JM (corresponding author), Tufts Med Ctr, 800 Washington St,Box 44, Boston, MA 02111 USA.	jdavis@tuftsmedicalcenter.org						Cohen-Wolkowiez M, 2012, ANTIMICROB AGENTS CH, V56, P1828, DOI 10.1128/AAC.06071-11; Institute of Medicine of the National Academies, SAF EFF MED CHILDR P; Institute of Medicine of the National Academies, PRET BIRTH CAUS CONS; Kumar P, 2008, J PEDIATR, V152, P412, DOI 10.1016/j.jpeds.2007.07.050; Moore TJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e53; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; US Food Drug Administration, NEW PED LAB INF DAT; US Government Accountability Office, PED RES PROD STUD 2	8	33	33	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1435	1436		10.1001/jama.2012.12883	http://dx.doi.org/10.1001/jama.2012.12883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047355				2022-12-28	WOS:000309579300019
J	Hewett, N; Halligan, A; Boyce, T				Hewett, Nigel; Halligan, Aidan; Boyce, Trudy			A general practitioner and nurse led approach to improving hospital care for homeless people	BRITISH MEDICAL JOURNAL			English	Article									[Hewett, Nigel] Univ Coll London Hosp NHS Fdn Trust, Univ Coll Hosp, Pathway Homelessness Team, London NW1 2BU, England; [Halligan, Aidan] Univ Coll London Hosp NHS Fdn Trust, Univ Coll Hosp, Educ Ctr, London NW1 2PG, England; [Halligan, Aidan] Brighton & Sussex Univ Hosp NHS Trust, Brighton & Sussex Univ Hosp, Brighton, E Sussex, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Hewett, N (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Univ Coll Hosp, Pathway Homelessness Team, London NW1 2BU, England.	nigelhewett@nhs.net						Hewett N, 2011, BRIT J GEN PRACT, V61, P200, DOI 10.3399/bjgp11X561203; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; National Health Care for the Homeless Council, 2011, MED RESP CAR HOM; Office of the Chief Analyst, 2010, HEALTHC SINGL HOM PE	4	37	38	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 28	2012	345								e5999	10.1136/bmj.e5999	http://dx.doi.org/10.1136/bmj.e5999			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014PD	23045316				2022-12-28	WOS:000309387100001
J	Heusch, G				Heusch, Gerd			Cardioprotection: chances and challenges of its translation to the clinic	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; BYPASS GRAFT-SURGERY; DOSE INTRACORONARY ADENOSINE; ISCHEMIA-REPERFUSION INJURY; COLD BLOOD CARDIOPLEGIA; HUMAN HEART; VALVE-REPLACEMENT; CARDIAC-SURGERY; STENT IMPLANTATION	Myocardial infarct size is a major determinant of prognosis. Ischaemic preconditioning with brief coronary occlusion and reperfusion before a sustained period of coronary occlusion with reperfusion delays infarct development. Ischaemic postconditioning uses repetitive brief coronary occlusion during early reperfusion of myocardial infarction and reduces infarct size. Remote ischaemic preconditioning uses brief ischaemia and reperfusion of a distant organ to protect the myocardium. These conditioning protocols recruit a complex signal cascade of sarcolemmal receptor activation, intracellular enzyme activation, and ultimately mitochondrial stabilisation and inhibition of death signalling. Conditioning protocols have been successfully used in patients undergoing elective coronary revascularisation and reperfusion after acute myocardial infarction. Pharmacological recruitment of cardioprotective signalling has also been used to reduce infarct size, but so far without prognostic benefit. Outcomes of cardioprotection are affected by age, sex, comorbidities, and drugs, but also by technical issues related to determination of infarct size and revascularisation procedure.	Univ Klinikum Essen, Inst Pathophysiol, D-45122 Essen, Germany	University of Duisburg Essen	Heusch, G (corresponding author), Univ Klinikum Essen, Inst Pathophysiol, Hufelandstr 55, D-45122 Essen, Germany.	gerd.heusch@uk-essen.de	Heusch, Gerd/ABE-6675-2020		German Research Foundation [He 1320]	German Research Foundation(German Research Foundation (DFG))	This Review is an extended version of the William Harvey Lecture, held at the congress of the European Society of Cardiology on Aug 26, 2012, in Munich, Germany. Harvey not only discovered the systemic circulation of blood, but also reported key experiments on ischaemia and reperfusion, in which he observed arterial pulse and venous filling distal to a ligature on the upper arm. GH has been supported in his research by the German Research Foundation (He 1320) over many years.	Ali N, 2010, JCPSP-J COLL PHYSICI, V20, P427, DOI 07.2010/JCPSP.427431; ALKHULAIFI AM, 1994, EUR J CARDIO-THORAC, V8, P270, DOI 10.1016/1010-7940(94)90159-7; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1986, LANCET, V2, P57; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Buyukates M, 2005, J CARDIAC SURG, V20, P241, DOI 10.1111/j.1540-8191.2005.200427.x; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Cremer J, 1997, EUR J CARDIO-THORAC, V12, P753, DOI 10.1016/S1010-7940(97)00255-8; Desmet W, 2011, EUR HEART J, V32, P867, DOI 10.1093/eurheartj/ehq492; Downey JM, 2005, CIRCULATION, V111, P120, DOI 10.1161/01.CIR.0000153622.49496.10; Fokkema ML, 2009, CIRC-CARDIOVASC INTE, V2, P323, DOI 10.1161/CIRCINTERVENTIONS.109.858977.109.858977; Freixa X, 2012, EUR HEART J, V33, P103, DOI 10.1093/eurheartj/ehr297; Garcia S, 2011, J CARDIOVASC TRANSL, V4, P92, DOI 10.1007/s12265-010-9252-0; Ghosh S, 2003, J THORAC CARDIOV SUR, V126, P133, DOI 10.1016/S0022-5223(02)73293-5; Gunaydin B, 2000, PHARMACOL RES, V41, P493, DOI 10.1006/phrs.1999.0611; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; HEARSE DJ, 1972, BIOCHEM J, V128, P1125, DOI 10.1042/bj1281125; Heusch G, 2004, J AM COLL CARDIOL, V44, P1111, DOI 10.1016/j.jacc.2004.06.013; Heusch G, 2005, AM J PHYSIOL-HEART C, V288, pH984, DOI 10.1152/ajpheart.01109.2004; Heusch G, 2001, CIRCULATION, V103, P2876, DOI 10.1161/01.CIR.103.24.2876; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Heusch G, 2011, LANCET, V378, P1827, DOI 10.1016/S0140-6736(11)61648-6; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Heusch G, 2010, BASIC RES CARDIOL, V105, P151, DOI 10.1007/s00395-009-0080-9; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Hong DM, 2010, ANAESTH INTENS CARE, V38, P924, DOI 10.1177/0310057X1003800518; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Iliodromitis EK, 2006, HEART, V92, P1821, DOI 10.1136/hrt.2006.089060; Illes RW, 1998, ANN THORAC SURG, V65, P748, DOI 10.1016/S0003-4975(97)01346-5; Jebeli M, 2010, ANN THORAC CARDIOVAS, V16, P248; Jenkins DP, 1997, HEART, V77, P314, DOI 10.1136/hrt.77.4.314; Ji BY, 2007, J CARDIAC SURG, V22, P394, DOI 10.1111/j.1540-8191.2007.00433.x; Karuppasamy P, 2011, BASIC RES CARDIOL, V106, P511, DOI 10.1007/s00395-011-0185-9; Kaukoranta PK, 1997, ANN THORAC SURG, V63, P1268, DOI 10.1016/S0003-4975(97)00100-8; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274; Laskey WK, 2008, CATHETER CARDIO INTE, V72, P212, DOI 10.1002/ccd.21583; Laskey WK, 1999, CIRCULATION, V99, P2085, DOI 10.1161/01.CIR.99.16.2085; Lee JH, 2012, BRIT J ANAESTH, V108, P223, DOI 10.1093/bja/aer388; Li GH, 1999, EUR J CARDIO-THORAC, V15, P653, DOI 10.1016/S1010-7940(99)00070-6; Li L, 2010, J SURG RES, V164, pE21, DOI 10.1016/j.jss.2010.06.016; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Loubeyre C, 2002, J AM COLL CARDIOL, V39, P15, DOI 10.1016/S0735-1097(01)01701-6; Lu EX, 1997, ANN THORAC SURG, V64, P1320, DOI 10.1016/S0003-4975(97)00838-2; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P296, DOI 10.1097/ALN.0b013e318242349a; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; Mahaffey KW, 1999, J AM COLL CARDIOL, V34, P1711, DOI 10.1016/S0735-1097(99)00418-0; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; MAROKO PR, 1972, J CLIN INVEST, V51, P2710, DOI 10.1172/JCI107090; Meier JJ, 2004, HEART, V90, P9, DOI 10.1136/heart.90.1.9; Mensah K, 2005, J AM COLL CARDIOL, V45, P1287, DOI 10.1016/j.jacc.2005.01.021; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Mewton N, 2011, BASIC RES CARDIOL, V106, P1247, DOI 10.1007/s00395-011-0214-8; Miura T, 2008, BASIC RES CARDIOL, V103, P501, DOI 10.1007/s00395-008-0743-y; Mochly-Rosen D, 2011, J MOL CELL CARDIOL, V51, P451, DOI 10.1016/j.yjmcc.2011.08.002; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; Murph E, 2007, CARDIOVASC RES, V75, P478, DOI 10.1016/j.cardiores.2007.03.025; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425; Pavione MA, 2012, J THORAC CARDIOVASC, V144, P178; Perrault LP, 1996, J THORAC CARDIOV SUR, V112, P1378, DOI 10.1016/S0022-5223(96)70155-1; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Piper HM, 2003, ANN THORAC SURG, V75, pS644, DOI 10.1016/S0003-4975(02)04686-6; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Przyklenk K, 2011, J CARDIOVASC PHARM T, V16, P255, DOI 10.1177/1074248411409040; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rentoukas I, 2010, JACC-CARDIOVASC INTE, V3, P49, DOI 10.1016/j.jcin.2009.10.015; Rezkalla SH, 2004, NAT CLIN PRACT CARD, V1, P96, DOI 10.1038/ncpcardio0047; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061; Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865; SHEN AC, 1972, AM J PATHOL, V67, P441; Skyschally A, 2008, HERZ, V33, P88, DOI 10.1007/s00059-008-3101-9; Skyschally A, 2007, CIRC RES, V100, P140, DOI 10.1161/01.RES.0000255031.15793.86; Sorensson P, 2010, HEART, V96, P1710, DOI 10.1136/hrt.2010.199430; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Szmagala P, 1998, J CARDIOVASC SURG, V39, P791; Teoh LKK, 2002, CARDIOVASC SURG, V10, P251, DOI 10.1016/S0967-2109(02)00007-8; Teoh LKK, 2002, CARDIOVASC RES, V53, P175, DOI 10.1016/S0008-6363(01)00435-7; Theroux P, 2000, CIRCULATION, V102, P3032; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Wagner R, 2010, INTERACT CARDIOV TH, V11, P758, DOI 10.1510/icvts.2010.243600; Wu QP, 2011, CIRC J, V75, P1885, DOI 10.1253/circj.CJ-10-1130; Wu ZK, 2001, CHEST, V119, P1061, DOI 10.1378/chest.119.4.1061; Xie JJ, 2012, HEART, V98, P384, DOI 10.1136/heartjnl-2011-300860; Xue F, 2010, CLIN CARDIOL, V33, P439, DOI 10.1002/clc.20796; Yang Xin-Chun, 2007, J Invasive Cardiol, V19, P424; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Young PJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0256-6; Zhao WS, 2009, APOPTOSIS, V14, P1204, DOI 10.1007/s10495-009-0387-x; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	109	397	409	2	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					166	175		10.1016/S0140-6736(12)60916-7	http://dx.doi.org/10.1016/S0140-6736(12)60916-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23095318				2022-12-28	WOS:000313420900033
J	King, MA; Bingham, RJ; Moore, P; Whitehouse, PL; Bentley, MJ; Milne, GA				King, Matt A.; Bingham, Rory J.; Moore, Phil; Whitehouse, Pippa L.; Bentley, Michael J.; Milne, Glenn A.			Lower satellite-gravimetry estimates of Antarctic sea-level contribution	NATURE			English	Article							GLACIAL ISOSTATIC-ADJUSTMENT; ICE-SHEET; GRACE; RETREAT; DRIVEN; SIGNAL; MODEL	Recent estimates of Antarctica's present-day rate of ice-mass contribution to changes in sea level range from 31 gigatonnes a year (Gt yr(-1); ref. 1) to 246 Gt yr(-1) (ref. 2), a range that cannot be reconciled within formal errors(3). Time-varying rates of mass loss(2,4-6) contribute to this, but substantial technique-specific systematic errors also exist(3). In particular, estimates of secular ice-mass change derived from Gravity Recovery and Climate Experiment (GRACE) satellite data are dominated by significant uncertainty in the accuracy of models of mass change due to glacial isostatic adjustment(7,8) (GIA). Here we adopt a new model of GIA, developed from geological constraints, which produces GIA rates systematically lower than those of previous models, and an improved fit to independent uplift data(9). After applying the model to 99 months (from August 2002 to December 2010) of GRACE data, we estimate a continent-wide ice-mass change of -69 +/- 18 Gt yr(-1) (+0.19 +/- 0.05 mm yr(-1) sea-level equivalent). This is about a third to a half of the most recently published GRACE estimates(2,5), which cover a similar time period but are based on older GIA models. Plausible GIA model uncertainties, and errors relating to removing longitudinal GRACE artefacts ('destriping'), confine our estimate to the range -126 Gt yr(-1) to -29 Gt yr(-1) (0.08-0.35 mm yr(-1) sea-level equivalent). We resolve 26 independent drainage basins and find that Antarctic mass loss, and its acceleration, is concentrated in basins along the Amundsen Sea coast. Outside this region, we find that West Antarctica is nearly in balance and that East Antarctica is gaining substantial mass.	[King, Matt A.; Bingham, Rory J.; Moore, Phil] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Whitehouse, Pippa L.; Bentley, Michael J.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Milne, Glenn A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada	Newcastle University - UK; University of Tasmania; Durham University; University of Ottawa	King, MA (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.a.king@newcastle.ac.uk	King, Matt/B-4622-2008; Bentley, Michael J/F-7386-2011	King, Matt/0000-0001-5611-9498; Bentley, Michael J/0000-0002-2048-0019; Whitehouse, Pippa/0000-0002-9092-3444	NERC; RCUK Academic Fellowship; COST Action [ES0701]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs programme; NERC [NE/E007023/1, NE/F014260/1, NE/F01466X/1, NE/E004806/1, NE/F01452X/1] Funding Source: UKRI; Natural Environment Research Council [NE/E004806/1, NE/E007023/1, NE/F01452X/1, NE/F014260/1, NE/F01466X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); RCUK Academic Fellowship(UK Research & Innovation (UKRI)); COST Action(European Cooperation in Science and Technology (COST)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs programme(Canada Research Chairs); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC, and an RCUK Academic Fellowship to M. A. K., and partially supported by COST Action ES0701. G.A.M. acknowledges support from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chairs programme. We thank E. Ivins for discussions.	Barletta VR, 2008, GEOPHYS J INT, V172, P18, DOI 10.1111/j.1365-246X.2007.03630.x; Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Gladstone RM, 2012, EARTH PLANET SC LETT, V333, P191, DOI 10.1016/j.epsl.2012.04.022; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Horwath M, 2009, GEOPHYS J INT, V177, P849, DOI 10.1111/j.1365-246X.2009.04139.x; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Purcell A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048624; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stammer D, 2011, SURV GEOPHYS, V32, P621, DOI 10.1007/s10712-011-9142-2; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Swenson S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005338; Tamisiea ME, 2011, GEOPHYS J INT, V186, P1036, DOI 10.1111/j.1365-246X.2011.05116.x; Tamisiea ME, 2001, J GEOPHYS RES-SOL EA, V106, P30849, DOI 10.1029/2000JB000011; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Tregoning P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006161; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5	37	138	147	1	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					586	+		10.1038/nature11621	http://dx.doi.org/10.1038/nature11621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086145				2022-12-28	WOS:000311339800050
J	McCarthy, DP; Donald, PF; Scharlemann, JPW; Buchanan, GM; Balmford, A; Green, JMH; Bennun, LA; Burgess, ND; Fishpool, LDC; Garnett, ST; Leonard, DL; Maloney, RF; Morling, P; Schaefer, HM; Symes, A; Wiedenfeld, DA; Butchart, SHM				McCarthy, Donal P.; Donald, Paul F.; Scharlemann, Joern P. W.; Buchanan, Graeme M.; Balmford, Andrew; Green, Jonathan M. H.; Bennun, Leon A.; Burgess, Neil D.; Fishpool, Lincoln D. C.; Garnett, Stephen T.; Leonard, David L.; Maloney, Richard F.; Morling, Paul; Schaefer, H. Martin; Symes, Andy; Wiedenfeld, David A.; Butchart, Stuart H. M.			Financial Costs of Meeting Global Biodiversity Conservation Targets: Current Spending and Unmet Needs	SCIENCE			English	Article							PROTECTED-AREA; ALLOCATION; RESOURCES; BENEFITS; PROGRESS	World governments have committed to halting human-induced extinctions and safeguarding important sites for biodiversity by 2020, but the financial costs of meeting these targets are largely unknown. We estimate the cost of reducing the extinction risk of all globally threatened bird species (by >= 1 International Union for Conservation of Nature Red List category) to be U. S. $0.875 to $1.23 billion annually over the next decade, of which 12% is currently funded. Incorporating threatened nonavian species increases this total to U. S. $3.41 to $4.76 billion annually. We estimate that protecting and effectively managing all terrestrial sites of global avian conservation significance (11,731 Important Bird Areas) would cost U. S. $65.1 billion annually. Adding sites for other taxa increases this to U. S. $76.1 billion annually. Meeting these targets will require conservation funding to increase by at least an order of magnitude.	[McCarthy, Donal P.; Bennun, Leon A.; Fishpool, Lincoln D. C.; Symes, Andy; Butchart, Stuart H. M.] BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England; [McCarthy, Donal P.; Donald, Paul F.; Buchanan, Graeme M.; Morling, Paul] RSPB, Sandy SG19 2DL, Beds, England; [Scharlemann, Joern P. W.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Balmford, Andrew; Green, Jonathan M. H.; Burgess, Neil D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Green, Jonathan M. H.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Burgess, Neil D.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-1165 Copenhagen, Denmark; [Burgess, Neil D.] World Wildlife Fund, Conservat Sci Program, Washington, DC 20090 USA; [Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Leonard, David L.] Univ Hawaii Manoa, Hawaii Div Forestry & Wildlife, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Maloney, Richard F.] Dept Conservat, Sci & Tech Grp, Christchurch, New Zealand; [Schaefer, H. Martin] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Wiedenfeld, David A.] 12 Fishback Court, Warrenton, VA 20186 USA	BirdLife International; Royal Society for Protection of Birds; University of Sussex; University of Cambridge; Princeton University; University of Copenhagen; World Wildlife Fund; Charles Darwin University; University of Hawaii System; University of Hawaii Manoa; University of Freiburg	Butchart, SHM (corresponding author), BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England.	stuart.butchart@birdlife.org	Butchart, Stuart/AAJ-1852-2021; Scharlemann, Jorn/A-4737-2008; Green, Jonathan M H/D-7081-2017; Garnett, Stephen/M-3877-2013; Butchart, Stuart HM/Y-2711-2018	Butchart, Stuart/0000-0002-1140-4049; Scharlemann, Jorn/0000-0002-2834-6367; Garnett, Stephen/0000-0002-0724-7060; Green, Jonathan/0000-0002-5003-0203; Donald, Paul F./0000-0003-0023-6200; Balmford, Andrew/0000-0002-0144-3589	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	This work was supported by the Cambridge Conservation Initiative Collaborative Fund for Conservation and by Arcadia. For helpful comments and assistance, we thank A. Bruner, R. Naidoo, M. Ausden, L. Donaldson, and many other individuals who kindly provided estimates of costs of species conservation or site management; a full list is given in the supplementary materials. All data sources are listed in the supplementary materials.	[Anonymous], 2009, EC ECOSYSTEMS BIODIV; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BirdLife International, 2004, STAT WORLDS BIRDS 20; BirdLife International, 2011, IUCN RED LIST BIRDS; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Convention on Biological Diversity (CBD), 2011, C PART DEC 10 2 STRA; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Donald P. F., 2010, FACING EXTINCTION WO; Drechsler M, 2011, BIODIVERS CONSERV, V20, P1045, DOI 10.1007/s10531-011-0013-4; Dudley N., 2008, GUIDELINES APPPL PRO; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Foster Matthew N., 2012, Journal of Threatened Taxa, V4, P2733; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; IUCN, 2012, IUCN RED LIST THREAT; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Laycock HF, 2011, ECOL ECON, V70, P1789, DOI 10.1016/j.ecolecon.2011.05.002; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; McKinney ML, 2002, CONSERV BIOL, V16, P539, DOI 10.1046/j.1523-1739.2002.00442.x; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; RTS Resource Ltd, 2012, SOFT DRINKS FACT SHE; UN Environment Programme-Financial Initiative and Principles for Responsible Investment, 2010, UN OWN WHY ENV EXT M; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x	33	394	402	10	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					946	949		10.1126/science.1229803	http://dx.doi.org/10.1126/science.1229803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23065904				2022-12-28	WOS:000311083600043
J	Wang, RC; Wei, YJ; An, ZY; Zou, ZJ; Xiao, GH; Bhagat, G; White, M; Reichelt, J; Levine, B				Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Xiao, Guanghua; Bhagat, Govind; White, Michael; Reichelt, Julia; Levine, Beth			Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation	SCIENCE			English	Article							MAMMALIAN AUTOPHAGY; INHIBITION; GROWTH; CANCER; TUMORS; CELLS	Aberrant signaling through the class I phosphatidylinositol 3-kinase (PI3K)-Akt axis is frequent in human cancer. Here, we show that Beclin 1, an essential autophagy and tumor suppressor protein, is a target of the protein kinase Akt. Expression of a Beclin 1 mutant resistant to Akt-mediated phosphorylation increased autophagy, reduced anchorage-independent growth, and inhibited Akt-driven tumorigenesis. Akt-mediated phosphorylation of Beclin 1 enhanced its interactions with 14-3-3 and vimentin intermediate filament proteins, and vimentin depletion increased autophagy and inhibited Akt-driven transformation. Thus, Akt-mediated phosphorylation of Beclin 1 functions in autophagy inhibition, oncogenesis, and the formation of an autophagy-inhibitory Beclin 1/14-3-3/vimentin intermediate filament complex. These findings have broad implications for understanding the role of Akt signaling and intermediate filament proteins in autophagy and cancer.	[Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Wang, Richard C.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] New York Presbyterian Hosp, New York, NY 10032 USA; [White, Michael] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Reichelt, Julia] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Wang, Richard/AAW-3066-2021; An, Zhenyi/H-9061-2016; Bhagat, Govind/AAE-9493-2021; Reichelt, Julia/AAP-1842-2021	Wang, Richard/0000-0003-4543-8295; Bhagat, Govind/0000-0001-6250-048X; Reichelt, Julia/0000-0002-4358-7011	NIH/National Cancer Institute [ROI CA84254-S1, RO1 CA109618, ROI CA129451, KO8 CA164047]; Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists; German Research Foundation [RE2673/1-1]; NATIONAL CANCER INSTITUTE [K08CA164047, R01CA109618, R01CA084254, P30CA142543, R01CA071443, R01CA129451] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. De Berardinis, W. Hahn, D. Lev, P. Mischel, N. Mizushima, B. Omary, G. Pearson, W. Sellers, R. Weinberg, and M. Yaffe for providing critical reagents and A. Diehl and H. Harrington for help with manuscript preparation. This work was supported by NIH/National Cancer Institute grants ROI CA84254-S1 and RO1 CA109618 to B. L., ROI CA129451 to M. W., KO8 CA164047 to R. W., a Dermatology Foundation Career Development Award, a Burroughs Wellcome Fund Career Award for Medical Scientists to R. W., and German Research Foundation grant RE2673/1-1 to J.R.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	21	513	551	10	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					956	959		10.1126/science.1225967	http://dx.doi.org/10.1126/science.1225967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23112296	Green Accepted			2022-12-28	WOS:000311083600046
J	Kraus, EJH				Kraus, Erica J. Hemphill			A Shift on "Pay for Delay" - Reopening Doors for Pharmaceutical Competition?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Patton Boggs, Washington, DC USA		Kraus, EJH (corresponding author), Patton Boggs, Washington, DC USA.								0	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1681	1683		10.1056/NEJMp1209693	http://dx.doi.org/10.1056/NEJMp1209693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113478				2022-12-28	WOS:000310440800003
J	Godlee, F				Godlee, Fiona			Open letter to Roche about oseltamivir trial data	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; COMPLICATIONS; EFFICACY; SAFETY					fgodlee@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	7	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7305	10.1136/bmj.e7305	http://dx.doi.org/10.1136/bmj.e7305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109484	Bronze			2022-12-28	WOS:000310778000012
J	Moore, W				Moore, Wendy			Marie Stopes: botany and birth control	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Hall LA, 1880, OXFORD DICT NATL BIO; STOPES M, 1918, MARRIED LOVE; Stopes Marie C., 1918, WISE PARENTHOOD	3	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7208	10.1136/bmj.e7208	http://dx.doi.org/10.1136/bmj.e7208			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109327				2022-12-28	WOS:000310778000002
J	Park, HY; Man, SFP; Sin, DD				Park, Hye Yun; Man, S. F. Paul; Sin, Don D.			Inhaled corticosteroids for chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; METERED-DOSE INHALER; SHORT-TERM RESPONSE; OF-THE-LITERATURE; SALMETEROL/FLUTICASONE PROPIONATE; SPUTUM-EOSINOPHILIA; FLUTICASONE PROPIONATE; TIOTROPIUM BROMIDE; CLINICAL-TRIAL; DOUBLE-BLIND		[Sin, Don D.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of British Columbia	Sin, DD (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	don.sin@hli.ubc.ca	park, hy/O-5934-2014; Sin, Don/AAC-2219-2021					Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barnes PJ, 2010, PHARMACEUTICALS, V3, P514, DOI 10.3390/ph3030514; Briggs AH, 2010, EUR RESPIR J, V35, P532, DOI 10.1183/09031936.00153108; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dal Negro Roberto, 2007, Int J Chron Obstruct Pulmon Dis, V2, P169; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Johnell O, 2002, EUR RESPIR J, V19, P1058, DOI 10.1183/09031936.02.00276602; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; Pizzichini E, 1998, AM J RESP CRIT CARE, V158, P1511, DOI 10.1164/ajrccm.158.5.9804028; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Roland NJ, 2004, CHEST, V126, P213, DOI 10.1378/chest.126.1.213; Sharafkhaneh A, 2012, RESP MED, V106, P257, DOI 10.1016/j.rmed.2011.07.020; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Singh D, 2008, THORAX, V63, P592, DOI 10.1136/thx.2007.087213; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Sobieraj DM, 2008, CLIN THER, V30, P1416, DOI 10.1016/j.clinthera.2008.08.004; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	31	9	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2012	345								e6843	10.1136/bmj.e6843	http://dx.doi.org/10.1136/bmj.e6843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MZ	23100329				2022-12-28	WOS:000310427800008
J	Ramsey, CB; Staff, RA; Bryant, CL; Brock, F; Kitagawa, H; van der Plicht, J; Schlolaut, G; Marshall, MH; Brauer, A; Lamb, HF; Payne, RL; Tarasov, PE; Haraguchi, T; Gotanda, K; Yonenobu, H; Yokoyama, Y; Tada, R; Nakagawa, T				Ramsey, Christopher Bronk; Staff, Richard A.; Bryant, Charlotte L.; Brock, Fiona; Kitagawa, Hiroyuki; van der Plicht, Johannes; Schlolaut, Gordon; Marshall, Michael H.; Brauer, Achim; Lamb, Henry F.; Payne, Rebecca L.; Tarasov, Pavel E.; Haraguchi, Tsuyoshi; Gotanda, Katsuya; Yonenobu, Hitoshi; Yokoyama, Yusuke; Tada, Ryuji; Nakagawa, Takeshi			A Complete Terrestrial Radiocarbon Record for 11.2 to 52.8 kyr BP	SCIENCE			English	Article							C-14 CALIBRATION; ICE CORES; CAL BP; YR BP; CHRONOLOGY	Radiocarbon (C-14) provides a way to date material that contains carbon with an age up to similar to 50,000 years and is also an important tracer of the global carbon cycle. However, the lack of a comprehensive record reflecting atmospheric C-14 prior to 12.5 thousand years before the present (kyr B. P.) has limited the application of radiocarbon dating of samples from the Last Glacial period. Here, we report C-14 results from Lake Suigetsu, Japan (35 degrees 35'N, 135 degrees 53'E), which provide a comprehensive record of terrestrial radiocarbon to the present limit of the C-14 method. The time scale we present in this work allows direct comparison of Lake Suigetsu paleoclimatic data with other terrestrial climatic records and gives information on the connection between global atmospheric and regional marine radiocarbon levels.	[Ramsey, Christopher Bronk; Staff, Richard A.; Brock, Fiona] Univ Oxford, Oxford, England; [Bryant, Charlotte L.] Scottish Univ Environm Res Ctr, Nat Environm Res Council, Radiocarbon Facil, E Kilbride, Lanark, Scotland; [Kitagawa, Hiroyuki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [van der Plicht, Johannes] Univ Groningen, Groningen, Netherlands; [van der Plicht, Johannes] Leiden Univ, Leiden, Netherlands; [Schlolaut, Gordon; Brauer, Achim] German Res Ctr Geosci, GeoForschungsZentrum, Potsdam, Germany; [Payne, Rebecca L.; Nakagawa, Takeshi] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Marshall, Michael H.; Lamb, Henry F.] Aberystwyth Univ, Aberystwyth, Dyfed, Wales; [Tarasov, Pavel E.] Free Univ Berlin, Berlin, Germany; [Haraguchi, Tsuyoshi] Osaka City Univ, Osaka 558, Japan; [Gotanda, Katsuya] Chiba Univ Commerce, Chiba, Japan; [Yonenobu, Hitoshi] Naruto Univ Educ, Naruto 772, Japan; [Yokoyama, Yusuke; Tada, Ryuji] Univ Tokyo, Tokyo, Japan	University of Oxford; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Nagoya University; University of Groningen; Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Newcastle University - UK; Aberystwyth University; Free University of Berlin; Osaka Metropolitan University; Naruto University of Education; University of Tokyo	Ramsey, CB (corresponding author), Univ Oxford, Oxford, England.	christopher.ramsey@rlaha.ox.ac.uk	Tarasov, Pavel/ABG-3993-2020; van der Plicht, Johannes/B-9994-2013; Ramsey, Christopher Bronk/A-3277-2012; Yonenobu, Hitoshi/AAB-1500-2021; Ramsey, Christopher Bronk/AAQ-2227-2021; Yokoyama, Yusuke/N-9623-2013; Brock, Fiona/I-4970-2016	Tarasov, Pavel/0000-0002-7219-5009; Ramsey, Christopher Bronk/0000-0002-8641-9309; Yonenobu, Hitoshi/0000-0002-1596-7543; Ramsey, Christopher Bronk/0000-0002-8641-9309; Brock, Fiona/0000-0003-0728-6091; Brauer, Achim/0000-0002-6655-9451; Lamb, Henry Francis/0000-0003-0025-0766; Nakagawa, Takeshi/0000-0003-0831-6803; Staff, Richard/0000-0002-8634-014X; Marshall, Dr Michael/0000-0001-8279-7532	UK Natural Environment Research Council [NE/D000289/1, NE/F003048/1]; Deutsche Forschungsgemeinschaft [BR 2208/7-1, TA 540/3-1]; Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI [21101002]; John Fell Oxford University Press Research Fund; NERC [NRCF010001, NE/F004400/1, NRCF010002, NE/F003056/1, NE/G011001/1, NE/F003048/1] Funding Source: UKRI; Natural Environment Research Council [NE/G011001/1, NRCF010002, NE/F004400/1, NE/F003048/1, NE/F003056/1, NRCF010001] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22500974, 23221002, 23240116] Funding Source: KAKEN	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); John Fell Oxford University Press Research Fund; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was funded by the UK Natural Environment Research Council (NE/D000289/1 and NE/F003048/1, as well as Radiocarbon Facility support); the Deutsche Forschungsgemeinschaft (BR 2208/7-1 and TA 540/3-1); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI (21101002); and the John Fell Oxford University Press Research Fund.	Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; Brauer A, 1999, QUATERN INT, V61, P17, DOI 10.1016/S1040-6182(99)00014-2; HAJDAS I, 1993, CLIM DYNAM, V9, P107, DOI 10.1007/BF00209748; Hoffmann DL, 2010, EARTH PLANET SC LETT, V289, P1, DOI 10.1016/j.epsl.2009.10.004; Hua Q, 2009, QUATERNARY SCI REV, V28, P2982, DOI 10.1016/j.quascirev.2009.08.013; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; Marshall M., 2012, QUAT GEOCHRONOL; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Muscheler R., COMMUNICATION; Nakagawa T, 2012, QUATERNARY SCI REV, V36, P164, DOI 10.1016/j.quascirev.2010.12.013; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schlolaut G., 2012, QUAT GEOCHRONOL; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Staff RA, 2010, NUCL INSTRUM METH B, V268, P960, DOI 10.1016/j.nimb.2009.10.074; Staff RA, 2011, RADIOCARBON, V53, P511, DOI 10.1017/S0033822200034627; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; van der Plicht J, 2004, RADIOCARBON, V46, P1225, DOI 10.1017/S0033822200033117	21	178	184	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					370	374		10.1126/science.1226660	http://dx.doi.org/10.1126/science.1226660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087245	Green Published			2022-12-28	WOS:000309955800038
J	Paik, JM; Curhan, GC; Taylor, EN				Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.			Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARATHYROID CELL-PROLIFERATION; CHRONIC-RENAL-FAILURE; SEX-RELATED INCIDENCE; SERUM-CALCIUM; HORMONE; REPRODUCIBILITY; ROCHESTER; VALIDITY; AGE; QUESTIONNAIRE	Objective To examine the association between calcium intake and risk of primary hyperparathyroidism in women. Design Prospective cohort study. Setting Nurses' Health Study I, which originally recruited participants from the 11 most populous states in the United States. Participants 58 354 female registered nurses enrolled in the Nurses' Health Study I aged 39-66 years in 1986 and with no history of primary hyperparathyroidism. Calcium intake was assessed every four years using semiquantitative questionnaires on food frequency. Main outcome measure Incident primary hyperparathyroidism, confirmed by medical record review. Results During 22 years of follow-up, we recorded 277 incident cases of primary hyperparathyroidism. Women were divided into five equal groups, according to intake of dietary calcium. After adjusting for age, body mass index, race, and other factors, the relative risk of primary hyperparathyroidism for women in the group with the highest intake of dietary calcium was 0.56 (95% confidence interval 0.37 to 0.86, P=0.009 for trend), compared with the group with the lowest intake. The multivariable relative risk of primary hyperparathyroidism for women taking more than 500 mg/day of calcium supplements compared with no calcium supplements was 0.41 (95% confidence interval 0.29 to 0.60, P<0.001 for trend). Analyses restricted to participants with regular physical exams did not significantly change the association between calcium intake and risk of primary hyperparathyroidism. Conclusion Increased calcium intake is independently associated with a reduced risk of primary hyperparathyroidism in women.	[Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Paik, Julie M.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Taylor, Eric N.] Maine Med Ctr, Div Nephrol & Transplantat, Portland, ME 04102 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Maine Medical Center	Paik, JM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA.	jmpaik@partners.org			US National Institutes of Health [DK084707, HL092947, DK91417, CA087969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK091417, F32DK084707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the US National Institutes of Health grants DK084707, HL092947, DK91417, and CA087969.	ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ARNOLD A, 1995, J CLIN INVEST, V95, P2047, DOI 10.1172/JCI117890; BEARD CM, 1989, ARCH INTERN MED, V149, P1887, DOI 10.1001/archinte.149.8.1887; Bilezikian J P, 2000, Rev Endocr Metab Disord, V1, P237, DOI 10.1023/A:1026508829397; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DENT CE, 1961, LANCET, V2, P336; INSOGNA KL, 1985, NEW ENGL J MED, V313, P1126, DOI 10.1056/NEJM198510313131805; Jorde R, 2000, J CLIN EPIDEMIOL, V53, P1164, DOI 10.1016/S0895-4356(00)00239-0; Jorde R, 2002, EUR J NUTR, V41, P258, DOI 10.1007/s00394-002-0383-1; Kanesaka Y, 2001, ENDOCRINOLOGY, V142, P407, DOI 10.1210/en.142.1.407; KAO PC, 1992, MAYO CLIN PROC, V67, P637, DOI 10.1016/S0025-6196(12)60717-4; Karp HJ, 2009, BRIT J NUTR, V102, P1341, DOI 10.1017/S0007114509990195; LJUNGHALL S, 1991, SURGERY, V110, P47; Locker FG, 1997, AM J MED, V102, P543, DOI 10.1016/S0002-9343(97)00053-3; Lundgren E, 1997, SURGERY, V121, P287, DOI 10.1016/S0039-6060(97)90357-3; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; McKane WR, 1996, J CLIN ENDOCR METAB, V81, P1699, DOI 10.1210/jc.81.5.1699; Melton LJ, 2002, J BONE MINER RES, V17, pN12; Miedlich S, 2003, CLIN ENDOCRINOL, V59, P539, DOI 10.1046/j.1365-2265.2003.t01-1-01755.x; Miedlich S, 2000, EUR J ENDOCRINOL, V143, P47, DOI 10.1530/eje.0.1430047; Miller BS, 2008, WORLD J SURG, V32, P795, DOI 10.1007/s00268-007-9427-2; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; Norman J, 2011, ENDOCR PRACT, V17, P384, DOI 10.4158/EP09346.OR; POTTS JT, 1991, ANN INTERN MED, V114, P593, DOI 10.7326/0003-4819-114-7-593; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Ruda JM, 2005, OTOLARYNG HEAD NECK, V132, P359, DOI 10.1016/j.otohns.2004.10.005; RUTLEDGE R, 1985, SURGERY, V98, P1107; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Shan L, 1997, VIRCHOWS ARCH, V430, P247, DOI 10.1007/BF01324809; Shelby H, 2008, WORLD J SURG, V32, P800, DOI 10.1007/s00268-007-9422-7; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Tordoff MG, 1998, AM J PHYSIOL-REG I, V274, pR214, DOI 10.1152/ajpregu.1998.274.1.R214; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	42	23	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2012	345								e6390	10.1136/bmj.e6390	http://dx.doi.org/10.1136/bmj.e6390			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WU	23080543	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000310142300001
J	Eagle, K; Vaishnava, P				Eagle, Kim; Vaishnava, Prashant			QRISK2-2011 predicted cardiovascular disease in adult general practice patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		[Eagle, Kim; Vaishnava, Prashant] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eagle, K (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316				D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-12	10.7326/0003-4819-157-8-201210160-02012	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070514				2022-12-28	WOS:000309906000011
J	Landis, SC; Amara, SG; Asadullah, K; Austin, CP; Blumenstein, R; Bradley, EW; Crystal, RG; Darnell, RB; Ferrante, RJ; Fillit, H; Finkelstein, R; Fisher, M; Gendelman, HE; Golub, RM; Goudreau, JL; Gross, RA; Gubitz, AK; Hesterlee, SE; Howells, DW; Huguenard, J; Kelner, K; Koroshetz, W; Krainc, D; Lazic, SE; Levine, MS; Macleod, MR; McCall, JM; Moxley, RT; Narasimhan, K; Noble, LJ; Perrin, S; Porter, JD; Steward, O; Unger, E; Utz, U; Silberberg, SD				Landis, Story C.; Amara, Susan G.; Asadullah, Khusru; Austin, Chris P.; Blumenstein, Robi; Bradley, Eileen W.; Crystal, Ronald G.; Darnell, Robert B.; Ferrante, Robert J.; Fillit, Howard; Finkelstein, Robert; Fisher, Marc; Gendelman, Howard E.; Golub, Robert M.; Goudreau, John L.; Gross, Robert A.; Gubitz, Amelie K.; Hesterlee, Sharon E.; Howells, David W.; Huguenard, John; Kelner, Katrina; Koroshetz, Walter; Krainc, Dimitri; Lazic, Stanley E.; Levine, Michael S.; Macleod, Malcolm R.; McCall, John M.; Moxley, Richard T., III; Narasimhan, Kalyani; Noble, Linda J.; Perrin, Steve; Porter, John D.; Steward, Oswald; Unger, Ellis; Utz, Ursula; Silberberg, Shai D.			A call for transparent reporting to optimize the predictive value of preclinical research	NATURE			English	Article							RANDOMIZED CONTROLLED-TRIALS; EMPIRICAL-EVIDENCE; STATISTICAL-ANALYSIS; CLINICAL-TRIALS; ANIMAL RESEARCH; QUALITY; DESIGN; EFFICACY; BIAS; PUBLICATION	The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.	[Landis, Story C.; Finkelstein, Robert; Gubitz, Amelie K.; Koroshetz, Walter; Porter, John D.; Utz, Ursula; Silberberg, Shai D.] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA; [Amara, Susan G.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Asadullah, Khusru] Bayer HealthCare, D-13342 Berlin, Germany; [Austin, Chris P.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20854 USA; [Blumenstein, Robi] CHDI Management CHDI Fdn, New York, NY 10001 USA; [Bradley, Eileen W.] NIH, Ctr Review, Bethesda, MD 20892 USA; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Genet Med, New York, NY 10021 USA; [Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Ferrante, Robert J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Fillit, Howard] Alzheimers Drug Discovery Fdn, New York, NY 10019 USA; [Fisher, Marc] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01545 USA; [Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Golub, Robert M.] JAMA, Chicago, IL 60654 USA; [Goudreau, John L.] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA; [Gross, Robert A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Hesterlee, Sharon E.] Parent Project Muscular Dystrophy, Hackensack, NJ 07601 USA; [Howells, David W.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3081, Australia; [Huguenard, John] Stanford Univ, Stanford, CA 94305 USA; [Kelner, Katrina] AAAS, Washington, DC USA; [Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Lazic, Stanley E.] F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland; [Levine, Michael S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Macleod, Malcolm R.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Moxley, Richard T., III] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; [McCall, John M.] PharMac LLC, Boca Grande, FL 33921 USA; [Narasimhan, Kalyani] Nat Neurosci, New York, NY 10013 USA; [Noble, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Perrin, Steve] ALS Therapy Dev Inst, Cambridge, MA 02139 USA; [Steward, Oswald] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Unger, Ellis] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bayer AG; Bayer Healthcare Pharmaceuticals; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; Cornell University; Howard Hughes Medical Institute; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; University of Nebraska System; University of Nebraska Medical Center; Michigan State University; University of Rochester; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; University of California System; University of California Los Angeles; University of Edinburgh; University of Rochester; University of California System; University of California San Francisco; University of California System; University of California Irvine; US Food & Drug Administration (FDA)	Silberberg, SD (corresponding author), Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA.	silberbs@ninds.nih.gov	Lazic, Stanley/F-1160-2011; Ritter, Stefanie L/D-9312-2012; Huguenard, John/I-5016-2012; Asadullah, Khusru/AAG-9810-2021; Darnell, Robert B/B-9022-2008; Huguenard, John/K-6429-2019; Macleod, Malcolm Robert/B-2052-2010; Silberberg, Shai/ABA-2778-2020	Huguenard, John/0000-0002-6950-1191; Darnell, Robert B/0000-0002-5134-8088; Huguenard, John/0000-0002-6950-1191; Macleod, Malcolm Robert/0000-0001-9187-9839; Subramoni, Hari/0000-0002-1200-2754; Howells, David/0000-0002-2512-7724; Steward, Oswald/0000-0001-7069-8756; Amara, Susan/0000-0001-8914-1106	NINDS; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946, P30MH062261, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS012151, R01NS041574, R01NS034774, T32NS007280, R01NS006477] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NINDS.	BEAL KG, 1991, CONDOR, V93, P1023, DOI 10.2307/3247741; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Festing Michael F W, 2002, ILAR J, V43, P244; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gallo JM, 2010, MT SINAI J MED, V77, P381, DOI 10.1002/msj.20193; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hess KR, 2011, CANCER RES, V71, P625, DOI 10.1158/0008-5472.CAN-10-3296; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P16; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Macleod MR, 2005, J PINEAL RES, V38, P35, DOI 10.1111/j.1600-079X.2004.00172.x; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2011, BMJ-BRIT MED J, V340, pc869; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Prady SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001577; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Rockwell S, 2006, RADIAT RES, V165, P623, DOI 10.1667/RR3573.1; Rooke EDM, 2011, PARKINSONISM RELAT D, V17, P313, DOI 10.1016/j.parkreldis.2011.02.010; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smith BA, 2008, NURS OUTLOOK, V56, P31, DOI 10.1016/j.outlook.2007.09.002; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Unger EF, 2007, J AM COLL CARDIOL, V50, P738, DOI 10.1016/j.jacc.2007.04.067; van der Worp HB, 2011, J MOL CELL CARDIOL, V51, P449, DOI 10.1016/j.yjmcc.2011.04.008; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Wheble PCR, 2008, CEREBROVASC DIS, V25, P5, DOI 10.1159/000111493; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	64	791	801	3	122	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					187	191		10.1038/nature11556	http://dx.doi.org/10.1038/nature11556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23060188	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000309733300036
J	Atun, R; Knaul, FM; Akachi, Y; Frenk, J				Atun, Rifat; Marie Knaul, Felicia; Akachi, Yoko; Frenk, Julio			Innovative financing for health: what is truly innovative?	LANCET			English	Article							DEVELOPMENT ASSISTANCE; SYSTEM REFORM; PROGRAMS	Development assistance for health has increased every year between 2000 and 2010, particularly for HIV/AIDS, tuberculosis, and malaria, to reach US$26.66 billion in 2010. The continued global economic crisis means that increased external financing from traditional donors is unlikely in the near term. Hence, new funding has to be sought from innovative financing sources to sustain the gains made in global health, to achieve the health Millennium Development Goals, and to address the emerging burden from non-communicable diseases. We use the value chain approach to conceptualise innovative financing. With this framework, we identify three integrated innovative financing mechanisms-GAVI, Global Fund, and UNITAID-that have reached a global scale. These three financing mechanisms have innovated along each step of the innovative finance value chain-namely resource mobilisation, pooling, channelling, resource allocation, and implementation-and integrated these steps to channel large amounts of funding rapidly to low-income and middle-income countries to address HIV/AIDS, malaria, tuberculosis, and vaccine-preventable diseases. However, resources mobilised from international innovative financing sources are relatively modest compared with donor assistance from traditional sources. Instead, the real innovation has been establishment of new organisational forms as integrated financing mechanisms that link elements of the financing value chain to more effectively and efficiently mobilise, pool, allocate, and channel financial resources to low-income and middle-income countries and to create incentives to improve implementation and performance of national programmes. These mechanisms provide platforms for health funding in the future, especially as efforts to grow innovative financing have faltered. The lessons learnt from these mechanisms can be used to develop and expand innovative financing from international sources to address health needs in low-income and middle-income countries.	[Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England; [Marie Knaul, Felicia] Harvard Global Equity Initiat, Boston, MA USA; [Marie Knaul, Felicia] Mexican Hlth Fdn, Mexico City, DF, Mexico; [Akachi, Yoko] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Imperial College London; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Business, S Kensington Campus, London SW7 2AZ, England.	r.atun@imperial.ac.uk	Atun, Rifat/AAH-5537-2021	Knaul, Felicia/0000-0002-0512-4788; Atun, Rifat/0000-0002-1531-5983				[Anonymous], 2009, MOR MON HLTH MOR HLT; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS72, DOI 10.1097/QAI.0b013e318221842a; Atun R, 2009, JAIDS-J ACQ IMM DEF, V52, pS67, DOI 10.1097/QAI.0b013e3181bbcd58; Atun RA, 2007, INT J INNOV MANAG, V11, P299, DOI 10.1142/S1363919607001709; Frenk J, 2006, LANCET, V368, P3, DOI 10.1016/S0140-6736(06)68942-3; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Gates B., 2011, INNOVATION IMPACT FI; GAVI Alliance, 2011, KEY FIG DON CONTR PL; GAVI Alliance, FUND FIN; Girishankar N., 2009, 5111 WORLD BANK; Griffin C, 2008, 2 BROOK GLOB EC DEV; Hecht R, 2010, INNOVATIVE FINANCING; Institute for Health Metrics and Evaluation, 2010, FIN GLOB HLTH 2011 C; Knaul F, 2012, CLOSING CANC DIVIDE; Leading group on Innovative Financing for Development, 2009, WHAT IS INN FIN; Millennium Foundation for Innovative Finance for Health, 2011, MASSIVEGOOD WHO WE A; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Organisation for Economic Co-operation and Development, CRED REP SYST AID AC; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Porter M.E., 1985, COMPETITIVE ADVANTAG, DOI 10.1590/S0034-75901985000200009; Rasschaert F, 2011, J INT AIDS SOC, V14, P110; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shumpeter JA, 1939, BUSINESS CYCLES, VI; SIMONETTI R, 1995, SCIENTOMETRICS, V32, P77, DOI 10.1007/BF02020190; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; The Global Fund, DON CONTR; UNITAID, FIN REP; United Nations, 2003, MONT CONS INT C FIN; Vujicic M, 2012, HLTH POLICY PLAN, DOI 10.1093/heapol/czs012; WHO, 2010, WOR HEALT REP, P1; WHO, 2011, SOL TOB CONTR	31	57	57	0	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					2044	2049		10.1016/S0140-6736(12)61460-3	http://dx.doi.org/10.1016/S0140-6736(12)61460-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23102585				2022-12-28	WOS:000312124900035
J	Efstathiou, JA				Efstathiou, Jason A.			Postoperative radiation for prostate cancer	LANCET			English	Editorial Material							RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; SALVAGE RADIOTHERAPY; METASTASES; THERAPY		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Efstathiou, JA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.	jefstathiou@partners.org						Bolla M, 2012, LANCET; Briganti A, 2011, EUR UROL, V59, P832, DOI 10.1016/j.eururo.2011.02.024; Moinpour CM, 2008, J CLIN ONCOL, V26, P112, DOI 10.1200/JCO.2006.10.4505; Ross RW, 2009, CLIN IMAG, V33, P301, DOI 10.1016/j.clinimag.2009.01.013; Shipley WU, 2011, J CLIN ONCOLOGY S, V29, P1; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2012, EUR UROL, V61, P443, DOI 10.1016/j.eururo.2011.10.010; Swanson GP, 2008, J UROLOGY, V180, P2453, DOI 10.1016/j.juro.2008.08.037; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Van der Kwast TH, 2007, J CLIN ONCOL, V25, P4178, DOI 10.1200/JCO.2006.10.4067; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563	13	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					1974	1976		10.1016/S0140-6736(12)61608-0	http://dx.doi.org/10.1016/S0140-6736(12)61608-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23084480				2022-12-28	WOS:000312124900007
J	Johnson, JE; Reyes, FE; Polaski, JT; Batey, RT				Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.			B-12 cofactors directly stabilize an mRNA regulatory switch	NATURE			English	Article							VITAMIN-B-12 METABOLISM; COMPARATIVE GENOMICS; GENETIC-CONTROL; FOLDING MOTIF; RIBOSWITCHES; RECOGNITION; MECHANISMS; EXPRESSION; BACTERIA; ELEMENTS	Structures of riboswitch receptor domains bound to their effector have shown how messenger RNAs recognize diverse small molecules, but mechanistic details linking the structures to the regulation of gene expression remain elusive(1,2). To address this, here we solve crystal structures of two different classes of cobalamin (vitamin B-12)-binding riboswitches that include the structural switch of the downstream regulatory domain. These classes share a common cobalamin-binding core, but use distinct peripheral extensions to recognize different B12 derivatives. In each case, recognition is accomplished through shape complementarity between the RNA and cobalamin, with relatively few hydrogen bonding interactions that typically govern RNA-small molecule recognition. We show that a composite cobalamin-RNA scaffold stabilizes an unusual long-range intramolecular kissing-loop interaction that controls mRNA expression. This is the first, to our knowledge, riboswitch crystal structure detailing how the receptor and regulatory domains communicate in a ligand-dependent fashion to regulate mRNA expression.	[Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 596, Boulder, CO 80309 USA.	francis.reyes@colorado.edu; robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625; Polaski, Jacob/0000-0001-6570-1789	National Institutes of Health [GM073850, 1S10RR026516]; Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship [F32GM095121]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850, F32GM095121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM073850 and 1S10RR026516) to R. T. B. and by a Colorado Diversity Initiative Fellowship and NIH Ruth L. Kirschstein fellowship (F32GM095121) to J.E.J. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare AR, 2010, METHODS, V52, P159, DOI 10.1016/j.ymeth.2010.06.008; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Franklund CV, 1997, J BACTERIOL, V179, P4039, DOI 10.1128/jb.179.12.4039-4042.1997; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Gilbert Sunny D., 2009, V540, P97, DOI 10.1007/978-1-59745-558-9_8; GREGORIAN RS, 1995, J MOL BIOL, V248, P968, DOI 10.1006/jmbi.1995.0275; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; LUNDRIGAN MD, 1991, P NATL ACAD SCI USA, V88, P1479, DOI 10.1073/pnas.88.4.1479; LUNDRIGAN MD, 1989, J BACTERIOL, V171, P154, DOI 10.1128/jb.171.1.154-161.1989; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Pyle AM, 2002, J BIOL INORG CHEM, V7, P679, DOI 10.1007/s00775-002-0387-6; Reyes FE, 2009, METHOD ENZYMOL, V469, P119, DOI 10.1016/S0076-6879(09)69006-6; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Sussman D, 2000, NAT STRUCT BIOL, V7, P53, DOI 10.1038/71253; TAYLOR RT, 1973, ARCH BIOCHEM BIOPHYS, V156, P521, DOI 10.1016/0003-9861(73)90301-9; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208	40	115	115	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					133	+		10.1038/nature11607	http://dx.doi.org/10.1038/nature11607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23064232	Green Accepted			2022-12-28	WOS:000311893400060
J	Jemal, A				Jemal, Ahmedin			Global burden of cancer: opportunities for prevention	LANCET			English	Editorial Material									Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30303 USA	American Cancer Society	Jemal, A (corresponding author), Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30303 USA.	ajemal@cancer.org						American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; [Anonymous], 2008, MMWR-MORBID MORTAL W, V57, P1249; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Soerjomataram I, 2012, LANCET; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; WHO, IMM SURV ASS MON IMM; World Health Organization, WHO FRAM CONV TOB CO; World Health Organization, 2019, WHO REP GLOB TOB EP; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	15	40	41	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1797	1799		10.1016/S0140-6736(12)61688-2	http://dx.doi.org/10.1016/S0140-6736(12)61688-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	041XK	23079587				2022-12-28	WOS:000311435000007
J	Feng, Y; Li, WF; Li, J; Wang, JW; Ge, JP; Xu, D; Liu, YJ; Wu, KQ; Zeng, QY; Wu, JW; Tian, CL; Zhou, B; Yang, MJ				Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Liu, Yanjing; Wu, Kaiqi; Zeng, Qingyin; Wu, Jia-Wei; Tian, Changlin; Zhou, Bing; Yang, Maojun			Structural insight into the type-II mitochondrial NADH dehydrogenases	NATURE			English	Article							QUINONE OXIDOREDUCTASE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; PROTON; NDI1; IDENTIFICATION; SOFTWARE; OXIDASE	The single-component type-II NADH dehydrogenases (NDH-2s) serve as alternatives to the multisubunit respiratory complex I (type-I NADH dehydrogenase (NDH-1), also called NADH: ubiquinone oxidoreductase; EC 1.6.5.3) in catalysing electron transfer from NADH to ubiquinone in the mitochondrial respiratory chain(1). The yeast NDH-2 (Ndi1) oxidizes NADH on the matrix side and reduces ubiquinone to maintain mitochondrial NADH/NAD(+) homeostasis. Ndi1 is a potential therapeutic agent for human diseases caused by complex I defects(2-9), particularly Parkinson's disease, because its expression restores the mitochondrial activity in animals with complex I deficiency. NDH-2s in pathogenic microorganisms are viable targets for new antibiotics(10,11). Here we solve the crystal structures of Ndi1 in its substrate-free, NADH-, ubiquinone-and NADH-ubiquinone-bound states, to help understand the catalytic mechanism of NDH-2s. We find that Ndi1 homodimerization through its carboxy-terminal domain is critical for its catalytic activity and membrane targeting. The structures reveal two ubiquinone-binding sites (UQ(I) and UQ(II)) in Ndi1. NADH and UQ(I) can bind to Ndi1 simultaneously to form a substrate-protein complex. We propose that UQ(I) interacts with FAD to act as an intermediate for electron transfer, and that NADH transfers electrons through this FAD-UQ(I) complex to UQ(II). Together our data reveal the regulatory and catalytic mechanisms of Ndi1 and may facilitate the development or targeting of NDH-2s for potential therapeutic applications.	[Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Wu, Jia-Wei; Zhou, Bing; Yang, Maojun] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Yanjing; Zeng, Qingyin] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wu, Kaiqi; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Yang, MJ (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Xu, Duo/M-9378-2019; 刘, 妍婧/HCI-6701-2022; Tian, Changlin/P-1469-2014; Ge, Jingpeng/AGG-3471-2022; Gai, Jingpeng/AAT-9369-2021; Feng, Yue/HGE-4589-2022	Wang, Jiawei/0000-0001-9893-8539; Xu, Duo/0000-0003-0483-8719; Gai, Jingpeng/0000-0001-6164-1221; Feng, Yue/0000-0002-1576-1385; Zeng, Qing-Yin/0000-0002-5730-3016; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology of China [2011CB910502, 2011CB910900, 2012CB911101]; National Natural Science Foundation of China [31030020, 31170679]; Chinese Key Research Plan-Protein Sciences [2011CB911104]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Research Plan-Protein Sciences	We would like to thank the staff at beamline BL17U of the Shanghai Synchrotron Radiation Facility for their assistance with data collection. We thank W. Tong for maintenance and support of the EPR facility at the High Magnetic Field Laboratory, Chinese Academy of Sciences. This work was supported by the Ministry of Science and Technology of China (2011CB910502, 2011CB910900 and 2012CB911101), the National Natural Science Foundation of China (31030020 and 31170679) and Chinese Key Research Plan-Protein Sciences (2011CB911104).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adelroth P, 2000, P NATL ACAD SCI USA, V97, P13086, DOI 10.1073/pnas.230439597; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barber-Singh J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/438370; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Biagini GA, 2012, P NATL ACAD SCI USA, V109, P8298, DOI 10.1073/pnas.1205651109; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Maas MFPM, 2010, J MOL BIOL, V399, P31, DOI 10.1016/j.jmb.2010.04.015; Marella M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025910; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; OHNISHI T, 1966, B SOC CHIM BIOL, V48, P1189; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Ohnishi T, 2012, BBA-BIOENERGETICS, V1817, P1803, DOI 10.1016/j.bbabio.2012.03.032; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Teh J. S., 2007, Infectious Disorders - Drug Targets, V7, P169; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P2213, DOI 10.1107/S0907444902016384; Villegas JM, 2011, ARCH BIOCHEM BIOPHYS, V505, P155, DOI 10.1016/j.abb.2010.10.001; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yang Y, 2011, J BIOL CHEM, V286, P9287, DOI 10.1074/jbc.M110.175547	42	83	85	5	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					478	+		10.1038/nature11541	http://dx.doi.org/10.1038/nature11541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086143				2022-12-28	WOS:000311031600053
J	Pfeffer, C; Larsen, S; Song, J; Dong, MD; Besenbacher, F; Meyer, RL; Kjeldsen, KU; Schreiber, L; Gorby, YA; El-Naggar, MY; Leung, KM; Schramm, A; Risgaard-Petersen, N; Nielsen, LP				Pfeffer, Christian; Larsen, Steffen; Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise; Kjeldsen, Kasper Urup; Schreiber, Lars; Gorby, Yuri A.; El-Naggar, Mohamed Y.; Leung, Kar Man; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter			Filamentous bacteria transport electrons over centimetre distances	NATURE			English	Article							MICROSENSOR; REDUCTION; NANOWIRES; SEDIMENT	Oxygen consumption in marine sediments is often coupled to the oxidation of sulphide generated by degradation of organic matter in deeper, oxygen-free layers. Geochemical observations have shown that this coupling can be mediated by electric currents carried by unidentified electron transporters across centimetre-wide zones. Here we present evidence that the native conductors are long, filamentous bacteria. They abounded in sediment zones with electric currents and along their length they contained strings with distinct properties in accordance with a function as electron transporters. Living, electrical cables add a new dimension to the understanding of interactions in nature and may find use in technology development.	[Pfeffer, Christian; Kjeldsen, Kasper Urup; Schreiber, Lars; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Larsen, Steffen; Meyer, Rikke Louise; Schramm, Andreas; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise] Aarhus Univ, Ctr DNA Nanotechnol CDNA, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark; [Gorby, Yuri A.; Leung, Kar Man] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [El-Naggar, Mohamed Y.; Leung, Kar Man] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA	Aarhus University; Aarhus University; Aarhus University; University of Southern California; University of Southern California	Risgaard-Petersen, N (corresponding author), Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark.	nils.risgaard-petersen@biology.au.dk; biolpn@biology.au.dk	Schramm, Andreas/J-2655-2013; dong, mingdong/AAK-9315-2020; Schramm, Andreas/AAE-1616-2022; Dong, Mingdong/B-3341-2010; Risgaard-Petersen, Nils/J-2479-2013; Schreiber, Lars/J-5937-2013; Dong, Mingdong/AAC-3023-2020; Meyer, Rikke Louise/AAB-5377-2021; Nielsen, Lars Peter/AAL-6274-2021; Kjeldsen, Kasper U/A-4151-2011; Risgaard-Petersen, Nils/AAX-6747-2021; Nielsen, Lars Peter/J-7401-2013	Schramm, Andreas/0000-0002-7614-9616; Schramm, Andreas/0000-0002-7614-9616; Dong, Mingdong/0000-0002-2025-2171; Risgaard-Petersen, Nils/0000-0002-2767-2080; Schreiber, Lars/0000-0003-3411-0083; Dong, Mingdong/0000-0002-2025-2171; Meyer, Rikke Louise/0000-0002-6485-5134; Nielsen, Lars Peter/0000-0002-7269-4860; Kjeldsen, Kasper U/0000-0002-7805-5605; Risgaard-Petersen, Nils/0000-0002-2767-2080; Nielsen, Lars Peter/0000-0002-7269-4860	European Research Council; Danish National Research Foundation; Danish Council for Independent Research \ Natural Sciences (FNU); German Max Planck Society; Villum Foundation; Villum Fonden [00007194] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research \ Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); German Max Planck Society(Max Planck Society); Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	The authors thank P. G. Sorensen and L. B. Pedersen for construction of microsensors. Thanks to K. E. Thomsen for operating the TEM. B. B. Jorgensen is thanked for his general support. This research was financially supported by the European Research Council (L.P.N.), the Danish National Research Foundation (N.R.-P., C. P., K. U. K., L. S., M. D.), the Danish Council for Independent Research vertical bar Natural Sciences (FNU) (L.P.N.), the German Max Planck Society (N.R.-P., C. P., K. U. K., L. S.) and the Villum Foundation (M.D.).	CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Cherniavskaya O, 2003, J PHYS CHEM B, V107, P1525, DOI 10.1021/jp0265438; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Lu W, 2007, NANO LETT, V7, P2729, DOI 10.1021/nl071208m; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; Nielsen LP, 2010, NATURE, V463, P1071, DOI 10.1038/nature08790; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Risgaard-Petersen N, 2012, GEOCHIM COSMOCHIM AC, V92, P1, DOI 10.1016/j.gca.2012.05.036; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526	20	355	373	30	586	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					218	221		10.1038/nature11586	http://dx.doi.org/10.1038/nature11586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103872				2022-12-28	WOS:000310774300036
J	Barskey, AE; Schulte, C; Rosen, JB; Handschur, EF; Rausch-Phung, E; Doll, MK; Cummings, KP; Alleyne, EO; High, P; Lawler, J; Apostolou, A; Blog, D; Zimmerman, CM; Montana, B; Harpaz, R; Hickman, CJ; Rota, PA; Rota, JS; Bellini, WJ; Gallagher, KM				Barskey, Albert E.; Schulte, Cynthia; Rosen, Jennifer B.; Handschur, Elizabeth F.; Rausch-Phung, Elizabeth; Doll, Margaret K.; Cummings, Kisha P.; Alleyne, E. Oscar; High, Patricia; Lawler, Jacqueline; Apostolou, Andria; Blog, Debra; Zimmerman, Christopher M.; Montana, Barbara; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.			Mumps Outbreak in Orthodox Jewish Communities in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE EFFECTIVENESS; UNIVERSITY-STUDENTS; RECENT RESURGENCE; NETHERLANDS; INFECTION	Background By 2005, vaccination had reduced the annual incidence of mumps in the United States by more than 99%, with few outbreaks reported. However, in 2006, a large outbreak occurred among highly vaccinated populations in the United States, and similar outbreaks have been reported worldwide. The outbreak described in this report occurred among U. S. Orthodox Jewish communities during 2009 and 2010. Methods Cases of salivary-gland swelling and other symptoms clinically compatible with mumps were investigated, and demographic, clinical, laboratory, and vaccination data were evaluated. Results From June 28, 2009, through June 27, 2010, a total of 3502 outbreak-related cases of mumps were reported in New York City, two upstate New York counties, and one New Jersey county. Of the 1648 cases for which clinical specimens were available, 50% were laboratory-confirmed. Orthodox Jewish persons accounted for 97% of case patients. Adolescents 13 to 17 years of age (27% of all patients) and males (78% of patients in that age group) were disproportionately affected. Among case patients 13 to 17 years of age with documented vaccination status, 89% had previously received two doses of a mumps-containing vaccine, and 8% had received one dose. Transmission was focused within Jewish schools for boys, where students spend many hours daily in intense, face-to-face interaction. Orchitis was the most common complication (120 cases, 7% of male patients >= 12 years of age), with rates significantly higher among unvaccinated persons than among persons who had received two doses of vaccine. Conclusions The epidemiologic features of this outbreak suggest that intense exposures, particularly among boys in schools, facilitated transmission and overcame vaccine-induced protection in these patients. High rates of two-dose coverage reduced the severity of the disease and the transmission to persons in settings of less intense exposure.	[Barskey, Albert E.; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.] Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Apostolou, Andria] Ctr Res Dis Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Schulte, Cynthia; Rausch-Phung, Elizabeth; Blog, Debra] New York State Dept Hlth, Albany, NY USA; [Rosen, Jennifer B.; Doll, Margaret K.; Cummings, Kisha P.; Zimmerman, Christopher M.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Alleyne, E. Oscar] Rockland Cty Dept Hlth, Pomona, NY USA; [Lawler, Jacqueline] Orange Cty Hlth Dept, Goshen, NY USA; [Handschur, Elizabeth F.; Montana, Barbara] New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; [High, Patricia] Ocean Cty Hlth Dept, Toms River, NJ USA	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; New York City Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services	Barskey, AE (corresponding author), Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-34, Atlanta, GA 30333 USA.	abarskey@cdc.gov	Doll, Margaret K./AAR-3987-2021; Rausch-Phung, Elizabeth/AGL-7956-2022	Doll, Margaret K./0000-0002-2125-7820; 				AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; Anis E, 2012, EPIDEMIOL INFECT, V140, P439, DOI 10.1017/S095026881100063X; [Anonymous], 2010, MMWR-MORBID MORTAL W, V59, P594; [Anonymous], 2012, MMWR-MORBID MORTAL W, V60, P1762; [Anonymous], 1967, MMWR-MORBID MORTAL W, V16, P430; Bangor-Jones RD, 2009, MED J AUSTRALIA, V191, P398, DOI 10.5694/j.1326-5377.2009.tb02850.x; Barskey AE, 2009, VACCINE, V27, P6186, DOI 10.1016/j.vaccine.2009.06.109; Boddicker JD, 2007, J CLIN MICROBIOL, V45, P2902, DOI 10.1128/JCM.00614-07; Capua I, 2004, AVIAN PATHOL, V33, P158, DOI 10.1080/03079450310001652077; Carr MJ, 2010, J CLIN MICROBIOL, V48, P3288, DOI 10.1128/JCM.00434-10; Centers for Disease Control and Prevention, STAT SURV VACC COV U; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P629; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cortese MM, 2008, CLIN INFECT DIS, V46, P1172, DOI 10.1086/529141; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Council of State and Territorial Epidemiologists, CSTE POS STAT 09 ID; Davidkin I, 2010, EXPERT REV VACCINES, V9, P1045, DOI [10.1586/erv.10.99, 10.1586/ERV.10.99]; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; ENNIS FA, 1969, J INFECT DIS, V119, P654, DOI 10.1093/infdis/119.6.654; Greenland K, 2012, VACCINE, V30, P4676, DOI 10.1016/j.vaccine.2012.04.083; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; High P., 2010, Morbidity and Mortality Weekly Report, V59, P125; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Kutty P, 2011, 45 NAT IMM C WASH DC; LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207; Livingston KA, 2011, 45 NAT IMM C WASH DC; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Plotkin S, 2008, VACCINES, P435; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Roberts C, 2009, EUROSURVEILLANCE, V14; Rota JS, 2009, J MED VIROL, V81, P1819, DOI 10.1002/jmv.21557; Rubin SA, 2008, J INFECT DIS, V198, P508, DOI 10.1086/590115; SIMPSON REH, 1952, LANCET, V263, P549; Snijders BEP, 2012, VACCINE, V30, P2999, DOI 10.1016/j.vaccine.2012.02.035; STOKES J, 1946, J EXP MED, V84, P407, DOI 10.1084/jem.84.5.407; 1977, MMWR MORB MORTAL WKL, V26, P393	39	109	111	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1704	1713		10.1056/NEJMoa1202865	http://dx.doi.org/10.1056/NEJMoa1202865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113481	Bronze			2022-12-28	WOS:000310440800007
J	Acuna, GP; Moller, FM; Holzmeister, P; Beater, S; Lalkens, B; Tinnefeld, P				Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.			Fluorescence Enhancement at Docking Sites of DNA-Directed Self-Assembled Nanoantennas	SCIENCE			English	Article							SINGLE-MOLECULE; NANOSCALE; EMISSION; ORIGAMI; LIGHT; MICROSCOPY; RESOLUTION; ANTENNAS; BIOLOGY; SURFACE	We introduce self-assembled nanoantennas to enhance the fluorescence intensity in a plasmonic hotspot of zeptoliter volume. The nanoantennas are prepared by attaching one or two gold nanoparticles (NPs) to DNA origami structures, which also incorporated docking sites for a single fluorescent dye next to one NP or in the gap between two NPs. We measured the dependence of the fluorescence enhancement on NP size and number and compare it to numerical simulations. A maximum of 117-fold fluorescence enhancement was obtained for a dye molecule positioned in the 23-nanometer gap between 100-nanometer gold NPs. Direct visualization of the binding and unbinding of short DNA strands, as well as the conformational dynamics of a DNA Holliday junction in the hotspot of the nanoantenna, show the compatibility with single-molecule assays.	[Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Acuna, GP (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, Hans Sommer Str 10, D-38106 Braunschweig, Germany.	g.acuna@tu-bs.de; p.tinnefeld@tu-bs.de	Acuna, Guillermo/L-8169-2016	Acuna, Guillermo/0000-0001-8066-2677; Zumsande, Friederike/0000-0002-0902-7619	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation; Center for NanoScience	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation(Volkswagen); Center for NanoScience	We thank A. Gietl, J. J. Schmied, D. Grohmann, T. Liedl, and F. Stefani for fruitful discussion; A. Tiefnig for sample preparation; F. Demming for assistance with the numerical simulations; and S. Carregal Romero for the transmission electron microscopy images. This work was carried out at the NanoBioScience group, Braunschweig University of Technology, and was supported by a starting grant (SiMBA) of the European Research Council, the Volkswagen Foundation, and the Center for NanoScience. Technische Universitat Braunschweig, G.P.A., and P.T. have filed a provisional patent application, EP1260316.1., on the described method of creating hotspots using self-assembled DNA origami.	Acuna GP, 2012, ACS NANO, V6, P3189, DOI 10.1021/nn2050483; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Bek A, 2008, NANO LETT, V8, P485, DOI 10.1021/nl072602n; Busson MP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1964; Cang H, 2011, NATURE, V469, P385, DOI 10.1038/nature09698; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Coronado EA, 2011, NANOSCALE, V3, P4042, DOI 10.1039/c1nr10788g; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Di Fiori N, 2010, BIOPHYS J, V98, P2265, DOI 10.1016/j.bpj.2010.02.008; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Gietl A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks326; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lin HZ, 2012, CHEMPHYSCHEM, V13, P973, DOI 10.1002/cphc.201100743; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Ringler M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203002; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518	28	508	520	22	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					506	510		10.1126/science.1228638	http://dx.doi.org/10.1126/science.1228638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112329				2022-12-28	WOS:000310195800052
J	Pallais, JC; Blake, MA; Deshpande, V				Pallais, J. Carl; Blake, Michael A.; Deshpande, Vikram			Case 33-2012: A 34-Year-Old Woman with Episodic Paresthesias and Altered Mental Status after Childbirth Pancreatic neuroendocrine neoplasm, grade 1 (insulinoma)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIPHERAL GLUCOSE-UPTAKE; HYPOGLYCEMIC DISORDERS; MANAGEMENT; DIAGNOSIS; TUMORS; UNAWARENESS; MECHANISMS; PHYSIOLOGY; PREGNANCY; WOMEN		[Pallais, J. Carl] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Blake, Michael A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pallais, J. Carl] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Blake, Michael A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pallais, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Besemer B, 2010, EXP CLIN ENDOCR DIAB, V118, P9, DOI 10.1055/s-0029-1202272; Brown GK, 2000, J INHERIT METAB DIS, V23, P237, DOI 10.1023/A:1005632012591; Cryer PE, 1999, ENDOCRIN METAB CLIN, V28, P495, DOI 10.1016/S0889-8529(05)70084-0; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; FRIZZELL RT, 1988, DIABETES METAB REV, V4, P51, DOI 10.1002/dmr.5610040107; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Herwick Steven, 2006, AJR Am J Roentgenol, V187, pW472, DOI 10.2214/AJR.05.0809; Ichikawa T, 2000, RADIOLOGY, V216, P163, DOI 10.1148/radiology.216.1.r00jl26163; JACKSON RA, 1984, J CLIN ENDOCR METAB, V59, P857, DOI 10.1210/jcem-59-5-857; JACKSON RA, 1983, METABOLISM, V32, P706, DOI 10.1016/0026-0495(83)90128-2; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; KERNDT PR, 1982, WESTERN J MED, V137, P379; Koita J, 2010, EMERG MED CLIN N AM, V28, P439, DOI 10.1016/j.emc.2010.03.008; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; LEVRAN A, 1981, DIABETES, V30, P996, DOI 10.2337/diabetes.30.12.996; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Marks V, 1999, ENDOCRIN METAB CLIN, V28, P579, DOI 10.1016/S0889-8529(05)70089-X; Marks V, 1999, ENDOCRIN METAB CLIN, V28, P555, DOI 10.1016/S0889-8529(05)70088-8; MERIMEE TJ, 1974, NEW ENGL J MED, V291, P1275, DOI 10.1056/NEJM197412122912404; MITRAKOU A, 1993, NEW ENGL J MED, V329, P834, DOI 10.1056/NEJM199309163291203; Mohammad MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE879, DOI 10.1152/ajpendo.00364.2009; Mohammad MA, 2009, AM J CLIN NUTR, V89, P1821, DOI 10.3945/ajcn.2008.26877; Nikfarjam M, 2008, ANN SURG, V247, P165, DOI 10.1097/SLA.0b013e31815792ed; Noone TC, 2005, BEST PRACT RES CL EN, V19, P195, DOI 10.1016/j.beem.2004.11.013; Riviello C, 2009, ENDOCR PRACT, V15, P187, DOI 10.4158/EP.15.3.187; Sacks DB, 2002, CLIN CHEM, V48, P436; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; Service FJ, 2000, J CLIN ENDOCR METAB, V85, P3973, DOI 10.1210/jc.85.11.3973; Takacs CA, 2002, OBSTET GYNECOL SURV, V57, P229, DOI 10.1097/00006254-200204000-00022; Vella A, 2011, GOLDMANS CECIL MED, P1499; Waickus C M, 1999, J Am Board Fam Pract, V12, P133; Whipple AO, 1938, J INT CHIR, V3, P237	34	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1637	1646		10.1056/NEJMcpc1114037	http://dx.doi.org/10.1056/NEJMcpc1114037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094726				2022-12-28	WOS:000310131700012
J	Reimer, PJ				Reimer, Paula J.			Refining the Radiocarbon Time Scale	SCIENCE			English	Editorial Material							C-14; CHRONOLOGY; CAVE; BP		Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Reimer, PJ (corresponding author), Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland.	p.j.reimer@qub.ac.uk	Reimer, Paula/I-5915-2015					Fedele FG, 2008, J HUM EVOL, V55, P834, DOI 10.1016/j.jhevol.2008.08.012; Hoffmann DL, 2010, EARTH PLANET SC LETT, V289, P1, DOI 10.1016/j.epsl.2009.10.004; Kitagawa H, 1998, RADIOCARBON, V40, P505; Nakagawa T, 2012, QUATERNARY SCI REV, V36, P164, DOI 10.1016/j.quascirev.2010.12.013; Ramsey CB, 2012, SCIENCE, V338, P370, DOI 10.1126/science.1226660; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Sarnthein M., 2007, OCEAN CIRCULATION ME, P175, DOI [10.1029/173gm13, DOI 10.1029/173GM13]; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Talamo S, 2012, J ARCHAEOL SCI, V39, P2464, DOI 10.1016/j.jas.2012.01.042; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265	12	5	5	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					337	338		10.1126/science.1228653	http://dx.doi.org/10.1126/science.1228653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087237	Green Published			2022-12-28	WOS:000309955800028
J	Landsberg, J; Kohlmeyer, J; Renn, M; Bald, T; Rogava, M; Cron, M; Fatho, M; Lennerz, V; Wolfel, T; Holzel, M; Tuting, T				Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Fatho, Martina; Lennerz, Volker; Woelfel, Thomas; Hoelzel, Michael; Tueting, Thomas			Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation	NATURE			English	Article							METASTATIC MELANOMA; CANCER REGRESSION; IN-VIVO; IMMUNOTHERAPY; ANTIGEN; LYMPHOCYTES; MICE; GROWTH; AUTOIMMUNITY; RESPONSES	Adoptive cell transfer therapies (ACTs) with cytotoxic T cells that target melanocytic antigens can achieve remissions in patients with metastatic melanomas, but tumours frequently relapse(1,2). Hypotheses explaining the acquired resistance to ACTs include the selection of antigen-deficient tumour cell variants(3-5) and the induction of T-cell tolerance(6). However, the lack of appropriate experimental melanoma models has so far impeded clear insights into the underlying mechanisms. Here we establish an effective ACT protocol in a genetically engineered mouse melanoma model that recapitulates tumour regression, remission and relapse as seen in patients. We report the unexpected observation that melanomas acquire ACT resistance through an inflammation-induced reversible loss of melanocytic antigens. In serial transplantation experiments, melanoma cells switch between a differentiated and a dedifferentiated phenotype in response to T-cell-driven inflammatory stimuli. We identified the proinflammatory cytokine tumour necrosis factor (TNF)-alpha as a crucial factor that directly caused reversible dedifferentiation of mouse and human melanoma cells. Tumour cells exposed to TNF-alpha were poorly recognized by T cells specific for melanocytic antigens, whereas recognition by T cells specific for non-melanocytic antigens was unaffected or even increased. Our results demonstrate that the phenotypic plasticity of melanoma cells in an inflammatory microenvironment contributes to tumour relapse after initially successful T-cell immunotherapy. On the basis of our work, we propose that future ACT protocols should simultaneously target melanocytic and non-melanocytic antigens to ensure broad recognition of both differentiated and dedifferentiated melanoma cells, and include strategies to sustain T-cell effector functions by blocking immune-inhibitory mechanisms in the tumour microenvironment.	[Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany; [Fatho, Martina; Lennerz, Volker; Woelfel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55101 Mainz, Germany; [Hoelzel, Michael] Univ Bonn, Unit RNA Biol, Dept Clin Chem & Clin Pharmacol, D-53105 Bonn, Germany	University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn	Tuting, T (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de	Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022; Wölfel, Thomas/G-6519-2012; Bald, Tobias/H-9525-2018; Landsberg, Jennifer/AAF-5113-2019	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Bald, Tobias/0000-0003-0061-235X; Rogava, Meri/0000-0002-0314-5323; Renn, Marcel/0000-0002-0120-4035; Sirokay, Judith/0000-0003-3945-845X	DFG [SFB832, SFB704, SFB 432]; Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	We would like to thank G. Merlino and M. Barbacid for providing genetically engineered mice; E. Endl for help with FACS sorting; S. Herms and P. Hoffmann for the cDNA microarrays; S. Mikus, A. Sporleder and C. Lemke for managing the mouse colony and performing histopathology, immunohistopatholgoy, immunoblotting and real-time PCR. This research was supported in part by grants from the DFG (A12 in the SFB832 and A22 in the SFB704) and the Deutsche Krebshilfe (P9 in the Melanoma Research Network) to T. T., by grants from BONFOR to J.L. and J.K., and by a DFG grant (A1 in the SFB 432) to T. W. T. T. and M. H. are members of the Excellence Cluster ImmunoSensation.	[Anonymous], 2010, R LANG ENV STAT COMP; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kanik AB, 1996, J CUTAN PATHOL, V23, P205, DOI 10.1111/j.1600-0560.1996.tb01468.x; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Rourke MGE, 2007, MELANOMA RES, V17, P316, DOI 10.1097/CMR.0b013e3282c3a73b; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tormo D, 2006, AM J PATHOL, V169, P665, DOI 10.2353/ajpath.2006.060017; Tormo D, 2006, CANCER RES, V66, P5427, DOI 10.1158/0008-5472.CAN-06-0399; van der Laan M. J., 2009, U C BERKELEY DIV BIO; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	43	377	387	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					412	+		10.1038/nature11538	http://dx.doi.org/10.1038/nature11538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23051752				2022-12-28	WOS:000309918500048
J	Sandborn, WJ; Gasink, C; Gao, LL; Blank, MA; Johanns, J; Guzzo, C; Sands, BE; Hanauer, SB; Targan, S; Rutgeerts, P; Ghosh, S; de Villiers, WJS; Panaccione, R; Greenberg, G; Schreiber, S; Lichtiger, S; Feagan, BG				Sandborn, William J.; Gasink, Christopher; Gao, Long-Long; Blank, Marion A.; Johanns, Jewel; Guzzo, Cynthia; Sands, Bruce E.; Hanauer, Stephen B.; Targan, Stephan; Rutgeerts, Paul; Ghosh, Subrata; de Villiers, Willem J. S.; Panaccione, Remo; Greenberg, Gordon; Schreiber, Stefan; Lichtiger, Simon; Feagan, Brian G.		CERTIFI Study Grp	Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; EXPERIMENTAL COLITIS; CERTOLIZUMAB PEGOL; INFLAMMATION; IL-23; INTERLEUKIN-12; ADALIMUMAB; INFLIXIMAB; DISCOVERY	BACKGROUND In patients with Crohn's disease, the efficacy of ustekinumab, a human monoclonal antibody against interleukin-12 and interleukin-23, is unknown. METHODS We evaluated ustekinumab in adults with moderate-to-severe Crohn's disease that was resistant to anti-tumor necrosis factor (TNF) treatment. During induction, 526 patients were randomly assigned to receive intravenous ustekinumab (at a dose of 1, 3, or 6 mg per kilogram of body weight) or placebo at week 0. During the maintenance phase, 145 patients who had a response to ustekinumab at 6 weeks underwent a second randomization to receive subcutaneous injections of ustekinumab (90 mg) or placebo at weeks 8 and 16. The primary end point was a clinical response at 6 weeks. RESULTS The proportions of patients who reached the primary end point were 36.6%, 34.1%, and 39.7% for 1, 3, and 6 mg of ustekinumab per kilogram, respectively, as compared with 23.5% for placebo (P = 0.005 for the comparison with the 6-mg group). The rate of clinical remission with the 6-mg dose did not differ significantly from the rate with placebo at 6 weeks. Maintenance therapy with ustekinumab, as compared with placebo, resulted in significantly increased rates of clinical remission (41.7% vs. 27.4%, P = 0.03) and response (69.4% vs. 42.5%, P < 0.001) at 22 weeks. Serious infections occurred in 7 patients (6 receiving ustekinumab) during induction and 11 patients (4 receiving ustekinumab) during maintenance. Basal-cell carcinoma developed in 1 patient receiving ustekinumab. CONCLUSIONS Patients with moderate-to-severe Crohn's disease that was resistant to TNF antagonists had an increased rate of response to induction with ustekinumab, as compared with placebo. Patients with an initial response to ustekinumab had significantly increased rates of response and remission with ustekinumab as maintenance therapy. (Funded by Janssen Research and Development; CERTIFI ClinicalTrials.gov number, NCT00771667.)	[Sandborn, William J.] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Targan, Stephan] Cedars Sinai Med Ctr, Los Angeles, CA USA; [Gasink, Christopher; Gao, Long-Long; Blank, Marion A.; Johanns, Jewel; Guzzo, Cynthia] Janssen Res & Dev, Spring House, PA USA; [Sands, Bruce E.; Lichtiger, Simon] Mt Sinai Sch Med, New York, NY USA; [Hanauer, Stephen B.] Univ Chicago, Chicago, IL 60637 USA; [Rutgeerts, Paul] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Ghosh, Subrata] Univ Calgary, Calgary, AB, Canada; [Greenberg, Gordon] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Feagan, Brian G.] Robarts Res Inst, London, ON N6A 5C1, Canada; [de Villiers, Willem J. S.] Univ Kentucky, Lexington, KY 40506 USA; [Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Kiel, Germany	University of California System; University of California San Diego; Cedars Sinai Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Icahn School of Medicine at Mount Sinai; University of Chicago; KU Leuven; University Hospital Leuven; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Western University (University of Western Ontario); University of Kentucky; University of Kiel; Schleswig Holstein University Hospital	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu	Higgins, Peter D.R./A-3511-2009; Panaccione, Remo/ABC-1140-2021; Sands, Bruce/R-7887-2019; RIESTRA, SABINO/N-2897-2019; Ghosh, Subrata/AAC-2676-2021; Feagan, Brian G/M-4283-2015; Feagan, Brian/G-3292-2011; Leong, Rupert WL/J-7839-2012; Greenberg, Gordon/C-4620-2015; Sandborn, William/ABE-8342-2020; Pavli, Paul/GZL-0607-2022; Radford-Smith, Graham L/G-5749-2017; Sorrentino, Dario/K-7253-2019	Higgins, Peter D.R./0000-0003-1602-4341; Panaccione, Remo/0000-0002-5247-940X; Sands, Bruce/0000-0001-5762-5042; Ghosh, Subrata/0000-0002-1713-7797; Leong, Rupert WL/0000-0001-5944-3488; Radford-Smith, Graham L/0000-0002-2047-6239; Vermeire, Severine/0000-0001-9942-3019; Abreu, Maria T./0000-0002-7294-0574; Dryden, Gerald/0000-0001-9787-4537	Janssen Research and Development	Janssen Research and Development	Supported by Janssen Research and Development.	Baumgart D, 2012, LANCET; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Benson JM, 2011, MABS-AUSTIN, V3, P535, DOI 10.4161/mabs.3.6.17815; Berrebi D, 1998, AM J PATHOL, V152, P667; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Geng D, 2005, J PHARMACEUT BIOMED, V39, P364, DOI 10.1016/j.jpba.2005.04.045; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mannon PJ, 2005, NEW ENGL J MED, V352, P1276; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sandborn WJ, 2007, ANN INTERN MED, V146, P829, DOI 10.7326/0003-4819-146-12-200706190-00159; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	25	741	767	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1519	1528		10.1056/NEJMoa1203572	http://dx.doi.org/10.1056/NEJMoa1203572			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23075178				2022-12-28	WOS:000309904500009
J	Elinoff, JM; Danner, RL				Elinoff, Jason M.; Danner, Robert L.			Hydroxyethyl starch 130/0.42 increased death at 90 days compared with Ringer's acetate in severe sepsis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESUSCITATION		[Elinoff, Jason M.; Danner, Robert L.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Elinoff, JM (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Hartog CS, 2012, INTENS CARE MED, V38, P1258, DOI 10.1007/s00134-012-2614-0; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308	5	0	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8							JC4-6	10.7326/0003-4819-157-8-201210160-02006	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	23070508				2022-12-28	WOS:000309906000005
J	Norris, DP; Grimes, DT				Norris, Dominic P.; Grimes, Daniel T.			Cilia Discern Left from Right	SCIENCE			English	Editorial Material							LEFT-RIGHT ASYMMETRY; RIGHT AXIS DETERMINATION; MOUSE; MICE; POLYCYSTIN-2; PROTEIN; LACKING; KIF3A; CELLS; FLOW		[Norris, Dominic P.; Grimes, Daniel T.] MRC Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England		Norris, DP (corresponding author), MRC Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	d.norris@har.mrc.ac.uk		Grimes, Daniel/0000-0003-0173-1887	Medical Research Council [MC_U142670370] Funding Source: Medline; MRC [MC_U142670370] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Ma L, 2009, J BIOL CHEM, V284, P32942, DOI 10.1074/jbc.M109.021832; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Viotti M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001276; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538	14	16	16	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					206	207		10.1126/science.1230401	http://dx.doi.org/10.1126/science.1230401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066068				2022-12-28	WOS:000309712300029
J	Carlson, DW; Atwood, JE				Carlson, Daniel W.; Atwood, John E.			An Audible Case of Acute Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carlson, Daniel W.; Atwood, John E.] Walter Reed Army Med Ctr, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Carlson, DW (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.	daniel.w.carlson.mil@health.mil							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15								10.1056/NEJMicm1211055	http://dx.doi.org/10.1056/NEJMicm1211055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050547				2022-12-28	WOS:000309652700012
J	O'Keeffe, A; Terris, J				O'Keeffe, Andrew; Terris, Jane			Post-traumatic swelling	BRITISH MEDICAL JOURNAL			English	Editorial Material							SUBCUTANEOUS EMPHYSEMA; MEDIASTINAL EMPHYSEMA; AIRWAY MANAGEMENT; PNEUMOMEDIASTINUM; EMERGENCY; ANASARCA; TONSILLECTOMY; PNEUMOTHORAX; DIAGNOSIS		[O'Keeffe, Andrew] Univ Oxford, Oxford OX4 3DS, England; [O'Keeffe, Andrew; Terris, Jane] John Radcliffe Hosp, Emergency Dept, Oxford, England; [O'Keeffe, Andrew] Univ Calif Los Angeles, Los Angeles, CA USA	University of Oxford; University of Oxford; University of California System; University of California Los Angeles	O'Keeffe, A (corresponding author), Univ Oxford, Oxford OX4 3DS, England.	andrewbokeeffe@yahoo.com						ABYHOLM FE, 1973, THORAX, V28, P376, DOI 10.1136/thx.28.3.376; Boldt J, 2010, BRIT J ANAESTH, V104, P276, DOI 10.1093/bja/aep393; BREMNER WGM, 1993, BRIT J ANAESTH, V71, P296, DOI 10.1093/bja/71.2.296; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; Chai YH, 2011, NEUROMUSCULAR DISORD, V21, P439, DOI 10.1016/j.nmd.2011.03.003; Dierckx R, 2008, CIRCULATION, V118, P1304, DOI 10.1161/CIRCULATIONAHA.108.767632; Feinstone T., 1991, J AM DENT ASSOC, V83, P1309; GIBNEY RTN, 1984, INTENS CARE MED, V10, P43; Graham CA, 1997, J ACCID EMERG MED, V14, P219; GRAY JM, 1966, THORAX, V21, P325, DOI 10.1136/thx.21.4.325; Hampton SM, 1997, J LARYNGOL OTOL, V111, P1077, DOI 10.1017/S0022215100139398; HERLAN DB, 1992, CHEST, V102, P503, DOI 10.1378/chest.102.2.503; Kovacs G, 2004, CAN J ANAESTH, V51, P174, DOI 10.1007/BF03018780; Kumar P, 2005, CLIN MED, P695; LAWS D, 2003, THORAX S2, V58, P53, DOI DOI 10.1136/THX.58.SUPPL_2.II53; LIPMAN JS, 1967, ORAL SURG ORAL MED O, V23, P717, DOI 10.1016/0030-4220(67)90359-3; Long B, 1995, ADULT NURSING NURSIN, P328; Macklin CC, 1939, ARCH INTERN MED, V64, P913, DOI 10.1001/archinte.1939.00190050019003; MAUNDER RJ, 1984, ARCH INTERN MED, V144, P1447, DOI 10.1001/archinte.144.7.1447; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Oe K, 2010, INTERNAL MED, V49, P799, DOI 10.2169/internalmedicine.49.3336; ONEILL S, 1987, IRISH MED J, V80, P306; PASCUAL JB, 1990, ENDOSCOPY, V22, P59, DOI 10.1055/s-2007-1012791; SHARPE DAC, 1995, EUR RESPIR J, V8, P1611; Stewart AE, 2004, ARCH OTOLARYNGOL, V130, P1324, DOI 10.1001/archotol.130.11.1324; Tatebe S, 1996, ANN THORAC SURG, V62, P1011, DOI 10.1016/0003-4975(96)00445-6; Woodwark A. S., 1908, BRIT MED J, V2, P24	27	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6363	10.1136/bmj.e6363	http://dx.doi.org/10.1136/bmj.e6363			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044987				2022-12-28	WOS:000309386700010
J	Becker, C; Chiari, L				Becker, Clemens; Chiari, Lorenzo			What videos can tell us about falling	LANCET			English	Editorial Material							PEOPLE		[Becker, Clemens] Robert Bosch Krankenhaus, D-70597 Stuttgart, Germany; [Chiari, Lorenzo] Univ Bologna, Dept Elect Comp Sci & Syst, I-40126 Bologna, Italy	Bosch; Robert Bosch Krankenhaus; University of Bologna	Becker, C (corresponding author), Robert Bosch Krankenhaus, D-70597 Stuttgart, Germany.	clemens.becker@rbk.de	Chiari, Lorenzo/N-7622-2015; Becker, Clemens/ABI-5405-2020	Chiari, Lorenzo/0000-0002-2318-4370; 				[Anonymous], 2004, BBC NEWS; Becker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024311; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; Robinovitch S, 2012, LANCET; Zecevic AA, 2006, GERONTOLOGIST, V46, P367, DOI 10.1093/geront/46.3.367	9	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					8	9		10.1016/S0140-6736(12)61724-3	http://dx.doi.org/10.1016/S0140-6736(12)61724-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23083888				2022-12-28	WOS:000313044300007
J	Jorm, AF; Reavley, NJ				Jorm, Anthony F.; Reavley, Nicola J.			Depression and stigma: from attitudes to discrimination	LANCET			English	Editorial Material							MENTAL-ILLNESS; PEOPLE; CARE		[Jorm, Anthony F.; Reavley, Nicola J.] Univ Melbourne, Melbourne Sch Populat Hlth, Populat Mental Hlth Grp, Melbourne, Vic 3010, Australia	University of Melbourne	Jorm, AF (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Populat Mental Hlth Grp, Melbourne, Vic 3010, Australia.	ajorm@unimelb.edu.au	Jorm, Anthony F/B-5555-2009; Reavley, Nicola/ABE-6510-2020	Jorm, Anthony F/0000-0002-1424-4116; Reavley, Nicola/0000-0001-5513-8291				Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Griffiths KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-25; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Lasalvia A., 2012, LANCET; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; McNair BG, 2002, MED J AUSTRALIA, V176, pS69; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Wahl OF, 1999, SCHIZOPHRENIA BULL, V25, P467, DOI 10.1093/oxfordjournals.schbul.a033394; WELLS JE, 1994, SOC PSYCH PSYCH EPID, V29, P155	11	16	17	1	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					10	11		10.1016/S0140-6736(12)61457-3	http://dx.doi.org/10.1016/S0140-6736(12)61457-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23083628				2022-12-28	WOS:000313044300008
J	Keller, KE; Tan, IS; Lee, YS				Keller, Kirstie E.; Tan, Irene S.; Lee, Young-Sam			SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions	SCIENCE			English	Article							TUMOR; METABOLISM; INHIBITION	Pyruvate kinase isoform M2 (PKM2) plays an important role in the growth and metabolic reprogramming of cancer cells in stress conditions. Here, we report that SAICAR (succinylaminoimidazolecarboxamide ribose-5'-phosphate, an intermediate of the de novo purine nucleotide synthesis pathway) specifically stimulates PKM2. Upon glucose starvation, cellular SAICAR concentration increased in an oscillatory manner and stimulated PKM2 activity in cancer cells. Changes in SAICAR amounts in cancer cells altered cellular energy level, glucose uptake, and lactate production. The SAICAR-PKM2 interaction also promoted cancer cell survival in glucose-limited conditions. SAICAR accumulation was not observed in normal adult epithelial cells or lung fibroblasts, regardless of glucose conditions. This allosteric regulation may explain how cancer cells coordinate different metabolic pathways to optimize their growth in the nutrient-limited conditions commonly observed in the tumor microenvironment.	[Keller, Kirstie E.; Lee, Young-Sam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Tan, Irene S.] Natl Inst Hlth Johns Hopkins Univ Grad Partnershi, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA	Lee, YS (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	ylee99@jhu.edu	Lee, Young-Sam/A-2499-2013		Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Coupet, D. Meyer, and E. Pryce for technical assistance; R. Coleman, Y. Wang, C. Arrowsmith, and members of our department for sharing their equipment and materials; and A. Le, E. O'Shea, and members of our department for comments on the manuscript. Supported by Johns Hopkins University Krieger School of Arts and Sciences startup fund to Y.-S.L. The authors declare no conflict of interest.	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee P, 2007, PROTEIN EXPRES PURIF, V51, P227, DOI 10.1016/j.pep.2006.07.023; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; SANT ME, 1992, J BIOL CHEM, V267, P11038; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470	17	145	155	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1069	1072		10.1126/science.1224409	http://dx.doi.org/10.1126/science.1224409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086999	Green Accepted			2022-12-28	WOS:000311390600041
J	Kim, B; Eggel, A; Tarchevskaya, SS; Vogel, M; Prinz, H; Jardetzky, TS				Kim, Beomkyu; Eggel, Alexander; Tarchevskaya, Svetlana S.; Vogel, Monique; Prinz, Heino; Jardetzky, Theodore S.			Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor	NATURE			English	Article							CONFORMATIONAL FLEXIBILITY; DISSOCIATION RATE; CRYSTAL-STRUCTURE; FC; REVEALS; LIGANDS; BINDING; SITE	IgE antibodies bind the high-affinity IgE Fc receptor (Fc epsilon RI), found primarily on mast cells and basophils, and trigger inflammatory cascades of the allergic response(1,2). Inhibitors of IgE-Fc epsilon RI binding have been identified and an anti-IgE therapeutic antibody (omalizumab) is used to treat severe allergic asthma(3,4). However, preformed IgE-Fc epsilon RI complexes that prime cells before allergen exposure dissociate extremely slowly(5) and cannot be disrupted by strictly competitive inhibitors. IgE-Fc conformational flexibility indicated that inhibition could be mediated by allosteric or other non-classical mechanisms(6-8). Here we demonstrate that an engineered protein inhibitor, DARPin E2_79 (refs 9-11), acts through a non-classical inhibition mechanism, not only blocking IgE-Fc epsilon RI interactions, but actively stimulating the dissociation of preformed ligand-receptor complexes. The structure of the E2_79-IgE-Fc(3-4) complex predicts the presence of two non-equivalent E2_79 sites in the asymmetric IgE-Fc epsilon RI complex, with site 1 distant from the receptor and site 2 exhibiting partial steric overlap. Although the structure is indicative of an allosteric inhibition mechanism, mutational studies and quantitative kinetic modelling indicate that E2_79 acts through a facilitated dissociation mechanism at site 2 alone. These results demonstrate that high-affinity IgE-Fc epsilon RI complexes can be actively dissociated to block the allergic response and suggest that protein-protein complexes may be more generally amenable to active disruption by macromolecular inhibitors.	[Kim, Beomkyu; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Eggel, Alexander; Vogel, Monique] Univ Bern, Inst Immunol, CH-3010 Bern, Switzerland; [Prinz, Heino] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Stanford University; University of Bern; Max Planck Society	Jardetzky, TS (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Kim, Beomkyu/AAM-7220-2020; Eggel, Alexander/J-8177-2019	Eggel, Alexander/0000-0001-8746-3339	NIH [AI-18939]; American Asthma Foundation; Swiss National Science Foundation [310030_127350]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018939, R37AI038972, R37AI018939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Wurzburg and other past and present members of the Jardetzky Laboratory. This research was supported in part by an NIH research grant (AI-18939) and an American Asthma Foundation Senior Investigator Award as well as the Swiss National Science Foundation grant number 310030_127350 to T.S.J. We also thank C. A. Dahinden and B. M. Stadler and members of their groups for valuable discussions. Furthermore, we thank M. J. Baumann for technical support and Molecular Partners AG, especially P. Amstutz, M. T. Stumpp, P. Forrer and D. Steiner, for placing DARPin libraries at our disposal and providing scientific support.	BASU M, 1993, J BIOL CHEM, V268, P13118; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; BOULAIN JC, 1982, SCIENCE, V217, P732, DOI 10.1126/science.7100919; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Amato Gennaro, 2006, Treat Respir Med, V5, P393, DOI 10.2165/00151829-200605060-00004; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gutfreund H., 1995, KINETICS LIFE SCI RE; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRINZ H, 1993, J BIOL CHEM, V268, P18580; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WANG CC, 1988, P NATL ACAD SCI USA, V85, P8400, DOI 10.1073/pnas.85.22.8400; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiegand TW, 1996, J IMMUNOL, V157, P221; Wright JD, 1998, PROTEIN ENG, V11, P421, DOI 10.1093/protein/11.6.421; Wuezburg B.A., J BIOL CHEM; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	34	78	79	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					613	+		10.1038/nature11546	http://dx.doi.org/10.1038/nature11546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103871	Green Accepted			2022-12-28	WOS:000311339800056
J	Derr, ND; Goodman, BS; Jungmann, R; Leschziner, AE; Shih, WM; Reck-Peterson, SL				Derr, N. D.; Goodman, B. S.; Jungmann, R.; Leschziner, A. E.; Shih, W. M.; Reck-Peterson, S. L.			Tug-of-War in Motor Protein Ensembles Revealed with a Programmable DNA Origami Scaffold	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; ORGANELLE TRANSPORT; TRANSIENT BINDING; STEPPING BEHAVIOR; MOLECULAR MOTORS; CARGO TRANSPORT; KINESIN; MICROTUBULES	Cytoplasmic dynein and kinesin-1 are microtubule-based motors with opposite polarity that transport a wide variety of cargo in eukaryotic cells. Many cellular cargos demonstrate bidirectional movement due to the presence of ensembles of dynein and kinesin, but are ultimately sorted with spatial and temporal precision. To investigate the mechanisms that coordinate motor ensemble behavior, we built a programmable synthetic cargo using three-dimensional DNA origami to which varying numbers of DNA oligonucleotide-linked motors could be attached, allowing for control of motor type, number, spacing, and orientation in vitro. In ensembles of one to seven identical-polarity motors, motor number had minimal affect on directional velocity, whereas ensembles of opposite-polarity motors engaged in a tug-of-war resolvable by disengaging one motor species.	[Derr, N. D.; Goodman, B. S.; Reck-Peterson, S. L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jungmann, R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Jungmann, R.; Shih, W. M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Leschziner, A. E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu	Jungmann, Ralf/A-6357-2015	Jungmann, Ralf/0000-0003-4607-3312; Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023	Alexander von Humboldt Foundation; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1, 1U54GM094608, 1DP2OD004641]; ONR [N000014091118, N000141010241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268, DP2OD004641] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Lin for assistance with electron microscopy; F. Aguet for assistance with data analysis; J. Huang, W. Qiu, W. B. Redwine, and A. Roberts for helpful advice and critical reading of the manuscript; members of the Reck-Peterson and Shih labs for advice and helpful discussions; and J. Iwasa for illustrations. EM data were collected at the Center for Nanoscale Systems, Harvard University. DNA-PAINT data were collected at the Nikon Imaging Center, Harvard Medical School. R. J. is supported from the Alexander von Humboldt Foundation through a Feodor Lynen fellowship. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and a NIH New Innovator award (1 DP2 OD004268-1). W. M. S. is funded by NIH awards (1U54GM094608 and 1DP2OD004641) and ONR awards (N000014091118 and N000141010241).	Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Bryantseva SA, 2012, CELL BIOL INT, V36, P1, DOI 10.1042/CBI20110413; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Constantinou PE, 2010, J BIOMECH, V43, P31, DOI 10.1016/j.jbiomech.2009.09.006; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Ko SH, 2012, ADV FUNCT MATER, V22, P1015, DOI 10.1002/adfm.201102077; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leduc C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128103; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Lu HL, 2012, J BIOL CHEM, V287, P27753, DOI 10.1074/jbc.M112.371393; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xu J, 2012, TRAFFIC, V13, P1198, DOI 10.1111/j.1600-0854.2012.01385.x; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	38	282	294	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					662	665		10.1126/science.1226734	http://dx.doi.org/10.1126/science.1226734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23065903	Green Accepted, Green Submitted			2022-12-28	WOS:000310516000052
J	Boonen, S; Reginster, JY; Kaufman, JM; Lippuner, K; Zanchetta, J; Langdahl, B; Rizzoli, R; Lipschitz, S; Dimai, HP; Witvrouw, R; Eriksen, E; Brixen, K; Russo, L; Claessens, F; Papanastasiou, P; Antunez, O; Su, GQ; Bucci-Rechtweg, C; Hruska, J; Incera, E; Vanderschueren, D; Orwoll, E				Boonen, Steven; Reginster, Jean-Yves; Kaufman, Jean-Marc; Lippuner, Kurt; Zanchetta, Jose; Langdahl, Bente; Rizzoli, Rene; Lipschitz, Stanley; Dimai, Hans Peter; Witvrouw, Richard; Eriksen, Erik; Brixen, Kim; Russo, Luis; Claessens, Frank; Papanastasiou, Philemon; Antunez, Oscar; Su, Guoqin; Bucci-Rechtweg, Christina; Hruska, Josef; Incera, Elodie; Vanderschueren, Dirk; Orwoll, Eric			Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERTEBRAL FRACTURES; ORAL ALENDRONATE; HIP FRACTURE; BONE-DENSITY; DOUBLE-BLIND; WOMEN; MORTALITY; RISEDRONATE; PREVALENCE; DENOSUMAB	Background Fractures in men are a major health issue, and data on the antifracture efficacy of therapies for osteoporosis in men are limited. We studied the effect of zoledronic acid on fracture risk among men with osteoporosis. Methods In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1199 men with primary or hypogonadism-associated osteoporosis who were 50 to 85 years of age to receive an intravenous infusion of zoledronic acid (5 mg) or placebo at baseline and at 12 months. Participants received daily calcium and vitamin D supplementation. The primary end point was the proportion of participants with one or more new morphometric vertebral fractures over a period of 24 months. Results The rate of any new morphometric vertebral fracture was 1.6% in the zoledronic acid group and 4.9% in the placebo group over the 24-month period, representing a 67% risk reduction with zoledronic acid (relative risk, 0.33; 95% confidence interval, 0.16 to 0.70; P = 0.002). As compared with men who received placebo, men who received zoledronic acid had fewer moderate-to-severe vertebral fractures (P = 0.03) and less height loss (P = 0.002). Fewer participants who received zoledronic acid had clinical vertebral or nonvertebral fractures, although this difference did not reach significance because of the small number of fractures. Bone mineral density was higher and bone-turnover markers were lower in the men who received zoledronic acid (P<0.05 for both comparisons). Results were similar in men with low serum levels of total testosterone. The zoledronic acid and placebo groups did not differ significantly with respect to the incidence of death (2.6% and 2.9%, respectively) or serious adverse events (25.3% and 25.2%). Conclusions Zoledronic acid treatment was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis. (Funded by Novartis Pharma; ClinicalTrials.gov number, NCT00439647.)	[Boonen, Steven; Claessens, Frank; Vanderschueren, Dirk] Katholieke Univ Leuven, Louvain, Belgium; [Reginster, Jean-Yves] Univ Liege, Liege, Belgium; [Kaufman, Jean-Marc] Univ Ghent, B-9000 Ghent, Belgium; [Witvrouw, Richard] Ziekenhuis Oost Limburg, Genk, Belgium; [Rizzoli, Rene] Univ Hosp Geneva, Geneva, Switzerland; [Papanastasiou, Philemon; Hruska, Josef; Incera, Elodie] Novartis Pharmaceut, Basel, Switzerland; [Zanchetta, Jose] Univ Salvador, Buenos Aires, DF, Argentina; [Langdahl, Bente] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Brixen, Kim] Univ So Denmark, Odense, Denmark; [Lipschitz, Stanley] Bone Mineral Dens Clin, Johannesburg, South Africa; [Dimai, Hans Peter] Med Univ Graz, Graz, Austria; [Eriksen, Erik] Univ Oslo, Oslo, Norway; [Russo, Luis] Brazil Ctr Clin & Basic Res, Rio De Janeiro, Brazil; [Antunez, Oscar; Su, Guoqin; Bucci-Rechtweg, Christina] Novartis Pharmaceut, E Hanover, NJ USA; [Orwoll, Eric] Oregon Hlth & Sci Univ, Portland, OR USA	KU Leuven; University of Liege; Ghent University; East Limburg Hospital; University of Geneva; Novartis; Aarhus University; University of Southern Denmark; Medical University of Graz; University of Oslo; Center Clinical & Basic Research; Novartis; Oregon Health & Science University	Boonen, S (corresponding author), Univ Hosp Leuven, Ctr Metab Bone Dis, Herestr 49, B-3000 Louvain, Belgium.	steven.boonen@uz.kuleuven.ac.be	Claessens, Frank/M-8565-2016; Eriksen, Erik Fink/AAF-5056-2020	Claessens, Frank/0000-0002-8676-7709; Lippuner, Kurt/0000-0002-7195-3779; vanderschueren, dirk/0000-0003-1395-0104; Orwoll, Eric/0000-0002-8520-7355	Amgen; Novartis; Servier; Warner Chilcott; Osteologix; GlaxoSmithKline; Merck Sharp Dohme; Natural Product Sciences Pharmaceuticals; Eli Lilly; Nycomed; Daiichi-Sankyo; Kyphon; Merck; Novo Nordisk; Sanofi-Aventis; Roche; Procter Gamble; Pfizer; Axon Advisors; GTx; RAND; Wright Medical Technology; O.N. Diagnostics; County of Placer, California; U.S. Department of Justice; Springer; Academic Press (Elsevier); Negma; Wyeth; Merckle; Theramex; Union Chimique Belge; Bristol-Myers Squibb; Rottapharm; Teva; Institut Biochimique; Genevrier; Teijin; Ebewe Pharma; Zodiac; Analis; Nolver; Danone; Nestle; Novartis Pharma	Amgen(Amgen); Novartis(Novartis); Servier(Servier); Warner Chilcott; Osteologix; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Natural Product Sciences Pharmaceuticals; Eli Lilly(Eli Lilly); Nycomed; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Kyphon; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Procter Gamble(Procter & Gamble); Pfizer(Pfizer); Axon Advisors; GTx; RAND; Wright Medical Technology; O.N. Diagnostics; County of Placer, California; U.S. Department of Justice; Springer; Academic Press (Elsevier); Negma; Wyeth(Wyeth); Merckle; Theramex; Union Chimique Belge; Bristol-Myers Squibb(Bristol-Myers Squibb); Rottapharm; Teva(Teva Pharmaceutical Industries); Institut Biochimique(Centre National de la Recherche Scientifique (CNRS)); Genevrier; Teijin; Ebewe Pharma; Zodiac; Analis; Nolver; Danone(Danone Nutricia); Nestle(Nestle SA); Novartis Pharma	Dr. Antunez reports being an employee of and owning stock in Novartis. Dr. Boonen reports receiving payment to his institution, the University Hospitals Leuven, for serving on the board of Amgen, Novartis, and Servier; consulting fees from Amgen, Novartis, Servier, and Warner Chilcott; grant support from Novartis; and lecture fees and payment for travel accommodations from Amgen, Novartis, and Servier. Dr. Brixen reports serving on the board for Osteologix, Servier, Amgen, and Novartis and receiving payment for expert testimony on a patent for strontium maleate in the United States and consulting fees from Osteologix; lecture fees from Servier, Amgen, GlaxoSmithKline, and Novartis; and payment for travel accommodation from Amgen, Eli Lilly, Servier, and Novartis. Dr. Brixen reports receiving grant support to his institution, Odense University Hospital, from Merck Sharp & Dohme and Novartis and investigator payments from Merck Sharp & Dohme, Osteologix, Servier, Amgen, Natural Product Sciences Pharmaceuticals, and Eli Lilly. Dr. Bucci-Rechtweg reports being an employee of and owning stock in Novartis. Dr. Dimai reports serving on the board and receiving consulting fees and payment for travel accommodations from Novartis, Nycomed, Amgen, Eli Lilly, Merck Sharp & Dohme, Servier, and Daiichi-Sankyo; lecture fees from Novartis, Nycomed, Amgen, Eli Lilly, Merck Sharp & Dohme, Servier, Kyphon, and Daiichi-Sankyo; payment for manuscript preparation from Amgen and Servier; payment for development of educational presentations from Servier and Merck Sharp & Dohme; and grant support to his institution, the Medical University of Graz, from Novartis, Nycomed, Amgen, Eli Lilly, Merck Sharp & Dohme, Servier, and Kyphon. Dr. Eriksen reports receiving consulting fees from Eli Lilly and Amgen and lecture fees from Eli Lilly, Amgen, and Novartis. Dr. Hruska reports being an employee of Novartis. Ms. Incera reports being an employee of Novartis. Dr. Kaufman reports receiving consulting fees from Servier and payment for travel accommodations from Merck, Novo Nordisk, Eli Lilly, Novartis, and Servier. Dr. Kaufman reports receiving payment to his institution, Ghent University Hospital, for serving on the board of Servier; payment for expert testimony about teriparatide and consulting fees from Eli Lilly; and grant support from Novartis, Merck, Sanofi-Aventis, GlaxoSmithKline, Servier, Roche, Procter & Gamble, Amgen, and Nycomed. Dr. Langdahl reports serving on the board for Novartis, Eli Lilly, Merck Sharp & Dohme, Nycomed, and Amgen and receiving lecture fees from Eli Lilly, Merck Sharp & Dohme, Amgen, GlaxoSmithKline, and Servier and grant support to his institution, the Aarhus University Hospital, from Eli Lilly, Amgen, and Merck Sharp & Dohme. Dr. Lippuner reports receiving consulting fees from Amgen, Daiichi-Sankyo, Eli Lilly, Merck Sharp & Dohme, Nycomed, Pfizer, and Roche; lecture fees from Amgen and Daiichi-Sankyo; and grant support to his institution, University of Bern, from Amgen, Merck Sharp & Dohme, Roche, and Servier. Dr. Lipschitz reports serving on the board for Novartis, Servier, and Merck Sharp & Dohme; receiving consulting fees and payment for development of educational presentations from Servier; lecture fees from Merck Sharp & Dohme, Servier, Novartis, and Eli Lilly; and payment for travel and accommodations from Merck Sharp & Dohme and Servier. Dr.; Orwoll reports receiving consulting fees from Amgen, Axon Advisors, Eli Lilly, GTx, Merck Sharp & Dohme, RAND, and Wright Medical Technology; grants to his institution, Oregon Health and Science University, from Amgen, Eli Lilly, Merck Sharp & Dohme, and O.N. Diagnostics; payment for expert testimony from the County of Placer, California, and the U.S. Department of Justice; and royalty payments from Springer and Academic Press (Elsevier). Dr. Papanastasiou reports being an employee of and owning stock in Novartis. Dr. Reginster reports receiving consulting fees from Servier, Novartis, Negma, Eli Lilly, Wyeth, Amgen, GlaxoSmithKline, Roche, Merckle, Nycomed, Natural Product Sciences Pharmaceuticals, Theramex, and Union Chimique Belge; grants from Bristol-Myers Squibb, Merck Sharp & Dohme, Rottapharm, Teva, Eli Lilly, Novartis, Roche, GlaxoSmithKline, Amgen, and Servier; and lecture fees from Merck Sharp & Dohme, Eli Lilly, Rottapharm, Institut Biochimique, Genevrier, Novartis, Servier, Roche, GlaxoSmithKline, Teijin, Teva, Ebewe Pharma, Zodiac, Analis, Theramex, Nycomed, Novo Nordisk, and Nolver. Dr. Rizzoli reports serving on the board and receiving consulting and lecture fees from Novartis, Amgen, Servier, Eli Lilly, Danone, Nestle, and Nycomed and grant support from Danone, Servier, and Novartis. Dr. Su reports being an employee of and owning stock in Novartis. Dr. Zanchetta reports serving on the board for Pfizer and receiving consulting fees from Eli Lilly, Merck Sharp & Dohme, GlaxoSmithKline, and Servier and lecture fees from Eli Lilly.; Supported by Novartis Pharma.	Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Boonen S, 2009, J BONE MINER RES, V24, P719, DOI 10.1359/JBMR.081214; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P953, DOI 10.1007/s00198-005-1950-0; Frost M, 2012, AGE AGEING, V41, P171, DOI 10.1093/ageing/afr170; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Lunt M, 2003, BONE, V33, P505, DOI 10.1016/S8756-3282(03)00248-5; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Neuenschwander B, 2010, CLIN TRIALS, V7, P5, DOI 10.1177/1740774509356002; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Orwoll ES, 2010, J BONE MINER RES, V25, P2239, DOI 10.1002/jbmr.119; Orwoll ES, 2010, BONE, V46, P970, DOI 10.1016/j.bone.2009.12.034; Puisto V, 2011, OSTEOPOROSIS INT, V22, P63, DOI 10.1007/s00198-010-1195-4; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Roerholt C, 2009, OSTEOPOROSIS INT, V20, P299, DOI 10.1007/s00198-008-0651-x; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; World Medical Association, 2004, DECL HELS ETH PRINC	27	196	217	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1714	1723		10.1056/NEJMoa1204061	http://dx.doi.org/10.1056/NEJMoa1204061			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113482	Bronze, Green Published			2022-12-28	WOS:000310440800008
J	Metaxas, PT; Mustafaraj, E				Metaxas, Panagiotis T.; Mustafaraj, Eni			Social Media and the Elections	SCIENCE			English	Editorial Material									[Metaxas, Panagiotis T.; Mustafaraj, Eni] Wellesley Coll, Dept Comp Sci, Wellesley, MA 02481 USA	Wellesley College	Metaxas, PT (corresponding author), Wellesley Coll, Dept Comp Sci, 106 Cent St, Wellesley, MA 02481 USA.	pmetaxas@wellesley.edu; emustafa@wellesley.edu						[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; [Anonymous], WALL STREET J; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Castillo Carlos, 2011, Foundations and Trends in Information Retrieval, V4, P377, DOI 10.1561/1500000021; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Edsal T., 2012, NY TIMES; Foundation Pew, 2012, SEARCH ENG US 2012; Foundation Pew, 2011, 65 ONL AD US SOC NET; Gayo-Avello D., 2012, METAANALYSIS STATE A; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Google bomb, 2012, GOOGL BOMB; Jungherr A, 2012, SOC SCI COMPUT REV, V30, P229, DOI 10.1177/0894439311404119; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Metaxas P.T., 2010, P WEBSCI10 EXT FRONT; Metaxas P. T., 2011, WORKSH INF DEC SOC N; Metaxas PT, 2010, LECT NOTES BUS INF P, V45, P170; Moore MT, 2012, US TODAY; Mustafaraj E., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P103, DOI 10.1109/PASSAT/SocialCom.2011.188; Mustafaraj E., 2009, P IEEE COMPUT SCI EN, V4, P320; Mustafaraj E., 2009, P ACM INF RETR ADV W; Petermann M. C., 2012, TWITTER UNDERGROUND; Varian, 2009, PREDICTING PRESENT G	23	88	93	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					472	473		10.1126/science.1230456	http://dx.doi.org/10.1126/science.1230456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112315	Green Submitted			2022-12-28	WOS:000310195800037
J	Liao, XY; Lochhead, P; Nishihara, R; Morikawa, T; Kuchiba, A; Yamauchi, M; Imamura, Y; Qian, ZR; Baba, Y; Shima, K; Sun, RF; Nosho, K; Meyerhardt, JA; Giovannucci, E; Fuchs, CS; Chan, AT; Ogino, S				Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Baba, Yoshifumi; Shima, Kaori; Sun, Ruifang; Nosho, Katsuhiko; Meyerhardt, Jeffrey A.; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji			Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; MICROSATELLITE INSTABILITY; COLON-CANCER; PERSONALIZED MEDICINE; RANDOMIZED-TRIALS; BRAF MUTATION; RISK; METASTASIS; INHIBITION	BACKGROUND Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers. METHODS We obtained data on 964 patients with rectal or colon cancer from the Nurses' Health Study and the Health Professionals Follow-up Study, including data on aspirin use after diagnosis and the presence or absence of PIK3CA mutation. We used a Cox proportional-hazards model to compute the multivariate hazard ratio for death. We examined tumor markers, including PTGS2, phosphorylated AKT, KRAS, BRAF, microsatellite instability, CpG island methylator phenotype, and methylation of long interspersed nucleotide element 1. RESULTS Among patients with mutated-PIK3CA colorectal cancers, regular use of aspirin after diagnosis was associated with superior colorectal cancer-specific survival (multivariate hazard ratio for cancer-related death, 0.18; 95% confidence interval [CI], 0.06 to 0.61; P<0.001 by the log-rank test) and overall survival (multivariate hazard ratio for death from any cause, 0.54; 95% CI, 0.31 to 0.94; P = 0.01 by the log-rank test). In contrast, among patients with wild-type PIK3CA, regular use of aspirin after diagnosis was not associated with colorectal cancer-specific survival (multivariate hazard ratio, 0.96; 95% CI, 0.69 to 1.32; P = 0.76 by the log-rank test; P = 0.009 for interaction between aspirin and PIK3CA variables) or overall survival (multivariate hazard ratio, 0.94; 95% CI, 0.75 to 1.17; P = 0.96 by the log-rank test; P = 0.07 for interaction). CONCLUSIONS Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. The findings from this molecular pathological epidemiology study suggest that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy. (Funded by The National Institutes of Health and others.)	[Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Baba, Yoshifumi] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan; [Shima, Kaori] Kagoshima Univ, Dept Oral Pathol, Kagoshima 890, Japan; [Nosho, Katsuhiko] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Tokyo; Kumamoto University; Kagoshima University; Sapporo Medical University	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02115 USA.	achan@partners.org; shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323; Qian, Zhi rong/0000-0003-1633-4120	National Institutes of Health [P01 CA87969, P01 CA55075, P50 CA127003, R01 CA149222, R01 CA137178, R01 CA151993]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; Chief Scientist Office [CAF/10/15] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA149222, R01CA151993, P01CA087969, P01CA055075, R01CA137178, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (P01 CA87969 and P01 CA55075; P50 CA127003, to Dr. Fuchs; R01 CA149222, to Dr. Meyerhardt; R01 CA137178, to Dr. Chan; and R01 CA151993, to Dr. Ogino), the Bennett Family Fund for Targeted Therapies Research, and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; by the Frank Knox Memorial Fellowship at Harvard University and a fellowship from the Chief Scientist Office, Scotland (to Dr. Lochhead); and by a Damon Runyon Clinical Investigator Award (to Dr. Chan).	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; He YJ, 2009, CLIN CANCER RES, V15, P6956, DOI 10.1158/1078-0432.CCR-09-1165; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kaur J, 2010, TUMOR BIOL, V31, P623, DOI 10.1007/s13277-010-0078-9; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	40	621	646	7	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1596	1606		10.1056/NEJMoa1207756	http://dx.doi.org/10.1056/NEJMoa1207756			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094721	Green Accepted, Bronze			2022-12-28	WOS:000310131700006
J	Burden, M; Bakere, H				Burden, Mel; Bakere, Hugh			Tuberculosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burden, Mel; Bakere, Hugh] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Burden, M (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	mel.burden@nhs.net							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 16	2012	345								e6713	10.1136/bmj.e6713	http://dx.doi.org/10.1136/bmj.e6713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WG	23077324	Green Submitted, Bronze			2022-12-28	WOS:000310140600016
J	Schlierf, M; Ha, T				Schlierf, Michael; Ha, Taekjip			A Helicase with an Extra Spring in Its Step	CELL			English	Editorial Material							DNAB HELICASE; MECHANISM; TRANSLOCATION; PRIMASE		[Schlierf, Michael] Tech Univ Dresden, Ctr Mol Bioengn, B CUBE, D-01062 Dresden, Germany; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Dept Phys, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Ctr Phys Living Cells, Urbana, IL 61801 USA	Technische Universitat Dresden; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Schlierf, M (corresponding author), Tech Univ Dresden, Ctr Mol Bioengn, B CUBE, D-01062 Dresden, Germany.	schlierf@bcube-dresden.de; tjha@illinois.edu	Schlierf, Michael/F-5343-2012; Ha, Taekjip/B-9506-2009	Schlierf, Michael/0000-0002-6209-2364; Ha, Taekjip/0000-0003-2195-6258	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065367, R01 GM065367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Lee G, 2012, SCIENCE, V336, P1726, DOI 10.1126/science.1216848; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356	10	3	4	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					244	246		10.1016/j.cell.2012.09.031	http://dx.doi.org/10.1016/j.cell.2012.09.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063116	Bronze			2022-12-28	WOS:000309981000002
J	Verhaegen, J; Gallos, ID; van Mello, NM; Abdel-Aziz, M; Takwoingi, Y; Harb, H; Deeks, JJ; Mol, BWJ; Coomarasamy, A				Verhaegen, Jorine; Gallos, Ioannis D.; van Mello, Norah M.; Abdel-Aziz, Mohamed; Takwoingi, Yemisi; Harb, Hoda; Deeks, Jonathan J.; Mol, Ben W. J.; Coomarasamy, Arri			Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies	BRITISH MEDICAL JOURNAL			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ECTOPIC PREGNANCY; SERUM PROGESTERONE; DIFFERENTIAL-DIAGNOSIS; UNKNOWN LOCATION; MANAGEMENT; HCG; THRESHOLDS; ESTRADIOL; PROTEIN	Objective To determine the accuracy with which a single progesterone measurement in early pregnancy discriminates between viable and non-viable pregnancy. Design Systematic review and meta-analysis of diagnostic accuracy studies. Data sources Medline, Embase, CINAHL, Web of Science, ProQuest, Conference Proceedings Citation Index, and the Cochrane Library from inception until April 2012, plus reference lists of relevant studies. Study selection Studies were selected on the basis of participants (women with spontaneous pregnancy of less than 14 weeks of gestation); test (single serum progesterone measurement); outcome (viable intrauterine pregnancy, miscarriage, or ectopic pregnancy) diagnosed on the basis of combinations of pregnancy test, ultrasound scan, laparoscopy, and histological examination; design (cohort studies of test accuracy); and sufficient data being reported. Results 26 cohort studies, including 9436 pregnant women, were included, consisting of 7 studies in women with symptoms and in conclusive ultrasound assessment and 19 studies in women with symptoms alone. Among women with symptoms and inconclusive ultrasound assessments, the progesterone test (5 studies with 1998 participants and cut-off values from 3.2 to 6 ng/mL) predicted a non-viable pregnancy with pooled sensitivity of 74.6% (95% confidence interval 50.6% to 89.4%), specificity of 98.4% (90.9% to 99.7%), positive likelihood ratio of 45 (7.1 to 289), and negative likelihood ratio of 0.26 (0.12 to 0.57). The median prevalence of a non-viable pregnancy was 73.2%, and the probability of a non-viable pregnancy was raised to 99.2% if the progesterone was low. For women with symptoms alone, the progesterone test had a higher specificity when a threshold of 10 ng/mL was used (9 studies with 4689 participants) and predicted a non-viable pregnancy with pooled sensitivity of 66.5% (53.6% to 77.4%), specificity of 96.3% (91.1% to 98.5%), positive likelihood ratio of 18 (7.2 to 45), and negative likelihood ratio of 0.35 (0.24 to 0.50). The probability of a non-viable pregnancy was raised from 62.9% to 96.8%. Conclusion A single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy.	[Verhaegen, Jorine; Mol, Ben W. J.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Gallos, Ioannis D.; Abdel-Aziz, Mohamed; Harb, Hoda; Coomarasamy, Arri] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [van Mello, Norah M.; Takwoingi, Yemisi; Deeks, Jonathan J.] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Birmingham	Gallos, ID (corresponding author), Univ Oxford, Oxford Radcliffe Hosp NHS Trust, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England.	ioannis.gallos@nhs.net	Mol, Ben/I-4526-2012; Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Gallos, Ioannis/0000-0002-2766-358X; Takwoingi, Yemisi/0000-0002-5828-9746; Van Mello, Norah Melina/0000-0002-0805-2994	National Institute for Health Research [ACF-2012-13-018] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Alberman E., 1992, SPONTANEOUS ABORTION, P9; Banerjee S, 1999, ULTRASOUND OBST GYN, V14, P231, DOI 10.1046/j.1469-0705.1999.14040231.x; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; Buckley RG, 2000, ANN EMERG MED, V36, P95, DOI 10.1067/mem.2000.108653; Camejo MI, 2003, EUR J OBSTET GYN R B, V109, P181, DOI 10.1016/S0301-2115(03)00124-6; CHOE JK, 1992, GYNECOL OBSTET INVES, V34, P133, DOI 10.1159/000292745; Condous G, 2003, ULTRASOUND OBST GYN, V22, P420, DOI 10.1002/uog.236; Dart R, 2002, AM J EMERG MED, V20, P575, DOI 10.1053/ajem.2002.35460; Dart R, 1998, ACAD EMERG MED, V5, P304, DOI 10.1111/j.1553-2712.1998.tb02709.x; Day A, 2009, ULTRASOUND OBST GYN, V33, P704, DOI 10.1002/uog.6380; Dukic V, 2003, BIOMETRICS, V59, P936, DOI 10.1111/j.0006-341X.2003.00108.x; El Bishry G, 2008, J OBSTET GYNAECOL, V28, P413, DOI 10.1080/01443610802149806; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; Florio P, 2007, J CLIN ENDOCR METAB, V92, P1748, DOI 10.1210/jc.2006-2188; GELDER MS, 1991, FERTIL STERIL, V55, P497; GROSSKINSKY CM, 1993, OBSTET GYNECOL, V81, P705; HAHLIN M, 1991, FERTIL STERIL, V55, P492; Hamza TH, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-73; Hinshaw K, 2006, MANAGEMENT EARLY PRE; HUBINONT CJ, 1987, AM J OBSTET GYNECOL, V156, P669, DOI 10.1016/0002-9378(87)90075-5; KADAR N, 1981, OBSTET GYNECOL, V58, P162; Kester ADM, 2000, MED DECIS MAKING, V20, P430, DOI 10.1177/0272989X0002000407; KRATZER PG, 1990, AM J OBSTET GYNECOL, V163, P1497, DOI 10.1016/0002-9378(90)90613-C; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; McCord ML, 1996, FERTIL STERIL, V66, P513, DOI 10.1016/S0015-0282(16)58560-4; MESROGLI M, 1988, Z GEBURTSH PERINATOL, V192, P130; Mol BWJ, 1999, FERTIL STERIL, V72, P643, DOI 10.1016/S0015-0282(99)00328-3; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; OLeary P, 1996, AUST NZ J OBSTET GYN, V36, P319, DOI 10.1111/j.1479-828X.1996.tb02720.x; Perkins SL, 2000, FERTIL STERIL, V73, P499, DOI 10.1016/S0015-0282(99)00543-9; PETERSON CM, 1992, AM J OBSTET GYNECOL, V166, P562, DOI 10.1016/0002-9378(92)91673-X; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; SAUER MV, 1989, HUM REPROD, V4, P331, DOI 10.1093/oxfordjournals.humrep.a136899; Shillito J, 1997, Br J Hosp Med, V58, P505; TAKAHASHI K, 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P147, DOI 10.3109/01443619209013621; Valley VT, 1998, ACAD EMERG MED, V5, P309, DOI 10.1111/j.1553-2712.1998.tb02710.x; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Williams R S, 1992, J Fla Med Assoc, V79, P237; WITT BR, 1990, FERTIL STERIL, V53, P1029; YEKO TR, 1987, FERTIL STERIL, V48, P1048	40	58	65	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6077	10.1136/bmj.e6077	http://dx.doi.org/10.1136/bmj.e6077			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014OZ	23045257	Green Published, hybrid			2022-12-28	WOS:000309386700002
J	Kauffman, CA; Pappas, PG; Patterson, TF				Kauffman, Carol A.; Pappas, Peter G.; Patterson, Thomas F.			Fungal Infections Associated with Contaminated Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VORICONAZOLE CONCENTRATIONS; MENINGITIS; OUTBREAK; SAFETY		[Kauffman, Carol A.] Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Div Infect Dis, Ann Arbor, MI USA; [Pappas, Peter G.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Infect Dis, San Antonio, TX 78229 USA; [Patterson, Thomas F.] South Texas Vet Healthcare Syst, San Antonio, TX USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Kauffman, CA (corresponding author), VA Ann Arbor Healthcare Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	ckauff@umich.edu			Merck; Gilead; Astellas; T2 Biosystems; Pfizer; Toyoma; Viamet	Merck(Merck & Company); Gilead(Gilead Sciences); Astellas(Astellas Pharmaceuticals); T2 Biosystems; Pfizer(Pfizer); Toyoma; Viamet	Dr. Kauffman reports serving on a data and safety monitoring board for Merck and an adjudication panel for New England Research Institutes; Dr. Pappas, receiving consulting fees from Merck, Gilead, Astellas, and T2 Biosystems and grant support through his institution from Merck, Gilead, Astellas, T2 Biosystems, and Pfizer; and Dr. Patterson, receiving consulting fees from Astellas, Merck, Pfizer, Toyoma, and Viamet, grant support through his institution from Astellas and Merck, and lecture fees through his institution from Merck and Pfizer. No other potential conflict of interest relevant to this article was reported.	Boyd NK, 2012, ANTIMICROB AGENTS CH, V56, P6001, DOI 10.1128/AAC.00700-12; Centers for Disease Control and Prevention, 2013, LAB TEST RES OUTBR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; da Cunha KC, 2012, ANTIMICROB AGENTS CH, V56, P4951, DOI 10.1128/AAC.00488-12; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Lashof AMLO, 2012, ANTIMICROB AGENTS CH, V56, P3133, DOI 10.1128/AAC.05841-11; Lutsar I, 2003, CLIN INFECT DIS, V37, P728, DOI 10.1086/377131; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Nucci M, 2002, CLIN INFECT DIS, V34, P1475, DOI 10.1086/340344; Pascual A, 2012, CLIN INFECT DIS, V55, P381, DOI 10.1093/cid/cis437; Perfect JR, 2012, ANN INTERN MED, V157, P825, DOI 10.7326/0003-4819-157-11-201212040-00558; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978	15	46	48	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2495	2500		10.1056/NEJMra1212617	http://dx.doi.org/10.1056/NEJMra1212617			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23083312				2022-12-28	WOS:000320926900010
J	Zhang, Y; Feng, Y; Chatterjee, S; Tuske, S; Ho, MX; Arnold, E; Ebright, RH				Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.			Structural Basis of Transcription Initiation	SCIENCE			English	Article							RNA-POLYMERASE HOLOENZYME; PROMOTER OPEN COMPLEX; SIGMA-SUBUNIT; ANGSTROM RESOLUTION; RECOGNITION; ELEMENT; ORGANIZATION; ARCHITECTURE; ELONGATION; MECHANISM	During transcription initiation, RNA polymerase (RNAP) binds and unwinds promoter DNA to form an RNAP-promoter open complex. We have determined crystal structures at 2.9 and 3.0 angstrom resolution of functional transcription initiation complexes comprising Thermus thermophilus RNA polymerase, sigma(A), and a promoter DNA fragment corresponding to the transcription bubble and downstream double-stranded DNA of the RNAP-promoter open complex. The structures show that sigma recognizes the -10 element and discriminator element through interactions that include the unstacking and insertion into pockets of three DNA bases and that RNAP recognizes the -4/+2 region through interactions that include the unstacking and insertion into a pocket of the +2 base. The structures further show that interactions between sigma and template-strand single-stranded DNA (ssDNA) preorganize template-strand ssDNA to engage the RNAP active center.	[Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tuske, Steve; Ho, Mary X.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	Zhang, Yu/J-5225-2014; Ebright, Richard/O-3321-2019; Chatterjee, Sujoy/L-7325-2015; Zhang, Yu/AAV-5722-2021	Ebright, Richard/0000-0001-8915-7140; Zhang, Yu/0000-0002-1778-8389; Feng, Yu/0000-0003-4239-8320	NIH [GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Brookhaven National Synchrotron Light Source and Cornell High Energy Synchrotron Source for beamline access; the Argonne Photon Source CCP4 School for training; and S. Borukhov, P. deHaseth, K. Kuznedelov, L. Minakhin, K. Severinov, and D. Temiakov for plasmids and discussion. This work was funded by NIH grants GM41376 and AI072766 and a Howard Hughes Medical Institute Investigatorship to R. H. E. PDB accession codes are 4G7H, 4G7Z, and 4G7O.	Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Kireeva ML, 2011, J BIOL CHEM, V286, P30898, DOI 10.1074/jbc.M111.260844; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Liu X, 2011, CELL, V147, P1218, DOI 10.1016/j.cell.2011.11.033; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P22600, DOI 10.1074/jbc.M111.247080; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6	29	236	239	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1076	1080		10.1126/science.1227786	http://dx.doi.org/10.1126/science.1227786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086998	Green Accepted			2022-12-28	WOS:000311390600043
J	McCartney, M				McCartney, Margaret			The doctor won't see you now: online consulting and prescribing	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 30	2012	345								e7238	10.1136/bmj.e7238	http://dx.doi.org/10.1136/bmj.e7238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EY	23112121				2022-12-28	WOS:000310778200011
J	Fang, FC; Baumler, AJ				Fang, Ferric C.; Baeumler, Andreas J.			A Tollgate for Typhoid	CELL			English	Editorial Material							SALMONELLA; FEVER; MICE	Humans are uniquely susceptible to typhoid fever caused by infection with Salmonella enterica serovar Typhi. Mathur et al. now report that mice lacking Toll-like receptor 11, which is absent in humans, can be lethally infected with S. Typhi, a breakthrough that promises to speed the development of better vaccines.	[Fang, Ferric C.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Fang, Ferric C.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Davis	Fang, FC (corresponding author), Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@uw.edu	Baumler, Andreas J/H-2301-2011	Baumler, Andreas J/0000-0001-9152-7809; Fang, Ferric/0000-0002-3243-110X	NIAID NIH HHS [AI44170, AI91966, AI90882, U19 AI090882, AI76246, R21 AI091966] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090882, R21AI091966, R01AI044170, R01AI076246] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; LOCKMAN HA, 1990, INFECT IMMUN, V58, P137, DOI 10.1128/IAI.58.1.137-143.1990; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Sabbagh SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036643; Sztein MB, 2007, CLIN INFECT DIS, V45, pS15, DOI 10.1086/518140; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	10	5	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					473	475		10.1016/j.cell.2012.10.016	http://dx.doi.org/10.1016/j.cell.2012.10.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101620	Green Accepted, Bronze			2022-12-28	WOS:000310529300005
J	Gamerdinger, M; Deuerling, E				Gamerdinger, Martin; Deuerling, Elke			Macrolides: The Plug Is Out	CELL			English	Editorial Material							LARGE RIBOSOMAL-SUBUNIT; ANTIBIOTICS	Macrolide antibiotics are thought to clog up the ribosomal tunnel and thereby block general protein synthesis. By using a combination of elegant in vivo and in vitro approaches, Kannan et al. show that the inhibitory action of these drugs on bacterial protein synthesis is selective rather than global.	[Gamerdinger, Martin; Deuerling, Elke] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Deuerling, E (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	elke.deuerling@uni-konstanz.de		Gamerdinger, Martin/0000-0003-1483-8181				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kannan K, 2012, CELL, V151, P508, DOI 10.1016/j.cell.2012.09.018; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200	9	8	8	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					469	471		10.1016/j.cell.2012.10.015	http://dx.doi.org/10.1016/j.cell.2012.10.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101618	Green Submitted, Bronze			2022-12-28	WOS:000310529300003
J	Goldman, SA; Nedergaard, M; Windrem, MS				Goldman, Steven A.; Nedergaard, Maiken; Windrem, Martha S.			Glial Progenitor Cell-Based Treatment and Modeling of Neurological Disease	SCIENCE			English	Review							PLURIPOTENT STEM-CELLS; SUBCORTICAL WHITE-MATTER; SPINAL-CORD; HUMAN OLIGODENDROCYTES; LYSOSOMAL STORAGE; DIFFERENTIATION; TRANSPLANTATION; MICE; IDENTIFICATION; REMYELINATION	The diseases of myelin are among the most prevalent and disabling conditions in neurology. These diseases include both the vascular and inflammatory demyelinating disorders of adulthood, as well as the childhood leukodystrophies and cerebral palsy. These fundamentally glial disorders may be amenable to treatment by glial progenitor cells (GPCs), which give rise to astroglia and myelin-producing oligodendrocytes. Given the development of new methods for generating and isolating human GPCs, the myelin disorders may now be compelling targets for cell-based therapy. In addition, the efficient engraftment and expansion of human GPCs in murine hosts has led to the development of human glial chimeric mouse brains, which provides new opportunities for studying the species-specific roles of human glia in cognition, as well as in disease pathogenesis.	[Goldman, Steven A.; Nedergaard, Maiken; Windrem, Martha S.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA	University of Rochester	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303	National Institute of Neurological Disorders and Stroke [R01NS75345, R01NS39559]; National Multiple Sclerosis Society; Adelson Medical Research Foundation; Mathers Charitable Foundation; New York State Stem Cell Research Program (NYSTEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345, R01NS039559, R01NS078167, R01NS078304, R01NS075177] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Adelson Medical Research Foundation; Mathers Charitable Foundation; New York State Stem Cell Research Program (NYSTEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work discussed in the Goldman lab was supported by grants from the National Institute of Neurological Disorders and Stroke (R01NS75345 and R01NS39559), the National Multiple Sclerosis Society, the Adelson Medical Research Foundation, the Mathers Charitable Foundation, and the New York State Stem Cell Research Program (NYSTEM). S. A. G. is an inventor on the following patents held by the University of Rochester and/or Cornell University: U.S. Patent 7,524,491 B2 ("Non-human animals with human glial chimeric brains"), U.S. Patent 8,206,699 ("Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells"), and U.S. Patent 8,263,402 ("A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells").	Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Givogri MI, 2006, J NEUROSCI, V26, P3109, DOI 10.1523/JNEUROSCI.4366-05.2006; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Han SSW, 2004, GLIA, V45, P1, DOI 10.1002/glia.10282; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Powers J., 2004, MYELIN BIOL DISORDER, P663; Roy N., 2004, MYELIN BIOL DISORDER, P259; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Shihabuddin LS, 2004, J NEUROSCI, V24, P10642, DOI 10.1523/JNEUROSCI.3584-04.2004; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaki SJ, 2009, CELL STEM CELL, V5, P310, DOI 10.1016/j.stem.2009.05.022; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Weinstock-Guttman B, 2012, NAT REV NEUROL, V8, P66, DOI 10.1038/nrneurol.2011.213; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Windrem M. S., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; [No title captured]	51	130	142	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					491	495		10.1126/science.1218071	http://dx.doi.org/10.1126/science.1218071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112326	Green Accepted			2022-12-28	WOS:000310195800048
J	Duraes, AR; Brito, JC				Duraes, Andre R.; Brito, Jose C.			Selective Intraarterial Thrombolysis for Cardioembolic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Duraes, Andre R.; Brito, Jose C.] Hosp Santa Izabel, Salvador, BA, Brazil		Duraes, AR (corresponding author), Hosp Santa Izabel, Salvador, BA, Brazil.		Duraes, Andre/X-8916-2019; Duraes, Andre R/N-2593-2017	Duraes, Andre/0000-0002-1506-0327; Duraes, Andre R/0000-0002-1506-0327					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					E24	E24		10.1056/NEJMicm1211164	http://dx.doi.org/10.1056/NEJMicm1211164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094751				2022-12-28	WOS:000310131700011
J	Cai, XL; Wang, JW; Strain, MJ; Johnson-Morris, B; Zhu, JB; Sorel, M; O'Brien, JL; Thompson, MG; Yu, ST				Cai, Xinlun; Wang, Jianwei; Strain, Michael J.; Johnson-Morris, Benjamin; Zhu, Jiangbo; Sorel, Marc; O'Brien, Jeremy L.; Thompson, Mark G.; Yu, Siyuan			Integrated Compact Optical Vortex Beam Emitters	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; PANCHARATNAM-BERRY PHASE; POLARIZED BEAMS; WAVE-GUIDES; LIGHT; MANIPULATION; PHOTONS	Emerging applications based on optical beams carrying orbital angular momentum (OAM) will probably require photonic integrated devices and circuits for miniaturization, improved performance, and enhanced functionality. We demonstrate silicon-integrated optical vortex emitters, using angular gratings to extract light confined in whispering gallery modes with high OAM into free-space beams with well-controlled amounts of OAM. The smallest device has a radius of 3.9 micrometers. Experimental characterization confirms the theoretical prediction that the emitted beams carry exactly defined and adjustable OAM. Fabrication of integrated arrays and demonstration of simultaneous emission of multiple identical optical vortices provide the potential for large-scale integration of optical vortex emitters on complementary metal-oxide-semiconductor compatible silicon chips for wide-ranging applications.	[Cai, Xinlun; Johnson-Morris, Benjamin; Yu, Siyuan] Univ Bristol, Photon Grp, Merchant Venturers Sch Engn, Bristol, Avon, England; [Wang, Jianwei; O'Brien, Jeremy L.; Thompson, Mark G.] Univ Bristol, Ctr Quantum Photon, Bristol, Avon, England; [Strain, Michael J.; Sorel, Marc] Univ Glasgow, Dept Elect & Elect Engn, Glasgow G12 8QQ, Lanark, Scotland; [Zhu, Jiangbo; Yu, Siyuan] Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Jiangbo; Yu, Siyuan] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Jiangbo] Fudan Univ, State Key Lab Applicat Specif Integrated Circuits, Shanghai 200433, Peoples R China; [Zhu, Jiangbo] Fudan Univ, Dept Commun Sci & Engn, Shanghai 200433, Peoples R China	University of Bristol; University of Bristol; University of Glasgow; Sun Yat Sen University; Sun Yat Sen University; Fudan University; Fudan University	Yu, ST (corresponding author), Univ Bristol, Photon Grp, Merchant Venturers Sch Engn, Bristol, Avon, England.	s.yu@bristol.ac.uk	Yu, Siyuan/G-5713-2017; Strain, Michael J./E-9710-2018; O'Brien, Jeremy L/A-6290-2008; Zhu, Jiangbo/AAR-4535-2020	Yu, Siyuan/0000-0002-2550-8201; Strain, Michael J./0000-0002-9752-3144; Zhu, Jiangbo/0000-0001-9188-3862; Thompson, Mark/0000-0002-2865-9558; O'Brien, Jeremy/0000-0002-3576-8285; Wang, Jianwei/0000-0003-1313-9266; Sorel, Marc/0000-0001-8365-4496	European Union FP7 FET-OPEN project PHORBITEC; EPSRC [EP/J017175/1, EP/F010524/1, EP/K023063/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K023063/1, EP/F010524/1, EP/J017175/1] Funding Source: researchfish	European Union FP7 FET-OPEN project PHORBITEC; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Berry and M. Dennis (Department of Physics, University of Bristol, UK), S. Barnett (Department of Physics, University of Strathclyde, UK), and M. Padgett (Department of Physics, University of Glasgow, UK) for very useful discussions and C. Railton (Merchant Venturers School of Engineering, University of Bristol, UK) for providing the finite-difference time-domain simulation tool. J.W. is funded by European Union FP7 FET-OPEN project PHORBITEC.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Biener G, 2002, OPT LETT, V27, P1875, DOI 10.1364/OL.27.001875; Bomzon Z, 2001, OPT LETT, V26, P1424, DOI 10.1364/OL.26.001424; Doerr CR, 2011, OPT LETT, V36, P1209, DOI 10.1364/OL.36.001209; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Fontaine N. K., 2012, OPT FIB COMM C OSA; Furhapter S, 2005, OPT LETT, V30, P1953, DOI 10.1364/OL.30.001953; Gibson G, 2004, OPT EXPRESS, V12, P5448, DOI 10.1364/OPEX.12.005448; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; HECKENBERG NR, 1992, OPT LETT, V17, P221, DOI 10.1364/OL.17.000221; Ladavac K, 2004, OPT EXPRESS, V12, P1144, DOI 10.1364/OPEX.12.001144; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Manipatruni S, 2007, OPT EXPRESS, V15, P13035, DOI 10.1364/OE.15.013035; Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Matsko AB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.143904; Molina-Terriza G, 2007, NAT PHYS, V3, P305, DOI 10.1038/nphys607; Moreno I, 2010, OPT EXPRESS, V18, P7173, DOI 10.1364/OE.18.007173; Niv A, 2006, OPT EXPRESS, V14, P4208, DOI 10.1364/OE.14.004208; Smit M, 2012, LASER PHOTONICS REV, V6, P1, DOI 10.1002/lpor.201100001; Taillaert D, 2006, JPN J APPL PHYS 1, V45, P6071, DOI 10.1143/JJAP.45.6071; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Yariv A, 2000, ELECTRON LETT, V36, P321, DOI 10.1049/el:20000340; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Yu Y., 1992, IEEE PHOTONIC TECH L, V14, P1397	25	652	679	41	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					363	366		10.1126/science.1226528	http://dx.doi.org/10.1126/science.1226528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087243	Green Accepted			2022-12-28	WOS:000309955800036
J	Grebenev, SA; Lutovinov, AA; Tsygankov, SS; Winkler, C				Grebenev, S. A.; Lutovinov, A. A.; Tsygankov, S. S.; Winkler, C.			Hard-X-ray emission lines from the decay of Ti-44 in the remnant of supernova 1987A	NATURE			English	Article							SN 1987A; GALACTIC SUPERNOVA; SN-1987A; SPECTRUM; CASSIOPEIA; EJECTA; CO-57	It is assumed(1-3) that the radioactive decay of Ti-44 powers the infrared, optical and ultraviolet emission of supernova remnants after the complete decay of Co-56 and Co-57 (the isotopes that dominated the energy balance during the first three to four years after the explosion) until the beginning of active interaction of the ejecta with the surrounding matter. Simulations(4,5) show that the initial mass of Ti-44 synthesized in core-collapse supernovae is (0.02-2.5) x 10(-4) solar masses (M-circle dot). Hard X-rays and gamma-rays from the decay of this Ti-44 have been unambiguously observed from Cassiopeia A only(6-8), leading to the suggestion that values of the initial mass of Ti-44 near the upper bound of the predictions occur only in exceptional cases(9). For the remnant of supernova 1987A(10,11), an upper limit to the initial mass of Ti-44 of <10(-3)M(circle dot) has been obtained from direct X-ray observations(12), and an estimate of (1-2) x 10(-4)M(circle dot) has been made from infrared light curves and ultraviolet spectra by complex and model-dependent computations(13-15). Here we report observations of hard X-rays from the remnant of supernova 1987A in the narrow band containing two direct-escape lines of Ti-44 at 67.9 and 78.4 keV. The measured line fluxes imply that this decay provided sufficient energy to power the remnant at late times. We estimate that the initial mass of Ti-44 was (3.1 +/- 0.8) x 10(-4)M(circle dot), which is near the upper bound of theoretical predictions.	[Grebenev, S. A.; Lutovinov, A. A.; Tsygankov, S. S.] RAS, Space Res Inst, Moscow 117997, Russia; [Tsygankov, S. S.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Tsygankov, S. S.] Univ Turku, FINCA, FI-21500 Piikkio, Finland; [Tsygankov, S. S.] Univ Oulu, Astron Div, Dept Phys, FI-90014 Oulu, Finland; [Winkler, C.] European Space Agcy, Estec, NL-2200 AG Noordwijk, Netherlands	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Max Planck Society; University of Turku; University of Oulu; European Space Agency	Grebenev, SA (corresponding author), RAS, Space Res Inst, Profsoyuznaya 84-32, Moscow 117997, Russia.	sergei@hea.iki.rssi.ru	Grebenev, Sergei/L-4134-2019	Grebenev, Sergei/0000-0002-5501-4253	 [RFBR-11-02-12285ofi-m-2011];  [RAS-P20]	; 	We thank R. A. Sunyaev for reading the manuscript and for comments; V. S. Imshennik, D. K. Nadezhin and N. N. Chugai for discussions about aspects of the physics of the supernova 1987A explosion; R. A. Krivonos for information regarding the analysis of INTEGRAL/IBIS data; and M. Coe for allowing us access to his INTEGRAL data of the LMC observations (similar to 1 Ms) before the end of the proprietary period. This work is based on data obtained through the Russian and European INTEGRAL science data centres, and was supported by grants RFBR-11-02-12285ofi-m-2011 and RAS-P20 'The origin, structure and evolution of objects of the Universe'.	Ahmad I, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.065803; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Berezhko EG, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/58; Borkowski KJ, 2010, ASTROPHYS J LETT, V724, pL161, DOI 10.1088/2041-8205/724/2/L161; Chugai NN, 1997, ASTROPHYS J, V483, P925, DOI 10.1086/304253; Churazov E, 2011, MON NOT R ASTRON SOC, V411, P1727, DOI 10.1111/j.1365-2966.2010.17804.x; CLAYTON DD, 1992, ASTROPHYS J, V399, pL141, DOI 10.1086/186627; FRANSSON C, 1993, ASTROPHYS J, V408, pL25, DOI 10.1086/186822; Imshennik V. S., 1989, SOV SCI REV E, V8, P1; IYUDIN AF, 1994, ASTRON ASTROPHYS, V284, pL1; Iyudin AF, 1998, NATURE, V396, P142, DOI 10.1038/24106; Jerkstrand A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015937; Krivonos R, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200913814; Larsson J, 2011, NATURE, V474, P484, DOI 10.1038/nature10090; MATZ SM, 1988, NATURE, V331, P416, DOI 10.1038/331416a0; MEABURN J, 1995, ASTRON ASTROPHYS, V299, pL1; Park S, 2005, ASTROPHYS J, V634, pL73, DOI 10.1086/498848; Renaud M, 2006, ASTROPHYS J, V647, pL41, DOI 10.1086/507300; Shtykovskiy PE, 2005, ASTRON LETT+, V31, P258, DOI 10.1134/1.1896069; Sturm R, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913317; SUNTZEFF NB, 1992, ASTROPHYS J, V384, pL33, DOI 10.1086/186256; SUNYAEV R, 1987, NATURE, V330, P227, DOI 10.1038/330227a0; Sunyaev R. A., 1990, SOV ASTRON LETT, V16, P171; The LS, 2006, ASTRON ASTROPHYS, V450, P1037, DOI 10.1051/0004-6361:20054626; Thielemann FK, 1996, ASTROPHYS J, V460, P408, DOI 10.1086/176980; THIELEMANN FK, 1990, ASTROPHYS J, V349, P222, DOI 10.1086/168308; Vink J, 2001, ASTROPHYS J, V560, pL79, DOI 10.1086/324172; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; WOOSLEY SE, 1991, ASTROPHYS J, V368, pL31, DOI 10.1086/185941	29	88	89	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					373	375		10.1038/nature11473	http://dx.doi.org/10.1038/nature11473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075986	Green Submitted			2022-12-28	WOS:000309918500039
J	Beaglehole, R; Bonita, R; Horton, R; Ezzati, M; Bhala, N; Amuyunzu-Nyamongo, M; Mwatsama, M; Reddy, KS				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Ezzati, Majid; Bhala, Neeraj; Amuyunzu-Nyamongo, Mary; Mwatsama, Modi; Reddy, K. Srinath			Measuring progress on NCDs: one goal and five targets	LANCET			English	Editorial Material							CHRONIC DISEASES; CARDIOVASCULAR-DISEASE; INCOME COUNTRIES; MIDDLE-INCOME; PREVENTION; HEALTH; PROGRAMS; POLICIES; ALCOHOL; REDUCE		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1142, New Zealand; [Horton, Richard] The Lancet, London NW1 7BY, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Bhala, Neeraj] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Amuyunzu-Nyamongo, Mary] Consortium NCD Prevent & Control Sub Saharan Afri, Nairobi, Kenya; [Mwatsama, Modi] Natl Heart Forum, London, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of Auckland; Imperial College London; University of Birmingham; Public Health Foundation of India	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1142, New Zealand.			Reddy, K Srinath/0000-0003-3416-3548; Bhala, Neeraj/0000-0003-2502-1177	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abascal W, 2012, LANCET; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], SMOKEFREE 2025; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Joint WHO/FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases, 2002, DIET NUTRITION AND T; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacMahon S, 2005, LANCET, V365, P1108; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; Mehta S, 2014, EUR J PREV CARDIOL, V21, P192, DOI 10.1177/2047487312462150; Mendez D, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050147, DOI 10.1136/T0BACCOCONTROL-2011-050147]; Sadler K, 2011, NATIONAL DIET AND NU; UN General Assembly, 2011, UNITED NATIONS A 66; WHO, 2012, 65TH WORLD HEALTH AS; WHO, 2012, MONITORING FRAMEWORK; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	20	65	70	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1283	1285		10.1016/S0140-6736(12)61692-4	http://dx.doi.org/10.1016/S0140-6736(12)61692-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	23063272				2022-12-28	WOS:000309931400004
J	Ezenwa, VO; Gerardo, NM; Inouye, DW; Medina, M; Xavier, JB				Ezenwa, Vanessa O.; Gerardo, Nicole M.; Inouye, David W.; Medina, Monica; Xavier, Joao B.			Animal Behavior and the Microbiome	SCIENCE			English	Editorial Material							GUT MICROBIOTA; ACQUISITION; DIVERSITY		[Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA; [Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Inouye, David W.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Inouye, David W.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Xavier, Joao B.] Mem Sloan Kettering Canc Ctr, Program Computat Biol, New York, NY 10021 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University; University System of Maryland; University of Maryland College Park; University of California System; University of California Merced; Memorial Sloan Kettering Cancer Center	Ezenwa, VO (corresponding author), Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA.	ngerard@emory.edu	Inouye, David W./C-2997-2011; Xavier, Joao/H-5471-2011	Inouye, David W./0000-0003-2076-7834; Xavier, Joao/0000-0003-3592-1689	Direct For Biological Sciences [1146880] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1229439] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Boettcher KJ, 1996, J COMP PHYSIOL A, V179, P65; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618	16	301	315	11	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					198	199		10.1126/science.1227412	http://dx.doi.org/10.1126/science.1227412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066064				2022-12-28	WOS:000309712300024
J	Pass, HI; Levin, SM; Harbut, MR; Melamed, J; Chiriboga, L; Donington, J; Huflejt, M; Carbone, M; Chia, D; Goodglick, L; Goodman, GE; Thornquist, MD; Liu, G; de Perrot, M; Tsao, MS; Goparaju, C				Pass, Harvey I.; Levin, Stephen M.; Harbut, Michael R.; Melamed, Jonathan; Chiriboga, Luis; Donington, Jessica; Huflejt, Margaret; Carbone, Michele; Chia, David; Goodglick, Lee; Goodman, Gary E.; Thornquist, Mark D.; Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound; Goparaju, Chandra			Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTER METHYLATION; LUNG-CANCER; ASBESTOS EXPOSURE; IN-VIVO; EXPRESSION; EFEMP1; PROTEIN; FAMILY; GENE; PROGRESSION	BACKGROUND New biomarkers are needed to detect pleural mesothelioma at an earlier stage and to individualize treatment strategies. We investigated whether fibulin-3 in plasma and pleural effusions could meet sensitivity and specificity criteria for a robust biomarker. METHODS We measured fibulin-3 levels in plasma (from 92 patients with mesothelioma, 136 asbestos-exposed persons without cancer, 93 patients with effusions not due to mesothelioma, and 43 healthy controls), effusions (from 74 patients with mesothelioma, 39 with benign effusions, and 54 with malignant effusions not due to mesothelioma), or both. A blinded validation was subsequently performed. Tumor tissue was examined for fibulin-3 by immunohistochemical analysis, and levels of fibulin-3 in plasma and effusions were measured with an enzyme-linked immunosorbent assay. RESULTS Plasma fibulin-3 levels did not vary according to age, sex, duration of asbestos exposure, or degree of radiographic changes and were significantly higher in patients with pleural mesothelioma (105 +/- 7 ng per milliliter in the Detroit cohort and 113 +/- 8 ng per milliliter in the New York cohort) than in asbestos-exposed persons without mesothelioma (14 +/- 1 ng per milliliter and 24 +/- 1 ng per milliliter, respectively; P<0.001). Effusion fibulin-3 levels were significantly higher in patients with pleural mesothelioma (694 +/- 37 ng per milliliter in the Detroit cohort and 636 +/- 92 ng per milliliter in the New York cohort) than in patients with effusions not due to mesothelioma (212 +/- 25 and 151 +/- 23 ng per milliliter, respectively; P<0.001). Fibulin-3 preferentially stained tumor cells in 26 of 26 samples. In an overall comparison of patients with and those without mesothelioma, the receiver-operating-characteristic curve for plasma fibulin-3 levels had a sensitivity of 96.7% and a specificity of 95.5% at a cutoff value of 52.8 ng of fibulin-3 per milliliter. In a comparison of patients with early-stage mesothelioma with asbestos-exposed persons, the sensitivity was 100% and the specificity was 94.1% at a cutoff value of 46.0 ng of fibulin-3 per milliliter. Blinded validation revealed an area under the curve of 0.87 for plasma specimens from 96 asbestos-exposed persons as compared with 48 patients with mesothelioma. CONCLUSIONS Plasma fibulin-3 levels can distinguish healthy persons with exposure to asbestos from patients with mesothelioma. In conjunction with effusion fibulin-3 levels, plasma fibulin-3 levels can further differentiate mesothelioma effusions from other malignant and benign effusions. (Funded by the Early Detection Research Network, National Institutes of Health, and others.)	[Pass, Harvey I.; Donington, Jessica; Huflejt, Margaret; Goparaju, Chandra] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Melamed, Jonathan; Chiriboga, Luis] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Levin, Stephen M.] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [Harbut, Michael R.] Karmanos Canc Inst, Natl Ctr Vermiculite & Asbestos Related Canc, Detroit, MI USA; [Carbone, Michele] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Chia, David; Goodglick, Lee] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Goodman, Gary E.] Swedish Canc Inst, Seattle, WA USA; [Thornquist, Mark D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Univ Toronto, Toronto, ON, Canada; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Barbara Ann Karmanos Cancer Institute; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; Swedish Cancer Institute; Swedish Medical Center; Fred Hutchinson Cancer Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Pass, HI (corresponding author), NYU, Langone Med Ctr, Dept Cardiothorac Surg, 530 1st Ave,9V, New York, NY 10016 USA.	harvey.pass@med.nyu.edu	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Melamed, Jonathan/AAV-3769-2020	Tsao, Ming Sound/0000-0002-9160-5405; Melamed, Jonathan/0000-0003-2844-7990; Liu, Geoffrey/0000-0002-2603-7296; Huflejt, Malgorzata/0000-0002-2016-8367; Chiriboga, Luis/0000-0002-2028-6873; Pass, Harvey/0000-0003-3222-3471; de Perrot, Marc/0000-0003-2000-9427	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers [Local 793]; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care; Early Detection Research Network, National Institutes of Health [U01 CA-111295, U01 CA-113913]; NATIONAL CANCER INSTITUTE [U01CA113913, U01CA111295] Funding Source: NIH RePORTER	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Early Detection Research Network, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Princess Margaret Hospital Foundation and the Princess Margaret Hospital Mesothelioma Research Program (funded by the Masters Insulators Association of Ontario, International Association of Heat and Frost Insulators and Asbestos Workers, Local 793, and other unions, and the Imperial Oil Charitable Foundation) for plasma banking; by the M. Qasim Choksi Chair in Lung Cancer Translational Research (held by Dr. Tsao), the Alan B. Brown Chair in Molecular Genetics (held by Dr. Liu), and the Ontario Ministry of Health and Long-Term Care; and by donations from Belluck and Fox, the Simmons Foundation, Levi Phillips and Konigsberg, the Stephen E. Banner Fund for Lung Cancer Research, the Rosenwald Family, and the Anderson Family and grants from the Early Detection Research Network, National Institutes of Health, to the New York University Thoracic Oncology Research Laboratories (U01 CA-111295) and to Beth Israel Deaconess Medical Center (U01 CA-113913).	AISNER J, 1995, CHEST, V108, P1122; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Barnhart S, 1997, AM J IND MED, V32, P573, DOI 10.1002/(SICI)1097-0274(199712)32:6<573::AID-AJIM1>3.0.CO;2-R; Davidson B, 2011, J CELL MOL MED, V15, P535, DOI [10.1111/j.1582-4934.2010.01019.x, 10.1111/j.1582-4934.2010.01023.x]; Fiorelli A, 2011, INTERACT CARDIOV TH, V12, P420, DOI 10.1510/icvts.2010.250357; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hirayama N, 2011, RESP MED, V105, P137, DOI 10.1016/j.rmed.2010.10.010; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michaelides M, 2006, INVEST OPHTH VIS SCI, V47, P3085, DOI 10.1167/iovs.05-1600; Moore RM, 2009, PLACENTA, V30, P335, DOI 10.1016/j.placenta.2009.01.007; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Roberts HC, 2009, J THORAC ONCOL, V4, P620, DOI 10.1097/JTO.0b013e31819f2e0e; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Sasaki T, 1996, EUR J BIOCHEM, V240, P427, DOI 10.1111/j.1432-1033.1996.0427h.x; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Segade F, 2010, GENE, V464, P17, DOI 10.1016/j.gene.2010.05.003; SELIKOFF IJ, 1992, AM J IND MED, V22, P481, DOI 10.1002/ajim.4700220403; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	201	209	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1417	1427		10.1056/NEJMoa1115050	http://dx.doi.org/10.1056/NEJMoa1115050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050525	Green Accepted			2022-12-28	WOS:000309652700008
J	Tornqvist, B; Stromberg, C; Persson, G; Nilsson, M				Tornqvist, Bjorn; Stromberg, Cecilia; Persson, Gunnar; Nilsson, Magnus			Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEPATIC-ARTERY INJURY; LAPAROSCOPIC CHOLECYSTECTOMY; VOLUME; STRICTURES; LESIONS; LEAKS; RISK	Objectives To determine whether the routine use of intraoperative cholangiography can improve survival from complications related to bile duct injuries. Design Population based cohort study. Setting Prospectively collected data from the Swedish national registry of gallstone surgery and endoscopic retrograde cholangiopancreatography, GallRiks. Multivariate analysis done by Cox regression. Population All cholecystectomies recorded in GallRiks between 1 May 2005 and 31 December 2010. Main outcome measures Evidence of bile duct injury, rate of intended use of intraoperative cholangiography, and rate of survival after cholecytectomy. Results During the study, 51 041 cholecystectomies were registered in GallRiks and 747 (1.5%) iatrogenic bile duct injuries identified. Patients with bile duct injuries had an impaired survival compared with those without injury (mortality at one year 3.9% v 1.1%). Kaplan-Meier analysis showed that early detection of a bile duct injury, during the primary operation, improved survival. The intention to use intraoperative cholangiography reduced the risk of death after cholecystectomy by 62% (hazard ratio 0.38 (95% confidence interval 0.31 to 0.46)). Conclusions The high incidence of bile duct injury recorded is probably from GallRiks' ability to detect the entire range of injury severities, from minor ductal lesions to complete transections of major ducts. Patients with bile duct injury during cholecystectomy had impaired survival, and early detection of the injury improved survival. The intention to perform an intraoperative cholangiography reduced the risk of death after cholecystectomy.	[Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden; [Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Karolinska Inst, CLINTEC, Div Surg, SE-14186 Stockholm, Sweden; [Persson, Gunnar] Ryhov Hosp, Dept Surg, Jonkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tornqvist, B (corresponding author), Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden.	bjorn.tornqvist@karolinska.se		Nilsson, Magnus/0000-0002-6215-8132; Stromberg, Cecilia/0000-0003-0843-7920				Alves A, 2003, ANN SURG, V238, P93, DOI 10.1097/01.sla.0000074983.39297.c5; Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; Bektas H, 2007, BRIT J SURG, V94, P1119, DOI 10.1002/bjs.5752; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1016/S0039-6060(99)70152-2; Bismuth H, 2001, WORLD J SURG, V25, P1241, DOI 10.1007/s00268-001-0102-8; Connor S, 2006, BRIT J SURG, V93, P158, DOI 10.1002/bjs.5266; Dolan JP, 2005, SURG ENDOSC, V19, P967, DOI 10.1007/s00464-004-8942-6; Eisenstein S, 2008, ARCH SURG-CHICAGO, V143, P1178, DOI 10.1001/archsurg.143.12.1178; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; GOUMA DJ, 1994, J AM COLL SURGEONS, V178, P229; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lillemoe KD, 1997, ANN SURG, V225, P459, DOI 10.1097/00000658-199705000-00003; Murphy MM, 2010, J AM COLL SURGEONS, V211, P73, DOI 10.1016/j.jamcollsurg.2010.02.050; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Persson G, 2011, GALLRIKS ANN REPORT; Persson G, 2010, GALLRIKS ANN REPORT; Pinkas H, 2008, HEPATOB PANCREAT DIS, V7, P628; Richardson MC, 1996, BRIT J SURG, V83, P1356, DOI 10.1002/bjs.1800831009; Savader SJ, 1997, ANN SURG, V225, P268, DOI 10.1097/00000658-199703000-00005; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIEWERT JR, 1994, CHIRURG, V65, P748; Stewart L, 2004, J GASTROINTEST SURG, V8, P523, DOI 10.1016/j.gassur.2004.02.010; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Tornqvist B, 2009, CLIN GASTROENTEROL H, V7, P1013, DOI 10.1016/j.cgh.2009.05.014; Tzovaras G, 2001, HPB (Oxford), V3, P165, DOI 10.1080/136518201317077189; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207	29	132	135	3	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 11	2012	345								e6457	10.1136/bmj.e6457	http://dx.doi.org/10.1136/bmj.e6457			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TI	23060654	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000309907900001
J	Okun, MS				Okun, Michael S.			Deep-Brain Stimulation for Parkinson's Disease Reply	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							SUBTHALAMIC NUCLEUS		Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu		Okun, Michael/0000-0002-6247-9358				Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Merello M, 1999, CLIN NEUROPHARMACOL, V22, P273; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596	4	278	294	9	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					483	484		10.1056/NEJMct1208070	http://dx.doi.org/10.1056/NEJMct1208070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363512				2022-12-28	WOS:000314215400030
J	Okun, MS				Okun, Michael S.			Deep-Brain Stimulation for Parkinson's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIGH-FREQUENCY STIMULATION; SUBTHALAMIC NUCLEUS; MOVEMENT-DISORDERS; MEDICAL THERAPY; BASAL GANGLIA; COMPLICATIONS; HARDWARE; OUTCOMES; SURGERY	A 72-year-old right-handed man with a 12-year history of Parkinson's disease presents with a diminished response to medication and right-sided dyskinesia (involuntary movements). During the past several years, he has been taking multiple drugs for Parkinson's disease, including a monoamine oxidase inhibitor, amantadine, a dopamine agonist, and carbidopa-levodopa. He reports that with his current regimen, which includes 1.5 tablets of 25/100 carbidopa-levodopa taken every 2 hours, he has marked reductions in tremor, rigidity, and bradykinesia and substantial improvement in his walking. Despite multiple interval and dose adjustments, however, he also reports 6 hours per day of "off" time, when his symptoms are unresponsive to his current medication regimen. In addition, he has severe, disabling right-sided dyskinesia 4 hours per day. Symptoms affecting his left side are mild and not bothersome. His cognition is excellent, his neurologic examination is otherwise normal, and he has no other coexisting medical conditions. His neurologist refers him to a neurosurgeon for consideration of deep-brain stimulation.	[Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Dept Neurosurg, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), 3450 Hull Rd,4th Fl, Gainesville, FL 32607 USA.	okun@neurology.ufl.edu		Okun, Michael/0000-0002-6247-9358	National Parkinson Foundation; Michael J. Fox Foundation; Prime and PeerView Press	National Parkinson Foundation; Michael J. Fox Foundation; Prime and PeerView Press	Dr. Okun reports receiving consulting fees on behalf of himself and his institution from the National Parkinson Foundation, grant support from the Michael J. Fox Foundation and the National Parkinson Foundation, and support from Prime and PeerView Press for educational presentations.	Alberts JL, 2008, PARKINSONISM RELAT D, V14, P481, DOI 10.1016/j.parkreldis.2007.11.014; Alberts JL, 2008, EXP NEUROL, V214, P1, DOI 10.1016/j.expneurol.2008.07.019; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baumann Christian R, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS90, DOI 10.1016/S1353-8020(11)70029-3; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Coley E, 2009, BRIT J NEUROSURG, V23, P179, DOI 10.1080/02688690802673197; DELONG MR, 1984, CIBA F SYMP, V107, P64; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dodel RC, 1998, MOVEMENT DISORD, V13, P249, DOI 10.1002/mds.870130209; Dodel RC, 1997, NERVENARZT, V68, P978, DOI 10.1007/s001150050226; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Ellis TM, 2008, NEUROSURGERY, V63, P754, DOI 10.1227/01.NEU.0000325492.58799.35; Fahn S, 2000, ANN NEUROL, V47, pS2; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P173, DOI 10.1159/000338254; Fenoy AJ, 2012, J NEUROSURG, V116, P1324, DOI 10.3171/2012.1.JNS111798; Findley L, 2003, MOVEMENT DISORD, V18, P1139, DOI 10.1002/mds.10507; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Goetz CG, 2012, MOVEMENT DISORD, V27, P1239, DOI 10.1002/mds.25122; Hauser RA, 2006, CLIN NEUROPHARMACOL, V29, P322, DOI 10.1097/01.WNF.0000229546.81245.7F; Hooper AK, 2008, STEREOT FUNCT NEUROS, V86, P147, DOI 10.1159/000120426; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee KH, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046001; Lee KH, 2004, J NEUROSURG, V101, P511, DOI 10.3171/jns.2004.101.3.0511; Martikainen KK, 2006, MOVEMENT DISORD, V21, P2187, DOI 10.1002/mds.21171; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Meissner W, 2005, J NEUROL, V252, P218, DOI 10.1007/s00415-005-0640-3; Moro E, 2009, J NEUROL, V256, P83, DOI 10.1007/s00415-009-0069-1; Moum SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029768; Okun MS, 2008, PARKINSONISM RELAT D, V14, P532, DOI 10.1016/j.parkreldis.2008.01.001; Okun MS, 2007, GERIATRICS, V62, P18; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Okun MS, 2009, ARCH NEUROL-CHICAGO, V66, P778, DOI 10.1001/archneurol.2009.82; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Okun MS, 2005, ARCH NEUROL-CHICAGO, V62, P1250, DOI 10.1001/archneur.62.8.noc40425; Okun MS, 2004, NEUROLOGIST, V10, P290, DOI 10.1097/01.nrl.0000138737.97544.7c; Okun MS, 2004, NEUROLOGY, V63, P161, DOI 10.1212/01.WNL.0000133122.14824.25; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Rodriguez RL, 2007, NEUROLOGIST, V13, P253, DOI 10.1097/NRL.0b013e318095a4d5; Shukla AW, 2012, NEUROLOGY, V78, P1900, DOI 10.1212/WNL.0b013e318259e2af; Sillay KA, 2008, NEUROSURGERY, V62, P360, DOI 10.1227/01.neu.0000316002.03765.33; Taba HA, 2010, J NEUROSURG, V113, P1224, DOI 10.3171/2010.8.JNS10312; Tanner Caroline M., 2000, Current Opinion in Neurology, V13, P427, DOI 10.1097/00019052-200008000-00010; Tawfik VL, 2010, NEUROSURGERY, V67, P367, DOI 10.1227/01.NEU.0000371988.73620.4C; Temel Y, 2010, VITAM HORM, V82, P47, DOI 10.1016/S0083-6729(10)82003-5; Tomaszewski KJ, 2001, NEUROLOGY, V57, P663, DOI 10.1212/WNL.57.4.663; Vedam-Mai V, 2012, MOL PSYCHIATR, V17, P124, DOI 10.1038/mp.2011.61; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Weaver FM, 2012, NEUROLOGY, V79, P55, DOI 10.1212/WNL.0b013e31825dcdc1; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; WhettenGoldstein K, 1997, J AM GERIATR SOC, V45, P844, DOI 10.1111/j.1532-5415.1997.tb01512.x; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Willis AW, 2011, NEUROLOGY, V77, P851, DOI 10.1212/WNL.0b013e31822c9123; Zrinzo L, 2012, J NEUROSURG, V116, P84, DOI 10.3171/2011.8.JNS101407	61	278	294	9	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1529	1538		10.1056/NEJMct1208070	http://dx.doi.org/10.1056/NEJMct1208070			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SA	23363512				2022-12-28	WOS:000309904500010
